data_2jv6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jv6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 26.8 p90 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.055 0.455 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 104.03 6.36 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.26 144.06 42.36 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.184 2.193 . . . . 0.0 115.053 -176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 39.8 m -90.48 131.92 35.96 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.755 0.822 . . . . 0.0 109.005 160.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 78.8 p -133.41 3.6 3.62 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.73 158.5 20.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.515 1.052 . . . . 0.0 110.356 163.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.14 102.33 0.49 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.846 2.058 . . . . 0.0 112.132 -161.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.5 mtm -82.91 161.84 21.74 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.609 0.763 . . . . 0.0 112.166 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 92.2 p -147.36 163.26 37.01 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -84.11 126.52 33.16 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 161.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.02 -24.31 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.059 0.544 . . . . 0.0 110.235 163.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -145.23 126.3 14.62 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.132 2.173 . . . . 0.0 107.822 170.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -57.45 149.73 48.08 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.299 1.04 . . . . 0.0 112.099 173.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -57.32 136.74 78.04 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.263 1.975 . . . . 0.0 111.242 170.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 38.1 p -132.1 127.13 35.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.502 1.121 . . . . 0.0 111.017 171.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -56.32 117.39 3.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.451 1.5 . . . . 0.0 110.887 174.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 79.7 p -79.12 -12.27 59.99 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.169 0.987 . . . . 0.0 113.274 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.61 -8.16 1.22 Allowed Glycine 0 CA--C 1.539 1.538 0 CA-C-N 119.299 0.954 . . . . 0.0 114.468 -165.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -83.85 4.2 30.32 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.213 1.506 . . . . 0.0 111.706 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 99.48 4.18 56.17 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.858 1.694 . . . . 0.0 113.782 -172.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.8 p -127.18 165.14 20.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.512 1.156 . . . . 0.0 112.114 -168.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.11 112.14 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.494 1.517 . . . . 0.0 107.834 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.1 127.14 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.229 1.012 . . . . 0.0 112.952 -167.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -135.07 167.84 20.23 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.86 1.664 . . . . 0.0 113.263 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -125.16 135.38 52.57 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.062 1.345 . . . . 0.0 107.76 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.59 157.66 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.704 0.801 . . . . 0.0 112.062 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -132.75 145.99 51.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.503 1.521 . . . . 0.0 112.089 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.04 147.98 38.98 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 127.356 2.262 . . . . 0.0 107.354 163.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -109.37 -51.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 0 CA-C-N 122.923 2.08 . . . . 0.0 115.918 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 168.21 25.14 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.917 -1.115 . . . . 0.0 112.348 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.54 -0.17 3.16 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.578 2.037 . . . . 0.0 117.531 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.98 96.46 50.18 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.869 1.335 . . . . 0.0 112.961 -162.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.38 114.99 3.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.297 2.665 . . . . 0.0 108.82 152.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 13.6 p -160.63 146.0 14.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.26 104.36 13.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.295 1.838 . . . . 0.0 107.042 164.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.289 0.6 OUTLIER -68.06 118.73 61.49 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 119.42 -0.324 . . . . 0.0 110.944 -153.089 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.01 106.65 2.19 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.771 2.314 . . . . 0.0 112.147 -171.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 91.7 t -106.15 116.73 50.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 126.349 1.86 . . . . 0.0 109.686 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.42 160.8 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.093 1.357 . . . . 0.0 110.046 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . 0.462 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 60.0 t -143.73 128.13 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.8 175.8 9.42 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.575 0.75 . . . . 0.0 112.576 -164.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.446 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 64.2 m-20 -115.38 5.52 14.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.795 1.238 . . . . 0.0 111.949 171.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -132.85 6.56 3.99 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.33 1.852 . . . . 0.0 114.241 -159.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 40.1 mt 63.89 -6.34 0.25 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.382 2.273 . . . . 0.0 115.869 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.9 t -125.19 -7.17 7.09 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.606 1.548 . . . . 0.0 114.721 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 73.22 37.29 0.76 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.813 2.045 . . . . 0.0 113.028 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.78 -48.17 80.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 162.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 45.3 mm -75.03 152.53 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.219 1.008 . . . . 0.0 109.038 160.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.73 66.72 1.5 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.391 1.567 . . . . 0.0 109.682 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . 0.446 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 43.7 tttt -70.6 -62.68 1.3 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.393 2.277 . . . . 0.0 111.986 -161.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . 0.462 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -98.94 156.78 20.11 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.256 1.407 . . . . 0.0 115.757 -159.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.91 147.24 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.973 2.509 . . . . 0.0 109.51 -167.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.5 117.24 19.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.422 1.489 . . . . 0.0 108.877 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.2 t -79.62 -46.55 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.693 0.797 . . . . 0.0 110.622 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.3 t -95.12 179.56 5.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.819 0.848 . . . . 0.0 110.745 169.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 26.3 m -57.08 139.47 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.027 0.931 . . . . 0.0 111.039 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -77.26 112.7 25.16 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.548 -0.72 . . . . 0.0 109.636 168.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.6 175.01 11.78 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.936 2.424 . . . . 0.0 113.298 -171.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.66 121.98 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 126.822 2.049 . . . . 0.0 107.716 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.16 98.09 0.97 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.441 1.096 . . . . 0.0 109.578 168.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.1 t -98.9 -15.59 19.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.873 1.269 . . . . 0.0 112.573 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.23 133.62 55.88 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.927 1.691 . . . . 0.0 106.582 156.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -65.65 -16.98 64.26 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.604 -1.31 . . . . 0.0 114.093 -169.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -88.52 3.75 49.16 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.957 1.703 . . . . 0.0 113.584 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -53.05 135.61 36.88 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.717 -1.24 . . . . 0.0 113.313 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.21 146.7 52.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.542 1.537 . . . . 0.0 110.952 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.9 p -159.35 146.54 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -157.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.95 128.09 34.63 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.051 2.54 . . . . 0.0 110.053 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 13.8 mt -136.1 142.33 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.258 0.552 . . . . 0.0 109.767 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -114.54 140.67 48.57 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.692 1.197 . . . . 0.0 110.031 167.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.58 160.54 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.257 1.023 . . . . 0.0 111.448 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -132.38 104.28 13.54 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 126.146 1.778 . . . . 0.0 109.443 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.81 164.26 32.16 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.62 1.547 . . . . 0.0 109.985 159.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.5 -176.67 1.78 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.367 2.045 . . . . 0.0 110.347 160.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -57.23 149.27 20.32 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.526 -0.734 . . . . 0.0 111.096 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 89.4 -162.33 30.6 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 122.39 0.994 . . . . 0.0 115.292 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.33 158.64 33.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.663 1.985 . . . . 0.0 113.836 -167.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.5 m -169.28 161.0 9.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.38 1.472 . . . . 0.0 112.755 171.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -124.7 113.1 17.54 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.961 2.104 . . . . 0.0 106.879 161.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.6 mm -71.58 130.01 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.74 130.71 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.48 1.112 . . . . 0.0 109.375 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.2 104.08 14.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 125.474 1.509 . . . . 0.0 107.566 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 115.21 175.32 18.38 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 123.307 1.504 . . . . 0.0 116.383 170.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.34 161.13 34.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.267 2.227 . . . . 0.0 110.396 172.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.03 179.77 37.33 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.789 0.709 . . . . 0.0 112.751 -167.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.05 -25.72 46.08 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.216 -1.167 . . . . 0.0 112.321 172.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.3 m -58.41 -8.34 1.16 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 130.209 3.404 . . . . 0.0 117.337 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -85.79 149.89 24.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.323 0.965 . . . . 0.0 112.424 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 41.3 mt -119.22 166.87 12.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.969 0.908 . . . . 0.0 111.149 171.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 10.8 t -140.59 157.2 45.83 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 171.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -139.0 125.91 21.02 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.892 1.677 . . . . 0.0 109.522 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -70.64 131.49 44.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 111.897 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -144.22 126.69 15.9 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.825 0.85 . . . . 0.0 111.529 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 . . . . . 0 C--N 1.331 -0.205 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.266 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.4 p90 . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.31 104.8 8.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 160.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.3 ptm -65.9 149.82 49.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.892 1.677 . . . . 0.0 115.157 -173.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.7 m -99.7 143.13 30.29 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.526 1.13 . . . . 0.0 110.125 165.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.9 p -138.81 21.69 2.67 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -96.48 163.57 12.99 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.298 0.954 . . . . 0.0 110.606 165.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -66.3 105.03 1.32 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.231 2.212 . . . . 0.0 112.453 -159.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.6 mmt -70.61 160.27 32.86 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.001 0.92 . . . . 0.0 112.818 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 29.0 m -156.53 148.75 23.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.208 -0.932 . . . . 0.0 111.991 162.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.28 125.99 33.99 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 168.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.7 -27.62 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.629 0.772 . . . . 0.0 110.144 164.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -139.25 120.36 14.64 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.011 2.124 . . . . 0.0 107.706 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -56.74 154.3 18.6 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.933 0.893 . . . . 0.0 111.609 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -57.56 125.52 19.04 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.317 2.011 . . . . 0.0 111.115 166.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 8.0 p -130.16 129.16 43.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.038 0.935 . . . . 0.0 112.759 169.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -56.42 122.65 12.39 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.327 1.851 . . . . 0.0 111.562 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 82.2 p -78.07 -12.08 59.96 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.774 1.23 . . . . 0.0 113.191 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.66 -11.43 3.3 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.474 1.035 . . . . 0.0 113.796 -167.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -87.37 2.49 50.19 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.436 1.494 . . . . 0.0 112.239 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 101.52 9.72 43.15 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.241 1.401 . . . . 0.0 113.848 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.0 p -131.03 166.45 20.99 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.908 1.283 . . . . 0.0 112.12 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.64 120.38 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.75 2.02 . . . . 0.0 107.626 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.2 p -106.01 137.17 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.452 1.101 . . . . 0.0 112.655 -171.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -143.84 164.75 29.64 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.555 1.942 . . . . 0.0 113.45 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -123.87 127.0 47.39 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.136 1.774 . . . . 0.0 107.849 164.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.95 147.6 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.654 0.782 . . . . 0.0 111.695 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -124.62 144.11 50.35 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.539 1.935 . . . . 0.0 110.429 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.13 150.78 48.14 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.414 1.886 . . . . 0.0 107.943 163.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -110.03 -50.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 0 CA-C-N 122.203 1.822 . . . . 0.0 116.7 -165.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.89 169.21 19.61 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.049 1.295 . . . . 0.0 113.327 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.04 -15.62 0.08 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 128.182 2.801 . . . . 0.0 118.648 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -104.29 108.03 59.18 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 119.711 1.755 . . . . 0.0 113.822 -166.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.99 121.51 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.845 3.03 . . . . 0.0 109.904 155.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 8.1 p -162.77 149.42 12.85 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.36 108.45 16.56 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 161.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.296 0.5 OUTLIER -67.01 119.84 67.33 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.505 -153.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.53 114.32 3.68 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.141 2.561 . . . . 0.0 111.295 -171.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 52.4 t -116.18 114.48 46.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.365 1.466 . . . . 0.0 109.542 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.83 159.4 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.926 1.691 . . . . 0.0 108.835 -175.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.1 t -146.05 122.56 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.22 166.69 32.69 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -168.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -90.59 -5.33 56.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -114.87 6.15 15.35 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.618 1.567 . . . . 0.0 114.252 -160.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 25.4 mt 64.94 -7.96 0.25 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.25 2.22 . . . . 0.0 115.175 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.2 t -122.71 -12.07 8.13 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.191 1.359 . . . . 0.0 114.343 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 82.37 35.48 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.498 2.719 . . . . 0.0 113.261 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.68 67.32 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.093 0.557 . . . . 0.0 111.389 170.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.84 159.47 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.746 1.218 . . . . 0.0 108.227 162.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.12 123.46 16.96 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.328 -1.482 . . . . 0.0 110.903 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -128.2 -17.59 4.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -159.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -145.69 151.28 23.51 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -166.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.3 147.2 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.538 1.535 . . . . 0.0 111.921 -163.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.84 112.39 4.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.816 2.047 . . . . 0.0 109.399 171.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.49 -33.75 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.021 0.528 . . . . 0.0 110.938 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.1 t -96.61 179.27 5.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.035 0.934 . . . . 0.0 111.172 167.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.48 125.72 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.062 1.345 . . . . 0.0 110.662 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -66.69 113.37 12.69 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 118.427 0.558 . . . . 0.0 110.757 171.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.8 179.63 6.11 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.142 2.561 . . . . 0.0 113.781 -171.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.09 130.28 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 127.023 2.129 . . . . 0.0 108.038 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -78.45 96.76 5.46 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.852 1.261 . . . . 0.0 109.206 166.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -97.21 -18.64 19.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.55 1.14 . . . . 0.0 112.481 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.89 135.95 51.83 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 155.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -66.67 -14.24 62.23 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.774 -1.204 . . . . 0.0 113.913 -171.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -89.01 0.42 56.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.683 1.993 . . . . 0.0 113.499 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -53.89 138.27 36.8 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.612 1.196 . . . . 0.0 113.079 -172.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.42 142.05 49.11 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.921 1.288 . . . . 0.0 111.053 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.4 p -154.93 145.48 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -158.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.26 126.29 30.72 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.101 2.96 . . . . 0.0 110.563 173.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.61 137.14 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.248 0.619 . . . . 0.0 110.757 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -107.17 140.29 40.27 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.849 1.26 . . . . 0.0 111.019 161.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.23 158.34 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.249 1.02 . . . . 0.0 112.702 171.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -111.27 114.32 53.41 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.362 1.865 . . . . 0.0 110.526 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -76.82 174.02 13.53 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 124.063 3.175 . . . . 0.0 111.182 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.54 -174.4 2.25 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.4 2.067 . . . . 0.0 110.463 159.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -67.5 146.01 54.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 154.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 84.8 -159.85 34.93 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 122.043 0.802 . . . . 0.0 114.752 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.48 157.39 30.47 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.911 2.084 . . . . 0.0 113.994 -166.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.0 m -170.57 171.91 6.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.431 1.892 . . . . 0.0 112.051 170.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.34 125.83 46.78 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 126.801 2.04 . . . . 0.0 108.314 158.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.2 mm -77.65 119.78 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.5 mt -111.24 128.37 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.317 1.447 . . . . 0.0 109.819 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 66.6 t -116.19 107.47 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.466 1.907 . . . . 0.0 108.189 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.25 177.78 24.25 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 122.449 1.027 . . . . 0.0 114.94 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.48 169.82 16.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.213 1.805 . . . . 0.0 111.382 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 83.86 -157.39 33.93 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.922 0.772 . . . . 0.0 112.345 -172.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -72.9 -33.08 65.79 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.555 -0.968 . . . . 0.0 110.975 163.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 28.6 m -59.87 -6.96 1.44 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 130.005 3.322 . . . . 0.0 117.741 -173.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -80.25 153.73 28.33 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.876 1.27 . . . . 0.0 111.467 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 46.0 mt -121.48 165.24 15.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.382 0.673 . . . . 0.0 110.464 170.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.1 t -150.42 160.54 43.68 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -140.82 124.93 17.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.036 1.734 . . . . 0.0 110.077 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -67.77 133.44 49.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.035 1.334 . . . . 0.0 111.711 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -133.11 152.5 51.95 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.165 0.986 . . . . 0.0 111.545 170.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 . . . . . 0 C--N 1.332 -0.189 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 173.758 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.4 p90 . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.49 100.01 1.04 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 160.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.02 136.53 56.3 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.517 1.927 . . . . 0.0 113.888 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 22.1 m -87.53 135.41 33.36 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 153.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 68.3 p -138.12 -0.89 2.0 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 174.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.64 166.63 20.32 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 120.101 1.319 . . . . 0.0 110.498 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -67.08 101.03 0.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.713 1.605 . . . . 0.0 112.438 -165.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' MET . . . . . 0.47 ' HE3' ' H ' ' A' ' 380' ' ' THR . 37.9 mtm -90.51 165.07 13.99 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.778 1.231 . . . . 0.0 111.837 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.0 m -161.28 161.01 30.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.148 -0.97 . . . . 0.0 112.491 167.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.7 125.54 29.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.982 0.513 . . . . 0.0 109.952 161.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 81.2 t -76.9 -25.56 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.436 1.494 . . . . 0.0 110.677 165.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -137.61 131.24 31.29 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.191 1.796 . . . . 0.0 107.925 164.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -59.9 151.39 64.67 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.097 0.559 . . . . 0.0 111.858 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -55.74 130.21 39.17 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.383 2.056 . . . . 0.0 111.498 166.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 16.5 p -120.5 125.0 46.76 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.506 1.522 . . . . 0.0 110.629 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -55.75 118.07 4.22 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.567 1.147 . . . . 0.0 110.067 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.3 p -79.53 -16.38 56.08 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 60.31 -0.39 0.94 Allowed Glycine 0 CA--C 1.539 1.581 0 CA-C-N 119.467 1.03 . . . . 0.0 115.057 -161.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -86.46 18.15 3.43 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.284 1.542 . . . . 0.0 110.652 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.34 -2.84 87.94 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.771 1.177 . . . . 0.0 114.1 -168.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 25.0 p -122.47 175.37 6.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.043 1.421 . . . . 0.0 113.608 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.7 125.11 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 127.043 2.137 . . . . 0.0 107.938 172.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.84 131.72 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.903 1.281 . . . . 0.0 113.531 -169.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -140.73 169.37 17.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.7 2.0 . . . . 0.0 113.526 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.27 135.73 52.81 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.361 1.064 . . . . 0.0 108.411 164.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.95 152.77 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.247 1.019 . . . . 0.0 112.412 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -137.53 150.94 47.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.685 1.194 . . . . 0.0 113.008 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.2 t -119.66 141.13 30.5 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 128.243 2.617 . . . . 0.0 107.947 169.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -97.4 -67.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.88 2.387 . . . . 0.0 115.313 -174.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 174.87 10.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.88 1.272 . . . . 0.0 112.881 -173.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.9 -12.43 0.81 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.504 2.002 . . . . 0.0 117.712 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -123.58 96.62 43.23 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 119.525 1.663 . . . . 0.0 113.797 -160.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.81 120.5 6.43 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.84 1.693 . . . . 0.0 109.084 155.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.7 p -162.62 150.62 14.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -171.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -83.8 97.36 9.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.535 1.534 . . . . 0.0 107.265 162.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.252 1.2 pp -58.1 112.11 4.42 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.578 0.751 . . . . 0.0 111.87 -159.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.29 117.1 4.95 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.706 2.271 . . . . 0.0 112.991 -170.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 88.0 t -120.4 120.59 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 126.2 1.8 . . . . 0.0 108.765 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.26 160.01 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.035 1.734 . . . . 0.0 109.454 -175.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 3.9 t -138.53 113.62 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.82 -176.83 4.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.697 0.799 . . . . 0.0 112.163 -168.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.456 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 70.7 m-20 -115.74 6.59 14.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.325 1.05 . . . . 0.0 112.194 171.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -131.87 1.48 3.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -152.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 16.1 mt 64.48 0.11 1.02 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.304 2.242 . . . . 0.0 115.198 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.5 t -135.84 -6.16 2.16 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -170.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 57.54 48.29 14.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.552 1.941 . . . . 0.0 113.645 -174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.78 66.28 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.102 0.561 . . . . 0.0 110.012 159.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 8.9 mm -101.99 147.15 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 126.054 1.741 . . . . 0.0 108.479 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -126.05 108.35 11.29 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.431 -0.793 . . . . 0.0 111.847 163.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . 0.456 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 3.1 mmmm -66.4 -69.83 0.28 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 128.352 2.661 . . . . 0.0 111.425 172.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -100.33 169.32 21.51 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 -160.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.2 mp -115.82 154.99 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 128.0 2.52 . . . . 0.0 110.193 -169.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.47 134.94 40.71 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.115 0.966 . . . . 0.0 109.931 168.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.88 -47.08 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.382 0.673 . . . . 0.0 110.944 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.6 t -92.42 172.57 8.3 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.652 0.739 . . . . 0.0 111.647 168.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.2 m -66.64 126.36 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.118 1.367 . . . . 0.0 112.667 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.04 126.59 64.93 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.978 1.311 . . . . 0.0 110.099 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -80.98 -172.54 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.027 3.152 . . . . 0.0 112.926 -173.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.08 119.22 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 127.112 2.165 . . . . 0.0 107.451 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.78 90.16 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.377 1.071 . . . . 0.0 110.685 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 10.7 t -73.92 -37.94 64.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.733 -0.604 . . . . 0.0 110.247 159.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 39.7 p -102.37 123.46 46.2 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.389 1.875 . . . . 0.0 109.192 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -54.73 -19.8 7.03 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.9 5.98 8.6 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.605 1.562 . . . . 0.0 113.708 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -43.67 134.28 4.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.529 1.932 . . . . 0.0 114.203 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -150.88 129.62 12.36 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.846 1.658 . . . . 0.0 110.067 -167.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.3 p -154.16 145.77 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -166.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -78.68 123.03 26.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.484 2.714 . . . . 0.0 109.473 165.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 40.6 mt -129.16 144.21 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 118.464 0.574 . . . . 0.0 111.519 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -118.9 140.38 50.08 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.649 1.58 . . . . 0.0 110.947 164.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.2 160.46 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.074 1.35 . . . . 0.0 111.515 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -130.95 98.58 18.98 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.697 1.999 . . . . 0.0 109.788 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.17 166.65 16.32 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.33 2.687 . . . . 0.0 111.375 162.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.77 175.07 7.71 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.885 2.39 . . . . 0.0 110.857 163.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.82 154.35 30.18 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.842 -0.536 . . . . 0.0 111.04 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 91.03 -163.25 29.15 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 121.404 0.447 . . . . 0.0 113.24 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -66.03 157.12 31.79 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -168.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 20.5 m -168.03 164.62 13.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.061 1.744 . . . . 0.0 112.086 168.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -128.25 111.45 13.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.887 2.875 . . . . 0.0 107.543 166.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 1.8 mm -74.37 124.38 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 79.9 mt -113.58 129.83 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.835 1.254 . . . . 0.0 108.91 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.65 109.38 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 125.282 1.433 . . . . 0.0 107.863 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 107.52 177.89 22.48 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 123.363 1.535 . . . . 0.0 115.747 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' THR . . . . . 0.47 ' H ' ' HE3' ' A' ' 304' ' ' MET . 0.8 OUTLIER -133.4 163.93 28.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 127.669 2.387 . . . . 0.0 110.78 172.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.54 -179.97 36.05 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.199 0.428 . . . . 0.0 112.241 -166.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -56.81 -27.38 59.87 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.279 1.031 . . . . 0.0 112.375 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 46.6 m -58.95 -7.61 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.567 3.147 . . . . 0.0 116.651 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -81.15 149.07 29.28 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.503 1.121 . . . . 0.0 112.299 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 27.6 mt -118.69 165.22 14.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.957 0.903 . . . . 0.0 111.315 171.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.6 t -148.49 162.12 40.26 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -144.24 127.75 16.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.872 2.069 . . . . 0.0 110.14 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -75.21 135.83 41.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.817 1.647 . . . . 0.0 112.548 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -134.38 157.2 47.02 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.631 1.173 . . . . 0.0 111.763 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 . . . . . 0 CA--C 1.535 0.383 0 C-N-CA 125.844 1.657 . . . . 0.0 106.922 173.183 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.7 p90 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -73.28 101.68 3.47 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 164.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -82.11 165.91 20.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.54 1.536 . . . . 0.0 113.679 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.7 m -101.6 152.49 20.75 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.523 1.529 . . . . 0.0 109.86 167.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.7 p -142.67 6.44 1.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.461 ' CG ' ' HZ1' ' A' ' 326' ' ' LYS . 44.9 t0 -71.47 160.92 31.87 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.096 1.316 . . . . 0.0 110.966 165.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.06 97.01 0.05 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.212 1.405 . . . . 0.0 112.39 -171.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 34.2 mtm -84.99 169.0 14.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.021 1.328 . . . . 0.0 111.708 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.1 m -159.78 158.37 31.04 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.176 -0.953 . . . . 0.0 112.515 170.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.12 123.56 28.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.554 0.742 . . . . 0.0 110.111 161.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.68 -25.03 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.514 1.126 . . . . 0.0 110.574 165.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -141.88 137.75 31.6 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.685 1.994 . . . . 0.0 109.16 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -62.9 143.99 97.07 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.994 1.317 . . . . 0.0 112.989 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -54.64 124.8 17.08 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.52 2.813 . . . . 0.0 112.542 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 10.2 p -123.53 130.07 52.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.132 1.373 . . . . 0.0 111.802 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -57.83 123.27 15.19 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.846 0.858 . . . . 0.0 111.005 171.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 26.8 p -80.64 -11.72 59.6 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.841 1.256 . . . . 0.0 113.085 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 84.0 -11.16 58.34 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.863 1.221 . . . . 0.0 114.341 -169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -92.59 10.13 31.75 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.176 1.488 . . . . 0.0 112.509 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.47 13.19 71.1 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.848 0.737 . . . . 0.0 113.216 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 11.6 p -124.63 153.76 41.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.964 1.306 . . . . 0.0 110.959 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 26.0 t -128.48 118.16 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.869 1.668 . . . . 0.0 107.94 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.04 133.8 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.069 1.348 . . . . 0.0 113.299 -163.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 7.0 ptp -137.53 165.51 26.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.84 2.056 . . . . 0.0 112.023 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -115.69 133.96 55.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 163.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 6.8 m -136.41 149.01 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.543 1.137 . . . . 0.0 112.213 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -132.92 149.52 52.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.939 1.696 . . . . 0.0 112.621 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.1 151.93 51.33 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 127.644 2.378 . . . . 0.0 108.796 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -103.05 -76.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 123.255 2.637 . . . . 0.0 115.127 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.461 ' HZ1' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -138.65 165.12 27.75 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 121.221 1.828 . . . . 0.0 114.465 -177.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 70.89 15.59 74.04 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.255 0.931 . . . . 0.0 114.946 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.57 87.1 56.89 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 112.44 -164.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -79.74 114.31 3.18 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.028 2.485 . . . . 0.0 108.974 159.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.4 p -163.02 155.23 18.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -171.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -79.12 109.02 13.05 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 154.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.271 1.1 pp -64.34 122.96 81.06 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.993 -162.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.63 106.16 2.14 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.449 3.433 . . . . 0.0 113.334 -163.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 72.2 t -116.16 118.04 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.36 1.864 . . . . 0.0 109.844 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.47 158.65 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.934 1.294 . . . . 0.0 110.837 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 37.0 t -135.14 123.55 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.76 170.25 16.24 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -105.09 3.83 30.82 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.989 1.316 . . . . 0.0 112.039 169.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -129.4 10.75 5.76 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.732 1.613 . . . . 0.0 114.761 -161.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 46.9 mt 63.48 -10.83 0.11 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.692 2.397 . . . . 0.0 116.344 -175.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.5 t -127.93 -6.94 5.53 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.934 1.697 . . . . 0.0 114.594 -171.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.98 42.61 7.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.736 2.015 . . . . 0.0 112.87 -170.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -61.15 -31.27 70.99 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.726 159.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 7.9 mt -117.93 128.98 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 127.909 2.483 . . . . 0.0 107.199 167.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -95.52 108.57 20.83 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.192 0.905 . . . . 0.0 110.32 164.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -66.24 -57.85 6.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.791 2.036 . . . . 0.0 111.947 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -111.34 -177.46 20.35 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 -159.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.05 152.77 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.336 1.454 . . . . 0.0 111.438 -172.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.36 130.12 35.13 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.568 1.147 . . . . 0.0 109.51 169.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.79 -53.41 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 117.891 0.314 . . . . 0.0 111.032 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.2 m -83.66 153.19 24.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.923 0.889 . . . . 0.0 110.393 168.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 6.0 m -53.1 117.36 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.362 2.265 . . . . 0.0 114.989 -173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -82.79 118.85 73.11 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.763 1.225 . . . . 0.0 110.321 168.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.49 -177.32 3.78 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.549 3.5 . . . . 0.0 113.423 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.33 112.74 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.27 1.428 . . . . 0.0 107.223 167.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.2 85.23 0.37 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.15 1.38 . . . . 0.0 110.782 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 34.8 t -66.4 -58.6 4.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.936 0.494 . . . . 0.0 109.745 166.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 25.2 p -78.91 122.88 26.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.098 1.359 . . . . 0.0 109.963 163.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -62.54 -21.85 65.86 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.04 4.06 4.73 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.963 1.305 . . . . 0.0 113.519 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -42.32 129.4 3.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.72 2.008 . . . . 0.0 113.171 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.98 128.37 20.01 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.943 1.297 . . . . 0.0 110.309 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.2 p -149.29 150.79 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.583 0.706 . . . . 0.0 112.625 -159.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -89.12 121.74 31.74 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.298 2.639 . . . . 0.0 109.35 171.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 43.8 mt -135.31 146.86 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.444 0.698 . . . . 0.0 111.516 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -111.97 143.34 43.12 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.004 1.722 . . . . 0.0 111.624 167.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.78 149.15 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 123.513 0.725 . . . . 0.0 111.424 164.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -97.76 110.2 54.29 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.27 1.428 . . . . 0.0 109.466 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.8 126.03 6.37 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.979 2.452 . . . . 0.0 110.225 164.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.1 167.22 2.59 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.369 2.046 . . . . 0.0 111.444 155.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -60.26 155.79 16.91 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.429 0.633 . . . . 0.0 112.62 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.95 -169.88 39.03 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 123.007 1.337 . . . . 0.0 113.914 -173.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.57 163.01 9.55 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.151 1.78 . . . . 0.0 113.775 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 35.9 m -164.07 148.8 10.22 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.637 -1.289 . . . . 0.0 113.231 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -113.11 111.08 21.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.422 2.289 . . . . 0.0 106.87 161.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.4 mm -74.77 120.49 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 32.0 mt -117.7 126.59 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 122.273 1.035 . . . . 0.0 109.405 -171.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 54.9 t -118.02 99.29 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 127.361 2.265 . . . . 0.0 107.217 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 118.73 170.54 14.8 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 122.981 1.323 . . . . 0.0 115.502 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.49 165.55 24.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.514 2.326 . . . . 0.0 109.556 166.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.28 -172.66 55.11 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 123.211 0.434 . . . . 0.0 112.163 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -60.35 -32.3 71.13 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.324 -1.104 . . . . 0.0 111.708 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.9 m -56.58 -4.3 0.15 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 130.338 3.455 . . . . 0.0 117.782 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -86.96 144.09 27.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.129 0.877 . . . . 0.0 111.816 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.99 165.94 11.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.884 0.873 . . . . 0.0 110.142 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.2 t -146.97 158.71 44.0 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 169.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -139.92 131.51 27.16 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.642 1.977 . . . . 0.0 108.63 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.68 141.3 32.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.764 1.226 . . . . 0.0 111.739 -171.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -140.0 146.92 39.69 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.162 1.385 . . . . 0.0 109.578 170.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.714 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.5 p90 . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.053 0.454 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 112.05 23.83 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.186 1.794 . . . . 0.0 107.072 165.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -61.08 142.67 56.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.975 1.71 . . . . 0.0 115.054 -174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 4.5 m -94.8 148.77 21.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.818 0.847 . . . . 0.0 109.013 156.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.1 p -137.11 1.42 2.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -77.92 163.11 26.3 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.677 1.126 . . . . 0.0 110.958 168.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.44 98.81 0.51 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.148 1.779 . . . . 0.0 112.096 -164.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 32.5 mtm -84.54 166.29 17.33 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.736 1.214 . . . . 0.0 112.23 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.7 m -161.81 162.7 29.55 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.149 -0.969 . . . . 0.0 112.255 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.36 117.0 24.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.07 0.948 . . . . 0.0 110.602 164.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 74.7 t -68.25 -30.16 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.595 1.558 . . . . 0.0 110.684 167.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -136.16 118.37 15.54 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.165 1.786 . . . . 0.0 107.575 170.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -52.74 144.61 24.81 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.216 1.006 . . . . 0.0 111.24 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.09 130.78 37.95 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.325 1.35 . . . . 0.0 111.878 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.3 p -130.69 130.74 44.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.277 1.431 . . . . 0.0 111.2 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.4 140.21 58.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.735 1.214 . . . . 0.0 112.61 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 39.4 p -95.79 -9.85 30.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.851 1.26 . . . . 0.0 113.996 -174.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 68.11 -2.78 6.37 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 119.283 0.947 . . . . 0.0 115.231 -167.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -97.06 19.14 13.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.009 1.405 . . . . 0.0 111.43 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.02 0.43 88.97 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.817 1.199 . . . . 0.0 113.788 -171.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 22.3 p -121.76 169.75 10.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.526 1.163 . . . . 0.0 112.547 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.8 t -140.63 124.5 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.23 1.812 . . . . 0.0 108.287 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.82 134.16 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.665 1.186 . . . . 0.0 112.308 -170.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -142.57 168.7 19.11 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.583 1.953 . . . . 0.0 113.062 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -122.42 131.93 54.11 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.182 1.393 . . . . 0.0 107.932 164.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.58 153.27 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.057 0.943 . . . . 0.0 111.582 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -136.98 146.22 45.1 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.426 1.49 . . . . 0.0 112.89 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.27 149.91 42.22 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 128.483 2.713 . . . . 0.0 107.735 164.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -107.04 -57.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.354 2.036 . . . . 0.0 115.594 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.22 170.68 15.29 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.949 -1.094 . . . . 0.0 112.966 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 69.21 -3.81 7.03 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.292 1.901 . . . . 0.0 117.718 168.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.97 99.59 41.02 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 119.248 1.524 . . . . 0.0 113.579 -163.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.07 112.27 2.56 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.67 2.913 . . . . 0.0 109.417 157.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.2 p -157.61 155.48 30.18 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -87.65 93.36 9.41 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.793 2.037 . . . . 0.0 106.695 162.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.254 1.4 pp -56.93 111.69 3.65 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.526 0.73 . . . . 0.0 112.456 -155.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.34 115.75 3.06 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.096 2.531 . . . . 0.0 114.197 -167.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 82.0 t -122.73 109.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.317 1.447 . . . . 0.0 109.71 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.93 162.77 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.663 1.585 . . . . 0.0 109.519 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.65 127.08 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -140.27 168.8 18.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.495 0.589 . . . . 0.0 112.352 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -102.13 -2.92 28.37 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.005 0.922 . . . . 0.0 111.851 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -106.07 0.49 25.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.582 1.953 . . . . 0.0 114.558 -168.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 34.4 mt 61.4 0.7 0.47 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.324 2.249 . . . . 0.0 115.967 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.1 t -127.99 -2.44 5.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.238 1.381 . . . . 0.0 114.515 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.55 45.04 6.48 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.802 2.441 . . . . 0.0 113.209 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.86 -33.7 76.17 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 119.646 -0.216 . . . . 0.0 111.231 164.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 33.3 mt -131.9 117.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.346 1.458 . . . . 0.0 110.215 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -80.1 104.26 10.55 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.367 -0.833 . . . . 0.0 112.773 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -66.34 -56.09 12.8 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.585 2.354 . . . . 0.0 112.943 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -115.77 169.76 13.06 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 116.914 1.525 . . . . 0.0 116.914 -159.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.87 155.24 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.096 2.158 . . . . 0.0 111.863 -165.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.12 123.68 32.43 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.558 1.543 . . . . 0.0 108.723 166.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 93.3 t -89.47 -34.97 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.0 0.52 . . . . 0.0 111.446 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.0 t -113.3 175.12 5.58 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.213 1.005 . . . . 0.0 112.209 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.6 m -65.26 101.8 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.76 1.624 . . . . 0.0 112.474 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -63.09 125.31 86.59 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.854 165.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -82.09 -177.25 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.536 3.491 . . . . 0.0 114.007 -169.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.11 114.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 127.236 2.214 . . . . 0.0 107.674 171.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.86 75.39 0.11 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.837 1.655 . . . . 0.0 112.892 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -66.73 -11.46 54.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 169.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 31.5 p -134.52 127.34 31.16 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 127.846 2.458 . . . . 0.0 106.575 165.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -62.24 -15.29 46.1 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -170.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.79 5.98 10.08 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.237 1.815 . . . . 0.0 113.552 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -39.22 119.12 0.87 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 127.314 2.245 . . . . 0.0 113.584 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.57 144.59 50.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.057 0.943 . . . . 0.0 111.613 170.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.71 142.59 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -161.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.59 120.4 19.14 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.692 2.397 . . . . 0.0 109.455 165.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 48.0 mt -131.46 131.77 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.284 0.564 . . . . 0.0 110.732 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -96.51 139.8 32.07 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.989 0.916 . . . . 0.0 111.052 158.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.15 160.72 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.323 1.449 . . . . 0.0 110.957 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -125.41 92.87 46.09 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.068 1.747 . . . . 0.0 109.487 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.08 140.78 20.3 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.481 2.121 . . . . 0.0 109.987 160.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.35 179.93 3.65 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.812 2.341 . . . . 0.0 111.706 168.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -59.33 160.14 7.02 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.355 1.062 . . . . 0.0 113.444 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 86.83 -145.41 20.03 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.094 0.378 . . . . 0.0 112.193 -170.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -93.91 169.21 10.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.318 1.047 . . . . 0.0 113.653 -173.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 29.7 m -164.94 160.7 19.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.868 1.267 . . . . 0.0 112.423 168.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -129.05 109.4 11.16 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.636 1.974 . . . . 0.0 107.017 163.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.28 128.78 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 91.7 mt -119.42 125.65 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.122 1.369 . . . . 0.0 108.734 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.5 104.39 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.525 1.53 . . . . 0.0 108.02 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.32 -179.62 20.98 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 123.363 1.535 . . . . 0.0 116.644 171.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.95 170.0 16.82 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.581 2.752 . . . . 0.0 110.027 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 82.69 -158.6 37.32 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -168.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -72.82 -35.74 67.37 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.702 -0.881 . . . . 0.0 111.037 163.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.4 m -52.14 6.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 1 C-N-CA 132.202 4.201 . . . . 0.0 119.198 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.53 138.15 37.02 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.923 1.289 . . . . 0.0 111.808 -169.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.7 mt -107.76 166.55 10.61 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.027 0.531 . . . . 0.0 110.814 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.8 t -142.57 158.18 43.94 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 171.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -141.08 130.78 24.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.811 1.244 . . . . 0.0 110.948 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -64.41 137.13 57.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.439 2.296 . . . . 0.0 112.668 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -138.92 154.1 48.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.469 1.128 . . . . 0.0 113.012 163.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 126.86 2.064 . . . . 0.0 106.221 177.671 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 2.5 p90 . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 100.11 0.74 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 161.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 158.97 30.21 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.714 1.206 . . . . 0.0 114.08 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.4 m -105.71 137.63 43.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.709 1.204 . . . . 0.0 109.401 167.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.6 p -132.3 7.87 4.27 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -82.35 163.48 21.71 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.401 1.001 . . . . 0.0 110.735 165.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -62.22 109.04 1.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.613 1.965 . . . . 0.0 111.584 -165.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 15.1 mmt -72.99 159.27 33.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.769 0.795 . . . . 0.0 112.729 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.5 p -150.8 150.78 31.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.2 1.0 . . . . 0.0 111.134 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.3 119.44 35.83 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.651 0.78 . . . . 0.0 109.074 163.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -25.28 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.869 0.868 . . . . 0.0 110.425 165.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -142.31 127.84 19.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.911 2.084 . . . . 0.0 108.49 168.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -60.61 144.31 89.25 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.503 1.121 . . . . 0.0 111.443 171.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -54.79 136.57 72.2 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.22 1.947 . . . . 0.0 111.285 173.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 64.5 p -134.87 126.17 28.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.316 1.046 . . . . 0.0 111.198 171.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -55.76 119.18 5.34 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.327 1.451 . . . . 0.0 110.823 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 65.1 p -80.72 -12.59 59.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.906 0.883 . . . . 0.0 112.975 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.83 -7.49 1.54 Allowed Glycine 0 CA--C 1.538 1.494 0 CA-C-O 119.073 -0.848 . . . . 0.0 114.456 -166.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -81.77 2.66 28.97 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.352 1.576 . . . . 0.0 111.965 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.82 9.61 54.11 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.246 1.403 . . . . 0.0 113.677 -170.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.9 p -131.84 165.96 22.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.887 1.275 . . . . 0.0 112.874 -172.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.32 117.99 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.542 2.337 . . . . 0.0 107.152 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.0 p -102.45 132.08 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.586 0.755 . . . . 0.0 112.508 -174.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -137.59 165.29 26.68 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.853 1.661 . . . . 0.0 112.82 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.18 128.24 48.06 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.525 1.53 . . . . 0.0 107.177 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.93 148.45 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.666 0.787 . . . . 0.0 112.005 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -137.12 134.43 36.41 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.592 1.557 . . . . 0.0 112.114 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 m -98.86 159.26 30.74 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.995 1.718 . . . . 0.0 110.735 164.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -112.56 -55.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.886 2.391 . . . . 0.0 116.146 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 172.12 13.68 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.713 1.142 . . . . 0.0 113.139 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.11 -21.12 0.16 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 127.776 2.607 . . . . 0.0 118.291 168.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.39 107.86 56.91 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 119.366 1.583 . . . . 0.0 113.332 -165.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.57 125.91 5.8 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.996 2.464 . . . . 0.0 109.366 152.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 10.7 p -161.85 148.02 13.69 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.78 107.08 15.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.228 1.811 . . . . 0.0 106.635 163.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.284 0.6 OUTLIER -68.31 128.7 93.11 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.03 -153.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.97 109.48 2.89 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.117 3.211 . . . . 0.0 112.014 -172.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 93.5 t -111.18 108.89 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.861 1.665 . . . . 0.0 110.255 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.71 157.86 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 125.2 1.4 . . . . 0.0 110.019 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.6 t -144.48 125.54 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -149.59 170.18 19.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.098 0.559 . . . . 0.0 112.436 -170.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.453 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 18.8 m-20 -89.68 -1.09 57.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.434 1.094 . . . . 0.0 113.293 174.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -127.47 1.2 6.26 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -152.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.9 mt 61.8 -1.39 0.35 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.151 2.181 . . . . 0.0 115.392 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.7 t -129.91 -7.66 4.46 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -171.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.4 49.23 4.23 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.908 2.083 . . . . 0.0 114.096 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -78.24 -38.03 43.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.834 0.454 . . . . 0.0 110.379 158.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 67.0 mt -97.51 153.12 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 126.919 2.088 . . . . 0.0 108.284 170.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.59 125.83 18.65 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.65 -1.281 . . . . 0.0 112.555 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . 0.453 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 2.9 mmmm -129.7 -17.38 3.64 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -159.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -142.56 148.34 20.04 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 119.219 0.918 . . . . 0.0 114.813 -167.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.1 148.83 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.528 1.131 . . . . 0.0 113.095 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.14 115.47 3.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.33 2.652 . . . . 0.0 110.939 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 70.9 t -81.33 -38.41 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.074 0.949 . . . . 0.0 110.532 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 t -92.23 175.1 6.98 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 111.286 168.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.8 m -66.87 135.3 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.329 1.052 . . . . 0.0 111.052 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.39 113.54 13.14 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 121.608 -0.682 . . . . 0.0 111.558 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.58 175.8 10.62 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.282 2.655 . . . . 0.0 113.708 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.29 132.01 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.152 1.781 . . . . 0.0 109.062 -173.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -78.29 97.84 5.72 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.352 1.461 . . . . 0.0 109.797 166.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.0 t -92.5 -16.04 26.29 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.269 1.028 . . . . 0.0 112.618 170.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.27 135.38 54.73 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.716 2.006 . . . . 0.0 107.01 163.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.2 -14.82 63.27 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.563 -1.335 . . . . 0.0 114.443 -167.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.73 0.82 56.09 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.674 1.59 . . . . 0.0 113.146 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -53.18 138.51 31.49 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.743 -1.223 . . . . 0.0 113.28 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.11 142.63 49.57 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.939 1.296 . . . . 0.0 111.069 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.47 144.89 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -162.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -69.63 127.2 32.12 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.82 2.848 . . . . 0.0 110.195 169.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 18.0 mt -137.05 138.24 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.011 0.434 . . . . 0.0 110.308 168.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -110.19 143.43 40.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.201 1.001 . . . . 0.0 110.964 163.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.52 151.54 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.966 0.906 . . . . 0.0 112.406 173.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -94.23 115.93 65.81 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.438 1.895 . . . . 0.0 109.435 172.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.91 168.99 23.59 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.141 2.56 . . . . 0.0 111.07 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . 0.414 ' HG3' ' HE2' ' A' ' 346' ' ' LYS . 17.0 Cg_endo -75.7 -177.24 3.45 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.94 2.427 . . . . 0.0 109.813 163.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -75.05 152.56 38.64 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.293 -0.879 . . . . 0.0 109.639 149.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 75.32 -156.2 48.27 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.809 1.084 . . . . 0.0 115.809 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.97 145.83 55.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.255 2.622 . . . . 0.0 113.151 -166.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 6.2 m -179.24 160.46 1.03 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.709 1.603 . . . . 0.0 114.545 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -126.99 119.0 25.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 129.078 2.951 . . . . 0.0 108.586 170.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.2 mm -75.14 119.58 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.5 132.24 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 120.235 1.38 . . . . 0.0 110.076 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.6 106.49 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 126.069 1.748 . . . . 0.0 108.302 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 114.03 176.15 19.06 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 122.496 1.053 . . . . 0.0 115.234 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.63 166.4 23.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.851 2.061 . . . . 0.0 110.223 170.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.1 -175.65 45.14 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 123.09 0.376 . . . . 0.0 112.45 -165.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -58.55 -28.82 65.86 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.674 -0.897 . . . . 0.0 111.921 171.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 50.6 m -57.72 -10.44 1.62 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 130.106 3.362 . . . . 0.0 116.933 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -79.63 146.77 32.34 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.347 1.059 . . . . 0.0 112.039 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 44.3 mt -116.03 166.17 12.3 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.895 0.878 . . . . 0.0 110.513 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.2 t -152.5 161.37 42.68 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -139.66 131.78 28.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.625 1.57 . . . . 0.0 110.205 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -69.12 125.44 26.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.846 1.258 . . . . 0.0 111.264 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -137.29 90.44 2.52 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.5 1.12 . . . . 0.0 110.488 172.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.3 m170 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 171.597 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 121.173 0.511 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 95.43 0.35 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 156.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -65.93 162.38 19.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.728 2.011 . . . . 0.0 114.275 -172.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 32.7 m -103.25 139.34 38.83 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.195 0.998 . . . . 0.0 110.558 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.2 p -138.76 7.12 2.5 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.663 1.356 . . . . 0.0 114.663 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.33 165.55 19.21 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.795 1.18 . . . . 0.0 110.634 163.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -66.98 95.01 0.36 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.673 1.989 . . . . 0.0 111.375 -169.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 23.8 mtm -76.75 170.18 16.93 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.118 1.367 . . . . 0.0 112.653 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.1 m -156.48 158.94 38.11 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.037 -1.039 . . . . 0.0 112.976 166.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.82 114.95 23.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.598 0.759 . . . . 0.0 109.745 162.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.8 -29.81 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.866 1.267 . . . . 0.0 110.318 168.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -140.77 132.47 27.28 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.634 1.974 . . . . 0.0 108.53 165.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -61.17 148.13 85.39 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.417 1.487 . . . . 0.0 112.846 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.67 130.27 37.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.886 2.391 . . . . 0.0 111.619 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.5 p -127.11 125.14 40.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.615 1.166 . . . . 0.0 111.29 173.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -60.03 126.44 27.56 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.301 1.44 . . . . 0.0 111.89 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -77.78 -16.15 58.59 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.326 1.451 . . . . 0.0 113.762 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.81 -5.79 5.7 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 118.937 -0.924 . . . . 0.0 114.139 -165.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -89.42 -2.24 58.33 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.201 1.501 . . . . 0.0 112.115 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 102.91 -1.73 48.16 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.233 1.396 . . . . 0.0 114.035 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 17.1 p -121.09 159.15 26.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.768 1.227 . . . . 0.0 111.679 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.3 123.74 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.484 1.914 . . . . 0.0 108.091 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.3 p -111.96 129.14 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.183 0.993 . . . . 0.0 113.418 -166.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -136.11 168.13 19.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.886 2.075 . . . . 0.0 113.071 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -125.84 129.17 48.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.796 1.238 . . . . 0.0 108.083 166.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.07 153.0 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 119.21 0.914 . . . . 0.0 112.528 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -141.65 146.68 36.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.706 1.602 . . . . 0.0 113.455 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.99 155.41 41.71 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.835 2.054 . . . . 0.0 109.702 160.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -109.18 -49.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.286 1.991 . . . . 0.0 116.46 -175.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 173.81 13.8 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.738 1.154 . . . . 0.0 112.79 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.11 0.83 10.5 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.439 1.971 . . . . 0.0 117.645 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -119.37 97.28 50.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 119.015 1.408 . . . . 0.0 113.868 -160.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -81.19 111.71 2.45 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.845 3.03 . . . . 0.0 109.88 152.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 7.5 p -159.68 153.47 22.95 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -81.37 110.45 16.81 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 159.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.263 1.3 pp -66.14 112.74 9.83 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 119.429 -0.319 . . . . 0.0 111.387 -162.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.84 113.88 3.72 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.908 2.406 . . . . 0.0 112.345 -165.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 94.8 t -112.35 108.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 126.171 1.788 . . . . 0.0 110.004 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.0 158.22 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.62 1.568 . . . . 0.0 110.168 -176.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 77.7 t -145.8 116.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -171.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.01 -179.17 5.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.172 0.989 . . . . 0.0 113.048 -165.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.426 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 69.6 m-20 -111.07 -0.13 16.72 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.96 0.904 . . . . 0.0 112.33 163.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -123.35 6.72 9.03 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.751 1.621 . . . . 0.0 113.952 -159.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.2 mt 65.27 -6.02 0.4 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.252 2.221 . . . . 0.0 115.194 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -128.49 -3.08 5.48 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 68.33 37.43 2.76 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.825 2.05 . . . . 0.0 113.536 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.17 -49.07 68.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 165.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.46 150.39 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 126.626 1.97 . . . . 0.0 107.59 164.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.58 129.47 21.83 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.161 -0.962 . . . . 0.0 112.221 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . 0.426 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 31.6 mtmt -133.95 -8.55 2.71 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -160.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -127.72 130.14 6.63 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 -164.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -89.12 157.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.12 1.368 . . . . 0.0 111.905 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.77 119.92 32.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.091 2.156 . . . . 0.0 109.177 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.41 -25.22 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.502 0.721 . . . . 0.0 112.187 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.7 t -125.66 175.54 7.51 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.544 1.537 . . . . 0.0 111.084 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.78 107.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.155 1.782 . . . . 0.0 113.427 -175.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -71.55 113.53 20.47 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.826 1.25 . . . . 0.0 110.055 162.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -82.63 179.1 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.705 2.937 . . . . 0.0 114.419 -169.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.62 119.79 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 127.19 2.196 . . . . 0.0 106.058 163.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.0 84.63 0.08 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.56 1.144 . . . . 0.0 110.501 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.1 t -81.92 -9.73 59.49 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.54 122.84 37.71 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 127.399 2.28 . . . . 0.0 106.898 168.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -66.87 -10.8 52.23 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.285 -1.509 . . . . 0.0 114.752 -166.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -89.86 4.33 50.19 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.333 1.853 . . . . 0.0 113.375 170.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.33 134.89 11.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.222 1.409 . . . . 0.0 113.811 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.93 151.43 49.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.774 1.23 . . . . 0.0 111.56 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.29 144.57 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -166.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -79.23 121.47 25.1 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.708 2.403 . . . . 0.0 109.79 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 61.0 mt -131.1 136.35 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.359 0.599 . . . . 0.0 111.177 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -101.89 141.27 35.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.976 1.31 . . . . 0.0 110.762 161.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.7 159.49 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.391 1.076 . . . . 0.0 112.001 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -117.13 102.06 52.86 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.703 1.601 . . . . 0.0 109.949 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.78 179.89 3.89 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.676 2.917 . . . . 0.0 110.866 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -78.83 -179.85 5.84 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.219 1.946 . . . . 0.0 110.869 161.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -60.48 148.61 37.06 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 153.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.92 -163.72 43.96 Favored Glycine 0 CA--C 1.539 1.583 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -62.86 158.9 17.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.631 1.972 . . . . 0.0 114.471 -169.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.6 m -166.54 168.57 14.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.137 1.375 . . . . 0.0 113.079 166.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.91 111.29 12.41 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.659 2.383 . . . . 0.0 107.326 164.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 17.4 mm -69.44 129.04 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 59.2 mt -121.32 124.18 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.357 1.063 . . . . 0.0 108.926 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.99 100.56 11.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 126.069 1.747 . . . . 0.0 107.58 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 114.68 178.72 18.89 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 123.071 1.373 . . . . 0.0 116.159 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.57 167.25 22.04 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.744 2.418 . . . . 0.0 110.167 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.29 -174.85 46.81 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.569 0.604 . . . . 0.0 112.338 -167.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -59.22 -30.5 68.29 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 122.037 -0.684 . . . . 0.0 111.228 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 15.6 m -60.15 -6.98 1.61 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 129.88 3.272 . . . . 0.0 117.22 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.65 148.5 31.61 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.018 0.927 . . . . 0.0 112.005 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 18.0 mt -111.89 165.46 12.06 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.504 0.722 . . . . 0.0 110.563 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.9 t -147.06 157.74 43.71 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -139.71 121.29 15.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.334 1.854 . . . . 0.0 109.657 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -66.64 140.5 57.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.094 1.358 . . . . 0.0 111.89 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -135.95 155.95 49.49 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.46 1.104 . . . . 0.0 111.773 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.031 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 34.9 p90 . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 120.656 0.265 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.45 104.21 7.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.856 0.863 . . . . 0.0 108.995 170.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -66.84 146.95 53.88 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.972 2.109 . . . . 0.0 115.945 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.9 m -96.49 144.62 26.42 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.728 1.211 . . . . 0.0 109.075 159.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 57.8 p -139.56 2.1 1.99 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.463 ' CG ' ' HZ3' ' A' ' 326' ' ' LYS . 42.7 t0 -69.23 161.19 29.72 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 120.181 1.355 . . . . 0.0 111.157 165.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.87 95.46 0.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.0 1.72 . . . . 0.0 112.277 -171.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 31.6 mtm -81.38 166.64 20.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.927 1.291 . . . . 0.0 112.003 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 22.2 m -160.21 162.57 33.82 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.441 -0.787 . . . . 0.0 112.085 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -74.46 135.17 42.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.514 0.726 . . . . 0.0 109.426 166.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.99 -17.97 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.342 0.657 . . . . 0.0 110.81 161.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 28.6 tttm -147.87 123.72 10.61 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.452 2.301 . . . . 0.0 108.034 173.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.28 146.2 84.41 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.992 0.917 . . . . 0.0 112.069 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.77 130.06 35.53 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.694 2.929 . . . . 0.0 112.848 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.6 p -128.55 134.18 48.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.551 1.141 . . . . 0.0 110.585 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -60.55 122.12 13.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.29 0.636 . . . . 0.0 109.893 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.7 p -72.79 -14.16 61.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.284 1.034 . . . . 0.0 112.801 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.74 -4.94 13.3 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.277 0.942 . . . . 0.0 113.492 -165.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -90.16 1.14 56.74 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.886 1.343 . . . . 0.0 112.036 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.87 13.41 43.49 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.804 1.193 . . . . 0.0 113.72 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.8 p -133.66 153.9 51.32 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.044 1.338 . . . . 0.0 111.687 -174.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.49 121.14 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.669 1.187 . . . . 0.0 107.912 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.0 p -112.37 134.33 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.35 1.06 . . . . 0.0 113.067 -164.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -141.79 159.83 41.43 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.936 1.695 . . . . 0.0 112.893 -175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -107.92 132.36 53.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.1 1.36 . . . . 0.0 107.373 164.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.35 144.66 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.641 0.776 . . . . 0.0 111.314 -177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -131.04 144.28 51.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.368 1.467 . . . . 0.0 112.901 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.62 153.36 44.31 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 127.986 2.514 . . . . 0.0 108.835 168.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -108.93 -70.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.843 2.362 . . . . 0.0 116.277 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.463 ' HZ3' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -135.18 164.45 27.66 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 121.226 1.83 . . . . 0.0 114.339 -175.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 71.6 0.07 37.74 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.89 1.709 . . . . 0.0 117.037 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.87 102.53 53.99 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 118.879 1.34 . . . . 0.0 113.525 -166.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.06 120.22 2.95 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.717 2.944 . . . . 0.0 109.611 152.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 7.7 p -162.51 157.37 22.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -89.39 109.19 20.13 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 157.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.265 0.9 OUTLIER -65.3 122.79 81.88 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.744 -157.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -61.77 117.41 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.712 2.941 . . . . 0.0 113.522 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.1 t -124.94 111.43 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.251 1.421 . . . . 0.0 110.721 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.28 157.26 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.338 1.455 . . . . 0.0 110.096 -173.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.79 118.36 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.46 171.45 13.38 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -165.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.418 ' CG ' ' HE2' ' A' ' 346' ' ' LYS . 4.6 m-20 -90.89 -13.45 33.6 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.351 2.26 . . . . 0.0 112.577 166.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 341' ' ' THR . 40.1 p30 -114.99 0.18 13.59 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -154.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 36.4 mt 60.7 -25.95 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.664 2.786 . . . . 0.0 115.533 -171.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.417 ' H ' ' C ' ' A' ' 339' ' ' ASP . 11.1 t -99.8 -4.56 30.26 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.822 2.049 . . . . 0.0 114.567 -172.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.87 78.15 0.05 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 130.658 3.583 . . . . 0.0 115.175 -171.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -99.53 -38.91 8.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.295 1.438 . . . . 0.0 110.837 153.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 35.2 mm -98.96 128.5 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.771 1.228 . . . . 0.0 109.521 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -108.65 125.23 51.64 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.754 -0.591 . . . . 0.0 112.054 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . 0.418 ' HE2' ' CG ' ' A' ' 338' ' ' ASP . 47.8 mttm -75.49 -73.45 0.26 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.691 2.796 . . . . 0.0 110.902 166.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -98.31 167.16 22.35 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.063 1.316 . . . . 0.0 115.582 -155.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 12.6 mt -120.03 152.24 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.633 1.573 . . . . 0.0 110.318 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.3 135.97 54.16 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.472 1.909 . . . . 0.0 110.312 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.58 -50.14 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.949 0.5 . . . . 0.0 110.693 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.1 m -81.45 156.81 25.16 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.001 0.92 . . . . 0.0 109.348 160.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.05 161.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.255 1.422 . . . . 0.0 113.922 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -125.02 121.05 25.39 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.158 1.783 . . . . 0.0 109.227 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -82.28 -175.29 2.44 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.265 3.31 . . . . 0.0 113.548 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 123.12 63.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.578 1.551 . . . . 0.0 108.037 168.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.63 84.71 0.87 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.34 1.056 . . . . 0.0 111.548 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 25.0 t -79.29 -12.34 59.94 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 167.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.7 p -131.31 121.98 25.64 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 127.785 2.434 . . . . 0.0 105.939 167.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -59.51 -20.34 54.66 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.8 0.06 9.93 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.466 1.906 . . . . 0.0 113.737 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -37.13 121.82 0.83 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.481 2.312 . . . . 0.0 113.58 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.65 143.18 47.13 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.269 1.028 . . . . 0.0 111.285 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.2 p -154.17 150.47 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -163.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.93 121.82 27.48 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.793 2.437 . . . . 0.0 109.469 168.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 37.0 mt -135.71 150.13 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.956 0.798 . . . . 0.0 111.455 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.4 142.63 47.35 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.55 1.94 . . . . 0.0 111.467 170.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 3.8 m -123.11 145.47 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.569 1.148 . . . . 0.0 110.733 168.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -83.18 119.08 73.49 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.936 0.894 . . . . 0.0 109.787 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -82.34 151.33 15.54 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 122.844 2.363 . . . . 0.0 111.045 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.47 178.13 7.07 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.747 2.298 . . . . 0.0 110.442 158.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.73 151.66 46.88 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.611 -0.68 . . . . 0.0 110.449 163.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 77.63 -151.33 37.64 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 121.92 -0.488 . . . . 0.0 113.297 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.28 143.45 57.78 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -173.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 47.2 m -157.41 145.49 19.12 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.487 1.115 . . . . 0.0 112.512 167.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -122.77 105.2 9.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.404 1.082 . . . . 0.0 108.651 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 13.8 mm -76.69 113.78 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 127.444 2.298 . . . . 0.0 109.022 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 25.1 mt -116.79 133.96 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 122.449 1.118 . . . . 0.0 111.78 -168.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 81.6 t -116.77 114.58 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 C-N-CA 126.647 1.979 . . . . 0.0 108.023 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 96.98 -173.05 28.82 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 122.875 1.264 . . . . 0.0 115.521 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.95 164.01 31.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.308 2.243 . . . . 0.0 110.018 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.55 -174.12 42.68 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.008 0.337 . . . . 0.0 112.359 -167.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -59.17 -25.79 64.22 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.074 0.95 . . . . 0.0 112.497 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 63.4 m -60.38 -10.72 5.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.824 2.449 . . . . 0.0 115.684 172.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -77.39 124.71 28.24 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.508 1.049 . . . . 0.0 112.167 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 9.8 mt -97.71 161.3 13.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.983 0.513 . . . . 0.0 111.401 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.9 t -132.65 157.88 43.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.879 1.272 . . . . 0.0 112.042 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -145.0 136.52 25.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.078 1.351 . . . . 0.0 110.979 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.14 137.22 38.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.465 1.506 . . . . 0.0 113.139 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -138.01 147.39 44.14 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.917 1.287 . . . . 0.0 111.352 158.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 . . . . . 0 CA--C 1.536 0.435 0 C-N-CA 125.603 1.561 . . . . 0.0 107.598 169.185 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 29.5 p90 . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 121.477 0.656 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.35 105.94 13.83 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.123 1.769 . . . . 0.0 109.173 172.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -80.44 161.83 24.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.125 1.77 . . . . 0.0 114.162 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 13.7 m -100.86 148.58 24.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.343 1.057 . . . . 0.0 110.939 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 42.9 p -139.08 11.47 2.61 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 170.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -83.17 160.61 21.78 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.804 1.183 . . . . 0.0 110.039 163.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -65.29 98.72 0.35 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.095 1.758 . . . . 0.0 111.825 -163.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 27.6 mtm -83.01 164.06 20.6 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.716 0.806 . . . . 0.0 111.79 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.3 m -159.53 161.29 35.25 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.316 -0.865 . . . . 0.0 111.993 167.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.67 115.47 25.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.798 0.839 . . . . 0.0 110.573 167.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.69 -26.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.948 1.299 . . . . 0.0 110.548 168.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -142.31 130.86 22.52 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.539 1.936 . . . . 0.0 109.022 167.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -61.34 149.75 82.16 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.928 1.691 . . . . 0.0 113.313 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -55.86 130.57 41.07 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.345 2.697 . . . . 0.0 112.389 173.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.3 p -128.58 127.54 42.5 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.474 1.109 . . . . 0.0 111.297 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -60.82 123.89 18.83 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.73 1.612 . . . . 0.0 112.133 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.2 p -79.57 -11.81 59.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.487 1.515 . . . . 0.0 113.307 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 68.71 -10.36 1.55 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.418 1.009 . . . . 0.0 114.224 -168.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -83.23 3.63 30.33 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.618 1.567 . . . . 0.0 111.702 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 101.97 -1.47 51.59 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 126.043 1.782 . . . . 0.0 113.612 -174.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.2 p -118.06 159.11 23.79 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.771 1.286 . . . . 0.0 112.451 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.79 111.43 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.406 1.482 . . . . 0.0 107.916 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.46 133.1 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.245 1.018 . . . . 0.0 113.615 -162.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -139.69 161.54 37.27 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.245 2.218 . . . . 0.0 112.496 -172.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -113.33 130.12 56.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.454 1.102 . . . . 0.0 108.158 164.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.2 150.57 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.074 0.95 . . . . 0.0 111.874 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.8 tttp -135.73 148.38 48.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.826 1.651 . . . . 0.0 113.044 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.51 153.11 46.68 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 128.322 2.649 . . . . 0.0 108.17 165.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -107.97 -55.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.454 2.102 . . . . 0.0 115.695 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.94 171.01 16.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.275 1.03 . . . . 0.0 112.575 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.63 -5.14 1.8 Allowed Glycine 0 CA--C 1.537 1.425 0 C-N-CA 126.975 2.226 . . . . 0.0 118.093 166.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.53 95.59 48.09 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 119.286 1.543 . . . . 0.0 113.331 -161.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.93 117.82 4.83 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.114 2.543 . . . . 0.0 109.345 158.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.1 p -165.51 150.88 9.11 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.18 101.56 6.23 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.104 1.762 . . . . 0.0 106.588 158.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.253 1.3 pp -61.08 120.4 54.04 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-O 118.555 -0.735 . . . . 0.0 111.543 -158.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -61.89 114.85 2.47 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.492 2.795 . . . . 0.0 113.552 -171.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.62 120.15 62.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.979 1.312 . . . . 0.0 108.781 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 163.63 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.013 1.325 . . . . 0.0 110.643 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 48.2 t -142.81 118.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.69 163.39 38.23 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.1 6.2 38.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.069 0.948 . . . . 0.0 111.913 -175.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -115.14 1.98 14.01 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.937 2.495 . . . . 0.0 113.457 -164.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 32.8 mt 61.31 8.03 1.94 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.495 2.318 . . . . 0.0 114.994 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.9 t -142.62 -6.6 0.89 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 55.95 50.18 14.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.767 2.027 . . . . 0.0 114.925 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.71 72.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 152.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 34.2 mm -70.57 148.18 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 123.718 0.807 . . . . 0.0 108.927 162.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.08 74.26 1.51 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.432 -1.418 . . . . 0.0 109.349 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -75.27 -60.63 2.21 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.296 1.838 . . . . 0.0 112.886 -160.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . 0.452 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -94.44 175.88 34.9 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.655 1.598 . . . . 0.0 115.406 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -113.79 150.73 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.143 2.577 . . . . 0.0 110.377 -173.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.78 135.46 36.5 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.493 1.517 . . . . 0.0 109.685 165.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.8 t -114.86 -65.34 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.885 0.766 . . . . 0.0 111.208 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' THR . . . . . 0.433 ' H ' ' HB2' ' A' ' 366' ' ' GLU . 1.5 m -68.8 157.34 36.64 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 162.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 35.2 m -55.71 161.44 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.959 1.704 . . . . 0.0 114.759 -172.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -125.67 125.35 24.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.445 1.898 . . . . 0.0 108.108 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -80.88 -174.49 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.85 3.033 . . . . 0.0 112.667 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.27 120.49 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 162.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.97 67.25 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.778 2.031 . . . . 0.0 113.444 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -71.03 -20.81 62.35 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.912 0.885 . . . . 0.0 112.402 169.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.81 123.05 43.66 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 154.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -65.65 -16.31 63.61 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.55 -1.344 . . . . 0.0 112.803 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -81.13 2.79 25.91 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.29 1.836 . . . . 0.0 113.751 170.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.22 126.14 3.98 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.303 1.441 . . . . 0.0 113.243 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.14 149.19 52.46 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.064 0.946 . . . . 0.0 111.539 167.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.0 p -158.56 151.38 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -163.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.74 122.61 28.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.172 2.589 . . . . 0.0 109.624 169.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 20.7 mt -134.02 149.67 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.932 0.787 . . . . 0.0 110.619 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' A' ' 351' ' ' THR . 45.4 mt-10 -116.22 143.38 45.58 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.608 1.563 . . . . 0.0 110.977 167.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.02 157.8 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.448 0.699 . . . . 0.0 111.635 164.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -121.47 102.19 42.74 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 127.164 2.186 . . . . 0.0 108.501 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.36 165.33 27.73 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.17 1.914 . . . . 0.0 110.628 166.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -59.7 177.2 0.49 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.078 2.518 . . . . 0.0 111.668 156.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -59.65 142.59 52.61 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.845 -0.534 . . . . 0.0 110.527 165.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 101.92 -154.18 18.72 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.957 1.265 . . . . 0.0 115.381 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.82 140.97 38.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.412 2.685 . . . . 0.0 112.533 -170.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.63 174.04 8.05 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 159.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -111.94 119.64 39.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.272 1.429 . . . . 0.0 108.926 170.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.5 mm -78.28 119.79 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 173.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 83.4 mt -112.19 134.83 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.685 1.194 . . . . 0.0 109.783 -172.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.6 t -115.86 108.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 126.097 1.759 . . . . 0.0 107.982 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.78 -179.27 24.21 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.11 167.29 21.83 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.433 2.693 . . . . 0.0 110.245 175.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.33 -169.62 54.9 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.606 0.622 . . . . 0.0 112.247 -169.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -63.11 -32.48 73.87 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.089 -1.242 . . . . 0.0 111.352 168.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 70.3 m -54.89 8.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 1 C-N-CA 131.877 4.071 . . . . 0.0 118.474 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -103.95 146.42 28.71 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.628 1.171 . . . . 0.0 111.704 -172.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 21.6 mt -120.95 168.66 11.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.044 0.938 . . . . 0.0 110.926 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.0 t -145.88 159.38 43.3 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 172.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -132.72 130.46 40.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.347 1.459 . . . . 0.0 109.678 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -76.71 132.58 39.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.287 1.835 . . . . 0.0 111.63 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -133.2 151.22 51.95 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 122.208 1.004 . . . . 0.0 111.796 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 171.136 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 121.15 0.5 . . . . 0.0 111.801 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.82 96.89 0.31 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.329 1.452 . . . . 0.0 108.506 166.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -69.7 156.91 38.25 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.416 2.686 . . . . 0.0 115.177 -172.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 14.9 m -100.53 137.81 38.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.874 1.27 . . . . 0.0 109.787 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 66.7 p -138.15 4.31 2.46 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -80.54 165.55 22.01 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.876 1.216 . . . . 0.0 110.707 166.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -66.68 94.95 0.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.848 2.059 . . . . 0.0 111.366 -165.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 30.7 mtm -79.69 163.32 24.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.853 1.261 . . . . 0.0 112.317 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.4 p -150.43 161.88 41.65 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.556 1.143 . . . . 0.0 112.476 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -93.93 125.82 38.77 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.152 0.981 . . . . 0.0 108.723 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.72 -26.7 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 163.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -144.06 128.46 17.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.59 1.956 . . . . 0.0 108.743 171.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -59.22 143.81 84.29 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.961 0.904 . . . . 0.0 111.752 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -56.31 137.95 81.84 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.082 1.855 . . . . 0.0 111.513 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 41.2 p -132.49 124.59 28.83 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.37 1.068 . . . . 0.0 111.805 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -54.09 122.05 9.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.307 1.843 . . . . 0.0 111.517 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -84.24 -12.39 54.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.137 0.975 . . . . 0.0 113.296 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.95 -10.01 1.32 Allowed Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.271 0.939 . . . . 0.0 114.584 -167.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -83.38 7.02 17.95 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.29 1.545 . . . . 0.0 111.971 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 96.2 5.9 59.16 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.48 1.514 . . . . 0.0 113.713 -171.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.5 p -127.75 167.48 16.43 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.708 1.254 . . . . 0.0 112.825 -172.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.35 123.59 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.693 1.997 . . . . 0.0 107.817 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -110.32 131.7 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.74 1.216 . . . . 0.0 113.005 -170.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -138.45 167.13 22.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.685 1.594 . . . . 0.0 113.756 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -126.26 129.44 48.93 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.028 1.331 . . . . 0.0 108.594 166.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.1 m -127.26 154.87 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.79 0.836 . . . . 0.0 111.792 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -139.65 144.28 37.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.581 1.552 . . . . 0.0 111.717 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 12.7 p -120.04 154.23 55.56 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.153 2.181 . . . . 0.0 108.518 168.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -113.31 -45.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.2 0 CA-C-N 122.205 1.823 . . . . 0.0 116.602 -165.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.7 164.68 32.79 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.928 -1.107 . . . . 0.0 112.447 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.37 4.95 26.21 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.888 1.709 . . . . 0.0 117.188 168.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.89 95.66 46.04 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.0 1.4 . . . . 0.0 113.094 -164.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.62 115.08 1.51 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.048 3.166 . . . . 0.0 109.249 154.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 9.3 p -163.36 144.39 9.3 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.99 107.11 9.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 162.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.278 0.7 OUTLIER -68.87 122.2 84.16 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.13 -155.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -64.2 116.02 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.062 2.508 . . . . 0.0 112.987 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.91 108.17 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.828 1.651 . . . . 0.0 110.312 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.09 156.92 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.437 1.495 . . . . 0.0 109.581 -170.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 42.5 t -142.62 122.13 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 120.98 -1.075 . . . . 0.0 109.39 -170.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.19 173.71 11.27 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -161.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.516 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 68.1 m-20 -110.54 -1.99 16.67 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.517 1.527 . . . . 0.0 112.205 168.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -125.83 4.58 7.36 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.703 1.601 . . . . 0.0 113.996 -159.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 35.7 mt 62.56 -4.9 0.21 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.339 2.256 . . . . 0.0 115.52 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 5.0 t -125.33 0.71 7.73 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.074 1.307 . . . . 0.0 113.963 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 77.87 21.2 0.95 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.59 2.356 . . . . 0.0 113.945 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -61.43 -46.45 90.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.268 1.027 . . . . 0.0 111.475 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.7 mm -94.37 135.39 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.64 86.68 2.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 123.415 1.579 . . . . 0.0 113.31 -167.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . 0.516 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 14.3 mtpp -82.6 -49.08 10.24 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.708 2.403 . . . . 0.0 113.097 -158.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . 0.447 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -104.84 154.13 17.36 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -160.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.15 149.1 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 127.102 2.161 . . . . 0.0 109.749 -169.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.12 120.35 24.14 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.054 1.341 . . . . 0.0 109.277 170.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.93 -38.3 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.963 0.505 . . . . 0.0 111.052 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.1 t -97.59 175.41 6.21 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.351 0.66 . . . . 0.0 111.058 166.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.74 128.52 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.726 1.211 . . . . 0.0 110.507 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -66.31 114.96 19.29 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.673 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.86 174.7 10.71 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.311 2.674 . . . . 0.0 113.394 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.33 120.99 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 127.223 2.209 . . . . 0.0 107.986 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.95 99.53 0.5 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.553 1.141 . . . . 0.0 109.506 167.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 26.1 t -102.16 -11.12 19.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.689 1.596 . . . . 0.0 112.79 175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.59 152.33 33.27 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 147.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -72.86 -11.66 60.68 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 117.847 -1.073 . . . . 0.0 113.597 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.99 1.46 55.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.311 1.444 . . . . 0.0 112.457 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -54.18 134.14 44.44 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.443 1.116 . . . . 0.0 113.034 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.41 140.44 52.17 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.442 1.497 . . . . 0.0 110.634 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.35 142.63 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -158.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.06 127.8 33.63 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 129.491 3.116 . . . . 0.0 110.419 170.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 44.2 mt -137.85 144.62 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.096 0.558 . . . . 0.0 110.655 170.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -116.1 139.05 50.7 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.562 1.545 . . . . 0.0 111.125 165.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.36 158.32 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.737 1.215 . . . . 0.0 111.801 175.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -118.1 105.26 47.28 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 126.978 2.111 . . . . 0.0 108.687 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -80.84 169.63 16.31 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.533 2.822 . . . . 0.0 111.147 172.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.83 175.96 8.95 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.422 2.082 . . . . 0.0 110.846 162.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -65.72 148.42 51.8 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.797 -0.564 . . . . 0.0 109.853 161.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.41 -162.51 33.4 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-O 122.426 1.014 . . . . 0.0 114.833 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.3 156.31 29.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.563 1.945 . . . . 0.0 113.941 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 64.0 m -170.03 159.79 7.84 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.667 1.987 . . . . 0.0 112.063 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -124.42 123.56 40.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.887 1.675 . . . . 0.0 107.934 157.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.6 mm -76.69 111.0 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 87.1 mt -100.95 130.98 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.687 1.131 . . . . 0.0 109.391 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 83.5 t -117.76 109.45 27.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.898 1.679 . . . . 0.0 107.838 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.9 -176.21 22.72 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 123.333 1.518 . . . . 0.0 116.604 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.57 171.96 13.39 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.167 2.587 . . . . 0.0 110.357 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.37 -171.87 45.83 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -61.16 -31.1 70.83 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.811 -0.817 . . . . 0.0 111.7 170.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 53.2 m -61.39 -8.15 3.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 129.571 3.148 . . . . 0.0 117.364 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -74.38 144.89 44.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.855 0.752 . . . . 0.0 111.449 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 31.8 mt -116.8 167.64 10.92 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.263 0.625 . . . . 0.0 110.719 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.3 t -146.55 159.12 43.83 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -134.57 131.25 37.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.418 1.487 . . . . 0.0 109.57 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -73.89 131.51 41.55 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.312 2.245 . . . . 0.0 112.344 -173.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -142.59 118.02 10.28 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.24 1.016 . . . . 0.0 111.888 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.737 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 31.5 p90 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 111.39 23.13 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 166.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.37 134.76 57.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.872 1.669 . . . . 0.0 114.594 -173.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.2 m -85.26 132.77 34.22 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 152.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 66.8 p -132.94 6.21 3.93 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -83.32 161.35 21.46 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.176 0.898 . . . . 0.0 111.052 164.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -63.62 104.32 0.64 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.137 1.775 . . . . 0.0 112.711 -159.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 24.3 mtm -87.63 164.86 15.82 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.047 0.927 . . . . 0.0 112.004 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.5 m -160.6 160.48 31.77 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.24 -0.912 . . . . 0.0 111.717 170.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.91 126.13 30.29 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 165.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 40.6 t -78.97 -24.21 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.506 0.722 . . . . 0.0 110.527 161.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -139.94 127.23 21.24 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.226 1.81 . . . . 0.0 108.203 166.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -55.41 144.11 53.96 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.642 1.177 . . . . 0.0 111.719 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -55.07 133.09 56.13 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.309 2.006 . . . . 0.0 110.989 170.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 61.4 p -133.74 129.73 37.08 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.202 1.001 . . . . 0.0 110.742 171.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.24 125.65 24.13 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.342 1.057 . . . . 0.0 111.143 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 61.9 p -80.47 -9.2 59.77 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.192 0.997 . . . . 0.0 113.093 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 74.66 -8.49 14.33 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.798 1.19 . . . . 0.0 114.033 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -90.0 4.82 49.0 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.88 1.34 . . . . 0.0 112.468 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.65 6.73 62.15 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.674 1.13 . . . . 0.0 113.59 -169.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.6 p -120.73 157.04 30.53 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.843 1.257 . . . . 0.0 111.214 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 15.0 t -130.86 118.76 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.346 1.458 . . . . 0.0 108.038 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.9 p -108.01 129.78 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.978 1.311 . . . . 0.0 113.134 -166.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -139.76 162.71 34.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.972 1.709 . . . . 0.0 113.374 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -116.26 129.25 56.18 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.099 1.359 . . . . 0.0 107.764 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.6 m -126.17 145.75 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.594 0.757 . . . . 0.0 111.312 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -125.92 144.09 50.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.641 1.176 . . . . 0.0 112.526 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.7 t -111.86 150.88 42.99 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 127.501 2.32 . . . . 0.0 107.785 163.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -110.26 -59.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.576 2.184 . . . . 0.0 116.169 -176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.02 164.61 29.81 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.03 -1.044 . . . . 0.0 112.743 -176.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 64.41 7.07 24.46 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 117.622 1.809 . . . . 0.0 117.622 168.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.26 98.05 44.66 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 119.071 1.436 . . . . 0.0 113.279 -162.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.56 119.19 1.63 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.53 3.487 . . . . 0.0 110.072 157.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.2 p -161.1 157.91 26.8 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -172.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -88.46 112.51 23.04 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 157.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.297 0.5 OUTLIER -66.09 124.89 89.03 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.655 -160.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.75 104.53 1.9 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.457 2.771 . . . . 0.0 111.824 -171.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 75.2 t -105.08 107.88 23.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.471 1.508 . . . . 0.0 109.87 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.43 160.18 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 122.276 1.036 . . . . 0.0 110.992 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . 0.442 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 23.0 t -142.93 134.39 24.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -147.94 178.29 8.64 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.401 0.681 . . . . 0.0 112.046 -168.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -114.24 -6.2 13.0 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.648 0.779 . . . . 0.0 112.26 166.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -111.53 5.83 19.72 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.859 2.464 . . . . 0.0 113.788 -165.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 13.6 mt 64.16 -3.59 0.47 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.223 2.209 . . . . 0.0 115.048 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.6 t -126.89 -6.34 6.17 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -174.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 80.04 25.67 0.36 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 127.968 2.507 . . . . 0.0 113.832 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.2 81.24 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 166.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.83 138.42 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.826 0.85 . . . . 0.0 109.27 159.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.98 74.44 0.88 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 123.014 1.387 . . . . 0.0 109.178 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -76.61 -51.42 11.63 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 126.656 1.982 . . . . 0.0 114.089 -158.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -112.61 153.34 17.53 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 116.065 1.186 . . . . 0.0 116.065 -161.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.3 152.77 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 129.724 3.209 . . . . 0.0 110.171 -168.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.96 123.66 30.78 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.919 1.288 . . . . 0.0 110.101 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.66 -47.25 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.066 0.546 . . . . 0.0 110.16 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.7 t -86.79 178.19 7.08 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.262 1.025 . . . . 0.0 111.901 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.1 m -60.78 131.44 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.275 1.43 . . . . 0.0 111.063 169.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.26 116.03 46.89 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 120.989 -1.07 . . . . 0.0 110.036 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.69 -179.03 5.08 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 124.058 3.172 . . . . 0.0 113.777 -172.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.26 141.2 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.32 1.448 . . . . 0.0 108.598 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -86.84 100.37 12.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.997 0.919 . . . . 0.0 109.577 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -96.4 -16.0 21.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.81 0.844 . . . . 0.0 112.549 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.59 130.67 53.66 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 126.502 1.921 . . . . 0.0 106.676 165.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -66.04 -18.19 65.18 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.326 -1.484 . . . . 0.0 114.133 -165.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -78.84 -2.62 40.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.919 1.687 . . . . 0.0 113.637 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -51.42 133.04 29.9 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.4 1.571 . . . . 0.0 112.937 -170.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -140.81 123.73 16.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.742 2.017 . . . . 0.0 108.665 -164.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 10.5 p -149.04 142.28 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -155.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.97 125.31 26.51 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 128.566 2.747 . . . . 0.0 110.195 170.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 23.6 mt -135.44 140.54 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.195 0.522 . . . . 0.0 110.965 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -116.33 136.06 53.33 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.593 1.557 . . . . 0.0 110.775 166.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.68 159.0 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.768 1.227 . . . . 0.0 112.2 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -129.23 103.88 18.16 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.481 1.912 . . . . 0.0 109.768 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.79 163.85 30.85 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 121.886 1.724 . . . . 0.0 110.642 167.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -60.34 177.27 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.101 2.534 . . . . 0.0 111.746 157.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -60.98 141.12 57.56 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.623 -0.673 . . . . 0.0 110.595 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 96.31 -161.26 22.3 Favored Glycine 0 CA--C 1.535 1.327 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -67.6 159.53 29.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.772 1.629 . . . . 0.0 114.657 -169.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 22.6 m -170.02 164.37 9.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.729 1.612 . . . . 0.0 112.663 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -127.24 116.09 20.04 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 129.453 3.101 . . . . 0.0 107.395 165.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.6 mm -77.11 121.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.18 130.33 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.571 1.078 . . . . 0.0 109.511 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.7 t -114.92 105.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.584 1.154 . . . . 0.0 108.456 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.22 -177.41 20.87 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 123.091 1.384 . . . . 0.0 116.312 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.9 163.93 28.42 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.627 2.371 . . . . 0.0 110.46 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 80.76 -170.09 52.82 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.018 0.818 . . . . 0.0 112.989 -170.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -65.07 -23.87 67.29 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.951 -1.323 . . . . 0.0 111.814 167.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 72.8 m -62.61 -2.52 1.13 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 130.676 3.59 . . . . 0.0 117.676 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.52 147.92 22.55 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.452 1.024 . . . . 0.0 112.371 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 17.6 mt -113.39 165.41 12.48 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.416 0.686 . . . . 0.0 110.951 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.4 t -145.23 158.59 43.79 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 167.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -140.79 134.88 30.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.567 1.947 . . . . 0.0 109.029 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -74.29 138.08 43.33 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.225 1.41 . . . . 0.0 111.699 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -144.53 118.52 9.39 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.653 0.781 . . . . 0.0 112.991 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 . . . . . 0 CA--C 1.531 0.217 0 C-N-CA 124.84 1.256 . . . . 0.0 109.109 175.638 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 4.7 p90 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 121.166 0.508 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.98 103.9 11.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.377 2.271 . . . . 0.0 105.082 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -73.9 151.88 40.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.2 1.4 . . . . 0.0 114.165 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.2 m -95.75 150.92 19.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.354 0.661 . . . . 0.0 110.205 166.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.1 p -133.41 9.36 4.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.787 1.235 . . . . 0.0 113.705 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -79.24 154.55 29.1 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 120.348 1.431 . . . . 0.0 111.107 164.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 109.58 0.9 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.387 2.275 . . . . 0.0 111.89 -170.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 19.0 mtt -87.54 170.47 11.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.9 m -156.93 153.28 27.86 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.346 -0.846 . . . . 0.0 112.685 157.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.82 125.52 29.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.88 0.872 . . . . 0.0 109.343 160.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 5.3 t -82.43 -24.35 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.03 1.332 . . . . 0.0 110.873 172.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -134.24 125.6 28.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.283 2.233 . . . . 0.0 106.708 170.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -56.8 146.93 55.46 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 123.655 0.597 . . . . 0.0 111.154 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -56.66 124.35 16.05 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.507 1.471 . . . . 0.0 110.019 166.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.3 p -125.41 125.78 43.92 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.229 1.011 . . . . 0.0 110.977 170.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.62 121.32 11.9 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.839 0.712 . . . . 0.0 110.54 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 59.1 p -79.45 -7.28 58.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.201 1.4 . . . . 0.0 113.224 -173.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.56 -7.06 2.21 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.738 -164.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -86.68 6.17 32.47 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.659 1.729 . . . . 0.0 111.856 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.47 -2.0 67.23 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.088 1.328 . . . . 0.0 113.648 -170.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 27.9 p -119.07 166.89 12.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.112 1.365 . . . . 0.0 112.002 -170.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.48 114.79 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.014 1.726 . . . . 0.0 108.027 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.29 136.34 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.322 1.049 . . . . 0.0 113.235 -168.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -147.24 167.09 25.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.675 1.99 . . . . 0.0 112.996 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -115.32 134.89 54.7 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.47 1.908 . . . . 0.0 106.819 161.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 23.5 m -132.13 148.54 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.678 0.672 . . . . 0.0 111.703 176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -135.31 146.8 48.83 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.709 1.204 . . . . 0.0 112.272 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 22.8 m -115.13 157.65 43.03 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.604 1.561 . . . . 0.0 110.704 165.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -114.99 -54.49 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.479 2.119 . . . . 0.0 116.673 -171.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.64 175.3 9.8 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.164 1.802 . . . . 0.0 113.596 177.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.18 -13.47 0.23 Allowed Glycine 0 CA--C 1.541 1.716 0 N-CA-C 119.314 2.486 . . . . 0.0 119.314 164.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.48 104.78 54.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 119.939 1.87 . . . . 0.0 114.715 -159.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.41 117.25 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.746 2.964 . . . . 0.0 110.524 158.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.0 p -163.45 148.72 11.2 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -76.06 98.94 4.46 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 155.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.71 113.58 6.28 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 123.701 0.801 . . . . 0.0 111.305 -161.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.52 104.18 1.67 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.251 2.634 . . . . 0.0 112.942 -168.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 81.1 t -101.4 116.98 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 127.076 2.15 . . . . 0.0 109.726 172.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.26 161.43 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.375 1.07 . . . . 0.0 110.782 -176.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . 0.501 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 46.8 t -138.67 133.62 42.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -142.8 169.55 17.35 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.374 0.67 . . . . 0.0 111.652 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -102.22 1.74 36.31 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.243 0.617 . . . . 0.0 111.622 162.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -117.99 5.1 12.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.078 1.751 . . . . 0.0 114.473 -165.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 15.9 mt 61.89 -7.76 0.11 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.492 2.317 . . . . 0.0 116.098 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.7 t -121.75 -5.6 9.14 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.393 1.452 . . . . 0.0 114.132 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 63.47 44.57 5.27 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.78 2.032 . . . . 0.0 113.008 -173.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.91 99.06 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 159.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 22.1 mt -92.84 138.13 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.945 1.698 . . . . 0.0 108.745 166.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -109.25 70.97 0.75 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.226 1.012 . . . . 0.0 109.375 171.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -64.24 -63.0 1.26 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.647 2.379 . . . . 0.0 112.556 -161.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . 0.501 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -96.67 171.21 27.38 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.864 1.697 . . . . 0.0 115.537 -168.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.1 150.58 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 128.299 2.64 . . . . 0.0 110.915 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.98 122.82 30.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.059 1.744 . . . . 0.0 108.358 165.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 28.2 t -86.54 -43.79 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.359 0.527 . . . . 0.0 111.033 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.9 t -101.1 175.3 5.64 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.551 0.691 . . . . 0.0 112.017 172.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.41 124.17 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.587 1.555 . . . . 0.0 112.859 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -81.01 122.17 81.51 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.1 0.96 . . . . 0.0 109.709 166.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -81.75 -171.45 1.21 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.615 3.543 . . . . 0.0 112.815 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.42 129.32 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.332 1.453 . . . . 0.0 107.321 165.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.68 81.93 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.794 1.238 . . . . 0.0 111.666 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 27.7 t -85.57 -10.53 55.78 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.143 0.977 . . . . 0.0 112.49 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.8 127.54 50.7 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 128.201 2.6 . . . . 0.0 106.036 170.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -67.6 -17.46 64.63 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.405 -1.434 . . . . 0.0 113.595 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.24 1.84 26.84 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 127.488 2.315 . . . . 0.0 114.032 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.77 133.55 6.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.667 1.222 . . . . 0.0 113.937 -168.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -141.87 138.31 32.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.454 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 13.8 p -147.82 146.03 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.79 0.805 . . . . 0.0 112.905 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -75.19 120.23 20.4 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.382 2.673 . . . . 0.0 109.193 166.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mt -132.37 139.3 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.892 0.769 . . . . 0.0 111.871 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -111.17 135.66 51.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 110.206 161.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 31.4 m -117.74 161.01 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.344 1.057 . . . . 0.0 111.004 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -131.86 101.77 15.21 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.807 1.643 . . . . 0.0 109.153 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.36 164.71 28.54 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.075 1.85 . . . . 0.0 110.72 164.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.16 175.6 0.24 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.83 3.02 . . . . 0.0 113.313 160.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -58.55 144.23 43.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.278 0.631 . . . . 0.0 110.745 163.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 94.66 -142.97 16.31 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 115.469 0.948 . . . . 0.0 115.469 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.22 154.95 32.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.164 1.786 . . . . 0.0 113.21 -168.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 18.1 m -167.98 161.45 12.8 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.797 1.239 . . . . 0.0 113.5 168.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -124.75 110.34 14.22 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 127.963 2.505 . . . . 0.0 107.261 163.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 9.5 mm -73.85 124.97 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.2 mt -117.87 135.83 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.708 1.203 . . . . 0.0 109.145 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 68.6 t -126.51 97.13 3.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 126.393 1.877 . . . . 0.0 107.481 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 115.6 173.29 17.39 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 116.088 1.195 . . . . 0.0 116.088 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 74.0 p -130.58 173.06 11.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.989 1.716 . . . . 0.0 110.523 167.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 78.22 -161.31 48.74 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 -169.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -69.03 -30.78 69.22 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.476 -1.014 . . . . 0.0 111.597 167.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 54.7 m -58.44 -5.47 0.53 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 130.226 3.41 . . . . 0.0 118.411 -174.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -85.8 139.77 31.02 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.983 0.913 . . . . 0.0 111.669 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.1 mt -104.05 163.64 12.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 110.087 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.2 t -147.02 156.1 42.76 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 169.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -136.19 117.12 14.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.363 1.865 . . . . 0.0 108.69 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -65.21 134.92 54.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.17 0.988 . . . . 0.0 110.816 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -133.43 134.89 44.18 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.297 1.039 . . . . 0.0 110.891 171.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 C--N 1.329 -0.294 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.263 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 121.164 0.507 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.66 97.35 2.65 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 158.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -68.42 154.91 40.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.852 2.461 . . . . 0.0 115.153 -171.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.7 m -102.7 140.6 36.76 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.0 1.32 . . . . 0.0 109.428 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.7 p -138.16 5.9 2.56 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -78.63 160.43 27.55 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.781 1.173 . . . . 0.0 110.517 162.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.11 98.02 0.42 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.09 2.156 . . . . 0.0 112.236 -161.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' MET . . . . . 0.45 ' HE3' ' H ' ' A' ' 380' ' ' THR . 32.2 mtm -82.38 165.71 20.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.098 0.959 . . . . 0.0 111.919 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.4 m -160.62 163.53 32.54 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.363 -0.835 . . . . 0.0 111.768 169.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.1 125.9 30.09 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 164.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.64 -27.74 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.621 0.768 . . . . 0.0 109.737 159.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -144.29 119.06 9.86 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.541 2.337 . . . . 0.0 108.062 170.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -52.86 145.16 23.42 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.785 1.234 . . . . 0.0 111.803 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.36 129.65 35.8 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.916 2.411 . . . . 0.0 111.948 173.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.9 p -126.56 132.49 51.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.839 0.856 . . . . 0.0 111.093 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -61.9 135.89 57.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.026 1.73 . . . . 0.0 112.026 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.3 p -91.26 -13.41 32.78 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 64.94 0.11 4.95 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.979 1.276 . . . . 0.0 114.752 -167.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -90.53 9.75 28.17 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.992 1.396 . . . . 0.0 111.748 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.59 15.5 65.83 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.771 -1.016 . . . . 0.0 113.583 -167.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 22.3 p -131.51 168.83 16.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.001 1.401 . . . . 0.0 113.021 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.84 130.75 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.104 1.762 . . . . 0.0 108.245 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.91 133.34 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.511 1.124 . . . . 0.0 112.368 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -140.61 163.47 32.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.835 1.654 . . . . 0.0 113.155 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -120.7 123.7 43.36 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.814 1.246 . . . . 0.0 107.742 164.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.44 147.96 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.786 0.835 . . . . 0.0 111.678 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -132.68 142.45 49.08 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.393 1.477 . . . . 0.0 113.205 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 t -107.73 143.24 26.88 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.35 2.66 . . . . 0.0 107.829 162.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -103.36 -62.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.264 1.976 . . . . 0.0 115.679 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.48 170.45 15.9 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.808 1.185 . . . . 0.0 113.166 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.09 -14.27 0.44 Allowed Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.968 2.223 . . . . 0.0 117.692 171.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.03 99.8 44.32 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 119.204 1.502 . . . . 0.0 113.327 -167.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.19 113.52 3.2 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.288 2.659 . . . . 0.0 108.878 157.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 16.2 p -158.92 148.19 18.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -170.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.57 99.34 5.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.44 1.496 . . . . 0.0 106.997 161.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.267 0.9 OUTLIER -61.28 114.13 9.91 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 123.222 0.326 . . . . 0.0 111.617 -159.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.07 113.5 3.72 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.954 2.436 . . . . 0.0 112.668 -167.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.12 115.81 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.0 2.12 . . . . 0.0 109.424 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 159.31 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.662 1.185 . . . . 0.0 110.434 -175.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . 0.431 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 51.0 t -140.22 114.71 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.472 1.109 . . . . 0.0 108.136 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -144.49 170.18 16.54 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.018 0.826 . . . . 0.0 113.055 -169.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -106.39 6.37 30.33 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.947 0.899 . . . . 0.0 112.07 171.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -115.87 2.5 13.58 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.093 1.757 . . . . 0.0 113.98 -163.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 49.4 mt 60.68 3.9 0.68 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.737 2.415 . . . . 0.0 115.397 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 3.7 t -137.13 -9.36 1.76 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -173.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 55.82 51.59 12.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.858 2.063 . . . . 0.0 113.423 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -68.83 -34.97 76.38 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 157.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 44.8 mm -111.24 141.55 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.341 1.456 . . . . 0.0 108.71 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -114.8 128.4 56.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.86 0.838 . . . . 0.0 110.899 165.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -87.56 -68.24 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.494 2.318 . . . . 0.0 110.227 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . 0.431 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -93.33 166.78 28.43 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.224 1.392 . . . . 0.0 116.41 -162.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.7 152.85 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 128.027 2.531 . . . . 0.0 110.026 -167.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.0 127.45 31.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.837 1.255 . . . . 0.0 109.448 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.1 t -90.19 -37.42 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.176 0.444 . . . . 0.0 111.141 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.1 t -106.61 173.49 6.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 112.072 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.8 m -66.47 126.94 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.475 1.51 . . . . 0.0 112.177 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -96.0 129.57 33.67 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.653 1.581 . . . . 0.0 110.065 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -83.94 -176.48 2.67 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.263 3.309 . . . . 0.0 114.649 -168.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.47 120.81 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.686 2.394 . . . . 0.0 107.946 168.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.02 74.25 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.908 1.683 . . . . 0.0 112.97 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -67.09 -16.02 64.07 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 171.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.5 p -127.96 139.4 52.6 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 127.298 2.239 . . . . 0.0 106.074 157.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.7 -15.57 63.71 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -167.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.29 -2.0 14.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.03 2.532 . . . . 0.0 114.608 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -40.12 118.48 0.9 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.843 2.057 . . . . 0.0 114.264 -174.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.92 131.86 33.65 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.399 1.48 . . . . 0.0 111.427 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.76 148.76 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -160.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -75.8 126.26 30.66 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 128.513 2.725 . . . . 0.0 109.975 166.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 25.9 mt -136.1 137.59 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.76 0.709 . . . . 0.0 111.271 173.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -105.93 137.74 43.32 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.648 1.179 . . . . 0.0 111.542 159.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.5 150.73 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.311 1.444 . . . . 0.0 111.294 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -110.57 101.0 47.56 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.081 2.153 . . . . 0.0 109.078 175.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.21 162.84 31.03 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.776 2.318 . . . . 0.0 110.935 166.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.76 176.42 3.63 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.427 2.085 . . . . 0.0 111.663 162.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -70.97 147.43 48.69 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.894 -0.504 . . . . 0.0 111.117 165.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 95.35 -159.42 22.55 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.218 0.913 . . . . 0.0 113.492 -172.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.1 158.58 25.47 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.496 1.518 . . . . 0.0 114.9 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.9 m -167.57 150.3 5.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.838 1.655 . . . . 0.0 111.419 162.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -104.74 116.63 32.35 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.379 1.472 . . . . 0.0 108.15 155.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.9 mm -67.33 130.83 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 165.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.29 130.45 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.85 1.26 . . . . 0.0 108.828 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.8 t -117.54 100.02 9.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.393 1.877 . . . . 0.0 107.772 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 106.73 -178.48 22.32 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 123.096 1.387 . . . . 0.0 115.604 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' THR . . . . . 0.45 ' H ' ' HE3' ' A' ' 304' ' ' MET . 1.0 OUTLIER -135.5 169.76 17.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.098 2.559 . . . . 0.0 110.719 175.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 81.21 -166.9 48.67 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.925 0.774 . . . . 0.0 112.341 -171.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -65.21 -33.29 75.65 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.143 -1.21 . . . . 0.0 110.908 164.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 63.0 m -56.89 -1.59 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 131.041 3.736 . . . . 0.0 118.455 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -88.76 148.37 23.98 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.135 0.974 . . . . 0.0 111.684 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.0 mt -109.67 167.0 10.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.149 0.58 . . . . 0.0 110.837 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 9.9 t -147.06 159.27 43.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 172.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -149.82 125.99 10.68 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.55 1.54 . . . . 0.0 110.585 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.61 138.16 39.94 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 112.549 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -142.5 138.09 30.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.226 1.41 . . . . 0.0 111.457 164.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 10.1 t60 . . . . . 0 C--O 1.237 0.43 0 C-N-CA 124.82 1.248 . . . . 0.0 109.759 174.761 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.6 p90 . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.035 0.445 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.47 99.78 5.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.905 1.282 . . . . 0.0 108.723 169.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.91 162.34 22.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.029 1.332 . . . . 0.0 113.864 -177.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.3 m -92.94 149.47 21.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.424 0.689 . . . . 0.0 109.653 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 77.8 p -136.85 6.28 2.9 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.409 ' CG ' ' HZ2' ' A' ' 326' ' ' LYS . 40.1 t0 -78.63 158.98 28.29 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.467 1.03 . . . . 0.0 111.457 165.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.35 92.15 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.51 2.324 . . . . 0.0 112.635 -167.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 15.3 mtm -76.26 166.96 22.7 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.905 1.282 . . . . 0.0 112.618 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.9 m -158.23 157.23 32.18 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.113 -0.992 . . . . 0.0 112.774 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.42 120.24 25.64 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.52 0.728 . . . . 0.0 110.363 166.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.91 -27.99 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.082 1.753 . . . . 0.0 110.67 165.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -142.63 125.87 16.5 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.532 1.933 . . . . 0.0 108.024 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -57.43 144.88 70.31 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.385 1.074 . . . . 0.0 111.513 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.95 129.33 33.68 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.827 2.351 . . . . 0.0 111.529 170.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 41.2 p -124.21 123.15 39.64 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.373 1.069 . . . . 0.0 110.289 171.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -63.65 136.34 57.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.983 1.313 . . . . 0.0 111.157 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.8 p -89.62 -14.95 33.84 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.326 1.05 . . . . 0.0 113.065 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.24 -12.13 1.31 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.408 1.004 . . . . 0.0 114.405 -164.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -84.57 14.46 4.57 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.903 1.681 . . . . 0.0 112.057 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.37 5.18 63.74 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.679 1.133 . . . . 0.0 114.14 -172.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 64.9 p -131.68 165.86 22.77 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.937 1.368 . . . . 0.0 113.819 -170.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.62 138.09 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 127.854 2.462 . . . . 0.0 107.675 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 6.7 p -119.62 132.16 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.309 0.959 . . . . 0.0 112.517 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -139.92 167.16 22.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.503 1.521 . . . . 0.0 113.454 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -124.0 129.87 51.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.437 1.495 . . . . 0.0 107.583 166.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.52 150.76 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.061 0.944 . . . . 0.0 112.378 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -132.51 142.41 49.19 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.49 1.516 . . . . 0.0 112.818 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.09 148.46 37.53 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 128.226 2.611 . . . . 0.0 108.216 167.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -100.13 -72.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.59 2.193 . . . . 0.0 115.745 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.409 ' HZ2' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -138.79 165.37 27.18 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.556 1.525 . . . . 0.0 114.388 -172.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 69.33 -8.19 3.04 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 126.497 1.999 . . . . 0.0 117.274 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -108.49 99.86 35.2 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 119.078 1.439 . . . . 0.0 113.199 -168.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.99 121.95 6.47 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.789 2.326 . . . . 0.0 108.746 152.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.1 p -165.59 154.17 11.58 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -173.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -83.33 110.77 18.4 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 156.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.257 1.3 pp -67.45 132.29 93.06 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 120.324 -0.55 . . . . 0.0 112.349 -155.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.42 91.47 0.77 Allowed 'Trans proline' 0 CA--C 1.54 0.784 1 C-N-CA 125.449 4.099 . . . . 0.0 113.734 -168.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.09 117.03 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.215 1.406 . . . . 0.0 109.365 166.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.48 162.56 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.206 1.803 . . . . 0.0 109.359 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.62 127.3 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -136.48 174.56 10.49 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -170.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -118.6 -6.68 10.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.028 2.131 . . . . 0.0 112.966 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 29.5 p30 -106.98 0.48 23.75 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.063 2.145 . . . . 0.0 113.61 -166.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 74.7 mt 57.17 5.22 0.24 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.795 2.438 . . . . 0.0 115.734 -170.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.9 t -127.74 -3.12 5.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.427 1.491 . . . . 0.0 114.461 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 52.39 45.72 27.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.919 2.088 . . . . 0.0 113.584 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -72.93 -38.76 66.7 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 163.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 19.1 mm -108.05 128.67 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.774 1.23 . . . . 0.0 109.717 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -97.17 109.31 22.09 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.62 0.724 . . . . 0.0 111.829 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -63.99 -62.98 1.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.752 3.221 . . . . 0.0 112.789 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -104.23 -171.5 25.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.499 1.523 . . . . 0.0 115.756 -160.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 3.3 mm -132.68 152.74 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.755 2.022 . . . . 0.0 111.302 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.9 129.01 34.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.414 1.485 . . . . 0.0 109.507 170.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.35 -36.86 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.266 0.626 . . . . 0.0 110.737 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' THR . . . . . 0.605 ' HB ' ' H ' ' A' ' 366' ' ' GLU . 1.2 m -105.4 162.06 13.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.013 1.325 . . . . 0.0 111.478 175.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.5 m -47.82 107.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 127.367 2.267 . . . . 0.0 114.215 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -73.89 117.66 63.0 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.306 1.042 . . . . 0.0 109.595 162.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -82.33 -175.73 2.63 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.334 3.356 . . . . 0.0 114.118 -171.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 117.79 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.308 2.243 . . . . 0.0 107.808 170.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.67 74.62 0.82 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.547 1.139 . . . . 0.0 112.552 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -69.53 -18.7 63.69 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 23.3 p -123.81 121.27 34.98 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 127.148 2.179 . . . . 0.0 105.936 162.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.43 -18.87 53.84 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -166.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -71.79 3.96 3.7 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.507 1.923 . . . . 0.0 113.791 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -39.59 126.48 1.88 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.593 2.357 . . . . 0.0 113.913 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -141.3 112.1 7.14 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.868 2.067 . . . . 0.0 109.058 -168.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.14 148.37 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -160.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -86.65 124.53 33.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.523 2.729 . . . . 0.0 109.221 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 55.9 mt -135.31 132.21 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.409 0.623 . . . . 0.0 111.2 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . 0.605 ' H ' ' HB ' ' A' ' 351' ' ' THR . 25.0 mp0 -97.36 138.63 34.52 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.648 1.579 . . . . 0.0 111.497 161.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 22.1 t -129.19 153.93 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 127.564 2.345 . . . . 0.0 109.152 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -118.96 114.99 35.01 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.808 2.043 . . . . 0.0 109.576 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -82.81 162.0 16.21 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.207 2.604 . . . . 0.0 110.685 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -74.41 178.46 7.0 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.541 2.16 . . . . 0.0 110.738 163.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -71.02 130.84 42.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.009 1.324 . . . . 0.0 109.733 171.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.55 -143.55 16.34 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.12 0.866 . . . . 0.0 112.884 -176.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.12 152.69 42.15 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.185 2.594 . . . . 0.0 114.477 -173.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 17.0 m -166.36 153.18 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 113.145 167.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -120.53 109.6 15.46 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 128.36 2.664 . . . . 0.0 106.846 165.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 16.3 mm -68.13 120.01 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 172.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 80.7 mt -114.18 126.9 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.488 1.115 . . . . 0.0 109.067 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.8 t -119.69 101.81 11.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.794 1.638 . . . . 0.0 107.176 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 123.07 172.28 13.83 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 123.074 1.374 . . . . 0.0 115.903 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.5 161.05 39.05 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.507 2.323 . . . . 0.0 109.057 173.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.47 -167.42 53.43 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 -163.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -62.36 -31.6 72.27 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.775 -0.838 . . . . 0.0 111.869 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.2 m -55.65 3.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 130.642 3.577 . . . . 0.0 117.875 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -97.1 142.86 28.52 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.401 1.08 . . . . 0.0 111.859 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 22.2 mt -114.93 166.4 11.83 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.77 0.828 . . . . 0.0 110.678 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.2 t -146.1 161.89 39.16 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -145.68 128.38 16.21 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.028 1.731 . . . . 0.0 109.353 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -78.92 138.28 38.02 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.733 1.213 . . . . 0.0 111.67 -175.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -143.12 140.3 30.78 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.704 1.202 . . . . 0.0 111.651 168.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.3 m80 . . . . . 0 CA--C 1.531 0.228 0 C-N-CA 123.765 0.826 . . . . 0.0 109.399 164.286 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.1 p90 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.42 101.37 6.36 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.788 1.235 . . . . 0.0 108.455 166.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.65 153.1 37.43 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.45 1.9 . . . . 0.0 115.003 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 12.8 m -94.08 141.4 28.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.205 1.002 . . . . 0.0 109.319 164.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 80.7 p -135.46 2.52 2.98 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.71 164.1 23.99 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.592 1.087 . . . . 0.0 111.012 166.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -62.01 105.59 0.6 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.286 1.834 . . . . 0.0 112.54 -161.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 30.2 mtm -94.79 163.57 13.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.685 0.755 . . . . 0.0 111.907 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 32.3 m -160.77 156.88 25.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.206 -0.934 . . . . 0.0 112.0 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.69 120.04 19.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.909 0.883 . . . . 0.0 110.665 167.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.86 -29.0 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.35 1.46 . . . . 0.0 109.966 163.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -140.89 133.65 28.89 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.598 1.959 . . . . 0.0 109.329 170.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -59.02 144.2 82.83 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.024 0.929 . . . . 0.0 111.87 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -58.37 138.83 87.95 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.224 1.949 . . . . 0.0 111.9 171.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 35.6 p -133.89 125.13 27.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.195 1.398 . . . . 0.0 111.336 174.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -61.85 122.39 15.29 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.462 1.505 . . . . 0.0 111.537 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 74.6 p -80.79 -13.84 58.61 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.001 1.321 . . . . 0.0 113.83 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.03 -1.44 4.81 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 120.972 -1.08 . . . . 0.0 114.293 -164.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -85.59 12.16 9.25 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.198 1.499 . . . . 0.0 111.263 176.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.26 0.81 88.5 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.003 1.287 . . . . 0.0 113.874 -165.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.2 p -119.15 162.26 18.95 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.136 1.468 . . . . 0.0 112.807 -172.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.3 t -133.85 117.05 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.616 1.566 . . . . 0.0 107.748 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.3 p -104.97 130.03 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.243 1.017 . . . . 0.0 112.825 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -139.07 166.82 23.5 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.787 2.035 . . . . 0.0 111.499 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -135.47 145.08 46.79 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.779 -0.576 . . . . 0.0 111.007 160.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.6 m -137.11 161.14 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.062 1.345 . . . . 0.0 110.833 -168.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -128.78 145.69 51.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.988 1.315 . . . . 0.0 112.258 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.1 t -113.06 147.84 38.15 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 128.523 2.729 . . . . 0.0 107.113 165.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -111.41 -64.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 CA-C-N 122.538 1.942 . . . . 0.0 115.122 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 160.46 38.29 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -172.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.79 -0.08 2.52 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 127.385 2.422 . . . . 0.0 118.653 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.64 93.39 36.92 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 119.994 1.897 . . . . 0.0 114.464 -161.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.6 115.43 3.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.431 2.754 . . . . 0.0 109.864 161.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.2 p -164.2 153.58 13.91 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -172.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.92 105.39 12.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.009 1.723 . . . . 0.0 107.041 159.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.29 0.9 OUTLIER -67.16 120.31 71.27 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.045 -155.051 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.89 111.04 2.08 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.573 3.515 . . . . 0.0 114.237 -167.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.31 114.71 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 126.041 1.736 . . . . 0.0 109.114 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.04 159.03 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 126.659 1.984 . . . . 0.0 109.03 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . 0.402 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 6.2 t -140.64 120.54 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -145.32 171.45 14.57 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.707 1.14 . . . . 0.0 113.385 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.512 ' CG ' ' HZ1' ' A' ' 346' ' ' LYS . 65.7 m-20 -101.11 -3.03 29.97 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.413 0.685 . . . . 0.0 112.67 172.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -112.58 1.95 16.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.819 1.647 . . . . 0.0 114.265 -162.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.1 mt 63.0 -15.58 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.028 2.531 . . . . 0.0 115.645 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.3 t -107.87 -4.39 18.04 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 113.884 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 59.97 61.07 1.96 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.926 2.49 . . . . 0.0 113.126 -171.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -88.09 -39.89 14.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.412 0.685 . . . . 0.0 111.601 166.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 42.3 mm -111.15 105.03 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.587 1.555 . . . . 0.0 110.117 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -78.01 102.2 7.28 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.705 1.139 . . . . 0.0 112.699 172.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . 0.512 ' HZ1' ' CG ' ' A' ' 338' ' ' ASP . 2.1 mmmm -63.82 -53.63 47.76 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.2 2.6 . . . . 0.0 113.0 171.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -116.5 156.76 15.44 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.791 1.476 . . . . 0.0 116.791 -158.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.75 150.69 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.809 2.044 . . . . 0.0 109.772 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.69 130.4 36.75 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.132 1.373 . . . . 0.0 109.597 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 29.8 m -120.53 -30.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.3 m -101.0 152.93 19.99 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 160.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.5 m -48.78 132.33 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.135 1.774 . . . . 0.0 114.812 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -110.19 119.34 47.35 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.191 1.796 . . . . 0.0 108.337 168.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.88 -179.02 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.876 3.051 . . . . 0.0 114.394 -166.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.67 110.39 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 127.911 2.485 . . . . 0.0 106.517 169.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.89 84.05 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.537 1.535 . . . . 0.0 111.957 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 25.4 t -75.35 -8.93 57.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 166.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 13.6 p -131.25 128.47 39.93 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.997 2.119 . . . . 0.0 107.245 164.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.28 -19.25 65.28 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -172.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -84.66 6.99 21.88 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.64 1.176 . . . . 0.0 113.43 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -47.58 133.64 13.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.485 1.514 . . . . 0.0 113.582 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -138.54 132.59 31.39 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.087 1.355 . . . . 0.0 110.542 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.93 146.98 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -158.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.39 124.98 35.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.615 2.766 . . . . 0.0 109.799 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 12.7 mt -135.71 150.03 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.35 1.46 . . . . 0.0 109.859 -170.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -123.51 146.56 47.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.806 0.842 . . . . 0.0 111.223 163.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.25 151.96 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 124.664 1.186 . . . . 0.0 111.381 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -121.75 100.9 43.26 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.021 2.128 . . . . 0.0 109.499 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.63 168.93 12.45 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 123.677 2.918 . . . . 0.0 110.936 160.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.85 179.91 4.86 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.728 2.285 . . . . 0.0 111.046 166.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -58.12 145.24 37.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.288 0.635 . . . . 0.0 110.742 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.15 -163.96 28.18 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 121.783 0.657 . . . . 0.0 114.062 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.41 157.38 34.25 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.655 1.982 . . . . 0.0 114.778 -164.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.2 m -173.94 164.09 4.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.039 2.135 . . . . 0.0 112.203 169.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -122.47 117.21 25.41 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.83 2.852 . . . . 0.0 108.127 164.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mm -68.68 136.46 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 167.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 67.9 mt -127.94 123.76 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.977 1.311 . . . . 0.0 108.694 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 53.3 t -110.62 109.6 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.885 1.674 . . . . 0.0 107.363 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 117.2 171.82 15.84 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 122.923 1.291 . . . . 0.0 115.746 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.79 166.09 25.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.314 2.246 . . . . 0.0 109.329 169.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 68.61 -165.26 47.77 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 -166.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -64.65 -26.37 68.36 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.794 0.837 . . . . 0.0 112.539 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.7 m -64.72 4.39 0.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 129.105 2.962 . . . . 0.0 117.026 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -93.77 140.93 29.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.044 0.838 . . . . 0.0 112.659 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 20.8 mt -113.45 164.62 13.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.742 1.217 . . . . 0.0 110.701 173.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.0 t -146.66 160.78 41.77 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -151.07 127.62 10.78 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.849 1.66 . . . . 0.0 110.341 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -76.46 134.35 39.57 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.766 1.226 . . . . 0.0 111.894 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -143.67 135.5 26.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.687 1.195 . . . . 0.0 111.274 171.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 174.415 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 p90 . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.05 101.17 2.67 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 164.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.99 154.93 41.31 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.182 1.793 . . . . 0.0 113.831 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 141.25 38.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 162.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 76.0 p -130.94 10.48 5.02 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.906 0.883 . . . . 0.0 113.234 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -79.38 161.36 26.23 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.895 0.77 . . . . 0.0 110.981 165.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -65.22 103.76 0.83 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.127 2.171 . . . . 0.0 112.358 -163.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 33.6 mtt -83.71 168.5 16.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.961 0.886 . . . . 0.0 113.035 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.3 m -157.34 160.18 38.24 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.436 -0.79 . . . . 0.0 111.721 156.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -82.67 120.12 25.16 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.272 0.629 . . . . 0.0 110.155 166.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 22.6 t -66.61 -30.76 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.184 1.394 . . . . 0.0 110.698 163.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -142.17 123.33 14.65 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.557 1.943 . . . . 0.0 107.651 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -57.8 154.54 26.54 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.241 0.616 . . . . 0.0 111.797 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -56.22 124.39 16.14 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.876 2.384 . . . . 0.0 111.909 165.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.8 p -129.81 128.75 42.96 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.419 1.088 . . . . 0.0 111.569 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -61.78 126.75 28.45 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.344 0.658 . . . . 0.0 110.412 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.2 p -79.09 -12.97 60.02 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.818 1.247 . . . . 0.0 113.128 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.04 -6.69 1.98 Allowed Glycine 0 CA--C 1.539 1.553 0 CA-C-N 119.186 0.903 . . . . 0.0 114.231 -164.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -87.84 2.05 52.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.599 1.559 . . . . 0.0 111.643 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.99 2.31 39.25 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.756 1.646 . . . . 0.0 114.022 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.9 p -128.97 166.32 19.4 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.017 1.327 . . . . 0.0 111.975 -168.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 6.8 t -131.24 111.77 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.64 1.576 . . . . 0.0 108.377 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.58 137.07 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.064 1.346 . . . . 0.0 112.993 -168.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -142.47 164.45 30.11 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.998 2.119 . . . . 0.0 112.772 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -118.31 132.12 56.3 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.816 1.246 . . . . 0.0 108.016 161.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.3 152.44 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.741 0.817 . . . . 0.0 111.095 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -135.07 148.23 49.81 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.013 1.325 . . . . 0.0 112.327 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.43 150.65 46.92 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 128.043 2.537 . . . . 0.0 108.173 169.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -105.66 -68.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.366 2.044 . . . . 0.0 114.466 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 167.79 20.11 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -171.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.75 -6.73 0.32 Allowed Glycine 0 CA--C 1.537 1.46 0 C-N-CA 127.596 2.522 . . . . 0.0 118.496 170.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.15 94.03 37.42 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 119.872 1.836 . . . . 0.0 114.754 -160.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.8 121.32 7.26 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.753 2.302 . . . . 0.0 109.956 157.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.0 p -163.34 157.43 20.09 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -175.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -90.84 98.71 11.94 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 160.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.255 1.0 OUTLIER -60.9 123.03 73.2 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.811 -154.024 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.97 116.84 4.86 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.206 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 88.1 t -125.52 112.02 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.234 1.814 . . . . 0.0 109.812 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 157.41 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.362 1.065 . . . . 0.0 110.339 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 39.0 t -137.54 112.02 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -135.98 167.0 22.03 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -167.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -101.13 -2.4 31.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.671 0.788 . . . . 0.0 112.387 174.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 27.2 p30 -114.48 2.83 14.74 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.578 1.951 . . . . 0.0 113.723 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 20.4 mt 62.78 5.13 1.64 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.544 2.338 . . . . 0.0 115.436 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.9 t -135.94 -10.52 2.04 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 61.29 58.76 2.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.84 2.456 . . . . 0.0 113.83 -171.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.44 -36.12 58.13 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.189 152.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 15.8 mm -120.1 111.19 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.126 1.77 . . . . 0.0 109.956 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -89.67 120.25 30.79 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.294 -0.879 . . . . 0.0 112.241 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -72.3 -63.24 1.19 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.937 2.495 . . . . 0.0 111.722 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -106.2 161.03 14.37 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 116.903 1.521 . . . . 0.0 116.903 -155.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -104.39 152.25 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 127.108 2.163 . . . . 0.0 110.553 -173.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.12 125.9 30.03 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.288 1.435 . . . . 0.0 109.568 169.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 66.6 t -94.4 -45.84 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.426 0.69 . . . . 0.0 111.219 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.5 t -105.05 -179.15 3.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.413 0.685 . . . . 0.0 112.031 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 29.5 m -53.72 123.14 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.574 1.55 . . . . 0.0 113.168 -176.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -95.03 119.3 66.06 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.097 0.959 . . . . 0.0 108.84 165.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -80.36 179.61 6.0 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.984 3.123 . . . . 0.0 113.583 -167.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.89 114.74 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.834 2.054 . . . . 0.0 106.961 167.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.02 71.72 0.17 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.815 1.246 . . . . 0.0 111.547 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 26.4 t -69.15 -8.85 49.34 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.247 -0.908 . . . . 0.0 112.507 163.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 41.0 p -128.13 116.9 20.66 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 128.408 2.683 . . . . 0.0 106.501 166.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -53.34 -20.97 4.96 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -77.08 4.09 11.0 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.352 1.861 . . . . 0.0 113.604 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -41.45 127.8 3.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.503 1.921 . . . . 0.0 113.957 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.13 146.92 43.4 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.303 1.041 . . . . 0.0 111.356 171.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.7 p -156.83 145.81 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -163.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.14 121.3 23.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.366 2.267 . . . . 0.0 108.78 164.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.93 142.15 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.678 0.672 . . . . 0.0 111.076 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -114.39 139.18 49.7 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.144 1.778 . . . . 0.0 110.491 166.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.16 163.7 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.61 1.164 . . . . 0.0 111.547 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -131.25 98.79 18.2 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.244 1.817 . . . . 0.0 109.518 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -75.33 161.93 37.04 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.052 2.501 . . . . 0.0 111.458 160.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.21 -176.48 2.7 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.631 2.887 . . . . 0.0 111.154 163.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -55.75 151.68 10.78 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.124 1.37 . . . . 0.0 112.734 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 79.45 -159.06 44.26 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 121.283 0.38 . . . . 0.0 113.668 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -62.23 156.08 22.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.503 1.521 . . . . 0.0 114.116 -167.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.4 m -168.58 161.5 11.54 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.112 1.765 . . . . 0.0 111.946 165.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -122.33 113.48 19.47 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.944 2.098 . . . . 0.0 108.052 166.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.4 mm -74.03 120.3 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 79.4 mt -116.4 127.63 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.243 1.417 . . . . 0.0 109.566 -174.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 70.3 t -118.36 105.22 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 126.417 1.887 . . . . 0.0 108.12 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 111.5 175.83 20.13 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 122.485 1.047 . . . . 0.0 115.256 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 1.8 p -134.74 164.86 26.58 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.359 1.864 . . . . 0.0 110.548 169.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 82.64 -170.03 49.68 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 123.827 0.727 . . . . 0.0 112.594 -168.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -63.39 -29.96 71.17 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.995 -1.297 . . . . 0.0 111.317 165.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 27.3 m -55.66 1.35 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 131.478 3.911 . . . . 0.0 118.101 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -102.04 147.11 26.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.484 1.513 . . . . 0.0 111.573 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 40.9 mt -119.62 165.76 14.05 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.585 0.754 . . . . 0.0 111.036 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.1 t -148.32 158.97 44.42 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -141.55 137.81 32.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.838 1.655 . . . . 0.0 109.537 174.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -76.93 145.25 38.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.098 1.359 . . . . 0.0 111.927 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -140.34 159.38 42.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.831 1.252 . . . . 0.0 111.992 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 . . . . . 0 CA--C 1.533 0.311 0 C-N-CA 125.633 1.573 . . . . 0.0 107.553 173.978 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.9 p90 . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 120.828 0.347 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.87 92.74 1.63 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 169.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.54 152.15 46.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.344 2.258 . . . . 0.0 115.051 -175.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 22.4 m -91.73 145.21 24.76 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.083 0.953 . . . . 0.0 109.433 163.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 41.9 p -136.15 0.75 2.63 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -84.63 155.91 21.8 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.464 1.483 . . . . 0.0 111.307 168.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 100.48 0.05 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.552 1.941 . . . . 0.0 113.131 -163.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 31.7 mtm -86.97 168.75 13.06 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.579 1.152 . . . . 0.0 111.999 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 37.6 m -159.61 164.62 33.99 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.997 -1.064 . . . . 0.0 112.265 168.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.48 124.78 32.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.002 0.521 . . . . 0.0 110.362 163.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.8 t -70.52 -31.14 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.396 1.478 . . . . 0.0 110.269 163.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -135.92 124.47 23.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.904 2.082 . . . . 0.0 107.795 165.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -61.21 151.95 74.0 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.446 0.698 . . . . 0.0 112.572 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.39 134.13 55.98 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.529 2.82 . . . . 0.0 113.295 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.9 p -136.32 129.39 31.31 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.809 1.244 . . . . 0.0 111.929 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -53.71 123.1 11.33 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.333 1.453 . . . . 0.0 110.884 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 52.1 p -82.56 -10.72 58.86 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.964 0.905 . . . . 0.0 113.361 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 76.7 -6.93 36.36 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.889 1.233 . . . . 0.0 114.381 -168.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -102.7 18.94 20.16 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.042 1.421 . . . . 0.0 112.487 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.97 7.23 81.12 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.174 0.893 . . . . 0.0 113.41 -172.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 18.1 p -127.69 165.74 19.45 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.469 1.108 . . . . 0.0 112.295 -174.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.97 123.35 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 126.363 1.865 . . . . 0.0 107.701 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.3 135.06 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.304 1.041 . . . . 0.0 113.202 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -141.13 164.38 30.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.231 1.812 . . . . 0.0 112.998 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -121.74 126.05 48.0 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.191 1.396 . . . . 0.0 107.318 166.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.7 155.39 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.295 0.952 . . . . 0.0 112.204 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -140.32 147.75 40.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.351 1.46 . . . . 0.0 113.087 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 12.2 t -113.0 154.08 45.09 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 128.495 2.718 . . . . 0.0 108.486 167.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -108.32 -63.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.811 2.341 . . . . 0.0 115.187 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.27 170.53 15.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.358 1.063 . . . . 0.0 113.03 -173.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.53 -21.65 0.13 Allowed Glycine 0 CA--C 1.537 1.465 0 C-N-CA 127.676 2.56 . . . . 0.0 118.284 167.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.09 100.42 15.09 Favored Pre-proline 0 CA--C 1.552 1.043 0 CA-C-N 119.522 1.661 . . . . 0.0 113.936 -168.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.56 115.94 3.98 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.184 2.589 . . . . 0.0 109.198 158.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.7 p -162.79 154.69 18.26 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -170.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -78.46 112.24 15.31 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 155.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.283 1.1 pp -64.51 118.59 49.08 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.508 -163.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.25 113.67 1.77 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 124.039 3.16 . . . . 0.0 113.683 -172.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 69.2 t -121.88 111.41 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 125.428 1.491 . . . . 0.0 108.675 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.61 155.87 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.006 1.322 . . . . 0.0 110.108 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.5 t -140.31 111.89 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.62 -178.84 5.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.761 1.164 . . . . 0.0 113.287 -167.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.479 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 70.7 m-20 -112.73 2.59 16.12 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.674 0.79 . . . . 0.0 112.988 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -126.49 8.7 7.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.366 1.466 . . . . 0.0 114.074 -157.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 50.7 mt 60.51 -14.81 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.123 2.569 . . . . 0.0 116.25 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.6 t -111.61 -9.88 14.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.133 1.333 . . . . 0.0 113.793 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 69.67 44.02 0.92 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.94 2.496 . . . . 0.0 113.148 -171.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.82 -46.96 82.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.464 0.306 . . . . 0.0 110.905 166.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 17.8 mm -118.3 99.5 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.588 1.155 . . . . 0.0 110.489 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -70.42 105.38 3.03 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 121.086 -1.009 . . . . 0.0 112.66 172.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . 0.479 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 2.7 mmmm -65.86 -56.88 9.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 129.586 3.155 . . . . 0.0 113.233 171.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -103.36 -178.65 26.15 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 -160.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mm -124.9 160.34 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.842 2.457 . . . . 0.0 111.23 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.32 130.74 35.17 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.797 1.239 . . . . 0.0 110.125 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 85.2 t -92.46 -19.66 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.34 0.656 . . . . 0.0 111.096 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.1 t -137.76 174.43 10.58 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.366 1.067 . . . . 0.0 112.765 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.55 95.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 127.051 2.141 . . . . 0.0 113.687 -171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -57.83 119.1 31.03 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.512 1.125 . . . . 0.0 110.692 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -80.76 -176.62 3.26 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.337 3.358 . . . . 0.0 113.384 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.06 122.73 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.8 1.64 . . . . 0.0 107.883 171.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.01 64.28 0.33 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.799 1.64 . . . . 0.0 112.779 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 30.6 t -66.13 -10.81 44.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.591 1.156 . . . . 0.0 113.113 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 40.2 p -134.2 117.88 17.0 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.84 2.856 . . . . 0.0 106.475 163.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -61.4 -13.23 18.4 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -165.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -75.79 1.07 15.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.717 1.607 . . . . 0.0 114.012 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -35.56 119.7 0.54 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.455 2.302 . . . . 0.0 113.932 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.02 145.46 50.86 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.589 1.155 . . . . 0.0 112.183 170.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.32 147.16 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -160.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -78.73 123.42 27.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.766 2.426 . . . . 0.0 109.744 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 52.9 mt -132.81 137.34 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.485 0.66 . . . . 0.0 111.055 174.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -105.26 140.96 37.61 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.949 1.3 . . . . 0.0 110.827 160.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 20.2 m -122.6 158.32 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.547 1.139 . . . . 0.0 111.298 168.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -118.02 101.53 51.64 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.52 1.928 . . . . 0.0 108.736 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.96 159.57 37.76 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.093 1.862 . . . . 0.0 110.304 163.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -57.7 171.35 1.5 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.702 2.268 . . . . 0.0 112.094 159.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -62.18 147.81 46.56 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.464 -0.772 . . . . 0.0 109.993 157.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.31 -171.29 23.14 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 122.57 1.095 . . . . 0.0 113.185 -169.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -72.7 163.36 28.21 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.313 -1.11 . . . . 0.0 113.802 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.9 m -164.62 170.36 15.81 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.187 1.395 . . . . 0.0 112.222 164.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -124.95 114.49 19.21 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 129.381 3.073 . . . . 0.0 106.43 163.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.1 mm -71.74 135.02 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 74.8 mt -129.42 128.03 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 125.238 1.415 . . . . 0.0 108.83 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 83.9 t -118.71 105.02 16.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 126.196 1.798 . . . . 0.0 107.6 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.23 175.42 21.99 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 123.052 1.362 . . . . 0.0 115.935 175.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.82 167.61 21.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.656 2.382 . . . . 0.0 110.113 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 85.31 -156.9 31.19 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 123.356 0.503 . . . . 0.0 111.909 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -67.59 -36.8 81.56 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.534 0.667 . . . . 0.0 110.805 161.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.3 m -51.54 11.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 1 C-N-CA 132.981 4.513 . . . . 0.0 119.546 -173.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -114.36 139.58 49.35 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.63 1.105 . . . . 0.0 112.176 -165.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 30.9 mt -111.57 161.55 16.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.431 0.692 . . . . 0.0 110.252 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.8 t -145.57 156.64 43.82 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.047 0.539 . . . . 0.0 112.36 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -142.27 121.7 13.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.211 1.405 . . . . 0.0 109.812 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -67.92 134.42 50.78 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.194 1.397 . . . . 0.0 111.341 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -136.87 161.1 36.94 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 123.097 1.427 . . . . 0.0 112.592 173.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 . . . . . 0 N--CA 1.451 -0.42 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.56 -172.822 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 27.6 p90 . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 120.826 0.346 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.04 101.57 13.59 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.055 1.342 . . . . 0.0 107.611 168.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.09 149.8 39.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.216 2.206 . . . . 0.0 114.89 -171.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 4.7 m -86.52 144.52 27.19 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 164.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 61.1 p -137.37 0.73 2.33 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -71.32 166.17 22.17 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.603 1.092 . . . . 0.0 110.089 165.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -69.43 109.51 4.25 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.194 0.998 . . . . 0.0 111.203 -165.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 34.5 mtm -94.82 166.59 11.9 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.544 1.138 . . . . 0.0 112.255 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 58.5 m -160.89 157.75 27.08 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.734 1.214 . . . . 0.0 110.168 165.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.73 125.44 29.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.153 160.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 45.6 t -71.12 -18.92 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 126.18 1.792 . . . . 0.0 110.807 166.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -147.57 112.67 5.49 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.601 2.361 . . . . 0.0 106.76 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -55.31 147.59 36.1 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 118.553 0.615 . . . . 0.0 110.04 171.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.81 145.13 99.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.175 1.25 . . . . 0.0 111.168 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 23.3 p -131.24 135.98 47.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.222 1.409 . . . . 0.0 110.791 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -58.31 121.46 10.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.828 1.251 . . . . 0.0 110.601 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 60.1 p -81.78 -13.82 57.22 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.51 -0.96 7.89 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-N 119.391 0.996 . . . . 0.0 114.052 -165.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -95.11 8.22 43.65 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.257 1.528 . . . . 0.0 111.771 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.85 10.71 58.57 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.642 1.115 . . . . 0.0 114.056 -171.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 16.2 p -136.25 169.86 16.96 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.476 1.138 . . . . 0.0 112.741 -169.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.69 127.31 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.994 2.118 . . . . 0.0 108.829 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 11.3 p -118.15 124.15 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -163.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -130.95 157.17 43.67 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.694 1.598 . . . . 0.0 114.291 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -106.36 137.89 43.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.34 1.456 . . . . 0.0 107.215 161.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.56 136.99 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.739 1.216 . . . . 0.0 110.704 -175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -122.64 144.2 49.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.052 0.941 . . . . 0.0 112.199 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.7 143.59 31.67 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.746 2.818 . . . . 0.0 106.613 170.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -109.85 -63.68 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 CA-C-N 121.881 1.707 . . . . 0.0 115.875 -174.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 169.16 18.05 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 120.613 1.552 . . . . 0.0 113.233 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 68.6 -6.0 3.86 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.447 1.975 . . . . 0.0 117.341 169.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.61 102.07 45.32 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 119.135 1.468 . . . . 0.0 113.306 -163.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.29 118.42 2.94 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.249 2.632 . . . . 0.0 110.051 154.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.7 p -163.17 146.98 10.88 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -172.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -72.98 117.51 14.8 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 154.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.297 0.8 OUTLIER -69.89 122.65 86.69 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.884 -160.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.65 110.09 2.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 1 C-N-CA 125.781 4.32 . . . . 0.0 112.894 -166.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 98.6 t -122.66 124.79 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.534 1.534 . . . . 0.0 110.653 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.51 156.93 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.089 1.355 . . . . 0.0 110.817 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . 0.533 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 40.5 t -136.32 129.52 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -147.65 174.2 12.0 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.974 0.796 . . . . 0.0 112.145 -172.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -101.29 -1.01 34.65 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.513 0.725 . . . . 0.0 112.14 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -128.46 8.18 5.91 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -152.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 59.7 mt 62.51 -22.94 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.653 2.381 . . . . 0.0 115.95 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.1 t -106.99 -7.87 16.8 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.849 1.26 . . . . 0.0 113.873 -172.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . 0.261 . . 71.72 32.76 1.9 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.331 2.653 . . . . 0.0 113.917 -177.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -59.1 -46.27 88.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.684 0.394 . . . . 0.0 110.767 169.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 16.0 mm -96.81 129.23 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.596 1.158 . . . . 0.0 109.095 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.65 64.17 0.8 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 123.042 1.401 . . . . 0.0 112.18 -174.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -66.2 -45.62 80.13 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 128.623 2.769 . . . . 0.0 116.544 -156.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . 0.533 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -107.33 -175.32 22.61 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.799 1.666 . . . . 0.0 115.282 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.35 145.67 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 125.165 1.386 . . . . 0.0 112.305 -174.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.49 118.34 12.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.791 1.636 . . . . 0.0 109.688 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.9 t -87.84 -52.23 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.902 0.774 . . . . 0.0 111.647 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.4 t -84.44 171.87 12.2 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.647 0.737 . . . . 0.0 111.642 170.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.28 120.28 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.201 1.0 . . . . 0.0 111.761 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -79.32 128.17 76.43 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.282 1.433 . . . . 0.0 110.499 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.75 -168.14 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 124.906 3.737 . . . . 0.0 113.493 -168.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.12 123.51 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.782 1.633 . . . . 0.0 109.009 172.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.23 80.74 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.503 1.121 . . . . 0.0 110.756 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 47.6 t -69.2 -25.53 64.37 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.585 -0.697 . . . . 0.0 111.303 163.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 21.5 p -120.93 124.54 45.18 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.246 2.619 . . . . 0.0 107.425 169.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -59.19 -23.81 62.57 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -168.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.15 3.9 1.9 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.359 1.863 . . . . 0.0 114.337 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -45.91 135.0 7.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.567 1.547 . . . . 0.0 113.792 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -150.87 111.51 4.24 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.963 1.705 . . . . 0.0 108.61 -165.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.98 153.43 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -165.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -80.38 123.72 28.26 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 128.117 2.567 . . . . 0.0 109.383 165.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.34 143.07 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.138 0.881 . . . . 0.0 111.922 169.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -108.98 142.16 40.05 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.187 1.795 . . . . 0.0 111.224 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.47 152.77 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.703 0.801 . . . . 0.0 111.326 170.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -109.0 116.82 54.98 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.398 1.879 . . . . 0.0 109.807 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -91.18 145.91 3.51 Favored 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 123.771 2.98 . . . . 0.0 111.096 166.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.14 171.57 1.65 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.231 2.621 . . . . 0.0 112.582 153.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -61.71 140.78 58.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.115 0.566 . . . . 0.0 110.724 170.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 95.97 -164.63 23.89 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-O 122.749 1.194 . . . . 0.0 115.803 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.89 155.05 11.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 129.095 2.958 . . . . 0.0 113.618 -169.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.8 m -173.95 162.56 3.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.234 1.414 . . . . 0.0 113.409 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -129.22 115.99 18.49 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 130.986 3.714 . . . . 0.0 107.909 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.3 mm -82.5 118.71 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 26.3 mt -108.83 126.07 65.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.413 1.085 . . . . 0.0 108.605 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.7 110.8 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.823 1.649 . . . . 0.0 106.942 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 116.25 172.29 16.55 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 124.043 1.913 . . . . 0.0 116.343 174.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.69 162.76 36.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.736 2.414 . . . . 0.0 109.175 177.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.59 -167.37 52.29 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -162.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.36 -26.35 68.72 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.787 -0.831 . . . . 0.0 111.918 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 64.0 m -63.29 3.19 0.3 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 128.822 2.849 . . . . 0.0 116.329 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -87.43 123.68 32.62 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.149 0.886 . . . . 0.0 111.41 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.71 162.58 12.82 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 172.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.3 t -140.23 155.03 47.05 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.5 133.11 47.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.22 1.408 . . . . 0.0 109.218 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -75.3 133.06 41.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.629 1.571 . . . . 0.0 111.071 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -141.94 106.28 4.81 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.096 0.959 . . . . 0.0 112.559 175.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 C--N 1.33 -0.24 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.801 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.9 p90 . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 120.88 0.371 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.81 101.36 1.32 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 161.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.06 157.48 22.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.493 1.917 . . . . 0.0 114.171 -173.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 12.1 m -92.66 142.77 27.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.3 0.64 . . . . 0.0 109.958 170.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 80.4 p -136.71 5.98 2.92 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 174.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -83.61 164.81 19.49 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.92 1.236 . . . . 0.0 110.738 165.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -66.49 92.94 0.21 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.785 2.434 . . . . 0.0 112.173 -161.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' MET . . . . . 0.427 ' HE2' ' H ' ' A' ' 380' ' ' THR . 33.4 mtm -80.66 166.52 20.99 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.204 1.002 . . . . 0.0 112.381 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.5 m -158.87 157.76 32.11 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.287 -0.883 . . . . 0.0 112.531 167.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.03 120.03 24.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.418 0.687 . . . . 0.0 109.847 159.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.94 -25.03 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.638 1.175 . . . . 0.0 110.845 169.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -140.01 130.49 25.52 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.121 2.168 . . . . 0.0 108.034 168.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -60.86 144.89 89.56 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.624 1.169 . . . . 0.0 112.324 172.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.02 137.9 78.72 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.76 2.307 . . . . 0.0 112.145 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 37.2 p -132.32 126.74 34.02 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.259 1.424 . . . . 0.0 111.05 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -59.83 121.56 12.04 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.447 1.099 . . . . 0.0 110.569 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 65.3 p -80.19 -10.45 59.76 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.944 1.298 . . . . 0.0 113.123 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.13 -8.34 1.39 Allowed Glycine 0 CA--C 1.538 1.503 0 CA-C-N 119.186 0.903 . . . . 0.0 114.389 -166.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -82.71 2.59 32.96 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.251 1.525 . . . . 0.0 111.863 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.94 5.35 61.07 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.253 1.406 . . . . 0.0 113.413 -169.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 16.3 p -123.69 161.78 24.41 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.623 1.211 . . . . 0.0 112.039 -175.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 6.7 t -133.92 112.59 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.218 1.407 . . . . 0.0 107.863 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.0 p -108.87 130.88 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.383 1.073 . . . . 0.0 113.668 -160.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -140.84 163.27 33.38 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.936 2.094 . . . . 0.0 112.901 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -114.12 131.39 56.43 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.979 1.312 . . . . 0.0 107.585 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.04 153.72 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.413 1.006 . . . . 0.0 112.307 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -140.42 147.8 40.24 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.625 1.57 . . . . 0.0 113.071 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.46 147.7 38.61 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 128.14 2.576 . . . . 0.0 107.633 162.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -106.14 -56.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.057 0 CA-C-N 122.899 2.071 . . . . 0.0 115.816 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 172.35 12.94 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.944 -1.098 . . . . 0.0 112.293 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.99 0.58 7.42 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 117.354 1.702 . . . . 0.0 117.354 169.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.34 94.08 48.72 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 118.91 1.355 . . . . 0.0 113.065 -162.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.57 117.45 3.38 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.398 2.732 . . . . 0.0 108.984 156.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.9 p -166.54 155.31 10.7 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -174.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.31 111.2 15.32 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 154.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.16 116.17 23.05 Favored Pre-proline 0 CA--C 1.557 1.237 0 CA-C-O 119.056 -0.497 . . . . 0.0 111.651 -163.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -62.81 117.33 4.23 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.932 3.088 . . . . 0.0 113.912 -172.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.98 107.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.675 1.19 . . . . 0.0 110.131 173.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.43 157.82 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.437 1.495 . . . . 0.0 109.453 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 91.0 t -137.9 121.12 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -135.3 172.27 13.24 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -167.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -104.9 -0.42 27.07 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.712 1.205 . . . . 0.0 112.403 170.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -129.02 7.9 5.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.071 1.348 . . . . 0.0 114.575 -157.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.8 mt 67.46 -8.31 0.49 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.621 2.369 . . . . 0.0 115.644 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 7.8 t -129.14 -9.73 4.77 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 120.726 1.603 . . . . 0.0 115.235 -174.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 69.5 44.58 0.9 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.702 2.401 . . . . 0.0 113.114 -170.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.08 72.13 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.202 158.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 27.3 mt -125.2 109.65 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 127.611 2.365 . . . . 0.0 107.939 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -77.2 118.14 19.43 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.333 0.97 . . . . 0.0 110.382 162.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -77.68 -62.97 1.49 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.634 2.774 . . . . 0.0 111.498 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -112.19 171.14 13.93 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 117.086 1.594 . . . . 0.0 117.086 -162.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mm -109.91 156.33 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.95 2.1 . . . . 0.0 111.589 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.56 136.06 34.93 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.227 1.411 . . . . 0.0 109.696 170.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.7 t -110.48 -61.64 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.186 0.594 . . . . 0.0 110.374 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.8 m -79.98 153.3 28.99 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.756 0.822 . . . . 0.0 109.645 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.6 m -51.54 144.53 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.865 2.066 . . . . 0.0 115.471 -167.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -112.02 111.65 53.3 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.986 1.714 . . . . 0.0 108.845 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.16 -171.48 1.09 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.493 3.462 . . . . 0.0 113.866 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.71 117.15 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 127.575 2.35 . . . . 0.0 107.066 168.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.84 71.06 0.21 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.691 1.996 . . . . 0.0 112.559 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.0 t -67.79 -14.9 63.33 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.422 -0.799 . . . . 0.0 112.913 167.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 10.2 p -116.25 129.15 56.14 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 127.041 2.137 . . . . 0.0 106.959 161.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -66.83 -14.87 63.17 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -173.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.11 6.3 26.16 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.515 1.926 . . . . 0.0 113.407 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -42.95 124.43 3.14 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.427 1.891 . . . . 0.0 113.715 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.15 148.15 46.42 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.613 1.165 . . . . 0.0 111.529 172.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.55 152.52 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.658 0.742 . . . . 0.0 112.482 -164.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.0 123.24 31.89 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.796 2.439 . . . . 0.0 108.929 169.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 42.7 mt -130.99 149.75 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.863 0.865 . . . . 0.0 110.678 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -121.18 142.01 50.3 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.567 1.547 . . . . 0.0 110.569 167.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.36 153.92 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.387 0.675 . . . . 0.0 111.595 167.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -117.46 99.42 52.5 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 127.134 2.174 . . . . 0.0 108.536 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -80.86 161.8 21.15 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.675 2.25 . . . . 0.0 110.65 165.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.83 -174.42 1.51 Allowed 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.776 2.318 . . . . 0.0 110.604 158.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -61.28 160.71 10.13 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.446 -0.784 . . . . 0.0 111.859 164.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 97.58 -177.8 32.17 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.318 1.437 . . . . 0.0 113.445 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.26 163.06 16.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.46 1.504 . . . . 0.0 112.866 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.1 m -162.51 154.36 18.47 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.119 -0.988 . . . . 0.0 112.533 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -120.16 104.81 10.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.796 2.439 . . . . 0.0 106.966 166.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.2 mm -70.15 121.31 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 64.3 mt -118.28 125.28 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.943 1.297 . . . . 0.0 109.108 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.8 103.78 15.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.18 1.792 . . . . 0.0 107.815 -177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.87 177.71 23.75 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 123.308 1.505 . . . . 0.0 116.511 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' THR . . . . . 0.427 ' H ' ' HE2' ' A' ' 304' ' ' MET . 2.2 p -134.91 172.22 13.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.031 2.532 . . . . 0.0 110.722 175.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 81.64 -162.2 43.13 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 123.617 0.627 . . . . 0.0 111.642 -168.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -67.25 -38.04 84.49 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.717 -0.872 . . . . 0.0 110.764 162.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 47.2 m -53.81 8.12 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.54 1 C-N-CA 132.127 4.171 . . . . 0.0 119.016 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -99.88 146.91 26.1 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.108 1.363 . . . . 0.0 111.835 -172.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 19.7 mt -114.55 165.94 12.24 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.505 0.722 . . . . 0.0 110.918 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.6 t -146.82 158.17 43.85 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -139.2 132.04 29.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.943 1.697 . . . . 0.0 110.089 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -80.73 138.76 36.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.976 1.31 . . . . 0.0 112.193 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -132.51 159.79 38.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.702 1.601 . . . . 0.0 110.861 165.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 . . . . . 0 C--O 1.235 0.312 0 C-N-CA 125.168 1.387 . . . . 0.0 108.534 -177.099 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 42.8 p90 . . . . . 0 CA--C 1.541 0.604 0 CA-C-O 120.885 0.374 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.01 109.93 14.92 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -77.96 153.52 32.4 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.976 1.711 . . . . 0.0 114.745 -172.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -99.41 145.42 27.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.894 0.877 . . . . 0.0 108.974 162.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 53.0 p -135.0 10.5 3.58 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -75.96 160.8 29.5 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.086 0.857 . . . . 0.0 110.934 164.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -63.01 97.19 0.1 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.829 2.052 . . . . 0.0 111.506 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 5.9 mtm -76.66 164.79 25.56 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.001 0.92 . . . . 0.0 112.451 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 25.9 m -158.7 154.47 26.41 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.234 -0.916 . . . . 0.0 112.458 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 121.08 29.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.341 0.656 . . . . 0.0 110.106 170.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.8 t -70.12 -23.75 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.352 1.061 . . . . 0.0 110.488 164.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -144.86 119.41 9.72 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.716 2.006 . . . . 0.0 108.72 169.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -55.13 142.69 56.85 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.906 1.283 . . . . 0.0 111.315 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -51.59 134.88 47.59 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.865 2.377 . . . . 0.0 113.423 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.13 127.41 35.92 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.505 1.122 . . . . 0.0 111.693 173.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.24 124.93 21.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.053 0.541 . . . . 0.0 111.085 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 19.0 p -83.25 -8.32 59.47 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.268 1.027 . . . . 0.0 113.481 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 79.31 -14.62 15.15 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.481 1.038 . . . . 0.0 114.671 -169.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -87.14 5.84 35.86 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.479 1.64 . . . . 0.0 112.984 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.35 2.92 65.42 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.834 1.206 . . . . 0.0 113.743 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.8 p -115.69 165.73 12.72 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.322 1.449 . . . . 0.0 111.585 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.6 115.48 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.853 1.661 . . . . 0.0 108.87 -178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.8 p -102.78 130.95 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.567 1.547 . . . . 0.0 113.29 -167.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -137.76 164.2 29.47 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.536 1.934 . . . . 0.0 112.827 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -123.17 124.6 43.42 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.086 1.354 . . . . 0.0 107.718 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.14 138.22 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.071 0.948 . . . . 0.0 112.069 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -117.76 143.16 46.49 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.064 1.746 . . . . 0.0 111.501 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 10.2 t -111.79 149.95 41.56 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.354 1.862 . . . . 0.0 108.001 165.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -105.97 -74.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 122.038 1.825 . . . . 0.0 114.906 -172.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.88 165.84 25.02 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 121.323 1.874 . . . . 0.0 114.642 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 71.9 -4.87 14.54 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.053 1.787 . . . . 0.0 116.279 172.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -112.63 98.62 44.98 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.979 1.311 . . . . 0.0 113.093 -168.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.43 117.89 5.14 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.388 2.059 . . . . 0.0 108.226 152.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 8.9 p -161.37 154.99 21.77 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -88.57 102.11 14.62 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.093 2.157 . . . . 0.0 106.39 158.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.255 3.7 pt -59.73 123.5 71.77 Favored Pre-proline 0 CA--C 1.554 1.12 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -156.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -62.79 113.28 1.92 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.419 2.746 . . . . 0.0 112.933 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.91 110.14 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 109.801 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.85 163.37 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.971 1.708 . . . . 0.0 109.265 -172.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . 0.431 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 48.8 t -139.22 113.67 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.55 171.4 12.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.222 0.534 . . . . 0.0 112.038 -170.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.458 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 33.7 m-20 -114.61 2.74 14.61 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.149 1.38 . . . . 0.0 111.599 173.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -109.97 -5.29 15.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.894 2.077 . . . . 0.0 114.027 -167.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.7 mt 58.72 -1.95 0.1 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.233 2.613 . . . . 0.0 116.049 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -112.63 -7.06 13.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.419 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 45.11 77.13 0.08 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 130.279 3.432 . . . . 0.0 114.669 -166.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -92.99 -40.97 10.26 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.423 149.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 84.5 mt -74.57 150.06 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.872 1.669 . . . . 0.0 110.783 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -143.86 94.52 2.6 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.2 1.4 . . . . 0.0 111.521 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . 0.458 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 30.7 ttpt -102.57 -31.04 10.6 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -166.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . 0.431 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -116.41 159.42 13.92 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.657 1.122 . . . . 0.0 115.638 -168.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.81 145.23 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.633 1.973 . . . . 0.0 110.758 -169.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.61 120.01 22.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.776 1.63 . . . . 0.0 108.633 166.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.8 t -92.72 -41.25 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.149 0.58 . . . . 0.0 111.32 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 366' ' ' GLU . 3.0 t -98.01 176.41 5.77 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.695 0.759 . . . . 0.0 112.01 171.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 6.1 m -62.1 107.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.93 1.692 . . . . 0.0 113.493 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.77 121.06 79.88 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 118.14 -0.933 . . . . 0.0 109.29 160.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -82.69 -174.36 2.03 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 124.918 3.745 . . . . 0.0 113.717 -171.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 112.04 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 126.596 1.959 . . . . 0.0 108.168 169.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -72.22 77.83 0.98 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.668 1.187 . . . . 0.0 111.785 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 19.3 t -69.32 -19.94 63.88 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.351 -0.843 . . . . 0.0 113.149 171.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 17.7 p -118.82 118.21 30.95 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 127.134 2.173 . . . . 0.0 106.337 163.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -56.8 -24.22 49.06 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -165.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.67 0.98 7.45 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.712 2.005 . . . . 0.0 113.967 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -46.81 134.63 9.81 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.317 1.447 . . . . 0.0 113.385 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -137.97 133.01 33.16 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.587 1.155 . . . . 0.0 111.148 175.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.89 143.2 24.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.739 0.781 . . . . 0.0 112.954 -160.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.83 118.67 18.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.286 2.235 . . . . 0.0 109.469 166.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 32.5 mt -126.97 143.52 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.049 0.54 . . . . 0.0 110.458 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . 0.428 ' H ' HG22 ' A' ' 351' ' ' THR . 33.2 mt-10 -116.85 134.33 54.91 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.768 1.627 . . . . 0.0 110.06 167.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.4 159.63 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.594 1.158 . . . . 0.0 111.96 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -124.92 104.65 29.86 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.911 1.684 . . . . 0.0 109.944 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -86.47 163.08 9.59 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.786 2.991 . . . . 0.0 111.078 161.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.5 177.15 9.04 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.204 2.603 . . . . 0.0 112.467 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -63.52 116.95 6.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.861 1.264 . . . . 0.0 110.928 167.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 133.83 -145.74 17.76 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.921 1.248 . . . . 0.0 111.589 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -97.02 160.44 14.34 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.934 1.294 . . . . 0.0 113.3 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 21.9 m -169.17 152.38 5.02 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.801 1.64 . . . . 0.0 111.827 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -122.37 107.43 12.07 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 166.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.3 mm -73.71 120.66 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 72.0 mt -116.41 134.47 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.331 1.052 . . . . 0.0 110.996 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 67.4 t -120.93 107.15 19.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 126.04 1.736 . . . . 0.0 107.973 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.34 -175.6 19.07 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.85 159.34 42.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.195 1.798 . . . . 0.0 110.432 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.83 -173.22 53.71 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.296 0.474 . . . . 0.0 112.529 -168.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -55.93 -27.9 54.39 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.842 1.257 . . . . 0.0 112.291 171.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 24.6 m -59.43 -7.61 1.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.532 3.133 . . . . 0.0 116.608 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -87.04 125.93 34.42 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.08 0.952 . . . . 0.0 112.23 -173.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 15.1 mt -95.67 164.63 12.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.665 0.386 . . . . 0.0 111.897 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.3 t -135.12 152.08 51.31 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.321 1.048 . . . . 0.0 113.154 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -141.06 142.33 34.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.562 1.145 . . . . 0.0 111.583 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.03 140.58 36.49 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -140.98 138.61 33.87 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.173 0.987 . . . . 0.0 112.308 163.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--N 1.33 -0.272 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -173.099 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.3 m -69.82 4.58 1.91 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.33 -12.49 42.64 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.567 1.147 . . . . 0.0 113.55 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 51.2 mt -131.33 158.82 39.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.611 1.565 . . . . 0.0 110.343 170.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 16.2 m -48.07 -60.9 2.27 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.91 2.084 . . . . 0.0 115.029 -158.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.63 74.18 7.61 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.577 0.626 . . . . 0.0 111.31 -171.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.76 91.5 1.3 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 169.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.49 2.87 51.85 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.855 1.217 . . . . 0.0 115.756 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 18.3 p -72.44 -69.91 0.37 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.998 2.119 . . . . 0.0 112.017 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.5 m -169.75 140.0 2.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.636 1.575 . . . . 0.0 111.14 171.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -160.67 146.79 15.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.842 1.257 . . . . 0.0 110.693 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 104.03 6.36 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.26 144.06 42.36 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.184 2.193 . . . . 0.0 115.053 -176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 39.8 m -90.48 131.92 35.96 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.755 0.822 . . . . 0.0 109.005 160.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 78.8 p -133.41 3.6 3.62 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.73 158.5 20.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.515 1.052 . . . . 0.0 110.356 163.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.14 102.33 0.49 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.846 2.058 . . . . 0.0 112.132 -161.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.5 mtm -82.91 161.84 21.74 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.609 0.763 . . . . 0.0 112.166 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 92.2 p -147.36 163.26 37.01 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -84.11 126.52 33.16 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 161.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.02 -24.31 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.059 0.544 . . . . 0.0 110.235 163.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -145.23 126.3 14.62 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.132 2.173 . . . . 0.0 107.822 170.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -57.45 149.73 48.08 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.299 1.04 . . . . 0.0 112.099 173.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -57.32 136.74 78.04 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.263 1.975 . . . . 0.0 111.242 170.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 38.1 p -132.1 127.13 35.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.502 1.121 . . . . 0.0 111.017 171.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -56.32 117.39 3.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.451 1.5 . . . . 0.0 110.887 174.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 79.7 p -79.12 -12.27 59.99 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.169 0.987 . . . . 0.0 113.274 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.61 -8.16 1.22 Allowed Glycine 0 CA--C 1.539 1.538 0 CA-C-N 119.299 0.954 . . . . 0.0 114.468 -165.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -83.85 4.2 30.32 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.213 1.506 . . . . 0.0 111.706 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 99.48 4.18 56.17 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.858 1.694 . . . . 0.0 113.782 -172.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.8 p -127.18 165.14 20.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.512 1.156 . . . . 0.0 112.114 -168.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.11 112.14 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.494 1.517 . . . . 0.0 107.834 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.1 127.14 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.229 1.012 . . . . 0.0 112.952 -167.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -135.07 167.84 20.23 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.86 1.664 . . . . 0.0 113.263 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -125.16 135.38 52.57 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.062 1.345 . . . . 0.0 107.76 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.59 157.66 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.704 0.801 . . . . 0.0 112.062 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -132.75 145.99 51.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.503 1.521 . . . . 0.0 112.089 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.04 147.98 38.98 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 127.356 2.262 . . . . 0.0 107.354 163.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -109.37 -51.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 0 CA-C-N 122.923 2.08 . . . . 0.0 115.918 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 168.21 25.14 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.917 -1.115 . . . . 0.0 112.348 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.54 -0.17 3.16 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.578 2.037 . . . . 0.0 117.531 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.98 96.46 50.18 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.869 1.335 . . . . 0.0 112.961 -162.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.38 114.99 3.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.297 2.665 . . . . 0.0 108.82 152.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 13.6 p -160.63 146.0 14.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.26 104.36 13.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.295 1.838 . . . . 0.0 107.042 164.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.289 0.6 OUTLIER -68.06 118.73 61.49 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 119.42 -0.324 . . . . 0.0 110.944 -153.089 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.01 106.65 2.19 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.771 2.314 . . . . 0.0 112.147 -171.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 91.7 t -106.15 116.73 50.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 126.349 1.86 . . . . 0.0 109.686 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.42 160.8 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.093 1.357 . . . . 0.0 110.046 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . 0.462 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 60.0 t -143.73 128.13 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.8 175.8 9.42 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.575 0.75 . . . . 0.0 112.576 -164.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.446 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 64.2 m-20 -115.38 5.52 14.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.795 1.238 . . . . 0.0 111.949 171.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -132.85 6.56 3.99 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.33 1.852 . . . . 0.0 114.241 -159.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 40.1 mt 63.89 -6.34 0.25 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.382 2.273 . . . . 0.0 115.869 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.9 t -125.19 -7.17 7.09 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.606 1.548 . . . . 0.0 114.721 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 73.22 37.29 0.76 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.813 2.045 . . . . 0.0 113.028 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.78 -48.17 80.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 162.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 45.3 mm -75.03 152.53 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.219 1.008 . . . . 0.0 109.038 160.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.73 66.72 1.5 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.391 1.567 . . . . 0.0 109.682 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . 0.446 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 43.7 tttt -70.6 -62.68 1.3 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.393 2.277 . . . . 0.0 111.986 -161.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.462 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -98.94 156.78 20.11 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.256 1.407 . . . . 0.0 115.757 -159.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.91 147.24 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.973 2.509 . . . . 0.0 109.51 -167.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.5 117.24 19.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.422 1.489 . . . . 0.0 108.877 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.2 t -79.62 -46.55 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.693 0.797 . . . . 0.0 110.622 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.3 t -95.12 179.56 5.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.819 0.848 . . . . 0.0 110.745 169.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 26.3 m -57.08 139.47 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.027 0.931 . . . . 0.0 111.039 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -77.26 112.7 25.16 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.548 -0.72 . . . . 0.0 109.636 168.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.6 175.01 11.78 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.936 2.424 . . . . 0.0 113.298 -171.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.66 121.98 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 126.822 2.049 . . . . 0.0 107.716 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.16 98.09 0.97 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.441 1.096 . . . . 0.0 109.578 168.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.1 t -98.9 -15.59 19.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.873 1.269 . . . . 0.0 112.573 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.23 133.62 55.88 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.927 1.691 . . . . 0.0 106.582 156.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -65.65 -16.98 64.26 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.604 -1.31 . . . . 0.0 114.093 -169.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -88.52 3.75 49.16 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.957 1.703 . . . . 0.0 113.584 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -53.05 135.61 36.88 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.717 -1.24 . . . . 0.0 113.313 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.21 146.7 52.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.542 1.537 . . . . 0.0 110.952 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.9 p -159.35 146.54 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -157.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.95 128.09 34.63 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.051 2.54 . . . . 0.0 110.053 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 13.8 mt -136.1 142.33 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.258 0.552 . . . . 0.0 109.767 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -114.54 140.67 48.57 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.692 1.197 . . . . 0.0 110.031 167.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.58 160.54 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.257 1.023 . . . . 0.0 111.448 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -132.38 104.28 13.54 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 126.146 1.778 . . . . 0.0 109.443 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.81 164.26 32.16 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.62 1.547 . . . . 0.0 109.985 159.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.5 -176.67 1.78 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.367 2.045 . . . . 0.0 110.347 160.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -57.23 149.27 20.32 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.526 -0.734 . . . . 0.0 111.096 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 89.4 -162.33 30.6 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 122.39 0.994 . . . . 0.0 115.292 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.33 158.64 33.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.663 1.985 . . . . 0.0 113.836 -167.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.5 m -169.28 161.0 9.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.38 1.472 . . . . 0.0 112.755 171.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -124.7 113.1 17.54 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.961 2.104 . . . . 0.0 106.879 161.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.6 mm -71.58 130.01 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.74 130.71 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.48 1.112 . . . . 0.0 109.375 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.2 104.08 14.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 125.474 1.509 . . . . 0.0 107.566 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 115.21 175.32 18.38 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 123.307 1.504 . . . . 0.0 116.383 170.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.34 161.13 34.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.267 2.227 . . . . 0.0 110.396 172.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.03 179.77 37.33 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.789 0.709 . . . . 0.0 112.751 -167.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.05 -25.72 46.08 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.216 -1.167 . . . . 0.0 112.321 172.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.3 m -58.41 -8.34 1.16 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 130.209 3.404 . . . . 0.0 117.337 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -85.79 149.89 24.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.323 0.965 . . . . 0.0 112.424 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 41.3 mt -119.22 166.87 12.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.969 0.908 . . . . 0.0 111.149 171.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 10.8 t -140.59 157.2 45.83 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 171.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -139.0 125.91 21.02 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.892 1.677 . . . . 0.0 109.522 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -70.64 131.49 44.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 111.897 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -144.22 126.69 15.9 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.825 0.85 . . . . 0.0 111.529 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -108.99 130.26 55.47 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -96.9 148.39 22.99 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 11.9 pm0 -43.7 125.71 4.23 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.381 1.872 . . . . 0.0 113.572 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 125.95 4.49 6.62 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 118.24 2.056 . . . . 0.0 118.24 160.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 90.0 p -120.96 -83.22 0.66 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.391 2.096 . . . . 0.0 112.299 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 81.1 p -91.98 -19.37 22.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.921 2.088 . . . . 0.0 113.205 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 17.8 tt -148.82 158.99 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.102 1.761 . . . . 0.0 110.138 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.02 -11.02 77.36 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.546 -1.141 . . . . 0.0 115.179 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 6.8 tptp . . . . . 0 C--O 1.25 1.107 0 C-N-CA 127.062 2.145 . . . . 0.0 109.758 176.375 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.2 p -115.63 -14.62 11.45 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -75.34 38.86 0.14 Allowed 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 73.7 mt -137.86 178.35 7.18 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.132 1.373 . . . . 0.0 111.686 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 14.7 m -40.67 -63.86 0.6 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 128.716 2.806 . . . . 0.0 115.436 -164.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.7 67.69 10.13 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.035 0.922 . . . . 0.0 111.072 -173.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.16 99.6 2.96 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.728 0.811 . . . . 0.0 111.23 171.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 68.8 -21.94 0.33 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.772 1.653 . . . . 0.0 116.457 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.1 p -46.11 -63.08 1.07 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.91 2.484 . . . . 0.0 113.666 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 14.2 m -169.66 150.48 4.06 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.665 1.186 . . . . 0.0 112.54 167.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -162.6 154.0 17.86 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.094 1.758 . . . . 0.0 109.997 161.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.31 104.8 8.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 160.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.3 ptm -65.9 149.82 49.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.892 1.677 . . . . 0.0 115.157 -173.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.7 m -99.7 143.13 30.29 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.526 1.13 . . . . 0.0 110.125 165.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.9 p -138.81 21.69 2.67 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -96.48 163.57 12.99 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.298 0.954 . . . . 0.0 110.606 165.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -66.3 105.03 1.32 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.231 2.212 . . . . 0.0 112.453 -159.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.6 mmt -70.61 160.27 32.86 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.001 0.92 . . . . 0.0 112.818 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 29.0 m -156.53 148.75 23.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.208 -0.932 . . . . 0.0 111.991 162.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.28 125.99 33.99 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 168.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.7 -27.62 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.629 0.772 . . . . 0.0 110.144 164.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -139.25 120.36 14.64 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.011 2.124 . . . . 0.0 107.706 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -56.74 154.3 18.6 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.933 0.893 . . . . 0.0 111.609 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -57.56 125.52 19.04 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.317 2.011 . . . . 0.0 111.115 166.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 8.0 p -130.16 129.16 43.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.038 0.935 . . . . 0.0 112.759 169.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -56.42 122.65 12.39 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.327 1.851 . . . . 0.0 111.562 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 82.2 p -78.07 -12.08 59.96 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.774 1.23 . . . . 0.0 113.191 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.66 -11.43 3.3 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.474 1.035 . . . . 0.0 113.796 -167.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -87.37 2.49 50.19 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.436 1.494 . . . . 0.0 112.239 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 101.52 9.72 43.15 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.241 1.401 . . . . 0.0 113.848 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.0 p -131.03 166.45 20.99 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.908 1.283 . . . . 0.0 112.12 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.64 120.38 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.75 2.02 . . . . 0.0 107.626 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.2 p -106.01 137.17 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.452 1.101 . . . . 0.0 112.655 -171.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -143.84 164.75 29.64 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.555 1.942 . . . . 0.0 113.45 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -123.87 127.0 47.39 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.136 1.774 . . . . 0.0 107.849 164.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.95 147.6 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.654 0.782 . . . . 0.0 111.695 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -124.62 144.11 50.35 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.539 1.935 . . . . 0.0 110.429 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.13 150.78 48.14 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.414 1.886 . . . . 0.0 107.943 163.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -110.03 -50.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 0 CA-C-N 122.203 1.822 . . . . 0.0 116.7 -165.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.89 169.21 19.61 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.049 1.295 . . . . 0.0 113.327 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.04 -15.62 0.08 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 128.182 2.801 . . . . 0.0 118.648 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -104.29 108.03 59.18 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 119.711 1.755 . . . . 0.0 113.822 -166.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.99 121.51 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.845 3.03 . . . . 0.0 109.904 155.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 8.1 p -162.77 149.42 12.85 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.36 108.45 16.56 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 161.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.296 0.5 OUTLIER -67.01 119.84 67.33 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.505 -153.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.53 114.32 3.68 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.141 2.561 . . . . 0.0 111.295 -171.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 52.4 t -116.18 114.48 46.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.365 1.466 . . . . 0.0 109.542 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.83 159.4 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.926 1.691 . . . . 0.0 108.835 -175.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.1 t -146.05 122.56 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.22 166.69 32.69 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -168.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -90.59 -5.33 56.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -114.87 6.15 15.35 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.618 1.567 . . . . 0.0 114.252 -160.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 25.4 mt 64.94 -7.96 0.25 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.25 2.22 . . . . 0.0 115.175 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.2 t -122.71 -12.07 8.13 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.191 1.359 . . . . 0.0 114.343 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 82.37 35.48 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.498 2.719 . . . . 0.0 113.261 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.68 67.32 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.093 0.557 . . . . 0.0 111.389 170.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.84 159.47 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.746 1.218 . . . . 0.0 108.227 162.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.12 123.46 16.96 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.328 -1.482 . . . . 0.0 110.903 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -128.2 -17.59 4.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -159.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -145.69 151.28 23.51 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -166.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.3 147.2 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.538 1.535 . . . . 0.0 111.921 -163.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.84 112.39 4.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.816 2.047 . . . . 0.0 109.399 171.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.49 -33.75 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.021 0.528 . . . . 0.0 110.938 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.1 t -96.61 179.27 5.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.035 0.934 . . . . 0.0 111.172 167.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.48 125.72 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.062 1.345 . . . . 0.0 110.662 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -66.69 113.37 12.69 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 118.427 0.558 . . . . 0.0 110.757 171.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.8 179.63 6.11 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.142 2.561 . . . . 0.0 113.781 -171.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.09 130.28 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 127.023 2.129 . . . . 0.0 108.038 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -78.45 96.76 5.46 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.852 1.261 . . . . 0.0 109.206 166.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -97.21 -18.64 19.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.55 1.14 . . . . 0.0 112.481 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.89 135.95 51.83 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 155.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -66.67 -14.24 62.23 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.774 -1.204 . . . . 0.0 113.913 -171.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -89.01 0.42 56.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.683 1.993 . . . . 0.0 113.499 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -53.89 138.27 36.8 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.612 1.196 . . . . 0.0 113.079 -172.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.42 142.05 49.11 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.921 1.288 . . . . 0.0 111.053 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.4 p -154.93 145.48 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -158.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.26 126.29 30.72 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.101 2.96 . . . . 0.0 110.563 173.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.61 137.14 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.248 0.619 . . . . 0.0 110.757 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -107.17 140.29 40.27 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.849 1.26 . . . . 0.0 111.019 161.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.23 158.34 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.249 1.02 . . . . 0.0 112.702 171.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -111.27 114.32 53.41 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.362 1.865 . . . . 0.0 110.526 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -76.82 174.02 13.53 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 124.063 3.175 . . . . 0.0 111.182 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.54 -174.4 2.25 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.4 2.067 . . . . 0.0 110.463 159.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -67.5 146.01 54.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 154.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 84.8 -159.85 34.93 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 122.043 0.802 . . . . 0.0 114.752 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.48 157.39 30.47 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.911 2.084 . . . . 0.0 113.994 -166.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.0 m -170.57 171.91 6.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.431 1.892 . . . . 0.0 112.051 170.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.34 125.83 46.78 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 126.801 2.04 . . . . 0.0 108.314 158.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.2 mm -77.65 119.78 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.5 mt -111.24 128.37 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.317 1.447 . . . . 0.0 109.819 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 66.6 t -116.19 107.47 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.466 1.907 . . . . 0.0 108.189 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.25 177.78 24.25 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 122.449 1.027 . . . . 0.0 114.94 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.48 169.82 16.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.213 1.805 . . . . 0.0 111.382 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 83.86 -157.39 33.93 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.922 0.772 . . . . 0.0 112.345 -172.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -72.9 -33.08 65.79 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.555 -0.968 . . . . 0.0 110.975 163.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 28.6 m -59.87 -6.96 1.44 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 130.005 3.322 . . . . 0.0 117.741 -173.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -80.25 153.73 28.33 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.876 1.27 . . . . 0.0 111.467 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 46.0 mt -121.48 165.24 15.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.382 0.673 . . . . 0.0 110.464 170.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.1 t -150.42 160.54 43.68 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -140.82 124.93 17.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.036 1.734 . . . . 0.0 110.077 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -67.77 133.44 49.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.035 1.334 . . . . 0.0 111.711 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -133.11 152.5 51.95 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.165 0.986 . . . . 0.0 111.545 170.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -134.58 136.81 43.24 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 173.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -117.54 130.85 56.67 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 124.217 1.007 . . . . 0.0 109.135 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -22.91 105.05 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 129.814 3.245 . . . . 0.0 115.247 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 133.43 17.69 1.08 Allowed Glycine 0 CA--C 1.534 1.247 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 167.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 94.0 p -133.22 -101.98 0.26 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.803 2.302 . . . . 0.0 112.775 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 92.0 p -70.49 -19.29 62.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.535 1.934 . . . . 0.0 112.77 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 16.3 tt -147.49 160.71 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 126.533 1.933 . . . . 0.0 110.063 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.86 -11.97 64.68 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.335 -1.258 . . . . 0.0 115.081 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 6.8 tptp . . . . . 0 C--O 1.249 1.062 0 C-N-CA 127.301 2.24 . . . . 0.0 109.501 176.251 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 8.4 mmt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 26.1 p -101.0 -13.36 18.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.528 1.531 . . . . 0.0 114.274 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.21 -7.04 20.81 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.21 129.2 38.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.019 1.328 . . . . 0.0 109.275 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 21.6 p -43.04 -56.54 3.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.926 1.69 . . . . 0.0 113.162 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 31.3 tp -55.74 -16.58 4.51 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.42 ' HE2' ' O ' ' A' ' 347' ' ' GLY . 25.8 mmmt -104.13 70.21 0.97 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.672 1.589 . . . . 0.0 111.209 -171.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 78.82 -25.68 2.5 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.06 1.79 . . . . 0.0 114.804 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 10.0 m -76.13 -42.13 47.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -168.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.8 m -171.94 120.06 0.44 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.178 1.391 . . . . 0.0 113.384 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -153.71 155.35 35.8 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.322 1.849 . . . . 0.0 109.073 167.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.49 100.01 1.04 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 160.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.02 136.53 56.3 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.517 1.927 . . . . 0.0 113.888 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 22.1 m -87.53 135.41 33.36 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 153.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 68.3 p -138.12 -0.89 2.0 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 174.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.64 166.63 20.32 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 120.101 1.319 . . . . 0.0 110.498 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -67.08 101.03 0.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.713 1.605 . . . . 0.0 112.438 -165.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' MET . . . . . 0.47 ' HE3' ' H ' ' A' ' 380' ' ' THR . 37.9 mtm -90.51 165.07 13.99 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.778 1.231 . . . . 0.0 111.837 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.0 m -161.28 161.01 30.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.148 -0.97 . . . . 0.0 112.491 167.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.7 125.54 29.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.982 0.513 . . . . 0.0 109.952 161.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 81.2 t -76.9 -25.56 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.436 1.494 . . . . 0.0 110.677 165.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -137.61 131.24 31.29 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.191 1.796 . . . . 0.0 107.925 164.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -59.9 151.39 64.67 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.097 0.559 . . . . 0.0 111.858 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -55.74 130.21 39.17 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.383 2.056 . . . . 0.0 111.498 166.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 16.5 p -120.5 125.0 46.76 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.506 1.522 . . . . 0.0 110.629 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -55.75 118.07 4.22 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.567 1.147 . . . . 0.0 110.067 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.3 p -79.53 -16.38 56.08 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 60.31 -0.39 0.94 Allowed Glycine 0 CA--C 1.539 1.581 0 CA-C-N 119.467 1.03 . . . . 0.0 115.057 -161.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -86.46 18.15 3.43 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.284 1.542 . . . . 0.0 110.652 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.34 -2.84 87.94 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.771 1.177 . . . . 0.0 114.1 -168.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 25.0 p -122.47 175.37 6.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.043 1.421 . . . . 0.0 113.608 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.7 125.11 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 127.043 2.137 . . . . 0.0 107.938 172.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.84 131.72 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.903 1.281 . . . . 0.0 113.531 -169.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -140.73 169.37 17.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.7 2.0 . . . . 0.0 113.526 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.27 135.73 52.81 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.361 1.064 . . . . 0.0 108.411 164.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.95 152.77 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.247 1.019 . . . . 0.0 112.412 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -137.53 150.94 47.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.685 1.194 . . . . 0.0 113.008 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.2 t -119.66 141.13 30.5 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 128.243 2.617 . . . . 0.0 107.947 169.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -97.4 -67.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.88 2.387 . . . . 0.0 115.313 -174.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 174.87 10.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.88 1.272 . . . . 0.0 112.881 -173.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.9 -12.43 0.81 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.504 2.002 . . . . 0.0 117.712 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -123.58 96.62 43.23 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 119.525 1.663 . . . . 0.0 113.797 -160.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.81 120.5 6.43 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.84 1.693 . . . . 0.0 109.084 155.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.7 p -162.62 150.62 14.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -171.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -83.8 97.36 9.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.535 1.534 . . . . 0.0 107.265 162.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.252 1.2 pp -58.1 112.11 4.42 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.578 0.751 . . . . 0.0 111.87 -159.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.29 117.1 4.95 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.706 2.271 . . . . 0.0 112.991 -170.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 88.0 t -120.4 120.59 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 126.2 1.8 . . . . 0.0 108.765 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.26 160.01 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.035 1.734 . . . . 0.0 109.454 -175.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 3.9 t -138.53 113.62 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.82 -176.83 4.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.697 0.799 . . . . 0.0 112.163 -168.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.456 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 70.7 m-20 -115.74 6.59 14.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.325 1.05 . . . . 0.0 112.194 171.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -131.87 1.48 3.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -152.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 16.1 mt 64.48 0.11 1.02 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.304 2.242 . . . . 0.0 115.198 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.5 t -135.84 -6.16 2.16 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -170.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 57.54 48.29 14.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.552 1.941 . . . . 0.0 113.645 -174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.78 66.28 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.102 0.561 . . . . 0.0 110.012 159.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 8.9 mm -101.99 147.15 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 126.054 1.741 . . . . 0.0 108.479 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -126.05 108.35 11.29 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.431 -0.793 . . . . 0.0 111.847 163.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . 0.456 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 3.1 mmmm -66.4 -69.83 0.28 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 128.352 2.661 . . . . 0.0 111.425 172.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -100.33 169.32 21.51 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 -160.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.2 mp -115.82 154.99 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 128.0 2.52 . . . . 0.0 110.193 -169.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.47 134.94 40.71 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.115 0.966 . . . . 0.0 109.931 168.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.88 -47.08 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.382 0.673 . . . . 0.0 110.944 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.6 t -92.42 172.57 8.3 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.652 0.739 . . . . 0.0 111.647 168.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.2 m -66.64 126.36 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.118 1.367 . . . . 0.0 112.667 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.04 126.59 64.93 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.978 1.311 . . . . 0.0 110.099 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -80.98 -172.54 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.027 3.152 . . . . 0.0 112.926 -173.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.08 119.22 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 127.112 2.165 . . . . 0.0 107.451 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.78 90.16 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.377 1.071 . . . . 0.0 110.685 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 10.7 t -73.92 -37.94 64.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.733 -0.604 . . . . 0.0 110.247 159.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 39.7 p -102.37 123.46 46.2 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.389 1.875 . . . . 0.0 109.192 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -54.73 -19.8 7.03 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.9 5.98 8.6 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.605 1.562 . . . . 0.0 113.708 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -43.67 134.28 4.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.529 1.932 . . . . 0.0 114.203 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -150.88 129.62 12.36 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.846 1.658 . . . . 0.0 110.067 -167.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.3 p -154.16 145.77 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -166.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -78.68 123.03 26.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.484 2.714 . . . . 0.0 109.473 165.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 40.6 mt -129.16 144.21 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 118.464 0.574 . . . . 0.0 111.519 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -118.9 140.38 50.08 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.649 1.58 . . . . 0.0 110.947 164.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.2 160.46 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.074 1.35 . . . . 0.0 111.515 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -130.95 98.58 18.98 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.697 1.999 . . . . 0.0 109.788 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.17 166.65 16.32 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.33 2.687 . . . . 0.0 111.375 162.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.77 175.07 7.71 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.885 2.39 . . . . 0.0 110.857 163.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.82 154.35 30.18 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.842 -0.536 . . . . 0.0 111.04 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 91.03 -163.25 29.15 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 121.404 0.447 . . . . 0.0 113.24 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -66.03 157.12 31.79 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -168.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 20.5 m -168.03 164.62 13.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.061 1.744 . . . . 0.0 112.086 168.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -128.25 111.45 13.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.887 2.875 . . . . 0.0 107.543 166.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 1.8 mm -74.37 124.38 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 79.9 mt -113.58 129.83 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.835 1.254 . . . . 0.0 108.91 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.65 109.38 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 125.282 1.433 . . . . 0.0 107.863 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 107.52 177.89 22.48 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 123.363 1.535 . . . . 0.0 115.747 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' THR . . . . . 0.47 ' H ' ' HE3' ' A' ' 304' ' ' MET . 0.8 OUTLIER -133.4 163.93 28.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 127.669 2.387 . . . . 0.0 110.78 172.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.54 -179.97 36.05 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.199 0.428 . . . . 0.0 112.241 -166.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -56.81 -27.38 59.87 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.279 1.031 . . . . 0.0 112.375 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 46.6 m -58.95 -7.61 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.567 3.147 . . . . 0.0 116.651 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -81.15 149.07 29.28 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.503 1.121 . . . . 0.0 112.299 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 27.6 mt -118.69 165.22 14.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.957 0.903 . . . . 0.0 111.315 171.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.6 t -148.49 162.12 40.26 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -144.24 127.75 16.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.872 2.069 . . . . 0.0 110.14 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -75.21 135.83 41.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.817 1.647 . . . . 0.0 112.548 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -134.38 157.2 47.02 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.631 1.173 . . . . 0.0 111.763 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -129.65 107.45 9.45 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.844 1.657 . . . . 0.0 106.922 173.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -93.12 126.11 38.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.092 1.357 . . . . 0.0 112.709 -160.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 50.71 102.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 129.328 3.051 . . . . 0.0 114.845 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -61.81 70.3 0.02 OUTLIER Glycine 0 CA--C 1.533 1.161 0 C-N-CA 128.324 2.869 . . . . 0.0 115.321 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 27.1 t -54.92 8.74 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 130.269 3.428 . . . . 0.0 116.902 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 33.5 t -128.5 1.17 5.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.234 1.814 . . . . 0.0 113.646 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 11.2 tt -144.48 -17.48 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 143.82 -48.27 0.75 Allowed Glycine 0 CA--C 1.53 0.992 0 CA-C-N 119.414 1.007 . . . . 0.0 113.754 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.003 0 C-N-CA 127.007 2.123 . . . . 0.0 108.504 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 33.9 m -93.36 10.3 32.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.967 1.307 . . . . 0.0 113.125 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -103.29 6.5 38.08 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.434 1.494 . . . . 0.0 114.803 -166.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 91.1 mt -120.61 159.23 25.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.139 0.976 . . . . 0.0 111.068 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 29.4 p -42.69 -73.44 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.778 2.431 . . . . 0.0 113.152 -168.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 19.8 tp -65.66 3.8 0.69 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 128.563 2.745 . . . . 0.0 113.887 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.53 71.64 1.3 Allowed 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.073 -1.642 . . . . 0.0 109.824 -171.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.79 -23.38 1.32 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.478 1.514 . . . . 0.0 115.661 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 46.7 m -67.62 -61.81 1.71 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.388 1.594 . . . . 0.0 112.502 -173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 9.5 m -174.73 134.53 0.37 Allowed 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.573 1.079 . . . . 0.0 112.844 174.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -162.08 153.52 18.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.76 2.024 . . . . 0.0 109.591 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -73.28 101.68 3.47 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 164.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -82.11 165.91 20.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.54 1.536 . . . . 0.0 113.679 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.7 m -101.6 152.49 20.75 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.523 1.529 . . . . 0.0 109.86 167.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.7 p -142.67 6.44 1.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.461 ' CG ' ' HZ1' ' A' ' 326' ' ' LYS . 44.9 t0 -71.47 160.92 31.87 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.096 1.316 . . . . 0.0 110.966 165.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.06 97.01 0.05 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.212 1.405 . . . . 0.0 112.39 -171.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 34.2 mtm -84.99 169.0 14.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.021 1.328 . . . . 0.0 111.708 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.1 m -159.78 158.37 31.04 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.176 -0.953 . . . . 0.0 112.515 170.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.12 123.56 28.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.554 0.742 . . . . 0.0 110.111 161.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.68 -25.03 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.514 1.126 . . . . 0.0 110.574 165.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -141.88 137.75 31.6 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.685 1.994 . . . . 0.0 109.16 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -62.9 143.99 97.07 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.994 1.317 . . . . 0.0 112.989 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -54.64 124.8 17.08 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.52 2.813 . . . . 0.0 112.542 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 10.2 p -123.53 130.07 52.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.132 1.373 . . . . 0.0 111.802 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -57.83 123.27 15.19 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.846 0.858 . . . . 0.0 111.005 171.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 26.8 p -80.64 -11.72 59.6 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.841 1.256 . . . . 0.0 113.085 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 84.0 -11.16 58.34 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.863 1.221 . . . . 0.0 114.341 -169.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -92.59 10.13 31.75 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.176 1.488 . . . . 0.0 112.509 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.47 13.19 71.1 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.848 0.737 . . . . 0.0 113.216 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 11.6 p -124.63 153.76 41.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.964 1.306 . . . . 0.0 110.959 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 26.0 t -128.48 118.16 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.869 1.668 . . . . 0.0 107.94 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.04 133.8 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.069 1.348 . . . . 0.0 113.299 -163.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 7.0 ptp -137.53 165.51 26.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.84 2.056 . . . . 0.0 112.023 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -115.69 133.96 55.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 163.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 6.8 m -136.41 149.01 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.543 1.137 . . . . 0.0 112.213 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -132.92 149.52 52.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.939 1.696 . . . . 0.0 112.621 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.1 151.93 51.33 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 127.644 2.378 . . . . 0.0 108.796 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -103.05 -76.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 123.255 2.637 . . . . 0.0 115.127 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.461 ' HZ1' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -138.65 165.12 27.75 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 121.221 1.828 . . . . 0.0 114.465 -177.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 70.89 15.59 74.04 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.255 0.931 . . . . 0.0 114.946 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.57 87.1 56.89 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 112.44 -164.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -79.74 114.31 3.18 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.028 2.485 . . . . 0.0 108.974 159.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.4 p -163.02 155.23 18.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -171.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -79.12 109.02 13.05 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 154.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.271 1.1 pp -64.34 122.96 81.06 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.993 -162.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.63 106.16 2.14 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.449 3.433 . . . . 0.0 113.334 -163.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 72.2 t -116.16 118.04 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.36 1.864 . . . . 0.0 109.844 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.47 158.65 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.934 1.294 . . . . 0.0 110.837 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 37.0 t -135.14 123.55 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.76 170.25 16.24 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -105.09 3.83 30.82 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.989 1.316 . . . . 0.0 112.039 169.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -129.4 10.75 5.76 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.732 1.613 . . . . 0.0 114.761 -161.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 46.9 mt 63.48 -10.83 0.11 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.692 2.397 . . . . 0.0 116.344 -175.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.5 t -127.93 -6.94 5.53 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.934 1.697 . . . . 0.0 114.594 -171.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.98 42.61 7.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.736 2.015 . . . . 0.0 112.87 -170.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -61.15 -31.27 70.99 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.726 159.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 7.9 mt -117.93 128.98 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 127.909 2.483 . . . . 0.0 107.199 167.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -95.52 108.57 20.83 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.192 0.905 . . . . 0.0 110.32 164.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -66.24 -57.85 6.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.791 2.036 . . . . 0.0 111.947 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -111.34 -177.46 20.35 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 -159.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.05 152.77 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.336 1.454 . . . . 0.0 111.438 -172.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.36 130.12 35.13 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.568 1.147 . . . . 0.0 109.51 169.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.79 -53.41 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 117.891 0.314 . . . . 0.0 111.032 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.2 m -83.66 153.19 24.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.923 0.889 . . . . 0.0 110.393 168.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 6.0 m -53.1 117.36 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.362 2.265 . . . . 0.0 114.989 -173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -82.79 118.85 73.11 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.763 1.225 . . . . 0.0 110.321 168.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.49 -177.32 3.78 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.549 3.5 . . . . 0.0 113.423 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.33 112.74 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.27 1.428 . . . . 0.0 107.223 167.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.2 85.23 0.37 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.15 1.38 . . . . 0.0 110.782 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 34.8 t -66.4 -58.6 4.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.936 0.494 . . . . 0.0 109.745 166.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 25.2 p -78.91 122.88 26.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.098 1.359 . . . . 0.0 109.963 163.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -62.54 -21.85 65.86 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.04 4.06 4.73 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.963 1.305 . . . . 0.0 113.519 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -42.32 129.4 3.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.72 2.008 . . . . 0.0 113.171 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.98 128.37 20.01 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.943 1.297 . . . . 0.0 110.309 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.2 p -149.29 150.79 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.583 0.706 . . . . 0.0 112.625 -159.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -89.12 121.74 31.74 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.298 2.639 . . . . 0.0 109.35 171.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 43.8 mt -135.31 146.86 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.444 0.698 . . . . 0.0 111.516 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -111.97 143.34 43.12 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.004 1.722 . . . . 0.0 111.624 167.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.78 149.15 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 123.513 0.725 . . . . 0.0 111.424 164.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -97.76 110.2 54.29 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.27 1.428 . . . . 0.0 109.466 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.8 126.03 6.37 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.979 2.452 . . . . 0.0 110.225 164.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.1 167.22 2.59 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.369 2.046 . . . . 0.0 111.444 155.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -60.26 155.79 16.91 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.429 0.633 . . . . 0.0 112.62 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.95 -169.88 39.03 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 123.007 1.337 . . . . 0.0 113.914 -173.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.57 163.01 9.55 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.151 1.78 . . . . 0.0 113.775 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 35.9 m -164.07 148.8 10.22 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.637 -1.289 . . . . 0.0 113.231 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -113.11 111.08 21.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.422 2.289 . . . . 0.0 106.87 161.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.4 mm -74.77 120.49 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 32.0 mt -117.7 126.59 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 122.273 1.035 . . . . 0.0 109.405 -171.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 54.9 t -118.02 99.29 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 127.361 2.265 . . . . 0.0 107.217 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 118.73 170.54 14.8 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 122.981 1.323 . . . . 0.0 115.502 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.49 165.55 24.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.514 2.326 . . . . 0.0 109.556 166.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.28 -172.66 55.11 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 123.211 0.434 . . . . 0.0 112.163 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -60.35 -32.3 71.13 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.324 -1.104 . . . . 0.0 111.708 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.9 m -56.58 -4.3 0.15 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 130.338 3.455 . . . . 0.0 117.782 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -86.96 144.09 27.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.129 0.877 . . . . 0.0 111.816 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.99 165.94 11.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.884 0.873 . . . . 0.0 110.142 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.2 t -146.97 158.71 44.0 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 169.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -139.92 131.51 27.16 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.642 1.977 . . . . 0.0 108.63 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.68 141.3 32.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.764 1.226 . . . . 0.0 111.739 -171.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -140.0 146.92 39.69 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.162 1.385 . . . . 0.0 109.578 170.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -122.77 105.78 10.34 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 20.3 tptt -89.3 141.68 28.32 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 392' ' ' GLU . 0.0 OUTLIER -40.74 124.38 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.082 2.553 . . . . 0.0 113.286 -172.451 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 100.76 19.96 16.03 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.545 1.545 . . . . 0.0 113.893 -163.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 85.5 p -87.6 163.19 16.74 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -171.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 95.9 p -50.7 -37.17 39.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.367 2.267 . . . . 0.0 114.455 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 24.7 pt -76.47 -0.42 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.16 1.384 . . . . 0.0 113.426 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 88.14 12.36 65.78 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.771 -1.016 . . . . 0.0 114.048 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.484 0 C-N-CA 125.047 1.339 . . . . 0.0 109.435 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 118.8 -0.619 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 33.4 p -102.6 -7.52 21.73 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.603 1.561 . . . . 0.0 114.572 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.02 -24.89 66.84 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -171.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 37.4 tp -82.32 139.44 34.14 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.049 0.94 . . . . 0.0 110.048 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 38.0 p -33.52 -67.98 0.12 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.017 2.527 . . . . 0.0 114.52 -174.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -6.93 7.04 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.317 1.447 . . . . 0.0 114.431 -174.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.03 68.44 3.77 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 120.467 -1.395 . . . . 0.0 110.925 -173.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 79.8 -53.26 4.3 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.2 0.905 . . . . 0.0 112.143 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 90.8 m -48.4 -37.63 17.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 128.382 2.673 . . . . 0.0 115.498 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 36.7 m -161.25 103.44 1.26 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.304 1.411 . . . . 0.0 113.118 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -151.94 153.02 33.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.434 1.094 . . . . 0.0 110.995 163.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 112.05 23.83 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.186 1.794 . . . . 0.0 107.072 165.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -61.08 142.67 56.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.975 1.71 . . . . 0.0 115.054 -174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 4.5 m -94.8 148.77 21.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.818 0.847 . . . . 0.0 109.013 156.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.1 p -137.11 1.42 2.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -77.92 163.11 26.3 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.677 1.126 . . . . 0.0 110.958 168.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.44 98.81 0.51 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.148 1.779 . . . . 0.0 112.096 -164.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 32.5 mtm -84.54 166.29 17.33 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.736 1.214 . . . . 0.0 112.23 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.7 m -161.81 162.7 29.55 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.149 -0.969 . . . . 0.0 112.255 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.36 117.0 24.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.07 0.948 . . . . 0.0 110.602 164.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 74.7 t -68.25 -30.16 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.595 1.558 . . . . 0.0 110.684 167.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -136.16 118.37 15.54 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.165 1.786 . . . . 0.0 107.575 170.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -52.74 144.61 24.81 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.216 1.006 . . . . 0.0 111.24 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.09 130.78 37.95 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.325 1.35 . . . . 0.0 111.878 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.3 p -130.69 130.74 44.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.277 1.431 . . . . 0.0 111.2 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.4 140.21 58.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.735 1.214 . . . . 0.0 112.61 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 39.4 p -95.79 -9.85 30.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.851 1.26 . . . . 0.0 113.996 -174.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 68.11 -2.78 6.37 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 119.283 0.947 . . . . 0.0 115.231 -167.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -97.06 19.14 13.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.009 1.405 . . . . 0.0 111.43 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.02 0.43 88.97 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.817 1.199 . . . . 0.0 113.788 -171.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 22.3 p -121.76 169.75 10.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.526 1.163 . . . . 0.0 112.547 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.8 t -140.63 124.5 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.23 1.812 . . . . 0.0 108.287 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.82 134.16 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.665 1.186 . . . . 0.0 112.308 -170.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -142.57 168.7 19.11 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.583 1.953 . . . . 0.0 113.062 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -122.42 131.93 54.11 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.182 1.393 . . . . 0.0 107.932 164.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.58 153.27 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.057 0.943 . . . . 0.0 111.582 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -136.98 146.22 45.1 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.426 1.49 . . . . 0.0 112.89 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.27 149.91 42.22 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 128.483 2.713 . . . . 0.0 107.735 164.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -107.04 -57.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.354 2.036 . . . . 0.0 115.594 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.22 170.68 15.29 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.949 -1.094 . . . . 0.0 112.966 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 69.21 -3.81 7.03 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.292 1.901 . . . . 0.0 117.718 168.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.97 99.59 41.02 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 119.248 1.524 . . . . 0.0 113.579 -163.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.07 112.27 2.56 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.67 2.913 . . . . 0.0 109.417 157.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.2 p -157.61 155.48 30.18 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -87.65 93.36 9.41 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.793 2.037 . . . . 0.0 106.695 162.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.254 1.4 pp -56.93 111.69 3.65 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.526 0.73 . . . . 0.0 112.456 -155.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.34 115.75 3.06 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.096 2.531 . . . . 0.0 114.197 -167.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 82.0 t -122.73 109.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.317 1.447 . . . . 0.0 109.71 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.93 162.77 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.663 1.585 . . . . 0.0 109.519 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.65 127.08 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -140.27 168.8 18.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.495 0.589 . . . . 0.0 112.352 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -102.13 -2.92 28.37 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.005 0.922 . . . . 0.0 111.851 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -106.07 0.49 25.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.582 1.953 . . . . 0.0 114.558 -168.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 34.4 mt 61.4 0.7 0.47 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.324 2.249 . . . . 0.0 115.967 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.1 t -127.99 -2.44 5.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.238 1.381 . . . . 0.0 114.515 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.55 45.04 6.48 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.802 2.441 . . . . 0.0 113.209 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.86 -33.7 76.17 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 119.646 -0.216 . . . . 0.0 111.231 164.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 33.3 mt -131.9 117.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.346 1.458 . . . . 0.0 110.215 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -80.1 104.26 10.55 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.367 -0.833 . . . . 0.0 112.773 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -66.34 -56.09 12.8 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.585 2.354 . . . . 0.0 112.943 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -115.77 169.76 13.06 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 116.914 1.525 . . . . 0.0 116.914 -159.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.87 155.24 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.096 2.158 . . . . 0.0 111.863 -165.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.12 123.68 32.43 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.558 1.543 . . . . 0.0 108.723 166.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 93.3 t -89.47 -34.97 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.0 0.52 . . . . 0.0 111.446 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.0 t -113.3 175.12 5.58 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.213 1.005 . . . . 0.0 112.209 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.6 m -65.26 101.8 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.76 1.624 . . . . 0.0 112.474 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -63.09 125.31 86.59 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.854 165.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -82.09 -177.25 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.536 3.491 . . . . 0.0 114.007 -169.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.11 114.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 127.236 2.214 . . . . 0.0 107.674 171.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.86 75.39 0.11 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.837 1.655 . . . . 0.0 112.892 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -66.73 -11.46 54.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 169.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 31.5 p -134.52 127.34 31.16 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 127.846 2.458 . . . . 0.0 106.575 165.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -62.24 -15.29 46.1 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -170.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.79 5.98 10.08 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.237 1.815 . . . . 0.0 113.552 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -39.22 119.12 0.87 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 127.314 2.245 . . . . 0.0 113.584 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.57 144.59 50.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.057 0.943 . . . . 0.0 111.613 170.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.71 142.59 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -161.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.59 120.4 19.14 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.692 2.397 . . . . 0.0 109.455 165.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 48.0 mt -131.46 131.77 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.284 0.564 . . . . 0.0 110.732 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -96.51 139.8 32.07 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.989 0.916 . . . . 0.0 111.052 158.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.15 160.72 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.323 1.449 . . . . 0.0 110.957 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -125.41 92.87 46.09 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.068 1.747 . . . . 0.0 109.487 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.08 140.78 20.3 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.481 2.121 . . . . 0.0 109.987 160.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.35 179.93 3.65 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.812 2.341 . . . . 0.0 111.706 168.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -59.33 160.14 7.02 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.355 1.062 . . . . 0.0 113.444 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 86.83 -145.41 20.03 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.094 0.378 . . . . 0.0 112.193 -170.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -93.91 169.21 10.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.318 1.047 . . . . 0.0 113.653 -173.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 29.7 m -164.94 160.7 19.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.868 1.267 . . . . 0.0 112.423 168.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -129.05 109.4 11.16 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.636 1.974 . . . . 0.0 107.017 163.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.28 128.78 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 91.7 mt -119.42 125.65 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.122 1.369 . . . . 0.0 108.734 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.5 104.39 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.525 1.53 . . . . 0.0 108.02 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.32 -179.62 20.98 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 123.363 1.535 . . . . 0.0 116.644 171.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.95 170.0 16.82 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.581 2.752 . . . . 0.0 110.027 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 82.69 -158.6 37.32 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -168.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -72.82 -35.74 67.37 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.702 -0.881 . . . . 0.0 111.037 163.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.4 m -52.14 6.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 1 C-N-CA 132.202 4.201 . . . . 0.0 119.198 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.53 138.15 37.02 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.923 1.289 . . . . 0.0 111.808 -169.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.7 mt -107.76 166.55 10.61 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.027 0.531 . . . . 0.0 110.814 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.8 t -142.57 158.18 43.94 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 171.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -141.08 130.78 24.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.811 1.244 . . . . 0.0 110.948 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -64.41 137.13 57.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.439 2.296 . . . . 0.0 112.668 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -138.92 154.1 48.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.469 1.128 . . . . 0.0 113.012 163.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -138.27 121.49 16.93 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.86 2.064 . . . . 0.0 106.221 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -79.51 157.82 27.35 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.963 0.887 . . . . 0.0 111.645 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.14 155.38 11.29 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.799 1.639 . . . . 0.0 113.414 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 49.07 12.78 0.28 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 127.003 2.239 . . . . 0.0 116.764 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 53.9 p -148.64 -44.58 0.15 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.109 1.455 . . . . 0.0 114.006 -161.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 23.6 t -125.45 -27.04 3.49 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.09 0.859 . . . . 0.0 112.953 168.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.0 tt -131.93 172.64 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.905 0.882 . . . . 0.0 109.845 163.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -58.89 -65.33 3.56 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.921 0.772 . . . . 0.0 112.0 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? . . . . . 0 C--O 1.253 1.25 0 CA-C-O 116.489 -1.719 . . . . 0.0 109.697 170.437 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 118.333 -0.841 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.4 p -122.34 -6.93 8.76 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -170.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.92 22.02 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -170.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.36 174.68 7.18 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.978 1.263 . . . . 0.0 112.1 -176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 11.0 p -46.88 -63.1 1.11 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.819 2.448 . . . . 0.0 115.166 -168.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.24 71.24 4.7 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.907 0.86 . . . . 0.0 110.769 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.43 ' HE3' ' HA ' ' A' ' 293' ' ' LYS . 0.5 OUTLIER -149.43 90.59 1.74 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.496 0.718 . . . . 0.0 112.156 176.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 67.82 -14.64 0.55 Allowed Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.585 1.564 . . . . 0.0 116.157 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 23.2 p -56.26 -68.06 0.24 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.212 2.605 . . . . 0.0 113.925 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 18.5 m -168.2 138.27 2.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.108 0.963 . . . . 0.0 112.686 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -164.26 147.96 9.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.402 1.881 . . . . 0.0 109.549 167.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 100.11 0.74 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 161.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 158.97 30.21 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.714 1.206 . . . . 0.0 114.08 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.4 m -105.71 137.63 43.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.709 1.204 . . . . 0.0 109.401 167.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.6 p -132.3 7.87 4.27 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -82.35 163.48 21.71 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.401 1.001 . . . . 0.0 110.735 165.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -62.22 109.04 1.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.613 1.965 . . . . 0.0 111.584 -165.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 15.1 mmt -72.99 159.27 33.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.769 0.795 . . . . 0.0 112.729 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.5 p -150.8 150.78 31.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.2 1.0 . . . . 0.0 111.134 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.3 119.44 35.83 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.651 0.78 . . . . 0.0 109.074 163.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -25.28 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.869 0.868 . . . . 0.0 110.425 165.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -142.31 127.84 19.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.911 2.084 . . . . 0.0 108.49 168.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -60.61 144.31 89.25 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.503 1.121 . . . . 0.0 111.443 171.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -54.79 136.57 72.2 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.22 1.947 . . . . 0.0 111.285 173.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 64.5 p -134.87 126.17 28.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.316 1.046 . . . . 0.0 111.198 171.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -55.76 119.18 5.34 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.327 1.451 . . . . 0.0 110.823 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 65.1 p -80.72 -12.59 59.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.906 0.883 . . . . 0.0 112.975 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.83 -7.49 1.54 Allowed Glycine 0 CA--C 1.538 1.494 0 CA-C-O 119.073 -0.848 . . . . 0.0 114.456 -166.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -81.77 2.66 28.97 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.352 1.576 . . . . 0.0 111.965 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.82 9.61 54.11 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.246 1.403 . . . . 0.0 113.677 -170.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.9 p -131.84 165.96 22.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.887 1.275 . . . . 0.0 112.874 -172.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.32 117.99 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.542 2.337 . . . . 0.0 107.152 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.0 p -102.45 132.08 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.586 0.755 . . . . 0.0 112.508 -174.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -137.59 165.29 26.68 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.853 1.661 . . . . 0.0 112.82 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.18 128.24 48.06 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.525 1.53 . . . . 0.0 107.177 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.93 148.45 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.666 0.787 . . . . 0.0 112.005 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -137.12 134.43 36.41 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.592 1.557 . . . . 0.0 112.114 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 m -98.86 159.26 30.74 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.995 1.718 . . . . 0.0 110.735 164.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -112.56 -55.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.886 2.391 . . . . 0.0 116.146 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 172.12 13.68 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.713 1.142 . . . . 0.0 113.139 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.11 -21.12 0.16 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 127.776 2.607 . . . . 0.0 118.291 168.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.39 107.86 56.91 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 119.366 1.583 . . . . 0.0 113.332 -165.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.57 125.91 5.8 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.996 2.464 . . . . 0.0 109.366 152.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 10.7 p -161.85 148.02 13.69 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.78 107.08 15.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.228 1.811 . . . . 0.0 106.635 163.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.284 0.6 OUTLIER -68.31 128.7 93.11 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.03 -153.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.97 109.48 2.89 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.117 3.211 . . . . 0.0 112.014 -172.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 93.5 t -111.18 108.89 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.861 1.665 . . . . 0.0 110.255 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.71 157.86 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 125.2 1.4 . . . . 0.0 110.019 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.6 t -144.48 125.54 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -149.59 170.18 19.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.098 0.559 . . . . 0.0 112.436 -170.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.453 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 18.8 m-20 -89.68 -1.09 57.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.434 1.094 . . . . 0.0 113.293 174.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -127.47 1.2 6.26 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -152.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.9 mt 61.8 -1.39 0.35 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.151 2.181 . . . . 0.0 115.392 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.7 t -129.91 -7.66 4.46 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -171.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.4 49.23 4.23 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.908 2.083 . . . . 0.0 114.096 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -78.24 -38.03 43.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.834 0.454 . . . . 0.0 110.379 158.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 67.0 mt -97.51 153.12 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 126.919 2.088 . . . . 0.0 108.284 170.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.59 125.83 18.65 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.65 -1.281 . . . . 0.0 112.555 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . 0.453 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 2.9 mmmm -129.7 -17.38 3.64 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -159.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -142.56 148.34 20.04 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 119.219 0.918 . . . . 0.0 114.813 -167.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.1 148.83 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.528 1.131 . . . . 0.0 113.095 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.14 115.47 3.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.33 2.652 . . . . 0.0 110.939 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 70.9 t -81.33 -38.41 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.074 0.949 . . . . 0.0 110.532 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 t -92.23 175.1 6.98 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 111.286 168.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.8 m -66.87 135.3 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.329 1.052 . . . . 0.0 111.052 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.39 113.54 13.14 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 121.608 -0.682 . . . . 0.0 111.558 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.58 175.8 10.62 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.282 2.655 . . . . 0.0 113.708 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.29 132.01 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.152 1.781 . . . . 0.0 109.062 -173.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -78.29 97.84 5.72 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.352 1.461 . . . . 0.0 109.797 166.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.0 t -92.5 -16.04 26.29 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.269 1.028 . . . . 0.0 112.618 170.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.27 135.38 54.73 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.716 2.006 . . . . 0.0 107.01 163.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.2 -14.82 63.27 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.563 -1.335 . . . . 0.0 114.443 -167.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.73 0.82 56.09 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.674 1.59 . . . . 0.0 113.146 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -53.18 138.51 31.49 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.743 -1.223 . . . . 0.0 113.28 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.11 142.63 49.57 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.939 1.296 . . . . 0.0 111.069 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.47 144.89 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -162.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -69.63 127.2 32.12 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.82 2.848 . . . . 0.0 110.195 169.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 18.0 mt -137.05 138.24 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.011 0.434 . . . . 0.0 110.308 168.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -110.19 143.43 40.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.201 1.001 . . . . 0.0 110.964 163.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.52 151.54 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.966 0.906 . . . . 0.0 112.406 173.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -94.23 115.93 65.81 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.438 1.895 . . . . 0.0 109.435 172.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.91 168.99 23.59 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.141 2.56 . . . . 0.0 111.07 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . 0.414 ' HG3' ' HE2' ' A' ' 346' ' ' LYS . 17.0 Cg_endo -75.7 -177.24 3.45 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.94 2.427 . . . . 0.0 109.813 163.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -75.05 152.56 38.64 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.293 -0.879 . . . . 0.0 109.639 149.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 75.32 -156.2 48.27 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.809 1.084 . . . . 0.0 115.809 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.97 145.83 55.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.255 2.622 . . . . 0.0 113.151 -166.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 6.2 m -179.24 160.46 1.03 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.709 1.603 . . . . 0.0 114.545 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -126.99 119.0 25.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 129.078 2.951 . . . . 0.0 108.586 170.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.2 mm -75.14 119.58 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.5 132.24 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 120.235 1.38 . . . . 0.0 110.076 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.6 106.49 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 126.069 1.748 . . . . 0.0 108.302 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 114.03 176.15 19.06 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 122.496 1.053 . . . . 0.0 115.234 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.63 166.4 23.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.851 2.061 . . . . 0.0 110.223 170.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.1 -175.65 45.14 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 123.09 0.376 . . . . 0.0 112.45 -165.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -58.55 -28.82 65.86 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.674 -0.897 . . . . 0.0 111.921 171.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 50.6 m -57.72 -10.44 1.62 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 130.106 3.362 . . . . 0.0 116.933 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -79.63 146.77 32.34 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.347 1.059 . . . . 0.0 112.039 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 44.3 mt -116.03 166.17 12.3 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.895 0.878 . . . . 0.0 110.513 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.2 t -152.5 161.37 42.68 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -139.66 131.78 28.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.625 1.57 . . . . 0.0 110.205 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -69.12 125.44 26.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.846 1.258 . . . . 0.0 111.264 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -137.29 90.44 2.52 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.5 1.12 . . . . 0.0 110.488 172.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -85.35 126.34 33.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -104.91 158.21 16.69 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.65 1.58 . . . . 0.0 109.533 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -42.38 124.51 2.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.172 1.789 . . . . 0.0 112.672 174.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 126.06 -0.53 7.71 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 167.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 91.7 p -135.47 -81.11 0.42 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 120.081 1.94 . . . . 0.0 112.45 170.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 67.6 p -104.09 0.77 30.1 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.105 1.762 . . . . 0.0 113.798 -170.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 7.4 tp -143.24 156.75 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.908 1.283 . . . . 0.0 110.323 167.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.19 -36.65 14.23 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.127 0.87 . . . . 0.0 113.492 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 5.8 tptp . . . . . 0 C--O 1.25 1.128 0 C-N-CA 128.577 2.751 . . . . 0.0 108.07 173.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 2.0 p -95.65 -7.9 36.27 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -170.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.6 21.98 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -165.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 51.8 tp -147.69 148.73 31.35 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.859 1.209 . . . . 0.0 112.188 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 72.6 p 23.28 -92.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 130.529 3.532 . . . . 0.0 116.98 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 11.6 tp -83.84 75.53 10.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.582 1.153 . . . . 0.0 112.026 -167.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.48 92.68 1.96 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.857 0.863 . . . . 0.0 111.425 171.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 67.7 -2.74 5.77 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.744 1.164 . . . . 0.0 115.757 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 1.5 p -64.42 -58.23 7.05 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.49 2.316 . . . . 0.0 112.592 -172.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.6 m -170.37 135.6 1.26 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.312 1.045 . . . . 0.0 112.365 171.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -163.83 143.22 8.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.613 1.165 . . . . 0.0 112.064 168.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 95.43 0.35 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 156.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -65.93 162.38 19.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.728 2.011 . . . . 0.0 114.275 -172.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 32.7 m -103.25 139.34 38.83 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.195 0.998 . . . . 0.0 110.558 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.2 p -138.76 7.12 2.5 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.663 1.356 . . . . 0.0 114.663 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.33 165.55 19.21 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.795 1.18 . . . . 0.0 110.634 163.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -66.98 95.01 0.36 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.673 1.989 . . . . 0.0 111.375 -169.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 23.8 mtm -76.75 170.18 16.93 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.118 1.367 . . . . 0.0 112.653 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.1 m -156.48 158.94 38.11 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.037 -1.039 . . . . 0.0 112.976 166.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.82 114.95 23.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.598 0.759 . . . . 0.0 109.745 162.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.8 -29.81 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.866 1.267 . . . . 0.0 110.318 168.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -140.77 132.47 27.28 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.634 1.974 . . . . 0.0 108.53 165.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -61.17 148.13 85.39 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.417 1.487 . . . . 0.0 112.846 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.67 130.27 37.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.886 2.391 . . . . 0.0 111.619 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.5 p -127.11 125.14 40.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.615 1.166 . . . . 0.0 111.29 173.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' A' ' 391' ' ' LYS . 44.7 t0 -60.03 126.44 27.56 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.301 1.44 . . . . 0.0 111.89 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -77.78 -16.15 58.59 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.326 1.451 . . . . 0.0 113.762 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.81 -5.79 5.7 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 118.937 -0.924 . . . . 0.0 114.139 -165.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -89.42 -2.24 58.33 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.201 1.501 . . . . 0.0 112.115 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 102.91 -1.73 48.16 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.233 1.396 . . . . 0.0 114.035 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 17.1 p -121.09 159.15 26.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.768 1.227 . . . . 0.0 111.679 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.3 123.74 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.484 1.914 . . . . 0.0 108.091 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.3 p -111.96 129.14 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.183 0.993 . . . . 0.0 113.418 -166.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -136.11 168.13 19.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.886 2.075 . . . . 0.0 113.071 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -125.84 129.17 48.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.796 1.238 . . . . 0.0 108.083 166.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.07 153.0 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 119.21 0.914 . . . . 0.0 112.528 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -141.65 146.68 36.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.706 1.602 . . . . 0.0 113.455 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.99 155.41 41.71 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.835 2.054 . . . . 0.0 109.702 160.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -109.18 -49.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.286 1.991 . . . . 0.0 116.46 -175.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 173.81 13.8 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.738 1.154 . . . . 0.0 112.79 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.11 0.83 10.5 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.439 1.971 . . . . 0.0 117.645 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -119.37 97.28 50.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 119.015 1.408 . . . . 0.0 113.868 -160.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -81.19 111.71 2.45 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.845 3.03 . . . . 0.0 109.88 152.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 7.5 p -159.68 153.47 22.95 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -81.37 110.45 16.81 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 159.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.263 1.3 pp -66.14 112.74 9.83 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 119.429 -0.319 . . . . 0.0 111.387 -162.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.84 113.88 3.72 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.908 2.406 . . . . 0.0 112.345 -165.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 94.8 t -112.35 108.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 126.171 1.788 . . . . 0.0 110.004 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.0 158.22 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.62 1.568 . . . . 0.0 110.168 -176.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 77.7 t -145.8 116.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -171.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.01 -179.17 5.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.172 0.989 . . . . 0.0 113.048 -165.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.426 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 69.6 m-20 -111.07 -0.13 16.72 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.96 0.904 . . . . 0.0 112.33 163.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -123.35 6.72 9.03 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.751 1.621 . . . . 0.0 113.952 -159.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.2 mt 65.27 -6.02 0.4 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.252 2.221 . . . . 0.0 115.194 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -128.49 -3.08 5.48 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 68.33 37.43 2.76 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.825 2.05 . . . . 0.0 113.536 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.17 -49.07 68.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 165.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.46 150.39 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 126.626 1.97 . . . . 0.0 107.59 164.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.58 129.47 21.83 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.161 -0.962 . . . . 0.0 112.221 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . 0.426 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 31.6 mtmt -133.95 -8.55 2.71 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -160.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -127.72 130.14 6.63 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 -164.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -89.12 157.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.12 1.368 . . . . 0.0 111.905 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.77 119.92 32.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.091 2.156 . . . . 0.0 109.177 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.41 -25.22 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.502 0.721 . . . . 0.0 112.187 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.7 t -125.66 175.54 7.51 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.544 1.537 . . . . 0.0 111.084 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.78 107.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.155 1.782 . . . . 0.0 113.427 -175.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -71.55 113.53 20.47 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.826 1.25 . . . . 0.0 110.055 162.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -82.63 179.1 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.705 2.937 . . . . 0.0 114.419 -169.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.62 119.79 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 127.19 2.196 . . . . 0.0 106.058 163.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.0 84.63 0.08 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.56 1.144 . . . . 0.0 110.501 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.1 t -81.92 -9.73 59.49 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.54 122.84 37.71 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 127.399 2.28 . . . . 0.0 106.898 168.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -66.87 -10.8 52.23 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.285 -1.509 . . . . 0.0 114.752 -166.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -89.86 4.33 50.19 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.333 1.853 . . . . 0.0 113.375 170.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.33 134.89 11.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.222 1.409 . . . . 0.0 113.811 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.93 151.43 49.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.774 1.23 . . . . 0.0 111.56 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.29 144.57 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -166.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -79.23 121.47 25.1 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.708 2.403 . . . . 0.0 109.79 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 61.0 mt -131.1 136.35 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.359 0.599 . . . . 0.0 111.177 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -101.89 141.27 35.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.976 1.31 . . . . 0.0 110.762 161.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.7 159.49 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.391 1.076 . . . . 0.0 112.001 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -117.13 102.06 52.86 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.703 1.601 . . . . 0.0 109.949 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.78 179.89 3.89 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.676 2.917 . . . . 0.0 110.866 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -78.83 -179.85 5.84 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.219 1.946 . . . . 0.0 110.869 161.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -60.48 148.61 37.06 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 153.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.92 -163.72 43.96 Favored Glycine 0 CA--C 1.539 1.583 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -62.86 158.9 17.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.631 1.972 . . . . 0.0 114.471 -169.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.6 m -166.54 168.57 14.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.137 1.375 . . . . 0.0 113.079 166.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.91 111.29 12.41 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.659 2.383 . . . . 0.0 107.326 164.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 17.4 mm -69.44 129.04 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 59.2 mt -121.32 124.18 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.357 1.063 . . . . 0.0 108.926 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.99 100.56 11.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 126.069 1.747 . . . . 0.0 107.58 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 114.68 178.72 18.89 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 123.071 1.373 . . . . 0.0 116.159 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.57 167.25 22.04 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.744 2.418 . . . . 0.0 110.167 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.29 -174.85 46.81 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.569 0.604 . . . . 0.0 112.338 -167.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -59.22 -30.5 68.29 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 122.037 -0.684 . . . . 0.0 111.228 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 15.6 m -60.15 -6.98 1.61 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 129.88 3.272 . . . . 0.0 117.22 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.65 148.5 31.61 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.018 0.927 . . . . 0.0 112.005 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 18.0 mt -111.89 165.46 12.06 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.504 0.722 . . . . 0.0 110.563 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.9 t -147.06 157.74 43.71 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -139.71 121.29 15.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.334 1.854 . . . . 0.0 109.657 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -66.64 140.5 57.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.094 1.358 . . . . 0.0 111.89 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -135.95 155.95 49.49 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.46 1.104 . . . . 0.0 111.773 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -133.39 108.21 8.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' A' ' 312' ' ' ASP . 9.9 tptp -81.04 154.34 26.91 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -43.22 132.57 4.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.021 1.728 . . . . 0.0 112.313 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 114.07 12.7 10.78 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 118.018 1.967 . . . . 0.0 118.018 162.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 90.9 p -135.26 -79.59 0.43 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.189 1.994 . . . . 0.0 111.853 169.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 85.8 p -98.33 -12.77 21.16 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 127.803 2.441 . . . . 0.0 113.118 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 7.9 tp -131.84 147.99 32.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 125.979 1.711 . . . . 0.0 109.59 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.88 -55.56 6.38 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 3.9 tptp . . . . . 0 C--O 1.25 1.131 0 C-N-CA 128.212 2.605 . . . . 0.0 108.492 171.749 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.411 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 54.3 p -120.57 -6.12 9.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.831 1.652 . . . . 0.0 113.95 175.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.52 11.21 0.27 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.25 1.82 . . . . 0.0 115.719 -170.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.87 151.74 49.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.582 1.553 . . . . 0.0 110.136 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 26.9 p -41.89 -68.65 0.17 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.578 2.351 . . . . 0.0 113.206 -172.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.47 -11.52 16.57 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.169 1.788 . . . . 0.0 114.087 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.417 ' HE2' ' ND2' ' A' ' 345' ' ' ASN . 1.2 mmmt -103.34 64.19 0.82 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.779 -1.201 . . . . 0.0 111.34 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 80.41 -18.85 7.71 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.421 -1.211 . . . . 0.0 115.026 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 23.0 m -71.66 -51.61 22.22 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.444 1.622 . . . . 0.0 112.65 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.3 m -171.44 124.81 0.6 Allowed 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.232 1.378 . . . . 0.0 113.239 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -158.01 155.82 30.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.106 1.762 . . . . 0.0 110.431 167.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.45 104.21 7.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.856 0.863 . . . . 0.0 108.995 170.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -66.84 146.95 53.88 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.972 2.109 . . . . 0.0 115.945 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.9 m -96.49 144.62 26.42 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.728 1.211 . . . . 0.0 109.075 159.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 57.8 p -139.56 2.1 1.99 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.463 ' CG ' ' HZ3' ' A' ' 326' ' ' LYS . 42.7 t0 -69.23 161.19 29.72 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 120.181 1.355 . . . . 0.0 111.157 165.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.87 95.46 0.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.0 1.72 . . . . 0.0 112.277 -171.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 31.6 mtm -81.38 166.64 20.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.927 1.291 . . . . 0.0 112.003 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 22.2 m -160.21 162.57 33.82 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.441 -0.787 . . . . 0.0 112.085 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -74.46 135.17 42.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.514 0.726 . . . . 0.0 109.426 166.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.99 -17.97 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.342 0.657 . . . . 0.0 110.81 161.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 28.6 tttm -147.87 123.72 10.61 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.452 2.301 . . . . 0.0 108.034 173.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.28 146.2 84.41 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.992 0.917 . . . . 0.0 112.069 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.77 130.06 35.53 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.694 2.929 . . . . 0.0 112.848 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.6 p -128.55 134.18 48.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.551 1.141 . . . . 0.0 110.585 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -60.55 122.12 13.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.29 0.636 . . . . 0.0 109.893 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.7 p -72.79 -14.16 61.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.284 1.034 . . . . 0.0 112.801 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.74 -4.94 13.3 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.277 0.942 . . . . 0.0 113.492 -165.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -90.16 1.14 56.74 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.886 1.343 . . . . 0.0 112.036 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.87 13.41 43.49 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.804 1.193 . . . . 0.0 113.72 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.8 p -133.66 153.9 51.32 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.044 1.338 . . . . 0.0 111.687 -174.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.49 121.14 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.669 1.187 . . . . 0.0 107.912 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.0 p -112.37 134.33 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.35 1.06 . . . . 0.0 113.067 -164.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -141.79 159.83 41.43 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.936 1.695 . . . . 0.0 112.893 -175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -107.92 132.36 53.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.1 1.36 . . . . 0.0 107.373 164.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.35 144.66 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.641 0.776 . . . . 0.0 111.314 -177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -131.04 144.28 51.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.368 1.467 . . . . 0.0 112.901 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.62 153.36 44.31 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 127.986 2.514 . . . . 0.0 108.835 168.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -108.93 -70.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.843 2.362 . . . . 0.0 116.277 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.463 ' HZ3' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -135.18 164.45 27.66 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 121.226 1.83 . . . . 0.0 114.339 -175.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 71.6 0.07 37.74 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.89 1.709 . . . . 0.0 117.037 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.87 102.53 53.99 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 118.879 1.34 . . . . 0.0 113.525 -166.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.06 120.22 2.95 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.717 2.944 . . . . 0.0 109.611 152.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 7.7 p -162.51 157.37 22.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -89.39 109.19 20.13 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 157.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.265 0.9 OUTLIER -65.3 122.79 81.88 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.744 -157.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -61.77 117.41 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.712 2.941 . . . . 0.0 113.522 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.1 t -124.94 111.43 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.251 1.421 . . . . 0.0 110.721 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.28 157.26 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.338 1.455 . . . . 0.0 110.096 -173.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.79 118.36 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.46 171.45 13.38 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -165.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.418 ' CG ' ' HE2' ' A' ' 346' ' ' LYS . 4.6 m-20 -90.89 -13.45 33.6 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.351 2.26 . . . . 0.0 112.577 166.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 341' ' ' THR . 40.1 p30 -114.99 0.18 13.59 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -154.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 36.4 mt 60.7 -25.95 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.664 2.786 . . . . 0.0 115.533 -171.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.417 ' H ' ' C ' ' A' ' 339' ' ' ASP . 11.1 t -99.8 -4.56 30.26 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.822 2.049 . . . . 0.0 114.567 -172.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.87 78.15 0.05 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 130.658 3.583 . . . . 0.0 115.175 -171.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -99.53 -38.91 8.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.295 1.438 . . . . 0.0 110.837 153.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 35.2 mm -98.96 128.5 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.771 1.228 . . . . 0.0 109.521 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . 0.417 ' ND2' ' HE2' ' A' ' 293' ' ' LYS . 12.8 t30 -108.65 125.23 51.64 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.754 -0.591 . . . . 0.0 112.054 172.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . 0.418 ' HE2' ' CG ' ' A' ' 338' ' ' ASP . 47.8 mttm -75.49 -73.45 0.26 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.691 2.796 . . . . 0.0 110.902 166.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -98.31 167.16 22.35 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.063 1.316 . . . . 0.0 115.582 -155.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 12.6 mt -120.03 152.24 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.633 1.573 . . . . 0.0 110.318 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.3 135.97 54.16 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.472 1.909 . . . . 0.0 110.312 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.58 -50.14 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.949 0.5 . . . . 0.0 110.693 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.1 m -81.45 156.81 25.16 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.001 0.92 . . . . 0.0 109.348 160.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.05 161.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.255 1.422 . . . . 0.0 113.922 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -125.02 121.05 25.39 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.158 1.783 . . . . 0.0 109.227 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -82.28 -175.29 2.44 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.265 3.31 . . . . 0.0 113.548 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 123.12 63.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.578 1.551 . . . . 0.0 108.037 168.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.63 84.71 0.87 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.34 1.056 . . . . 0.0 111.548 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 25.0 t -79.29 -12.34 59.94 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 167.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.7 p -131.31 121.98 25.64 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 127.785 2.434 . . . . 0.0 105.939 167.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -59.51 -20.34 54.66 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.8 0.06 9.93 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.466 1.906 . . . . 0.0 113.737 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -37.13 121.82 0.83 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.481 2.312 . . . . 0.0 113.58 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.65 143.18 47.13 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.269 1.028 . . . . 0.0 111.285 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.2 p -154.17 150.47 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -163.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.93 121.82 27.48 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.793 2.437 . . . . 0.0 109.469 168.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 37.0 mt -135.71 150.13 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.956 0.798 . . . . 0.0 111.455 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -118.4 142.63 47.35 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.55 1.94 . . . . 0.0 111.467 170.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 3.8 m -123.11 145.47 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.569 1.148 . . . . 0.0 110.733 168.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -83.18 119.08 73.49 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.936 0.894 . . . . 0.0 109.787 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -82.34 151.33 15.54 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 122.844 2.363 . . . . 0.0 111.045 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.47 178.13 7.07 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.747 2.298 . . . . 0.0 110.442 158.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.73 151.66 46.88 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.611 -0.68 . . . . 0.0 110.449 163.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 77.63 -151.33 37.64 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 121.92 -0.488 . . . . 0.0 113.297 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.28 143.45 57.78 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -173.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 47.2 m -157.41 145.49 19.12 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.487 1.115 . . . . 0.0 112.512 167.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -122.77 105.2 9.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.404 1.082 . . . . 0.0 108.651 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 13.8 mm -76.69 113.78 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 127.444 2.298 . . . . 0.0 109.022 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 25.1 mt -116.79 133.96 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 122.449 1.118 . . . . 0.0 111.78 -168.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 81.6 t -116.77 114.58 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 C-N-CA 126.647 1.979 . . . . 0.0 108.023 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 96.98 -173.05 28.82 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 122.875 1.264 . . . . 0.0 115.521 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.95 164.01 31.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.308 2.243 . . . . 0.0 110.018 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.55 -174.12 42.68 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.008 0.337 . . . . 0.0 112.359 -167.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -59.17 -25.79 64.22 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.074 0.95 . . . . 0.0 112.497 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 63.4 m -60.38 -10.72 5.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.824 2.449 . . . . 0.0 115.684 172.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -77.39 124.71 28.24 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.508 1.049 . . . . 0.0 112.167 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 9.8 mt -97.71 161.3 13.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.983 0.513 . . . . 0.0 111.401 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.9 t -132.65 157.88 43.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.879 1.272 . . . . 0.0 112.042 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -145.0 136.52 25.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.078 1.351 . . . . 0.0 110.979 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.14 137.22 38.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.465 1.506 . . . . 0.0 113.139 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -138.01 147.39 44.14 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.917 1.287 . . . . 0.0 111.352 158.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -123.53 111.74 16.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.603 1.561 . . . . 0.0 107.598 169.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -98.62 117.82 33.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.494 1.118 . . . . 0.0 112.156 -167.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 70.78 140.88 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.693 3.197 . . . . 0.0 113.591 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -64.81 66.88 0.07 OUTLIER Glycine 0 C--N 1.341 0.837 0 C-N-CA 128.567 2.984 . . . . 0.0 112.754 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 50.8 m -67.5 -4.97 12.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.809 2.444 . . . . 0.0 113.919 -167.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 34.1 t -104.25 4.01 33.34 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.294 1.838 . . . . 0.0 113.813 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 15.2 tt -134.2 -31.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.319 1.047 . . . . 0.0 113.147 170.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 144.36 -24.47 2.03 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.927 1.251 . . . . 0.0 114.893 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? . . . . . 0 C--O 1.247 0.946 0 C-N-CA 126.389 1.876 . . . . 0.0 109.446 178.591 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 119.608 -0.234 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 26.3 p -67.01 9.63 0.19 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.765 2.426 . . . . 0.0 117.12 -170.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.63 -2.43 6.78 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -172.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 33.2 tp -138.86 146.07 40.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.066 1.346 . . . . 0.0 109.26 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 11.5 m -46.57 -49.06 19.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.556 1.942 . . . . 0.0 114.506 -165.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.93 49.71 0.19 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.752 1.621 . . . . 0.0 112.053 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.05 89.19 0.92 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.39 1.476 . . . . 0.0 110.157 174.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.87 -22.07 2.41 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 117.847 -1.529 . . . . 0.0 116.765 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 30.9 p -56.42 -69.29 0.15 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.872 1.836 . . . . 0.0 113.354 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.0 m -176.31 120.91 0.15 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.608 2.363 . . . . 0.0 109.727 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -155.42 156.33 35.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.477 0.656 . . . . 0.0 112.526 173.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.35 105.94 13.83 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.123 1.769 . . . . 0.0 109.173 172.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -80.44 161.83 24.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.125 1.77 . . . . 0.0 114.162 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 13.7 m -100.86 148.58 24.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.343 1.057 . . . . 0.0 110.939 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 42.9 p -139.08 11.47 2.61 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 170.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -83.17 160.61 21.78 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.804 1.183 . . . . 0.0 110.039 163.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -65.29 98.72 0.35 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.095 1.758 . . . . 0.0 111.825 -163.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 27.6 mtm -83.01 164.06 20.6 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.716 0.806 . . . . 0.0 111.79 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.3 m -159.53 161.29 35.25 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.316 -0.865 . . . . 0.0 111.993 167.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.67 115.47 25.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.798 0.839 . . . . 0.0 110.573 167.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.69 -26.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.948 1.299 . . . . 0.0 110.548 168.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -142.31 130.86 22.52 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.539 1.936 . . . . 0.0 109.022 167.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -61.34 149.75 82.16 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.928 1.691 . . . . 0.0 113.313 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -55.86 130.57 41.07 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.345 2.697 . . . . 0.0 112.389 173.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.3 p -128.58 127.54 42.5 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.474 1.109 . . . . 0.0 111.297 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -60.82 123.89 18.83 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.73 1.612 . . . . 0.0 112.133 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.2 p -79.57 -11.81 59.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.487 1.515 . . . . 0.0 113.307 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 68.71 -10.36 1.55 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.418 1.009 . . . . 0.0 114.224 -168.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -83.23 3.63 30.33 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.618 1.567 . . . . 0.0 111.702 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 101.97 -1.47 51.59 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 126.043 1.782 . . . . 0.0 113.612 -174.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.2 p -118.06 159.11 23.79 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.771 1.286 . . . . 0.0 112.451 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.79 111.43 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.406 1.482 . . . . 0.0 107.916 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.46 133.1 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.245 1.018 . . . . 0.0 113.615 -162.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -139.69 161.54 37.27 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.245 2.218 . . . . 0.0 112.496 -172.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -113.33 130.12 56.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.454 1.102 . . . . 0.0 108.158 164.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.2 150.57 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.074 0.95 . . . . 0.0 111.874 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.8 tttp -135.73 148.38 48.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.826 1.651 . . . . 0.0 113.044 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.51 153.11 46.68 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 128.322 2.649 . . . . 0.0 108.17 165.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -107.97 -55.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.454 2.102 . . . . 0.0 115.695 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.94 171.01 16.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.275 1.03 . . . . 0.0 112.575 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.63 -5.14 1.8 Allowed Glycine 0 CA--C 1.537 1.425 0 C-N-CA 126.975 2.226 . . . . 0.0 118.093 166.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.53 95.59 48.09 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 119.286 1.543 . . . . 0.0 113.331 -161.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.93 117.82 4.83 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.114 2.543 . . . . 0.0 109.345 158.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.1 p -165.51 150.88 9.11 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.18 101.56 6.23 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.104 1.762 . . . . 0.0 106.588 158.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.253 1.3 pp -61.08 120.4 54.04 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-O 118.555 -0.735 . . . . 0.0 111.543 -158.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -61.89 114.85 2.47 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.492 2.795 . . . . 0.0 113.552 -171.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.62 120.15 62.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.979 1.312 . . . . 0.0 108.781 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 163.63 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.013 1.325 . . . . 0.0 110.643 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 48.2 t -142.81 118.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.69 163.39 38.23 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.1 6.2 38.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.069 0.948 . . . . 0.0 111.913 -175.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -115.14 1.98 14.01 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.937 2.495 . . . . 0.0 113.457 -164.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 32.8 mt 61.31 8.03 1.94 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.495 2.318 . . . . 0.0 114.994 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.9 t -142.62 -6.6 0.89 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 55.95 50.18 14.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.767 2.027 . . . . 0.0 114.925 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.71 72.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 152.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 34.2 mm -70.57 148.18 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 123.718 0.807 . . . . 0.0 108.927 162.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.08 74.26 1.51 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.432 -1.418 . . . . 0.0 109.349 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -75.27 -60.63 2.21 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.296 1.838 . . . . 0.0 112.886 -160.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.452 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -94.44 175.88 34.9 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.655 1.598 . . . . 0.0 115.406 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -113.79 150.73 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.143 2.577 . . . . 0.0 110.377 -173.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.78 135.46 36.5 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.493 1.517 . . . . 0.0 109.685 165.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.8 t -114.86 -65.34 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.885 0.766 . . . . 0.0 111.208 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' THR . . . . . 0.433 ' H ' ' HB2' ' A' ' 366' ' ' GLU . 1.5 m -68.8 157.34 36.64 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 162.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 35.2 m -55.71 161.44 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.959 1.704 . . . . 0.0 114.759 -172.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -125.67 125.35 24.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.445 1.898 . . . . 0.0 108.108 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -80.88 -174.49 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.85 3.033 . . . . 0.0 112.667 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.27 120.49 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 162.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.97 67.25 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.778 2.031 . . . . 0.0 113.444 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -71.03 -20.81 62.35 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.912 0.885 . . . . 0.0 112.402 169.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.81 123.05 43.66 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 154.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -65.65 -16.31 63.61 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.55 -1.344 . . . . 0.0 112.803 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -81.13 2.79 25.91 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.29 1.836 . . . . 0.0 113.751 170.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.22 126.14 3.98 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.303 1.441 . . . . 0.0 113.243 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.14 149.19 52.46 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.064 0.946 . . . . 0.0 111.539 167.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.0 p -158.56 151.38 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -163.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.74 122.61 28.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.172 2.589 . . . . 0.0 109.624 169.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 20.7 mt -134.02 149.67 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.932 0.787 . . . . 0.0 110.619 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' A' ' 351' ' ' THR . 45.4 mt-10 -116.22 143.38 45.58 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.608 1.563 . . . . 0.0 110.977 167.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.02 157.8 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.448 0.699 . . . . 0.0 111.635 164.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -121.47 102.19 42.74 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 127.164 2.186 . . . . 0.0 108.501 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.36 165.33 27.73 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.17 1.914 . . . . 0.0 110.628 166.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -59.7 177.2 0.49 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.078 2.518 . . . . 0.0 111.668 156.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -59.65 142.59 52.61 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.845 -0.534 . . . . 0.0 110.527 165.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 101.92 -154.18 18.72 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.957 1.265 . . . . 0.0 115.381 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.82 140.97 38.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.412 2.685 . . . . 0.0 112.533 -170.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.63 174.04 8.05 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 159.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -111.94 119.64 39.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.272 1.429 . . . . 0.0 108.926 170.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.5 mm -78.28 119.79 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 173.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 83.4 mt -112.19 134.83 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.685 1.194 . . . . 0.0 109.783 -172.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.6 t -115.86 108.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 126.097 1.759 . . . . 0.0 107.982 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.78 -179.27 24.21 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.11 167.29 21.83 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.433 2.693 . . . . 0.0 110.245 175.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.33 -169.62 54.9 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.606 0.622 . . . . 0.0 112.247 -169.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -63.11 -32.48 73.87 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.089 -1.242 . . . . 0.0 111.352 168.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 70.3 m -54.89 8.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 1 C-N-CA 131.877 4.071 . . . . 0.0 118.474 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -103.95 146.42 28.71 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.628 1.171 . . . . 0.0 111.704 -172.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 21.6 mt -120.95 168.66 11.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.044 0.938 . . . . 0.0 110.926 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.0 t -145.88 159.38 43.3 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 172.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -132.72 130.46 40.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.347 1.459 . . . . 0.0 109.678 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -76.71 132.58 39.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.287 1.835 . . . . 0.0 111.63 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -133.2 151.22 51.95 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 122.208 1.004 . . . . 0.0 111.796 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -137.75 123.76 20.24 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 171.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . 0.485 ' HZ2' ' CD ' ' A' ' 392' ' ' GLU . 59.0 tttp -128.16 110.88 12.86 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.689 0.796 . . . . 0.0 111.755 -168.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.485 ' CD ' ' HZ2' ' A' ' 391' ' ' LYS . 1.4 pt-20 30.76 87.31 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 128.87 2.868 . . . . 0.0 117.175 171.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 120.34 29.05 1.68 Allowed Glycine 0 CA--C 1.533 1.202 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 159.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 99.7 p -128.73 -86.13 0.56 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.411 1.606 . . . . 0.0 111.307 167.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 88.0 p -91.53 -11.68 36.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.44 2.296 . . . . 0.0 112.938 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.3 tp -139.31 153.22 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.028 1.731 . . . . 0.0 110.528 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.64 -17.11 66.72 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.995 0.807 . . . . 0.0 114.483 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 6.8 tptp . . . . . 0 C--O 1.245 0.826 0 C-N-CA 126.548 1.939 . . . . 0.0 109.217 175.789 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 28.1 p -71.72 -5.17 31.99 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.493 1.517 . . . . 0.0 115.066 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -62.17 -12.05 17.77 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.823 1.649 . . . . 0.0 115.028 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.8 tt -125.86 125.83 43.47 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 163.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.5 m -55.6 -25.95 41.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.983 1.713 . . . . 0.0 114.699 -161.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.54 68.64 0.58 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.938 1.295 . . . . 0.0 111.411 171.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.466 ' HE3' ' HA ' ' A' ' 293' ' ' LYS . 0.4 OUTLIER -155.18 82.62 1.06 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.451 1.5 . . . . 0.0 110.865 169.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 70.31 -9.67 3.1 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 117.099 1.6 . . . . 0.0 117.099 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 65.1 p -54.92 -64.01 0.97 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.216 1.807 . . . . 0.0 113.232 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.9 m -173.23 128.69 0.45 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.678 1.991 . . . . 0.0 110.764 173.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -158.14 147.36 19.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.715 0.806 . . . . 0.0 111.801 168.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.82 96.89 0.31 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.329 1.452 . . . . 0.0 108.506 166.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -69.7 156.91 38.25 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.416 2.686 . . . . 0.0 115.177 -172.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 14.9 m -100.53 137.81 38.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.874 1.27 . . . . 0.0 109.787 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 66.7 p -138.15 4.31 2.46 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -80.54 165.55 22.01 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.876 1.216 . . . . 0.0 110.707 166.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -66.68 94.95 0.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.848 2.059 . . . . 0.0 111.366 -165.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 30.7 mtm -79.69 163.32 24.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.853 1.261 . . . . 0.0 112.317 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.4 p -150.43 161.88 41.65 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.556 1.143 . . . . 0.0 112.476 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -93.93 125.82 38.77 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.152 0.981 . . . . 0.0 108.723 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.72 -26.7 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 163.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -144.06 128.46 17.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.59 1.956 . . . . 0.0 108.743 171.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -59.22 143.81 84.29 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.961 0.904 . . . . 0.0 111.752 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -56.31 137.95 81.84 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.082 1.855 . . . . 0.0 111.513 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 41.2 p -132.49 124.59 28.83 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.37 1.068 . . . . 0.0 111.805 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -54.09 122.05 9.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.307 1.843 . . . . 0.0 111.517 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -84.24 -12.39 54.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.137 0.975 . . . . 0.0 113.296 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.95 -10.01 1.32 Allowed Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.271 0.939 . . . . 0.0 114.584 -167.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -83.38 7.02 17.95 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.29 1.545 . . . . 0.0 111.971 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 96.2 5.9 59.16 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.48 1.514 . . . . 0.0 113.713 -171.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.5 p -127.75 167.48 16.43 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.708 1.254 . . . . 0.0 112.825 -172.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.35 123.59 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.693 1.997 . . . . 0.0 107.817 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -110.32 131.7 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.74 1.216 . . . . 0.0 113.005 -170.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -138.45 167.13 22.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.685 1.594 . . . . 0.0 113.756 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -126.26 129.44 48.93 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.028 1.331 . . . . 0.0 108.594 166.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.1 m -127.26 154.87 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.79 0.836 . . . . 0.0 111.792 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -139.65 144.28 37.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.581 1.552 . . . . 0.0 111.717 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 12.7 p -120.04 154.23 55.56 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.153 2.181 . . . . 0.0 108.518 168.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -113.31 -45.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.2 0 CA-C-N 122.205 1.823 . . . . 0.0 116.602 -165.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.7 164.68 32.79 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.928 -1.107 . . . . 0.0 112.447 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.37 4.95 26.21 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.888 1.709 . . . . 0.0 117.188 168.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.89 95.66 46.04 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.0 1.4 . . . . 0.0 113.094 -164.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.62 115.08 1.51 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.048 3.166 . . . . 0.0 109.249 154.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 9.3 p -163.36 144.39 9.3 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.99 107.11 9.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 162.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.278 0.7 OUTLIER -68.87 122.2 84.16 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.13 -155.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -64.2 116.02 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.062 2.508 . . . . 0.0 112.987 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.91 108.17 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.828 1.651 . . . . 0.0 110.312 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.09 156.92 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.437 1.495 . . . . 0.0 109.581 -170.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 42.5 t -142.62 122.13 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 120.98 -1.075 . . . . 0.0 109.39 -170.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.19 173.71 11.27 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -161.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.516 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 68.1 m-20 -110.54 -1.99 16.67 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.517 1.527 . . . . 0.0 112.205 168.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -125.83 4.58 7.36 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.703 1.601 . . . . 0.0 113.996 -159.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 35.7 mt 62.56 -4.9 0.21 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.339 2.256 . . . . 0.0 115.52 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 5.0 t -125.33 0.71 7.73 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.074 1.307 . . . . 0.0 113.963 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 77.87 21.2 0.95 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.59 2.356 . . . . 0.0 113.945 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -61.43 -46.45 90.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.268 1.027 . . . . 0.0 111.475 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.7 mm -94.37 135.39 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . 0.407 ' OD1' ' HE2' ' A' ' 293' ' ' LYS . 0.6 OUTLIER -132.64 86.68 2.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 123.415 1.579 . . . . 0.0 113.31 -167.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . 0.516 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 14.3 mtpp -82.6 -49.08 10.24 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.708 2.403 . . . . 0.0 113.097 -158.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.447 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -104.84 154.13 17.36 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -160.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.15 149.1 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 127.102 2.161 . . . . 0.0 109.749 -169.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.12 120.35 24.14 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.054 1.341 . . . . 0.0 109.277 170.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.93 -38.3 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.963 0.505 . . . . 0.0 111.052 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.1 t -97.59 175.41 6.21 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.351 0.66 . . . . 0.0 111.058 166.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.74 128.52 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.726 1.211 . . . . 0.0 110.507 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -66.31 114.96 19.29 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.673 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.86 174.7 10.71 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.311 2.674 . . . . 0.0 113.394 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.33 120.99 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 127.223 2.209 . . . . 0.0 107.986 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.95 99.53 0.5 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.553 1.141 . . . . 0.0 109.506 167.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 26.1 t -102.16 -11.12 19.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.689 1.596 . . . . 0.0 112.79 175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.59 152.33 33.27 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 147.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -72.86 -11.66 60.68 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 117.847 -1.073 . . . . 0.0 113.597 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.99 1.46 55.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.311 1.444 . . . . 0.0 112.457 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -54.18 134.14 44.44 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.443 1.116 . . . . 0.0 113.034 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.41 140.44 52.17 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.442 1.497 . . . . 0.0 110.634 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.35 142.63 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -158.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.06 127.8 33.63 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 129.491 3.116 . . . . 0.0 110.419 170.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 44.2 mt -137.85 144.62 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.096 0.558 . . . . 0.0 110.655 170.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -116.1 139.05 50.7 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.562 1.545 . . . . 0.0 111.125 165.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.36 158.32 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.737 1.215 . . . . 0.0 111.801 175.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -118.1 105.26 47.28 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 126.978 2.111 . . . . 0.0 108.687 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -80.84 169.63 16.31 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.533 2.822 . . . . 0.0 111.147 172.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.83 175.96 8.95 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.422 2.082 . . . . 0.0 110.846 162.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -65.72 148.42 51.8 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.797 -0.564 . . . . 0.0 109.853 161.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.41 -162.51 33.4 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-O 122.426 1.014 . . . . 0.0 114.833 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.3 156.31 29.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.563 1.945 . . . . 0.0 113.941 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 64.0 m -170.03 159.79 7.84 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.667 1.987 . . . . 0.0 112.063 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -124.42 123.56 40.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.887 1.675 . . . . 0.0 107.934 157.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.6 mm -76.69 111.0 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 87.1 mt -100.95 130.98 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.687 1.131 . . . . 0.0 109.391 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 83.5 t -117.76 109.45 27.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.898 1.679 . . . . 0.0 107.838 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.9 -176.21 22.72 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 123.333 1.518 . . . . 0.0 116.604 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.57 171.96 13.39 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.167 2.587 . . . . 0.0 110.357 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.37 -171.87 45.83 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -61.16 -31.1 70.83 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.811 -0.817 . . . . 0.0 111.7 170.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 53.2 m -61.39 -8.15 3.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 129.571 3.148 . . . . 0.0 117.364 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -74.38 144.89 44.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.855 0.752 . . . . 0.0 111.449 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 31.8 mt -116.8 167.64 10.92 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.263 0.625 . . . . 0.0 110.719 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.3 t -146.55 159.12 43.83 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -134.57 131.25 37.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.418 1.487 . . . . 0.0 109.57 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -73.89 131.51 41.55 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.312 2.245 . . . . 0.0 112.344 -173.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -142.59 118.02 10.28 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.24 1.016 . . . . 0.0 111.888 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -105.78 105.14 15.04 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 392' ' ' GLU . 10.2 tptp -74.93 150.88 38.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.446 ' CD ' ' HZ1' ' A' ' 391' ' ' LYS . 8.0 pm0 -42.29 125.68 3.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.859 2.064 . . . . 0.0 114.209 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 120.23 10.27 7.47 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 117.78 1.872 . . . . 0.0 117.78 158.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 94.4 p -126.87 -94.66 0.45 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.299 2.049 . . . . 0.0 112.408 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 85.8 p -77.91 -11.59 59.91 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.508 1.923 . . . . 0.0 112.874 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.3 tt -142.09 156.42 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.819 1.647 . . . . 0.0 110.911 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -80.66 -38.75 15.85 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.122 -0.821 . . . . 0.0 113.51 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 4.8 tptp . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.632 2.373 . . . . 0.0 109.278 178.943 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 33.6 tpp . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 12.8 m -56.99 -15.49 5.08 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -167.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -82.6 -12.63 57.56 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.62 117.79 20.94 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.198 1.363 . . . . 0.0 114.113 -164.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 29.2 p 65.26 -154.09 0.27 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.806 2.042 . . . . 0.0 112.317 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.53 94.15 0.11 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.15 -0.968 . . . . 0.0 109.207 174.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.43 ' HE3' ' HA ' ' A' ' 293' ' ' LYS . 1.0 OUTLIER -150.9 92.46 1.82 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 176.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.55 -25.2 0.61 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.92 1.724 . . . . 0.0 117.174 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 22.2 p -58.0 -45.21 87.19 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.257 1.528 . . . . 0.0 113.519 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 18.3 m -167.37 131.21 1.81 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.371 1.068 . . . . 0.0 112.124 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -153.64 158.49 41.18 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.141 1.376 . . . . 0.0 109.832 157.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 111.39 23.13 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 166.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.37 134.76 57.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.872 1.669 . . . . 0.0 114.594 -173.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.2 m -85.26 132.77 34.22 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 152.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 66.8 p -132.94 6.21 3.93 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -83.32 161.35 21.46 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.176 0.898 . . . . 0.0 111.052 164.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -63.62 104.32 0.64 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.137 1.775 . . . . 0.0 112.711 -159.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 24.3 mtm -87.63 164.86 15.82 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.047 0.927 . . . . 0.0 112.004 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.5 m -160.6 160.48 31.77 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.24 -0.912 . . . . 0.0 111.717 170.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.91 126.13 30.29 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 165.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 40.6 t -78.97 -24.21 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.506 0.722 . . . . 0.0 110.527 161.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -139.94 127.23 21.24 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.226 1.81 . . . . 0.0 108.203 166.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -55.41 144.11 53.96 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.642 1.177 . . . . 0.0 111.719 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -55.07 133.09 56.13 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.309 2.006 . . . . 0.0 110.989 170.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 61.4 p -133.74 129.73 37.08 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.202 1.001 . . . . 0.0 110.742 171.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.24 125.65 24.13 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.342 1.057 . . . . 0.0 111.143 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 61.9 p -80.47 -9.2 59.77 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.192 0.997 . . . . 0.0 113.093 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 74.66 -8.49 14.33 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.798 1.19 . . . . 0.0 114.033 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -90.0 4.82 49.0 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.88 1.34 . . . . 0.0 112.468 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.65 6.73 62.15 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.674 1.13 . . . . 0.0 113.59 -169.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.6 p -120.73 157.04 30.53 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.843 1.257 . . . . 0.0 111.214 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 15.0 t -130.86 118.76 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.346 1.458 . . . . 0.0 108.038 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.9 p -108.01 129.78 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.978 1.311 . . . . 0.0 113.134 -166.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -139.76 162.71 34.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.972 1.709 . . . . 0.0 113.374 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -116.26 129.25 56.18 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.099 1.359 . . . . 0.0 107.764 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.6 m -126.17 145.75 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.594 0.757 . . . . 0.0 111.312 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -125.92 144.09 50.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.641 1.176 . . . . 0.0 112.526 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.7 t -111.86 150.88 42.99 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 127.501 2.32 . . . . 0.0 107.785 163.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -110.26 -59.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.576 2.184 . . . . 0.0 116.169 -176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.02 164.61 29.81 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.03 -1.044 . . . . 0.0 112.743 -176.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 64.41 7.07 24.46 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 117.622 1.809 . . . . 0.0 117.622 168.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.26 98.05 44.66 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 119.071 1.436 . . . . 0.0 113.279 -162.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.56 119.19 1.63 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.53 3.487 . . . . 0.0 110.072 157.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.2 p -161.1 157.91 26.8 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -172.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -88.46 112.51 23.04 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 157.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.297 0.5 OUTLIER -66.09 124.89 89.03 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.655 -160.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.75 104.53 1.9 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.457 2.771 . . . . 0.0 111.824 -171.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 75.2 t -105.08 107.88 23.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.471 1.508 . . . . 0.0 109.87 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.43 160.18 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 122.276 1.036 . . . . 0.0 110.992 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . 0.442 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 23.0 t -142.93 134.39 24.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -147.94 178.29 8.64 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.401 0.681 . . . . 0.0 112.046 -168.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -114.24 -6.2 13.0 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.648 0.779 . . . . 0.0 112.26 166.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -111.53 5.83 19.72 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.859 2.464 . . . . 0.0 113.788 -165.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 13.6 mt 64.16 -3.59 0.47 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.223 2.209 . . . . 0.0 115.048 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.6 t -126.89 -6.34 6.17 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -174.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 80.04 25.67 0.36 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 127.968 2.507 . . . . 0.0 113.832 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.2 81.24 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 166.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.83 138.42 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.826 0.85 . . . . 0.0 109.27 159.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.98 74.44 0.88 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 123.014 1.387 . . . . 0.0 109.178 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -76.61 -51.42 11.63 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 126.656 1.982 . . . . 0.0 114.089 -158.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -112.61 153.34 17.53 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 116.065 1.186 . . . . 0.0 116.065 -161.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.3 152.77 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 129.724 3.209 . . . . 0.0 110.171 -168.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.96 123.66 30.78 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.919 1.288 . . . . 0.0 110.101 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.66 -47.25 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.066 0.546 . . . . 0.0 110.16 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.7 t -86.79 178.19 7.08 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.262 1.025 . . . . 0.0 111.901 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.1 m -60.78 131.44 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.275 1.43 . . . . 0.0 111.063 169.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.26 116.03 46.89 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 120.989 -1.07 . . . . 0.0 110.036 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.69 -179.03 5.08 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 124.058 3.172 . . . . 0.0 113.777 -172.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.26 141.2 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.32 1.448 . . . . 0.0 108.598 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -86.84 100.37 12.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.997 0.919 . . . . 0.0 109.577 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -96.4 -16.0 21.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.81 0.844 . . . . 0.0 112.549 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.59 130.67 53.66 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 126.502 1.921 . . . . 0.0 106.676 165.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -66.04 -18.19 65.18 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.326 -1.484 . . . . 0.0 114.133 -165.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -78.84 -2.62 40.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.919 1.687 . . . . 0.0 113.637 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -51.42 133.04 29.9 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.4 1.571 . . . . 0.0 112.937 -170.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -140.81 123.73 16.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.742 2.017 . . . . 0.0 108.665 -164.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 10.5 p -149.04 142.28 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -155.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.97 125.31 26.51 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 128.566 2.747 . . . . 0.0 110.195 170.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 23.6 mt -135.44 140.54 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.195 0.522 . . . . 0.0 110.965 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -116.33 136.06 53.33 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.593 1.557 . . . . 0.0 110.775 166.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.68 159.0 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.768 1.227 . . . . 0.0 112.2 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -129.23 103.88 18.16 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.481 1.912 . . . . 0.0 109.768 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.79 163.85 30.85 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 121.886 1.724 . . . . 0.0 110.642 167.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -60.34 177.27 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.101 2.534 . . . . 0.0 111.746 157.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -60.98 141.12 57.56 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.623 -0.673 . . . . 0.0 110.595 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 96.31 -161.26 22.3 Favored Glycine 0 CA--C 1.535 1.327 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -67.6 159.53 29.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.772 1.629 . . . . 0.0 114.657 -169.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 22.6 m -170.02 164.37 9.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.729 1.612 . . . . 0.0 112.663 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -127.24 116.09 20.04 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 129.453 3.101 . . . . 0.0 107.395 165.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.6 mm -77.11 121.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.18 130.33 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.571 1.078 . . . . 0.0 109.511 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.7 t -114.92 105.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.584 1.154 . . . . 0.0 108.456 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.22 -177.41 20.87 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 123.091 1.384 . . . . 0.0 116.312 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.9 163.93 28.42 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.627 2.371 . . . . 0.0 110.46 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 80.76 -170.09 52.82 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.018 0.818 . . . . 0.0 112.989 -170.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -65.07 -23.87 67.29 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.951 -1.323 . . . . 0.0 111.814 167.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 72.8 m -62.61 -2.52 1.13 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 130.676 3.59 . . . . 0.0 117.676 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.52 147.92 22.55 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.452 1.024 . . . . 0.0 112.371 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 17.6 mt -113.39 165.41 12.48 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.416 0.686 . . . . 0.0 110.951 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.4 t -145.23 158.59 43.79 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 167.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -140.79 134.88 30.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.567 1.947 . . . . 0.0 109.029 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -74.29 138.08 43.33 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.225 1.41 . . . . 0.0 111.699 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -144.53 118.52 9.39 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.653 0.781 . . . . 0.0 112.991 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.92 117.09 33.49 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.84 1.256 . . . . 0.0 109.109 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -95.7 151.48 19.32 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.66 0.784 . . . . 0.0 110.059 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -37.97 110.89 0.14 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.796 2.438 . . . . 0.0 112.022 171.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 152.73 -97.99 0.18 Allowed Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.708 -0.495 . . . . 0.0 113.76 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.4 p -66.67 -41.27 88.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 63.8 p -135.59 -5.41 2.25 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -162.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 5.7 tp -147.66 158.92 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.796 0.838 . . . . 0.0 110.378 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -78.89 -50.66 5.8 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.429 1.014 . . . . 0.0 112.103 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 3.8 tptp . . . . . 0 C--O 1.251 1.167 0 C-N-CA 128.832 2.853 . . . . 0.0 107.262 167.828 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 13.3 mmt . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 118.967 -0.539 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 22.7 p -75.38 -4.34 38.83 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -165.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -63.75 -6.01 5.03 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.934 1.294 . . . . 0.0 114.34 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 67.4 tp -117.97 123.09 44.91 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.601 1.96 . . . . 0.0 109.265 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.4 m -40.09 -45.86 2.05 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.777 2.431 . . . . 0.0 116.357 -163.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.81 -22.04 65.19 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.029 0.931 . . . . 0.0 112.837 -177.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 70.14 7.72 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.179 -1.575 . . . . 0.0 109.08 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 86.04 -50.0 4.2 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.078 1.323 . . . . 0.0 113.548 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.9 m -48.71 -41.91 33.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.6 1.96 . . . . 0.0 115.111 -167.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.6 m -162.12 123.3 2.66 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.603 1.547 . . . . 0.0 113.278 166.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -159.12 159.58 34.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.197 1.399 . . . . 0.0 111.157 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.98 103.9 11.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.377 2.271 . . . . 0.0 105.082 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -73.9 151.88 40.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.2 1.4 . . . . 0.0 114.165 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.2 m -95.75 150.92 19.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.354 0.661 . . . . 0.0 110.205 166.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.1 p -133.41 9.36 4.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.787 1.235 . . . . 0.0 113.705 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -79.24 154.55 29.1 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 120.348 1.431 . . . . 0.0 111.107 164.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 109.58 0.9 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.387 2.275 . . . . 0.0 111.89 -170.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 19.0 mtt -87.54 170.47 11.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.9 m -156.93 153.28 27.86 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.346 -0.846 . . . . 0.0 112.685 157.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.82 125.52 29.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.88 0.872 . . . . 0.0 109.343 160.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 5.3 t -82.43 -24.35 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.03 1.332 . . . . 0.0 110.873 172.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -134.24 125.6 28.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.283 2.233 . . . . 0.0 106.708 170.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -56.8 146.93 55.46 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 123.655 0.597 . . . . 0.0 111.154 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -56.66 124.35 16.05 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.507 1.471 . . . . 0.0 110.019 166.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.3 p -125.41 125.78 43.92 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.229 1.011 . . . . 0.0 110.977 170.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.62 121.32 11.9 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.839 0.712 . . . . 0.0 110.54 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 59.1 p -79.45 -7.28 58.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.201 1.4 . . . . 0.0 113.224 -173.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.56 -7.06 2.21 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.738 -164.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -86.68 6.17 32.47 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.659 1.729 . . . . 0.0 111.856 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.47 -2.0 67.23 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.088 1.328 . . . . 0.0 113.648 -170.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 27.9 p -119.07 166.89 12.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.112 1.365 . . . . 0.0 112.002 -170.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.48 114.79 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.014 1.726 . . . . 0.0 108.027 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.29 136.34 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.322 1.049 . . . . 0.0 113.235 -168.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -147.24 167.09 25.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.675 1.99 . . . . 0.0 112.996 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -115.32 134.89 54.7 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.47 1.908 . . . . 0.0 106.819 161.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 23.5 m -132.13 148.54 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.678 0.672 . . . . 0.0 111.703 176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -135.31 146.8 48.83 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.709 1.204 . . . . 0.0 112.272 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 22.8 m -115.13 157.65 43.03 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.604 1.561 . . . . 0.0 110.704 165.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -114.99 -54.49 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.479 2.119 . . . . 0.0 116.673 -171.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.64 175.3 9.8 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.164 1.802 . . . . 0.0 113.596 177.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.18 -13.47 0.23 Allowed Glycine 0 CA--C 1.541 1.716 0 N-CA-C 119.314 2.486 . . . . 0.0 119.314 164.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.48 104.78 54.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 119.939 1.87 . . . . 0.0 114.715 -159.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.41 117.25 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.746 2.964 . . . . 0.0 110.524 158.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.0 p -163.45 148.72 11.2 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -76.06 98.94 4.46 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 155.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.71 113.58 6.28 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 123.701 0.801 . . . . 0.0 111.305 -161.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.52 104.18 1.67 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.251 2.634 . . . . 0.0 112.942 -168.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 81.1 t -101.4 116.98 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 127.076 2.15 . . . . 0.0 109.726 172.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.26 161.43 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.375 1.07 . . . . 0.0 110.782 -176.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . 0.501 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 46.8 t -138.67 133.62 42.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -142.8 169.55 17.35 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.374 0.67 . . . . 0.0 111.652 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -102.22 1.74 36.31 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.243 0.617 . . . . 0.0 111.622 162.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -117.99 5.1 12.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.078 1.751 . . . . 0.0 114.473 -165.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 15.9 mt 61.89 -7.76 0.11 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.492 2.317 . . . . 0.0 116.098 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.7 t -121.75 -5.6 9.14 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.393 1.452 . . . . 0.0 114.132 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 63.47 44.57 5.27 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.78 2.032 . . . . 0.0 113.008 -173.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.91 99.06 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 159.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 22.1 mt -92.84 138.13 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.945 1.698 . . . . 0.0 108.745 166.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -109.25 70.97 0.75 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.226 1.012 . . . . 0.0 109.375 171.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -64.24 -63.0 1.26 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.647 2.379 . . . . 0.0 112.556 -161.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.501 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -96.67 171.21 27.38 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.864 1.697 . . . . 0.0 115.537 -168.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.1 150.58 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 128.299 2.64 . . . . 0.0 110.915 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.98 122.82 30.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.059 1.744 . . . . 0.0 108.358 165.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 28.2 t -86.54 -43.79 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.359 0.527 . . . . 0.0 111.033 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.9 t -101.1 175.3 5.64 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.551 0.691 . . . . 0.0 112.017 172.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.41 124.17 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.587 1.555 . . . . 0.0 112.859 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -81.01 122.17 81.51 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.1 0.96 . . . . 0.0 109.709 166.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -81.75 -171.45 1.21 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.615 3.543 . . . . 0.0 112.815 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.42 129.32 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.332 1.453 . . . . 0.0 107.321 165.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.68 81.93 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.794 1.238 . . . . 0.0 111.666 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 27.7 t -85.57 -10.53 55.78 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.143 0.977 . . . . 0.0 112.49 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.8 127.54 50.7 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 128.201 2.6 . . . . 0.0 106.036 170.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -67.6 -17.46 64.63 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.405 -1.434 . . . . 0.0 113.595 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.24 1.84 26.84 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 127.488 2.315 . . . . 0.0 114.032 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.77 133.55 6.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.667 1.222 . . . . 0.0 113.937 -168.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -141.87 138.31 32.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.454 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 13.8 p -147.82 146.03 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.79 0.805 . . . . 0.0 112.905 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -75.19 120.23 20.4 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.382 2.673 . . . . 0.0 109.193 166.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mt -132.37 139.3 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.892 0.769 . . . . 0.0 111.871 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -111.17 135.66 51.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 110.206 161.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 31.4 m -117.74 161.01 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.344 1.057 . . . . 0.0 111.004 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -131.86 101.77 15.21 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.807 1.643 . . . . 0.0 109.153 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.36 164.71 28.54 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.075 1.85 . . . . 0.0 110.72 164.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.16 175.6 0.24 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.83 3.02 . . . . 0.0 113.313 160.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -58.55 144.23 43.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.278 0.631 . . . . 0.0 110.745 163.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 94.66 -142.97 16.31 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 115.469 0.948 . . . . 0.0 115.469 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.22 154.95 32.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.164 1.786 . . . . 0.0 113.21 -168.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 18.1 m -167.98 161.45 12.8 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.797 1.239 . . . . 0.0 113.5 168.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -124.75 110.34 14.22 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 127.963 2.505 . . . . 0.0 107.261 163.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 9.5 mm -73.85 124.97 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.2 mt -117.87 135.83 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.708 1.203 . . . . 0.0 109.145 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 68.6 t -126.51 97.13 3.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 126.393 1.877 . . . . 0.0 107.481 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 115.6 173.29 17.39 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 116.088 1.195 . . . . 0.0 116.088 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 74.0 p -130.58 173.06 11.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.989 1.716 . . . . 0.0 110.523 167.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 78.22 -161.31 48.74 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 -169.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -69.03 -30.78 69.22 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.476 -1.014 . . . . 0.0 111.597 167.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 54.7 m -58.44 -5.47 0.53 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 130.226 3.41 . . . . 0.0 118.411 -174.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -85.8 139.77 31.02 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.983 0.913 . . . . 0.0 111.669 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.1 mt -104.05 163.64 12.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 110.087 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.2 t -147.02 156.1 42.76 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 169.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -136.19 117.12 14.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.363 1.865 . . . . 0.0 108.69 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -65.21 134.92 54.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.17 0.988 . . . . 0.0 110.816 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -133.43 134.89 44.18 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.297 1.039 . . . . 0.0 110.891 171.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -115.64 126.76 54.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -127.0 150.23 49.53 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.582 1.553 . . . . 0.0 109.001 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -27.39 107.69 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.979 1.711 . . . . 0.0 114.326 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 159.75 -124.35 1.34 Allowed Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.971 -0.455 . . . . 0.0 114.167 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 4.5 p -55.72 -38.59 69.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.227 2.211 . . . . 0.0 115.067 -171.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 57.5 p -132.21 -1.74 3.6 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -166.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.4 tp -154.3 157.29 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.816 0.846 . . . . 0.0 111.212 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.8 -16.45 67.93 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.94 -0.922 . . . . 0.0 115.072 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 10.5 tptp . . . . . 0 C--O 1.276 2.483 0 CA-C-O 115.951 -1.976 . . . . 0.0 109.699 175.534 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 119.418 -0.325 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 40.7 p -113.06 -14.36 12.97 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.468 1.907 . . . . 0.0 114.316 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.99 1.34 2.76 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 10.4 mp -98.91 140.35 33.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.435 1.894 . . . . 0.0 109.223 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 22.3 p -41.01 -69.05 0.15 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.93 2.092 . . . . 0.0 113.148 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.43 -12.84 16.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.51 1.524 . . . . 0.0 113.817 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.45 59.12 0.87 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.899 -1.125 . . . . 0.0 111.544 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 88.38 -43.15 3.1 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.671 1.605 . . . . 0.0 113.477 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 19.1 m -63.17 -34.55 77.86 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -168.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 34.3 m -165.41 110.58 0.89 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 121.16 1.8 . . . . 0.0 114.252 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.51 156.77 43.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.94 1.296 . . . . 0.0 111.309 164.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.66 97.35 2.65 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 158.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -68.42 154.91 40.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.852 2.461 . . . . 0.0 115.153 -171.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.7 m -102.7 140.6 36.76 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.0 1.32 . . . . 0.0 109.428 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.7 p -138.16 5.9 2.56 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -78.63 160.43 27.55 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.781 1.173 . . . . 0.0 110.517 162.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.11 98.02 0.42 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.09 2.156 . . . . 0.0 112.236 -161.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' MET . . . . . 0.45 ' HE3' ' H ' ' A' ' 380' ' ' THR . 32.2 mtm -82.38 165.71 20.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.098 0.959 . . . . 0.0 111.919 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.4 m -160.62 163.53 32.54 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.363 -0.835 . . . . 0.0 111.768 169.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.1 125.9 30.09 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 164.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.64 -27.74 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.621 0.768 . . . . 0.0 109.737 159.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -144.29 119.06 9.86 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.541 2.337 . . . . 0.0 108.062 170.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -52.86 145.16 23.42 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.785 1.234 . . . . 0.0 111.803 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.36 129.65 35.8 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.916 2.411 . . . . 0.0 111.948 173.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.9 p -126.56 132.49 51.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.839 0.856 . . . . 0.0 111.093 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -61.9 135.89 57.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.026 1.73 . . . . 0.0 112.026 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.3 p -91.26 -13.41 32.78 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 64.94 0.11 4.95 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.979 1.276 . . . . 0.0 114.752 -167.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -90.53 9.75 28.17 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.992 1.396 . . . . 0.0 111.748 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.59 15.5 65.83 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.771 -1.016 . . . . 0.0 113.583 -167.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 22.3 p -131.51 168.83 16.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.001 1.401 . . . . 0.0 113.021 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.84 130.75 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.104 1.762 . . . . 0.0 108.245 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.91 133.34 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.511 1.124 . . . . 0.0 112.368 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -140.61 163.47 32.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.835 1.654 . . . . 0.0 113.155 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -120.7 123.7 43.36 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.814 1.246 . . . . 0.0 107.742 164.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.44 147.96 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.786 0.835 . . . . 0.0 111.678 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -132.68 142.45 49.08 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.393 1.477 . . . . 0.0 113.205 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 t -107.73 143.24 26.88 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.35 2.66 . . . . 0.0 107.829 162.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -103.36 -62.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.264 1.976 . . . . 0.0 115.679 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.48 170.45 15.9 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.808 1.185 . . . . 0.0 113.166 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.09 -14.27 0.44 Allowed Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.968 2.223 . . . . 0.0 117.692 171.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.03 99.8 44.32 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 119.204 1.502 . . . . 0.0 113.327 -167.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.19 113.52 3.2 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.288 2.659 . . . . 0.0 108.878 157.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 16.2 p -158.92 148.19 18.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -170.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.57 99.34 5.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.44 1.496 . . . . 0.0 106.997 161.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.267 0.9 OUTLIER -61.28 114.13 9.91 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 123.222 0.326 . . . . 0.0 111.617 -159.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.07 113.5 3.72 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.954 2.436 . . . . 0.0 112.668 -167.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.12 115.81 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.0 2.12 . . . . 0.0 109.424 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 159.31 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.662 1.185 . . . . 0.0 110.434 -175.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . 0.431 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 51.0 t -140.22 114.71 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.472 1.109 . . . . 0.0 108.136 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -144.49 170.18 16.54 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.018 0.826 . . . . 0.0 113.055 -169.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -106.39 6.37 30.33 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.947 0.899 . . . . 0.0 112.07 171.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -115.87 2.5 13.58 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.093 1.757 . . . . 0.0 113.98 -163.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 49.4 mt 60.68 3.9 0.68 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.737 2.415 . . . . 0.0 115.397 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 3.7 t -137.13 -9.36 1.76 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -173.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 55.82 51.59 12.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.858 2.063 . . . . 0.0 113.423 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -68.83 -34.97 76.38 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 157.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 44.8 mm -111.24 141.55 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.341 1.456 . . . . 0.0 108.71 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -114.8 128.4 56.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.86 0.838 . . . . 0.0 110.899 165.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -87.56 -68.24 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.494 2.318 . . . . 0.0 110.227 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.431 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -93.33 166.78 28.43 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.224 1.392 . . . . 0.0 116.41 -162.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.7 152.85 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 128.027 2.531 . . . . 0.0 110.026 -167.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.0 127.45 31.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.837 1.255 . . . . 0.0 109.448 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.1 t -90.19 -37.42 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.176 0.444 . . . . 0.0 111.141 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.1 t -106.61 173.49 6.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 112.072 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.8 m -66.47 126.94 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.475 1.51 . . . . 0.0 112.177 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -96.0 129.57 33.67 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.653 1.581 . . . . 0.0 110.065 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -83.94 -176.48 2.67 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.263 3.309 . . . . 0.0 114.649 -168.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.47 120.81 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.686 2.394 . . . . 0.0 107.946 168.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.02 74.25 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.908 1.683 . . . . 0.0 112.97 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -67.09 -16.02 64.07 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 171.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.5 p -127.96 139.4 52.6 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 127.298 2.239 . . . . 0.0 106.074 157.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.7 -15.57 63.71 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -167.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.29 -2.0 14.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.03 2.532 . . . . 0.0 114.608 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -40.12 118.48 0.9 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.843 2.057 . . . . 0.0 114.264 -174.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.92 131.86 33.65 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.399 1.48 . . . . 0.0 111.427 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.76 148.76 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -160.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -75.8 126.26 30.66 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 128.513 2.725 . . . . 0.0 109.975 166.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 25.9 mt -136.1 137.59 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.76 0.709 . . . . 0.0 111.271 173.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -105.93 137.74 43.32 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.648 1.179 . . . . 0.0 111.542 159.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.5 150.73 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.311 1.444 . . . . 0.0 111.294 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -110.57 101.0 47.56 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.081 2.153 . . . . 0.0 109.078 175.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.21 162.84 31.03 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.776 2.318 . . . . 0.0 110.935 166.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.76 176.42 3.63 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.427 2.085 . . . . 0.0 111.663 162.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -70.97 147.43 48.69 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.894 -0.504 . . . . 0.0 111.117 165.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 95.35 -159.42 22.55 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.218 0.913 . . . . 0.0 113.492 -172.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.1 158.58 25.47 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.496 1.518 . . . . 0.0 114.9 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.9 m -167.57 150.3 5.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.838 1.655 . . . . 0.0 111.419 162.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -104.74 116.63 32.35 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.379 1.472 . . . . 0.0 108.15 155.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.9 mm -67.33 130.83 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 165.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.29 130.45 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.85 1.26 . . . . 0.0 108.828 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.8 t -117.54 100.02 9.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.393 1.877 . . . . 0.0 107.772 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 106.73 -178.48 22.32 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 123.096 1.387 . . . . 0.0 115.604 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' THR . . . . . 0.45 ' H ' ' HE3' ' A' ' 304' ' ' MET . 1.0 OUTLIER -135.5 169.76 17.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.098 2.559 . . . . 0.0 110.719 175.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 81.21 -166.9 48.67 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.925 0.774 . . . . 0.0 112.341 -171.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -65.21 -33.29 75.65 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.143 -1.21 . . . . 0.0 110.908 164.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 63.0 m -56.89 -1.59 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 131.041 3.736 . . . . 0.0 118.455 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -88.76 148.37 23.98 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.135 0.974 . . . . 0.0 111.684 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.0 mt -109.67 167.0 10.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.149 0.58 . . . . 0.0 110.837 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 9.9 t -147.06 159.27 43.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 172.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -149.82 125.99 10.68 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.55 1.54 . . . . 0.0 110.585 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.61 138.16 39.94 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 112.549 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -142.5 138.09 30.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.226 1.41 . . . . 0.0 111.457 164.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -118.31 129.09 55.25 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.82 1.248 . . . . 0.0 109.759 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -85.63 144.81 27.64 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 392' ' ' GLU . 5.6 pm0 -56.9 156.2 7.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 130.407 3.483 . . . . 0.0 115.857 -173.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 83.6 28.78 34.54 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.551 1.072 . . . . 0.0 113.499 -170.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 63.6 p -108.93 175.44 5.46 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.086 1.754 . . . . 0.0 115.465 -163.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 42.5 p -66.84 -18.59 65.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.127 1.771 . . . . 0.0 114.486 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 14.1 pt -91.79 6.38 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.69 1.132 . . . . 0.0 113.314 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 86.71 5.95 80.79 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 123.954 0.788 . . . . 0.0 114.441 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 54.2 tttm . . . . . 0 C--O 1.246 0.871 0 C-N-CA 127.234 2.213 . . . . 0.0 108.14 169.521 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 33.7 p -123.29 -12.69 7.8 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -172.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.85 23.31 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.5 2.32 . . . . 0.0 115.853 -172.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 45.0 tp -142.46 148.41 37.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.885 1.674 . . . . 0.0 110.052 -175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 23.6 p -41.6 -63.15 0.75 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.307 2.643 . . . . 0.0 113.26 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.04 -13.84 13.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.356 2.262 . . . . 0.0 114.037 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.408 ' HZ2' ' CG2' ' A' ' 335' ' ' ILE . 0.1 OUTLIER -103.78 64.11 0.79 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.093 -1.63 . . . . 0.0 110.177 -177.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 78.13 -38.04 1.77 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.971 1.748 . . . . 0.0 114.095 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.1 m -54.01 -47.54 71.4 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.917 1.287 . . . . 0.0 114.273 -170.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 8.6 m -178.26 115.0 0.07 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 120.262 1.392 . . . . 0.0 112.458 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -155.89 155.62 33.2 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.567 0.747 . . . . 0.0 111.468 164.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.47 99.78 5.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.905 1.282 . . . . 0.0 108.723 169.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.91 162.34 22.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.029 1.332 . . . . 0.0 113.864 -177.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.3 m -92.94 149.47 21.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.424 0.689 . . . . 0.0 109.653 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 77.8 p -136.85 6.28 2.9 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.409 ' CG ' ' HZ2' ' A' ' 326' ' ' LYS . 40.1 t0 -78.63 158.98 28.29 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.467 1.03 . . . . 0.0 111.457 165.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.35 92.15 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.51 2.324 . . . . 0.0 112.635 -167.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 15.3 mtm -76.26 166.96 22.7 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.905 1.282 . . . . 0.0 112.618 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.9 m -158.23 157.23 32.18 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.113 -0.992 . . . . 0.0 112.774 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.42 120.24 25.64 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.52 0.728 . . . . 0.0 110.363 166.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.91 -27.99 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.082 1.753 . . . . 0.0 110.67 165.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -142.63 125.87 16.5 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.532 1.933 . . . . 0.0 108.024 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -57.43 144.88 70.31 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.385 1.074 . . . . 0.0 111.513 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.95 129.33 33.68 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.827 2.351 . . . . 0.0 111.529 170.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 41.2 p -124.21 123.15 39.64 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.373 1.069 . . . . 0.0 110.289 171.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -63.65 136.34 57.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.983 1.313 . . . . 0.0 111.157 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.8 p -89.62 -14.95 33.84 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.326 1.05 . . . . 0.0 113.065 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.24 -12.13 1.31 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.408 1.004 . . . . 0.0 114.405 -164.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -84.57 14.46 4.57 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.903 1.681 . . . . 0.0 112.057 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.37 5.18 63.74 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.679 1.133 . . . . 0.0 114.14 -172.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 64.9 p -131.68 165.86 22.77 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.937 1.368 . . . . 0.0 113.819 -170.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.62 138.09 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 127.854 2.462 . . . . 0.0 107.675 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 6.7 p -119.62 132.16 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.309 0.959 . . . . 0.0 112.517 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -139.92 167.16 22.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.503 1.521 . . . . 0.0 113.454 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -124.0 129.87 51.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.437 1.495 . . . . 0.0 107.583 166.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.52 150.76 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.061 0.944 . . . . 0.0 112.378 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -132.51 142.41 49.19 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.49 1.516 . . . . 0.0 112.818 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.09 148.46 37.53 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 128.226 2.611 . . . . 0.0 108.216 167.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -100.13 -72.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.59 2.193 . . . . 0.0 115.745 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.409 ' HZ2' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -138.79 165.37 27.18 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.556 1.525 . . . . 0.0 114.388 -172.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 69.33 -8.19 3.04 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 126.497 1.999 . . . . 0.0 117.274 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -108.49 99.86 35.2 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 119.078 1.439 . . . . 0.0 113.199 -168.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.99 121.95 6.47 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.789 2.326 . . . . 0.0 108.746 152.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.1 p -165.59 154.17 11.58 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -173.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -83.33 110.77 18.4 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 156.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.257 1.3 pp -67.45 132.29 93.06 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 120.324 -0.55 . . . . 0.0 112.349 -155.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.42 91.47 0.77 Allowed 'Trans proline' 0 CA--C 1.54 0.784 1 C-N-CA 125.449 4.099 . . . . 0.0 113.734 -168.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.09 117.03 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.215 1.406 . . . . 0.0 109.365 166.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.408 ' CG2' ' HZ2' ' A' ' 293' ' ' LYS . 0.0 OUTLIER -130.48 162.56 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.206 1.803 . . . . 0.0 109.359 175.338 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.62 127.3 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -136.48 174.56 10.49 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -170.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -118.6 -6.68 10.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.028 2.131 . . . . 0.0 112.966 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 29.5 p30 -106.98 0.48 23.75 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.063 2.145 . . . . 0.0 113.61 -166.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 74.7 mt 57.17 5.22 0.24 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.795 2.438 . . . . 0.0 115.734 -170.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.9 t -127.74 -3.12 5.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.427 1.491 . . . . 0.0 114.461 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 52.39 45.72 27.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.919 2.088 . . . . 0.0 113.584 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -72.93 -38.76 66.7 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 163.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 19.1 mm -108.05 128.67 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.774 1.23 . . . . 0.0 109.717 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -97.17 109.31 22.09 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.62 0.724 . . . . 0.0 111.829 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -63.99 -62.98 1.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.752 3.221 . . . . 0.0 112.789 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -104.23 -171.5 25.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.499 1.523 . . . . 0.0 115.756 -160.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 3.3 mm -132.68 152.74 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.755 2.022 . . . . 0.0 111.302 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.9 129.01 34.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.414 1.485 . . . . 0.0 109.507 170.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.35 -36.86 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.266 0.626 . . . . 0.0 110.737 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' THR . . . . . 0.605 ' HB ' ' H ' ' A' ' 366' ' ' GLU . 1.2 m -105.4 162.06 13.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.013 1.325 . . . . 0.0 111.478 175.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.5 m -47.82 107.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 127.367 2.267 . . . . 0.0 114.215 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -73.89 117.66 63.0 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.306 1.042 . . . . 0.0 109.595 162.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -82.33 -175.73 2.63 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.334 3.356 . . . . 0.0 114.118 -171.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 117.79 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.308 2.243 . . . . 0.0 107.808 170.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.67 74.62 0.82 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.547 1.139 . . . . 0.0 112.552 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -69.53 -18.7 63.69 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 23.3 p -123.81 121.27 34.98 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 127.148 2.179 . . . . 0.0 105.936 162.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.43 -18.87 53.84 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -166.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -71.79 3.96 3.7 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.507 1.923 . . . . 0.0 113.791 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -39.59 126.48 1.88 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.593 2.357 . . . . 0.0 113.913 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -141.3 112.1 7.14 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.868 2.067 . . . . 0.0 109.058 -168.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.14 148.37 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -160.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -86.65 124.53 33.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.523 2.729 . . . . 0.0 109.221 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 55.9 mt -135.31 132.21 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.409 0.623 . . . . 0.0 111.2 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . 0.605 ' H ' ' HB ' ' A' ' 351' ' ' THR . 25.0 mp0 -97.36 138.63 34.52 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.648 1.579 . . . . 0.0 111.497 161.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 22.1 t -129.19 153.93 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 127.564 2.345 . . . . 0.0 109.152 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -118.96 114.99 35.01 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.808 2.043 . . . . 0.0 109.576 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -82.81 162.0 16.21 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.207 2.604 . . . . 0.0 110.685 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -74.41 178.46 7.0 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.541 2.16 . . . . 0.0 110.738 163.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -71.02 130.84 42.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.009 1.324 . . . . 0.0 109.733 171.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.55 -143.55 16.34 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.12 0.866 . . . . 0.0 112.884 -176.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.12 152.69 42.15 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.185 2.594 . . . . 0.0 114.477 -173.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 17.0 m -166.36 153.18 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 113.145 167.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -120.53 109.6 15.46 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 128.36 2.664 . . . . 0.0 106.846 165.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 16.3 mm -68.13 120.01 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 172.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 80.7 mt -114.18 126.9 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.488 1.115 . . . . 0.0 109.067 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.8 t -119.69 101.81 11.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.794 1.638 . . . . 0.0 107.176 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 123.07 172.28 13.83 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 123.074 1.374 . . . . 0.0 115.903 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.5 161.05 39.05 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.507 2.323 . . . . 0.0 109.057 173.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.47 -167.42 53.43 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 -163.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -62.36 -31.6 72.27 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.775 -0.838 . . . . 0.0 111.869 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.2 m -55.65 3.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 130.642 3.577 . . . . 0.0 117.875 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -97.1 142.86 28.52 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.401 1.08 . . . . 0.0 111.859 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 22.2 mt -114.93 166.4 11.83 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.77 0.828 . . . . 0.0 110.678 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.2 t -146.1 161.89 39.16 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -145.68 128.38 16.21 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.028 1.731 . . . . 0.0 109.353 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -78.92 138.28 38.02 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.733 1.213 . . . . 0.0 111.67 -175.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -143.12 140.3 30.78 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.704 1.202 . . . . 0.0 111.651 168.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -110.04 138.18 46.77 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.765 0.826 . . . . 0.0 109.399 164.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.95 113.27 25.48 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.851 1.66 . . . . 0.0 108.383 173.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.474 ' CD ' ' HZ3' ' A' ' 398' ' ' LYS . 31.9 mt-10 88.16 146.44 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 129.706 3.202 . . . . 0.0 112.069 -172.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -86.36 60.81 4.51 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.456 1.027 . . . . 0.0 113.815 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 26.2 m -60.24 12.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.185 2.194 . . . . 0.0 116.603 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 63.9 p -81.76 -15.73 53.36 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.17 1.788 . . . . 0.0 113.976 172.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.87 -24.66 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.596 1.158 . . . . 0.0 113.173 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 165.75 178.32 38.62 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 126.58 2.038 . . . . 0.0 109.548 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.474 ' HZ3' ' CD ' ' A' ' 392' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.873 -1.537 . . . . 0.0 109.942 174.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 12.5 mmt . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 118.967 -0.539 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 59.7 p -96.62 -2.77 44.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.99 1.316 . . . . 0.0 114.488 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.63 18.39 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.474 2.31 . . . . 0.0 116.15 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 39.7 tp -133.7 138.16 45.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.707 2.003 . . . . 0.0 108.088 172.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.6 p -35.66 -62.93 0.38 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.733 2.413 . . . . 0.0 113.619 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 49.1 tp -55.76 -12.21 1.22 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.184 2.594 . . . . 0.0 115.319 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 69.1 0.85 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 120.443 -1.41 . . . . 0.0 110.948 -170.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.89 -45.03 2.15 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.272 1.415 . . . . 0.0 113.277 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 90.9 m -48.91 -51.74 28.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.807 2.443 . . . . 0.0 115.013 -171.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 14.0 m -175.38 122.56 0.21 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.674 1.579 . . . . 0.0 113.119 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -157.79 154.14 27.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.385 1.074 . . . . 0.0 112.135 168.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.42 101.37 6.36 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.788 1.235 . . . . 0.0 108.455 166.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.65 153.1 37.43 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.45 1.9 . . . . 0.0 115.003 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 12.8 m -94.08 141.4 28.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.205 1.002 . . . . 0.0 109.319 164.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 80.7 p -135.46 2.52 2.98 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.71 164.1 23.99 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.592 1.087 . . . . 0.0 111.012 166.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -62.01 105.59 0.6 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.286 1.834 . . . . 0.0 112.54 -161.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 30.2 mtm -94.79 163.57 13.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.685 0.755 . . . . 0.0 111.907 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 32.3 m -160.77 156.88 25.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.206 -0.934 . . . . 0.0 112.0 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.69 120.04 19.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.909 0.883 . . . . 0.0 110.665 167.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.86 -29.0 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.35 1.46 . . . . 0.0 109.966 163.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -140.89 133.65 28.89 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.598 1.959 . . . . 0.0 109.329 170.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -59.02 144.2 82.83 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.024 0.929 . . . . 0.0 111.87 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -58.37 138.83 87.95 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.224 1.949 . . . . 0.0 111.9 171.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 35.6 p -133.89 125.13 27.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.195 1.398 . . . . 0.0 111.336 174.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -61.85 122.39 15.29 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.462 1.505 . . . . 0.0 111.537 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 74.6 p -80.79 -13.84 58.61 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.001 1.321 . . . . 0.0 113.83 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.03 -1.44 4.81 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 120.972 -1.08 . . . . 0.0 114.293 -164.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -85.59 12.16 9.25 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.198 1.499 . . . . 0.0 111.263 176.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.26 0.81 88.5 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.003 1.287 . . . . 0.0 113.874 -165.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.2 p -119.15 162.26 18.95 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.136 1.468 . . . . 0.0 112.807 -172.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.3 t -133.85 117.05 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.616 1.566 . . . . 0.0 107.748 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.3 p -104.97 130.03 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.243 1.017 . . . . 0.0 112.825 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -139.07 166.82 23.5 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.787 2.035 . . . . 0.0 111.499 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -135.47 145.08 46.79 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.779 -0.576 . . . . 0.0 111.007 160.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.6 m -137.11 161.14 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.062 1.345 . . . . 0.0 110.833 -168.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -128.78 145.69 51.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.988 1.315 . . . . 0.0 112.258 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.1 t -113.06 147.84 38.15 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 128.523 2.729 . . . . 0.0 107.113 165.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -111.41 -64.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 CA-C-N 122.538 1.942 . . . . 0.0 115.122 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 160.46 38.29 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -172.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.79 -0.08 2.52 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 127.385 2.422 . . . . 0.0 118.653 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.64 93.39 36.92 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 119.994 1.897 . . . . 0.0 114.464 -161.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.6 115.43 3.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.431 2.754 . . . . 0.0 109.864 161.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.2 p -164.2 153.58 13.91 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -172.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.92 105.39 12.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.009 1.723 . . . . 0.0 107.041 159.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.29 0.9 OUTLIER -67.16 120.31 71.27 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.045 -155.051 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.89 111.04 2.08 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.573 3.515 . . . . 0.0 114.237 -167.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.31 114.71 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 126.041 1.736 . . . . 0.0 109.114 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.04 159.03 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 126.659 1.984 . . . . 0.0 109.03 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . 0.402 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 6.2 t -140.64 120.54 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -145.32 171.45 14.57 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.707 1.14 . . . . 0.0 113.385 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.512 ' CG ' ' HZ1' ' A' ' 346' ' ' LYS . 65.7 m-20 -101.11 -3.03 29.97 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.413 0.685 . . . . 0.0 112.67 172.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -112.58 1.95 16.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.819 1.647 . . . . 0.0 114.265 -162.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.1 mt 63.0 -15.58 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.028 2.531 . . . . 0.0 115.645 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.3 t -107.87 -4.39 18.04 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 113.884 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 59.97 61.07 1.96 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.926 2.49 . . . . 0.0 113.126 -171.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -88.09 -39.89 14.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.412 0.685 . . . . 0.0 111.601 166.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 42.3 mm -111.15 105.03 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.587 1.555 . . . . 0.0 110.117 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -78.01 102.2 7.28 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.705 1.139 . . . . 0.0 112.699 172.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . 0.512 ' HZ1' ' CG ' ' A' ' 338' ' ' ASP . 2.1 mmmm -63.82 -53.63 47.76 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.2 2.6 . . . . 0.0 113.0 171.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -116.5 156.76 15.44 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.791 1.476 . . . . 0.0 116.791 -158.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.75 150.69 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.809 2.044 . . . . 0.0 109.772 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.69 130.4 36.75 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.132 1.373 . . . . 0.0 109.597 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 29.8 m -120.53 -30.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.3 m -101.0 152.93 19.99 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 160.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.5 m -48.78 132.33 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.135 1.774 . . . . 0.0 114.812 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -110.19 119.34 47.35 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.191 1.796 . . . . 0.0 108.337 168.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.88 -179.02 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.876 3.051 . . . . 0.0 114.394 -166.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.67 110.39 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 127.911 2.485 . . . . 0.0 106.517 169.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.89 84.05 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.537 1.535 . . . . 0.0 111.957 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 25.4 t -75.35 -8.93 57.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 166.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 13.6 p -131.25 128.47 39.93 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.997 2.119 . . . . 0.0 107.245 164.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.28 -19.25 65.28 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -172.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -84.66 6.99 21.88 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.64 1.176 . . . . 0.0 113.43 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -47.58 133.64 13.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.485 1.514 . . . . 0.0 113.582 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -138.54 132.59 31.39 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.087 1.355 . . . . 0.0 110.542 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.93 146.98 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -158.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.39 124.98 35.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.615 2.766 . . . . 0.0 109.799 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 12.7 mt -135.71 150.03 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.35 1.46 . . . . 0.0 109.859 -170.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -123.51 146.56 47.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.806 0.842 . . . . 0.0 111.223 163.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.25 151.96 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 124.664 1.186 . . . . 0.0 111.381 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -121.75 100.9 43.26 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.021 2.128 . . . . 0.0 109.499 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.63 168.93 12.45 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 123.677 2.918 . . . . 0.0 110.936 160.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.85 179.91 4.86 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.728 2.285 . . . . 0.0 111.046 166.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -58.12 145.24 37.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.288 0.635 . . . . 0.0 110.742 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.15 -163.96 28.18 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 121.783 0.657 . . . . 0.0 114.062 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.41 157.38 34.25 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.655 1.982 . . . . 0.0 114.778 -164.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.2 m -173.94 164.09 4.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.039 2.135 . . . . 0.0 112.203 169.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -122.47 117.21 25.41 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.83 2.852 . . . . 0.0 108.127 164.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mm -68.68 136.46 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 167.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 67.9 mt -127.94 123.76 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.977 1.311 . . . . 0.0 108.694 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 53.3 t -110.62 109.6 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.885 1.674 . . . . 0.0 107.363 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 117.2 171.82 15.84 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 122.923 1.291 . . . . 0.0 115.746 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.79 166.09 25.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.314 2.246 . . . . 0.0 109.329 169.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 68.61 -165.26 47.77 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 -166.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -64.65 -26.37 68.36 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.794 0.837 . . . . 0.0 112.539 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.7 m -64.72 4.39 0.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 129.105 2.962 . . . . 0.0 117.026 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -93.77 140.93 29.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.044 0.838 . . . . 0.0 112.659 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 20.8 mt -113.45 164.62 13.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.742 1.217 . . . . 0.0 110.701 173.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.0 t -146.66 160.78 41.77 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -151.07 127.62 10.78 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.849 1.66 . . . . 0.0 110.341 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -76.46 134.35 39.57 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.766 1.226 . . . . 0.0 111.894 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -143.67 135.5 26.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.687 1.195 . . . . 0.0 111.274 171.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -116.16 116.32 27.62 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -82.96 123.57 29.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.226 1.011 . . . . 0.0 112.04 -172.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 64.33 132.62 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 1 C-N-CA 131.782 4.033 . . . . 0.0 115.259 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -58.71 60.35 0.01 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 129.271 3.32 . . . . 0.0 113.681 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 68.8 m -64.76 7.57 0.15 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 130.547 3.539 . . . . 0.0 116.169 -157.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 33.5 t -107.71 -5.5 17.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.122 1.369 . . . . 0.0 113.399 169.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.5 tt -152.02 -24.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 171.6 -147.34 10.12 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 120.268 1.394 . . . . 0.0 114.207 -173.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.247 0.929 0 C-N-CA 125.993 1.717 . . . . 0.0 111.502 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.96 6.87 5.5 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -173.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.51 -0.17 4.74 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -169.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.65 146.02 32.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.776 1.23 . . . . 0.0 109.957 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 p -31.42 -63.44 0.17 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.146 2.579 . . . . 0.0 113.003 173.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.37 -9.47 5.44 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.393 1.877 . . . . 0.0 115.067 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.27 74.53 0.89 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.744 1.218 . . . . 0.0 110.532 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 69.2 -5.27 5.22 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.489 1.519 . . . . 0.0 116.023 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 22.1 m -89.53 -42.65 11.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.199 1.499 . . . . 0.0 112.675 -167.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.8 m -176.93 126.26 0.16 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.215 1.806 . . . . 0.0 112.285 172.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -161.29 152.08 18.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.634 1.574 . . . . 0.0 110.109 169.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.05 101.17 2.67 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 164.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.99 154.93 41.31 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.182 1.793 . . . . 0.0 113.831 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 141.25 38.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 162.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 76.0 p -130.94 10.48 5.02 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.906 0.883 . . . . 0.0 113.234 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -79.38 161.36 26.23 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.895 0.77 . . . . 0.0 110.981 165.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -65.22 103.76 0.83 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.127 2.171 . . . . 0.0 112.358 -163.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 33.6 mtt -83.71 168.5 16.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.961 0.886 . . . . 0.0 113.035 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.3 m -157.34 160.18 38.24 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.436 -0.79 . . . . 0.0 111.721 156.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -82.67 120.12 25.16 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.272 0.629 . . . . 0.0 110.155 166.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 22.6 t -66.61 -30.76 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.184 1.394 . . . . 0.0 110.698 163.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -142.17 123.33 14.65 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.557 1.943 . . . . 0.0 107.651 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -57.8 154.54 26.54 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.241 0.616 . . . . 0.0 111.797 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -56.22 124.39 16.14 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.876 2.384 . . . . 0.0 111.909 165.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.8 p -129.81 128.75 42.96 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.419 1.088 . . . . 0.0 111.569 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -61.78 126.75 28.45 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.344 0.658 . . . . 0.0 110.412 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.2 p -79.09 -12.97 60.02 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.818 1.247 . . . . 0.0 113.128 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.04 -6.69 1.98 Allowed Glycine 0 CA--C 1.539 1.553 0 CA-C-N 119.186 0.903 . . . . 0.0 114.231 -164.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -87.84 2.05 52.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.599 1.559 . . . . 0.0 111.643 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.99 2.31 39.25 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.756 1.646 . . . . 0.0 114.022 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.9 p -128.97 166.32 19.4 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.017 1.327 . . . . 0.0 111.975 -168.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 6.8 t -131.24 111.77 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.64 1.576 . . . . 0.0 108.377 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.58 137.07 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.064 1.346 . . . . 0.0 112.993 -168.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -142.47 164.45 30.11 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.998 2.119 . . . . 0.0 112.772 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -118.31 132.12 56.3 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.816 1.246 . . . . 0.0 108.016 161.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.3 152.44 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.741 0.817 . . . . 0.0 111.095 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -135.07 148.23 49.81 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.013 1.325 . . . . 0.0 112.327 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.43 150.65 46.92 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 128.043 2.537 . . . . 0.0 108.173 169.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -105.66 -68.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.366 2.044 . . . . 0.0 114.466 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 167.79 20.11 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -171.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.75 -6.73 0.32 Allowed Glycine 0 CA--C 1.537 1.46 0 C-N-CA 127.596 2.522 . . . . 0.0 118.496 170.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.15 94.03 37.42 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 119.872 1.836 . . . . 0.0 114.754 -160.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.8 121.32 7.26 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.753 2.302 . . . . 0.0 109.956 157.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.0 p -163.34 157.43 20.09 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -175.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -90.84 98.71 11.94 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 160.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.255 1.0 OUTLIER -60.9 123.03 73.2 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.811 -154.024 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.97 116.84 4.86 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.206 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 88.1 t -125.52 112.02 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.234 1.814 . . . . 0.0 109.812 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 157.41 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.362 1.065 . . . . 0.0 110.339 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 39.0 t -137.54 112.02 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -135.98 167.0 22.03 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -167.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -101.13 -2.4 31.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.671 0.788 . . . . 0.0 112.387 174.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 27.2 p30 -114.48 2.83 14.74 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.578 1.951 . . . . 0.0 113.723 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 20.4 mt 62.78 5.13 1.64 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.544 2.338 . . . . 0.0 115.436 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.9 t -135.94 -10.52 2.04 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 61.29 58.76 2.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.84 2.456 . . . . 0.0 113.83 -171.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.44 -36.12 58.13 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.189 152.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 15.8 mm -120.1 111.19 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.126 1.77 . . . . 0.0 109.956 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -89.67 120.25 30.79 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.294 -0.879 . . . . 0.0 112.241 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -72.3 -63.24 1.19 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.937 2.495 . . . . 0.0 111.722 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -106.2 161.03 14.37 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 116.903 1.521 . . . . 0.0 116.903 -155.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -104.39 152.25 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 127.108 2.163 . . . . 0.0 110.553 -173.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.12 125.9 30.03 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.288 1.435 . . . . 0.0 109.568 169.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 66.6 t -94.4 -45.84 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.426 0.69 . . . . 0.0 111.219 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.5 t -105.05 -179.15 3.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.413 0.685 . . . . 0.0 112.031 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 29.5 m -53.72 123.14 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.574 1.55 . . . . 0.0 113.168 -176.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -95.03 119.3 66.06 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.097 0.959 . . . . 0.0 108.84 165.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -80.36 179.61 6.0 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.984 3.123 . . . . 0.0 113.583 -167.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.89 114.74 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.834 2.054 . . . . 0.0 106.961 167.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.02 71.72 0.17 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.815 1.246 . . . . 0.0 111.547 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 26.4 t -69.15 -8.85 49.34 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.247 -0.908 . . . . 0.0 112.507 163.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 41.0 p -128.13 116.9 20.66 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 128.408 2.683 . . . . 0.0 106.501 166.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -53.34 -20.97 4.96 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -77.08 4.09 11.0 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.352 1.861 . . . . 0.0 113.604 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -41.45 127.8 3.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.503 1.921 . . . . 0.0 113.957 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.13 146.92 43.4 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.303 1.041 . . . . 0.0 111.356 171.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.7 p -156.83 145.81 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -163.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.14 121.3 23.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.366 2.267 . . . . 0.0 108.78 164.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.93 142.15 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.678 0.672 . . . . 0.0 111.076 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -114.39 139.18 49.7 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.144 1.778 . . . . 0.0 110.491 166.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.16 163.7 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.61 1.164 . . . . 0.0 111.547 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -131.25 98.79 18.2 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.244 1.817 . . . . 0.0 109.518 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -75.33 161.93 37.04 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.052 2.501 . . . . 0.0 111.458 160.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.21 -176.48 2.7 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.631 2.887 . . . . 0.0 111.154 163.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -55.75 151.68 10.78 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.124 1.37 . . . . 0.0 112.734 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 79.45 -159.06 44.26 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 121.283 0.38 . . . . 0.0 113.668 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -62.23 156.08 22.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.503 1.521 . . . . 0.0 114.116 -167.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.4 m -168.58 161.5 11.54 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.112 1.765 . . . . 0.0 111.946 165.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -122.33 113.48 19.47 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.944 2.098 . . . . 0.0 108.052 166.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.4 mm -74.03 120.3 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 79.4 mt -116.4 127.63 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.243 1.417 . . . . 0.0 109.566 -174.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 70.3 t -118.36 105.22 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 126.417 1.887 . . . . 0.0 108.12 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 111.5 175.83 20.13 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 122.485 1.047 . . . . 0.0 115.256 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 1.8 p -134.74 164.86 26.58 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.359 1.864 . . . . 0.0 110.548 169.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 82.64 -170.03 49.68 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 123.827 0.727 . . . . 0.0 112.594 -168.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -63.39 -29.96 71.17 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.995 -1.297 . . . . 0.0 111.317 165.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 27.3 m -55.66 1.35 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 131.478 3.911 . . . . 0.0 118.101 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -102.04 147.11 26.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.484 1.513 . . . . 0.0 111.573 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 40.9 mt -119.62 165.76 14.05 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.585 0.754 . . . . 0.0 111.036 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.1 t -148.32 158.97 44.42 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -141.55 137.81 32.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.838 1.655 . . . . 0.0 109.537 174.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -76.93 145.25 38.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.098 1.359 . . . . 0.0 111.927 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -140.34 159.38 42.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.831 1.252 . . . . 0.0 111.992 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -139.77 114.74 9.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.633 1.573 . . . . 0.0 107.553 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.73 120.85 29.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.131 0.973 . . . . 0.0 111.792 -172.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 75.15 132.68 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 130.924 3.69 . . . . 0.0 114.647 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -65.04 64.72 0.08 OUTLIER Glycine 0 C--N 1.343 0.97 0 C-N-CA 128.817 3.103 . . . . 0.0 113.345 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 45.5 m -65.05 -10.59 31.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.607 1.963 . . . . 0.0 113.613 -173.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 30.1 t -74.84 -5.86 45.85 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.166 1.387 . . . . 0.0 114.127 167.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 5.5 tp -140.68 -41.52 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.779 1.632 . . . . 0.0 112.009 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 155.7 -33.1 0.63 Allowed Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.219 0.914 . . . . 0.0 114.525 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? . . . . . 0 C--O 1.248 1.009 0 C-N-CA 126.063 1.745 . . . . 0.0 109.832 -179.037 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.3 p -83.67 -14.08 52.64 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.97 1.308 . . . . 0.0 113.59 170.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.47 23.89 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.561 2.744 . . . . 0.0 116.34 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 61.3 tp -138.13 139.83 39.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.808 1.643 . . . . 0.0 108.75 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 38.8 p -42.65 -61.67 1.18 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.584 1.954 . . . . 0.0 113.188 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 54.7 tp -56.2 -14.43 2.76 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.191 2.197 . . . . 0.0 114.913 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -110.74 72.12 0.77 Allowed 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.96 1.304 . . . . 0.0 109.274 -168.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 77.7 -45.83 2.5 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.934 1.254 . . . . 0.0 113.637 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 5.9 m -49.04 -56.84 7.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.865 1.666 . . . . 0.0 114.801 -172.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 18.4 m -173.14 114.53 0.25 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.439 1.472 . . . . 0.0 112.136 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -149.98 150.61 32.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.598 1.159 . . . . 0.0 111.155 169.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.87 92.74 1.63 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 169.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.54 152.15 46.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.344 2.258 . . . . 0.0 115.051 -175.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 22.4 m -91.73 145.21 24.76 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.083 0.953 . . . . 0.0 109.433 163.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 41.9 p -136.15 0.75 2.63 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -84.63 155.91 21.8 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.464 1.483 . . . . 0.0 111.307 168.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 100.48 0.05 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.552 1.941 . . . . 0.0 113.131 -163.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 31.7 mtm -86.97 168.75 13.06 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.579 1.152 . . . . 0.0 111.999 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 37.6 m -159.61 164.62 33.99 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.997 -1.064 . . . . 0.0 112.265 168.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.48 124.78 32.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.002 0.521 . . . . 0.0 110.362 163.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.8 t -70.52 -31.14 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.396 1.478 . . . . 0.0 110.269 163.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -135.92 124.47 23.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.904 2.082 . . . . 0.0 107.795 165.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -61.21 151.95 74.0 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.446 0.698 . . . . 0.0 112.572 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.39 134.13 55.98 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.529 2.82 . . . . 0.0 113.295 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.9 p -136.32 129.39 31.31 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.809 1.244 . . . . 0.0 111.929 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -53.71 123.1 11.33 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.333 1.453 . . . . 0.0 110.884 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 52.1 p -82.56 -10.72 58.86 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.964 0.905 . . . . 0.0 113.361 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 76.7 -6.93 36.36 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.889 1.233 . . . . 0.0 114.381 -168.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -102.7 18.94 20.16 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.042 1.421 . . . . 0.0 112.487 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.97 7.23 81.12 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.174 0.893 . . . . 0.0 113.41 -172.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 18.1 p -127.69 165.74 19.45 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.469 1.108 . . . . 0.0 112.295 -174.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.97 123.35 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 126.363 1.865 . . . . 0.0 107.701 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.3 135.06 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.304 1.041 . . . . 0.0 113.202 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -141.13 164.38 30.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.231 1.812 . . . . 0.0 112.998 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -121.74 126.05 48.0 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.191 1.396 . . . . 0.0 107.318 166.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.7 155.39 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.295 0.952 . . . . 0.0 112.204 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -140.32 147.75 40.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.351 1.46 . . . . 0.0 113.087 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 12.2 t -113.0 154.08 45.09 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 128.495 2.718 . . . . 0.0 108.486 167.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -108.32 -63.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.811 2.341 . . . . 0.0 115.187 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.27 170.53 15.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.358 1.063 . . . . 0.0 113.03 -173.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.53 -21.65 0.13 Allowed Glycine 0 CA--C 1.537 1.465 0 C-N-CA 127.676 2.56 . . . . 0.0 118.284 167.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.09 100.42 15.09 Favored Pre-proline 0 CA--C 1.552 1.043 0 CA-C-N 119.522 1.661 . . . . 0.0 113.936 -168.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.56 115.94 3.98 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.184 2.589 . . . . 0.0 109.198 158.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.7 p -162.79 154.69 18.26 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -170.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -78.46 112.24 15.31 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 155.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.283 1.1 pp -64.51 118.59 49.08 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.508 -163.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.25 113.67 1.77 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 124.039 3.16 . . . . 0.0 113.683 -172.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 69.2 t -121.88 111.41 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 125.428 1.491 . . . . 0.0 108.675 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.61 155.87 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.006 1.322 . . . . 0.0 110.108 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.5 t -140.31 111.89 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.62 -178.84 5.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.761 1.164 . . . . 0.0 113.287 -167.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.479 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 70.7 m-20 -112.73 2.59 16.12 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.674 0.79 . . . . 0.0 112.988 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -126.49 8.7 7.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.366 1.466 . . . . 0.0 114.074 -157.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 50.7 mt 60.51 -14.81 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.123 2.569 . . . . 0.0 116.25 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.6 t -111.61 -9.88 14.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.133 1.333 . . . . 0.0 113.793 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 69.67 44.02 0.92 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.94 2.496 . . . . 0.0 113.148 -171.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.82 -46.96 82.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.464 0.306 . . . . 0.0 110.905 166.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 17.8 mm -118.3 99.5 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.588 1.155 . . . . 0.0 110.489 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -70.42 105.38 3.03 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 121.086 -1.009 . . . . 0.0 112.66 172.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . 0.479 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 2.7 mmmm -65.86 -56.88 9.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 129.586 3.155 . . . . 0.0 113.233 171.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -103.36 -178.65 26.15 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 -160.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mm -124.9 160.34 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.842 2.457 . . . . 0.0 111.23 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.32 130.74 35.17 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.797 1.239 . . . . 0.0 110.125 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 85.2 t -92.46 -19.66 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.34 0.656 . . . . 0.0 111.096 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.1 t -137.76 174.43 10.58 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.366 1.067 . . . . 0.0 112.765 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.55 95.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 127.051 2.141 . . . . 0.0 113.687 -171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -57.83 119.1 31.03 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.512 1.125 . . . . 0.0 110.692 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -80.76 -176.62 3.26 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.337 3.358 . . . . 0.0 113.384 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.06 122.73 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.8 1.64 . . . . 0.0 107.883 171.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.01 64.28 0.33 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.799 1.64 . . . . 0.0 112.779 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 30.6 t -66.13 -10.81 44.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.591 1.156 . . . . 0.0 113.113 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 40.2 p -134.2 117.88 17.0 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.84 2.856 . . . . 0.0 106.475 163.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -61.4 -13.23 18.4 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -165.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -75.79 1.07 15.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.717 1.607 . . . . 0.0 114.012 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -35.56 119.7 0.54 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.455 2.302 . . . . 0.0 113.932 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.02 145.46 50.86 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.589 1.155 . . . . 0.0 112.183 170.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.32 147.16 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -160.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -78.73 123.42 27.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.766 2.426 . . . . 0.0 109.744 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 52.9 mt -132.81 137.34 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.485 0.66 . . . . 0.0 111.055 174.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -105.26 140.96 37.61 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.949 1.3 . . . . 0.0 110.827 160.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 20.2 m -122.6 158.32 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.547 1.139 . . . . 0.0 111.298 168.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -118.02 101.53 51.64 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.52 1.928 . . . . 0.0 108.736 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.96 159.57 37.76 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.093 1.862 . . . . 0.0 110.304 163.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -57.7 171.35 1.5 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.702 2.268 . . . . 0.0 112.094 159.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -62.18 147.81 46.56 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.464 -0.772 . . . . 0.0 109.993 157.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.31 -171.29 23.14 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 122.57 1.095 . . . . 0.0 113.185 -169.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -72.7 163.36 28.21 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.313 -1.11 . . . . 0.0 113.802 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.9 m -164.62 170.36 15.81 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.187 1.395 . . . . 0.0 112.222 164.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -124.95 114.49 19.21 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 129.381 3.073 . . . . 0.0 106.43 163.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.1 mm -71.74 135.02 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 74.8 mt -129.42 128.03 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 125.238 1.415 . . . . 0.0 108.83 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 83.9 t -118.71 105.02 16.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 126.196 1.798 . . . . 0.0 107.6 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.23 175.42 21.99 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 123.052 1.362 . . . . 0.0 115.935 175.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.82 167.61 21.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.656 2.382 . . . . 0.0 110.113 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 85.31 -156.9 31.19 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 123.356 0.503 . . . . 0.0 111.909 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -67.59 -36.8 81.56 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.534 0.667 . . . . 0.0 110.805 161.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.3 m -51.54 11.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 1 C-N-CA 132.981 4.513 . . . . 0.0 119.546 -173.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -114.36 139.58 49.35 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.63 1.105 . . . . 0.0 112.176 -165.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 30.9 mt -111.57 161.55 16.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.431 0.692 . . . . 0.0 110.252 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.8 t -145.57 156.64 43.82 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.047 0.539 . . . . 0.0 112.36 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -142.27 121.7 13.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.211 1.405 . . . . 0.0 109.812 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -67.92 134.42 50.78 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.194 1.397 . . . . 0.0 111.341 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -136.87 161.1 36.94 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 123.097 1.427 . . . . 0.0 112.592 173.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -136.87 103.24 5.11 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.56 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -92.29 138.61 31.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -39.38 111.87 0.21 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.813 2.845 . . . . 0.0 113.455 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 109.91 18.91 8.47 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.336 1.922 . . . . 0.0 113.271 -164.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 3.3 t -76.03 155.21 35.1 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.449 1.899 . . . . 0.0 113.271 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 6.7 m -56.18 -20.29 17.26 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.81 1.644 . . . . 0.0 113.812 169.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 5.6 tt -79.34 -10.94 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.051 0.94 . . . . 0.0 112.799 174.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 93.07 3.25 65.69 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.945 1.26 . . . . 0.0 114.62 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? . . . . . 0 C--O 1.246 0.886 0 C-N-CA 125.888 1.675 . . . . 0.0 110.683 172.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 15.4 mmt . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.49 -0.76 29.44 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -173.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.98 13.29 0.11 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.63 1.972 . . . . 0.0 115.283 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 37.9 tp -124.17 147.29 48.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.866 2.066 . . . . 0.0 109.641 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.1 p -38.96 -59.85 0.93 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.11 2.164 . . . . 0.0 113.373 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.5 -9.96 0.85 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.67 1.988 . . . . 0.0 115.093 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.42 ' HE2' ' OD1' ' A' ' 345' ' ' ASN . 10.2 mmmm -121.4 83.06 2.02 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.598 1.09 . . . . 0.0 110.905 -165.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 69.12 -28.07 0.31 Allowed Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.807 1.67 . . . . 0.0 115.755 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 79.2 m -71.05 -63.51 1.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.554 1.541 . . . . 0.0 113.073 -167.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.1 m -175.14 132.88 0.31 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.222 1.374 . . . . 0.0 112.988 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -160.55 158.03 28.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.569 1.548 . . . . 0.0 111.091 169.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.04 101.57 13.59 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.055 1.342 . . . . 0.0 107.611 168.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.09 149.8 39.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.216 2.206 . . . . 0.0 114.89 -171.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 4.7 m -86.52 144.52 27.19 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 164.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 61.1 p -137.37 0.73 2.33 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -71.32 166.17 22.17 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.603 1.092 . . . . 0.0 110.089 165.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -69.43 109.51 4.25 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.194 0.998 . . . . 0.0 111.203 -165.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 34.5 mtm -94.82 166.59 11.9 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.544 1.138 . . . . 0.0 112.255 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 58.5 m -160.89 157.75 27.08 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.734 1.214 . . . . 0.0 110.168 165.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.73 125.44 29.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.153 160.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 45.6 t -71.12 -18.92 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 126.18 1.792 . . . . 0.0 110.807 166.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -147.57 112.67 5.49 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.601 2.361 . . . . 0.0 106.76 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -55.31 147.59 36.1 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 118.553 0.615 . . . . 0.0 110.04 171.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.81 145.13 99.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.175 1.25 . . . . 0.0 111.168 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 23.3 p -131.24 135.98 47.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.222 1.409 . . . . 0.0 110.791 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -58.31 121.46 10.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.828 1.251 . . . . 0.0 110.601 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 60.1 p -81.78 -13.82 57.22 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.51 -0.96 7.89 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-N 119.391 0.996 . . . . 0.0 114.052 -165.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -95.11 8.22 43.65 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.257 1.528 . . . . 0.0 111.771 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.85 10.71 58.57 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.642 1.115 . . . . 0.0 114.056 -171.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 16.2 p -136.25 169.86 16.96 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.476 1.138 . . . . 0.0 112.741 -169.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.69 127.31 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.994 2.118 . . . . 0.0 108.829 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 11.3 p -118.15 124.15 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -163.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -130.95 157.17 43.67 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.694 1.598 . . . . 0.0 114.291 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -106.36 137.89 43.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.34 1.456 . . . . 0.0 107.215 161.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.56 136.99 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.739 1.216 . . . . 0.0 110.704 -175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -122.64 144.2 49.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.052 0.941 . . . . 0.0 112.199 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.7 143.59 31.67 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.746 2.818 . . . . 0.0 106.613 170.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -109.85 -63.68 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 CA-C-N 121.881 1.707 . . . . 0.0 115.875 -174.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 169.16 18.05 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 120.613 1.552 . . . . 0.0 113.233 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 68.6 -6.0 3.86 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.447 1.975 . . . . 0.0 117.341 169.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.61 102.07 45.32 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 119.135 1.468 . . . . 0.0 113.306 -163.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.29 118.42 2.94 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.249 2.632 . . . . 0.0 110.051 154.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.7 p -163.17 146.98 10.88 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -172.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -72.98 117.51 14.8 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 154.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.297 0.8 OUTLIER -69.89 122.65 86.69 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.884 -160.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.65 110.09 2.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 1 C-N-CA 125.781 4.32 . . . . 0.0 112.894 -166.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 98.6 t -122.66 124.79 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.534 1.534 . . . . 0.0 110.653 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.51 156.93 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.089 1.355 . . . . 0.0 110.817 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . 0.533 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 40.5 t -136.32 129.52 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -147.65 174.2 12.0 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.974 0.796 . . . . 0.0 112.145 -172.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -101.29 -1.01 34.65 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.513 0.725 . . . . 0.0 112.14 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -128.46 8.18 5.91 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -152.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 59.7 mt 62.51 -22.94 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.653 2.381 . . . . 0.0 115.95 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.1 t -106.99 -7.87 16.8 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.849 1.26 . . . . 0.0 113.873 -172.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . 0.261 . . 71.72 32.76 1.9 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.331 2.653 . . . . 0.0 113.917 -177.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -59.1 -46.27 88.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.684 0.394 . . . . 0.0 110.767 169.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 16.0 mm -96.81 129.23 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.596 1.158 . . . . 0.0 109.095 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . 0.42 ' OD1' ' HE2' ' A' ' 293' ' ' LYS . 0.8 OUTLIER -103.65 64.17 0.8 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 123.042 1.401 . . . . 0.0 112.18 -174.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -66.2 -45.62 80.13 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 128.623 2.769 . . . . 0.0 116.544 -156.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.533 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -107.33 -175.32 22.61 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.799 1.666 . . . . 0.0 115.282 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.35 145.67 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 125.165 1.386 . . . . 0.0 112.305 -174.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.49 118.34 12.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.791 1.636 . . . . 0.0 109.688 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.9 t -87.84 -52.23 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.902 0.774 . . . . 0.0 111.647 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.4 t -84.44 171.87 12.2 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.647 0.737 . . . . 0.0 111.642 170.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.28 120.28 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.201 1.0 . . . . 0.0 111.761 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -79.32 128.17 76.43 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.282 1.433 . . . . 0.0 110.499 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.75 -168.14 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 124.906 3.737 . . . . 0.0 113.493 -168.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.12 123.51 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.782 1.633 . . . . 0.0 109.009 172.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.23 80.74 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.503 1.121 . . . . 0.0 110.756 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 47.6 t -69.2 -25.53 64.37 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.585 -0.697 . . . . 0.0 111.303 163.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 21.5 p -120.93 124.54 45.18 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.246 2.619 . . . . 0.0 107.425 169.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -59.19 -23.81 62.57 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -168.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.15 3.9 1.9 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.359 1.863 . . . . 0.0 114.337 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -45.91 135.0 7.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.567 1.547 . . . . 0.0 113.792 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -150.87 111.51 4.24 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.963 1.705 . . . . 0.0 108.61 -165.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.98 153.43 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -165.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -80.38 123.72 28.26 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 128.117 2.567 . . . . 0.0 109.383 165.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.34 143.07 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.138 0.881 . . . . 0.0 111.922 169.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -108.98 142.16 40.05 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.187 1.795 . . . . 0.0 111.224 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.47 152.77 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.703 0.801 . . . . 0.0 111.326 170.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -109.0 116.82 54.98 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.398 1.879 . . . . 0.0 109.807 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -91.18 145.91 3.51 Favored 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 123.771 2.98 . . . . 0.0 111.096 166.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.14 171.57 1.65 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.231 2.621 . . . . 0.0 112.582 153.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -61.71 140.78 58.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.115 0.566 . . . . 0.0 110.724 170.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 95.97 -164.63 23.89 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-O 122.749 1.194 . . . . 0.0 115.803 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.89 155.05 11.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 129.095 2.958 . . . . 0.0 113.618 -169.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.8 m -173.95 162.56 3.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.234 1.414 . . . . 0.0 113.409 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -129.22 115.99 18.49 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 130.986 3.714 . . . . 0.0 107.909 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.3 mm -82.5 118.71 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 26.3 mt -108.83 126.07 65.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.413 1.085 . . . . 0.0 108.605 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.7 110.8 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.823 1.649 . . . . 0.0 106.942 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 116.25 172.29 16.55 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 124.043 1.913 . . . . 0.0 116.343 174.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.69 162.76 36.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.736 2.414 . . . . 0.0 109.175 177.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.59 -167.37 52.29 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -162.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.36 -26.35 68.72 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.787 -0.831 . . . . 0.0 111.918 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 64.0 m -63.29 3.19 0.3 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 128.822 2.849 . . . . 0.0 116.329 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -87.43 123.68 32.62 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.149 0.886 . . . . 0.0 111.41 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.71 162.58 12.82 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 172.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.3 t -140.23 155.03 47.05 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.5 133.11 47.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.22 1.408 . . . . 0.0 109.218 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -75.3 133.06 41.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.629 1.571 . . . . 0.0 111.071 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -141.94 106.28 4.81 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.096 0.959 . . . . 0.0 112.559 175.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -100.15 112.79 25.11 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -80.11 151.46 29.81 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -39.55 131.71 1.67 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.357 2.263 . . . . 0.0 113.556 173.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 119.28 4.13 12.44 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 160.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 94.1 p -131.41 -80.98 0.52 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.694 2.247 . . . . 0.0 112.133 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 91.9 p -105.56 -6.19 19.53 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.731 2.012 . . . . 0.0 113.464 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 13.7 tt -133.9 150.55 31.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.299 1.84 . . . . 0.0 109.43 166.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -67.87 -58.98 6.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.148 0.88 . . . . 0.0 112.307 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 3.1 tptp . . . . . 0 C--O 1.253 1.253 0 C-N-CA 128.559 2.744 . . . . 0.0 108.406 179.325 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.21 4.76 9.76 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -176.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.4 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.563 2.345 . . . . 0.0 116.027 -170.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 15.7 mt -138.88 153.9 48.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.558 1.543 . . . . 0.0 110.214 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 13.7 p -42.64 -64.19 0.65 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.563 2.345 . . . . 0.0 111.643 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.1 -22.95 43.53 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.725 2.01 . . . . 0.0 114.08 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.84 58.84 2.7 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.895 -1.128 . . . . 0.0 111.134 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.07 1.16 62.46 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.836 1.684 . . . . 0.0 115.493 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 61.1 m -84.84 -45.66 12.09 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.2 1.5 . . . . 0.0 112.259 -173.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.2 m -174.75 120.09 0.22 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.047 1.339 . . . . 0.0 112.146 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -161.92 154.64 20.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.612 1.165 . . . . 0.0 111.34 167.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.81 101.36 1.32 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 161.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.06 157.48 22.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.493 1.917 . . . . 0.0 114.171 -173.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 12.1 m -92.66 142.77 27.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.3 0.64 . . . . 0.0 109.958 170.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 80.4 p -136.71 5.98 2.92 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 174.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -83.61 164.81 19.49 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.92 1.236 . . . . 0.0 110.738 165.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -66.49 92.94 0.21 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.785 2.434 . . . . 0.0 112.173 -161.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' MET . . . . . 0.427 ' HE2' ' H ' ' A' ' 380' ' ' THR . 33.4 mtm -80.66 166.52 20.99 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.204 1.002 . . . . 0.0 112.381 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.5 m -158.87 157.76 32.11 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.287 -0.883 . . . . 0.0 112.531 167.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.03 120.03 24.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.418 0.687 . . . . 0.0 109.847 159.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.94 -25.03 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.638 1.175 . . . . 0.0 110.845 169.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -140.01 130.49 25.52 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.121 2.168 . . . . 0.0 108.034 168.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -60.86 144.89 89.56 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.624 1.169 . . . . 0.0 112.324 172.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.02 137.9 78.72 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.76 2.307 . . . . 0.0 112.145 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 37.2 p -132.32 126.74 34.02 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.259 1.424 . . . . 0.0 111.05 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -59.83 121.56 12.04 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.447 1.099 . . . . 0.0 110.569 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 65.3 p -80.19 -10.45 59.76 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.944 1.298 . . . . 0.0 113.123 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.13 -8.34 1.39 Allowed Glycine 0 CA--C 1.538 1.503 0 CA-C-N 119.186 0.903 . . . . 0.0 114.389 -166.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -82.71 2.59 32.96 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.251 1.525 . . . . 0.0 111.863 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.94 5.35 61.07 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.253 1.406 . . . . 0.0 113.413 -169.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 16.3 p -123.69 161.78 24.41 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.623 1.211 . . . . 0.0 112.039 -175.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 6.7 t -133.92 112.59 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.218 1.407 . . . . 0.0 107.863 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.0 p -108.87 130.88 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.383 1.073 . . . . 0.0 113.668 -160.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -140.84 163.27 33.38 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.936 2.094 . . . . 0.0 112.901 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -114.12 131.39 56.43 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.979 1.312 . . . . 0.0 107.585 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.04 153.72 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.413 1.006 . . . . 0.0 112.307 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -140.42 147.8 40.24 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.625 1.57 . . . . 0.0 113.071 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.46 147.7 38.61 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 128.14 2.576 . . . . 0.0 107.633 162.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -106.14 -56.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.057 0 CA-C-N 122.899 2.071 . . . . 0.0 115.816 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 172.35 12.94 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.944 -1.098 . . . . 0.0 112.293 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.99 0.58 7.42 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 117.354 1.702 . . . . 0.0 117.354 169.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.34 94.08 48.72 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 118.91 1.355 . . . . 0.0 113.065 -162.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.57 117.45 3.38 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.398 2.732 . . . . 0.0 108.984 156.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.9 p -166.54 155.31 10.7 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -174.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.31 111.2 15.32 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 154.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.16 116.17 23.05 Favored Pre-proline 0 CA--C 1.557 1.237 0 CA-C-O 119.056 -0.497 . . . . 0.0 111.651 -163.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -62.81 117.33 4.23 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.932 3.088 . . . . 0.0 113.912 -172.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.98 107.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.675 1.19 . . . . 0.0 110.131 173.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.43 157.82 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.437 1.495 . . . . 0.0 109.453 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 91.0 t -137.9 121.12 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -135.3 172.27 13.24 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -167.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -104.9 -0.42 27.07 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.712 1.205 . . . . 0.0 112.403 170.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -129.02 7.9 5.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.071 1.348 . . . . 0.0 114.575 -157.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.8 mt 67.46 -8.31 0.49 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.621 2.369 . . . . 0.0 115.644 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 7.8 t -129.14 -9.73 4.77 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 120.726 1.603 . . . . 0.0 115.235 -174.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 69.5 44.58 0.9 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.702 2.401 . . . . 0.0 113.114 -170.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.08 72.13 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.202 158.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 27.3 mt -125.2 109.65 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 127.611 2.365 . . . . 0.0 107.939 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -77.2 118.14 19.43 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.333 0.97 . . . . 0.0 110.382 162.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -77.68 -62.97 1.49 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.634 2.774 . . . . 0.0 111.498 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -112.19 171.14 13.93 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 117.086 1.594 . . . . 0.0 117.086 -162.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mm -109.91 156.33 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.95 2.1 . . . . 0.0 111.589 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.56 136.06 34.93 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.227 1.411 . . . . 0.0 109.696 170.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.7 t -110.48 -61.64 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.186 0.594 . . . . 0.0 110.374 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.8 m -79.98 153.3 28.99 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.756 0.822 . . . . 0.0 109.645 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.6 m -51.54 144.53 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.865 2.066 . . . . 0.0 115.471 -167.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -112.02 111.65 53.3 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.986 1.714 . . . . 0.0 108.845 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.16 -171.48 1.09 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.493 3.462 . . . . 0.0 113.866 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.71 117.15 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 127.575 2.35 . . . . 0.0 107.066 168.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.84 71.06 0.21 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.691 1.996 . . . . 0.0 112.559 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.0 t -67.79 -14.9 63.33 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.422 -0.799 . . . . 0.0 112.913 167.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 10.2 p -116.25 129.15 56.14 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 127.041 2.137 . . . . 0.0 106.959 161.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -66.83 -14.87 63.17 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -173.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.11 6.3 26.16 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.515 1.926 . . . . 0.0 113.407 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -42.95 124.43 3.14 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.427 1.891 . . . . 0.0 113.715 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.15 148.15 46.42 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.613 1.165 . . . . 0.0 111.529 172.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.55 152.52 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.658 0.742 . . . . 0.0 112.482 -164.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.0 123.24 31.89 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.796 2.439 . . . . 0.0 108.929 169.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 42.7 mt -130.99 149.75 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.863 0.865 . . . . 0.0 110.678 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -121.18 142.01 50.3 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.567 1.547 . . . . 0.0 110.569 167.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.36 153.92 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.387 0.675 . . . . 0.0 111.595 167.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -117.46 99.42 52.5 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 127.134 2.174 . . . . 0.0 108.536 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -80.86 161.8 21.15 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.675 2.25 . . . . 0.0 110.65 165.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.83 -174.42 1.51 Allowed 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.776 2.318 . . . . 0.0 110.604 158.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -61.28 160.71 10.13 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.446 -0.784 . . . . 0.0 111.859 164.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 97.58 -177.8 32.17 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.318 1.437 . . . . 0.0 113.445 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.26 163.06 16.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.46 1.504 . . . . 0.0 112.866 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.1 m -162.51 154.36 18.47 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.119 -0.988 . . . . 0.0 112.533 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -120.16 104.81 10.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.796 2.439 . . . . 0.0 106.966 166.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.2 mm -70.15 121.31 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 64.3 mt -118.28 125.28 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.943 1.297 . . . . 0.0 109.108 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.8 103.78 15.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.18 1.792 . . . . 0.0 107.815 -177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.87 177.71 23.75 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 123.308 1.505 . . . . 0.0 116.511 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' THR . . . . . 0.427 ' H ' ' HE2' ' A' ' 304' ' ' MET . 2.2 p -134.91 172.22 13.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.031 2.532 . . . . 0.0 110.722 175.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 81.64 -162.2 43.13 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 123.617 0.627 . . . . 0.0 111.642 -168.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -67.25 -38.04 84.49 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.717 -0.872 . . . . 0.0 110.764 162.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 47.2 m -53.81 8.12 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.54 1 C-N-CA 132.127 4.171 . . . . 0.0 119.016 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -99.88 146.91 26.1 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.108 1.363 . . . . 0.0 111.835 -172.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 19.7 mt -114.55 165.94 12.24 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.505 0.722 . . . . 0.0 110.918 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.6 t -146.82 158.17 43.85 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -139.2 132.04 29.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.943 1.697 . . . . 0.0 110.089 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -80.73 138.76 36.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.976 1.31 . . . . 0.0 112.193 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -132.51 159.79 38.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.702 1.601 . . . . 0.0 110.861 165.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -139.42 97.86 3.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.168 1.387 . . . . 0.0 108.534 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -96.68 132.31 42.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.241 0.543 . . . . 0.0 111.023 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 392' ' ' GLU . 0.1 OUTLIER -28.66 109.96 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 130.508 3.523 . . . . 0.0 113.754 -176.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 115.02 25.01 4.03 Favored Glycine 0 CA--C 1.54 1.648 0 C-N-CA 127.11 2.29 . . . . 0.0 113.233 -157.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 23.7 p -114.6 160.94 18.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 120.068 1.934 . . . . 0.0 116.187 -162.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 83.1 p -54.22 -32.9 57.07 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 127.364 2.266 . . . . 0.0 115.039 -174.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.45 0.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.823 1.249 . . . . 0.0 113.263 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 87.83 15.4 61.42 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.286 0.945 . . . . 0.0 113.117 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.437 0 C-N-CA 125.936 1.694 . . . . 0.0 108.733 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' MET . . . . . 0.402 ' H2 ' ' CD1' ' A' ' 348' ' ' ILE . 8.0 tmm? . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 59.2 p -77.18 -4.3 43.91 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -166.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.62 27.23 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -172.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 71.6 mt -139.71 160.26 40.29 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.479 1.512 . . . . 0.0 111.24 171.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 22.3 p -54.88 -53.76 51.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.85 1.66 . . . . 0.0 110.896 167.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -22.47 60.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.546 1.938 . . . . 0.0 114.283 177.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.1 66.91 2.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.839 1.255 . . . . 0.0 110.267 -173.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 80.78 -27.37 2.99 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.456 1.503 . . . . 0.0 114.748 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 19.1 m -59.48 -58.87 6.72 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.781 1.633 . . . . 0.0 113.692 -173.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.5 m -173.92 126.75 0.37 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.803 1.241 . . . . 0.0 112.751 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -156.79 151.21 25.39 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.757 1.223 . . . . 0.0 111.413 165.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.01 109.93 14.92 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -77.96 153.52 32.4 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.976 1.711 . . . . 0.0 114.745 -172.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -99.41 145.42 27.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.894 0.877 . . . . 0.0 108.974 162.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 53.0 p -135.0 10.5 3.58 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -75.96 160.8 29.5 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.086 0.857 . . . . 0.0 110.934 164.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -63.01 97.19 0.1 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.829 2.052 . . . . 0.0 111.506 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 5.9 mtm -76.66 164.79 25.56 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.001 0.92 . . . . 0.0 112.451 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 25.9 m -158.7 154.47 26.41 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.234 -0.916 . . . . 0.0 112.458 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 121.08 29.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.341 0.656 . . . . 0.0 110.106 170.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.8 t -70.12 -23.75 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.352 1.061 . . . . 0.0 110.488 164.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -144.86 119.41 9.72 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.716 2.006 . . . . 0.0 108.72 169.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -55.13 142.69 56.85 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.906 1.283 . . . . 0.0 111.315 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -51.59 134.88 47.59 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.865 2.377 . . . . 0.0 113.423 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.13 127.41 35.92 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.505 1.122 . . . . 0.0 111.693 173.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.24 124.93 21.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.053 0.541 . . . . 0.0 111.085 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 19.0 p -83.25 -8.32 59.47 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.268 1.027 . . . . 0.0 113.481 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 79.31 -14.62 15.15 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.481 1.038 . . . . 0.0 114.671 -169.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -87.14 5.84 35.86 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.479 1.64 . . . . 0.0 112.984 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.35 2.92 65.42 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.834 1.206 . . . . 0.0 113.743 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.8 p -115.69 165.73 12.72 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.322 1.449 . . . . 0.0 111.585 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.6 115.48 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.853 1.661 . . . . 0.0 108.87 -178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.8 p -102.78 130.95 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.567 1.547 . . . . 0.0 113.29 -167.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -137.76 164.2 29.47 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.536 1.934 . . . . 0.0 112.827 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -123.17 124.6 43.42 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.086 1.354 . . . . 0.0 107.718 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.14 138.22 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.071 0.948 . . . . 0.0 112.069 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -117.76 143.16 46.49 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.064 1.746 . . . . 0.0 111.501 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 10.2 t -111.79 149.95 41.56 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.354 1.862 . . . . 0.0 108.001 165.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -105.97 -74.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 122.038 1.825 . . . . 0.0 114.906 -172.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.88 165.84 25.02 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 121.323 1.874 . . . . 0.0 114.642 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 71.9 -4.87 14.54 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.053 1.787 . . . . 0.0 116.279 172.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -112.63 98.62 44.98 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.979 1.311 . . . . 0.0 113.093 -168.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.43 117.89 5.14 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.388 2.059 . . . . 0.0 108.226 152.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 8.9 p -161.37 154.99 21.77 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -88.57 102.11 14.62 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.093 2.157 . . . . 0.0 106.39 158.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.255 3.7 pt -59.73 123.5 71.77 Favored Pre-proline 0 CA--C 1.554 1.12 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -156.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -62.79 113.28 1.92 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.419 2.746 . . . . 0.0 112.933 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.91 110.14 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 109.801 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.85 163.37 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.971 1.708 . . . . 0.0 109.265 -172.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . 0.431 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 48.8 t -139.22 113.67 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.55 171.4 12.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.222 0.534 . . . . 0.0 112.038 -170.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.458 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 33.7 m-20 -114.61 2.74 14.61 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.149 1.38 . . . . 0.0 111.599 173.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -109.97 -5.29 15.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.894 2.077 . . . . 0.0 114.027 -167.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.7 mt 58.72 -1.95 0.1 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.233 2.613 . . . . 0.0 116.049 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -112.63 -7.06 13.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.419 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 45.11 77.13 0.08 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 130.279 3.432 . . . . 0.0 114.669 -166.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -92.99 -40.97 10.26 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.423 149.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 84.5 mt -74.57 150.06 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.872 1.669 . . . . 0.0 110.783 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -143.86 94.52 2.6 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.2 1.4 . . . . 0.0 111.521 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . 0.458 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 30.7 ttpt -102.57 -31.04 10.6 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -166.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.431 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -116.41 159.42 13.92 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.657 1.122 . . . . 0.0 115.638 -168.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.402 ' CD1' ' H2 ' ' A' ' 287' ' ' MET . 1.7 mp -102.81 145.23 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.633 1.973 . . . . 0.0 110.758 -169.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.61 120.01 22.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.776 1.63 . . . . 0.0 108.633 166.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.8 t -92.72 -41.25 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.149 0.58 . . . . 0.0 111.32 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 366' ' ' GLU . 3.0 t -98.01 176.41 5.77 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.695 0.759 . . . . 0.0 112.01 171.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 6.1 m -62.1 107.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.93 1.692 . . . . 0.0 113.493 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.77 121.06 79.88 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 118.14 -0.933 . . . . 0.0 109.29 160.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -82.69 -174.36 2.03 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 124.918 3.745 . . . . 0.0 113.717 -171.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 112.04 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 126.596 1.959 . . . . 0.0 108.168 169.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -72.22 77.83 0.98 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.668 1.187 . . . . 0.0 111.785 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 19.3 t -69.32 -19.94 63.88 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.351 -0.843 . . . . 0.0 113.149 171.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 17.7 p -118.82 118.21 30.95 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 127.134 2.173 . . . . 0.0 106.337 163.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -56.8 -24.22 49.06 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -165.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.67 0.98 7.45 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.712 2.005 . . . . 0.0 113.967 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -46.81 134.63 9.81 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.317 1.447 . . . . 0.0 113.385 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -137.97 133.01 33.16 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.587 1.155 . . . . 0.0 111.148 175.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.89 143.2 24.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.739 0.781 . . . . 0.0 112.954 -160.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.83 118.67 18.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.286 2.235 . . . . 0.0 109.469 166.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 32.5 mt -126.97 143.52 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.049 0.54 . . . . 0.0 110.458 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . 0.428 ' H ' HG22 ' A' ' 351' ' ' THR . 33.2 mt-10 -116.85 134.33 54.91 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.768 1.627 . . . . 0.0 110.06 167.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.4 159.63 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.594 1.158 . . . . 0.0 111.96 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -124.92 104.65 29.86 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.911 1.684 . . . . 0.0 109.944 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -86.47 163.08 9.59 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.786 2.991 . . . . 0.0 111.078 161.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.5 177.15 9.04 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.204 2.603 . . . . 0.0 112.467 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -63.52 116.95 6.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.861 1.264 . . . . 0.0 110.928 167.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 133.83 -145.74 17.76 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.921 1.248 . . . . 0.0 111.589 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -97.02 160.44 14.34 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.934 1.294 . . . . 0.0 113.3 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 21.9 m -169.17 152.38 5.02 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.801 1.64 . . . . 0.0 111.827 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -122.37 107.43 12.07 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 166.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.3 mm -73.71 120.66 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 72.0 mt -116.41 134.47 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.331 1.052 . . . . 0.0 110.996 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 67.4 t -120.93 107.15 19.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 126.04 1.736 . . . . 0.0 107.973 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.34 -175.6 19.07 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.85 159.34 42.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.195 1.798 . . . . 0.0 110.432 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.83 -173.22 53.71 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.296 0.474 . . . . 0.0 112.529 -168.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -55.93 -27.9 54.39 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.842 1.257 . . . . 0.0 112.291 171.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 24.6 m -59.43 -7.61 1.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.532 3.133 . . . . 0.0 116.608 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -87.04 125.93 34.42 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.08 0.952 . . . . 0.0 112.23 -173.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 15.1 mt -95.67 164.63 12.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.665 0.386 . . . . 0.0 111.897 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.3 t -135.12 152.08 51.31 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.321 1.048 . . . . 0.0 113.154 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -141.06 142.33 34.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.562 1.145 . . . . 0.0 111.583 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.03 140.58 36.49 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -140.98 138.61 33.87 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.173 0.987 . . . . 0.0 112.308 163.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -142.4 122.46 13.71 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -173.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -92.32 157.16 16.79 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -161.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -32.38 119.69 0.29 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 129.725 3.21 . . . . 0.0 115.424 168.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 62.55 7.82 16.94 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.329 1.443 . . . . 0.0 114.784 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.0 m -129.47 -42.12 1.34 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.898 1.279 . . . . 0.0 111.061 -161.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 23.2 t -141.86 -24.47 0.69 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.364 1.066 . . . . 0.0 112.929 169.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 2.7 tp -148.97 -170.33 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 O-C-N 120.908 -1.12 . . . . 0.0 111.529 163.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -73.13 -21.1 80.06 Favored Glycine 0 CA--C 1.539 1.562 0 O-C-N 120.397 -1.439 . . . . 0.0 116.226 -172.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.655 1.982 . . . . 0.0 108.565 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 26.8 p90 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.055 0.455 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 104.03 6.36 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.26 144.06 42.36 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.184 2.193 . . . . 0.0 115.053 -176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 39.8 m -90.48 131.92 35.96 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.755 0.822 . . . . 0.0 109.005 160.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 78.8 p -133.41 3.6 3.62 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.73 158.5 20.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.515 1.052 . . . . 0.0 110.356 163.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.14 102.33 0.49 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.846 2.058 . . . . 0.0 112.132 -161.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.5 mtm -82.91 161.84 21.74 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.609 0.763 . . . . 0.0 112.166 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 92.2 p -147.36 163.26 37.01 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -84.11 126.52 33.16 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 161.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.02 -24.31 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.059 0.544 . . . . 0.0 110.235 163.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -145.23 126.3 14.62 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.132 2.173 . . . . 0.0 107.822 170.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -57.45 149.73 48.08 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.299 1.04 . . . . 0.0 112.099 173.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -57.32 136.74 78.04 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.263 1.975 . . . . 0.0 111.242 170.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 38.1 p -132.1 127.13 35.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.502 1.121 . . . . 0.0 111.017 171.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -56.32 117.39 3.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.451 1.5 . . . . 0.0 110.887 174.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 79.7 p -79.12 -12.27 59.99 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.169 0.987 . . . . 0.0 113.274 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.61 -8.16 1.22 Allowed Glycine 0 CA--C 1.539 1.538 0 CA-C-N 119.299 0.954 . . . . 0.0 114.468 -165.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -83.85 4.2 30.32 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.213 1.506 . . . . 0.0 111.706 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 99.48 4.18 56.17 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.858 1.694 . . . . 0.0 113.782 -172.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.8 p -127.18 165.14 20.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.512 1.156 . . . . 0.0 112.114 -168.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.11 112.14 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.494 1.517 . . . . 0.0 107.834 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.1 127.14 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.229 1.012 . . . . 0.0 112.952 -167.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -135.07 167.84 20.23 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.86 1.664 . . . . 0.0 113.263 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -125.16 135.38 52.57 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.062 1.345 . . . . 0.0 107.76 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.59 157.66 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.704 0.801 . . . . 0.0 112.062 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -132.75 145.99 51.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.503 1.521 . . . . 0.0 112.089 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.04 147.98 38.98 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 127.356 2.262 . . . . 0.0 107.354 163.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -109.37 -51.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 0 CA-C-N 122.923 2.08 . . . . 0.0 115.918 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 168.21 25.14 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.917 -1.115 . . . . 0.0 112.348 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.54 -0.17 3.16 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.578 2.037 . . . . 0.0 117.531 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.98 96.46 50.18 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.869 1.335 . . . . 0.0 112.961 -162.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.38 114.99 3.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.297 2.665 . . . . 0.0 108.82 152.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 13.6 p -160.63 146.0 14.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.26 104.36 13.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.295 1.838 . . . . 0.0 107.042 164.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.289 0.6 OUTLIER -68.06 118.73 61.49 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 119.42 -0.324 . . . . 0.0 110.944 -153.089 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.01 106.65 2.19 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.771 2.314 . . . . 0.0 112.147 -171.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 91.7 t -106.15 116.73 50.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 126.349 1.86 . . . . 0.0 109.686 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.42 160.8 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.093 1.357 . . . . 0.0 110.046 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' VAL . . . . . 0.48 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 60.0 t -143.73 128.13 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -141.8 175.8 9.42 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.575 0.75 . . . . 0.0 112.576 -164.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ASP . . . . . 0.474 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 64.2 m-20 -115.38 5.52 14.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.795 1.238 . . . . 0.0 111.949 171.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -132.85 6.56 3.99 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.33 1.852 . . . . 0.0 114.241 -159.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 40.1 mt 63.89 -6.34 0.25 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.382 2.273 . . . . 0.0 115.869 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.9 t -125.19 -7.17 7.09 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.606 1.548 . . . . 0.0 114.721 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 337' ' ' ALA . . . 73.22 37.29 0.76 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.813 2.045 . . . . 0.0 113.028 -176.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.78 -48.17 80.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 162.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 45.3 mm -75.03 152.53 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.219 1.008 . . . . 0.0 109.038 160.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.73 66.72 1.5 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.391 1.567 . . . . 0.0 109.682 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' LYS . . . . . 0.474 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 43.7 tttt -70.6 -62.68 1.3 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.393 2.277 . . . . 0.0 111.986 -161.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' GLY . . . . . 0.48 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -98.94 156.78 20.11 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.256 1.407 . . . . 0.0 115.757 -159.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.91 147.24 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.973 2.509 . . . . 0.0 109.51 -167.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.5 117.24 19.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.422 1.489 . . . . 0.0 108.877 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.2 t -79.62 -46.55 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.693 0.797 . . . . 0.0 110.622 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 366' ' ' GLU . 7.3 t -95.12 179.56 5.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.819 0.848 . . . . 0.0 110.745 169.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 26.3 m -57.08 139.47 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.027 0.931 . . . . 0.0 111.039 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -77.26 112.7 25.16 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.548 -0.72 . . . . 0.0 109.636 168.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.6 175.01 11.78 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.936 2.424 . . . . 0.0 113.298 -171.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.66 121.98 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 126.822 2.049 . . . . 0.0 107.716 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.16 98.09 0.97 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.441 1.096 . . . . 0.0 109.578 168.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.1 t -98.9 -15.59 19.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.873 1.269 . . . . 0.0 112.573 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.23 133.62 55.88 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.927 1.691 . . . . 0.0 106.582 156.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -65.65 -16.98 64.26 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.604 -1.31 . . . . 0.0 114.093 -169.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -88.52 3.75 49.16 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.957 1.703 . . . . 0.0 113.584 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -53.05 135.61 36.88 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.717 -1.24 . . . . 0.0 113.313 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.21 146.7 52.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.542 1.537 . . . . 0.0 110.952 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.9 p -159.35 146.54 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -157.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.95 128.09 34.63 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.051 2.54 . . . . 0.0 110.053 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 13.8 mt -136.1 142.33 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.258 0.552 . . . . 0.0 109.767 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' GLU . . . . . 0.477 ' H ' HG22 ' A' ' 351' ' ' THR . 22.7 mt-10 -114.54 140.67 48.57 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.692 1.197 . . . . 0.0 110.031 167.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.58 160.54 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.257 1.023 . . . . 0.0 111.448 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -132.38 104.28 13.54 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 126.146 1.778 . . . . 0.0 109.443 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.81 164.26 32.16 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.62 1.547 . . . . 0.0 109.985 159.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.5 -176.67 1.78 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.367 2.045 . . . . 0.0 110.347 160.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -57.23 149.27 20.32 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.526 -0.734 . . . . 0.0 111.096 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 89.4 -162.33 30.6 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 122.39 0.994 . . . . 0.0 115.292 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.33 158.64 33.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.663 1.985 . . . . 0.0 113.836 -167.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.5 m -169.28 161.0 9.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.38 1.472 . . . . 0.0 112.755 171.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -124.7 113.1 17.54 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.961 2.104 . . . . 0.0 106.879 161.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.6 mm -71.58 130.01 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.74 130.71 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.48 1.112 . . . . 0.0 109.375 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.2 104.08 14.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 125.474 1.509 . . . . 0.0 107.566 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 115.21 175.32 18.38 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 123.307 1.504 . . . . 0.0 116.383 170.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.34 161.13 34.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.267 2.227 . . . . 0.0 110.396 172.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.03 179.77 37.33 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.789 0.709 . . . . 0.0 112.751 -167.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.05 -25.72 46.08 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.216 -1.167 . . . . 0.0 112.321 172.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.3 m -58.41 -8.34 1.16 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 130.209 3.404 . . . . 0.0 117.337 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -85.79 149.89 24.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.323 0.965 . . . . 0.0 112.424 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 41.3 mt -119.22 166.87 12.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.969 0.908 . . . . 0.0 111.149 171.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 10.8 t -140.59 157.2 45.83 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 171.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -139.0 125.91 21.02 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.892 1.677 . . . . 0.0 109.522 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -70.64 131.49 44.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 111.897 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -144.22 126.69 15.9 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.825 0.85 . . . . 0.0 111.529 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 . . . . . 0 C--N 1.331 -0.205 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.266 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.4 p90 . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.31 104.8 8.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 160.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.3 ptm -65.9 149.82 49.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.892 1.677 . . . . 0.0 115.157 -173.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.7 m -99.7 143.13 30.29 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.526 1.13 . . . . 0.0 110.125 165.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.9 p -138.81 21.69 2.67 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -96.48 163.57 12.99 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.298 0.954 . . . . 0.0 110.606 165.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -66.3 105.03 1.32 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.231 2.212 . . . . 0.0 112.453 -159.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.6 mmt -70.61 160.27 32.86 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.001 0.92 . . . . 0.0 112.818 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 29.0 m -156.53 148.75 23.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.208 -0.932 . . . . 0.0 111.991 162.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.28 125.99 33.99 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 168.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.7 -27.62 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.629 0.772 . . . . 0.0 110.144 164.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -139.25 120.36 14.64 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.011 2.124 . . . . 0.0 107.706 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -56.74 154.3 18.6 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.933 0.893 . . . . 0.0 111.609 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -57.56 125.52 19.04 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.317 2.011 . . . . 0.0 111.115 166.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 8.0 p -130.16 129.16 43.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.038 0.935 . . . . 0.0 112.759 169.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -56.42 122.65 12.39 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.327 1.851 . . . . 0.0 111.562 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 82.2 p -78.07 -12.08 59.96 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.774 1.23 . . . . 0.0 113.191 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.66 -11.43 3.3 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.474 1.035 . . . . 0.0 113.796 -167.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -87.37 2.49 50.19 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.436 1.494 . . . . 0.0 112.239 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 101.52 9.72 43.15 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.241 1.401 . . . . 0.0 113.848 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.0 p -131.03 166.45 20.99 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.908 1.283 . . . . 0.0 112.12 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.64 120.38 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.75 2.02 . . . . 0.0 107.626 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.2 p -106.01 137.17 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.452 1.101 . . . . 0.0 112.655 -171.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -143.84 164.75 29.64 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.555 1.942 . . . . 0.0 113.45 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -123.87 127.0 47.39 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.136 1.774 . . . . 0.0 107.849 164.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.95 147.6 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.654 0.782 . . . . 0.0 111.695 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -124.62 144.11 50.35 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.539 1.935 . . . . 0.0 110.429 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 7.6 p -118.13 150.78 48.14 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.414 1.886 . . . . 0.0 107.943 163.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 72.2 Cg_endo -110.03 -50.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 0 CA-C-N 122.203 1.822 . . . . 0.0 116.7 -165.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.89 169.21 19.61 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.049 1.295 . . . . 0.0 113.327 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.04 -15.62 0.08 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 128.182 2.801 . . . . 0.0 118.648 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -104.29 108.03 59.18 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 119.711 1.755 . . . . 0.0 113.822 -166.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.99 121.51 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.845 3.03 . . . . 0.0 109.904 155.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 8.1 p -162.77 149.42 12.85 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.36 108.45 16.56 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 161.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.296 0.5 OUTLIER -67.01 119.84 67.33 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.505 -153.592 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.53 114.32 3.68 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.141 2.561 . . . . 0.0 111.295 -171.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 349' ' ' LEU . 52.4 t -116.18 114.48 46.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.365 1.466 . . . . 0.0 109.542 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.83 159.4 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.926 1.691 . . . . 0.0 108.835 -175.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.1 t -146.05 122.56 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.22 166.69 32.69 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -168.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -90.59 -5.33 56.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -114.87 6.15 15.35 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.618 1.567 . . . . 0.0 114.252 -160.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 25.4 mt 64.94 -7.96 0.25 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.25 2.22 . . . . 0.0 115.175 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.2 t -122.71 -12.07 8.13 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.191 1.359 . . . . 0.0 114.343 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 82.37 35.48 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.498 2.719 . . . . 0.0 113.261 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.68 67.32 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.093 0.557 . . . . 0.0 111.389 170.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.84 159.47 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.746 1.218 . . . . 0.0 108.227 162.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.12 123.46 16.96 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.328 -1.482 . . . . 0.0 110.903 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -128.2 -17.59 4.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -159.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -145.69 151.28 23.51 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -166.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.3 147.2 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.538 1.535 . . . . 0.0 111.921 -163.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 334' ' ' VAL . 2.7 mm? -67.84 112.39 4.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.816 2.047 . . . . 0.0 109.399 171.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.49 -33.75 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.021 0.528 . . . . 0.0 110.938 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.1 t -96.61 179.27 5.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.035 0.934 . . . . 0.0 111.172 167.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.48 125.72 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.062 1.345 . . . . 0.0 110.662 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -66.69 113.37 12.69 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 118.427 0.558 . . . . 0.0 110.757 171.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.8 179.63 6.11 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.142 2.561 . . . . 0.0 113.781 -171.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.09 130.28 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 127.023 2.129 . . . . 0.0 108.038 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -78.45 96.76 5.46 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.852 1.261 . . . . 0.0 109.206 166.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -97.21 -18.64 19.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.55 1.14 . . . . 0.0 112.481 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.89 135.95 51.83 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 155.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -66.67 -14.24 62.23 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.774 -1.204 . . . . 0.0 113.913 -171.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -89.01 0.42 56.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.683 1.993 . . . . 0.0 113.499 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -53.89 138.27 36.8 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.612 1.196 . . . . 0.0 113.079 -172.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.42 142.05 49.11 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.921 1.288 . . . . 0.0 111.053 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.4 p -154.93 145.48 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -158.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.26 126.29 30.72 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.101 2.96 . . . . 0.0 110.563 173.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.61 137.14 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.248 0.619 . . . . 0.0 110.757 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -107.17 140.29 40.27 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.849 1.26 . . . . 0.0 111.019 161.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.23 158.34 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.249 1.02 . . . . 0.0 112.702 171.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -111.27 114.32 53.41 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.362 1.865 . . . . 0.0 110.526 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -76.82 174.02 13.53 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 124.063 3.175 . . . . 0.0 111.182 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.54 -174.4 2.25 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.4 2.067 . . . . 0.0 110.463 159.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -67.5 146.01 54.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 154.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 84.8 -159.85 34.93 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 122.043 0.802 . . . . 0.0 114.752 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.48 157.39 30.47 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.911 2.084 . . . . 0.0 113.994 -166.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.0 m -170.57 171.91 6.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.431 1.892 . . . . 0.0 112.051 170.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.34 125.83 46.78 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 126.801 2.04 . . . . 0.0 108.314 158.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.2 mm -77.65 119.78 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.5 mt -111.24 128.37 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.317 1.447 . . . . 0.0 109.819 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 66.6 t -116.19 107.47 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.466 1.907 . . . . 0.0 108.189 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.25 177.78 24.25 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 122.449 1.027 . . . . 0.0 114.94 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.48 169.82 16.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.213 1.805 . . . . 0.0 111.382 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 83.86 -157.39 33.93 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.922 0.772 . . . . 0.0 112.345 -172.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -72.9 -33.08 65.79 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.555 -0.968 . . . . 0.0 110.975 163.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 28.6 m -59.87 -6.96 1.44 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 130.005 3.322 . . . . 0.0 117.741 -173.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -80.25 153.73 28.33 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.876 1.27 . . . . 0.0 111.467 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 46.0 mt -121.48 165.24 15.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.382 0.673 . . . . 0.0 110.464 170.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.1 t -150.42 160.54 43.68 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -140.82 124.93 17.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.036 1.734 . . . . 0.0 110.077 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -67.77 133.44 49.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.035 1.334 . . . . 0.0 111.711 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -133.11 152.5 51.95 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.165 0.986 . . . . 0.0 111.545 170.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 . . . . . 0 C--N 1.332 -0.189 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 173.758 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.4 p90 . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.49 100.01 1.04 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 160.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.02 136.53 56.3 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.517 1.927 . . . . 0.0 113.888 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 22.1 m -87.53 135.41 33.36 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 153.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 68.3 p -138.12 -0.89 2.0 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 174.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.64 166.63 20.32 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 120.101 1.319 . . . . 0.0 110.498 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -67.08 101.03 0.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.713 1.605 . . . . 0.0 112.438 -165.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 37.9 mtm -90.51 165.07 13.99 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.778 1.231 . . . . 0.0 111.837 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.0 m -161.28 161.01 30.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.148 -0.97 . . . . 0.0 112.491 167.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.7 125.54 29.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.982 0.513 . . . . 0.0 109.952 161.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 81.2 t -76.9 -25.56 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.436 1.494 . . . . 0.0 110.677 165.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -137.61 131.24 31.29 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.191 1.796 . . . . 0.0 107.925 164.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -59.9 151.39 64.67 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.097 0.559 . . . . 0.0 111.858 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -55.74 130.21 39.17 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.383 2.056 . . . . 0.0 111.498 166.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 16.5 p -120.5 125.0 46.76 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.506 1.522 . . . . 0.0 110.629 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -55.75 118.07 4.22 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.567 1.147 . . . . 0.0 110.067 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.3 p -79.53 -16.38 56.08 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 60.31 -0.39 0.94 Allowed Glycine 0 CA--C 1.539 1.581 0 CA-C-N 119.467 1.03 . . . . 0.0 115.057 -161.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -86.46 18.15 3.43 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.284 1.542 . . . . 0.0 110.652 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.34 -2.84 87.94 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.771 1.177 . . . . 0.0 114.1 -168.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 25.0 p -122.47 175.37 6.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.043 1.421 . . . . 0.0 113.608 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.7 125.11 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 127.043 2.137 . . . . 0.0 107.938 172.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.84 131.72 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.903 1.281 . . . . 0.0 113.531 -169.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -140.73 169.37 17.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.7 2.0 . . . . 0.0 113.526 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.27 135.73 52.81 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.361 1.064 . . . . 0.0 108.411 164.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.95 152.77 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.247 1.019 . . . . 0.0 112.412 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -137.53 150.94 47.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.685 1.194 . . . . 0.0 113.008 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.2 t -119.66 141.13 30.5 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 128.243 2.617 . . . . 0.0 107.947 169.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -97.4 -67.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.88 2.387 . . . . 0.0 115.313 -174.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 174.87 10.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.88 1.272 . . . . 0.0 112.881 -173.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.9 -12.43 0.81 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.504 2.002 . . . . 0.0 117.712 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -123.58 96.62 43.23 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 119.525 1.663 . . . . 0.0 113.797 -160.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.81 120.5 6.43 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.84 1.693 . . . . 0.0 109.084 155.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.7 p -162.62 150.62 14.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -171.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -83.8 97.36 9.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.535 1.534 . . . . 0.0 107.265 162.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.252 1.2 pp -58.1 112.11 4.42 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.578 0.751 . . . . 0.0 111.87 -159.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.29 117.1 4.95 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.706 2.271 . . . . 0.0 112.991 -170.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 88.0 t -120.4 120.59 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 126.2 1.8 . . . . 0.0 108.765 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.26 160.01 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.035 1.734 . . . . 0.0 109.454 -175.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 3.9 t -138.53 113.62 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.82 -176.83 4.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.697 0.799 . . . . 0.0 112.163 -168.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -115.74 6.59 14.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.325 1.05 . . . . 0.0 112.194 171.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -131.87 1.48 3.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -152.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 16.1 mt 64.48 0.11 1.02 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.304 2.242 . . . . 0.0 115.198 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.5 t -135.84 -6.16 2.16 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -170.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 57.54 48.29 14.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.552 1.941 . . . . 0.0 113.645 -174.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.78 66.28 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.102 0.561 . . . . 0.0 110.012 159.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 8.9 mm -101.99 147.15 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 126.054 1.741 . . . . 0.0 108.479 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -126.05 108.35 11.29 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.431 -0.793 . . . . 0.0 111.847 163.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -66.4 -69.83 0.28 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 128.352 2.661 . . . . 0.0 111.425 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -100.33 169.32 21.51 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 -160.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.2 mp -115.82 154.99 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 128.0 2.52 . . . . 0.0 110.193 -169.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.47 134.94 40.71 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.115 0.966 . . . . 0.0 109.931 168.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.88 -47.08 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.382 0.673 . . . . 0.0 110.944 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 366' ' ' GLU . 3.6 t -92.42 172.57 8.3 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.652 0.739 . . . . 0.0 111.647 168.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.2 m -66.64 126.36 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.118 1.367 . . . . 0.0 112.667 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.04 126.59 64.93 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.978 1.311 . . . . 0.0 110.099 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -80.98 -172.54 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.027 3.152 . . . . 0.0 112.926 -173.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.08 119.22 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 127.112 2.165 . . . . 0.0 107.451 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.78 90.16 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.377 1.071 . . . . 0.0 110.685 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 10.7 t -73.92 -37.94 64.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.733 -0.604 . . . . 0.0 110.247 159.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 39.7 p -102.37 123.46 46.2 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.389 1.875 . . . . 0.0 109.192 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -54.73 -19.8 7.03 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.9 5.98 8.6 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.605 1.562 . . . . 0.0 113.708 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -43.67 134.28 4.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.529 1.932 . . . . 0.0 114.203 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -150.88 129.62 12.36 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.846 1.658 . . . . 0.0 110.067 -167.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.3 p -154.16 145.77 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -166.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -78.68 123.03 26.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.484 2.714 . . . . 0.0 109.473 165.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 40.6 mt -129.16 144.21 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 118.464 0.574 . . . . 0.0 111.519 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 351' ' ' THR . 21.6 mt-10 -118.9 140.38 50.08 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.649 1.58 . . . . 0.0 110.947 164.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.2 160.46 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.074 1.35 . . . . 0.0 111.515 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -130.95 98.58 18.98 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.697 1.999 . . . . 0.0 109.788 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.17 166.65 16.32 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.33 2.687 . . . . 0.0 111.375 162.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.77 175.07 7.71 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.885 2.39 . . . . 0.0 110.857 163.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.82 154.35 30.18 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.842 -0.536 . . . . 0.0 111.04 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 91.03 -163.25 29.15 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 121.404 0.447 . . . . 0.0 113.24 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -66.03 157.12 31.79 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -168.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 20.5 m -168.03 164.62 13.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.061 1.744 . . . . 0.0 112.086 168.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -128.25 111.45 13.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.887 2.875 . . . . 0.0 107.543 166.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 1.8 mm -74.37 124.38 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 79.9 mt -113.58 129.83 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.835 1.254 . . . . 0.0 108.91 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.65 109.38 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 125.282 1.433 . . . . 0.0 107.863 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 107.52 177.89 22.48 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 123.363 1.535 . . . . 0.0 115.747 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.4 163.93 28.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 127.669 2.387 . . . . 0.0 110.78 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.54 -179.97 36.05 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.199 0.428 . . . . 0.0 112.241 -166.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -56.81 -27.38 59.87 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.279 1.031 . . . . 0.0 112.375 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 46.6 m -58.95 -7.61 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.567 3.147 . . . . 0.0 116.651 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -81.15 149.07 29.28 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.503 1.121 . . . . 0.0 112.299 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 27.6 mt -118.69 165.22 14.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.957 0.903 . . . . 0.0 111.315 171.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.6 t -148.49 162.12 40.26 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -144.24 127.75 16.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.872 2.069 . . . . 0.0 110.14 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -75.21 135.83 41.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.817 1.647 . . . . 0.0 112.548 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -134.38 157.2 47.02 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.631 1.173 . . . . 0.0 111.763 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 . . . . . 0 CA--C 1.535 0.383 0 C-N-CA 125.844 1.657 . . . . 0.0 106.922 173.183 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.7 p90 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -73.28 101.68 3.47 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 164.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -82.11 165.91 20.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.54 1.536 . . . . 0.0 113.679 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.7 m -101.6 152.49 20.75 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.523 1.529 . . . . 0.0 109.86 167.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.7 p -142.67 6.44 1.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.47 160.92 31.87 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.096 1.316 . . . . 0.0 110.966 165.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.06 97.01 0.05 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.212 1.405 . . . . 0.0 112.39 -171.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 34.2 mtm -84.99 169.0 14.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.021 1.328 . . . . 0.0 111.708 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.1 m -159.78 158.37 31.04 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.176 -0.953 . . . . 0.0 112.515 170.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.12 123.56 28.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.554 0.742 . . . . 0.0 110.111 161.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.68 -25.03 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.514 1.126 . . . . 0.0 110.574 165.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -141.88 137.75 31.6 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.685 1.994 . . . . 0.0 109.16 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -62.9 143.99 97.07 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.994 1.317 . . . . 0.0 112.989 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -54.64 124.8 17.08 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.52 2.813 . . . . 0.0 112.542 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 10.2 p -123.53 130.07 52.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.132 1.373 . . . . 0.0 111.802 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -57.83 123.27 15.19 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.846 0.858 . . . . 0.0 111.005 171.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 26.8 p -80.64 -11.72 59.6 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.841 1.256 . . . . 0.0 113.085 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 84.0 -11.16 58.34 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.863 1.221 . . . . 0.0 114.341 -169.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -92.59 10.13 31.75 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.176 1.488 . . . . 0.0 112.509 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.47 13.19 71.1 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.848 0.737 . . . . 0.0 113.216 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 11.6 p -124.63 153.76 41.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.964 1.306 . . . . 0.0 110.959 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 26.0 t -128.48 118.16 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.869 1.668 . . . . 0.0 107.94 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.04 133.8 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.069 1.348 . . . . 0.0 113.299 -163.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 7.0 ptp -137.53 165.51 26.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.84 2.056 . . . . 0.0 112.023 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -115.69 133.96 55.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 163.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 6.8 m -136.41 149.01 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.543 1.137 . . . . 0.0 112.213 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -132.92 149.52 52.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.939 1.696 . . . . 0.0 112.621 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 8.2 t -119.1 151.93 51.33 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 127.644 2.378 . . . . 0.0 108.796 169.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 1.1 Cg_endo -103.05 -76.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 123.255 2.637 . . . . 0.0 115.127 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.65 165.12 27.75 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 121.221 1.828 . . . . 0.0 114.465 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 70.89 15.59 74.04 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.255 0.931 . . . . 0.0 114.946 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.57 87.1 56.89 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 112.44 -164.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -79.74 114.31 3.18 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.028 2.485 . . . . 0.0 108.974 159.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.4 p -163.02 155.23 18.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -171.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -79.12 109.02 13.05 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 154.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.271 1.1 pp -64.34 122.96 81.06 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.993 -162.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.423 ' HG2' ' HA2' ' A' ' 379' ' ' GLY . 73.8 Cg_endo -73.63 106.16 2.14 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.449 3.433 . . . . 0.0 113.334 -163.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 72.2 t -116.16 118.04 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.36 1.864 . . . . 0.0 109.844 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.47 158.65 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.934 1.294 . . . . 0.0 110.837 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 37.0 t -135.14 123.55 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.76 170.25 16.24 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -105.09 3.83 30.82 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.989 1.316 . . . . 0.0 112.039 169.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -129.4 10.75 5.76 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.732 1.613 . . . . 0.0 114.761 -161.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 46.9 mt 63.48 -10.83 0.11 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.692 2.397 . . . . 0.0 116.344 -175.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.5 t -127.93 -6.94 5.53 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.934 1.697 . . . . 0.0 114.594 -171.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.98 42.61 7.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.736 2.015 . . . . 0.0 112.87 -170.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -61.15 -31.27 70.99 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.726 159.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 7.9 mt -117.93 128.98 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 127.909 2.483 . . . . 0.0 107.199 167.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -95.52 108.57 20.83 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.192 0.905 . . . . 0.0 110.32 164.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -66.24 -57.85 6.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.791 2.036 . . . . 0.0 111.947 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -111.34 -177.46 20.35 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 -159.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.05 152.77 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.336 1.454 . . . . 0.0 111.438 -172.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.36 130.12 35.13 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.568 1.147 . . . . 0.0 109.51 169.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.79 -53.41 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 117.891 0.314 . . . . 0.0 111.032 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.2 m -83.66 153.19 24.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.923 0.889 . . . . 0.0 110.393 168.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 6.0 m -53.1 117.36 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.362 2.265 . . . . 0.0 114.989 -173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -82.79 118.85 73.11 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.763 1.225 . . . . 0.0 110.321 168.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.49 -177.32 3.78 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.549 3.5 . . . . 0.0 113.423 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.33 112.74 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.27 1.428 . . . . 0.0 107.223 167.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.2 85.23 0.37 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.15 1.38 . . . . 0.0 110.782 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 34.8 t -66.4 -58.6 4.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.936 0.494 . . . . 0.0 109.745 166.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 25.2 p -78.91 122.88 26.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.098 1.359 . . . . 0.0 109.963 163.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -62.54 -21.85 65.86 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.04 4.06 4.73 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.963 1.305 . . . . 0.0 113.519 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -42.32 129.4 3.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.72 2.008 . . . . 0.0 113.171 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.98 128.37 20.01 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.943 1.297 . . . . 0.0 110.309 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.2 p -149.29 150.79 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.583 0.706 . . . . 0.0 112.625 -159.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -89.12 121.74 31.74 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.298 2.639 . . . . 0.0 109.35 171.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 43.8 mt -135.31 146.86 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.444 0.698 . . . . 0.0 111.516 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -111.97 143.34 43.12 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.004 1.722 . . . . 0.0 111.624 167.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.78 149.15 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 123.513 0.725 . . . . 0.0 111.424 164.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -97.76 110.2 54.29 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.27 1.428 . . . . 0.0 109.466 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.8 126.03 6.37 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.979 2.452 . . . . 0.0 110.225 164.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.1 167.22 2.59 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.369 2.046 . . . . 0.0 111.444 155.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -60.26 155.79 16.91 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.429 0.633 . . . . 0.0 112.62 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.95 -169.88 39.03 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 123.007 1.337 . . . . 0.0 113.914 -173.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.57 163.01 9.55 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.151 1.78 . . . . 0.0 113.775 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 35.9 m -164.07 148.8 10.22 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.637 -1.289 . . . . 0.0 113.231 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -113.11 111.08 21.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.422 2.289 . . . . 0.0 106.87 161.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.4 mm -74.77 120.49 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 32.0 mt -117.7 126.59 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 122.273 1.035 . . . . 0.0 109.405 -171.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 54.9 t -118.02 99.29 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 127.361 2.265 . . . . 0.0 107.217 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' GLY . . . . . 0.423 ' HA2' ' HG2' ' A' ' 333' ' ' PRO . . . 118.73 170.54 14.8 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 122.981 1.323 . . . . 0.0 115.502 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.49 165.55 24.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.514 2.326 . . . . 0.0 109.556 166.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.28 -172.66 55.11 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 123.211 0.434 . . . . 0.0 112.163 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -60.35 -32.3 71.13 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.324 -1.104 . . . . 0.0 111.708 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.9 m -56.58 -4.3 0.15 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 130.338 3.455 . . . . 0.0 117.782 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -86.96 144.09 27.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.129 0.877 . . . . 0.0 111.816 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.99 165.94 11.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.884 0.873 . . . . 0.0 110.142 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.2 t -146.97 158.71 44.0 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 169.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -139.92 131.51 27.16 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.642 1.977 . . . . 0.0 108.63 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.68 141.3 32.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.764 1.226 . . . . 0.0 111.739 -171.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -140.0 146.92 39.69 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.162 1.385 . . . . 0.0 109.578 170.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.714 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.5 p90 . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.053 0.454 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 112.05 23.83 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.186 1.794 . . . . 0.0 107.072 165.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -61.08 142.67 56.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.975 1.71 . . . . 0.0 115.054 -174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 4.5 m -94.8 148.77 21.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.818 0.847 . . . . 0.0 109.013 156.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.1 p -137.11 1.42 2.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -77.92 163.11 26.3 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.677 1.126 . . . . 0.0 110.958 168.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.44 98.81 0.51 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.148 1.779 . . . . 0.0 112.096 -164.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 32.5 mtm -84.54 166.29 17.33 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.736 1.214 . . . . 0.0 112.23 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.7 m -161.81 162.7 29.55 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.149 -0.969 . . . . 0.0 112.255 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.36 117.0 24.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.07 0.948 . . . . 0.0 110.602 164.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 74.7 t -68.25 -30.16 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.595 1.558 . . . . 0.0 110.684 167.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -136.16 118.37 15.54 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.165 1.786 . . . . 0.0 107.575 170.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -52.74 144.61 24.81 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.216 1.006 . . . . 0.0 111.24 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.09 130.78 37.95 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.325 1.35 . . . . 0.0 111.878 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.3 p -130.69 130.74 44.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.277 1.431 . . . . 0.0 111.2 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.4 140.21 58.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.735 1.214 . . . . 0.0 112.61 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 39.4 p -95.79 -9.85 30.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.851 1.26 . . . . 0.0 113.996 -174.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 68.11 -2.78 6.37 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 119.283 0.947 . . . . 0.0 115.231 -167.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -97.06 19.14 13.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.009 1.405 . . . . 0.0 111.43 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.02 0.43 88.97 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.817 1.199 . . . . 0.0 113.788 -171.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 22.3 p -121.76 169.75 10.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.526 1.163 . . . . 0.0 112.547 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.8 t -140.63 124.5 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.23 1.812 . . . . 0.0 108.287 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.82 134.16 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.665 1.186 . . . . 0.0 112.308 -170.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -142.57 168.7 19.11 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.583 1.953 . . . . 0.0 113.062 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -122.42 131.93 54.11 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.182 1.393 . . . . 0.0 107.932 164.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.58 153.27 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.057 0.943 . . . . 0.0 111.582 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -136.98 146.22 45.1 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.426 1.49 . . . . 0.0 112.89 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.27 149.91 42.22 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 128.483 2.713 . . . . 0.0 107.735 164.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -107.04 -57.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.354 2.036 . . . . 0.0 115.594 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.22 170.68 15.29 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.949 -1.094 . . . . 0.0 112.966 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 69.21 -3.81 7.03 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.292 1.901 . . . . 0.0 117.718 168.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.97 99.59 41.02 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 119.248 1.524 . . . . 0.0 113.579 -163.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.07 112.27 2.56 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.67 2.913 . . . . 0.0 109.417 157.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.2 p -157.61 155.48 30.18 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -87.65 93.36 9.41 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.793 2.037 . . . . 0.0 106.695 162.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.254 1.4 pp -56.93 111.69 3.65 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.526 0.73 . . . . 0.0 112.456 -155.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.34 115.75 3.06 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.096 2.531 . . . . 0.0 114.197 -167.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 82.0 t -122.73 109.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.317 1.447 . . . . 0.0 109.71 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.93 162.77 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.663 1.585 . . . . 0.0 109.519 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.65 127.08 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -140.27 168.8 18.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.495 0.589 . . . . 0.0 112.352 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -102.13 -2.92 28.37 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.005 0.922 . . . . 0.0 111.851 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -106.07 0.49 25.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.582 1.953 . . . . 0.0 114.558 -168.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 34.4 mt 61.4 0.7 0.47 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.324 2.249 . . . . 0.0 115.967 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.1 t -127.99 -2.44 5.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.238 1.381 . . . . 0.0 114.515 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.524 ' HB3' HH22 ' A' ' 384' ' ' ARG . . . 62.55 45.04 6.48 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.802 2.441 . . . . 0.0 113.209 -172.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.86 -33.7 76.17 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 119.646 -0.216 . . . . 0.0 111.231 164.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 33.3 mt -131.9 117.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.346 1.458 . . . . 0.0 110.215 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -80.1 104.26 10.55 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.367 -0.833 . . . . 0.0 112.773 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -66.34 -56.09 12.8 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.585 2.354 . . . . 0.0 112.943 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -115.77 169.76 13.06 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 116.914 1.525 . . . . 0.0 116.914 -159.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.87 155.24 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.096 2.158 . . . . 0.0 111.863 -165.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.12 123.68 32.43 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.558 1.543 . . . . 0.0 108.723 166.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 93.3 t -89.47 -34.97 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.0 0.52 . . . . 0.0 111.446 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.0 t -113.3 175.12 5.58 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.213 1.005 . . . . 0.0 112.209 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.6 m -65.26 101.8 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.76 1.624 . . . . 0.0 112.474 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -63.09 125.31 86.59 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.854 165.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -82.09 -177.25 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.536 3.491 . . . . 0.0 114.007 -169.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.11 114.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 127.236 2.214 . . . . 0.0 107.674 171.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.86 75.39 0.11 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.837 1.655 . . . . 0.0 112.892 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -66.73 -11.46 54.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 169.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 31.5 p -134.52 127.34 31.16 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 127.846 2.458 . . . . 0.0 106.575 165.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -62.24 -15.29 46.1 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -170.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.79 5.98 10.08 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.237 1.815 . . . . 0.0 113.552 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -39.22 119.12 0.87 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 127.314 2.245 . . . . 0.0 113.584 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.57 144.59 50.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.057 0.943 . . . . 0.0 111.613 170.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.71 142.59 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -161.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.59 120.4 19.14 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.692 2.397 . . . . 0.0 109.455 165.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 48.0 mt -131.46 131.77 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.284 0.564 . . . . 0.0 110.732 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -96.51 139.8 32.07 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.989 0.916 . . . . 0.0 111.052 158.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.15 160.72 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.323 1.449 . . . . 0.0 110.957 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -125.41 92.87 46.09 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.068 1.747 . . . . 0.0 109.487 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.08 140.78 20.3 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.481 2.121 . . . . 0.0 109.987 160.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.35 179.93 3.65 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.812 2.341 . . . . 0.0 111.706 168.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -59.33 160.14 7.02 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.355 1.062 . . . . 0.0 113.444 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 86.83 -145.41 20.03 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.094 0.378 . . . . 0.0 112.193 -170.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -93.91 169.21 10.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.318 1.047 . . . . 0.0 113.653 -173.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 29.7 m -164.94 160.7 19.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.868 1.267 . . . . 0.0 112.423 168.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -129.05 109.4 11.16 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.636 1.974 . . . . 0.0 107.017 163.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.28 128.78 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 91.7 mt -119.42 125.65 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.122 1.369 . . . . 0.0 108.734 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.5 104.39 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.525 1.53 . . . . 0.0 108.02 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.32 -179.62 20.98 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 123.363 1.535 . . . . 0.0 116.644 171.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.95 170.0 16.82 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.581 2.752 . . . . 0.0 110.027 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 82.69 -158.6 37.32 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -168.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -72.82 -35.74 67.37 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.702 -0.881 . . . . 0.0 111.037 163.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.4 m -52.14 6.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 1 C-N-CA 132.202 4.201 . . . . 0.0 119.198 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' ARG . . . . . 0.524 HH22 ' HB3' ' A' ' 342' ' ' ALA . 0.5 OUTLIER -99.53 138.15 37.02 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.923 1.289 . . . . 0.0 111.808 -169.018 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.7 mt -107.76 166.55 10.61 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.027 0.531 . . . . 0.0 110.814 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.8 t -142.57 158.18 43.94 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 171.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -141.08 130.78 24.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.811 1.244 . . . . 0.0 110.948 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -64.41 137.13 57.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.439 2.296 . . . . 0.0 112.668 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -138.92 154.1 48.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.469 1.128 . . . . 0.0 113.012 163.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 126.86 2.064 . . . . 0.0 106.221 177.671 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 2.5 p90 . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 100.11 0.74 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 161.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 158.97 30.21 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.714 1.206 . . . . 0.0 114.08 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.4 m -105.71 137.63 43.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.709 1.204 . . . . 0.0 109.401 167.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.6 p -132.3 7.87 4.27 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -82.35 163.48 21.71 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.401 1.001 . . . . 0.0 110.735 165.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -62.22 109.04 1.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.613 1.965 . . . . 0.0 111.584 -165.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 15.1 mmt -72.99 159.27 33.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.769 0.795 . . . . 0.0 112.729 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.5 p -150.8 150.78 31.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.2 1.0 . . . . 0.0 111.134 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.3 119.44 35.83 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.651 0.78 . . . . 0.0 109.074 163.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -25.28 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.869 0.868 . . . . 0.0 110.425 165.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -142.31 127.84 19.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.911 2.084 . . . . 0.0 108.49 168.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -60.61 144.31 89.25 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.503 1.121 . . . . 0.0 111.443 171.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -54.79 136.57 72.2 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.22 1.947 . . . . 0.0 111.285 173.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 64.5 p -134.87 126.17 28.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.316 1.046 . . . . 0.0 111.198 171.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -55.76 119.18 5.34 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.327 1.451 . . . . 0.0 110.823 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 65.1 p -80.72 -12.59 59.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.906 0.883 . . . . 0.0 112.975 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.83 -7.49 1.54 Allowed Glycine 0 CA--C 1.538 1.494 0 CA-C-O 119.073 -0.848 . . . . 0.0 114.456 -166.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -81.77 2.66 28.97 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.352 1.576 . . . . 0.0 111.965 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.82 9.61 54.11 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.246 1.403 . . . . 0.0 113.677 -170.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.9 p -131.84 165.96 22.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.887 1.275 . . . . 0.0 112.874 -172.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.32 117.99 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.542 2.337 . . . . 0.0 107.152 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.0 p -102.45 132.08 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.586 0.755 . . . . 0.0 112.508 -174.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -137.59 165.29 26.68 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.853 1.661 . . . . 0.0 112.82 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.18 128.24 48.06 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.525 1.53 . . . . 0.0 107.177 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.93 148.45 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.666 0.787 . . . . 0.0 112.005 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -137.12 134.43 36.41 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.592 1.557 . . . . 0.0 112.114 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 m -98.86 159.26 30.74 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.995 1.718 . . . . 0.0 110.735 164.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -112.56 -55.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.886 2.391 . . . . 0.0 116.146 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 172.12 13.68 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.713 1.142 . . . . 0.0 113.139 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.11 -21.12 0.16 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 127.776 2.607 . . . . 0.0 118.291 168.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.39 107.86 56.91 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 119.366 1.583 . . . . 0.0 113.332 -165.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.57 125.91 5.8 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.996 2.464 . . . . 0.0 109.366 152.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 10.7 p -161.85 148.02 13.69 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.78 107.08 15.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.228 1.811 . . . . 0.0 106.635 163.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.284 0.6 OUTLIER -68.31 128.7 93.11 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.03 -153.002 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.97 109.48 2.89 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.117 3.211 . . . . 0.0 112.014 -172.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 93.5 t -111.18 108.89 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.861 1.665 . . . . 0.0 110.255 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.71 157.86 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 125.2 1.4 . . . . 0.0 110.019 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.6 t -144.48 125.54 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -149.59 170.18 19.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.098 0.559 . . . . 0.0 112.436 -170.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -89.68 -1.09 57.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.434 1.094 . . . . 0.0 113.293 174.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -127.47 1.2 6.26 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -152.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.9 mt 61.8 -1.39 0.35 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.151 2.181 . . . . 0.0 115.392 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.7 t -129.91 -7.66 4.46 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -171.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.4 49.23 4.23 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.908 2.083 . . . . 0.0 114.096 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -78.24 -38.03 43.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.834 0.454 . . . . 0.0 110.379 158.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 67.0 mt -97.51 153.12 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 126.919 2.088 . . . . 0.0 108.284 170.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.59 125.83 18.65 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.65 -1.281 . . . . 0.0 112.555 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' LYS . . . . . 0.484 ' HE2' ' HG3' ' A' ' 370' ' ' PRO . 2.9 mmmm -129.7 -17.38 3.64 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -159.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -142.56 148.34 20.04 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 119.219 0.918 . . . . 0.0 114.813 -167.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.1 148.83 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.528 1.131 . . . . 0.0 113.095 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.14 115.47 3.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.33 2.652 . . . . 0.0 110.939 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 70.9 t -81.33 -38.41 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.074 0.949 . . . . 0.0 110.532 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 t -92.23 175.1 6.98 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 111.286 168.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.8 m -66.87 135.3 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.329 1.052 . . . . 0.0 111.052 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.39 113.54 13.14 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 121.608 -0.682 . . . . 0.0 111.558 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.58 175.8 10.62 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.282 2.655 . . . . 0.0 113.708 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.29 132.01 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.152 1.781 . . . . 0.0 109.062 -173.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -78.29 97.84 5.72 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.352 1.461 . . . . 0.0 109.797 166.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.0 t -92.5 -16.04 26.29 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.269 1.028 . . . . 0.0 112.618 170.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.27 135.38 54.73 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.716 2.006 . . . . 0.0 107.01 163.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.2 -14.82 63.27 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.563 -1.335 . . . . 0.0 114.443 -167.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.73 0.82 56.09 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.674 1.59 . . . . 0.0 113.146 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -53.18 138.51 31.49 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.743 -1.223 . . . . 0.0 113.28 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.11 142.63 49.57 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.939 1.296 . . . . 0.0 111.069 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.47 144.89 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -162.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -69.63 127.2 32.12 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.82 2.848 . . . . 0.0 110.195 169.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 18.0 mt -137.05 138.24 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.011 0.434 . . . . 0.0 110.308 168.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -110.19 143.43 40.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.201 1.001 . . . . 0.0 110.964 163.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.52 151.54 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.966 0.906 . . . . 0.0 112.406 173.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -94.23 115.93 65.81 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.438 1.895 . . . . 0.0 109.435 172.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.91 168.99 23.59 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.141 2.56 . . . . 0.0 111.07 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' PRO . . . . . 0.484 ' HG3' ' HE2' ' A' ' 346' ' ' LYS . 17.0 Cg_endo -75.7 -177.24 3.45 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.94 2.427 . . . . 0.0 109.813 163.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -75.05 152.56 38.64 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.293 -0.879 . . . . 0.0 109.639 149.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 75.32 -156.2 48.27 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.809 1.084 . . . . 0.0 115.809 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.97 145.83 55.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.255 2.622 . . . . 0.0 113.151 -166.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 6.2 m -179.24 160.46 1.03 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.709 1.603 . . . . 0.0 114.545 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -126.99 119.0 25.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 129.078 2.951 . . . . 0.0 108.586 170.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.2 mm -75.14 119.58 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.5 132.24 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 120.235 1.38 . . . . 0.0 110.076 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.6 106.49 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 126.069 1.748 . . . . 0.0 108.302 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 114.03 176.15 19.06 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 122.496 1.053 . . . . 0.0 115.234 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.63 166.4 23.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.851 2.061 . . . . 0.0 110.223 170.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.1 -175.65 45.14 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 123.09 0.376 . . . . 0.0 112.45 -165.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -58.55 -28.82 65.86 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.674 -0.897 . . . . 0.0 111.921 171.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 50.6 m -57.72 -10.44 1.62 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 130.106 3.362 . . . . 0.0 116.933 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -79.63 146.77 32.34 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.347 1.059 . . . . 0.0 112.039 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 44.3 mt -116.03 166.17 12.3 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.895 0.878 . . . . 0.0 110.513 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.2 t -152.5 161.37 42.68 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -139.66 131.78 28.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.625 1.57 . . . . 0.0 110.205 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -69.12 125.44 26.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.846 1.258 . . . . 0.0 111.264 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -137.29 90.44 2.52 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.5 1.12 . . . . 0.0 110.488 172.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 121.173 0.511 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 95.43 0.35 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 156.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -65.93 162.38 19.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.728 2.011 . . . . 0.0 114.275 -172.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 32.7 m -103.25 139.34 38.83 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.195 0.998 . . . . 0.0 110.558 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.2 p -138.76 7.12 2.5 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.663 1.356 . . . . 0.0 114.663 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.33 165.55 19.21 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.795 1.18 . . . . 0.0 110.634 163.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -66.98 95.01 0.36 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.673 1.989 . . . . 0.0 111.375 -169.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 23.8 mtm -76.75 170.18 16.93 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.118 1.367 . . . . 0.0 112.653 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.1 m -156.48 158.94 38.11 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.037 -1.039 . . . . 0.0 112.976 166.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.82 114.95 23.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.598 0.759 . . . . 0.0 109.745 162.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.8 -29.81 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.866 1.267 . . . . 0.0 110.318 168.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -140.77 132.47 27.28 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.634 1.974 . . . . 0.0 108.53 165.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -61.17 148.13 85.39 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.417 1.487 . . . . 0.0 112.846 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.67 130.27 37.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.886 2.391 . . . . 0.0 111.619 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.5 p -127.11 125.14 40.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.615 1.166 . . . . 0.0 111.29 173.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -60.03 126.44 27.56 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.301 1.44 . . . . 0.0 111.89 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -77.78 -16.15 58.59 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.326 1.451 . . . . 0.0 113.762 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.81 -5.79 5.7 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 118.937 -0.924 . . . . 0.0 114.139 -165.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -89.42 -2.24 58.33 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.201 1.501 . . . . 0.0 112.115 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 102.91 -1.73 48.16 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.233 1.396 . . . . 0.0 114.035 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 17.1 p -121.09 159.15 26.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.768 1.227 . . . . 0.0 111.679 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.3 123.74 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.484 1.914 . . . . 0.0 108.091 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.3 p -111.96 129.14 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.183 0.993 . . . . 0.0 113.418 -166.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -136.11 168.13 19.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.886 2.075 . . . . 0.0 113.071 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -125.84 129.17 48.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.796 1.238 . . . . 0.0 108.083 166.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.07 153.0 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 119.21 0.914 . . . . 0.0 112.528 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -141.65 146.68 36.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.706 1.602 . . . . 0.0 113.455 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.99 155.41 41.71 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.835 2.054 . . . . 0.0 109.702 160.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -109.18 -49.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.286 1.991 . . . . 0.0 116.46 -175.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 173.81 13.8 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.738 1.154 . . . . 0.0 112.79 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.11 0.83 10.5 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.439 1.971 . . . . 0.0 117.645 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -119.37 97.28 50.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 119.015 1.408 . . . . 0.0 113.868 -160.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -81.19 111.71 2.45 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.845 3.03 . . . . 0.0 109.88 152.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 7.5 p -159.68 153.47 22.95 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -81.37 110.45 16.81 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 159.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.263 1.3 pp -66.14 112.74 9.83 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 119.429 -0.319 . . . . 0.0 111.387 -162.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.84 113.88 3.72 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.908 2.406 . . . . 0.0 112.345 -165.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 94.8 t -112.35 108.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 126.171 1.788 . . . . 0.0 110.004 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.0 158.22 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.62 1.568 . . . . 0.0 110.168 -176.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 77.7 t -145.8 116.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -171.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -131.01 -179.17 5.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.172 0.989 . . . . 0.0 113.048 -165.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -111.07 -0.13 16.72 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.96 0.904 . . . . 0.0 112.33 163.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -123.35 6.72 9.03 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.751 1.621 . . . . 0.0 113.952 -159.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.2 mt 65.27 -6.02 0.4 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.252 2.221 . . . . 0.0 115.194 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -128.49 -3.08 5.48 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' A' ' 337' ' ' ALA . . . 68.33 37.43 2.76 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.825 2.05 . . . . 0.0 113.536 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.17 -49.07 68.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 165.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.46 150.39 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 126.626 1.97 . . . . 0.0 107.59 164.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.58 129.47 21.83 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.161 -0.962 . . . . 0.0 112.221 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -133.95 -8.55 2.71 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -160.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -127.72 130.14 6.63 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 -164.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -89.12 157.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.12 1.368 . . . . 0.0 111.905 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.77 119.92 32.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.091 2.156 . . . . 0.0 109.177 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.41 -25.22 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.502 0.721 . . . . 0.0 112.187 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 366' ' ' GLU . 8.7 t -125.66 175.54 7.51 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.544 1.537 . . . . 0.0 111.084 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.78 107.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.155 1.782 . . . . 0.0 113.427 -175.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -71.55 113.53 20.47 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.826 1.25 . . . . 0.0 110.055 162.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -82.63 179.1 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.705 2.937 . . . . 0.0 114.419 -169.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.62 119.79 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 127.19 2.196 . . . . 0.0 106.058 163.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.0 84.63 0.08 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.56 1.144 . . . . 0.0 110.501 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.1 t -81.92 -9.73 59.49 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.54 122.84 37.71 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 127.399 2.28 . . . . 0.0 106.898 168.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -66.87 -10.8 52.23 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.285 -1.509 . . . . 0.0 114.752 -166.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -89.86 4.33 50.19 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.333 1.853 . . . . 0.0 113.375 170.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.33 134.89 11.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.222 1.409 . . . . 0.0 113.811 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.93 151.43 49.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.774 1.23 . . . . 0.0 111.56 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.29 144.57 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -166.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -79.23 121.47 25.1 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.708 2.403 . . . . 0.0 109.79 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 61.0 mt -131.1 136.35 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.359 0.599 . . . . 0.0 111.177 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' GLU . . . . . 0.454 ' H ' HG22 ' A' ' 351' ' ' THR . 24.7 mt-10 -101.89 141.27 35.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.976 1.31 . . . . 0.0 110.762 161.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.7 159.49 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.391 1.076 . . . . 0.0 112.001 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -117.13 102.06 52.86 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.703 1.601 . . . . 0.0 109.949 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.78 179.89 3.89 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.676 2.917 . . . . 0.0 110.866 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -78.83 -179.85 5.84 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.219 1.946 . . . . 0.0 110.869 161.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -60.48 148.61 37.06 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 153.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.92 -163.72 43.96 Favored Glycine 0 CA--C 1.539 1.583 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -62.86 158.9 17.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.631 1.972 . . . . 0.0 114.471 -169.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.6 m -166.54 168.57 14.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.137 1.375 . . . . 0.0 113.079 166.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.91 111.29 12.41 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.659 2.383 . . . . 0.0 107.326 164.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 17.4 mm -69.44 129.04 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 59.2 mt -121.32 124.18 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.357 1.063 . . . . 0.0 108.926 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.99 100.56 11.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 126.069 1.747 . . . . 0.0 107.58 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 114.68 178.72 18.89 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 123.071 1.373 . . . . 0.0 116.159 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.57 167.25 22.04 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.744 2.418 . . . . 0.0 110.167 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.29 -174.85 46.81 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.569 0.604 . . . . 0.0 112.338 -167.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -59.22 -30.5 68.29 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 122.037 -0.684 . . . . 0.0 111.228 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 15.6 m -60.15 -6.98 1.61 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 129.88 3.272 . . . . 0.0 117.22 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.65 148.5 31.61 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.018 0.927 . . . . 0.0 112.005 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 18.0 mt -111.89 165.46 12.06 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.504 0.722 . . . . 0.0 110.563 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.9 t -147.06 157.74 43.71 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -139.71 121.29 15.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.334 1.854 . . . . 0.0 109.657 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -66.64 140.5 57.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.094 1.358 . . . . 0.0 111.89 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -135.95 155.95 49.49 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.46 1.104 . . . . 0.0 111.773 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.031 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 34.9 p90 . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 120.656 0.265 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.45 104.21 7.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.856 0.863 . . . . 0.0 108.995 170.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -66.84 146.95 53.88 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.972 2.109 . . . . 0.0 115.945 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.9 m -96.49 144.62 26.42 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.728 1.211 . . . . 0.0 109.075 159.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 57.8 p -139.56 2.1 1.99 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -69.23 161.19 29.72 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 120.181 1.355 . . . . 0.0 111.157 165.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.87 95.46 0.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.0 1.72 . . . . 0.0 112.277 -171.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 31.6 mtm -81.38 166.64 20.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.927 1.291 . . . . 0.0 112.003 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 22.2 m -160.21 162.57 33.82 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.441 -0.787 . . . . 0.0 112.085 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -74.46 135.17 42.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.514 0.726 . . . . 0.0 109.426 166.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.99 -17.97 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.342 0.657 . . . . 0.0 110.81 161.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 28.6 tttm -147.87 123.72 10.61 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.452 2.301 . . . . 0.0 108.034 173.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.28 146.2 84.41 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.992 0.917 . . . . 0.0 112.069 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.77 130.06 35.53 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.694 2.929 . . . . 0.0 112.848 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.6 p -128.55 134.18 48.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.551 1.141 . . . . 0.0 110.585 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -60.55 122.12 13.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.29 0.636 . . . . 0.0 109.893 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.7 p -72.79 -14.16 61.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.284 1.034 . . . . 0.0 112.801 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.74 -4.94 13.3 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.277 0.942 . . . . 0.0 113.492 -165.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -90.16 1.14 56.74 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.886 1.343 . . . . 0.0 112.036 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.87 13.41 43.49 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.804 1.193 . . . . 0.0 113.72 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.8 p -133.66 153.9 51.32 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.044 1.338 . . . . 0.0 111.687 -174.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.49 121.14 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.669 1.187 . . . . 0.0 107.912 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.0 p -112.37 134.33 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.35 1.06 . . . . 0.0 113.067 -164.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -141.79 159.83 41.43 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.936 1.695 . . . . 0.0 112.893 -175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -107.92 132.36 53.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.1 1.36 . . . . 0.0 107.373 164.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.35 144.66 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.641 0.776 . . . . 0.0 111.314 -177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -131.04 144.28 51.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.368 1.467 . . . . 0.0 112.901 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.62 153.36 44.31 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 127.986 2.514 . . . . 0.0 108.835 168.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -108.93 -70.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.843 2.362 . . . . 0.0 116.277 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.18 164.45 27.66 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 121.226 1.83 . . . . 0.0 114.339 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 71.6 0.07 37.74 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.89 1.709 . . . . 0.0 117.037 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.87 102.53 53.99 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 118.879 1.34 . . . . 0.0 113.525 -166.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.06 120.22 2.95 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.717 2.944 . . . . 0.0 109.611 152.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 7.7 p -162.51 157.37 22.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -89.39 109.19 20.13 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 157.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.265 0.9 OUTLIER -65.3 122.79 81.88 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.744 -157.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -61.77 117.41 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.712 2.941 . . . . 0.0 113.522 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.1 t -124.94 111.43 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.251 1.421 . . . . 0.0 110.721 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.28 157.26 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.338 1.455 . . . . 0.0 110.096 -173.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.79 118.36 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.46 171.45 13.38 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -165.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ASP . . . . . 0.435 ' CG ' ' HE2' ' A' ' 346' ' ' LYS . 4.6 m-20 -90.89 -13.45 33.6 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.351 2.26 . . . . 0.0 112.577 166.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -114.99 0.18 13.59 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -154.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 36.4 mt 60.7 -25.95 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.664 2.786 . . . . 0.0 115.533 -171.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 11.1 t -99.8 -4.56 30.26 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.822 2.049 . . . . 0.0 114.567 -172.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.87 78.15 0.05 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 130.658 3.583 . . . . 0.0 115.175 -171.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -99.53 -38.91 8.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.295 1.438 . . . . 0.0 110.837 153.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 35.2 mm -98.96 128.5 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.771 1.228 . . . . 0.0 109.521 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -108.65 125.23 51.64 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.754 -0.591 . . . . 0.0 112.054 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' LYS . . . . . 0.435 ' HE2' ' CG ' ' A' ' 338' ' ' ASP . 47.8 mttm -75.49 -73.45 0.26 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.691 2.796 . . . . 0.0 110.902 166.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -98.31 167.16 22.35 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.063 1.316 . . . . 0.0 115.582 -155.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 12.6 mt -120.03 152.24 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.633 1.573 . . . . 0.0 110.318 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.3 135.97 54.16 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.472 1.909 . . . . 0.0 110.312 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.58 -50.14 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.949 0.5 . . . . 0.0 110.693 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.408 ' H ' ' HB2' ' A' ' 366' ' ' GLU . 1.1 m -81.45 156.81 25.16 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.001 0.92 . . . . 0.0 109.348 160.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.05 161.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.255 1.422 . . . . 0.0 113.922 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -125.02 121.05 25.39 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.158 1.783 . . . . 0.0 109.227 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -82.28 -175.29 2.44 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.265 3.31 . . . . 0.0 113.548 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 123.12 63.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.578 1.551 . . . . 0.0 108.037 168.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.63 84.71 0.87 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.34 1.056 . . . . 0.0 111.548 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 25.0 t -79.29 -12.34 59.94 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 167.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.7 p -131.31 121.98 25.64 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 127.785 2.434 . . . . 0.0 105.939 167.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -59.51 -20.34 54.66 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.8 0.06 9.93 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.466 1.906 . . . . 0.0 113.737 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -37.13 121.82 0.83 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.481 2.312 . . . . 0.0 113.58 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.65 143.18 47.13 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.269 1.028 . . . . 0.0 111.285 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.2 p -154.17 150.47 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -163.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.93 121.82 27.48 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.793 2.437 . . . . 0.0 109.469 168.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 37.0 mt -135.71 150.13 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.956 0.798 . . . . 0.0 111.455 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' GLU . . . . . 0.408 ' HB2' ' H ' ' A' ' 351' ' ' THR . 48.3 mt-10 -118.4 142.63 47.35 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.55 1.94 . . . . 0.0 111.467 170.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 3.8 m -123.11 145.47 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.569 1.148 . . . . 0.0 110.733 168.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -83.18 119.08 73.49 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.936 0.894 . . . . 0.0 109.787 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -82.34 151.33 15.54 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 122.844 2.363 . . . . 0.0 111.045 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.47 178.13 7.07 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.747 2.298 . . . . 0.0 110.442 158.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.73 151.66 46.88 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.611 -0.68 . . . . 0.0 110.449 163.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 77.63 -151.33 37.64 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 121.92 -0.488 . . . . 0.0 113.297 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.28 143.45 57.78 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -173.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 47.2 m -157.41 145.49 19.12 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.487 1.115 . . . . 0.0 112.512 167.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -122.77 105.2 9.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.404 1.082 . . . . 0.0 108.651 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 13.8 mm -76.69 113.78 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 127.444 2.298 . . . . 0.0 109.022 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 25.1 mt -116.79 133.96 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 122.449 1.118 . . . . 0.0 111.78 -168.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 81.6 t -116.77 114.58 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 C-N-CA 126.647 1.979 . . . . 0.0 108.023 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 96.98 -173.05 28.82 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 122.875 1.264 . . . . 0.0 115.521 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.95 164.01 31.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.308 2.243 . . . . 0.0 110.018 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.55 -174.12 42.68 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.008 0.337 . . . . 0.0 112.359 -167.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -59.17 -25.79 64.22 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.074 0.95 . . . . 0.0 112.497 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 63.4 m -60.38 -10.72 5.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.824 2.449 . . . . 0.0 115.684 172.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -77.39 124.71 28.24 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.508 1.049 . . . . 0.0 112.167 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 9.8 mt -97.71 161.3 13.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.983 0.513 . . . . 0.0 111.401 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.9 t -132.65 157.88 43.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.879 1.272 . . . . 0.0 112.042 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -145.0 136.52 25.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.078 1.351 . . . . 0.0 110.979 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.14 137.22 38.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.465 1.506 . . . . 0.0 113.139 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -138.01 147.39 44.14 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.917 1.287 . . . . 0.0 111.352 158.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 . . . . . 0 CA--C 1.536 0.435 0 C-N-CA 125.603 1.561 . . . . 0.0 107.598 169.185 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 29.5 p90 . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 121.477 0.656 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.35 105.94 13.83 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.123 1.769 . . . . 0.0 109.173 172.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -80.44 161.83 24.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.125 1.77 . . . . 0.0 114.162 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 13.7 m -100.86 148.58 24.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.343 1.057 . . . . 0.0 110.939 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 42.9 p -139.08 11.47 2.61 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 170.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -83.17 160.61 21.78 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.804 1.183 . . . . 0.0 110.039 163.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -65.29 98.72 0.35 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.095 1.758 . . . . 0.0 111.825 -163.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 27.6 mtm -83.01 164.06 20.6 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.716 0.806 . . . . 0.0 111.79 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.3 m -159.53 161.29 35.25 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.316 -0.865 . . . . 0.0 111.993 167.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.67 115.47 25.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.798 0.839 . . . . 0.0 110.573 167.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.69 -26.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.948 1.299 . . . . 0.0 110.548 168.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -142.31 130.86 22.52 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.539 1.936 . . . . 0.0 109.022 167.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -61.34 149.75 82.16 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.928 1.691 . . . . 0.0 113.313 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -55.86 130.57 41.07 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.345 2.697 . . . . 0.0 112.389 173.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.3 p -128.58 127.54 42.5 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.474 1.109 . . . . 0.0 111.297 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -60.82 123.89 18.83 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.73 1.612 . . . . 0.0 112.133 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.2 p -79.57 -11.81 59.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.487 1.515 . . . . 0.0 113.307 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 68.71 -10.36 1.55 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.418 1.009 . . . . 0.0 114.224 -168.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -83.23 3.63 30.33 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.618 1.567 . . . . 0.0 111.702 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 101.97 -1.47 51.59 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 126.043 1.782 . . . . 0.0 113.612 -174.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.2 p -118.06 159.11 23.79 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.771 1.286 . . . . 0.0 112.451 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.79 111.43 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.406 1.482 . . . . 0.0 107.916 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.46 133.1 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.245 1.018 . . . . 0.0 113.615 -162.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -139.69 161.54 37.27 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.245 2.218 . . . . 0.0 112.496 -172.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -113.33 130.12 56.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.454 1.102 . . . . 0.0 108.158 164.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.2 150.57 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.074 0.95 . . . . 0.0 111.874 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.8 tttp -135.73 148.38 48.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.826 1.651 . . . . 0.0 113.044 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.51 153.11 46.68 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 128.322 2.649 . . . . 0.0 108.17 165.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -107.97 -55.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.454 2.102 . . . . 0.0 115.695 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.94 171.01 16.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.275 1.03 . . . . 0.0 112.575 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.63 -5.14 1.8 Allowed Glycine 0 CA--C 1.537 1.425 0 C-N-CA 126.975 2.226 . . . . 0.0 118.093 166.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.53 95.59 48.09 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 119.286 1.543 . . . . 0.0 113.331 -161.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.93 117.82 4.83 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.114 2.543 . . . . 0.0 109.345 158.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.1 p -165.51 150.88 9.11 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.18 101.56 6.23 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.104 1.762 . . . . 0.0 106.588 158.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.253 1.3 pp -61.08 120.4 54.04 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-O 118.555 -0.735 . . . . 0.0 111.543 -158.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -61.89 114.85 2.47 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.492 2.795 . . . . 0.0 113.552 -171.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.62 120.15 62.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.979 1.312 . . . . 0.0 108.781 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 163.63 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.013 1.325 . . . . 0.0 110.643 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' VAL . . . . . 0.498 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 48.2 t -142.81 118.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.69 163.39 38.23 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.1 6.2 38.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.069 0.948 . . . . 0.0 111.913 -175.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -115.14 1.98 14.01 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.937 2.495 . . . . 0.0 113.457 -164.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 32.8 mt 61.31 8.03 1.94 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.495 2.318 . . . . 0.0 114.994 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.9 t -142.62 -6.6 0.89 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 55.95 50.18 14.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.767 2.027 . . . . 0.0 114.925 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.71 72.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 152.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 34.2 mm -70.57 148.18 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 123.718 0.807 . . . . 0.0 108.927 162.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.08 74.26 1.51 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.432 -1.418 . . . . 0.0 109.349 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -75.27 -60.63 2.21 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.296 1.838 . . . . 0.0 112.886 -160.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' GLY . . . . . 0.498 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -94.44 175.88 34.9 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.655 1.598 . . . . 0.0 115.406 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -113.79 150.73 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.143 2.577 . . . . 0.0 110.377 -173.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.78 135.46 36.5 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.493 1.517 . . . . 0.0 109.685 165.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.8 t -114.86 -65.34 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.885 0.766 . . . . 0.0 111.208 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.526 ' H ' ' HB2' ' A' ' 366' ' ' GLU . 1.5 m -68.8 157.34 36.64 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 162.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 35.2 m -55.71 161.44 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.959 1.704 . . . . 0.0 114.759 -172.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -125.67 125.35 24.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.445 1.898 . . . . 0.0 108.108 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -80.88 -174.49 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.85 3.033 . . . . 0.0 112.667 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.27 120.49 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 162.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.97 67.25 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.778 2.031 . . . . 0.0 113.444 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -71.03 -20.81 62.35 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.912 0.885 . . . . 0.0 112.402 169.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.81 123.05 43.66 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 154.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -65.65 -16.31 63.61 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.55 -1.344 . . . . 0.0 112.803 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -81.13 2.79 25.91 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.29 1.836 . . . . 0.0 113.751 170.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.22 126.14 3.98 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.303 1.441 . . . . 0.0 113.243 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.14 149.19 52.46 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.064 0.946 . . . . 0.0 111.539 167.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.0 p -158.56 151.38 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -163.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.74 122.61 28.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.172 2.589 . . . . 0.0 109.624 169.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 20.7 mt -134.02 149.67 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.932 0.787 . . . . 0.0 110.619 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' A' ' 351' ' ' THR . 45.4 mt-10 -116.22 143.38 45.58 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.608 1.563 . . . . 0.0 110.977 167.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.02 157.8 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.448 0.699 . . . . 0.0 111.635 164.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -121.47 102.19 42.74 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 127.164 2.186 . . . . 0.0 108.501 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.36 165.33 27.73 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.17 1.914 . . . . 0.0 110.628 166.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -59.7 177.2 0.49 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.078 2.518 . . . . 0.0 111.668 156.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -59.65 142.59 52.61 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.845 -0.534 . . . . 0.0 110.527 165.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 101.92 -154.18 18.72 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.957 1.265 . . . . 0.0 115.381 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.82 140.97 38.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.412 2.685 . . . . 0.0 112.533 -170.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.63 174.04 8.05 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 159.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -111.94 119.64 39.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.272 1.429 . . . . 0.0 108.926 170.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.5 mm -78.28 119.79 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 173.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 83.4 mt -112.19 134.83 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.685 1.194 . . . . 0.0 109.783 -172.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.6 t -115.86 108.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 126.097 1.759 . . . . 0.0 107.982 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.78 -179.27 24.21 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.11 167.29 21.83 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.433 2.693 . . . . 0.0 110.245 175.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.33 -169.62 54.9 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.606 0.622 . . . . 0.0 112.247 -169.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -63.11 -32.48 73.87 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.089 -1.242 . . . . 0.0 111.352 168.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 70.3 m -54.89 8.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 1 C-N-CA 131.877 4.071 . . . . 0.0 118.474 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -103.95 146.42 28.71 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.628 1.171 . . . . 0.0 111.704 -172.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 21.6 mt -120.95 168.66 11.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.044 0.938 . . . . 0.0 110.926 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.0 t -145.88 159.38 43.3 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 172.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -132.72 130.46 40.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.347 1.459 . . . . 0.0 109.678 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -76.71 132.58 39.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.287 1.835 . . . . 0.0 111.63 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -133.2 151.22 51.95 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 122.208 1.004 . . . . 0.0 111.796 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 171.136 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 121.15 0.5 . . . . 0.0 111.801 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.82 96.89 0.31 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.329 1.452 . . . . 0.0 108.506 166.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -69.7 156.91 38.25 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.416 2.686 . . . . 0.0 115.177 -172.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 14.9 m -100.53 137.81 38.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.874 1.27 . . . . 0.0 109.787 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 66.7 p -138.15 4.31 2.46 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -80.54 165.55 22.01 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.876 1.216 . . . . 0.0 110.707 166.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -66.68 94.95 0.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.848 2.059 . . . . 0.0 111.366 -165.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 30.7 mtm -79.69 163.32 24.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.853 1.261 . . . . 0.0 112.317 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.4 p -150.43 161.88 41.65 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.556 1.143 . . . . 0.0 112.476 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -93.93 125.82 38.77 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.152 0.981 . . . . 0.0 108.723 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.72 -26.7 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 163.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -144.06 128.46 17.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.59 1.956 . . . . 0.0 108.743 171.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -59.22 143.81 84.29 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.961 0.904 . . . . 0.0 111.752 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -56.31 137.95 81.84 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.082 1.855 . . . . 0.0 111.513 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 41.2 p -132.49 124.59 28.83 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.37 1.068 . . . . 0.0 111.805 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -54.09 122.05 9.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.307 1.843 . . . . 0.0 111.517 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -84.24 -12.39 54.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.137 0.975 . . . . 0.0 113.296 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.95 -10.01 1.32 Allowed Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.271 0.939 . . . . 0.0 114.584 -167.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -83.38 7.02 17.95 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.29 1.545 . . . . 0.0 111.971 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 96.2 5.9 59.16 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.48 1.514 . . . . 0.0 113.713 -171.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.5 p -127.75 167.48 16.43 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.708 1.254 . . . . 0.0 112.825 -172.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.35 123.59 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.693 1.997 . . . . 0.0 107.817 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -110.32 131.7 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.74 1.216 . . . . 0.0 113.005 -170.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -138.45 167.13 22.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.685 1.594 . . . . 0.0 113.756 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -126.26 129.44 48.93 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.028 1.331 . . . . 0.0 108.594 166.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.1 m -127.26 154.87 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.79 0.836 . . . . 0.0 111.792 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -139.65 144.28 37.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.581 1.552 . . . . 0.0 111.717 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 12.7 p -120.04 154.23 55.56 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.153 2.181 . . . . 0.0 108.518 168.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 10.2 Cg_endo -113.31 -45.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.2 0 CA-C-N 122.205 1.823 . . . . 0.0 116.602 -165.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.7 164.68 32.79 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.928 -1.107 . . . . 0.0 112.447 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.37 4.95 26.21 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.888 1.709 . . . . 0.0 117.188 168.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.89 95.66 46.04 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.0 1.4 . . . . 0.0 113.094 -164.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.62 115.08 1.51 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.048 3.166 . . . . 0.0 109.249 154.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 9.3 p -163.36 144.39 9.3 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.99 107.11 9.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 162.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.278 0.7 OUTLIER -68.87 122.2 84.16 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.13 -155.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -64.2 116.02 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.062 2.508 . . . . 0.0 112.987 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.91 108.17 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.828 1.651 . . . . 0.0 110.312 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.09 156.92 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.437 1.495 . . . . 0.0 109.581 -170.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 42.5 t -142.62 122.13 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 120.98 -1.075 . . . . 0.0 109.39 -170.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.19 173.71 11.27 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -161.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -110.54 -1.99 16.67 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.517 1.527 . . . . 0.0 112.205 168.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -125.83 4.58 7.36 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.703 1.601 . . . . 0.0 113.996 -159.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 35.7 mt 62.56 -4.9 0.21 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.339 2.256 . . . . 0.0 115.52 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 5.0 t -125.33 0.71 7.73 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.074 1.307 . . . . 0.0 113.963 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 77.87 21.2 0.95 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.59 2.356 . . . . 0.0 113.945 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -61.43 -46.45 90.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.268 1.027 . . . . 0.0 111.475 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.7 mm -94.37 135.39 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.64 86.68 2.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 123.415 1.579 . . . . 0.0 113.31 -167.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -82.6 -49.08 10.24 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.708 2.403 . . . . 0.0 113.097 -158.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -104.84 154.13 17.36 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -160.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.15 149.1 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 127.102 2.161 . . . . 0.0 109.749 -169.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.12 120.35 24.14 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.054 1.341 . . . . 0.0 109.277 170.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.93 -38.3 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.963 0.505 . . . . 0.0 111.052 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 366' ' ' GLU . 6.1 t -97.59 175.41 6.21 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.351 0.66 . . . . 0.0 111.058 166.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.74 128.52 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.726 1.211 . . . . 0.0 110.507 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -66.31 114.96 19.29 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.673 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.86 174.7 10.71 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.311 2.674 . . . . 0.0 113.394 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.33 120.99 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 127.223 2.209 . . . . 0.0 107.986 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.95 99.53 0.5 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.553 1.141 . . . . 0.0 109.506 167.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 26.1 t -102.16 -11.12 19.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.689 1.596 . . . . 0.0 112.79 175.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.59 152.33 33.27 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 147.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -72.86 -11.66 60.68 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 117.847 -1.073 . . . . 0.0 113.597 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.99 1.46 55.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.311 1.444 . . . . 0.0 112.457 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -54.18 134.14 44.44 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.443 1.116 . . . . 0.0 113.034 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.41 140.44 52.17 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.442 1.497 . . . . 0.0 110.634 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.35 142.63 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -158.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.06 127.8 33.63 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 129.491 3.116 . . . . 0.0 110.419 170.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 44.2 mt -137.85 144.62 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.096 0.558 . . . . 0.0 110.655 170.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' GLU . . . . . 0.557 ' H ' HG22 ' A' ' 351' ' ' THR . 11.1 mt-10 -116.1 139.05 50.7 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.562 1.545 . . . . 0.0 111.125 165.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.36 158.32 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.737 1.215 . . . . 0.0 111.801 175.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -118.1 105.26 47.28 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 126.978 2.111 . . . . 0.0 108.687 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -80.84 169.63 16.31 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.533 2.822 . . . . 0.0 111.147 172.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.83 175.96 8.95 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.422 2.082 . . . . 0.0 110.846 162.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -65.72 148.42 51.8 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.797 -0.564 . . . . 0.0 109.853 161.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.41 -162.51 33.4 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-O 122.426 1.014 . . . . 0.0 114.833 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.3 156.31 29.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.563 1.945 . . . . 0.0 113.941 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 64.0 m -170.03 159.79 7.84 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.667 1.987 . . . . 0.0 112.063 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -124.42 123.56 40.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.887 1.675 . . . . 0.0 107.934 157.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.6 mm -76.69 111.0 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 87.1 mt -100.95 130.98 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.687 1.131 . . . . 0.0 109.391 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 83.5 t -117.76 109.45 27.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.898 1.679 . . . . 0.0 107.838 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.9 -176.21 22.72 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 123.333 1.518 . . . . 0.0 116.604 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.57 171.96 13.39 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.167 2.587 . . . . 0.0 110.357 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.37 -171.87 45.83 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -61.16 -31.1 70.83 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.811 -0.817 . . . . 0.0 111.7 170.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 53.2 m -61.39 -8.15 3.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 129.571 3.148 . . . . 0.0 117.364 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -74.38 144.89 44.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.855 0.752 . . . . 0.0 111.449 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 31.8 mt -116.8 167.64 10.92 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.263 0.625 . . . . 0.0 110.719 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.3 t -146.55 159.12 43.83 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -134.57 131.25 37.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.418 1.487 . . . . 0.0 109.57 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -73.89 131.51 41.55 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.312 2.245 . . . . 0.0 112.344 -173.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -142.59 118.02 10.28 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.24 1.016 . . . . 0.0 111.888 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.737 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 31.5 p90 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 111.39 23.13 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 166.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.37 134.76 57.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.872 1.669 . . . . 0.0 114.594 -173.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.2 m -85.26 132.77 34.22 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 152.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 66.8 p -132.94 6.21 3.93 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -83.32 161.35 21.46 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.176 0.898 . . . . 0.0 111.052 164.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -63.62 104.32 0.64 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.137 1.775 . . . . 0.0 112.711 -159.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 24.3 mtm -87.63 164.86 15.82 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.047 0.927 . . . . 0.0 112.004 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.5 m -160.6 160.48 31.77 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.24 -0.912 . . . . 0.0 111.717 170.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.91 126.13 30.29 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 165.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 40.6 t -78.97 -24.21 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.506 0.722 . . . . 0.0 110.527 161.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -139.94 127.23 21.24 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.226 1.81 . . . . 0.0 108.203 166.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -55.41 144.11 53.96 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.642 1.177 . . . . 0.0 111.719 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -55.07 133.09 56.13 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.309 2.006 . . . . 0.0 110.989 170.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 61.4 p -133.74 129.73 37.08 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.202 1.001 . . . . 0.0 110.742 171.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.24 125.65 24.13 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.342 1.057 . . . . 0.0 111.143 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 61.9 p -80.47 -9.2 59.77 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.192 0.997 . . . . 0.0 113.093 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 74.66 -8.49 14.33 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.798 1.19 . . . . 0.0 114.033 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -90.0 4.82 49.0 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.88 1.34 . . . . 0.0 112.468 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.65 6.73 62.15 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.674 1.13 . . . . 0.0 113.59 -169.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.6 p -120.73 157.04 30.53 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.843 1.257 . . . . 0.0 111.214 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 15.0 t -130.86 118.76 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.346 1.458 . . . . 0.0 108.038 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.9 p -108.01 129.78 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.978 1.311 . . . . 0.0 113.134 -166.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -139.76 162.71 34.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.972 1.709 . . . . 0.0 113.374 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -116.26 129.25 56.18 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.099 1.359 . . . . 0.0 107.764 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.6 m -126.17 145.75 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.594 0.757 . . . . 0.0 111.312 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -125.92 144.09 50.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.641 1.176 . . . . 0.0 112.526 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.7 t -111.86 150.88 42.99 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 127.501 2.32 . . . . 0.0 107.785 163.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -110.26 -59.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.576 2.184 . . . . 0.0 116.169 -176.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.02 164.61 29.81 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.03 -1.044 . . . . 0.0 112.743 -176.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 64.41 7.07 24.46 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 117.622 1.809 . . . . 0.0 117.622 168.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.26 98.05 44.66 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 119.071 1.436 . . . . 0.0 113.279 -162.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.56 119.19 1.63 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.53 3.487 . . . . 0.0 110.072 157.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.2 p -161.1 157.91 26.8 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -172.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -88.46 112.51 23.04 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 157.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 333' ' ' PRO 0.297 0.5 OUTLIER -66.09 124.89 89.03 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.655 -160.477 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 4.7 Cg_exo -74.75 104.53 1.9 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.457 2.771 . . . . 0.0 111.824 -171.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 75.2 t -105.08 107.88 23.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.471 1.508 . . . . 0.0 109.87 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.43 160.18 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 122.276 1.036 . . . . 0.0 110.992 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 23.0 t -142.93 134.39 24.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -147.94 178.29 8.64 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.401 0.681 . . . . 0.0 112.046 -168.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -114.24 -6.2 13.0 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.648 0.779 . . . . 0.0 112.26 166.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -111.53 5.83 19.72 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.859 2.464 . . . . 0.0 113.788 -165.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 13.6 mt 64.16 -3.59 0.47 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.223 2.209 . . . . 0.0 115.048 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.6 t -126.89 -6.34 6.17 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -174.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 337' ' ' ALA . . . 80.04 25.67 0.36 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 127.968 2.507 . . . . 0.0 113.832 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.2 81.24 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 166.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.83 138.42 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.826 0.85 . . . . 0.0 109.27 159.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.98 74.44 0.88 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 123.014 1.387 . . . . 0.0 109.178 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -76.61 -51.42 11.63 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 126.656 1.982 . . . . 0.0 114.089 -158.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -112.61 153.34 17.53 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 116.065 1.186 . . . . 0.0 116.065 -161.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.3 152.77 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 129.724 3.209 . . . . 0.0 110.171 -168.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.96 123.66 30.78 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.919 1.288 . . . . 0.0 110.101 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.66 -47.25 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.066 0.546 . . . . 0.0 110.16 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.7 t -86.79 178.19 7.08 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.262 1.025 . . . . 0.0 111.901 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.1 m -60.78 131.44 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.275 1.43 . . . . 0.0 111.063 169.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.26 116.03 46.89 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 120.989 -1.07 . . . . 0.0 110.036 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.69 -179.03 5.08 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 124.058 3.172 . . . . 0.0 113.777 -172.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.26 141.2 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.32 1.448 . . . . 0.0 108.598 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -86.84 100.37 12.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.997 0.919 . . . . 0.0 109.577 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -96.4 -16.0 21.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.81 0.844 . . . . 0.0 112.549 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.59 130.67 53.66 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 126.502 1.921 . . . . 0.0 106.676 165.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -66.04 -18.19 65.18 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.326 -1.484 . . . . 0.0 114.133 -165.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -78.84 -2.62 40.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.919 1.687 . . . . 0.0 113.637 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -51.42 133.04 29.9 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.4 1.571 . . . . 0.0 112.937 -170.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -140.81 123.73 16.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.742 2.017 . . . . 0.0 108.665 -164.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 10.5 p -149.04 142.28 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -155.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.97 125.31 26.51 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 128.566 2.747 . . . . 0.0 110.195 170.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 23.6 mt -135.44 140.54 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.195 0.522 . . . . 0.0 110.965 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -116.33 136.06 53.33 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.593 1.557 . . . . 0.0 110.775 166.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.68 159.0 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.768 1.227 . . . . 0.0 112.2 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -129.23 103.88 18.16 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.481 1.912 . . . . 0.0 109.768 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.79 163.85 30.85 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 121.886 1.724 . . . . 0.0 110.642 167.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -60.34 177.27 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.101 2.534 . . . . 0.0 111.746 157.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -60.98 141.12 57.56 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.623 -0.673 . . . . 0.0 110.595 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 96.31 -161.26 22.3 Favored Glycine 0 CA--C 1.535 1.327 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -67.6 159.53 29.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.772 1.629 . . . . 0.0 114.657 -169.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 22.6 m -170.02 164.37 9.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.729 1.612 . . . . 0.0 112.663 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -127.24 116.09 20.04 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 129.453 3.101 . . . . 0.0 107.395 165.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.6 mm -77.11 121.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.18 130.33 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.571 1.078 . . . . 0.0 109.511 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.7 t -114.92 105.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.584 1.154 . . . . 0.0 108.456 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.22 -177.41 20.87 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 123.091 1.384 . . . . 0.0 116.312 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.9 163.93 28.42 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.627 2.371 . . . . 0.0 110.46 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 80.76 -170.09 52.82 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.018 0.818 . . . . 0.0 112.989 -170.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -65.07 -23.87 67.29 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.951 -1.323 . . . . 0.0 111.814 167.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 72.8 m -62.61 -2.52 1.13 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 130.676 3.59 . . . . 0.0 117.676 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.52 147.92 22.55 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.452 1.024 . . . . 0.0 112.371 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 17.6 mt -113.39 165.41 12.48 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.416 0.686 . . . . 0.0 110.951 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.4 t -145.23 158.59 43.79 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 167.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -140.79 134.88 30.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.567 1.947 . . . . 0.0 109.029 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -74.29 138.08 43.33 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.225 1.41 . . . . 0.0 111.699 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -144.53 118.52 9.39 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.653 0.781 . . . . 0.0 112.991 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 . . . . . 0 CA--C 1.531 0.217 0 C-N-CA 124.84 1.256 . . . . 0.0 109.109 175.638 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 4.7 p90 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 121.166 0.508 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.98 103.9 11.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.377 2.271 . . . . 0.0 105.082 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -73.9 151.88 40.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.2 1.4 . . . . 0.0 114.165 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.2 m -95.75 150.92 19.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.354 0.661 . . . . 0.0 110.205 166.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.1 p -133.41 9.36 4.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.787 1.235 . . . . 0.0 113.705 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -79.24 154.55 29.1 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 120.348 1.431 . . . . 0.0 111.107 164.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 109.58 0.9 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.387 2.275 . . . . 0.0 111.89 -170.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 19.0 mtt -87.54 170.47 11.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.9 m -156.93 153.28 27.86 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.346 -0.846 . . . . 0.0 112.685 157.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.82 125.52 29.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.88 0.872 . . . . 0.0 109.343 160.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 5.3 t -82.43 -24.35 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.03 1.332 . . . . 0.0 110.873 172.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -134.24 125.6 28.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.283 2.233 . . . . 0.0 106.708 170.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -56.8 146.93 55.46 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 123.655 0.597 . . . . 0.0 111.154 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -56.66 124.35 16.05 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.507 1.471 . . . . 0.0 110.019 166.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.3 p -125.41 125.78 43.92 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.229 1.011 . . . . 0.0 110.977 170.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.62 121.32 11.9 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.839 0.712 . . . . 0.0 110.54 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 59.1 p -79.45 -7.28 58.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.201 1.4 . . . . 0.0 113.224 -173.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.56 -7.06 2.21 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.738 -164.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -86.68 6.17 32.47 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.659 1.729 . . . . 0.0 111.856 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.47 -2.0 67.23 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.088 1.328 . . . . 0.0 113.648 -170.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 27.9 p -119.07 166.89 12.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.112 1.365 . . . . 0.0 112.002 -170.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.48 114.79 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.014 1.726 . . . . 0.0 108.027 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.29 136.34 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.322 1.049 . . . . 0.0 113.235 -168.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -147.24 167.09 25.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.675 1.99 . . . . 0.0 112.996 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -115.32 134.89 54.7 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.47 1.908 . . . . 0.0 106.819 161.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 23.5 m -132.13 148.54 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.678 0.672 . . . . 0.0 111.703 176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -135.31 146.8 48.83 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.709 1.204 . . . . 0.0 112.272 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 22.8 m -115.13 157.65 43.03 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.604 1.561 . . . . 0.0 110.704 165.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 24.2 Cg_endo -114.99 -54.49 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.479 2.119 . . . . 0.0 116.673 -171.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.64 175.3 9.8 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.164 1.802 . . . . 0.0 113.596 177.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.18 -13.47 0.23 Allowed Glycine 0 CA--C 1.541 1.716 0 N-CA-C 119.314 2.486 . . . . 0.0 119.314 164.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.48 104.78 54.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 119.939 1.87 . . . . 0.0 114.715 -159.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.41 117.25 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.746 2.964 . . . . 0.0 110.524 158.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.0 p -163.45 148.72 11.2 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -76.06 98.94 4.46 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 155.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.71 113.58 6.28 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 123.701 0.801 . . . . 0.0 111.305 -161.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.52 104.18 1.67 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.251 2.634 . . . . 0.0 112.942 -168.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 81.1 t -101.4 116.98 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 127.076 2.15 . . . . 0.0 109.726 172.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.26 161.43 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.375 1.07 . . . . 0.0 110.782 -176.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' VAL . . . . . 0.52 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 46.8 t -138.67 133.62 42.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -142.8 169.55 17.35 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.374 0.67 . . . . 0.0 111.652 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -102.22 1.74 36.31 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.243 0.617 . . . . 0.0 111.622 162.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -117.99 5.1 12.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.078 1.751 . . . . 0.0 114.473 -165.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 15.9 mt 61.89 -7.76 0.11 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.492 2.317 . . . . 0.0 116.098 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.7 t -121.75 -5.6 9.14 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.393 1.452 . . . . 0.0 114.132 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 63.47 44.57 5.27 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.78 2.032 . . . . 0.0 113.008 -173.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.91 99.06 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 159.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 22.1 mt -92.84 138.13 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.945 1.698 . . . . 0.0 108.745 166.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -109.25 70.97 0.75 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.226 1.012 . . . . 0.0 109.375 171.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -64.24 -63.0 1.26 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.647 2.379 . . . . 0.0 112.556 -161.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' GLY . . . . . 0.52 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -96.67 171.21 27.38 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.864 1.697 . . . . 0.0 115.537 -168.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.1 150.58 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 128.299 2.64 . . . . 0.0 110.915 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.98 122.82 30.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.059 1.744 . . . . 0.0 108.358 165.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 28.2 t -86.54 -43.79 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.359 0.527 . . . . 0.0 111.033 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 366' ' ' GLU . 4.9 t -101.1 175.3 5.64 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.551 0.691 . . . . 0.0 112.017 172.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.41 124.17 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.587 1.555 . . . . 0.0 112.859 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -81.01 122.17 81.51 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.1 0.96 . . . . 0.0 109.709 166.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -81.75 -171.45 1.21 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.615 3.543 . . . . 0.0 112.815 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.42 129.32 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.332 1.453 . . . . 0.0 107.321 165.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.68 81.93 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.794 1.238 . . . . 0.0 111.666 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 27.7 t -85.57 -10.53 55.78 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.143 0.977 . . . . 0.0 112.49 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.8 127.54 50.7 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 128.201 2.6 . . . . 0.0 106.036 170.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -67.6 -17.46 64.63 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.405 -1.434 . . . . 0.0 113.595 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.24 1.84 26.84 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 127.488 2.315 . . . . 0.0 114.032 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.77 133.55 6.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.667 1.222 . . . . 0.0 113.937 -168.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -141.87 138.31 32.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.454 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 13.8 p -147.82 146.03 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.79 0.805 . . . . 0.0 112.905 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -75.19 120.23 20.4 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.382 2.673 . . . . 0.0 109.193 166.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mt -132.37 139.3 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.892 0.769 . . . . 0.0 111.871 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' GLU . . . . . 0.468 ' H ' HG22 ' A' ' 351' ' ' THR . 31.3 mt-10 -111.17 135.66 51.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 110.206 161.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 31.4 m -117.74 161.01 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.344 1.057 . . . . 0.0 111.004 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -131.86 101.77 15.21 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.807 1.643 . . . . 0.0 109.153 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.36 164.71 28.54 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.075 1.85 . . . . 0.0 110.72 164.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.16 175.6 0.24 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.83 3.02 . . . . 0.0 113.313 160.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -58.55 144.23 43.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.278 0.631 . . . . 0.0 110.745 163.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 94.66 -142.97 16.31 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 115.469 0.948 . . . . 0.0 115.469 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.22 154.95 32.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.164 1.786 . . . . 0.0 113.21 -168.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 18.1 m -167.98 161.45 12.8 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.797 1.239 . . . . 0.0 113.5 168.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -124.75 110.34 14.22 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 127.963 2.505 . . . . 0.0 107.261 163.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 9.5 mm -73.85 124.97 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.2 mt -117.87 135.83 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.708 1.203 . . . . 0.0 109.145 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 68.6 t -126.51 97.13 3.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 126.393 1.877 . . . . 0.0 107.481 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 115.6 173.29 17.39 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 116.088 1.195 . . . . 0.0 116.088 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 74.0 p -130.58 173.06 11.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.989 1.716 . . . . 0.0 110.523 167.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 78.22 -161.31 48.74 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 -169.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -69.03 -30.78 69.22 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.476 -1.014 . . . . 0.0 111.597 167.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 54.7 m -58.44 -5.47 0.53 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 130.226 3.41 . . . . 0.0 118.411 -174.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -85.8 139.77 31.02 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.983 0.913 . . . . 0.0 111.669 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.1 mt -104.05 163.64 12.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 110.087 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.2 t -147.02 156.1 42.76 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 169.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -136.19 117.12 14.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.363 1.865 . . . . 0.0 108.69 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -65.21 134.92 54.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.17 0.988 . . . . 0.0 110.816 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -133.43 134.89 44.18 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.297 1.039 . . . . 0.0 110.891 171.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 C--N 1.329 -0.294 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.263 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 121.164 0.507 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.66 97.35 2.65 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 158.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -68.42 154.91 40.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.852 2.461 . . . . 0.0 115.153 -171.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.7 m -102.7 140.6 36.76 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.0 1.32 . . . . 0.0 109.428 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.7 p -138.16 5.9 2.56 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -78.63 160.43 27.55 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.781 1.173 . . . . 0.0 110.517 162.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.11 98.02 0.42 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.09 2.156 . . . . 0.0 112.236 -161.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' MET . . . . . 0.408 ' HE1' ' H ' ' A' ' 380' ' ' THR . 32.2 mtm -82.38 165.71 20.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.098 0.959 . . . . 0.0 111.919 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.4 m -160.62 163.53 32.54 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.363 -0.835 . . . . 0.0 111.768 169.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.1 125.9 30.09 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 164.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.64 -27.74 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.621 0.768 . . . . 0.0 109.737 159.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -144.29 119.06 9.86 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.541 2.337 . . . . 0.0 108.062 170.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -52.86 145.16 23.42 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.785 1.234 . . . . 0.0 111.803 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.36 129.65 35.8 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.916 2.411 . . . . 0.0 111.948 173.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.9 p -126.56 132.49 51.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.839 0.856 . . . . 0.0 111.093 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -61.9 135.89 57.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.026 1.73 . . . . 0.0 112.026 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.3 p -91.26 -13.41 32.78 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 64.94 0.11 4.95 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.979 1.276 . . . . 0.0 114.752 -167.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -90.53 9.75 28.17 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.992 1.396 . . . . 0.0 111.748 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.59 15.5 65.83 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.771 -1.016 . . . . 0.0 113.583 -167.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 22.3 p -131.51 168.83 16.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.001 1.401 . . . . 0.0 113.021 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.84 130.75 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.104 1.762 . . . . 0.0 108.245 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.91 133.34 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.511 1.124 . . . . 0.0 112.368 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -140.61 163.47 32.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.835 1.654 . . . . 0.0 113.155 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -120.7 123.7 43.36 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.814 1.246 . . . . 0.0 107.742 164.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.44 147.96 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.786 0.835 . . . . 0.0 111.678 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -132.68 142.45 49.08 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.393 1.477 . . . . 0.0 113.205 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 t -107.73 143.24 26.88 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.35 2.66 . . . . 0.0 107.829 162.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -103.36 -62.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.264 1.976 . . . . 0.0 115.679 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.48 170.45 15.9 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.808 1.185 . . . . 0.0 113.166 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.09 -14.27 0.44 Allowed Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.968 2.223 . . . . 0.0 117.692 171.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.03 99.8 44.32 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 119.204 1.502 . . . . 0.0 113.327 -167.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.19 113.52 3.2 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.288 2.659 . . . . 0.0 108.878 157.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 16.2 p -158.92 148.19 18.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -170.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.57 99.34 5.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.44 1.496 . . . . 0.0 106.997 161.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.267 0.9 OUTLIER -61.28 114.13 9.91 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 123.222 0.326 . . . . 0.0 111.617 -159.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.07 113.5 3.72 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.954 2.436 . . . . 0.0 112.668 -167.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.12 115.81 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.0 2.12 . . . . 0.0 109.424 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 159.31 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.662 1.185 . . . . 0.0 110.434 -175.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' VAL . . . . . 0.484 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 51.0 t -140.22 114.71 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.472 1.109 . . . . 0.0 108.136 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -144.49 170.18 16.54 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.018 0.826 . . . . 0.0 113.055 -169.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -106.39 6.37 30.33 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.947 0.899 . . . . 0.0 112.07 171.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -115.87 2.5 13.58 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.093 1.757 . . . . 0.0 113.98 -163.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 49.4 mt 60.68 3.9 0.68 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.737 2.415 . . . . 0.0 115.397 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 3.7 t -137.13 -9.36 1.76 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -173.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 55.82 51.59 12.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.858 2.063 . . . . 0.0 113.423 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -68.83 -34.97 76.38 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 157.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 44.8 mm -111.24 141.55 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.341 1.456 . . . . 0.0 108.71 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -114.8 128.4 56.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.86 0.838 . . . . 0.0 110.899 165.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -87.56 -68.24 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.494 2.318 . . . . 0.0 110.227 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' GLY . . . . . 0.484 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -93.33 166.78 28.43 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.224 1.392 . . . . 0.0 116.41 -162.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.7 152.85 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 128.027 2.531 . . . . 0.0 110.026 -167.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.0 127.45 31.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.837 1.255 . . . . 0.0 109.448 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.1 t -90.19 -37.42 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.176 0.444 . . . . 0.0 111.141 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 366' ' ' GLU . 6.1 t -106.61 173.49 6.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 112.072 175.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.8 m -66.47 126.94 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.475 1.51 . . . . 0.0 112.177 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -96.0 129.57 33.67 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.653 1.581 . . . . 0.0 110.065 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -83.94 -176.48 2.67 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.263 3.309 . . . . 0.0 114.649 -168.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.47 120.81 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.686 2.394 . . . . 0.0 107.946 168.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.02 74.25 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.908 1.683 . . . . 0.0 112.97 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -67.09 -16.02 64.07 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 171.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.5 p -127.96 139.4 52.6 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 127.298 2.239 . . . . 0.0 106.074 157.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.7 -15.57 63.71 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -167.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.29 -2.0 14.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.03 2.532 . . . . 0.0 114.608 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -40.12 118.48 0.9 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.843 2.057 . . . . 0.0 114.264 -174.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.92 131.86 33.65 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.399 1.48 . . . . 0.0 111.427 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.76 148.76 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -160.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -75.8 126.26 30.66 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 128.513 2.725 . . . . 0.0 109.975 166.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 25.9 mt -136.1 137.59 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.76 0.709 . . . . 0.0 111.271 173.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' GLU . . . . . 0.424 ' H ' HG22 ' A' ' 351' ' ' THR . 16.1 mt-10 -105.93 137.74 43.32 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.648 1.179 . . . . 0.0 111.542 159.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.5 150.73 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.311 1.444 . . . . 0.0 111.294 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -110.57 101.0 47.56 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.081 2.153 . . . . 0.0 109.078 175.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.21 162.84 31.03 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.776 2.318 . . . . 0.0 110.935 166.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.76 176.42 3.63 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.427 2.085 . . . . 0.0 111.663 162.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -70.97 147.43 48.69 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.894 -0.504 . . . . 0.0 111.117 165.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 95.35 -159.42 22.55 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.218 0.913 . . . . 0.0 113.492 -172.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.1 158.58 25.47 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.496 1.518 . . . . 0.0 114.9 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.9 m -167.57 150.3 5.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.838 1.655 . . . . 0.0 111.419 162.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -104.74 116.63 32.35 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.379 1.472 . . . . 0.0 108.15 155.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.9 mm -67.33 130.83 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 165.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.29 130.45 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.85 1.26 . . . . 0.0 108.828 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.8 t -117.54 100.02 9.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.393 1.877 . . . . 0.0 107.772 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 106.73 -178.48 22.32 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 123.096 1.387 . . . . 0.0 115.604 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' THR . . . . . 0.408 ' H ' ' HE1' ' A' ' 304' ' ' MET . 1.0 OUTLIER -135.5 169.76 17.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.098 2.559 . . . . 0.0 110.719 175.34 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 81.21 -166.9 48.67 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.925 0.774 . . . . 0.0 112.341 -171.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -65.21 -33.29 75.65 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.143 -1.21 . . . . 0.0 110.908 164.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 63.0 m -56.89 -1.59 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 131.041 3.736 . . . . 0.0 118.455 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -88.76 148.37 23.98 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.135 0.974 . . . . 0.0 111.684 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.0 mt -109.67 167.0 10.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.149 0.58 . . . . 0.0 110.837 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 9.9 t -147.06 159.27 43.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 172.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -149.82 125.99 10.68 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.55 1.54 . . . . 0.0 110.585 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.61 138.16 39.94 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 112.549 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -142.5 138.09 30.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.226 1.41 . . . . 0.0 111.457 164.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 10.1 t60 . . . . . 0 C--O 1.237 0.43 0 C-N-CA 124.82 1.248 . . . . 0.0 109.759 174.761 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.6 p90 . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.035 0.445 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.47 99.78 5.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.905 1.282 . . . . 0.0 108.723 169.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.91 162.34 22.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.029 1.332 . . . . 0.0 113.864 -177.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' CYS . . . . . 0.418 ' H ' ' HD3' ' A' ' 333' ' ' PRO . 3.3 m -92.94 149.47 21.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.424 0.689 . . . . 0.0 109.653 168.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 77.8 p -136.85 6.28 2.9 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -78.63 158.98 28.29 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.467 1.03 . . . . 0.0 111.457 165.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.35 92.15 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.51 2.324 . . . . 0.0 112.635 -167.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 15.3 mtm -76.26 166.96 22.7 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.905 1.282 . . . . 0.0 112.618 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.9 m -158.23 157.23 32.18 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.113 -0.992 . . . . 0.0 112.774 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.42 120.24 25.64 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.52 0.728 . . . . 0.0 110.363 166.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.91 -27.99 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.082 1.753 . . . . 0.0 110.67 165.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -142.63 125.87 16.5 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.532 1.933 . . . . 0.0 108.024 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -57.43 144.88 70.31 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.385 1.074 . . . . 0.0 111.513 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.95 129.33 33.68 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.827 2.351 . . . . 0.0 111.529 170.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 41.2 p -124.21 123.15 39.64 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.373 1.069 . . . . 0.0 110.289 171.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -63.65 136.34 57.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.983 1.313 . . . . 0.0 111.157 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.8 p -89.62 -14.95 33.84 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.326 1.05 . . . . 0.0 113.065 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.24 -12.13 1.31 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.408 1.004 . . . . 0.0 114.405 -164.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -84.57 14.46 4.57 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.903 1.681 . . . . 0.0 112.057 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.37 5.18 63.74 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.679 1.133 . . . . 0.0 114.14 -172.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 64.9 p -131.68 165.86 22.77 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.937 1.368 . . . . 0.0 113.819 -170.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.62 138.09 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 127.854 2.462 . . . . 0.0 107.675 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 6.7 p -119.62 132.16 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.309 0.959 . . . . 0.0 112.517 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -139.92 167.16 22.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.503 1.521 . . . . 0.0 113.454 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -124.0 129.87 51.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.437 1.495 . . . . 0.0 107.583 166.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.52 150.76 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.061 0.944 . . . . 0.0 112.378 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -132.51 142.41 49.19 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.49 1.516 . . . . 0.0 112.818 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.09 148.46 37.53 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 128.226 2.611 . . . . 0.0 108.216 167.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -100.13 -72.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.59 2.193 . . . . 0.0 115.745 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.79 165.37 27.18 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.556 1.525 . . . . 0.0 114.388 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 69.33 -8.19 3.04 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 126.497 1.999 . . . . 0.0 117.274 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -108.49 99.86 35.2 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 119.078 1.439 . . . . 0.0 113.199 -168.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.99 121.95 6.47 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.789 2.326 . . . . 0.0 108.746 152.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.1 p -165.59 154.17 11.58 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -173.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -83.33 110.77 18.4 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 156.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.257 1.3 pp -67.45 132.29 93.06 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 120.324 -0.55 . . . . 0.0 112.349 -155.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.418 ' HD3' ' H ' ' A' ' 300' ' ' CYS . 73.8 Cg_endo -72.42 91.47 0.77 Allowed 'Trans proline' 0 CA--C 1.54 0.784 1 C-N-CA 125.449 4.099 . . . . 0.0 113.734 -168.776 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.09 117.03 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.215 1.406 . . . . 0.0 109.365 166.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.48 162.56 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.206 1.803 . . . . 0.0 109.359 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.62 127.3 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -136.48 174.56 10.49 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -170.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -118.6 -6.68 10.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.028 2.131 . . . . 0.0 112.966 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 29.5 p30 -106.98 0.48 23.75 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.063 2.145 . . . . 0.0 113.61 -166.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 74.7 mt 57.17 5.22 0.24 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.795 2.438 . . . . 0.0 115.734 -170.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.9 t -127.74 -3.12 5.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.427 1.491 . . . . 0.0 114.461 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 52.39 45.72 27.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.919 2.088 . . . . 0.0 113.584 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -72.93 -38.76 66.7 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 163.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 19.1 mm -108.05 128.67 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.774 1.23 . . . . 0.0 109.717 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -97.17 109.31 22.09 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.62 0.724 . . . . 0.0 111.829 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -63.99 -62.98 1.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.752 3.221 . . . . 0.0 112.789 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -104.23 -171.5 25.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.499 1.523 . . . . 0.0 115.756 -160.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 3.3 mm -132.68 152.74 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.755 2.022 . . . . 0.0 111.302 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.9 129.01 34.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.414 1.485 . . . . 0.0 109.507 170.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.35 -36.86 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.266 0.626 . . . . 0.0 110.737 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.574 ' HB ' ' H ' ' A' ' 366' ' ' GLU . 1.2 m -105.4 162.06 13.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.013 1.325 . . . . 0.0 111.478 175.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.5 m -47.82 107.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 127.367 2.267 . . . . 0.0 114.215 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -73.89 117.66 63.0 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.306 1.042 . . . . 0.0 109.595 162.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -82.33 -175.73 2.63 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.334 3.356 . . . . 0.0 114.118 -171.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 117.79 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.308 2.243 . . . . 0.0 107.808 170.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.67 74.62 0.82 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.547 1.139 . . . . 0.0 112.552 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -69.53 -18.7 63.69 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 23.3 p -123.81 121.27 34.98 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 127.148 2.179 . . . . 0.0 105.936 162.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.43 -18.87 53.84 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -166.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -71.79 3.96 3.7 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.507 1.923 . . . . 0.0 113.791 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -39.59 126.48 1.88 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.593 2.357 . . . . 0.0 113.913 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -141.3 112.1 7.14 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.868 2.067 . . . . 0.0 109.058 -168.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.14 148.37 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -160.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -86.65 124.53 33.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.523 2.729 . . . . 0.0 109.221 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 55.9 mt -135.31 132.21 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.409 0.623 . . . . 0.0 111.2 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' GLU . . . . . 0.574 ' H ' ' HB ' ' A' ' 351' ' ' THR . 25.0 mp0 -97.36 138.63 34.52 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.648 1.579 . . . . 0.0 111.497 161.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 22.1 t -129.19 153.93 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 127.564 2.345 . . . . 0.0 109.152 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -118.96 114.99 35.01 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.808 2.043 . . . . 0.0 109.576 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -82.81 162.0 16.21 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.207 2.604 . . . . 0.0 110.685 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -74.41 178.46 7.0 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.541 2.16 . . . . 0.0 110.738 163.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -71.02 130.84 42.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.009 1.324 . . . . 0.0 109.733 171.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.55 -143.55 16.34 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.12 0.866 . . . . 0.0 112.884 -176.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.12 152.69 42.15 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.185 2.594 . . . . 0.0 114.477 -173.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 17.0 m -166.36 153.18 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 113.145 167.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -120.53 109.6 15.46 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 128.36 2.664 . . . . 0.0 106.846 165.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 16.3 mm -68.13 120.01 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 172.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 80.7 mt -114.18 126.9 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.488 1.115 . . . . 0.0 109.067 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.8 t -119.69 101.81 11.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.794 1.638 . . . . 0.0 107.176 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 123.07 172.28 13.83 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 123.074 1.374 . . . . 0.0 115.903 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.5 161.05 39.05 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.507 2.323 . . . . 0.0 109.057 173.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.47 -167.42 53.43 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 -163.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -62.36 -31.6 72.27 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.775 -0.838 . . . . 0.0 111.869 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.2 m -55.65 3.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 130.642 3.577 . . . . 0.0 117.875 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -97.1 142.86 28.52 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.401 1.08 . . . . 0.0 111.859 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 22.2 mt -114.93 166.4 11.83 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.77 0.828 . . . . 0.0 110.678 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.2 t -146.1 161.89 39.16 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -145.68 128.38 16.21 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.028 1.731 . . . . 0.0 109.353 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -78.92 138.28 38.02 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.733 1.213 . . . . 0.0 111.67 -175.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -143.12 140.3 30.78 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.704 1.202 . . . . 0.0 111.651 168.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.3 m80 . . . . . 0 CA--C 1.531 0.228 0 C-N-CA 123.765 0.826 . . . . 0.0 109.399 164.286 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.1 p90 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.42 101.37 6.36 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.788 1.235 . . . . 0.0 108.455 166.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.65 153.1 37.43 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.45 1.9 . . . . 0.0 115.003 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 12.8 m -94.08 141.4 28.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.205 1.002 . . . . 0.0 109.319 164.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 80.7 p -135.46 2.52 2.98 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.71 164.1 23.99 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.592 1.087 . . . . 0.0 111.012 166.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -62.01 105.59 0.6 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.286 1.834 . . . . 0.0 112.54 -161.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 30.2 mtm -94.79 163.57 13.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.685 0.755 . . . . 0.0 111.907 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 32.3 m -160.77 156.88 25.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.206 -0.934 . . . . 0.0 112.0 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.69 120.04 19.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.909 0.883 . . . . 0.0 110.665 167.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.86 -29.0 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.35 1.46 . . . . 0.0 109.966 163.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -140.89 133.65 28.89 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.598 1.959 . . . . 0.0 109.329 170.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -59.02 144.2 82.83 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.024 0.929 . . . . 0.0 111.87 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -58.37 138.83 87.95 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.224 1.949 . . . . 0.0 111.9 171.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 35.6 p -133.89 125.13 27.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.195 1.398 . . . . 0.0 111.336 174.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -61.85 122.39 15.29 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.462 1.505 . . . . 0.0 111.537 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 74.6 p -80.79 -13.84 58.61 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.001 1.321 . . . . 0.0 113.83 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.03 -1.44 4.81 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 120.972 -1.08 . . . . 0.0 114.293 -164.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -85.59 12.16 9.25 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.198 1.499 . . . . 0.0 111.263 176.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.26 0.81 88.5 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.003 1.287 . . . . 0.0 113.874 -165.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.2 p -119.15 162.26 18.95 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.136 1.468 . . . . 0.0 112.807 -172.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.3 t -133.85 117.05 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.616 1.566 . . . . 0.0 107.748 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.3 p -104.97 130.03 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.243 1.017 . . . . 0.0 112.825 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -139.07 166.82 23.5 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.787 2.035 . . . . 0.0 111.499 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -135.47 145.08 46.79 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.779 -0.576 . . . . 0.0 111.007 160.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.6 m -137.11 161.14 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.062 1.345 . . . . 0.0 110.833 -168.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -128.78 145.69 51.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.988 1.315 . . . . 0.0 112.258 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.1 t -113.06 147.84 38.15 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 128.523 2.729 . . . . 0.0 107.113 165.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -111.41 -64.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 CA-C-N 122.538 1.942 . . . . 0.0 115.122 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 160.46 38.29 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -172.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.79 -0.08 2.52 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 127.385 2.422 . . . . 0.0 118.653 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.64 93.39 36.92 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 119.994 1.897 . . . . 0.0 114.464 -161.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.6 115.43 3.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.431 2.754 . . . . 0.0 109.864 161.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.2 p -164.2 153.58 13.91 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -172.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.92 105.39 12.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.009 1.723 . . . . 0.0 107.041 159.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.29 0.9 OUTLIER -67.16 120.31 71.27 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.045 -155.051 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.89 111.04 2.08 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.573 3.515 . . . . 0.0 114.237 -167.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.31 114.71 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 126.041 1.736 . . . . 0.0 109.114 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.04 159.03 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 126.659 1.984 . . . . 0.0 109.03 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 6.2 t -140.64 120.54 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -145.32 171.45 14.57 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.707 1.14 . . . . 0.0 113.385 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -101.11 -3.03 29.97 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.413 0.685 . . . . 0.0 112.67 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -112.58 1.95 16.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.819 1.647 . . . . 0.0 114.265 -162.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.1 mt 63.0 -15.58 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.028 2.531 . . . . 0.0 115.645 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.3 t -107.87 -4.39 18.04 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 113.884 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 59.97 61.07 1.96 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.926 2.49 . . . . 0.0 113.126 -171.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -88.09 -39.89 14.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.412 0.685 . . . . 0.0 111.601 166.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 42.3 mm -111.15 105.03 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.587 1.555 . . . . 0.0 110.117 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -78.01 102.2 7.28 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.705 1.139 . . . . 0.0 112.699 172.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -63.82 -53.63 47.76 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.2 2.6 . . . . 0.0 113.0 171.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -116.5 156.76 15.44 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.791 1.476 . . . . 0.0 116.791 -158.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.75 150.69 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.809 2.044 . . . . 0.0 109.772 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.69 130.4 36.75 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.132 1.373 . . . . 0.0 109.597 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 29.8 m -120.53 -30.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.3 m -101.0 152.93 19.99 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 160.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.5 m -48.78 132.33 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.135 1.774 . . . . 0.0 114.812 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -110.19 119.34 47.35 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.191 1.796 . . . . 0.0 108.337 168.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.88 -179.02 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.876 3.051 . . . . 0.0 114.394 -166.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.67 110.39 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 127.911 2.485 . . . . 0.0 106.517 169.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.89 84.05 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.537 1.535 . . . . 0.0 111.957 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 25.4 t -75.35 -8.93 57.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 166.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 13.6 p -131.25 128.47 39.93 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.997 2.119 . . . . 0.0 107.245 164.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.28 -19.25 65.28 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -172.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -84.66 6.99 21.88 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.64 1.176 . . . . 0.0 113.43 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -47.58 133.64 13.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.485 1.514 . . . . 0.0 113.582 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -138.54 132.59 31.39 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.087 1.355 . . . . 0.0 110.542 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.93 146.98 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -158.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.39 124.98 35.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.615 2.766 . . . . 0.0 109.799 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 12.7 mt -135.71 150.03 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.35 1.46 . . . . 0.0 109.859 -170.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -123.51 146.56 47.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.806 0.842 . . . . 0.0 111.223 163.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.25 151.96 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 124.664 1.186 . . . . 0.0 111.381 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -121.75 100.9 43.26 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.021 2.128 . . . . 0.0 109.499 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.63 168.93 12.45 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 123.677 2.918 . . . . 0.0 110.936 160.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.85 179.91 4.86 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.728 2.285 . . . . 0.0 111.046 166.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -58.12 145.24 37.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.288 0.635 . . . . 0.0 110.742 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.15 -163.96 28.18 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 121.783 0.657 . . . . 0.0 114.062 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.41 157.38 34.25 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.655 1.982 . . . . 0.0 114.778 -164.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.2 m -173.94 164.09 4.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.039 2.135 . . . . 0.0 112.203 169.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -122.47 117.21 25.41 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.83 2.852 . . . . 0.0 108.127 164.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mm -68.68 136.46 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 167.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 67.9 mt -127.94 123.76 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.977 1.311 . . . . 0.0 108.694 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 53.3 t -110.62 109.6 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.885 1.674 . . . . 0.0 107.363 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 117.2 171.82 15.84 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 122.923 1.291 . . . . 0.0 115.746 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.79 166.09 25.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.314 2.246 . . . . 0.0 109.329 169.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 68.61 -165.26 47.77 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 -166.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -64.65 -26.37 68.36 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.794 0.837 . . . . 0.0 112.539 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.7 m -64.72 4.39 0.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 129.105 2.962 . . . . 0.0 117.026 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -93.77 140.93 29.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.044 0.838 . . . . 0.0 112.659 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 20.8 mt -113.45 164.62 13.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.742 1.217 . . . . 0.0 110.701 173.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.0 t -146.66 160.78 41.77 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -151.07 127.62 10.78 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.849 1.66 . . . . 0.0 110.341 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -76.46 134.35 39.57 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.766 1.226 . . . . 0.0 111.894 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -143.67 135.5 26.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.687 1.195 . . . . 0.0 111.274 171.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 174.415 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 p90 . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.05 101.17 2.67 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 164.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.99 154.93 41.31 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.182 1.793 . . . . 0.0 113.831 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 141.25 38.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 162.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 76.0 p -130.94 10.48 5.02 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.906 0.883 . . . . 0.0 113.234 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -79.38 161.36 26.23 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.895 0.77 . . . . 0.0 110.981 165.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -65.22 103.76 0.83 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.127 2.171 . . . . 0.0 112.358 -163.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 33.6 mtt -83.71 168.5 16.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.961 0.886 . . . . 0.0 113.035 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.3 m -157.34 160.18 38.24 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.436 -0.79 . . . . 0.0 111.721 156.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -82.67 120.12 25.16 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.272 0.629 . . . . 0.0 110.155 166.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 22.6 t -66.61 -30.76 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.184 1.394 . . . . 0.0 110.698 163.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -142.17 123.33 14.65 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.557 1.943 . . . . 0.0 107.651 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -57.8 154.54 26.54 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.241 0.616 . . . . 0.0 111.797 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -56.22 124.39 16.14 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.876 2.384 . . . . 0.0 111.909 165.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.8 p -129.81 128.75 42.96 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.419 1.088 . . . . 0.0 111.569 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -61.78 126.75 28.45 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.344 0.658 . . . . 0.0 110.412 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.2 p -79.09 -12.97 60.02 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.818 1.247 . . . . 0.0 113.128 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.04 -6.69 1.98 Allowed Glycine 0 CA--C 1.539 1.553 0 CA-C-N 119.186 0.903 . . . . 0.0 114.231 -164.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -87.84 2.05 52.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.599 1.559 . . . . 0.0 111.643 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.99 2.31 39.25 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.756 1.646 . . . . 0.0 114.022 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.9 p -128.97 166.32 19.4 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.017 1.327 . . . . 0.0 111.975 -168.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 6.8 t -131.24 111.77 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.64 1.576 . . . . 0.0 108.377 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.58 137.07 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.064 1.346 . . . . 0.0 112.993 -168.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -142.47 164.45 30.11 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.998 2.119 . . . . 0.0 112.772 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -118.31 132.12 56.3 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.816 1.246 . . . . 0.0 108.016 161.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.3 152.44 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.741 0.817 . . . . 0.0 111.095 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -135.07 148.23 49.81 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.013 1.325 . . . . 0.0 112.327 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.43 150.65 46.92 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 128.043 2.537 . . . . 0.0 108.173 169.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -105.66 -68.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.366 2.044 . . . . 0.0 114.466 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 167.79 20.11 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -171.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.75 -6.73 0.32 Allowed Glycine 0 CA--C 1.537 1.46 0 C-N-CA 127.596 2.522 . . . . 0.0 118.496 170.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.15 94.03 37.42 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 119.872 1.836 . . . . 0.0 114.754 -160.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.8 121.32 7.26 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.753 2.302 . . . . 0.0 109.956 157.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.0 p -163.34 157.43 20.09 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -175.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -90.84 98.71 11.94 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 160.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.255 1.0 OUTLIER -60.9 123.03 73.2 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.811 -154.024 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.97 116.84 4.86 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.206 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 88.1 t -125.52 112.02 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.234 1.814 . . . . 0.0 109.812 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 157.41 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.362 1.065 . . . . 0.0 110.339 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 39.0 t -137.54 112.02 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -135.98 167.0 22.03 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -167.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -101.13 -2.4 31.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.671 0.788 . . . . 0.0 112.387 174.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 27.2 p30 -114.48 2.83 14.74 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.578 1.951 . . . . 0.0 113.723 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 20.4 mt 62.78 5.13 1.64 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.544 2.338 . . . . 0.0 115.436 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.9 t -135.94 -10.52 2.04 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 61.29 58.76 2.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.84 2.456 . . . . 0.0 113.83 -171.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.44 -36.12 58.13 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.189 152.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 15.8 mm -120.1 111.19 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.126 1.77 . . . . 0.0 109.956 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -89.67 120.25 30.79 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.294 -0.879 . . . . 0.0 112.241 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -72.3 -63.24 1.19 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.937 2.495 . . . . 0.0 111.722 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -106.2 161.03 14.37 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 116.903 1.521 . . . . 0.0 116.903 -155.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -104.39 152.25 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 127.108 2.163 . . . . 0.0 110.553 -173.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.12 125.9 30.03 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.288 1.435 . . . . 0.0 109.568 169.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 66.6 t -94.4 -45.84 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.426 0.69 . . . . 0.0 111.219 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 366' ' ' GLU . 1.5 t -105.05 -179.15 3.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.413 0.685 . . . . 0.0 112.031 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 29.5 m -53.72 123.14 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.574 1.55 . . . . 0.0 113.168 -176.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -95.03 119.3 66.06 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.097 0.959 . . . . 0.0 108.84 165.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -80.36 179.61 6.0 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.984 3.123 . . . . 0.0 113.583 -167.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.89 114.74 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.834 2.054 . . . . 0.0 106.961 167.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.02 71.72 0.17 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.815 1.246 . . . . 0.0 111.547 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 26.4 t -69.15 -8.85 49.34 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.247 -0.908 . . . . 0.0 112.507 163.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 41.0 p -128.13 116.9 20.66 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 128.408 2.683 . . . . 0.0 106.501 166.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -53.34 -20.97 4.96 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -77.08 4.09 11.0 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.352 1.861 . . . . 0.0 113.604 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -41.45 127.8 3.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.503 1.921 . . . . 0.0 113.957 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.13 146.92 43.4 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.303 1.041 . . . . 0.0 111.356 171.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.7 p -156.83 145.81 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -163.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.14 121.3 23.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.366 2.267 . . . . 0.0 108.78 164.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.93 142.15 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.678 0.672 . . . . 0.0 111.076 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' GLU . . . . . 0.66 ' H ' HG22 ' A' ' 351' ' ' THR . 32.1 mt-10 -114.39 139.18 49.7 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.144 1.778 . . . . 0.0 110.491 166.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.16 163.7 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.61 1.164 . . . . 0.0 111.547 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -131.25 98.79 18.2 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.244 1.817 . . . . 0.0 109.518 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -75.33 161.93 37.04 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.052 2.501 . . . . 0.0 111.458 160.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.21 -176.48 2.7 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.631 2.887 . . . . 0.0 111.154 163.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -55.75 151.68 10.78 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.124 1.37 . . . . 0.0 112.734 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 79.45 -159.06 44.26 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 121.283 0.38 . . . . 0.0 113.668 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -62.23 156.08 22.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.503 1.521 . . . . 0.0 114.116 -167.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.4 m -168.58 161.5 11.54 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.112 1.765 . . . . 0.0 111.946 165.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -122.33 113.48 19.47 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.944 2.098 . . . . 0.0 108.052 166.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.4 mm -74.03 120.3 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 79.4 mt -116.4 127.63 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.243 1.417 . . . . 0.0 109.566 -174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 70.3 t -118.36 105.22 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 126.417 1.887 . . . . 0.0 108.12 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 111.5 175.83 20.13 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 122.485 1.047 . . . . 0.0 115.256 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 1.8 p -134.74 164.86 26.58 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.359 1.864 . . . . 0.0 110.548 169.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 82.64 -170.03 49.68 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 123.827 0.727 . . . . 0.0 112.594 -168.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -63.39 -29.96 71.17 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.995 -1.297 . . . . 0.0 111.317 165.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 27.3 m -55.66 1.35 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 131.478 3.911 . . . . 0.0 118.101 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -102.04 147.11 26.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.484 1.513 . . . . 0.0 111.573 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 40.9 mt -119.62 165.76 14.05 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.585 0.754 . . . . 0.0 111.036 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.1 t -148.32 158.97 44.42 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -141.55 137.81 32.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.838 1.655 . . . . 0.0 109.537 174.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -76.93 145.25 38.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.098 1.359 . . . . 0.0 111.927 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -140.34 159.38 42.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.831 1.252 . . . . 0.0 111.992 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 . . . . . 0 CA--C 1.533 0.311 0 C-N-CA 125.633 1.573 . . . . 0.0 107.553 173.978 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.9 p90 . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 120.828 0.347 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.87 92.74 1.63 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 169.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.54 152.15 46.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.344 2.258 . . . . 0.0 115.051 -175.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 22.4 m -91.73 145.21 24.76 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.083 0.953 . . . . 0.0 109.433 163.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 41.9 p -136.15 0.75 2.63 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -84.63 155.91 21.8 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.464 1.483 . . . . 0.0 111.307 168.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 100.48 0.05 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.552 1.941 . . . . 0.0 113.131 -163.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 31.7 mtm -86.97 168.75 13.06 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.579 1.152 . . . . 0.0 111.999 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 37.6 m -159.61 164.62 33.99 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.997 -1.064 . . . . 0.0 112.265 168.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.48 124.78 32.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.002 0.521 . . . . 0.0 110.362 163.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.8 t -70.52 -31.14 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.396 1.478 . . . . 0.0 110.269 163.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -135.92 124.47 23.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.904 2.082 . . . . 0.0 107.795 165.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -61.21 151.95 74.0 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.446 0.698 . . . . 0.0 112.572 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.39 134.13 55.98 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.529 2.82 . . . . 0.0 113.295 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.9 p -136.32 129.39 31.31 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.809 1.244 . . . . 0.0 111.929 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -53.71 123.1 11.33 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.333 1.453 . . . . 0.0 110.884 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 52.1 p -82.56 -10.72 58.86 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.964 0.905 . . . . 0.0 113.361 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 76.7 -6.93 36.36 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.889 1.233 . . . . 0.0 114.381 -168.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -102.7 18.94 20.16 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.042 1.421 . . . . 0.0 112.487 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.97 7.23 81.12 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.174 0.893 . . . . 0.0 113.41 -172.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 18.1 p -127.69 165.74 19.45 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.469 1.108 . . . . 0.0 112.295 -174.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.97 123.35 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 126.363 1.865 . . . . 0.0 107.701 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.3 135.06 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.304 1.041 . . . . 0.0 113.202 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -141.13 164.38 30.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.231 1.812 . . . . 0.0 112.998 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -121.74 126.05 48.0 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.191 1.396 . . . . 0.0 107.318 166.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.7 155.39 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.295 0.952 . . . . 0.0 112.204 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -140.32 147.75 40.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.351 1.46 . . . . 0.0 113.087 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 12.2 t -113.0 154.08 45.09 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 128.495 2.718 . . . . 0.0 108.486 167.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -108.32 -63.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.811 2.341 . . . . 0.0 115.187 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.27 170.53 15.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.358 1.063 . . . . 0.0 113.03 -173.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.53 -21.65 0.13 Allowed Glycine 0 CA--C 1.537 1.465 0 C-N-CA 127.676 2.56 . . . . 0.0 118.284 167.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.09 100.42 15.09 Favored Pre-proline 0 CA--C 1.552 1.043 0 CA-C-N 119.522 1.661 . . . . 0.0 113.936 -168.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.56 115.94 3.98 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.184 2.589 . . . . 0.0 109.198 158.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.7 p -162.79 154.69 18.26 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -170.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -78.46 112.24 15.31 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 155.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.283 1.1 pp -64.51 118.59 49.08 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.508 -163.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.25 113.67 1.77 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 124.039 3.16 . . . . 0.0 113.683 -172.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 69.2 t -121.88 111.41 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 125.428 1.491 . . . . 0.0 108.675 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.61 155.87 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.006 1.322 . . . . 0.0 110.108 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.5 t -140.31 111.89 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.62 -178.84 5.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.761 1.164 . . . . 0.0 113.287 -167.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -112.73 2.59 16.12 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.674 0.79 . . . . 0.0 112.988 176.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -126.49 8.7 7.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.366 1.466 . . . . 0.0 114.074 -157.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 50.7 mt 60.51 -14.81 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.123 2.569 . . . . 0.0 116.25 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.6 t -111.61 -9.88 14.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.133 1.333 . . . . 0.0 113.793 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 69.67 44.02 0.92 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.94 2.496 . . . . 0.0 113.148 -171.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.82 -46.96 82.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.464 0.306 . . . . 0.0 110.905 166.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 17.8 mm -118.3 99.5 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.588 1.155 . . . . 0.0 110.489 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -70.42 105.38 3.03 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 121.086 -1.009 . . . . 0.0 112.66 172.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -65.86 -56.88 9.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 129.586 3.155 . . . . 0.0 113.233 171.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -103.36 -178.65 26.15 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 -160.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mm -124.9 160.34 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.842 2.457 . . . . 0.0 111.23 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.32 130.74 35.17 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.797 1.239 . . . . 0.0 110.125 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 85.2 t -92.46 -19.66 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.34 0.656 . . . . 0.0 111.096 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 366' ' ' GLU . 6.1 t -137.76 174.43 10.58 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.366 1.067 . . . . 0.0 112.765 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.55 95.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 127.051 2.141 . . . . 0.0 113.687 -171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -57.83 119.1 31.03 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.512 1.125 . . . . 0.0 110.692 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -80.76 -176.62 3.26 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.337 3.358 . . . . 0.0 113.384 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.06 122.73 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.8 1.64 . . . . 0.0 107.883 171.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.01 64.28 0.33 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.799 1.64 . . . . 0.0 112.779 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 30.6 t -66.13 -10.81 44.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.591 1.156 . . . . 0.0 113.113 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 40.2 p -134.2 117.88 17.0 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.84 2.856 . . . . 0.0 106.475 163.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -61.4 -13.23 18.4 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -165.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -75.79 1.07 15.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.717 1.607 . . . . 0.0 114.012 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -35.56 119.7 0.54 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.455 2.302 . . . . 0.0 113.932 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.02 145.46 50.86 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.589 1.155 . . . . 0.0 112.183 170.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.32 147.16 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -160.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -78.73 123.42 27.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.766 2.426 . . . . 0.0 109.744 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 52.9 mt -132.81 137.34 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.485 0.66 . . . . 0.0 111.055 174.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' GLU . . . . . 0.487 ' H ' HG22 ' A' ' 351' ' ' THR . 26.9 mt-10 -105.26 140.96 37.61 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.949 1.3 . . . . 0.0 110.827 160.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 20.2 m -122.6 158.32 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.547 1.139 . . . . 0.0 111.298 168.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -118.02 101.53 51.64 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.52 1.928 . . . . 0.0 108.736 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.96 159.57 37.76 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.093 1.862 . . . . 0.0 110.304 163.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -57.7 171.35 1.5 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.702 2.268 . . . . 0.0 112.094 159.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -62.18 147.81 46.56 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.464 -0.772 . . . . 0.0 109.993 157.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.31 -171.29 23.14 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 122.57 1.095 . . . . 0.0 113.185 -169.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -72.7 163.36 28.21 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.313 -1.11 . . . . 0.0 113.802 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.9 m -164.62 170.36 15.81 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.187 1.395 . . . . 0.0 112.222 164.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -124.95 114.49 19.21 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 129.381 3.073 . . . . 0.0 106.43 163.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.1 mm -71.74 135.02 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 74.8 mt -129.42 128.03 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 125.238 1.415 . . . . 0.0 108.83 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 83.9 t -118.71 105.02 16.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 126.196 1.798 . . . . 0.0 107.6 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.23 175.42 21.99 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 123.052 1.362 . . . . 0.0 115.935 175.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.82 167.61 21.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.656 2.382 . . . . 0.0 110.113 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 85.31 -156.9 31.19 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 123.356 0.503 . . . . 0.0 111.909 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -67.59 -36.8 81.56 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.534 0.667 . . . . 0.0 110.805 161.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.3 m -51.54 11.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 1 C-N-CA 132.981 4.513 . . . . 0.0 119.546 -173.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -114.36 139.58 49.35 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.63 1.105 . . . . 0.0 112.176 -165.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 30.9 mt -111.57 161.55 16.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.431 0.692 . . . . 0.0 110.252 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.8 t -145.57 156.64 43.82 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.047 0.539 . . . . 0.0 112.36 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -142.27 121.7 13.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.211 1.405 . . . . 0.0 109.812 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -67.92 134.42 50.78 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.194 1.397 . . . . 0.0 111.341 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -136.87 161.1 36.94 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 123.097 1.427 . . . . 0.0 112.592 173.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 . . . . . 0 N--CA 1.451 -0.42 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.56 -172.822 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 27.6 p90 . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 120.826 0.346 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.04 101.57 13.59 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.055 1.342 . . . . 0.0 107.611 168.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.09 149.8 39.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.216 2.206 . . . . 0.0 114.89 -171.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 4.7 m -86.52 144.52 27.19 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 164.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 61.1 p -137.37 0.73 2.33 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -71.32 166.17 22.17 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.603 1.092 . . . . 0.0 110.089 165.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -69.43 109.51 4.25 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.194 0.998 . . . . 0.0 111.203 -165.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 34.5 mtm -94.82 166.59 11.9 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.544 1.138 . . . . 0.0 112.255 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 58.5 m -160.89 157.75 27.08 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.734 1.214 . . . . 0.0 110.168 165.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.73 125.44 29.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.153 160.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 45.6 t -71.12 -18.92 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 126.18 1.792 . . . . 0.0 110.807 166.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -147.57 112.67 5.49 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.601 2.361 . . . . 0.0 106.76 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -55.31 147.59 36.1 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 118.553 0.615 . . . . 0.0 110.04 171.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.81 145.13 99.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.175 1.25 . . . . 0.0 111.168 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 23.3 p -131.24 135.98 47.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.222 1.409 . . . . 0.0 110.791 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -58.31 121.46 10.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.828 1.251 . . . . 0.0 110.601 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 60.1 p -81.78 -13.82 57.22 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.51 -0.96 7.89 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-N 119.391 0.996 . . . . 0.0 114.052 -165.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -95.11 8.22 43.65 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.257 1.528 . . . . 0.0 111.771 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.85 10.71 58.57 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.642 1.115 . . . . 0.0 114.056 -171.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 16.2 p -136.25 169.86 16.96 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.476 1.138 . . . . 0.0 112.741 -169.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.69 127.31 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.994 2.118 . . . . 0.0 108.829 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 11.3 p -118.15 124.15 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -163.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -130.95 157.17 43.67 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.694 1.598 . . . . 0.0 114.291 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -106.36 137.89 43.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.34 1.456 . . . . 0.0 107.215 161.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.56 136.99 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.739 1.216 . . . . 0.0 110.704 -175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -122.64 144.2 49.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.052 0.941 . . . . 0.0 112.199 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.7 143.59 31.67 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.746 2.818 . . . . 0.0 106.613 170.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -109.85 -63.68 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 CA-C-N 121.881 1.707 . . . . 0.0 115.875 -174.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 169.16 18.05 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 120.613 1.552 . . . . 0.0 113.233 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 68.6 -6.0 3.86 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.447 1.975 . . . . 0.0 117.341 169.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.61 102.07 45.32 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 119.135 1.468 . . . . 0.0 113.306 -163.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.29 118.42 2.94 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.249 2.632 . . . . 0.0 110.051 154.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.7 p -163.17 146.98 10.88 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -172.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -72.98 117.51 14.8 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 154.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.297 0.8 OUTLIER -69.89 122.65 86.69 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.884 -160.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.459 ' HG2' ' HA2' ' A' ' 379' ' ' GLY . 71.5 Cg_endo -72.65 110.09 2.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 1 C-N-CA 125.781 4.32 . . . . 0.0 112.894 -166.823 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 98.6 t -122.66 124.79 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.534 1.534 . . . . 0.0 110.653 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.51 156.93 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.089 1.355 . . . . 0.0 110.817 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' VAL . . . . . 0.53 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 40.5 t -136.32 129.52 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -147.65 174.2 12.0 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.974 0.796 . . . . 0.0 112.145 -172.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -101.29 -1.01 34.65 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.513 0.725 . . . . 0.0 112.14 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -128.46 8.18 5.91 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -152.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 59.7 mt 62.51 -22.94 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.653 2.381 . . . . 0.0 115.95 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.1 t -106.99 -7.87 16.8 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.849 1.26 . . . . 0.0 113.873 -172.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 337' ' ' ALA 0.261 . . 71.72 32.76 1.9 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.331 2.653 . . . . 0.0 113.917 -177.706 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -59.1 -46.27 88.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.684 0.394 . . . . 0.0 110.767 169.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 16.0 mm -96.81 129.23 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.596 1.158 . . . . 0.0 109.095 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.65 64.17 0.8 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 123.042 1.401 . . . . 0.0 112.18 -174.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -66.2 -45.62 80.13 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 128.623 2.769 . . . . 0.0 116.544 -156.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' GLY . . . . . 0.53 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -107.33 -175.32 22.61 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.799 1.666 . . . . 0.0 115.282 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.35 145.67 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 125.165 1.386 . . . . 0.0 112.305 -174.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.49 118.34 12.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.791 1.636 . . . . 0.0 109.688 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.9 t -87.84 -52.23 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.902 0.774 . . . . 0.0 111.647 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.4 t -84.44 171.87 12.2 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.647 0.737 . . . . 0.0 111.642 170.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.28 120.28 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.201 1.0 . . . . 0.0 111.761 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -79.32 128.17 76.43 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.282 1.433 . . . . 0.0 110.499 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.47 ' HG3' HG11 ' A' ' 363' ' ' VAL . 2.4 Cg_endo -85.75 -168.14 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 124.906 3.737 . . . . 0.0 113.493 -168.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.12 123.51 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.782 1.633 . . . . 0.0 109.009 172.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.23 80.74 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.503 1.121 . . . . 0.0 110.756 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 47.6 t -69.2 -25.53 64.37 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.585 -0.697 . . . . 0.0 111.303 163.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 21.5 p -120.93 124.54 45.18 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.246 2.619 . . . . 0.0 107.425 169.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -59.19 -23.81 62.57 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -168.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.15 3.9 1.9 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.359 1.863 . . . . 0.0 114.337 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -45.91 135.0 7.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.567 1.547 . . . . 0.0 113.792 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -150.87 111.51 4.24 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.963 1.705 . . . . 0.0 108.61 -165.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' VAL . . . . . 0.47 HG11 ' HG3' ' A' ' 354' ' ' PRO . 9.9 p -138.98 153.43 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -165.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -80.38 123.72 28.26 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 128.117 2.567 . . . . 0.0 109.383 165.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.34 143.07 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.138 0.881 . . . . 0.0 111.922 169.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -108.98 142.16 40.05 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.187 1.795 . . . . 0.0 111.224 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.47 152.77 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.703 0.801 . . . . 0.0 111.326 170.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -109.0 116.82 54.98 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.398 1.879 . . . . 0.0 109.807 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -91.18 145.91 3.51 Favored 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 123.771 2.98 . . . . 0.0 111.096 166.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.14 171.57 1.65 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.231 2.621 . . . . 0.0 112.582 153.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -61.71 140.78 58.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.115 0.566 . . . . 0.0 110.724 170.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 95.97 -164.63 23.89 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-O 122.749 1.194 . . . . 0.0 115.803 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.89 155.05 11.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 129.095 2.958 . . . . 0.0 113.618 -169.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.8 m -173.95 162.56 3.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.234 1.414 . . . . 0.0 113.409 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -129.22 115.99 18.49 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 130.986 3.714 . . . . 0.0 107.909 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.3 mm -82.5 118.71 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 26.3 mt -108.83 126.07 65.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.413 1.085 . . . . 0.0 108.605 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.7 110.8 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.823 1.649 . . . . 0.0 106.942 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 333' ' ' PRO . . . 116.25 172.29 16.55 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 124.043 1.913 . . . . 0.0 116.343 174.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.69 162.76 36.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.736 2.414 . . . . 0.0 109.175 177.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.59 -167.37 52.29 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -162.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.36 -26.35 68.72 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.787 -0.831 . . . . 0.0 111.918 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 64.0 m -63.29 3.19 0.3 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 128.822 2.849 . . . . 0.0 116.329 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -87.43 123.68 32.62 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.149 0.886 . . . . 0.0 111.41 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.71 162.58 12.82 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 172.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.3 t -140.23 155.03 47.05 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.5 133.11 47.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.22 1.408 . . . . 0.0 109.218 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -75.3 133.06 41.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.629 1.571 . . . . 0.0 111.071 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -141.94 106.28 4.81 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.096 0.959 . . . . 0.0 112.559 175.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 C--N 1.33 -0.24 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.801 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.9 p90 . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 120.88 0.371 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.81 101.36 1.32 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 161.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.06 157.48 22.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.493 1.917 . . . . 0.0 114.171 -173.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 12.1 m -92.66 142.77 27.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.3 0.64 . . . . 0.0 109.958 170.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 80.4 p -136.71 5.98 2.92 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 174.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -83.61 164.81 19.49 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.92 1.236 . . . . 0.0 110.738 165.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -66.49 92.94 0.21 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.785 2.434 . . . . 0.0 112.173 -161.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' MET . . . . . 0.401 ' HE1' ' H ' ' A' ' 380' ' ' THR . 33.4 mtm -80.66 166.52 20.99 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.204 1.002 . . . . 0.0 112.381 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.5 m -158.87 157.76 32.11 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.287 -0.883 . . . . 0.0 112.531 167.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.03 120.03 24.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.418 0.687 . . . . 0.0 109.847 159.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.94 -25.03 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.638 1.175 . . . . 0.0 110.845 169.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -140.01 130.49 25.52 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.121 2.168 . . . . 0.0 108.034 168.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -60.86 144.89 89.56 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.624 1.169 . . . . 0.0 112.324 172.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.02 137.9 78.72 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.76 2.307 . . . . 0.0 112.145 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 37.2 p -132.32 126.74 34.02 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.259 1.424 . . . . 0.0 111.05 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -59.83 121.56 12.04 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.447 1.099 . . . . 0.0 110.569 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 65.3 p -80.19 -10.45 59.76 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.944 1.298 . . . . 0.0 113.123 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.13 -8.34 1.39 Allowed Glycine 0 CA--C 1.538 1.503 0 CA-C-N 119.186 0.903 . . . . 0.0 114.389 -166.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -82.71 2.59 32.96 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.251 1.525 . . . . 0.0 111.863 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.94 5.35 61.07 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.253 1.406 . . . . 0.0 113.413 -169.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 16.3 p -123.69 161.78 24.41 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.623 1.211 . . . . 0.0 112.039 -175.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 6.7 t -133.92 112.59 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.218 1.407 . . . . 0.0 107.863 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.0 p -108.87 130.88 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.383 1.073 . . . . 0.0 113.668 -160.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -140.84 163.27 33.38 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.936 2.094 . . . . 0.0 112.901 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -114.12 131.39 56.43 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.979 1.312 . . . . 0.0 107.585 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.04 153.72 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.413 1.006 . . . . 0.0 112.307 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -140.42 147.8 40.24 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.625 1.57 . . . . 0.0 113.071 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.46 147.7 38.61 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 128.14 2.576 . . . . 0.0 107.633 162.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -106.14 -56.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.057 0 CA-C-N 122.899 2.071 . . . . 0.0 115.816 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 172.35 12.94 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.944 -1.098 . . . . 0.0 112.293 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.99 0.58 7.42 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 117.354 1.702 . . . . 0.0 117.354 169.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.34 94.08 48.72 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 118.91 1.355 . . . . 0.0 113.065 -162.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.57 117.45 3.38 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.398 2.732 . . . . 0.0 108.984 156.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.9 p -166.54 155.31 10.7 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -174.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.31 111.2 15.32 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 154.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.16 116.17 23.05 Favored Pre-proline 0 CA--C 1.557 1.237 0 CA-C-O 119.056 -0.497 . . . . 0.0 111.651 -163.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -62.81 117.33 4.23 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.932 3.088 . . . . 0.0 113.912 -172.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.98 107.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.675 1.19 . . . . 0.0 110.131 173.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.43 157.82 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.437 1.495 . . . . 0.0 109.453 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 91.0 t -137.9 121.12 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -135.3 172.27 13.24 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -167.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -104.9 -0.42 27.07 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.712 1.205 . . . . 0.0 112.403 170.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -129.02 7.9 5.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.071 1.348 . . . . 0.0 114.575 -157.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.8 mt 67.46 -8.31 0.49 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.621 2.369 . . . . 0.0 115.644 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 7.8 t -129.14 -9.73 4.77 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 120.726 1.603 . . . . 0.0 115.235 -174.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 69.5 44.58 0.9 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.702 2.401 . . . . 0.0 113.114 -170.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.08 72.13 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.202 158.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 27.3 mt -125.2 109.65 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 127.611 2.365 . . . . 0.0 107.939 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -77.2 118.14 19.43 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.333 0.97 . . . . 0.0 110.382 162.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -77.68 -62.97 1.49 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.634 2.774 . . . . 0.0 111.498 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -112.19 171.14 13.93 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 117.086 1.594 . . . . 0.0 117.086 -162.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mm -109.91 156.33 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.95 2.1 . . . . 0.0 111.589 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.56 136.06 34.93 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.227 1.411 . . . . 0.0 109.696 170.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.7 t -110.48 -61.64 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.186 0.594 . . . . 0.0 110.374 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.8 m -79.98 153.3 28.99 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.756 0.822 . . . . 0.0 109.645 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.6 m -51.54 144.53 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.865 2.066 . . . . 0.0 115.471 -167.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -112.02 111.65 53.3 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.986 1.714 . . . . 0.0 108.845 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.16 -171.48 1.09 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.493 3.462 . . . . 0.0 113.866 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.71 117.15 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 127.575 2.35 . . . . 0.0 107.066 168.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.84 71.06 0.21 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.691 1.996 . . . . 0.0 112.559 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.0 t -67.79 -14.9 63.33 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.422 -0.799 . . . . 0.0 112.913 167.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 10.2 p -116.25 129.15 56.14 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 127.041 2.137 . . . . 0.0 106.959 161.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -66.83 -14.87 63.17 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -173.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.11 6.3 26.16 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.515 1.926 . . . . 0.0 113.407 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -42.95 124.43 3.14 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.427 1.891 . . . . 0.0 113.715 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.15 148.15 46.42 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.613 1.165 . . . . 0.0 111.529 172.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.55 152.52 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.658 0.742 . . . . 0.0 112.482 -164.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.0 123.24 31.89 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.796 2.439 . . . . 0.0 108.929 169.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 42.7 mt -130.99 149.75 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.863 0.865 . . . . 0.0 110.678 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -121.18 142.01 50.3 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.567 1.547 . . . . 0.0 110.569 167.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.36 153.92 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.387 0.675 . . . . 0.0 111.595 167.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -117.46 99.42 52.5 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 127.134 2.174 . . . . 0.0 108.536 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -80.86 161.8 21.15 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.675 2.25 . . . . 0.0 110.65 165.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.83 -174.42 1.51 Allowed 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.776 2.318 . . . . 0.0 110.604 158.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -61.28 160.71 10.13 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.446 -0.784 . . . . 0.0 111.859 164.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 97.58 -177.8 32.17 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.318 1.437 . . . . 0.0 113.445 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.26 163.06 16.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.46 1.504 . . . . 0.0 112.866 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.1 m -162.51 154.36 18.47 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.119 -0.988 . . . . 0.0 112.533 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -120.16 104.81 10.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.796 2.439 . . . . 0.0 106.966 166.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.2 mm -70.15 121.31 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 64.3 mt -118.28 125.28 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.943 1.297 . . . . 0.0 109.108 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.8 103.78 15.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.18 1.792 . . . . 0.0 107.815 -177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.87 177.71 23.75 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 123.308 1.505 . . . . 0.0 116.511 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' THR . . . . . 0.401 ' H ' ' HE1' ' A' ' 304' ' ' MET . 2.2 p -134.91 172.22 13.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.031 2.532 . . . . 0.0 110.722 175.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 81.64 -162.2 43.13 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 123.617 0.627 . . . . 0.0 111.642 -168.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -67.25 -38.04 84.49 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.717 -0.872 . . . . 0.0 110.764 162.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 47.2 m -53.81 8.12 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.54 1 C-N-CA 132.127 4.171 . . . . 0.0 119.016 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -99.88 146.91 26.1 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.108 1.363 . . . . 0.0 111.835 -172.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 19.7 mt -114.55 165.94 12.24 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.505 0.722 . . . . 0.0 110.918 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.6 t -146.82 158.17 43.85 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -139.2 132.04 29.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.943 1.697 . . . . 0.0 110.089 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -80.73 138.76 36.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.976 1.31 . . . . 0.0 112.193 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -132.51 159.79 38.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.702 1.601 . . . . 0.0 110.861 165.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 . . . . . 0 C--O 1.235 0.312 0 C-N-CA 125.168 1.387 . . . . 0.0 108.534 -177.099 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 42.8 p90 . . . . . 0 CA--C 1.541 0.604 0 CA-C-O 120.885 0.374 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.01 109.93 14.92 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -77.96 153.52 32.4 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.976 1.711 . . . . 0.0 114.745 -172.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -99.41 145.42 27.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.894 0.877 . . . . 0.0 108.974 162.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 53.0 p -135.0 10.5 3.58 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -75.96 160.8 29.5 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.086 0.857 . . . . 0.0 110.934 164.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -63.01 97.19 0.1 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.829 2.052 . . . . 0.0 111.506 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 5.9 mtm -76.66 164.79 25.56 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.001 0.92 . . . . 0.0 112.451 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 25.9 m -158.7 154.47 26.41 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.234 -0.916 . . . . 0.0 112.458 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 121.08 29.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.341 0.656 . . . . 0.0 110.106 170.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.8 t -70.12 -23.75 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.352 1.061 . . . . 0.0 110.488 164.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -144.86 119.41 9.72 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.716 2.006 . . . . 0.0 108.72 169.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -55.13 142.69 56.85 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.906 1.283 . . . . 0.0 111.315 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -51.59 134.88 47.59 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.865 2.377 . . . . 0.0 113.423 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.13 127.41 35.92 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.505 1.122 . . . . 0.0 111.693 173.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.24 124.93 21.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.053 0.541 . . . . 0.0 111.085 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 19.0 p -83.25 -8.32 59.47 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.268 1.027 . . . . 0.0 113.481 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 79.31 -14.62 15.15 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.481 1.038 . . . . 0.0 114.671 -169.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -87.14 5.84 35.86 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.479 1.64 . . . . 0.0 112.984 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.35 2.92 65.42 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.834 1.206 . . . . 0.0 113.743 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.8 p -115.69 165.73 12.72 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.322 1.449 . . . . 0.0 111.585 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.6 115.48 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.853 1.661 . . . . 0.0 108.87 -178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.8 p -102.78 130.95 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.567 1.547 . . . . 0.0 113.29 -167.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -137.76 164.2 29.47 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.536 1.934 . . . . 0.0 112.827 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -123.17 124.6 43.42 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.086 1.354 . . . . 0.0 107.718 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.14 138.22 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.071 0.948 . . . . 0.0 112.069 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -117.76 143.16 46.49 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.064 1.746 . . . . 0.0 111.501 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 10.2 t -111.79 149.95 41.56 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.354 1.862 . . . . 0.0 108.001 165.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 3.5 Cg_endo -105.97 -74.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 122.038 1.825 . . . . 0.0 114.906 -172.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.88 165.84 25.02 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 121.323 1.874 . . . . 0.0 114.642 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 71.9 -4.87 14.54 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.053 1.787 . . . . 0.0 116.279 172.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -112.63 98.62 44.98 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.979 1.311 . . . . 0.0 113.093 -168.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.43 117.89 5.14 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.388 2.059 . . . . 0.0 108.226 152.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 8.9 p -161.37 154.99 21.77 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -88.57 102.11 14.62 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.093 2.157 . . . . 0.0 106.39 158.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 333' ' ' PRO 0.255 3.7 pt -59.73 123.5 71.77 Favored Pre-proline 0 CA--C 1.554 1.12 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -156.162 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 9.7 Cg_exo -62.79 113.28 1.92 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.419 2.746 . . . . 0.0 112.933 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.91 110.14 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 109.801 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.85 163.37 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.971 1.708 . . . . 0.0 109.265 -172.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.22 113.67 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.55 171.4 12.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.222 0.534 . . . . 0.0 112.038 -170.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' ASP . . . . . 0.452 ' CG ' ' HZ3' ' A' ' 346' ' ' LYS . 33.7 m-20 -114.61 2.74 14.61 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.149 1.38 . . . . 0.0 111.599 173.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -109.97 -5.29 15.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.894 2.077 . . . . 0.0 114.027 -167.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.7 mt 58.72 -1.95 0.1 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.233 2.613 . . . . 0.0 116.049 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -112.63 -7.06 13.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.419 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 384' ' ' ARG . . . 45.11 77.13 0.08 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 130.279 3.432 . . . . 0.0 114.669 -166.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -92.99 -40.97 10.26 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.423 149.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 84.5 mt -74.57 150.06 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.872 1.669 . . . . 0.0 110.783 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -143.86 94.52 2.6 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.2 1.4 . . . . 0.0 111.521 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' A' ' 338' ' ' ASP . 30.7 ttpt -102.57 -31.04 10.6 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -166.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -116.41 159.42 13.92 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.657 1.122 . . . . 0.0 115.638 -168.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.81 145.23 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.633 1.973 . . . . 0.0 110.758 -169.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.61 120.01 22.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.776 1.63 . . . . 0.0 108.633 166.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.8 t -92.72 -41.25 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.149 0.58 . . . . 0.0 111.32 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 366' ' ' GLU . 3.0 t -98.01 176.41 5.77 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.695 0.759 . . . . 0.0 112.01 171.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 6.1 m -62.1 107.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.93 1.692 . . . . 0.0 113.493 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.77 121.06 79.88 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 118.14 -0.933 . . . . 0.0 109.29 160.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -82.69 -174.36 2.03 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 124.918 3.745 . . . . 0.0 113.717 -171.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 112.04 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 126.596 1.959 . . . . 0.0 108.168 169.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -72.22 77.83 0.98 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.668 1.187 . . . . 0.0 111.785 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 19.3 t -69.32 -19.94 63.88 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.351 -0.843 . . . . 0.0 113.149 171.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 17.7 p -118.82 118.21 30.95 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 127.134 2.173 . . . . 0.0 106.337 163.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -56.8 -24.22 49.06 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -165.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.67 0.98 7.45 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.712 2.005 . . . . 0.0 113.967 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -46.81 134.63 9.81 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.317 1.447 . . . . 0.0 113.385 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -137.97 133.01 33.16 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.587 1.155 . . . . 0.0 111.148 175.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.89 143.2 24.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.739 0.781 . . . . 0.0 112.954 -160.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.83 118.67 18.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.286 2.235 . . . . 0.0 109.469 166.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 32.5 mt -126.97 143.52 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.049 0.54 . . . . 0.0 110.458 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' GLU . . . . . 0.668 ' H ' HG22 ' A' ' 351' ' ' THR . 33.2 mt-10 -116.85 134.33 54.91 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.768 1.627 . . . . 0.0 110.06 167.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.4 159.63 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.594 1.158 . . . . 0.0 111.96 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -124.92 104.65 29.86 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.911 1.684 . . . . 0.0 109.944 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -86.47 163.08 9.59 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.786 2.991 . . . . 0.0 111.078 161.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.5 177.15 9.04 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.204 2.603 . . . . 0.0 112.467 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -63.52 116.95 6.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.861 1.264 . . . . 0.0 110.928 167.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 133.83 -145.74 17.76 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.921 1.248 . . . . 0.0 111.589 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -97.02 160.44 14.34 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.934 1.294 . . . . 0.0 113.3 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 21.9 m -169.17 152.38 5.02 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.801 1.64 . . . . 0.0 111.827 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -122.37 107.43 12.07 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 166.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.3 mm -73.71 120.66 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 72.0 mt -116.41 134.47 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.331 1.052 . . . . 0.0 110.996 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 67.4 t -120.93 107.15 19.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 126.04 1.736 . . . . 0.0 107.973 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.34 -175.6 19.07 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.85 159.34 42.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.195 1.798 . . . . 0.0 110.432 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.83 -173.22 53.71 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.296 0.474 . . . . 0.0 112.529 -168.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -55.93 -27.9 54.39 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.842 1.257 . . . . 0.0 112.291 171.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 24.6 m -59.43 -7.61 1.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.532 3.133 . . . . 0.0 116.608 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' ARG . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 342' ' ' ALA . 3.5 ptm180 -87.04 125.93 34.42 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.08 0.952 . . . . 0.0 112.23 -173.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 15.1 mt -95.67 164.63 12.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.665 0.386 . . . . 0.0 111.897 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.3 t -135.12 152.08 51.31 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.321 1.048 . . . . 0.0 113.154 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -141.06 142.33 34.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.562 1.145 . . . . 0.0 111.583 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.03 140.58 36.49 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -140.98 138.61 33.87 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.173 0.987 . . . . 0.0 112.308 163.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--N 1.33 -0.272 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -173.099 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.3 m -69.82 4.58 1.91 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.33 -12.49 42.64 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.567 1.147 . . . . 0.0 113.55 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 51.2 mt -131.33 158.82 39.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.611 1.565 . . . . 0.0 110.343 170.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 16.2 m -48.07 -60.9 2.27 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.91 2.084 . . . . 0.0 115.029 -158.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.63 74.18 7.61 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.577 0.626 . . . . 0.0 111.31 -171.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.76 91.5 1.3 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 169.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.49 2.87 51.85 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.855 1.217 . . . . 0.0 115.756 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 18.3 p -72.44 -69.91 0.37 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.998 2.119 . . . . 0.0 112.017 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.5 m -169.75 140.0 2.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.636 1.575 . . . . 0.0 111.14 171.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -160.67 146.79 15.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.842 1.257 . . . . 0.0 110.693 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 104.03 6.36 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.26 144.06 42.36 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.184 2.193 . . . . 0.0 115.053 -176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 39.8 m -90.48 131.92 35.96 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.755 0.822 . . . . 0.0 109.005 160.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 78.8 p -133.41 3.6 3.62 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.73 158.5 20.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.515 1.052 . . . . 0.0 110.356 163.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.14 102.33 0.49 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.846 2.058 . . . . 0.0 112.132 -161.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.5 mtm -82.91 161.84 21.74 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.609 0.763 . . . . 0.0 112.166 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 92.2 p -147.36 163.26 37.01 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -84.11 126.52 33.16 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 161.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.02 -24.31 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.059 0.544 . . . . 0.0 110.235 163.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -145.23 126.3 14.62 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.132 2.173 . . . . 0.0 107.822 170.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -57.45 149.73 48.08 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.299 1.04 . . . . 0.0 112.099 173.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -57.32 136.74 78.04 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.263 1.975 . . . . 0.0 111.242 170.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 38.1 p -132.1 127.13 35.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.502 1.121 . . . . 0.0 111.017 171.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -56.32 117.39 3.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.451 1.5 . . . . 0.0 110.887 174.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 79.7 p -79.12 -12.27 59.99 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.169 0.987 . . . . 0.0 113.274 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.61 -8.16 1.22 Allowed Glycine 0 CA--C 1.539 1.538 0 CA-C-N 119.299 0.954 . . . . 0.0 114.468 -165.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -83.85 4.2 30.32 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.213 1.506 . . . . 0.0 111.706 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 99.48 4.18 56.17 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.858 1.694 . . . . 0.0 113.782 -172.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.8 p -127.18 165.14 20.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.512 1.156 . . . . 0.0 112.114 -168.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.11 112.14 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.494 1.517 . . . . 0.0 107.834 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.1 127.14 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.229 1.012 . . . . 0.0 112.952 -167.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -135.07 167.84 20.23 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.86 1.664 . . . . 0.0 113.263 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -125.16 135.38 52.57 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.062 1.345 . . . . 0.0 107.76 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.59 157.66 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.704 0.801 . . . . 0.0 112.062 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -132.75 145.99 51.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.503 1.521 . . . . 0.0 112.089 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.04 147.98 38.98 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 127.356 2.262 . . . . 0.0 107.354 163.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -109.37 -51.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 0 CA-C-N 122.923 2.08 . . . . 0.0 115.918 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 168.21 25.14 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.917 -1.115 . . . . 0.0 112.348 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.54 -0.17 3.16 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.578 2.037 . . . . 0.0 117.531 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.98 96.46 50.18 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.869 1.335 . . . . 0.0 112.961 -162.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.38 114.99 3.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.297 2.665 . . . . 0.0 108.82 152.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 13.6 p -160.63 146.0 14.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.26 104.36 13.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.295 1.838 . . . . 0.0 107.042 164.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.289 0.6 OUTLIER -68.06 118.73 61.49 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 119.42 -0.324 . . . . 0.0 110.944 -153.089 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.01 106.65 2.19 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.771 2.314 . . . . 0.0 112.147 -171.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 91.7 t -106.15 116.73 50.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 126.349 1.86 . . . . 0.0 109.686 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.42 160.8 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.093 1.357 . . . . 0.0 110.046 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' VAL . . . . . 0.48 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 60.0 t -143.73 128.13 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -141.8 175.8 9.42 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.575 0.75 . . . . 0.0 112.576 -164.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ASP . . . . . 0.474 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 64.2 m-20 -115.38 5.52 14.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.795 1.238 . . . . 0.0 111.949 171.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -132.85 6.56 3.99 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.33 1.852 . . . . 0.0 114.241 -159.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 40.1 mt 63.89 -6.34 0.25 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.382 2.273 . . . . 0.0 115.869 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.9 t -125.19 -7.17 7.09 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.606 1.548 . . . . 0.0 114.721 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 337' ' ' ALA . . . 73.22 37.29 0.76 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.813 2.045 . . . . 0.0 113.028 -176.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.78 -48.17 80.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 162.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 45.3 mm -75.03 152.53 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.219 1.008 . . . . 0.0 109.038 160.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.73 66.72 1.5 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.391 1.567 . . . . 0.0 109.682 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' LYS . . . . . 0.474 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 43.7 tttt -70.6 -62.68 1.3 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.393 2.277 . . . . 0.0 111.986 -161.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.48 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -98.94 156.78 20.11 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.256 1.407 . . . . 0.0 115.757 -159.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.91 147.24 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.973 2.509 . . . . 0.0 109.51 -167.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.5 117.24 19.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.422 1.489 . . . . 0.0 108.877 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.2 t -79.62 -46.55 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.693 0.797 . . . . 0.0 110.622 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 366' ' ' GLU . 7.3 t -95.12 179.56 5.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.819 0.848 . . . . 0.0 110.745 169.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 26.3 m -57.08 139.47 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.027 0.931 . . . . 0.0 111.039 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -77.26 112.7 25.16 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.548 -0.72 . . . . 0.0 109.636 168.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.6 175.01 11.78 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.936 2.424 . . . . 0.0 113.298 -171.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.66 121.98 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 126.822 2.049 . . . . 0.0 107.716 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.16 98.09 0.97 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.441 1.096 . . . . 0.0 109.578 168.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.1 t -98.9 -15.59 19.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.873 1.269 . . . . 0.0 112.573 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.23 133.62 55.88 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.927 1.691 . . . . 0.0 106.582 156.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -65.65 -16.98 64.26 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.604 -1.31 . . . . 0.0 114.093 -169.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -88.52 3.75 49.16 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.957 1.703 . . . . 0.0 113.584 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -53.05 135.61 36.88 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.717 -1.24 . . . . 0.0 113.313 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.21 146.7 52.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.542 1.537 . . . . 0.0 110.952 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.9 p -159.35 146.54 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -157.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.95 128.09 34.63 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.051 2.54 . . . . 0.0 110.053 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 13.8 mt -136.1 142.33 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.258 0.552 . . . . 0.0 109.767 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLU . . . . . 0.477 ' H ' HG22 ' A' ' 351' ' ' THR . 22.7 mt-10 -114.54 140.67 48.57 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.692 1.197 . . . . 0.0 110.031 167.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.58 160.54 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.257 1.023 . . . . 0.0 111.448 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -132.38 104.28 13.54 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 126.146 1.778 . . . . 0.0 109.443 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.81 164.26 32.16 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.62 1.547 . . . . 0.0 109.985 159.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.5 -176.67 1.78 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.367 2.045 . . . . 0.0 110.347 160.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -57.23 149.27 20.32 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.526 -0.734 . . . . 0.0 111.096 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 89.4 -162.33 30.6 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 122.39 0.994 . . . . 0.0 115.292 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.33 158.64 33.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.663 1.985 . . . . 0.0 113.836 -167.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.5 m -169.28 161.0 9.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.38 1.472 . . . . 0.0 112.755 171.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -124.7 113.1 17.54 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.961 2.104 . . . . 0.0 106.879 161.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.6 mm -71.58 130.01 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.74 130.71 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.48 1.112 . . . . 0.0 109.375 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.2 104.08 14.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 125.474 1.509 . . . . 0.0 107.566 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 115.21 175.32 18.38 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 123.307 1.504 . . . . 0.0 116.383 170.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.34 161.13 34.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.267 2.227 . . . . 0.0 110.396 172.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.03 179.77 37.33 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.789 0.709 . . . . 0.0 112.751 -167.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.05 -25.72 46.08 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.216 -1.167 . . . . 0.0 112.321 172.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.3 m -58.41 -8.34 1.16 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 130.209 3.404 . . . . 0.0 117.337 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -85.79 149.89 24.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.323 0.965 . . . . 0.0 112.424 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 41.3 mt -119.22 166.87 12.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.969 0.908 . . . . 0.0 111.149 171.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 10.8 t -140.59 157.2 45.83 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 171.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -139.0 125.91 21.02 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.892 1.677 . . . . 0.0 109.522 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -70.64 131.49 44.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 111.897 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -144.22 126.69 15.9 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.825 0.85 . . . . 0.0 111.529 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -108.99 130.26 55.47 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -96.9 148.39 22.99 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 11.9 pm0 -43.7 125.71 4.23 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.381 1.872 . . . . 0.0 113.572 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 125.95 4.49 6.62 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 118.24 2.056 . . . . 0.0 118.24 160.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 90.0 p -120.96 -83.22 0.66 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.391 2.096 . . . . 0.0 112.299 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 81.1 p -91.98 -19.37 22.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.921 2.088 . . . . 0.0 113.205 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 17.8 tt -148.82 158.99 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.102 1.761 . . . . 0.0 110.138 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.02 -11.02 77.36 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.546 -1.141 . . . . 0.0 115.179 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 6.8 tptp . . . . . 0 C--O 1.25 1.107 0 C-N-CA 127.062 2.145 . . . . 0.0 109.758 176.375 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.2 p -115.63 -14.62 11.45 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -75.34 38.86 0.14 Allowed 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 73.7 mt -137.86 178.35 7.18 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.132 1.373 . . . . 0.0 111.686 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 14.7 m -40.67 -63.86 0.6 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 128.716 2.806 . . . . 0.0 115.436 -164.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.7 67.69 10.13 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.035 0.922 . . . . 0.0 111.072 -173.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.441 ' HA ' ' HE3' ' A' ' 293' ' ' LYS . 0.9 OUTLIER -149.16 99.6 2.96 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.728 0.811 . . . . 0.0 111.23 171.438 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 68.8 -21.94 0.33 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.772 1.653 . . . . 0.0 116.457 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.1 p -46.11 -63.08 1.07 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.91 2.484 . . . . 0.0 113.666 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 14.2 m -169.66 150.48 4.06 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.665 1.186 . . . . 0.0 112.54 167.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -162.6 154.0 17.86 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.094 1.758 . . . . 0.0 109.997 161.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.31 104.8 8.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 160.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.3 ptm -65.9 149.82 49.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.892 1.677 . . . . 0.0 115.157 -173.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.7 m -99.7 143.13 30.29 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.526 1.13 . . . . 0.0 110.125 165.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.9 p -138.81 21.69 2.67 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -96.48 163.57 12.99 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.298 0.954 . . . . 0.0 110.606 165.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -66.3 105.03 1.32 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.231 2.212 . . . . 0.0 112.453 -159.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.6 mmt -70.61 160.27 32.86 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.001 0.92 . . . . 0.0 112.818 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 29.0 m -156.53 148.75 23.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.208 -0.932 . . . . 0.0 111.991 162.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.28 125.99 33.99 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 168.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.7 -27.62 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.629 0.772 . . . . 0.0 110.144 164.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -139.25 120.36 14.64 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.011 2.124 . . . . 0.0 107.706 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -56.74 154.3 18.6 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.933 0.893 . . . . 0.0 111.609 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -57.56 125.52 19.04 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.317 2.011 . . . . 0.0 111.115 166.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 8.0 p -130.16 129.16 43.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.038 0.935 . . . . 0.0 112.759 169.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -56.42 122.65 12.39 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.327 1.851 . . . . 0.0 111.562 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 82.2 p -78.07 -12.08 59.96 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.774 1.23 . . . . 0.0 113.191 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.66 -11.43 3.3 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.474 1.035 . . . . 0.0 113.796 -167.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -87.37 2.49 50.19 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.436 1.494 . . . . 0.0 112.239 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 101.52 9.72 43.15 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.241 1.401 . . . . 0.0 113.848 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.0 p -131.03 166.45 20.99 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.908 1.283 . . . . 0.0 112.12 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.64 120.38 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.75 2.02 . . . . 0.0 107.626 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.2 p -106.01 137.17 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.452 1.101 . . . . 0.0 112.655 -171.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -143.84 164.75 29.64 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.555 1.942 . . . . 0.0 113.45 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -123.87 127.0 47.39 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.136 1.774 . . . . 0.0 107.849 164.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.95 147.6 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.654 0.782 . . . . 0.0 111.695 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -124.62 144.11 50.35 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.539 1.935 . . . . 0.0 110.429 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 7.6 p -118.13 150.78 48.14 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.414 1.886 . . . . 0.0 107.943 163.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 72.2 Cg_endo -110.03 -50.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 0 CA-C-N 122.203 1.822 . . . . 0.0 116.7 -165.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.89 169.21 19.61 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.049 1.295 . . . . 0.0 113.327 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.04 -15.62 0.08 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 128.182 2.801 . . . . 0.0 118.648 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -104.29 108.03 59.18 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 119.711 1.755 . . . . 0.0 113.822 -166.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.99 121.51 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.845 3.03 . . . . 0.0 109.904 155.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 8.1 p -162.77 149.42 12.85 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.36 108.45 16.56 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 161.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.296 0.5 OUTLIER -67.01 119.84 67.33 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.505 -153.592 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.53 114.32 3.68 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.141 2.561 . . . . 0.0 111.295 -171.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 349' ' ' LEU . 52.4 t -116.18 114.48 46.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.365 1.466 . . . . 0.0 109.542 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.83 159.4 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.926 1.691 . . . . 0.0 108.835 -175.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.1 t -146.05 122.56 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.22 166.69 32.69 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -168.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -90.59 -5.33 56.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -114.87 6.15 15.35 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.618 1.567 . . . . 0.0 114.252 -160.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 25.4 mt 64.94 -7.96 0.25 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.25 2.22 . . . . 0.0 115.175 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.2 t -122.71 -12.07 8.13 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.191 1.359 . . . . 0.0 114.343 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 82.37 35.48 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.498 2.719 . . . . 0.0 113.261 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.68 67.32 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.093 0.557 . . . . 0.0 111.389 170.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.84 159.47 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.746 1.218 . . . . 0.0 108.227 162.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.12 123.46 16.96 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.328 -1.482 . . . . 0.0 110.903 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -128.2 -17.59 4.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -159.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -145.69 151.28 23.51 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -166.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.3 147.2 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.538 1.535 . . . . 0.0 111.921 -163.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 334' ' ' VAL . 2.7 mm? -67.84 112.39 4.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.816 2.047 . . . . 0.0 109.399 171.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.49 -33.75 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.021 0.528 . . . . 0.0 110.938 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.1 t -96.61 179.27 5.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.035 0.934 . . . . 0.0 111.172 167.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.48 125.72 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.062 1.345 . . . . 0.0 110.662 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -66.69 113.37 12.69 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 118.427 0.558 . . . . 0.0 110.757 171.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.8 179.63 6.11 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.142 2.561 . . . . 0.0 113.781 -171.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.09 130.28 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 127.023 2.129 . . . . 0.0 108.038 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -78.45 96.76 5.46 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.852 1.261 . . . . 0.0 109.206 166.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -97.21 -18.64 19.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.55 1.14 . . . . 0.0 112.481 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.89 135.95 51.83 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 155.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -66.67 -14.24 62.23 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.774 -1.204 . . . . 0.0 113.913 -171.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -89.01 0.42 56.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.683 1.993 . . . . 0.0 113.499 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -53.89 138.27 36.8 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.612 1.196 . . . . 0.0 113.079 -172.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.42 142.05 49.11 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.921 1.288 . . . . 0.0 111.053 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.4 p -154.93 145.48 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -158.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.26 126.29 30.72 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.101 2.96 . . . . 0.0 110.563 173.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.61 137.14 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.248 0.619 . . . . 0.0 110.757 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -107.17 140.29 40.27 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.849 1.26 . . . . 0.0 111.019 161.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.23 158.34 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.249 1.02 . . . . 0.0 112.702 171.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -111.27 114.32 53.41 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.362 1.865 . . . . 0.0 110.526 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -76.82 174.02 13.53 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 124.063 3.175 . . . . 0.0 111.182 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.54 -174.4 2.25 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.4 2.067 . . . . 0.0 110.463 159.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -67.5 146.01 54.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 154.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 84.8 -159.85 34.93 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 122.043 0.802 . . . . 0.0 114.752 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.48 157.39 30.47 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.911 2.084 . . . . 0.0 113.994 -166.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.0 m -170.57 171.91 6.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.431 1.892 . . . . 0.0 112.051 170.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.34 125.83 46.78 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 126.801 2.04 . . . . 0.0 108.314 158.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.2 mm -77.65 119.78 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.5 mt -111.24 128.37 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.317 1.447 . . . . 0.0 109.819 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 66.6 t -116.19 107.47 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.466 1.907 . . . . 0.0 108.189 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.25 177.78 24.25 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 122.449 1.027 . . . . 0.0 114.94 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.48 169.82 16.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.213 1.805 . . . . 0.0 111.382 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 83.86 -157.39 33.93 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.922 0.772 . . . . 0.0 112.345 -172.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -72.9 -33.08 65.79 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.555 -0.968 . . . . 0.0 110.975 163.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 28.6 m -59.87 -6.96 1.44 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 130.005 3.322 . . . . 0.0 117.741 -173.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -80.25 153.73 28.33 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.876 1.27 . . . . 0.0 111.467 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 46.0 mt -121.48 165.24 15.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.382 0.673 . . . . 0.0 110.464 170.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.1 t -150.42 160.54 43.68 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -140.82 124.93 17.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.036 1.734 . . . . 0.0 110.077 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -67.77 133.44 49.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.035 1.334 . . . . 0.0 111.711 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -133.11 152.5 51.95 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.165 0.986 . . . . 0.0 111.545 170.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -134.58 136.81 43.24 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 173.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -117.54 130.85 56.67 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 124.217 1.007 . . . . 0.0 109.135 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -22.91 105.05 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 129.814 3.245 . . . . 0.0 115.247 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 133.43 17.69 1.08 Allowed Glycine 0 CA--C 1.534 1.247 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 167.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 94.0 p -133.22 -101.98 0.26 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.803 2.302 . . . . 0.0 112.775 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 92.0 p -70.49 -19.29 62.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.535 1.934 . . . . 0.0 112.77 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 16.3 tt -147.49 160.71 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 126.533 1.933 . . . . 0.0 110.063 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.86 -11.97 64.68 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.335 -1.258 . . . . 0.0 115.081 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 6.8 tptp . . . . . 0 C--O 1.249 1.062 0 C-N-CA 127.301 2.24 . . . . 0.0 109.501 176.251 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 8.4 mmt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 26.1 p -101.0 -13.36 18.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.528 1.531 . . . . 0.0 114.274 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.21 -7.04 20.81 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.21 129.2 38.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.019 1.328 . . . . 0.0 109.275 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 21.6 p -43.04 -56.54 3.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.926 1.69 . . . . 0.0 113.162 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 31.3 tp -55.74 -16.58 4.51 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.446 ' HE2' HD21 ' A' ' 345' ' ' ASN . 25.8 mmmt -104.13 70.21 0.97 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.672 1.589 . . . . 0.0 111.209 -171.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 78.82 -25.68 2.5 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.06 1.79 . . . . 0.0 114.804 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 10.0 m -76.13 -42.13 47.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -168.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.8 m -171.94 120.06 0.44 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.178 1.391 . . . . 0.0 113.384 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -153.71 155.35 35.8 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.322 1.849 . . . . 0.0 109.073 167.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.49 100.01 1.04 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 160.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.02 136.53 56.3 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.517 1.927 . . . . 0.0 113.888 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 22.1 m -87.53 135.41 33.36 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 153.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 68.3 p -138.12 -0.89 2.0 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 174.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.64 166.63 20.32 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 120.101 1.319 . . . . 0.0 110.498 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -67.08 101.03 0.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.713 1.605 . . . . 0.0 112.438 -165.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 37.9 mtm -90.51 165.07 13.99 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.778 1.231 . . . . 0.0 111.837 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.0 m -161.28 161.01 30.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.148 -0.97 . . . . 0.0 112.491 167.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.7 125.54 29.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.982 0.513 . . . . 0.0 109.952 161.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 81.2 t -76.9 -25.56 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.436 1.494 . . . . 0.0 110.677 165.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -137.61 131.24 31.29 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.191 1.796 . . . . 0.0 107.925 164.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -59.9 151.39 64.67 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.097 0.559 . . . . 0.0 111.858 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -55.74 130.21 39.17 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.383 2.056 . . . . 0.0 111.498 166.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 16.5 p -120.5 125.0 46.76 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.506 1.522 . . . . 0.0 110.629 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -55.75 118.07 4.22 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.567 1.147 . . . . 0.0 110.067 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.3 p -79.53 -16.38 56.08 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 60.31 -0.39 0.94 Allowed Glycine 0 CA--C 1.539 1.581 0 CA-C-N 119.467 1.03 . . . . 0.0 115.057 -161.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -86.46 18.15 3.43 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.284 1.542 . . . . 0.0 110.652 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.34 -2.84 87.94 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.771 1.177 . . . . 0.0 114.1 -168.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 25.0 p -122.47 175.37 6.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.043 1.421 . . . . 0.0 113.608 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.7 125.11 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 127.043 2.137 . . . . 0.0 107.938 172.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.84 131.72 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.903 1.281 . . . . 0.0 113.531 -169.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -140.73 169.37 17.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.7 2.0 . . . . 0.0 113.526 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.27 135.73 52.81 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.361 1.064 . . . . 0.0 108.411 164.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.95 152.77 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.247 1.019 . . . . 0.0 112.412 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -137.53 150.94 47.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.685 1.194 . . . . 0.0 113.008 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.2 t -119.66 141.13 30.5 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 128.243 2.617 . . . . 0.0 107.947 169.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -97.4 -67.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.88 2.387 . . . . 0.0 115.313 -174.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 174.87 10.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.88 1.272 . . . . 0.0 112.881 -173.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.9 -12.43 0.81 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.504 2.002 . . . . 0.0 117.712 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -123.58 96.62 43.23 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 119.525 1.663 . . . . 0.0 113.797 -160.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.81 120.5 6.43 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.84 1.693 . . . . 0.0 109.084 155.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.7 p -162.62 150.62 14.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -171.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -83.8 97.36 9.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.535 1.534 . . . . 0.0 107.265 162.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.252 1.2 pp -58.1 112.11 4.42 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.578 0.751 . . . . 0.0 111.87 -159.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.29 117.1 4.95 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.706 2.271 . . . . 0.0 112.991 -170.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 88.0 t -120.4 120.59 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 126.2 1.8 . . . . 0.0 108.765 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.26 160.01 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.035 1.734 . . . . 0.0 109.454 -175.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 3.9 t -138.53 113.62 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.82 -176.83 4.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.697 0.799 . . . . 0.0 112.163 -168.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -115.74 6.59 14.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.325 1.05 . . . . 0.0 112.194 171.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -131.87 1.48 3.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -152.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 16.1 mt 64.48 0.11 1.02 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.304 2.242 . . . . 0.0 115.198 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.5 t -135.84 -6.16 2.16 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -170.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 57.54 48.29 14.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.552 1.941 . . . . 0.0 113.645 -174.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.78 66.28 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.102 0.561 . . . . 0.0 110.012 159.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 8.9 mm -101.99 147.15 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 126.054 1.741 . . . . 0.0 108.479 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.446 HD21 ' HE2' ' A' ' 293' ' ' LYS . 11.3 t30 -126.05 108.35 11.29 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.431 -0.793 . . . . 0.0 111.847 163.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -66.4 -69.83 0.28 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 128.352 2.661 . . . . 0.0 111.425 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -100.33 169.32 21.51 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 -160.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.2 mp -115.82 154.99 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 128.0 2.52 . . . . 0.0 110.193 -169.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.47 134.94 40.71 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.115 0.966 . . . . 0.0 109.931 168.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.88 -47.08 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.382 0.673 . . . . 0.0 110.944 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 366' ' ' GLU . 3.6 t -92.42 172.57 8.3 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.652 0.739 . . . . 0.0 111.647 168.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.2 m -66.64 126.36 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.118 1.367 . . . . 0.0 112.667 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.04 126.59 64.93 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.978 1.311 . . . . 0.0 110.099 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -80.98 -172.54 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.027 3.152 . . . . 0.0 112.926 -173.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.08 119.22 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 127.112 2.165 . . . . 0.0 107.451 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.78 90.16 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.377 1.071 . . . . 0.0 110.685 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 10.7 t -73.92 -37.94 64.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.733 -0.604 . . . . 0.0 110.247 159.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 39.7 p -102.37 123.46 46.2 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.389 1.875 . . . . 0.0 109.192 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -54.73 -19.8 7.03 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.9 5.98 8.6 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.605 1.562 . . . . 0.0 113.708 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -43.67 134.28 4.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.529 1.932 . . . . 0.0 114.203 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -150.88 129.62 12.36 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.846 1.658 . . . . 0.0 110.067 -167.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.3 p -154.16 145.77 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -166.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -78.68 123.03 26.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.484 2.714 . . . . 0.0 109.473 165.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 40.6 mt -129.16 144.21 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 118.464 0.574 . . . . 0.0 111.519 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 351' ' ' THR . 21.6 mt-10 -118.9 140.38 50.08 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.649 1.58 . . . . 0.0 110.947 164.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.2 160.46 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.074 1.35 . . . . 0.0 111.515 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -130.95 98.58 18.98 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.697 1.999 . . . . 0.0 109.788 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.17 166.65 16.32 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.33 2.687 . . . . 0.0 111.375 162.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.77 175.07 7.71 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.885 2.39 . . . . 0.0 110.857 163.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.82 154.35 30.18 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.842 -0.536 . . . . 0.0 111.04 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 91.03 -163.25 29.15 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 121.404 0.447 . . . . 0.0 113.24 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -66.03 157.12 31.79 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -168.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 20.5 m -168.03 164.62 13.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.061 1.744 . . . . 0.0 112.086 168.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -128.25 111.45 13.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.887 2.875 . . . . 0.0 107.543 166.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 1.8 mm -74.37 124.38 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 79.9 mt -113.58 129.83 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.835 1.254 . . . . 0.0 108.91 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.65 109.38 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 125.282 1.433 . . . . 0.0 107.863 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 107.52 177.89 22.48 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 123.363 1.535 . . . . 0.0 115.747 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.4 163.93 28.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 127.669 2.387 . . . . 0.0 110.78 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.54 -179.97 36.05 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.199 0.428 . . . . 0.0 112.241 -166.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -56.81 -27.38 59.87 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.279 1.031 . . . . 0.0 112.375 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 46.6 m -58.95 -7.61 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.567 3.147 . . . . 0.0 116.651 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -81.15 149.07 29.28 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.503 1.121 . . . . 0.0 112.299 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 27.6 mt -118.69 165.22 14.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.957 0.903 . . . . 0.0 111.315 171.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.6 t -148.49 162.12 40.26 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -144.24 127.75 16.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.872 2.069 . . . . 0.0 110.14 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -75.21 135.83 41.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.817 1.647 . . . . 0.0 112.548 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -134.38 157.2 47.02 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.631 1.173 . . . . 0.0 111.763 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -129.65 107.45 9.45 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.844 1.657 . . . . 0.0 106.922 173.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -93.12 126.11 38.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.092 1.357 . . . . 0.0 112.709 -160.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 50.71 102.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 129.328 3.051 . . . . 0.0 114.845 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -61.81 70.3 0.02 OUTLIER Glycine 0 CA--C 1.533 1.161 0 C-N-CA 128.324 2.869 . . . . 0.0 115.321 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 27.1 t -54.92 8.74 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 130.269 3.428 . . . . 0.0 116.902 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 33.5 t -128.5 1.17 5.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.234 1.814 . . . . 0.0 113.646 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 11.2 tt -144.48 -17.48 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 143.82 -48.27 0.75 Allowed Glycine 0 CA--C 1.53 0.992 0 CA-C-N 119.414 1.007 . . . . 0.0 113.754 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.003 0 C-N-CA 127.007 2.123 . . . . 0.0 108.504 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 33.9 m -93.36 10.3 32.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.967 1.307 . . . . 0.0 113.125 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -103.29 6.5 38.08 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.434 1.494 . . . . 0.0 114.803 -166.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 91.1 mt -120.61 159.23 25.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.139 0.976 . . . . 0.0 111.068 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 29.4 p -42.69 -73.44 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.778 2.431 . . . . 0.0 113.152 -168.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 19.8 tp -65.66 3.8 0.69 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 128.563 2.745 . . . . 0.0 113.887 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.53 71.64 1.3 Allowed 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.073 -1.642 . . . . 0.0 109.824 -171.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.79 -23.38 1.32 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.478 1.514 . . . . 0.0 115.661 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 46.7 m -67.62 -61.81 1.71 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.388 1.594 . . . . 0.0 112.502 -173.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 9.5 m -174.73 134.53 0.37 Allowed 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.573 1.079 . . . . 0.0 112.844 174.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -162.08 153.52 18.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.76 2.024 . . . . 0.0 109.591 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -73.28 101.68 3.47 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 164.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -82.11 165.91 20.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.54 1.536 . . . . 0.0 113.679 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.7 m -101.6 152.49 20.75 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.523 1.529 . . . . 0.0 109.86 167.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.7 p -142.67 6.44 1.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.47 160.92 31.87 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.096 1.316 . . . . 0.0 110.966 165.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.06 97.01 0.05 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.212 1.405 . . . . 0.0 112.39 -171.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 34.2 mtm -84.99 169.0 14.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.021 1.328 . . . . 0.0 111.708 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.1 m -159.78 158.37 31.04 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.176 -0.953 . . . . 0.0 112.515 170.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.12 123.56 28.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.554 0.742 . . . . 0.0 110.111 161.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.68 -25.03 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.514 1.126 . . . . 0.0 110.574 165.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -141.88 137.75 31.6 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.685 1.994 . . . . 0.0 109.16 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -62.9 143.99 97.07 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.994 1.317 . . . . 0.0 112.989 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -54.64 124.8 17.08 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.52 2.813 . . . . 0.0 112.542 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 10.2 p -123.53 130.07 52.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.132 1.373 . . . . 0.0 111.802 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -57.83 123.27 15.19 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.846 0.858 . . . . 0.0 111.005 171.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 26.8 p -80.64 -11.72 59.6 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.841 1.256 . . . . 0.0 113.085 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 84.0 -11.16 58.34 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.863 1.221 . . . . 0.0 114.341 -169.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -92.59 10.13 31.75 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.176 1.488 . . . . 0.0 112.509 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.47 13.19 71.1 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.848 0.737 . . . . 0.0 113.216 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 11.6 p -124.63 153.76 41.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.964 1.306 . . . . 0.0 110.959 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 26.0 t -128.48 118.16 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.869 1.668 . . . . 0.0 107.94 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.04 133.8 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.069 1.348 . . . . 0.0 113.299 -163.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 7.0 ptp -137.53 165.51 26.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.84 2.056 . . . . 0.0 112.023 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -115.69 133.96 55.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 163.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 6.8 m -136.41 149.01 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.543 1.137 . . . . 0.0 112.213 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -132.92 149.52 52.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.939 1.696 . . . . 0.0 112.621 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 8.2 t -119.1 151.93 51.33 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 127.644 2.378 . . . . 0.0 108.796 169.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 1.1 Cg_endo -103.05 -76.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 123.255 2.637 . . . . 0.0 115.127 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.65 165.12 27.75 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 121.221 1.828 . . . . 0.0 114.465 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 70.89 15.59 74.04 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.255 0.931 . . . . 0.0 114.946 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.57 87.1 56.89 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 112.44 -164.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -79.74 114.31 3.18 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.028 2.485 . . . . 0.0 108.974 159.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.4 p -163.02 155.23 18.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -171.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -79.12 109.02 13.05 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 154.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.271 1.1 pp -64.34 122.96 81.06 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.993 -162.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.423 ' HG2' ' HA2' ' A' ' 379' ' ' GLY . 73.8 Cg_endo -73.63 106.16 2.14 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.449 3.433 . . . . 0.0 113.334 -163.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 72.2 t -116.16 118.04 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.36 1.864 . . . . 0.0 109.844 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.47 158.65 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.934 1.294 . . . . 0.0 110.837 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 37.0 t -135.14 123.55 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.76 170.25 16.24 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -105.09 3.83 30.82 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.989 1.316 . . . . 0.0 112.039 169.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -129.4 10.75 5.76 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.732 1.613 . . . . 0.0 114.761 -161.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 46.9 mt 63.48 -10.83 0.11 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.692 2.397 . . . . 0.0 116.344 -175.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.5 t -127.93 -6.94 5.53 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.934 1.697 . . . . 0.0 114.594 -171.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.98 42.61 7.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.736 2.015 . . . . 0.0 112.87 -170.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -61.15 -31.27 70.99 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.726 159.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 7.9 mt -117.93 128.98 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 127.909 2.483 . . . . 0.0 107.199 167.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -95.52 108.57 20.83 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.192 0.905 . . . . 0.0 110.32 164.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -66.24 -57.85 6.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.791 2.036 . . . . 0.0 111.947 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -111.34 -177.46 20.35 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 -159.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.05 152.77 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.336 1.454 . . . . 0.0 111.438 -172.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.36 130.12 35.13 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.568 1.147 . . . . 0.0 109.51 169.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.79 -53.41 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 117.891 0.314 . . . . 0.0 111.032 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.2 m -83.66 153.19 24.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.923 0.889 . . . . 0.0 110.393 168.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 6.0 m -53.1 117.36 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.362 2.265 . . . . 0.0 114.989 -173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -82.79 118.85 73.11 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.763 1.225 . . . . 0.0 110.321 168.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.49 -177.32 3.78 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.549 3.5 . . . . 0.0 113.423 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.33 112.74 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.27 1.428 . . . . 0.0 107.223 167.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.2 85.23 0.37 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.15 1.38 . . . . 0.0 110.782 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 34.8 t -66.4 -58.6 4.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.936 0.494 . . . . 0.0 109.745 166.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 25.2 p -78.91 122.88 26.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.098 1.359 . . . . 0.0 109.963 163.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -62.54 -21.85 65.86 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.04 4.06 4.73 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.963 1.305 . . . . 0.0 113.519 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -42.32 129.4 3.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.72 2.008 . . . . 0.0 113.171 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.98 128.37 20.01 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.943 1.297 . . . . 0.0 110.309 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.2 p -149.29 150.79 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.583 0.706 . . . . 0.0 112.625 -159.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -89.12 121.74 31.74 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.298 2.639 . . . . 0.0 109.35 171.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 43.8 mt -135.31 146.86 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.444 0.698 . . . . 0.0 111.516 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -111.97 143.34 43.12 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.004 1.722 . . . . 0.0 111.624 167.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.78 149.15 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 123.513 0.725 . . . . 0.0 111.424 164.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -97.76 110.2 54.29 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.27 1.428 . . . . 0.0 109.466 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.8 126.03 6.37 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.979 2.452 . . . . 0.0 110.225 164.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.1 167.22 2.59 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.369 2.046 . . . . 0.0 111.444 155.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -60.26 155.79 16.91 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.429 0.633 . . . . 0.0 112.62 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.95 -169.88 39.03 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 123.007 1.337 . . . . 0.0 113.914 -173.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.57 163.01 9.55 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.151 1.78 . . . . 0.0 113.775 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 35.9 m -164.07 148.8 10.22 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.637 -1.289 . . . . 0.0 113.231 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -113.11 111.08 21.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.422 2.289 . . . . 0.0 106.87 161.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.4 mm -74.77 120.49 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 32.0 mt -117.7 126.59 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 122.273 1.035 . . . . 0.0 109.405 -171.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 54.9 t -118.02 99.29 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 127.361 2.265 . . . . 0.0 107.217 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.423 ' HA2' ' HG2' ' A' ' 333' ' ' PRO . . . 118.73 170.54 14.8 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 122.981 1.323 . . . . 0.0 115.502 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.49 165.55 24.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.514 2.326 . . . . 0.0 109.556 166.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.28 -172.66 55.11 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 123.211 0.434 . . . . 0.0 112.163 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -60.35 -32.3 71.13 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.324 -1.104 . . . . 0.0 111.708 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.9 m -56.58 -4.3 0.15 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 130.338 3.455 . . . . 0.0 117.782 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -86.96 144.09 27.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.129 0.877 . . . . 0.0 111.816 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.99 165.94 11.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.884 0.873 . . . . 0.0 110.142 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.2 t -146.97 158.71 44.0 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 169.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -139.92 131.51 27.16 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.642 1.977 . . . . 0.0 108.63 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.68 141.3 32.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.764 1.226 . . . . 0.0 111.739 -171.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -140.0 146.92 39.69 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.162 1.385 . . . . 0.0 109.578 170.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -122.77 105.78 10.34 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 20.3 tptt -89.3 141.68 28.32 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 392' ' ' GLU . 0.0 OUTLIER -40.74 124.38 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.082 2.553 . . . . 0.0 113.286 -172.451 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 100.76 19.96 16.03 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.545 1.545 . . . . 0.0 113.893 -163.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 85.5 p -87.6 163.19 16.74 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -171.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 95.9 p -50.7 -37.17 39.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.367 2.267 . . . . 0.0 114.455 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 24.7 pt -76.47 -0.42 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.16 1.384 . . . . 0.0 113.426 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 88.14 12.36 65.78 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.771 -1.016 . . . . 0.0 114.048 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.484 0 C-N-CA 125.047 1.339 . . . . 0.0 109.435 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 118.8 -0.619 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 33.4 p -102.6 -7.52 21.73 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.603 1.561 . . . . 0.0 114.572 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.02 -24.89 66.84 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -171.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 37.4 tp -82.32 139.44 34.14 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.049 0.94 . . . . 0.0 110.048 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 38.0 p -33.52 -67.98 0.12 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.017 2.527 . . . . 0.0 114.52 -174.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -6.93 7.04 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.317 1.447 . . . . 0.0 114.431 -174.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.03 68.44 3.77 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 120.467 -1.395 . . . . 0.0 110.925 -173.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 79.8 -53.26 4.3 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.2 0.905 . . . . 0.0 112.143 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 90.8 m -48.4 -37.63 17.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 128.382 2.673 . . . . 0.0 115.498 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 36.7 m -161.25 103.44 1.26 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.304 1.411 . . . . 0.0 113.118 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -151.94 153.02 33.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.434 1.094 . . . . 0.0 110.995 163.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 112.05 23.83 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.186 1.794 . . . . 0.0 107.072 165.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -61.08 142.67 56.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.975 1.71 . . . . 0.0 115.054 -174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 4.5 m -94.8 148.77 21.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.818 0.847 . . . . 0.0 109.013 156.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.1 p -137.11 1.42 2.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -77.92 163.11 26.3 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.677 1.126 . . . . 0.0 110.958 168.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.44 98.81 0.51 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.148 1.779 . . . . 0.0 112.096 -164.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 32.5 mtm -84.54 166.29 17.33 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.736 1.214 . . . . 0.0 112.23 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.7 m -161.81 162.7 29.55 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.149 -0.969 . . . . 0.0 112.255 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.36 117.0 24.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.07 0.948 . . . . 0.0 110.602 164.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 74.7 t -68.25 -30.16 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.595 1.558 . . . . 0.0 110.684 167.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -136.16 118.37 15.54 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.165 1.786 . . . . 0.0 107.575 170.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -52.74 144.61 24.81 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.216 1.006 . . . . 0.0 111.24 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.09 130.78 37.95 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.325 1.35 . . . . 0.0 111.878 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.3 p -130.69 130.74 44.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.277 1.431 . . . . 0.0 111.2 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.4 140.21 58.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.735 1.214 . . . . 0.0 112.61 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 39.4 p -95.79 -9.85 30.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.851 1.26 . . . . 0.0 113.996 -174.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 68.11 -2.78 6.37 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 119.283 0.947 . . . . 0.0 115.231 -167.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -97.06 19.14 13.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.009 1.405 . . . . 0.0 111.43 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.02 0.43 88.97 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.817 1.199 . . . . 0.0 113.788 -171.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 22.3 p -121.76 169.75 10.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.526 1.163 . . . . 0.0 112.547 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.8 t -140.63 124.5 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.23 1.812 . . . . 0.0 108.287 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.82 134.16 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.665 1.186 . . . . 0.0 112.308 -170.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -142.57 168.7 19.11 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.583 1.953 . . . . 0.0 113.062 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -122.42 131.93 54.11 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.182 1.393 . . . . 0.0 107.932 164.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.58 153.27 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.057 0.943 . . . . 0.0 111.582 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -136.98 146.22 45.1 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.426 1.49 . . . . 0.0 112.89 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.27 149.91 42.22 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 128.483 2.713 . . . . 0.0 107.735 164.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -107.04 -57.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.354 2.036 . . . . 0.0 115.594 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.22 170.68 15.29 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.949 -1.094 . . . . 0.0 112.966 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 69.21 -3.81 7.03 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.292 1.901 . . . . 0.0 117.718 168.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.97 99.59 41.02 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 119.248 1.524 . . . . 0.0 113.579 -163.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.07 112.27 2.56 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.67 2.913 . . . . 0.0 109.417 157.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.2 p -157.61 155.48 30.18 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -87.65 93.36 9.41 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.793 2.037 . . . . 0.0 106.695 162.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.254 1.4 pp -56.93 111.69 3.65 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.526 0.73 . . . . 0.0 112.456 -155.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.34 115.75 3.06 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.096 2.531 . . . . 0.0 114.197 -167.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 82.0 t -122.73 109.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.317 1.447 . . . . 0.0 109.71 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.93 162.77 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.663 1.585 . . . . 0.0 109.519 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.65 127.08 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -140.27 168.8 18.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.495 0.589 . . . . 0.0 112.352 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -102.13 -2.92 28.37 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.005 0.922 . . . . 0.0 111.851 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -106.07 0.49 25.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.582 1.953 . . . . 0.0 114.558 -168.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 34.4 mt 61.4 0.7 0.47 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.324 2.249 . . . . 0.0 115.967 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.1 t -127.99 -2.44 5.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.238 1.381 . . . . 0.0 114.515 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.524 ' HB3' HH22 ' A' ' 384' ' ' ARG . . . 62.55 45.04 6.48 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.802 2.441 . . . . 0.0 113.209 -172.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.86 -33.7 76.17 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 119.646 -0.216 . . . . 0.0 111.231 164.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 33.3 mt -131.9 117.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.346 1.458 . . . . 0.0 110.215 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -80.1 104.26 10.55 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.367 -0.833 . . . . 0.0 112.773 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -66.34 -56.09 12.8 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.585 2.354 . . . . 0.0 112.943 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -115.77 169.76 13.06 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 116.914 1.525 . . . . 0.0 116.914 -159.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.87 155.24 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.096 2.158 . . . . 0.0 111.863 -165.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.12 123.68 32.43 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.558 1.543 . . . . 0.0 108.723 166.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 93.3 t -89.47 -34.97 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.0 0.52 . . . . 0.0 111.446 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.0 t -113.3 175.12 5.58 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.213 1.005 . . . . 0.0 112.209 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.6 m -65.26 101.8 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.76 1.624 . . . . 0.0 112.474 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -63.09 125.31 86.59 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.854 165.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -82.09 -177.25 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.536 3.491 . . . . 0.0 114.007 -169.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.11 114.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 127.236 2.214 . . . . 0.0 107.674 171.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.86 75.39 0.11 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.837 1.655 . . . . 0.0 112.892 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -66.73 -11.46 54.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 169.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 31.5 p -134.52 127.34 31.16 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 127.846 2.458 . . . . 0.0 106.575 165.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -62.24 -15.29 46.1 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -170.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.79 5.98 10.08 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.237 1.815 . . . . 0.0 113.552 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -39.22 119.12 0.87 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 127.314 2.245 . . . . 0.0 113.584 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.57 144.59 50.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.057 0.943 . . . . 0.0 111.613 170.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.71 142.59 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -161.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.59 120.4 19.14 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.692 2.397 . . . . 0.0 109.455 165.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 48.0 mt -131.46 131.77 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.284 0.564 . . . . 0.0 110.732 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -96.51 139.8 32.07 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.989 0.916 . . . . 0.0 111.052 158.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.15 160.72 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.323 1.449 . . . . 0.0 110.957 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -125.41 92.87 46.09 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.068 1.747 . . . . 0.0 109.487 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.08 140.78 20.3 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.481 2.121 . . . . 0.0 109.987 160.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.35 179.93 3.65 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.812 2.341 . . . . 0.0 111.706 168.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -59.33 160.14 7.02 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.355 1.062 . . . . 0.0 113.444 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 86.83 -145.41 20.03 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.094 0.378 . . . . 0.0 112.193 -170.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -93.91 169.21 10.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.318 1.047 . . . . 0.0 113.653 -173.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 29.7 m -164.94 160.7 19.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.868 1.267 . . . . 0.0 112.423 168.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -129.05 109.4 11.16 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.636 1.974 . . . . 0.0 107.017 163.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.28 128.78 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 91.7 mt -119.42 125.65 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.122 1.369 . . . . 0.0 108.734 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.5 104.39 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.525 1.53 . . . . 0.0 108.02 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.32 -179.62 20.98 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 123.363 1.535 . . . . 0.0 116.644 171.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.95 170.0 16.82 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.581 2.752 . . . . 0.0 110.027 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 82.69 -158.6 37.32 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -168.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -72.82 -35.74 67.37 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.702 -0.881 . . . . 0.0 111.037 163.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.4 m -52.14 6.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 1 C-N-CA 132.202 4.201 . . . . 0.0 119.198 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ARG . . . . . 0.524 HH22 ' HB3' ' A' ' 342' ' ' ALA . 0.5 OUTLIER -99.53 138.15 37.02 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.923 1.289 . . . . 0.0 111.808 -169.018 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.7 mt -107.76 166.55 10.61 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.027 0.531 . . . . 0.0 110.814 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.8 t -142.57 158.18 43.94 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 171.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -141.08 130.78 24.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.811 1.244 . . . . 0.0 110.948 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -64.41 137.13 57.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.439 2.296 . . . . 0.0 112.668 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -138.92 154.1 48.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.469 1.128 . . . . 0.0 113.012 163.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -138.27 121.49 16.93 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.86 2.064 . . . . 0.0 106.221 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -79.51 157.82 27.35 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.963 0.887 . . . . 0.0 111.645 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.14 155.38 11.29 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.799 1.639 . . . . 0.0 113.414 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 49.07 12.78 0.28 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 127.003 2.239 . . . . 0.0 116.764 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 53.9 p -148.64 -44.58 0.15 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.109 1.455 . . . . 0.0 114.006 -161.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 23.6 t -125.45 -27.04 3.49 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.09 0.859 . . . . 0.0 112.953 168.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.0 tt -131.93 172.64 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.905 0.882 . . . . 0.0 109.845 163.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -58.89 -65.33 3.56 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.921 0.772 . . . . 0.0 112.0 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? . . . . . 0 C--O 1.253 1.25 0 CA-C-O 116.489 -1.719 . . . . 0.0 109.697 170.437 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 118.333 -0.841 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.4 p -122.34 -6.93 8.76 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -170.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.92 22.02 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -170.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.36 174.68 7.18 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.978 1.263 . . . . 0.0 112.1 -176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 11.0 p -46.88 -63.1 1.11 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.819 2.448 . . . . 0.0 115.166 -168.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.24 71.24 4.7 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.907 0.86 . . . . 0.0 110.769 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.509 ' HA ' ' HE3' ' A' ' 293' ' ' LYS . 0.5 OUTLIER -149.43 90.59 1.74 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.496 0.718 . . . . 0.0 112.156 176.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 67.82 -14.64 0.55 Allowed Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.585 1.564 . . . . 0.0 116.157 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 23.2 p -56.26 -68.06 0.24 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.212 2.605 . . . . 0.0 113.925 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 18.5 m -168.2 138.27 2.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.108 0.963 . . . . 0.0 112.686 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -164.26 147.96 9.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.402 1.881 . . . . 0.0 109.549 167.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 100.11 0.74 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 161.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 158.97 30.21 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.714 1.206 . . . . 0.0 114.08 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.4 m -105.71 137.63 43.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.709 1.204 . . . . 0.0 109.401 167.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.6 p -132.3 7.87 4.27 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -82.35 163.48 21.71 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.401 1.001 . . . . 0.0 110.735 165.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -62.22 109.04 1.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.613 1.965 . . . . 0.0 111.584 -165.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 15.1 mmt -72.99 159.27 33.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.769 0.795 . . . . 0.0 112.729 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.5 p -150.8 150.78 31.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.2 1.0 . . . . 0.0 111.134 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.3 119.44 35.83 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.651 0.78 . . . . 0.0 109.074 163.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -25.28 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.869 0.868 . . . . 0.0 110.425 165.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -142.31 127.84 19.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.911 2.084 . . . . 0.0 108.49 168.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -60.61 144.31 89.25 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.503 1.121 . . . . 0.0 111.443 171.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -54.79 136.57 72.2 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.22 1.947 . . . . 0.0 111.285 173.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 64.5 p -134.87 126.17 28.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.316 1.046 . . . . 0.0 111.198 171.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -55.76 119.18 5.34 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.327 1.451 . . . . 0.0 110.823 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 65.1 p -80.72 -12.59 59.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.906 0.883 . . . . 0.0 112.975 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.83 -7.49 1.54 Allowed Glycine 0 CA--C 1.538 1.494 0 CA-C-O 119.073 -0.848 . . . . 0.0 114.456 -166.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -81.77 2.66 28.97 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.352 1.576 . . . . 0.0 111.965 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.82 9.61 54.11 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.246 1.403 . . . . 0.0 113.677 -170.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.9 p -131.84 165.96 22.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.887 1.275 . . . . 0.0 112.874 -172.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.32 117.99 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.542 2.337 . . . . 0.0 107.152 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.0 p -102.45 132.08 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.586 0.755 . . . . 0.0 112.508 -174.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -137.59 165.29 26.68 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.853 1.661 . . . . 0.0 112.82 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.18 128.24 48.06 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.525 1.53 . . . . 0.0 107.177 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.93 148.45 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.666 0.787 . . . . 0.0 112.005 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -137.12 134.43 36.41 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.592 1.557 . . . . 0.0 112.114 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 m -98.86 159.26 30.74 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.995 1.718 . . . . 0.0 110.735 164.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -112.56 -55.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.886 2.391 . . . . 0.0 116.146 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 172.12 13.68 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.713 1.142 . . . . 0.0 113.139 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.11 -21.12 0.16 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 127.776 2.607 . . . . 0.0 118.291 168.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.39 107.86 56.91 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 119.366 1.583 . . . . 0.0 113.332 -165.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.57 125.91 5.8 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.996 2.464 . . . . 0.0 109.366 152.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 10.7 p -161.85 148.02 13.69 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.78 107.08 15.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.228 1.811 . . . . 0.0 106.635 163.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.284 0.6 OUTLIER -68.31 128.7 93.11 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.03 -153.002 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.97 109.48 2.89 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.117 3.211 . . . . 0.0 112.014 -172.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 93.5 t -111.18 108.89 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.861 1.665 . . . . 0.0 110.255 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.71 157.86 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 125.2 1.4 . . . . 0.0 110.019 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.6 t -144.48 125.54 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -149.59 170.18 19.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.098 0.559 . . . . 0.0 112.436 -170.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -89.68 -1.09 57.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.434 1.094 . . . . 0.0 113.293 174.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -127.47 1.2 6.26 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -152.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.9 mt 61.8 -1.39 0.35 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.151 2.181 . . . . 0.0 115.392 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.7 t -129.91 -7.66 4.46 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -171.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.4 49.23 4.23 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.908 2.083 . . . . 0.0 114.096 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -78.24 -38.03 43.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.834 0.454 . . . . 0.0 110.379 158.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 67.0 mt -97.51 153.12 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 126.919 2.088 . . . . 0.0 108.284 170.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.59 125.83 18.65 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.65 -1.281 . . . . 0.0 112.555 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' LYS . . . . . 0.484 ' HE2' ' HG3' ' A' ' 370' ' ' PRO . 2.9 mmmm -129.7 -17.38 3.64 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -159.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -142.56 148.34 20.04 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 119.219 0.918 . . . . 0.0 114.813 -167.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.1 148.83 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.528 1.131 . . . . 0.0 113.095 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.14 115.47 3.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.33 2.652 . . . . 0.0 110.939 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 70.9 t -81.33 -38.41 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.074 0.949 . . . . 0.0 110.532 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 t -92.23 175.1 6.98 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 111.286 168.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.8 m -66.87 135.3 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.329 1.052 . . . . 0.0 111.052 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.39 113.54 13.14 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 121.608 -0.682 . . . . 0.0 111.558 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.58 175.8 10.62 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.282 2.655 . . . . 0.0 113.708 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.29 132.01 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.152 1.781 . . . . 0.0 109.062 -173.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -78.29 97.84 5.72 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.352 1.461 . . . . 0.0 109.797 166.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.0 t -92.5 -16.04 26.29 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.269 1.028 . . . . 0.0 112.618 170.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.27 135.38 54.73 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.716 2.006 . . . . 0.0 107.01 163.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.2 -14.82 63.27 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.563 -1.335 . . . . 0.0 114.443 -167.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.73 0.82 56.09 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.674 1.59 . . . . 0.0 113.146 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -53.18 138.51 31.49 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.743 -1.223 . . . . 0.0 113.28 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.11 142.63 49.57 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.939 1.296 . . . . 0.0 111.069 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.47 144.89 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -162.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -69.63 127.2 32.12 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.82 2.848 . . . . 0.0 110.195 169.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 18.0 mt -137.05 138.24 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.011 0.434 . . . . 0.0 110.308 168.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -110.19 143.43 40.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.201 1.001 . . . . 0.0 110.964 163.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.52 151.54 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.966 0.906 . . . . 0.0 112.406 173.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -94.23 115.93 65.81 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.438 1.895 . . . . 0.0 109.435 172.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.91 168.99 23.59 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.141 2.56 . . . . 0.0 111.07 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' PRO . . . . . 0.484 ' HG3' ' HE2' ' A' ' 346' ' ' LYS . 17.0 Cg_endo -75.7 -177.24 3.45 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.94 2.427 . . . . 0.0 109.813 163.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -75.05 152.56 38.64 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.293 -0.879 . . . . 0.0 109.639 149.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 75.32 -156.2 48.27 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.809 1.084 . . . . 0.0 115.809 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.97 145.83 55.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.255 2.622 . . . . 0.0 113.151 -166.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 6.2 m -179.24 160.46 1.03 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.709 1.603 . . . . 0.0 114.545 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -126.99 119.0 25.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 129.078 2.951 . . . . 0.0 108.586 170.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.2 mm -75.14 119.58 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.5 132.24 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 120.235 1.38 . . . . 0.0 110.076 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.6 106.49 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 126.069 1.748 . . . . 0.0 108.302 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 114.03 176.15 19.06 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 122.496 1.053 . . . . 0.0 115.234 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.63 166.4 23.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.851 2.061 . . . . 0.0 110.223 170.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.1 -175.65 45.14 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 123.09 0.376 . . . . 0.0 112.45 -165.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -58.55 -28.82 65.86 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.674 -0.897 . . . . 0.0 111.921 171.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 50.6 m -57.72 -10.44 1.62 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 130.106 3.362 . . . . 0.0 116.933 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -79.63 146.77 32.34 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.347 1.059 . . . . 0.0 112.039 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 44.3 mt -116.03 166.17 12.3 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.895 0.878 . . . . 0.0 110.513 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.2 t -152.5 161.37 42.68 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -139.66 131.78 28.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.625 1.57 . . . . 0.0 110.205 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -69.12 125.44 26.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.846 1.258 . . . . 0.0 111.264 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -137.29 90.44 2.52 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.5 1.12 . . . . 0.0 110.488 172.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -85.35 126.34 33.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -104.91 158.21 16.69 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.65 1.58 . . . . 0.0 109.533 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -42.38 124.51 2.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.172 1.789 . . . . 0.0 112.672 174.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 126.06 -0.53 7.71 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 167.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 91.7 p -135.47 -81.11 0.42 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 120.081 1.94 . . . . 0.0 112.45 170.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 67.6 p -104.09 0.77 30.1 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.105 1.762 . . . . 0.0 113.798 -170.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 7.4 tp -143.24 156.75 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.908 1.283 . . . . 0.0 110.323 167.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.19 -36.65 14.23 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.127 0.87 . . . . 0.0 113.492 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 5.8 tptp . . . . . 0 C--O 1.25 1.128 0 C-N-CA 128.577 2.751 . . . . 0.0 108.07 173.982 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 2.0 p -95.65 -7.9 36.27 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -170.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.6 21.98 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -165.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 51.8 tp -147.69 148.73 31.35 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.859 1.209 . . . . 0.0 112.188 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 72.6 p 23.28 -92.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 130.529 3.532 . . . . 0.0 116.98 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 11.6 tp -83.84 75.53 10.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.582 1.153 . . . . 0.0 112.026 -167.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.48 92.68 1.96 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.857 0.863 . . . . 0.0 111.425 171.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 67.7 -2.74 5.77 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.744 1.164 . . . . 0.0 115.757 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 1.5 p -64.42 -58.23 7.05 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.49 2.316 . . . . 0.0 112.592 -172.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.6 m -170.37 135.6 1.26 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.312 1.045 . . . . 0.0 112.365 171.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -163.83 143.22 8.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.613 1.165 . . . . 0.0 112.064 168.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 95.43 0.35 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 156.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -65.93 162.38 19.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.728 2.011 . . . . 0.0 114.275 -172.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 32.7 m -103.25 139.34 38.83 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.195 0.998 . . . . 0.0 110.558 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.2 p -138.76 7.12 2.5 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.663 1.356 . . . . 0.0 114.663 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.33 165.55 19.21 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.795 1.18 . . . . 0.0 110.634 163.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -66.98 95.01 0.36 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.673 1.989 . . . . 0.0 111.375 -169.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 23.8 mtm -76.75 170.18 16.93 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.118 1.367 . . . . 0.0 112.653 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.1 m -156.48 158.94 38.11 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.037 -1.039 . . . . 0.0 112.976 166.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.82 114.95 23.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.598 0.759 . . . . 0.0 109.745 162.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.8 -29.81 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.866 1.267 . . . . 0.0 110.318 168.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -140.77 132.47 27.28 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.634 1.974 . . . . 0.0 108.53 165.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -61.17 148.13 85.39 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.417 1.487 . . . . 0.0 112.846 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.67 130.27 37.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.886 2.391 . . . . 0.0 111.619 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.5 p -127.11 125.14 40.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.615 1.166 . . . . 0.0 111.29 173.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -60.03 126.44 27.56 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.301 1.44 . . . . 0.0 111.89 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -77.78 -16.15 58.59 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.326 1.451 . . . . 0.0 113.762 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.81 -5.79 5.7 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 118.937 -0.924 . . . . 0.0 114.139 -165.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -89.42 -2.24 58.33 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.201 1.501 . . . . 0.0 112.115 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 102.91 -1.73 48.16 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.233 1.396 . . . . 0.0 114.035 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 17.1 p -121.09 159.15 26.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.768 1.227 . . . . 0.0 111.679 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.3 123.74 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.484 1.914 . . . . 0.0 108.091 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.3 p -111.96 129.14 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.183 0.993 . . . . 0.0 113.418 -166.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -136.11 168.13 19.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.886 2.075 . . . . 0.0 113.071 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -125.84 129.17 48.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.796 1.238 . . . . 0.0 108.083 166.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.07 153.0 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 119.21 0.914 . . . . 0.0 112.528 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -141.65 146.68 36.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.706 1.602 . . . . 0.0 113.455 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.99 155.41 41.71 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.835 2.054 . . . . 0.0 109.702 160.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -109.18 -49.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.286 1.991 . . . . 0.0 116.46 -175.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 173.81 13.8 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.738 1.154 . . . . 0.0 112.79 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.11 0.83 10.5 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.439 1.971 . . . . 0.0 117.645 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -119.37 97.28 50.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 119.015 1.408 . . . . 0.0 113.868 -160.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -81.19 111.71 2.45 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.845 3.03 . . . . 0.0 109.88 152.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 7.5 p -159.68 153.47 22.95 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -81.37 110.45 16.81 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 159.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.263 1.3 pp -66.14 112.74 9.83 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 119.429 -0.319 . . . . 0.0 111.387 -162.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.84 113.88 3.72 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.908 2.406 . . . . 0.0 112.345 -165.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 94.8 t -112.35 108.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 126.171 1.788 . . . . 0.0 110.004 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.0 158.22 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.62 1.568 . . . . 0.0 110.168 -176.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 77.7 t -145.8 116.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -171.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -131.01 -179.17 5.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.172 0.989 . . . . 0.0 113.048 -165.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -111.07 -0.13 16.72 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.96 0.904 . . . . 0.0 112.33 163.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -123.35 6.72 9.03 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.751 1.621 . . . . 0.0 113.952 -159.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.2 mt 65.27 -6.02 0.4 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.252 2.221 . . . . 0.0 115.194 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -128.49 -3.08 5.48 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' A' ' 337' ' ' ALA . . . 68.33 37.43 2.76 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.825 2.05 . . . . 0.0 113.536 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.17 -49.07 68.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 165.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.46 150.39 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 126.626 1.97 . . . . 0.0 107.59 164.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.58 129.47 21.83 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.161 -0.962 . . . . 0.0 112.221 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -133.95 -8.55 2.71 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -160.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -127.72 130.14 6.63 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 -164.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -89.12 157.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.12 1.368 . . . . 0.0 111.905 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.77 119.92 32.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.091 2.156 . . . . 0.0 109.177 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.41 -25.22 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.502 0.721 . . . . 0.0 112.187 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 366' ' ' GLU . 8.7 t -125.66 175.54 7.51 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.544 1.537 . . . . 0.0 111.084 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.78 107.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.155 1.782 . . . . 0.0 113.427 -175.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -71.55 113.53 20.47 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.826 1.25 . . . . 0.0 110.055 162.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -82.63 179.1 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.705 2.937 . . . . 0.0 114.419 -169.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.62 119.79 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 127.19 2.196 . . . . 0.0 106.058 163.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.0 84.63 0.08 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.56 1.144 . . . . 0.0 110.501 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.1 t -81.92 -9.73 59.49 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.54 122.84 37.71 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 127.399 2.28 . . . . 0.0 106.898 168.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -66.87 -10.8 52.23 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.285 -1.509 . . . . 0.0 114.752 -166.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -89.86 4.33 50.19 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.333 1.853 . . . . 0.0 113.375 170.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.33 134.89 11.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.222 1.409 . . . . 0.0 113.811 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.93 151.43 49.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.774 1.23 . . . . 0.0 111.56 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.29 144.57 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -166.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -79.23 121.47 25.1 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.708 2.403 . . . . 0.0 109.79 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 61.0 mt -131.1 136.35 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.359 0.599 . . . . 0.0 111.177 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLU . . . . . 0.454 ' H ' HG22 ' A' ' 351' ' ' THR . 24.7 mt-10 -101.89 141.27 35.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.976 1.31 . . . . 0.0 110.762 161.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.7 159.49 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.391 1.076 . . . . 0.0 112.001 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -117.13 102.06 52.86 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.703 1.601 . . . . 0.0 109.949 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.78 179.89 3.89 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.676 2.917 . . . . 0.0 110.866 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -78.83 -179.85 5.84 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.219 1.946 . . . . 0.0 110.869 161.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -60.48 148.61 37.06 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 153.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.92 -163.72 43.96 Favored Glycine 0 CA--C 1.539 1.583 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -62.86 158.9 17.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.631 1.972 . . . . 0.0 114.471 -169.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.6 m -166.54 168.57 14.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.137 1.375 . . . . 0.0 113.079 166.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.91 111.29 12.41 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.659 2.383 . . . . 0.0 107.326 164.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 17.4 mm -69.44 129.04 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 59.2 mt -121.32 124.18 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.357 1.063 . . . . 0.0 108.926 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.99 100.56 11.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 126.069 1.747 . . . . 0.0 107.58 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 114.68 178.72 18.89 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 123.071 1.373 . . . . 0.0 116.159 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.57 167.25 22.04 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.744 2.418 . . . . 0.0 110.167 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.29 -174.85 46.81 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.569 0.604 . . . . 0.0 112.338 -167.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -59.22 -30.5 68.29 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 122.037 -0.684 . . . . 0.0 111.228 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 15.6 m -60.15 -6.98 1.61 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 129.88 3.272 . . . . 0.0 117.22 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.65 148.5 31.61 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.018 0.927 . . . . 0.0 112.005 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 18.0 mt -111.89 165.46 12.06 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.504 0.722 . . . . 0.0 110.563 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.9 t -147.06 157.74 43.71 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -139.71 121.29 15.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.334 1.854 . . . . 0.0 109.657 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -66.64 140.5 57.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.094 1.358 . . . . 0.0 111.89 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -135.95 155.95 49.49 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.46 1.104 . . . . 0.0 111.773 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -133.39 108.21 8.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 9.9 tptp -81.04 154.34 26.91 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -43.22 132.57 4.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.021 1.728 . . . . 0.0 112.313 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 114.07 12.7 10.78 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 118.018 1.967 . . . . 0.0 118.018 162.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 90.9 p -135.26 -79.59 0.43 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.189 1.994 . . . . 0.0 111.853 169.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 85.8 p -98.33 -12.77 21.16 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 127.803 2.441 . . . . 0.0 113.118 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 7.9 tp -131.84 147.99 32.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 125.979 1.711 . . . . 0.0 109.59 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.88 -55.56 6.38 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 3.9 tptp . . . . . 0 C--O 1.25 1.131 0 C-N-CA 128.212 2.605 . . . . 0.0 108.492 171.749 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.411 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 54.3 p -120.57 -6.12 9.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.831 1.652 . . . . 0.0 113.95 175.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.52 11.21 0.27 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.25 1.82 . . . . 0.0 115.719 -170.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.87 151.74 49.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.582 1.553 . . . . 0.0 110.136 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 26.9 p -41.89 -68.65 0.17 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.578 2.351 . . . . 0.0 113.206 -172.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.47 -11.52 16.57 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.169 1.788 . . . . 0.0 114.087 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.415 ' HE2' ' ND2' ' A' ' 345' ' ' ASN . 1.2 mmmt -103.34 64.19 0.82 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.779 -1.201 . . . . 0.0 111.34 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 80.41 -18.85 7.71 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.421 -1.211 . . . . 0.0 115.026 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 23.0 m -71.66 -51.61 22.22 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.444 1.622 . . . . 0.0 112.65 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.3 m -171.44 124.81 0.6 Allowed 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.232 1.378 . . . . 0.0 113.239 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -158.01 155.82 30.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.106 1.762 . . . . 0.0 110.431 167.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.45 104.21 7.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.856 0.863 . . . . 0.0 108.995 170.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -66.84 146.95 53.88 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.972 2.109 . . . . 0.0 115.945 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.9 m -96.49 144.62 26.42 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.728 1.211 . . . . 0.0 109.075 159.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 57.8 p -139.56 2.1 1.99 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -69.23 161.19 29.72 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 120.181 1.355 . . . . 0.0 111.157 165.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.87 95.46 0.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.0 1.72 . . . . 0.0 112.277 -171.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 31.6 mtm -81.38 166.64 20.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.927 1.291 . . . . 0.0 112.003 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 22.2 m -160.21 162.57 33.82 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.441 -0.787 . . . . 0.0 112.085 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -74.46 135.17 42.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.514 0.726 . . . . 0.0 109.426 166.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.99 -17.97 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.342 0.657 . . . . 0.0 110.81 161.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 28.6 tttm -147.87 123.72 10.61 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.452 2.301 . . . . 0.0 108.034 173.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.28 146.2 84.41 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.992 0.917 . . . . 0.0 112.069 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.77 130.06 35.53 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.694 2.929 . . . . 0.0 112.848 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.6 p -128.55 134.18 48.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.551 1.141 . . . . 0.0 110.585 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -60.55 122.12 13.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.29 0.636 . . . . 0.0 109.893 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.7 p -72.79 -14.16 61.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.284 1.034 . . . . 0.0 112.801 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.74 -4.94 13.3 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.277 0.942 . . . . 0.0 113.492 -165.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -90.16 1.14 56.74 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.886 1.343 . . . . 0.0 112.036 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.87 13.41 43.49 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.804 1.193 . . . . 0.0 113.72 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.8 p -133.66 153.9 51.32 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.044 1.338 . . . . 0.0 111.687 -174.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.49 121.14 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.669 1.187 . . . . 0.0 107.912 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.0 p -112.37 134.33 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.35 1.06 . . . . 0.0 113.067 -164.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -141.79 159.83 41.43 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.936 1.695 . . . . 0.0 112.893 -175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -107.92 132.36 53.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.1 1.36 . . . . 0.0 107.373 164.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.35 144.66 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.641 0.776 . . . . 0.0 111.314 -177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -131.04 144.28 51.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.368 1.467 . . . . 0.0 112.901 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.62 153.36 44.31 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 127.986 2.514 . . . . 0.0 108.835 168.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -108.93 -70.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.843 2.362 . . . . 0.0 116.277 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.18 164.45 27.66 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 121.226 1.83 . . . . 0.0 114.339 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 71.6 0.07 37.74 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.89 1.709 . . . . 0.0 117.037 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.87 102.53 53.99 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 118.879 1.34 . . . . 0.0 113.525 -166.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.06 120.22 2.95 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.717 2.944 . . . . 0.0 109.611 152.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 7.7 p -162.51 157.37 22.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -89.39 109.19 20.13 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 157.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.265 0.9 OUTLIER -65.3 122.79 81.88 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.744 -157.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -61.77 117.41 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.712 2.941 . . . . 0.0 113.522 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.1 t -124.94 111.43 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.251 1.421 . . . . 0.0 110.721 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.28 157.26 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.338 1.455 . . . . 0.0 110.096 -173.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.79 118.36 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.46 171.45 13.38 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -165.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ASP . . . . . 0.435 ' CG ' ' HE2' ' A' ' 346' ' ' LYS . 4.6 m-20 -90.89 -13.45 33.6 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.351 2.26 . . . . 0.0 112.577 166.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -114.99 0.18 13.59 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -154.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 36.4 mt 60.7 -25.95 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.664 2.786 . . . . 0.0 115.533 -171.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 11.1 t -99.8 -4.56 30.26 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.822 2.049 . . . . 0.0 114.567 -172.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.87 78.15 0.05 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 130.658 3.583 . . . . 0.0 115.175 -171.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -99.53 -38.91 8.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.295 1.438 . . . . 0.0 110.837 153.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 35.2 mm -98.96 128.5 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.771 1.228 . . . . 0.0 109.521 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.415 ' ND2' ' HE2' ' A' ' 293' ' ' LYS . 12.8 t30 -108.65 125.23 51.64 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.754 -0.591 . . . . 0.0 112.054 172.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' LYS . . . . . 0.435 ' HE2' ' CG ' ' A' ' 338' ' ' ASP . 47.8 mttm -75.49 -73.45 0.26 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.691 2.796 . . . . 0.0 110.902 166.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -98.31 167.16 22.35 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.063 1.316 . . . . 0.0 115.582 -155.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 12.6 mt -120.03 152.24 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.633 1.573 . . . . 0.0 110.318 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.3 135.97 54.16 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.472 1.909 . . . . 0.0 110.312 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.58 -50.14 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.949 0.5 . . . . 0.0 110.693 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.408 ' H ' ' HB2' ' A' ' 366' ' ' GLU . 1.1 m -81.45 156.81 25.16 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.001 0.92 . . . . 0.0 109.348 160.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.05 161.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.255 1.422 . . . . 0.0 113.922 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -125.02 121.05 25.39 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.158 1.783 . . . . 0.0 109.227 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -82.28 -175.29 2.44 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.265 3.31 . . . . 0.0 113.548 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 123.12 63.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.578 1.551 . . . . 0.0 108.037 168.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.63 84.71 0.87 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.34 1.056 . . . . 0.0 111.548 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 25.0 t -79.29 -12.34 59.94 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 167.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.7 p -131.31 121.98 25.64 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 127.785 2.434 . . . . 0.0 105.939 167.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -59.51 -20.34 54.66 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.8 0.06 9.93 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.466 1.906 . . . . 0.0 113.737 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -37.13 121.82 0.83 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.481 2.312 . . . . 0.0 113.58 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.65 143.18 47.13 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.269 1.028 . . . . 0.0 111.285 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.2 p -154.17 150.47 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -163.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.93 121.82 27.48 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.793 2.437 . . . . 0.0 109.469 168.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 37.0 mt -135.71 150.13 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.956 0.798 . . . . 0.0 111.455 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLU . . . . . 0.408 ' HB2' ' H ' ' A' ' 351' ' ' THR . 48.3 mt-10 -118.4 142.63 47.35 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.55 1.94 . . . . 0.0 111.467 170.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 3.8 m -123.11 145.47 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.569 1.148 . . . . 0.0 110.733 168.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -83.18 119.08 73.49 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.936 0.894 . . . . 0.0 109.787 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -82.34 151.33 15.54 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 122.844 2.363 . . . . 0.0 111.045 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.47 178.13 7.07 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.747 2.298 . . . . 0.0 110.442 158.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.73 151.66 46.88 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.611 -0.68 . . . . 0.0 110.449 163.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 77.63 -151.33 37.64 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 121.92 -0.488 . . . . 0.0 113.297 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.28 143.45 57.78 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -173.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 47.2 m -157.41 145.49 19.12 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.487 1.115 . . . . 0.0 112.512 167.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -122.77 105.2 9.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.404 1.082 . . . . 0.0 108.651 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 13.8 mm -76.69 113.78 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 127.444 2.298 . . . . 0.0 109.022 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 25.1 mt -116.79 133.96 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 122.449 1.118 . . . . 0.0 111.78 -168.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 81.6 t -116.77 114.58 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 C-N-CA 126.647 1.979 . . . . 0.0 108.023 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 96.98 -173.05 28.82 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 122.875 1.264 . . . . 0.0 115.521 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.95 164.01 31.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.308 2.243 . . . . 0.0 110.018 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.55 -174.12 42.68 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.008 0.337 . . . . 0.0 112.359 -167.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -59.17 -25.79 64.22 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.074 0.95 . . . . 0.0 112.497 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 63.4 m -60.38 -10.72 5.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.824 2.449 . . . . 0.0 115.684 172.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -77.39 124.71 28.24 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.508 1.049 . . . . 0.0 112.167 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 9.8 mt -97.71 161.3 13.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.983 0.513 . . . . 0.0 111.401 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.9 t -132.65 157.88 43.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.879 1.272 . . . . 0.0 112.042 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -145.0 136.52 25.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.078 1.351 . . . . 0.0 110.979 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.14 137.22 38.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.465 1.506 . . . . 0.0 113.139 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -138.01 147.39 44.14 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.917 1.287 . . . . 0.0 111.352 158.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -123.53 111.74 16.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.603 1.561 . . . . 0.0 107.598 169.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -98.62 117.82 33.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.494 1.118 . . . . 0.0 112.156 -167.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 70.78 140.88 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.693 3.197 . . . . 0.0 113.591 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -64.81 66.88 0.07 OUTLIER Glycine 0 C--N 1.341 0.837 0 C-N-CA 128.567 2.984 . . . . 0.0 112.754 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 50.8 m -67.5 -4.97 12.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.809 2.444 . . . . 0.0 113.919 -167.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 34.1 t -104.25 4.01 33.34 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.294 1.838 . . . . 0.0 113.813 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 15.2 tt -134.2 -31.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.319 1.047 . . . . 0.0 113.147 170.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 144.36 -24.47 2.03 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.927 1.251 . . . . 0.0 114.893 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? . . . . . 0 C--O 1.247 0.946 0 C-N-CA 126.389 1.876 . . . . 0.0 109.446 178.591 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 119.608 -0.234 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 26.3 p -67.01 9.63 0.19 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.765 2.426 . . . . 0.0 117.12 -170.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.63 -2.43 6.78 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -172.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 33.2 tp -138.86 146.07 40.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.066 1.346 . . . . 0.0 109.26 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 11.5 m -46.57 -49.06 19.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.556 1.942 . . . . 0.0 114.506 -165.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.93 49.71 0.19 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.752 1.621 . . . . 0.0 112.053 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.05 89.19 0.92 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.39 1.476 . . . . 0.0 110.157 174.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.87 -22.07 2.41 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 117.847 -1.529 . . . . 0.0 116.765 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 30.9 p -56.42 -69.29 0.15 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.872 1.836 . . . . 0.0 113.354 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.0 m -176.31 120.91 0.15 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.608 2.363 . . . . 0.0 109.727 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -155.42 156.33 35.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.477 0.656 . . . . 0.0 112.526 173.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.35 105.94 13.83 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.123 1.769 . . . . 0.0 109.173 172.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -80.44 161.83 24.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.125 1.77 . . . . 0.0 114.162 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 13.7 m -100.86 148.58 24.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.343 1.057 . . . . 0.0 110.939 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 42.9 p -139.08 11.47 2.61 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 170.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -83.17 160.61 21.78 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.804 1.183 . . . . 0.0 110.039 163.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -65.29 98.72 0.35 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.095 1.758 . . . . 0.0 111.825 -163.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 27.6 mtm -83.01 164.06 20.6 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.716 0.806 . . . . 0.0 111.79 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.3 m -159.53 161.29 35.25 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.316 -0.865 . . . . 0.0 111.993 167.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.67 115.47 25.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.798 0.839 . . . . 0.0 110.573 167.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.69 -26.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.948 1.299 . . . . 0.0 110.548 168.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -142.31 130.86 22.52 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.539 1.936 . . . . 0.0 109.022 167.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -61.34 149.75 82.16 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.928 1.691 . . . . 0.0 113.313 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -55.86 130.57 41.07 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.345 2.697 . . . . 0.0 112.389 173.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.3 p -128.58 127.54 42.5 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.474 1.109 . . . . 0.0 111.297 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -60.82 123.89 18.83 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.73 1.612 . . . . 0.0 112.133 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.2 p -79.57 -11.81 59.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.487 1.515 . . . . 0.0 113.307 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 68.71 -10.36 1.55 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.418 1.009 . . . . 0.0 114.224 -168.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -83.23 3.63 30.33 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.618 1.567 . . . . 0.0 111.702 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 101.97 -1.47 51.59 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 126.043 1.782 . . . . 0.0 113.612 -174.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.2 p -118.06 159.11 23.79 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.771 1.286 . . . . 0.0 112.451 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.79 111.43 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.406 1.482 . . . . 0.0 107.916 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.46 133.1 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.245 1.018 . . . . 0.0 113.615 -162.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -139.69 161.54 37.27 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.245 2.218 . . . . 0.0 112.496 -172.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -113.33 130.12 56.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.454 1.102 . . . . 0.0 108.158 164.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.2 150.57 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.074 0.95 . . . . 0.0 111.874 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.8 tttp -135.73 148.38 48.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.826 1.651 . . . . 0.0 113.044 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.51 153.11 46.68 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 128.322 2.649 . . . . 0.0 108.17 165.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -107.97 -55.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.454 2.102 . . . . 0.0 115.695 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.94 171.01 16.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.275 1.03 . . . . 0.0 112.575 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.63 -5.14 1.8 Allowed Glycine 0 CA--C 1.537 1.425 0 C-N-CA 126.975 2.226 . . . . 0.0 118.093 166.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.53 95.59 48.09 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 119.286 1.543 . . . . 0.0 113.331 -161.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.93 117.82 4.83 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.114 2.543 . . . . 0.0 109.345 158.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.1 p -165.51 150.88 9.11 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.18 101.56 6.23 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.104 1.762 . . . . 0.0 106.588 158.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.253 1.3 pp -61.08 120.4 54.04 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-O 118.555 -0.735 . . . . 0.0 111.543 -158.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -61.89 114.85 2.47 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.492 2.795 . . . . 0.0 113.552 -171.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.62 120.15 62.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.979 1.312 . . . . 0.0 108.781 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 163.63 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.013 1.325 . . . . 0.0 110.643 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' VAL . . . . . 0.498 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 48.2 t -142.81 118.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.69 163.39 38.23 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.1 6.2 38.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.069 0.948 . . . . 0.0 111.913 -175.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -115.14 1.98 14.01 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.937 2.495 . . . . 0.0 113.457 -164.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 32.8 mt 61.31 8.03 1.94 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.495 2.318 . . . . 0.0 114.994 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.9 t -142.62 -6.6 0.89 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 55.95 50.18 14.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.767 2.027 . . . . 0.0 114.925 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.71 72.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 152.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 34.2 mm -70.57 148.18 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 123.718 0.807 . . . . 0.0 108.927 162.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.08 74.26 1.51 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.432 -1.418 . . . . 0.0 109.349 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -75.27 -60.63 2.21 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.296 1.838 . . . . 0.0 112.886 -160.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.498 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -94.44 175.88 34.9 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.655 1.598 . . . . 0.0 115.406 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -113.79 150.73 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.143 2.577 . . . . 0.0 110.377 -173.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.78 135.46 36.5 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.493 1.517 . . . . 0.0 109.685 165.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.8 t -114.86 -65.34 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.885 0.766 . . . . 0.0 111.208 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.526 ' H ' ' HB2' ' A' ' 366' ' ' GLU . 1.5 m -68.8 157.34 36.64 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 162.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 35.2 m -55.71 161.44 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.959 1.704 . . . . 0.0 114.759 -172.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -125.67 125.35 24.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.445 1.898 . . . . 0.0 108.108 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -80.88 -174.49 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.85 3.033 . . . . 0.0 112.667 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.27 120.49 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 162.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.97 67.25 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.778 2.031 . . . . 0.0 113.444 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -71.03 -20.81 62.35 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.912 0.885 . . . . 0.0 112.402 169.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.81 123.05 43.66 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 154.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -65.65 -16.31 63.61 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.55 -1.344 . . . . 0.0 112.803 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -81.13 2.79 25.91 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.29 1.836 . . . . 0.0 113.751 170.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.22 126.14 3.98 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.303 1.441 . . . . 0.0 113.243 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.14 149.19 52.46 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.064 0.946 . . . . 0.0 111.539 167.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.0 p -158.56 151.38 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -163.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.74 122.61 28.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.172 2.589 . . . . 0.0 109.624 169.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 20.7 mt -134.02 149.67 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.932 0.787 . . . . 0.0 110.619 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' A' ' 351' ' ' THR . 45.4 mt-10 -116.22 143.38 45.58 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.608 1.563 . . . . 0.0 110.977 167.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.02 157.8 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.448 0.699 . . . . 0.0 111.635 164.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -121.47 102.19 42.74 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 127.164 2.186 . . . . 0.0 108.501 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.36 165.33 27.73 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.17 1.914 . . . . 0.0 110.628 166.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -59.7 177.2 0.49 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.078 2.518 . . . . 0.0 111.668 156.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -59.65 142.59 52.61 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.845 -0.534 . . . . 0.0 110.527 165.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 101.92 -154.18 18.72 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.957 1.265 . . . . 0.0 115.381 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.82 140.97 38.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.412 2.685 . . . . 0.0 112.533 -170.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.63 174.04 8.05 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 159.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -111.94 119.64 39.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.272 1.429 . . . . 0.0 108.926 170.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.5 mm -78.28 119.79 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 173.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 83.4 mt -112.19 134.83 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.685 1.194 . . . . 0.0 109.783 -172.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.6 t -115.86 108.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 126.097 1.759 . . . . 0.0 107.982 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.78 -179.27 24.21 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.11 167.29 21.83 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.433 2.693 . . . . 0.0 110.245 175.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.33 -169.62 54.9 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.606 0.622 . . . . 0.0 112.247 -169.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -63.11 -32.48 73.87 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.089 -1.242 . . . . 0.0 111.352 168.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 70.3 m -54.89 8.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 1 C-N-CA 131.877 4.071 . . . . 0.0 118.474 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -103.95 146.42 28.71 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.628 1.171 . . . . 0.0 111.704 -172.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 21.6 mt -120.95 168.66 11.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.044 0.938 . . . . 0.0 110.926 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.0 t -145.88 159.38 43.3 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 172.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -132.72 130.46 40.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.347 1.459 . . . . 0.0 109.678 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -76.71 132.58 39.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.287 1.835 . . . . 0.0 111.63 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -133.2 151.22 51.95 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 122.208 1.004 . . . . 0.0 111.796 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -137.75 123.76 20.24 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 171.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -128.16 110.88 12.86 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.689 0.796 . . . . 0.0 111.755 -168.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 30.76 87.31 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 128.87 2.868 . . . . 0.0 117.175 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 120.34 29.05 1.68 Allowed Glycine 0 CA--C 1.533 1.202 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 159.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 99.7 p -128.73 -86.13 0.56 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.411 1.606 . . . . 0.0 111.307 167.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 88.0 p -91.53 -11.68 36.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.44 2.296 . . . . 0.0 112.938 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.3 tp -139.31 153.22 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.028 1.731 . . . . 0.0 110.528 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.64 -17.11 66.72 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.995 0.807 . . . . 0.0 114.483 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 6.8 tptp . . . . . 0 C--O 1.245 0.826 0 C-N-CA 126.548 1.939 . . . . 0.0 109.217 175.789 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 28.1 p -71.72 -5.17 31.99 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.493 1.517 . . . . 0.0 115.066 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -62.17 -12.05 17.77 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.823 1.649 . . . . 0.0 115.028 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.8 tt -125.86 125.83 43.47 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 163.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.5 m -55.6 -25.95 41.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.983 1.713 . . . . 0.0 114.699 -161.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.54 68.64 0.58 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.938 1.295 . . . . 0.0 111.411 171.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.494 ' HA ' ' HE3' ' A' ' 293' ' ' LYS . 0.4 OUTLIER -155.18 82.62 1.06 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.451 1.5 . . . . 0.0 110.865 169.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 70.31 -9.67 3.1 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 117.099 1.6 . . . . 0.0 117.099 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 65.1 p -54.92 -64.01 0.97 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.216 1.807 . . . . 0.0 113.232 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.9 m -173.23 128.69 0.45 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.678 1.991 . . . . 0.0 110.764 173.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -158.14 147.36 19.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.715 0.806 . . . . 0.0 111.801 168.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.82 96.89 0.31 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.329 1.452 . . . . 0.0 108.506 166.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -69.7 156.91 38.25 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.416 2.686 . . . . 0.0 115.177 -172.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 14.9 m -100.53 137.81 38.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.874 1.27 . . . . 0.0 109.787 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 66.7 p -138.15 4.31 2.46 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -80.54 165.55 22.01 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.876 1.216 . . . . 0.0 110.707 166.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -66.68 94.95 0.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.848 2.059 . . . . 0.0 111.366 -165.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 30.7 mtm -79.69 163.32 24.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.853 1.261 . . . . 0.0 112.317 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.4 p -150.43 161.88 41.65 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.556 1.143 . . . . 0.0 112.476 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -93.93 125.82 38.77 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.152 0.981 . . . . 0.0 108.723 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.72 -26.7 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 163.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -144.06 128.46 17.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.59 1.956 . . . . 0.0 108.743 171.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -59.22 143.81 84.29 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.961 0.904 . . . . 0.0 111.752 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -56.31 137.95 81.84 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.082 1.855 . . . . 0.0 111.513 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 41.2 p -132.49 124.59 28.83 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.37 1.068 . . . . 0.0 111.805 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -54.09 122.05 9.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.307 1.843 . . . . 0.0 111.517 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -84.24 -12.39 54.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.137 0.975 . . . . 0.0 113.296 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.95 -10.01 1.32 Allowed Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.271 0.939 . . . . 0.0 114.584 -167.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -83.38 7.02 17.95 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.29 1.545 . . . . 0.0 111.971 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 96.2 5.9 59.16 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.48 1.514 . . . . 0.0 113.713 -171.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.5 p -127.75 167.48 16.43 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.708 1.254 . . . . 0.0 112.825 -172.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.35 123.59 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.693 1.997 . . . . 0.0 107.817 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -110.32 131.7 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.74 1.216 . . . . 0.0 113.005 -170.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -138.45 167.13 22.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.685 1.594 . . . . 0.0 113.756 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -126.26 129.44 48.93 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.028 1.331 . . . . 0.0 108.594 166.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.1 m -127.26 154.87 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.79 0.836 . . . . 0.0 111.792 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -139.65 144.28 37.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.581 1.552 . . . . 0.0 111.717 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 12.7 p -120.04 154.23 55.56 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.153 2.181 . . . . 0.0 108.518 168.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 10.2 Cg_endo -113.31 -45.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.2 0 CA-C-N 122.205 1.823 . . . . 0.0 116.602 -165.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.7 164.68 32.79 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.928 -1.107 . . . . 0.0 112.447 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.37 4.95 26.21 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.888 1.709 . . . . 0.0 117.188 168.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.89 95.66 46.04 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.0 1.4 . . . . 0.0 113.094 -164.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.62 115.08 1.51 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.048 3.166 . . . . 0.0 109.249 154.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 9.3 p -163.36 144.39 9.3 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.99 107.11 9.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 162.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.278 0.7 OUTLIER -68.87 122.2 84.16 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.13 -155.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -64.2 116.02 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.062 2.508 . . . . 0.0 112.987 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.91 108.17 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.828 1.651 . . . . 0.0 110.312 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.09 156.92 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.437 1.495 . . . . 0.0 109.581 -170.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 42.5 t -142.62 122.13 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 120.98 -1.075 . . . . 0.0 109.39 -170.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.19 173.71 11.27 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -161.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -110.54 -1.99 16.67 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.517 1.527 . . . . 0.0 112.205 168.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -125.83 4.58 7.36 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.703 1.601 . . . . 0.0 113.996 -159.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 35.7 mt 62.56 -4.9 0.21 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.339 2.256 . . . . 0.0 115.52 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 5.0 t -125.33 0.71 7.73 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.074 1.307 . . . . 0.0 113.963 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 77.87 21.2 0.95 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.59 2.356 . . . . 0.0 113.945 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -61.43 -46.45 90.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.268 1.027 . . . . 0.0 111.475 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.7 mm -94.37 135.39 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' A' ' 293' ' ' LYS . 0.6 OUTLIER -132.64 86.68 2.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 123.415 1.579 . . . . 0.0 113.31 -167.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -82.6 -49.08 10.24 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.708 2.403 . . . . 0.0 113.097 -158.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -104.84 154.13 17.36 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -160.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.15 149.1 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 127.102 2.161 . . . . 0.0 109.749 -169.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.12 120.35 24.14 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.054 1.341 . . . . 0.0 109.277 170.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.93 -38.3 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.963 0.505 . . . . 0.0 111.052 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 366' ' ' GLU . 6.1 t -97.59 175.41 6.21 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.351 0.66 . . . . 0.0 111.058 166.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.74 128.52 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.726 1.211 . . . . 0.0 110.507 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -66.31 114.96 19.29 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.673 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.86 174.7 10.71 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.311 2.674 . . . . 0.0 113.394 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.33 120.99 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 127.223 2.209 . . . . 0.0 107.986 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.95 99.53 0.5 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.553 1.141 . . . . 0.0 109.506 167.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 26.1 t -102.16 -11.12 19.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.689 1.596 . . . . 0.0 112.79 175.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.59 152.33 33.27 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 147.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -72.86 -11.66 60.68 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 117.847 -1.073 . . . . 0.0 113.597 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.99 1.46 55.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.311 1.444 . . . . 0.0 112.457 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -54.18 134.14 44.44 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.443 1.116 . . . . 0.0 113.034 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.41 140.44 52.17 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.442 1.497 . . . . 0.0 110.634 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.35 142.63 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -158.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.06 127.8 33.63 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 129.491 3.116 . . . . 0.0 110.419 170.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 44.2 mt -137.85 144.62 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.096 0.558 . . . . 0.0 110.655 170.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLU . . . . . 0.557 ' H ' HG22 ' A' ' 351' ' ' THR . 11.1 mt-10 -116.1 139.05 50.7 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.562 1.545 . . . . 0.0 111.125 165.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.36 158.32 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.737 1.215 . . . . 0.0 111.801 175.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -118.1 105.26 47.28 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 126.978 2.111 . . . . 0.0 108.687 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -80.84 169.63 16.31 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.533 2.822 . . . . 0.0 111.147 172.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.83 175.96 8.95 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.422 2.082 . . . . 0.0 110.846 162.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -65.72 148.42 51.8 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.797 -0.564 . . . . 0.0 109.853 161.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.41 -162.51 33.4 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-O 122.426 1.014 . . . . 0.0 114.833 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.3 156.31 29.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.563 1.945 . . . . 0.0 113.941 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 64.0 m -170.03 159.79 7.84 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.667 1.987 . . . . 0.0 112.063 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -124.42 123.56 40.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.887 1.675 . . . . 0.0 107.934 157.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.6 mm -76.69 111.0 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 87.1 mt -100.95 130.98 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.687 1.131 . . . . 0.0 109.391 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 83.5 t -117.76 109.45 27.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.898 1.679 . . . . 0.0 107.838 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.9 -176.21 22.72 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 123.333 1.518 . . . . 0.0 116.604 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.57 171.96 13.39 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.167 2.587 . . . . 0.0 110.357 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.37 -171.87 45.83 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -61.16 -31.1 70.83 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.811 -0.817 . . . . 0.0 111.7 170.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 53.2 m -61.39 -8.15 3.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 129.571 3.148 . . . . 0.0 117.364 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -74.38 144.89 44.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.855 0.752 . . . . 0.0 111.449 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 31.8 mt -116.8 167.64 10.92 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.263 0.625 . . . . 0.0 110.719 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.3 t -146.55 159.12 43.83 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -134.57 131.25 37.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.418 1.487 . . . . 0.0 109.57 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -73.89 131.51 41.55 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.312 2.245 . . . . 0.0 112.344 -173.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -142.59 118.02 10.28 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.24 1.016 . . . . 0.0 111.888 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -105.78 105.14 15.04 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -74.93 150.88 38.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 -42.29 125.68 3.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.859 2.064 . . . . 0.0 114.209 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 120.23 10.27 7.47 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 117.78 1.872 . . . . 0.0 117.78 158.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 94.4 p -126.87 -94.66 0.45 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.299 2.049 . . . . 0.0 112.408 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 85.8 p -77.91 -11.59 59.91 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.508 1.923 . . . . 0.0 112.874 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.3 tt -142.09 156.42 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.819 1.647 . . . . 0.0 110.911 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -80.66 -38.75 15.85 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.122 -0.821 . . . . 0.0 113.51 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 4.8 tptp . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.632 2.373 . . . . 0.0 109.278 178.943 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 33.6 tpp . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 12.8 m -56.99 -15.49 5.08 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -167.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -82.6 -12.63 57.56 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.62 117.79 20.94 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.198 1.363 . . . . 0.0 114.113 -164.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 29.2 p 65.26 -154.09 0.27 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.806 2.042 . . . . 0.0 112.317 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.53 94.15 0.11 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.15 -0.968 . . . . 0.0 109.207 174.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 293' ' ' LYS . 1.0 OUTLIER -150.9 92.46 1.82 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 176.536 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.55 -25.2 0.61 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.92 1.724 . . . . 0.0 117.174 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 22.2 p -58.0 -45.21 87.19 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.257 1.528 . . . . 0.0 113.519 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 18.3 m -167.37 131.21 1.81 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.371 1.068 . . . . 0.0 112.124 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -153.64 158.49 41.18 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.141 1.376 . . . . 0.0 109.832 157.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 111.39 23.13 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 166.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.37 134.76 57.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.872 1.669 . . . . 0.0 114.594 -173.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.2 m -85.26 132.77 34.22 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 152.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 66.8 p -132.94 6.21 3.93 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -83.32 161.35 21.46 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.176 0.898 . . . . 0.0 111.052 164.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -63.62 104.32 0.64 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.137 1.775 . . . . 0.0 112.711 -159.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 24.3 mtm -87.63 164.86 15.82 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.047 0.927 . . . . 0.0 112.004 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.5 m -160.6 160.48 31.77 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.24 -0.912 . . . . 0.0 111.717 170.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.91 126.13 30.29 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 165.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 40.6 t -78.97 -24.21 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.506 0.722 . . . . 0.0 110.527 161.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -139.94 127.23 21.24 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.226 1.81 . . . . 0.0 108.203 166.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -55.41 144.11 53.96 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.642 1.177 . . . . 0.0 111.719 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -55.07 133.09 56.13 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.309 2.006 . . . . 0.0 110.989 170.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 61.4 p -133.74 129.73 37.08 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.202 1.001 . . . . 0.0 110.742 171.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.24 125.65 24.13 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.342 1.057 . . . . 0.0 111.143 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 61.9 p -80.47 -9.2 59.77 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.192 0.997 . . . . 0.0 113.093 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 74.66 -8.49 14.33 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.798 1.19 . . . . 0.0 114.033 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -90.0 4.82 49.0 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.88 1.34 . . . . 0.0 112.468 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.65 6.73 62.15 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.674 1.13 . . . . 0.0 113.59 -169.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.6 p -120.73 157.04 30.53 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.843 1.257 . . . . 0.0 111.214 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 15.0 t -130.86 118.76 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.346 1.458 . . . . 0.0 108.038 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.9 p -108.01 129.78 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.978 1.311 . . . . 0.0 113.134 -166.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -139.76 162.71 34.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.972 1.709 . . . . 0.0 113.374 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -116.26 129.25 56.18 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.099 1.359 . . . . 0.0 107.764 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.6 m -126.17 145.75 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.594 0.757 . . . . 0.0 111.312 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -125.92 144.09 50.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.641 1.176 . . . . 0.0 112.526 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.7 t -111.86 150.88 42.99 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 127.501 2.32 . . . . 0.0 107.785 163.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -110.26 -59.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.576 2.184 . . . . 0.0 116.169 -176.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.02 164.61 29.81 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.03 -1.044 . . . . 0.0 112.743 -176.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 64.41 7.07 24.46 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 117.622 1.809 . . . . 0.0 117.622 168.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.26 98.05 44.66 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 119.071 1.436 . . . . 0.0 113.279 -162.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.56 119.19 1.63 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.53 3.487 . . . . 0.0 110.072 157.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.2 p -161.1 157.91 26.8 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -172.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -88.46 112.51 23.04 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 157.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 333' ' ' PRO 0.297 0.5 OUTLIER -66.09 124.89 89.03 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.655 -160.477 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 4.7 Cg_exo -74.75 104.53 1.9 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.457 2.771 . . . . 0.0 111.824 -171.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 75.2 t -105.08 107.88 23.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.471 1.508 . . . . 0.0 109.87 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.43 160.18 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 122.276 1.036 . . . . 0.0 110.992 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 23.0 t -142.93 134.39 24.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -147.94 178.29 8.64 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.401 0.681 . . . . 0.0 112.046 -168.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -114.24 -6.2 13.0 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.648 0.779 . . . . 0.0 112.26 166.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -111.53 5.83 19.72 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.859 2.464 . . . . 0.0 113.788 -165.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 13.6 mt 64.16 -3.59 0.47 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.223 2.209 . . . . 0.0 115.048 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.6 t -126.89 -6.34 6.17 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -174.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 337' ' ' ALA . . . 80.04 25.67 0.36 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 127.968 2.507 . . . . 0.0 113.832 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.2 81.24 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 166.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.83 138.42 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.826 0.85 . . . . 0.0 109.27 159.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.98 74.44 0.88 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 123.014 1.387 . . . . 0.0 109.178 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -76.61 -51.42 11.63 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 126.656 1.982 . . . . 0.0 114.089 -158.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -112.61 153.34 17.53 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 116.065 1.186 . . . . 0.0 116.065 -161.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.3 152.77 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 129.724 3.209 . . . . 0.0 110.171 -168.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.96 123.66 30.78 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.919 1.288 . . . . 0.0 110.101 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.66 -47.25 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.066 0.546 . . . . 0.0 110.16 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.7 t -86.79 178.19 7.08 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.262 1.025 . . . . 0.0 111.901 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.1 m -60.78 131.44 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.275 1.43 . . . . 0.0 111.063 169.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.26 116.03 46.89 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 120.989 -1.07 . . . . 0.0 110.036 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.69 -179.03 5.08 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 124.058 3.172 . . . . 0.0 113.777 -172.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.26 141.2 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.32 1.448 . . . . 0.0 108.598 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -86.84 100.37 12.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.997 0.919 . . . . 0.0 109.577 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -96.4 -16.0 21.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.81 0.844 . . . . 0.0 112.549 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.59 130.67 53.66 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 126.502 1.921 . . . . 0.0 106.676 165.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -66.04 -18.19 65.18 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.326 -1.484 . . . . 0.0 114.133 -165.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -78.84 -2.62 40.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.919 1.687 . . . . 0.0 113.637 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -51.42 133.04 29.9 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.4 1.571 . . . . 0.0 112.937 -170.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -140.81 123.73 16.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.742 2.017 . . . . 0.0 108.665 -164.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 10.5 p -149.04 142.28 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -155.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.97 125.31 26.51 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 128.566 2.747 . . . . 0.0 110.195 170.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 23.6 mt -135.44 140.54 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.195 0.522 . . . . 0.0 110.965 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -116.33 136.06 53.33 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.593 1.557 . . . . 0.0 110.775 166.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.68 159.0 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.768 1.227 . . . . 0.0 112.2 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -129.23 103.88 18.16 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.481 1.912 . . . . 0.0 109.768 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.79 163.85 30.85 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 121.886 1.724 . . . . 0.0 110.642 167.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -60.34 177.27 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.101 2.534 . . . . 0.0 111.746 157.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -60.98 141.12 57.56 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.623 -0.673 . . . . 0.0 110.595 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 96.31 -161.26 22.3 Favored Glycine 0 CA--C 1.535 1.327 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -67.6 159.53 29.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.772 1.629 . . . . 0.0 114.657 -169.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 22.6 m -170.02 164.37 9.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.729 1.612 . . . . 0.0 112.663 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -127.24 116.09 20.04 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 129.453 3.101 . . . . 0.0 107.395 165.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.6 mm -77.11 121.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.18 130.33 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.571 1.078 . . . . 0.0 109.511 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.7 t -114.92 105.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.584 1.154 . . . . 0.0 108.456 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.22 -177.41 20.87 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 123.091 1.384 . . . . 0.0 116.312 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.9 163.93 28.42 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.627 2.371 . . . . 0.0 110.46 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 80.76 -170.09 52.82 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.018 0.818 . . . . 0.0 112.989 -170.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -65.07 -23.87 67.29 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.951 -1.323 . . . . 0.0 111.814 167.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 72.8 m -62.61 -2.52 1.13 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 130.676 3.59 . . . . 0.0 117.676 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.52 147.92 22.55 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.452 1.024 . . . . 0.0 112.371 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 17.6 mt -113.39 165.41 12.48 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.416 0.686 . . . . 0.0 110.951 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.4 t -145.23 158.59 43.79 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 167.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -140.79 134.88 30.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.567 1.947 . . . . 0.0 109.029 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -74.29 138.08 43.33 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.225 1.41 . . . . 0.0 111.699 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -144.53 118.52 9.39 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.653 0.781 . . . . 0.0 112.991 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.92 117.09 33.49 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.84 1.256 . . . . 0.0 109.109 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -95.7 151.48 19.32 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.66 0.784 . . . . 0.0 110.059 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -37.97 110.89 0.14 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.796 2.438 . . . . 0.0 112.022 171.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 152.73 -97.99 0.18 Allowed Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.708 -0.495 . . . . 0.0 113.76 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.4 p -66.67 -41.27 88.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 63.8 p -135.59 -5.41 2.25 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -162.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 5.7 tp -147.66 158.92 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.796 0.838 . . . . 0.0 110.378 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -78.89 -50.66 5.8 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.429 1.014 . . . . 0.0 112.103 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 3.8 tptp . . . . . 0 C--O 1.251 1.167 0 C-N-CA 128.832 2.853 . . . . 0.0 107.262 167.828 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 13.3 mmt . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 118.967 -0.539 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 22.7 p -75.38 -4.34 38.83 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -165.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -63.75 -6.01 5.03 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.934 1.294 . . . . 0.0 114.34 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 67.4 tp -117.97 123.09 44.91 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.601 1.96 . . . . 0.0 109.265 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.4 m -40.09 -45.86 2.05 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.777 2.431 . . . . 0.0 116.357 -163.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.81 -22.04 65.19 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.029 0.931 . . . . 0.0 112.837 -177.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.473 ' HE3' HD23 ' A' ' 349' ' ' LEU . 0.0 OUTLIER -80.97 70.14 7.72 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.179 -1.575 . . . . 0.0 109.08 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 86.04 -50.0 4.2 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.078 1.323 . . . . 0.0 113.548 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.9 m -48.71 -41.91 33.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.6 1.96 . . . . 0.0 115.111 -167.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.6 m -162.12 123.3 2.66 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.603 1.547 . . . . 0.0 113.278 166.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -159.12 159.58 34.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.197 1.399 . . . . 0.0 111.157 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.98 103.9 11.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.377 2.271 . . . . 0.0 105.082 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -73.9 151.88 40.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.2 1.4 . . . . 0.0 114.165 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.2 m -95.75 150.92 19.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.354 0.661 . . . . 0.0 110.205 166.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.1 p -133.41 9.36 4.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.787 1.235 . . . . 0.0 113.705 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -79.24 154.55 29.1 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 120.348 1.431 . . . . 0.0 111.107 164.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 109.58 0.9 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.387 2.275 . . . . 0.0 111.89 -170.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 19.0 mtt -87.54 170.47 11.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.9 m -156.93 153.28 27.86 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.346 -0.846 . . . . 0.0 112.685 157.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.82 125.52 29.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.88 0.872 . . . . 0.0 109.343 160.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 5.3 t -82.43 -24.35 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.03 1.332 . . . . 0.0 110.873 172.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -134.24 125.6 28.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.283 2.233 . . . . 0.0 106.708 170.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -56.8 146.93 55.46 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 123.655 0.597 . . . . 0.0 111.154 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -56.66 124.35 16.05 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.507 1.471 . . . . 0.0 110.019 166.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.3 p -125.41 125.78 43.92 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.229 1.011 . . . . 0.0 110.977 170.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.62 121.32 11.9 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.839 0.712 . . . . 0.0 110.54 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 59.1 p -79.45 -7.28 58.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.201 1.4 . . . . 0.0 113.224 -173.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.56 -7.06 2.21 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.738 -164.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -86.68 6.17 32.47 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.659 1.729 . . . . 0.0 111.856 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.47 -2.0 67.23 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.088 1.328 . . . . 0.0 113.648 -170.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 27.9 p -119.07 166.89 12.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.112 1.365 . . . . 0.0 112.002 -170.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.48 114.79 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.014 1.726 . . . . 0.0 108.027 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.29 136.34 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.322 1.049 . . . . 0.0 113.235 -168.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -147.24 167.09 25.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.675 1.99 . . . . 0.0 112.996 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -115.32 134.89 54.7 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.47 1.908 . . . . 0.0 106.819 161.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 23.5 m -132.13 148.54 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.678 0.672 . . . . 0.0 111.703 176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -135.31 146.8 48.83 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.709 1.204 . . . . 0.0 112.272 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 22.8 m -115.13 157.65 43.03 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.604 1.561 . . . . 0.0 110.704 165.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 24.2 Cg_endo -114.99 -54.49 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.479 2.119 . . . . 0.0 116.673 -171.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.64 175.3 9.8 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.164 1.802 . . . . 0.0 113.596 177.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.18 -13.47 0.23 Allowed Glycine 0 CA--C 1.541 1.716 0 N-CA-C 119.314 2.486 . . . . 0.0 119.314 164.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.48 104.78 54.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 119.939 1.87 . . . . 0.0 114.715 -159.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.41 117.25 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.746 2.964 . . . . 0.0 110.524 158.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.0 p -163.45 148.72 11.2 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -76.06 98.94 4.46 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 155.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.71 113.58 6.28 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 123.701 0.801 . . . . 0.0 111.305 -161.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.52 104.18 1.67 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.251 2.634 . . . . 0.0 112.942 -168.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 81.1 t -101.4 116.98 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 127.076 2.15 . . . . 0.0 109.726 172.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.26 161.43 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.375 1.07 . . . . 0.0 110.782 -176.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' VAL . . . . . 0.52 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 46.8 t -138.67 133.62 42.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -142.8 169.55 17.35 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.374 0.67 . . . . 0.0 111.652 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -102.22 1.74 36.31 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.243 0.617 . . . . 0.0 111.622 162.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -117.99 5.1 12.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.078 1.751 . . . . 0.0 114.473 -165.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 15.9 mt 61.89 -7.76 0.11 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.492 2.317 . . . . 0.0 116.098 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.7 t -121.75 -5.6 9.14 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.393 1.452 . . . . 0.0 114.132 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 63.47 44.57 5.27 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.78 2.032 . . . . 0.0 113.008 -173.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.91 99.06 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 159.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 22.1 mt -92.84 138.13 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.945 1.698 . . . . 0.0 108.745 166.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -109.25 70.97 0.75 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.226 1.012 . . . . 0.0 109.375 171.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -64.24 -63.0 1.26 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.647 2.379 . . . . 0.0 112.556 -161.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.52 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -96.67 171.21 27.38 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.864 1.697 . . . . 0.0 115.537 -168.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.1 150.58 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 128.299 2.64 . . . . 0.0 110.915 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.473 HD23 ' HE3' ' A' ' 293' ' ' LYS . 3.7 mm? -85.98 122.82 30.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.059 1.744 . . . . 0.0 108.358 165.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 28.2 t -86.54 -43.79 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.359 0.527 . . . . 0.0 111.033 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 366' ' ' GLU . 4.9 t -101.1 175.3 5.64 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.551 0.691 . . . . 0.0 112.017 172.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.41 124.17 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.587 1.555 . . . . 0.0 112.859 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -81.01 122.17 81.51 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.1 0.96 . . . . 0.0 109.709 166.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -81.75 -171.45 1.21 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.615 3.543 . . . . 0.0 112.815 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.42 129.32 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.332 1.453 . . . . 0.0 107.321 165.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.68 81.93 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.794 1.238 . . . . 0.0 111.666 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 27.7 t -85.57 -10.53 55.78 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.143 0.977 . . . . 0.0 112.49 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.8 127.54 50.7 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 128.201 2.6 . . . . 0.0 106.036 170.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -67.6 -17.46 64.63 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.405 -1.434 . . . . 0.0 113.595 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.24 1.84 26.84 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 127.488 2.315 . . . . 0.0 114.032 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.77 133.55 6.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.667 1.222 . . . . 0.0 113.937 -168.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -141.87 138.31 32.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.454 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 13.8 p -147.82 146.03 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.79 0.805 . . . . 0.0 112.905 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -75.19 120.23 20.4 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.382 2.673 . . . . 0.0 109.193 166.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mt -132.37 139.3 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.892 0.769 . . . . 0.0 111.871 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' GLU . . . . . 0.468 ' H ' HG22 ' A' ' 351' ' ' THR . 31.3 mt-10 -111.17 135.66 51.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 110.206 161.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 31.4 m -117.74 161.01 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.344 1.057 . . . . 0.0 111.004 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -131.86 101.77 15.21 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.807 1.643 . . . . 0.0 109.153 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.36 164.71 28.54 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.075 1.85 . . . . 0.0 110.72 164.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.16 175.6 0.24 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.83 3.02 . . . . 0.0 113.313 160.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -58.55 144.23 43.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.278 0.631 . . . . 0.0 110.745 163.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 94.66 -142.97 16.31 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 115.469 0.948 . . . . 0.0 115.469 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.22 154.95 32.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.164 1.786 . . . . 0.0 113.21 -168.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 18.1 m -167.98 161.45 12.8 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.797 1.239 . . . . 0.0 113.5 168.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -124.75 110.34 14.22 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 127.963 2.505 . . . . 0.0 107.261 163.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 9.5 mm -73.85 124.97 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.2 mt -117.87 135.83 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.708 1.203 . . . . 0.0 109.145 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 68.6 t -126.51 97.13 3.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 126.393 1.877 . . . . 0.0 107.481 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 115.6 173.29 17.39 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 116.088 1.195 . . . . 0.0 116.088 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 74.0 p -130.58 173.06 11.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.989 1.716 . . . . 0.0 110.523 167.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 78.22 -161.31 48.74 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 -169.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -69.03 -30.78 69.22 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.476 -1.014 . . . . 0.0 111.597 167.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 54.7 m -58.44 -5.47 0.53 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 130.226 3.41 . . . . 0.0 118.411 -174.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -85.8 139.77 31.02 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.983 0.913 . . . . 0.0 111.669 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.1 mt -104.05 163.64 12.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 110.087 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.2 t -147.02 156.1 42.76 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 169.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -136.19 117.12 14.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.363 1.865 . . . . 0.0 108.69 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -65.21 134.92 54.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.17 0.988 . . . . 0.0 110.816 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -133.43 134.89 44.18 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.297 1.039 . . . . 0.0 110.891 171.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -115.64 126.76 54.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -127.0 150.23 49.53 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.582 1.553 . . . . 0.0 109.001 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -27.39 107.69 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.979 1.711 . . . . 0.0 114.326 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 159.75 -124.35 1.34 Allowed Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.971 -0.455 . . . . 0.0 114.167 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 4.5 p -55.72 -38.59 69.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.227 2.211 . . . . 0.0 115.067 -171.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 57.5 p -132.21 -1.74 3.6 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -166.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.4 tp -154.3 157.29 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.816 0.846 . . . . 0.0 111.212 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.8 -16.45 67.93 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.94 -0.922 . . . . 0.0 115.072 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 10.5 tptp . . . . . 0 C--O 1.276 2.483 0 CA-C-O 115.951 -1.976 . . . . 0.0 109.699 175.534 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 119.418 -0.325 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 40.7 p -113.06 -14.36 12.97 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.468 1.907 . . . . 0.0 114.316 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.99 1.34 2.76 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 10.4 mp -98.91 140.35 33.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.435 1.894 . . . . 0.0 109.223 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 22.3 p -41.01 -69.05 0.15 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.93 2.092 . . . . 0.0 113.148 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.43 -12.84 16.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.51 1.524 . . . . 0.0 113.817 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.45 59.12 0.87 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.899 -1.125 . . . . 0.0 111.544 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 88.38 -43.15 3.1 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.671 1.605 . . . . 0.0 113.477 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 19.1 m -63.17 -34.55 77.86 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -168.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 34.3 m -165.41 110.58 0.89 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 121.16 1.8 . . . . 0.0 114.252 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.51 156.77 43.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.94 1.296 . . . . 0.0 111.309 164.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.66 97.35 2.65 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 158.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -68.42 154.91 40.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.852 2.461 . . . . 0.0 115.153 -171.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.7 m -102.7 140.6 36.76 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.0 1.32 . . . . 0.0 109.428 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.7 p -138.16 5.9 2.56 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -78.63 160.43 27.55 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.781 1.173 . . . . 0.0 110.517 162.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.11 98.02 0.42 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.09 2.156 . . . . 0.0 112.236 -161.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' MET . . . . . 0.408 ' HE1' ' H ' ' A' ' 380' ' ' THR . 32.2 mtm -82.38 165.71 20.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.098 0.959 . . . . 0.0 111.919 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.4 m -160.62 163.53 32.54 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.363 -0.835 . . . . 0.0 111.768 169.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.1 125.9 30.09 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 164.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.64 -27.74 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.621 0.768 . . . . 0.0 109.737 159.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -144.29 119.06 9.86 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.541 2.337 . . . . 0.0 108.062 170.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -52.86 145.16 23.42 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.785 1.234 . . . . 0.0 111.803 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.36 129.65 35.8 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.916 2.411 . . . . 0.0 111.948 173.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.9 p -126.56 132.49 51.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.839 0.856 . . . . 0.0 111.093 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -61.9 135.89 57.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.026 1.73 . . . . 0.0 112.026 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.3 p -91.26 -13.41 32.78 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 64.94 0.11 4.95 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.979 1.276 . . . . 0.0 114.752 -167.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -90.53 9.75 28.17 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.992 1.396 . . . . 0.0 111.748 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.59 15.5 65.83 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.771 -1.016 . . . . 0.0 113.583 -167.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 22.3 p -131.51 168.83 16.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.001 1.401 . . . . 0.0 113.021 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.84 130.75 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.104 1.762 . . . . 0.0 108.245 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.91 133.34 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.511 1.124 . . . . 0.0 112.368 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -140.61 163.47 32.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.835 1.654 . . . . 0.0 113.155 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -120.7 123.7 43.36 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.814 1.246 . . . . 0.0 107.742 164.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.44 147.96 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.786 0.835 . . . . 0.0 111.678 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -132.68 142.45 49.08 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.393 1.477 . . . . 0.0 113.205 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 t -107.73 143.24 26.88 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.35 2.66 . . . . 0.0 107.829 162.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -103.36 -62.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.264 1.976 . . . . 0.0 115.679 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.48 170.45 15.9 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.808 1.185 . . . . 0.0 113.166 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.09 -14.27 0.44 Allowed Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.968 2.223 . . . . 0.0 117.692 171.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.03 99.8 44.32 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 119.204 1.502 . . . . 0.0 113.327 -167.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.19 113.52 3.2 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.288 2.659 . . . . 0.0 108.878 157.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 16.2 p -158.92 148.19 18.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -170.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.57 99.34 5.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.44 1.496 . . . . 0.0 106.997 161.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.267 0.9 OUTLIER -61.28 114.13 9.91 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 123.222 0.326 . . . . 0.0 111.617 -159.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.07 113.5 3.72 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.954 2.436 . . . . 0.0 112.668 -167.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.12 115.81 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.0 2.12 . . . . 0.0 109.424 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 159.31 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.662 1.185 . . . . 0.0 110.434 -175.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' VAL . . . . . 0.484 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 51.0 t -140.22 114.71 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.472 1.109 . . . . 0.0 108.136 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -144.49 170.18 16.54 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.018 0.826 . . . . 0.0 113.055 -169.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -106.39 6.37 30.33 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.947 0.899 . . . . 0.0 112.07 171.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -115.87 2.5 13.58 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.093 1.757 . . . . 0.0 113.98 -163.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 49.4 mt 60.68 3.9 0.68 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.737 2.415 . . . . 0.0 115.397 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 3.7 t -137.13 -9.36 1.76 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -173.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 55.82 51.59 12.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.858 2.063 . . . . 0.0 113.423 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -68.83 -34.97 76.38 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 157.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 44.8 mm -111.24 141.55 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.341 1.456 . . . . 0.0 108.71 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -114.8 128.4 56.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.86 0.838 . . . . 0.0 110.899 165.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -87.56 -68.24 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.494 2.318 . . . . 0.0 110.227 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.484 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -93.33 166.78 28.43 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.224 1.392 . . . . 0.0 116.41 -162.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.7 152.85 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 128.027 2.531 . . . . 0.0 110.026 -167.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.0 127.45 31.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.837 1.255 . . . . 0.0 109.448 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.1 t -90.19 -37.42 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.176 0.444 . . . . 0.0 111.141 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 366' ' ' GLU . 6.1 t -106.61 173.49 6.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 112.072 175.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.8 m -66.47 126.94 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.475 1.51 . . . . 0.0 112.177 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -96.0 129.57 33.67 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.653 1.581 . . . . 0.0 110.065 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -83.94 -176.48 2.67 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.263 3.309 . . . . 0.0 114.649 -168.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.47 120.81 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.686 2.394 . . . . 0.0 107.946 168.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.02 74.25 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.908 1.683 . . . . 0.0 112.97 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -67.09 -16.02 64.07 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 171.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.5 p -127.96 139.4 52.6 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 127.298 2.239 . . . . 0.0 106.074 157.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.7 -15.57 63.71 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -167.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.29 -2.0 14.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.03 2.532 . . . . 0.0 114.608 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -40.12 118.48 0.9 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.843 2.057 . . . . 0.0 114.264 -174.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.92 131.86 33.65 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.399 1.48 . . . . 0.0 111.427 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.76 148.76 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -160.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -75.8 126.26 30.66 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 128.513 2.725 . . . . 0.0 109.975 166.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 25.9 mt -136.1 137.59 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.76 0.709 . . . . 0.0 111.271 173.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' GLU . . . . . 0.424 ' H ' HG22 ' A' ' 351' ' ' THR . 16.1 mt-10 -105.93 137.74 43.32 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.648 1.179 . . . . 0.0 111.542 159.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.5 150.73 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.311 1.444 . . . . 0.0 111.294 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -110.57 101.0 47.56 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.081 2.153 . . . . 0.0 109.078 175.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.21 162.84 31.03 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.776 2.318 . . . . 0.0 110.935 166.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.76 176.42 3.63 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.427 2.085 . . . . 0.0 111.663 162.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -70.97 147.43 48.69 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.894 -0.504 . . . . 0.0 111.117 165.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 95.35 -159.42 22.55 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.218 0.913 . . . . 0.0 113.492 -172.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.1 158.58 25.47 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.496 1.518 . . . . 0.0 114.9 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.9 m -167.57 150.3 5.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.838 1.655 . . . . 0.0 111.419 162.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -104.74 116.63 32.35 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.379 1.472 . . . . 0.0 108.15 155.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.9 mm -67.33 130.83 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 165.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.29 130.45 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.85 1.26 . . . . 0.0 108.828 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.8 t -117.54 100.02 9.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.393 1.877 . . . . 0.0 107.772 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 106.73 -178.48 22.32 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 123.096 1.387 . . . . 0.0 115.604 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' THR . . . . . 0.408 ' H ' ' HE1' ' A' ' 304' ' ' MET . 1.0 OUTLIER -135.5 169.76 17.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.098 2.559 . . . . 0.0 110.719 175.34 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 81.21 -166.9 48.67 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.925 0.774 . . . . 0.0 112.341 -171.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -65.21 -33.29 75.65 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.143 -1.21 . . . . 0.0 110.908 164.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 63.0 m -56.89 -1.59 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 131.041 3.736 . . . . 0.0 118.455 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -88.76 148.37 23.98 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.135 0.974 . . . . 0.0 111.684 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.0 mt -109.67 167.0 10.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.149 0.58 . . . . 0.0 110.837 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 9.9 t -147.06 159.27 43.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 172.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -149.82 125.99 10.68 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.55 1.54 . . . . 0.0 110.585 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.61 138.16 39.94 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 112.549 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -142.5 138.09 30.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.226 1.41 . . . . 0.0 111.457 164.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -118.31 129.09 55.25 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.82 1.248 . . . . 0.0 109.759 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -85.63 144.81 27.64 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 392' ' ' GLU . 5.6 pm0 -56.9 156.2 7.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 130.407 3.483 . . . . 0.0 115.857 -173.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 83.6 28.78 34.54 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.551 1.072 . . . . 0.0 113.499 -170.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' SER . . . . . 0.407 ' OG ' ' OXT' ' A' ' 398' ' ' LYS . 63.6 p -108.93 175.44 5.46 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.086 1.754 . . . . 0.0 115.465 -163.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 42.5 p -66.84 -18.59 65.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.127 1.771 . . . . 0.0 114.486 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 14.1 pt -91.79 6.38 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.69 1.132 . . . . 0.0 113.314 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 86.71 5.95 80.79 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 123.954 0.788 . . . . 0.0 114.441 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.407 ' OXT' ' OG ' ' A' ' 394' ' ' SER . 54.2 tttm . . . . . 0 C--O 1.246 0.871 0 C-N-CA 127.234 2.213 . . . . 0.0 108.14 169.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 33.7 p -123.29 -12.69 7.8 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -172.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.85 23.31 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.5 2.32 . . . . 0.0 115.853 -172.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 45.0 tp -142.46 148.41 37.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.885 1.674 . . . . 0.0 110.052 -175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 23.6 p -41.6 -63.15 0.75 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.307 2.643 . . . . 0.0 113.26 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.04 -13.84 13.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.356 2.262 . . . . 0.0 114.037 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.78 64.11 0.79 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.093 -1.63 . . . . 0.0 110.177 -177.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 78.13 -38.04 1.77 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.971 1.748 . . . . 0.0 114.095 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.1 m -54.01 -47.54 71.4 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.917 1.287 . . . . 0.0 114.273 -170.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 8.6 m -178.26 115.0 0.07 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 120.262 1.392 . . . . 0.0 112.458 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -155.89 155.62 33.2 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.567 0.747 . . . . 0.0 111.468 164.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.47 99.78 5.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.905 1.282 . . . . 0.0 108.723 169.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.91 162.34 22.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.029 1.332 . . . . 0.0 113.864 -177.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' CYS . . . . . 0.418 ' H ' ' HD3' ' A' ' 333' ' ' PRO . 3.3 m -92.94 149.47 21.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.424 0.689 . . . . 0.0 109.653 168.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 77.8 p -136.85 6.28 2.9 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -78.63 158.98 28.29 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.467 1.03 . . . . 0.0 111.457 165.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.35 92.15 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.51 2.324 . . . . 0.0 112.635 -167.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 15.3 mtm -76.26 166.96 22.7 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.905 1.282 . . . . 0.0 112.618 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.9 m -158.23 157.23 32.18 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.113 -0.992 . . . . 0.0 112.774 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.42 120.24 25.64 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.52 0.728 . . . . 0.0 110.363 166.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.91 -27.99 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.082 1.753 . . . . 0.0 110.67 165.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -142.63 125.87 16.5 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.532 1.933 . . . . 0.0 108.024 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -57.43 144.88 70.31 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.385 1.074 . . . . 0.0 111.513 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.95 129.33 33.68 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.827 2.351 . . . . 0.0 111.529 170.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 41.2 p -124.21 123.15 39.64 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.373 1.069 . . . . 0.0 110.289 171.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -63.65 136.34 57.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.983 1.313 . . . . 0.0 111.157 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.8 p -89.62 -14.95 33.84 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.326 1.05 . . . . 0.0 113.065 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.24 -12.13 1.31 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.408 1.004 . . . . 0.0 114.405 -164.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -84.57 14.46 4.57 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.903 1.681 . . . . 0.0 112.057 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.37 5.18 63.74 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.679 1.133 . . . . 0.0 114.14 -172.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 64.9 p -131.68 165.86 22.77 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.937 1.368 . . . . 0.0 113.819 -170.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.62 138.09 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 127.854 2.462 . . . . 0.0 107.675 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 6.7 p -119.62 132.16 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.309 0.959 . . . . 0.0 112.517 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -139.92 167.16 22.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.503 1.521 . . . . 0.0 113.454 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -124.0 129.87 51.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.437 1.495 . . . . 0.0 107.583 166.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.52 150.76 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.061 0.944 . . . . 0.0 112.378 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -132.51 142.41 49.19 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.49 1.516 . . . . 0.0 112.818 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.09 148.46 37.53 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 128.226 2.611 . . . . 0.0 108.216 167.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -100.13 -72.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.59 2.193 . . . . 0.0 115.745 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.79 165.37 27.18 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.556 1.525 . . . . 0.0 114.388 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 69.33 -8.19 3.04 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 126.497 1.999 . . . . 0.0 117.274 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -108.49 99.86 35.2 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 119.078 1.439 . . . . 0.0 113.199 -168.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.99 121.95 6.47 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.789 2.326 . . . . 0.0 108.746 152.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.1 p -165.59 154.17 11.58 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -173.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -83.33 110.77 18.4 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 156.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.257 1.3 pp -67.45 132.29 93.06 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 120.324 -0.55 . . . . 0.0 112.349 -155.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.418 ' HD3' ' H ' ' A' ' 300' ' ' CYS . 73.8 Cg_endo -72.42 91.47 0.77 Allowed 'Trans proline' 0 CA--C 1.54 0.784 1 C-N-CA 125.449 4.099 . . . . 0.0 113.734 -168.776 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.09 117.03 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.215 1.406 . . . . 0.0 109.365 166.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.48 162.56 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.206 1.803 . . . . 0.0 109.359 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.62 127.3 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -136.48 174.56 10.49 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -170.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -118.6 -6.68 10.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.028 2.131 . . . . 0.0 112.966 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 29.5 p30 -106.98 0.48 23.75 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.063 2.145 . . . . 0.0 113.61 -166.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 74.7 mt 57.17 5.22 0.24 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.795 2.438 . . . . 0.0 115.734 -170.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.9 t -127.74 -3.12 5.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.427 1.491 . . . . 0.0 114.461 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 52.39 45.72 27.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.919 2.088 . . . . 0.0 113.584 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -72.93 -38.76 66.7 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 163.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 19.1 mm -108.05 128.67 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.774 1.23 . . . . 0.0 109.717 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -97.17 109.31 22.09 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.62 0.724 . . . . 0.0 111.829 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -63.99 -62.98 1.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.752 3.221 . . . . 0.0 112.789 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -104.23 -171.5 25.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.499 1.523 . . . . 0.0 115.756 -160.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 3.3 mm -132.68 152.74 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.755 2.022 . . . . 0.0 111.302 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.9 129.01 34.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.414 1.485 . . . . 0.0 109.507 170.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.35 -36.86 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.266 0.626 . . . . 0.0 110.737 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.574 ' HB ' ' H ' ' A' ' 366' ' ' GLU . 1.2 m -105.4 162.06 13.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.013 1.325 . . . . 0.0 111.478 175.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.5 m -47.82 107.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 127.367 2.267 . . . . 0.0 114.215 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -73.89 117.66 63.0 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.306 1.042 . . . . 0.0 109.595 162.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -82.33 -175.73 2.63 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.334 3.356 . . . . 0.0 114.118 -171.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 117.79 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.308 2.243 . . . . 0.0 107.808 170.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.67 74.62 0.82 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.547 1.139 . . . . 0.0 112.552 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -69.53 -18.7 63.69 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 23.3 p -123.81 121.27 34.98 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 127.148 2.179 . . . . 0.0 105.936 162.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.43 -18.87 53.84 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -166.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -71.79 3.96 3.7 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.507 1.923 . . . . 0.0 113.791 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -39.59 126.48 1.88 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.593 2.357 . . . . 0.0 113.913 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -141.3 112.1 7.14 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.868 2.067 . . . . 0.0 109.058 -168.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.14 148.37 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -160.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -86.65 124.53 33.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.523 2.729 . . . . 0.0 109.221 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 55.9 mt -135.31 132.21 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.409 0.623 . . . . 0.0 111.2 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' GLU . . . . . 0.574 ' H ' ' HB ' ' A' ' 351' ' ' THR . 25.0 mp0 -97.36 138.63 34.52 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.648 1.579 . . . . 0.0 111.497 161.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 22.1 t -129.19 153.93 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 127.564 2.345 . . . . 0.0 109.152 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -118.96 114.99 35.01 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.808 2.043 . . . . 0.0 109.576 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -82.81 162.0 16.21 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.207 2.604 . . . . 0.0 110.685 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -74.41 178.46 7.0 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.541 2.16 . . . . 0.0 110.738 163.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -71.02 130.84 42.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.009 1.324 . . . . 0.0 109.733 171.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.55 -143.55 16.34 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.12 0.866 . . . . 0.0 112.884 -176.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.12 152.69 42.15 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.185 2.594 . . . . 0.0 114.477 -173.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 17.0 m -166.36 153.18 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 113.145 167.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -120.53 109.6 15.46 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 128.36 2.664 . . . . 0.0 106.846 165.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 16.3 mm -68.13 120.01 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 172.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 80.7 mt -114.18 126.9 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.488 1.115 . . . . 0.0 109.067 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.8 t -119.69 101.81 11.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.794 1.638 . . . . 0.0 107.176 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 123.07 172.28 13.83 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 123.074 1.374 . . . . 0.0 115.903 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.5 161.05 39.05 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.507 2.323 . . . . 0.0 109.057 173.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.47 -167.42 53.43 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 -163.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -62.36 -31.6 72.27 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.775 -0.838 . . . . 0.0 111.869 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.2 m -55.65 3.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 130.642 3.577 . . . . 0.0 117.875 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -97.1 142.86 28.52 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.401 1.08 . . . . 0.0 111.859 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 22.2 mt -114.93 166.4 11.83 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.77 0.828 . . . . 0.0 110.678 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.2 t -146.1 161.89 39.16 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -145.68 128.38 16.21 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.028 1.731 . . . . 0.0 109.353 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -78.92 138.28 38.02 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.733 1.213 . . . . 0.0 111.67 -175.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -143.12 140.3 30.78 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.704 1.202 . . . . 0.0 111.651 168.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -110.04 138.18 46.77 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.765 0.826 . . . . 0.0 109.399 164.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.95 113.27 25.48 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.851 1.66 . . . . 0.0 108.383 173.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 88.16 146.44 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 129.706 3.202 . . . . 0.0 112.069 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -86.36 60.81 4.51 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.456 1.027 . . . . 0.0 113.815 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 26.2 m -60.24 12.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.185 2.194 . . . . 0.0 116.603 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 63.9 p -81.76 -15.73 53.36 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.17 1.788 . . . . 0.0 113.976 172.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.87 -24.66 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.596 1.158 . . . . 0.0 113.173 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 165.75 178.32 38.62 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 126.58 2.038 . . . . 0.0 109.548 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.873 -1.537 . . . . 0.0 109.942 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 12.5 mmt . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 118.967 -0.539 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 59.7 p -96.62 -2.77 44.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.99 1.316 . . . . 0.0 114.488 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.63 18.39 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.474 2.31 . . . . 0.0 116.15 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 39.7 tp -133.7 138.16 45.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.707 2.003 . . . . 0.0 108.088 172.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.6 p -35.66 -62.93 0.38 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.733 2.413 . . . . 0.0 113.619 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 49.1 tp -55.76 -12.21 1.22 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.184 2.594 . . . . 0.0 115.319 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 69.1 0.85 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 120.443 -1.41 . . . . 0.0 110.948 -170.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.89 -45.03 2.15 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.272 1.415 . . . . 0.0 113.277 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 90.9 m -48.91 -51.74 28.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.807 2.443 . . . . 0.0 115.013 -171.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 14.0 m -175.38 122.56 0.21 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.674 1.579 . . . . 0.0 113.119 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -157.79 154.14 27.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.385 1.074 . . . . 0.0 112.135 168.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.42 101.37 6.36 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.788 1.235 . . . . 0.0 108.455 166.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.65 153.1 37.43 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.45 1.9 . . . . 0.0 115.003 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 12.8 m -94.08 141.4 28.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.205 1.002 . . . . 0.0 109.319 164.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 80.7 p -135.46 2.52 2.98 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.71 164.1 23.99 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.592 1.087 . . . . 0.0 111.012 166.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -62.01 105.59 0.6 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.286 1.834 . . . . 0.0 112.54 -161.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 30.2 mtm -94.79 163.57 13.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.685 0.755 . . . . 0.0 111.907 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 32.3 m -160.77 156.88 25.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.206 -0.934 . . . . 0.0 112.0 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.69 120.04 19.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.909 0.883 . . . . 0.0 110.665 167.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.86 -29.0 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.35 1.46 . . . . 0.0 109.966 163.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -140.89 133.65 28.89 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.598 1.959 . . . . 0.0 109.329 170.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -59.02 144.2 82.83 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.024 0.929 . . . . 0.0 111.87 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -58.37 138.83 87.95 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.224 1.949 . . . . 0.0 111.9 171.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 35.6 p -133.89 125.13 27.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.195 1.398 . . . . 0.0 111.336 174.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -61.85 122.39 15.29 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.462 1.505 . . . . 0.0 111.537 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 74.6 p -80.79 -13.84 58.61 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.001 1.321 . . . . 0.0 113.83 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.03 -1.44 4.81 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 120.972 -1.08 . . . . 0.0 114.293 -164.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -85.59 12.16 9.25 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.198 1.499 . . . . 0.0 111.263 176.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.26 0.81 88.5 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.003 1.287 . . . . 0.0 113.874 -165.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.2 p -119.15 162.26 18.95 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.136 1.468 . . . . 0.0 112.807 -172.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.3 t -133.85 117.05 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.616 1.566 . . . . 0.0 107.748 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.3 p -104.97 130.03 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.243 1.017 . . . . 0.0 112.825 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -139.07 166.82 23.5 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.787 2.035 . . . . 0.0 111.499 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -135.47 145.08 46.79 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.779 -0.576 . . . . 0.0 111.007 160.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.6 m -137.11 161.14 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.062 1.345 . . . . 0.0 110.833 -168.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -128.78 145.69 51.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.988 1.315 . . . . 0.0 112.258 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.1 t -113.06 147.84 38.15 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 128.523 2.729 . . . . 0.0 107.113 165.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -111.41 -64.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 CA-C-N 122.538 1.942 . . . . 0.0 115.122 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 160.46 38.29 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -172.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.79 -0.08 2.52 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 127.385 2.422 . . . . 0.0 118.653 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.64 93.39 36.92 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 119.994 1.897 . . . . 0.0 114.464 -161.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.6 115.43 3.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.431 2.754 . . . . 0.0 109.864 161.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.2 p -164.2 153.58 13.91 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -172.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.92 105.39 12.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.009 1.723 . . . . 0.0 107.041 159.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.29 0.9 OUTLIER -67.16 120.31 71.27 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.045 -155.051 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.89 111.04 2.08 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.573 3.515 . . . . 0.0 114.237 -167.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.31 114.71 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 126.041 1.736 . . . . 0.0 109.114 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.04 159.03 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 126.659 1.984 . . . . 0.0 109.03 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 6.2 t -140.64 120.54 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -145.32 171.45 14.57 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.707 1.14 . . . . 0.0 113.385 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -101.11 -3.03 29.97 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.413 0.685 . . . . 0.0 112.67 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -112.58 1.95 16.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.819 1.647 . . . . 0.0 114.265 -162.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.1 mt 63.0 -15.58 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.028 2.531 . . . . 0.0 115.645 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.3 t -107.87 -4.39 18.04 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 113.884 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 59.97 61.07 1.96 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.926 2.49 . . . . 0.0 113.126 -171.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -88.09 -39.89 14.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.412 0.685 . . . . 0.0 111.601 166.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 42.3 mm -111.15 105.03 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.587 1.555 . . . . 0.0 110.117 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -78.01 102.2 7.28 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.705 1.139 . . . . 0.0 112.699 172.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -63.82 -53.63 47.76 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.2 2.6 . . . . 0.0 113.0 171.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -116.5 156.76 15.44 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.791 1.476 . . . . 0.0 116.791 -158.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.75 150.69 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.809 2.044 . . . . 0.0 109.772 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.69 130.4 36.75 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.132 1.373 . . . . 0.0 109.597 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 29.8 m -120.53 -30.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.3 m -101.0 152.93 19.99 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 160.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.5 m -48.78 132.33 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.135 1.774 . . . . 0.0 114.812 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -110.19 119.34 47.35 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.191 1.796 . . . . 0.0 108.337 168.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.88 -179.02 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.876 3.051 . . . . 0.0 114.394 -166.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.67 110.39 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 127.911 2.485 . . . . 0.0 106.517 169.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.89 84.05 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.537 1.535 . . . . 0.0 111.957 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 25.4 t -75.35 -8.93 57.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 166.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 13.6 p -131.25 128.47 39.93 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.997 2.119 . . . . 0.0 107.245 164.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.28 -19.25 65.28 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -172.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -84.66 6.99 21.88 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.64 1.176 . . . . 0.0 113.43 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -47.58 133.64 13.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.485 1.514 . . . . 0.0 113.582 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -138.54 132.59 31.39 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.087 1.355 . . . . 0.0 110.542 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.93 146.98 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -158.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.39 124.98 35.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.615 2.766 . . . . 0.0 109.799 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 12.7 mt -135.71 150.03 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.35 1.46 . . . . 0.0 109.859 -170.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -123.51 146.56 47.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.806 0.842 . . . . 0.0 111.223 163.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.25 151.96 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 124.664 1.186 . . . . 0.0 111.381 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -121.75 100.9 43.26 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.021 2.128 . . . . 0.0 109.499 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.63 168.93 12.45 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 123.677 2.918 . . . . 0.0 110.936 160.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.85 179.91 4.86 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.728 2.285 . . . . 0.0 111.046 166.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -58.12 145.24 37.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.288 0.635 . . . . 0.0 110.742 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.15 -163.96 28.18 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 121.783 0.657 . . . . 0.0 114.062 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.41 157.38 34.25 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.655 1.982 . . . . 0.0 114.778 -164.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.2 m -173.94 164.09 4.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.039 2.135 . . . . 0.0 112.203 169.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -122.47 117.21 25.41 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.83 2.852 . . . . 0.0 108.127 164.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mm -68.68 136.46 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 167.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 67.9 mt -127.94 123.76 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.977 1.311 . . . . 0.0 108.694 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 53.3 t -110.62 109.6 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.885 1.674 . . . . 0.0 107.363 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 117.2 171.82 15.84 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 122.923 1.291 . . . . 0.0 115.746 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.79 166.09 25.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.314 2.246 . . . . 0.0 109.329 169.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 68.61 -165.26 47.77 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 -166.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -64.65 -26.37 68.36 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.794 0.837 . . . . 0.0 112.539 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.7 m -64.72 4.39 0.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 129.105 2.962 . . . . 0.0 117.026 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -93.77 140.93 29.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.044 0.838 . . . . 0.0 112.659 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 20.8 mt -113.45 164.62 13.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.742 1.217 . . . . 0.0 110.701 173.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.0 t -146.66 160.78 41.77 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -151.07 127.62 10.78 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.849 1.66 . . . . 0.0 110.341 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -76.46 134.35 39.57 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.766 1.226 . . . . 0.0 111.894 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -143.67 135.5 26.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.687 1.195 . . . . 0.0 111.274 171.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -116.16 116.32 27.62 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -82.96 123.57 29.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.226 1.011 . . . . 0.0 112.04 -172.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 64.33 132.62 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 1 C-N-CA 131.782 4.033 . . . . 0.0 115.259 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -58.71 60.35 0.01 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 129.271 3.32 . . . . 0.0 113.681 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 68.8 m -64.76 7.57 0.15 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 130.547 3.539 . . . . 0.0 116.169 -157.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 33.5 t -107.71 -5.5 17.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.122 1.369 . . . . 0.0 113.399 169.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.5 tt -152.02 -24.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 171.6 -147.34 10.12 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 120.268 1.394 . . . . 0.0 114.207 -173.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.247 0.929 0 C-N-CA 125.993 1.717 . . . . 0.0 111.502 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.96 6.87 5.5 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -173.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.51 -0.17 4.74 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -169.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.65 146.02 32.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.776 1.23 . . . . 0.0 109.957 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 p -31.42 -63.44 0.17 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.146 2.579 . . . . 0.0 113.003 173.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.37 -9.47 5.44 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.393 1.877 . . . . 0.0 115.067 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.27 74.53 0.89 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.744 1.218 . . . . 0.0 110.532 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 69.2 -5.27 5.22 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.489 1.519 . . . . 0.0 116.023 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 22.1 m -89.53 -42.65 11.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.199 1.499 . . . . 0.0 112.675 -167.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.8 m -176.93 126.26 0.16 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.215 1.806 . . . . 0.0 112.285 172.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -161.29 152.08 18.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.634 1.574 . . . . 0.0 110.109 169.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.05 101.17 2.67 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 164.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.99 154.93 41.31 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.182 1.793 . . . . 0.0 113.831 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 141.25 38.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 162.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 76.0 p -130.94 10.48 5.02 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.906 0.883 . . . . 0.0 113.234 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -79.38 161.36 26.23 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.895 0.77 . . . . 0.0 110.981 165.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -65.22 103.76 0.83 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.127 2.171 . . . . 0.0 112.358 -163.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 33.6 mtt -83.71 168.5 16.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.961 0.886 . . . . 0.0 113.035 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.3 m -157.34 160.18 38.24 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.436 -0.79 . . . . 0.0 111.721 156.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -82.67 120.12 25.16 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.272 0.629 . . . . 0.0 110.155 166.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 22.6 t -66.61 -30.76 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.184 1.394 . . . . 0.0 110.698 163.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -142.17 123.33 14.65 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.557 1.943 . . . . 0.0 107.651 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -57.8 154.54 26.54 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.241 0.616 . . . . 0.0 111.797 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -56.22 124.39 16.14 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.876 2.384 . . . . 0.0 111.909 165.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.8 p -129.81 128.75 42.96 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.419 1.088 . . . . 0.0 111.569 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -61.78 126.75 28.45 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.344 0.658 . . . . 0.0 110.412 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.2 p -79.09 -12.97 60.02 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.818 1.247 . . . . 0.0 113.128 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.04 -6.69 1.98 Allowed Glycine 0 CA--C 1.539 1.553 0 CA-C-N 119.186 0.903 . . . . 0.0 114.231 -164.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -87.84 2.05 52.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.599 1.559 . . . . 0.0 111.643 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.99 2.31 39.25 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.756 1.646 . . . . 0.0 114.022 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.9 p -128.97 166.32 19.4 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.017 1.327 . . . . 0.0 111.975 -168.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 6.8 t -131.24 111.77 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.64 1.576 . . . . 0.0 108.377 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.58 137.07 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.064 1.346 . . . . 0.0 112.993 -168.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -142.47 164.45 30.11 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.998 2.119 . . . . 0.0 112.772 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -118.31 132.12 56.3 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.816 1.246 . . . . 0.0 108.016 161.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.3 152.44 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.741 0.817 . . . . 0.0 111.095 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -135.07 148.23 49.81 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.013 1.325 . . . . 0.0 112.327 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.43 150.65 46.92 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 128.043 2.537 . . . . 0.0 108.173 169.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -105.66 -68.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.366 2.044 . . . . 0.0 114.466 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 167.79 20.11 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -171.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.75 -6.73 0.32 Allowed Glycine 0 CA--C 1.537 1.46 0 C-N-CA 127.596 2.522 . . . . 0.0 118.496 170.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.15 94.03 37.42 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 119.872 1.836 . . . . 0.0 114.754 -160.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.8 121.32 7.26 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.753 2.302 . . . . 0.0 109.956 157.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.0 p -163.34 157.43 20.09 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -175.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -90.84 98.71 11.94 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 160.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.255 1.0 OUTLIER -60.9 123.03 73.2 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.811 -154.024 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.97 116.84 4.86 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.206 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 88.1 t -125.52 112.02 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.234 1.814 . . . . 0.0 109.812 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 157.41 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.362 1.065 . . . . 0.0 110.339 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 39.0 t -137.54 112.02 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -135.98 167.0 22.03 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -167.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -101.13 -2.4 31.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.671 0.788 . . . . 0.0 112.387 174.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 27.2 p30 -114.48 2.83 14.74 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.578 1.951 . . . . 0.0 113.723 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 20.4 mt 62.78 5.13 1.64 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.544 2.338 . . . . 0.0 115.436 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.9 t -135.94 -10.52 2.04 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 61.29 58.76 2.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.84 2.456 . . . . 0.0 113.83 -171.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.44 -36.12 58.13 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.189 152.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 15.8 mm -120.1 111.19 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.126 1.77 . . . . 0.0 109.956 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -89.67 120.25 30.79 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.294 -0.879 . . . . 0.0 112.241 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -72.3 -63.24 1.19 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.937 2.495 . . . . 0.0 111.722 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -106.2 161.03 14.37 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 116.903 1.521 . . . . 0.0 116.903 -155.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -104.39 152.25 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 127.108 2.163 . . . . 0.0 110.553 -173.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.12 125.9 30.03 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.288 1.435 . . . . 0.0 109.568 169.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 66.6 t -94.4 -45.84 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.426 0.69 . . . . 0.0 111.219 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 366' ' ' GLU . 1.5 t -105.05 -179.15 3.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.413 0.685 . . . . 0.0 112.031 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 29.5 m -53.72 123.14 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.574 1.55 . . . . 0.0 113.168 -176.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -95.03 119.3 66.06 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.097 0.959 . . . . 0.0 108.84 165.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -80.36 179.61 6.0 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.984 3.123 . . . . 0.0 113.583 -167.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.89 114.74 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.834 2.054 . . . . 0.0 106.961 167.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.02 71.72 0.17 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.815 1.246 . . . . 0.0 111.547 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 26.4 t -69.15 -8.85 49.34 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.247 -0.908 . . . . 0.0 112.507 163.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 41.0 p -128.13 116.9 20.66 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 128.408 2.683 . . . . 0.0 106.501 166.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -53.34 -20.97 4.96 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -77.08 4.09 11.0 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.352 1.861 . . . . 0.0 113.604 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -41.45 127.8 3.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.503 1.921 . . . . 0.0 113.957 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.13 146.92 43.4 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.303 1.041 . . . . 0.0 111.356 171.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.7 p -156.83 145.81 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -163.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.14 121.3 23.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.366 2.267 . . . . 0.0 108.78 164.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.93 142.15 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.678 0.672 . . . . 0.0 111.076 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' GLU . . . . . 0.66 ' H ' HG22 ' A' ' 351' ' ' THR . 32.1 mt-10 -114.39 139.18 49.7 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.144 1.778 . . . . 0.0 110.491 166.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.16 163.7 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.61 1.164 . . . . 0.0 111.547 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -131.25 98.79 18.2 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.244 1.817 . . . . 0.0 109.518 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -75.33 161.93 37.04 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.052 2.501 . . . . 0.0 111.458 160.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.21 -176.48 2.7 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.631 2.887 . . . . 0.0 111.154 163.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -55.75 151.68 10.78 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.124 1.37 . . . . 0.0 112.734 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 79.45 -159.06 44.26 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 121.283 0.38 . . . . 0.0 113.668 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -62.23 156.08 22.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.503 1.521 . . . . 0.0 114.116 -167.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.4 m -168.58 161.5 11.54 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.112 1.765 . . . . 0.0 111.946 165.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -122.33 113.48 19.47 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.944 2.098 . . . . 0.0 108.052 166.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.4 mm -74.03 120.3 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 79.4 mt -116.4 127.63 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.243 1.417 . . . . 0.0 109.566 -174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 70.3 t -118.36 105.22 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 126.417 1.887 . . . . 0.0 108.12 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 111.5 175.83 20.13 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 122.485 1.047 . . . . 0.0 115.256 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 1.8 p -134.74 164.86 26.58 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.359 1.864 . . . . 0.0 110.548 169.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 82.64 -170.03 49.68 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 123.827 0.727 . . . . 0.0 112.594 -168.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -63.39 -29.96 71.17 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.995 -1.297 . . . . 0.0 111.317 165.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 27.3 m -55.66 1.35 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 131.478 3.911 . . . . 0.0 118.101 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -102.04 147.11 26.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.484 1.513 . . . . 0.0 111.573 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 40.9 mt -119.62 165.76 14.05 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.585 0.754 . . . . 0.0 111.036 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.1 t -148.32 158.97 44.42 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -141.55 137.81 32.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.838 1.655 . . . . 0.0 109.537 174.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -76.93 145.25 38.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.098 1.359 . . . . 0.0 111.927 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -140.34 159.38 42.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.831 1.252 . . . . 0.0 111.992 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -139.77 114.74 9.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.633 1.573 . . . . 0.0 107.553 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.73 120.85 29.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.131 0.973 . . . . 0.0 111.792 -172.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 75.15 132.68 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 130.924 3.69 . . . . 0.0 114.647 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -65.04 64.72 0.08 OUTLIER Glycine 0 C--N 1.343 0.97 0 C-N-CA 128.817 3.103 . . . . 0.0 113.345 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 45.5 m -65.05 -10.59 31.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.607 1.963 . . . . 0.0 113.613 -173.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 30.1 t -74.84 -5.86 45.85 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.166 1.387 . . . . 0.0 114.127 167.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 5.5 tp -140.68 -41.52 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.779 1.632 . . . . 0.0 112.009 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 155.7 -33.1 0.63 Allowed Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.219 0.914 . . . . 0.0 114.525 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? . . . . . 0 C--O 1.248 1.009 0 C-N-CA 126.063 1.745 . . . . 0.0 109.832 -179.037 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.3 p -83.67 -14.08 52.64 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.97 1.308 . . . . 0.0 113.59 170.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.47 23.89 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.561 2.744 . . . . 0.0 116.34 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 61.3 tp -138.13 139.83 39.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.808 1.643 . . . . 0.0 108.75 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 38.8 p -42.65 -61.67 1.18 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.584 1.954 . . . . 0.0 113.188 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 54.7 tp -56.2 -14.43 2.76 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.191 2.197 . . . . 0.0 114.913 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -110.74 72.12 0.77 Allowed 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.96 1.304 . . . . 0.0 109.274 -168.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 77.7 -45.83 2.5 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.934 1.254 . . . . 0.0 113.637 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 5.9 m -49.04 -56.84 7.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.865 1.666 . . . . 0.0 114.801 -172.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 18.4 m -173.14 114.53 0.25 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.439 1.472 . . . . 0.0 112.136 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -149.98 150.61 32.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.598 1.159 . . . . 0.0 111.155 169.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.87 92.74 1.63 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 169.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.54 152.15 46.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.344 2.258 . . . . 0.0 115.051 -175.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 22.4 m -91.73 145.21 24.76 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.083 0.953 . . . . 0.0 109.433 163.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 41.9 p -136.15 0.75 2.63 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -84.63 155.91 21.8 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.464 1.483 . . . . 0.0 111.307 168.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 100.48 0.05 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.552 1.941 . . . . 0.0 113.131 -163.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 31.7 mtm -86.97 168.75 13.06 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.579 1.152 . . . . 0.0 111.999 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 37.6 m -159.61 164.62 33.99 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.997 -1.064 . . . . 0.0 112.265 168.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.48 124.78 32.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.002 0.521 . . . . 0.0 110.362 163.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.8 t -70.52 -31.14 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.396 1.478 . . . . 0.0 110.269 163.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -135.92 124.47 23.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.904 2.082 . . . . 0.0 107.795 165.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -61.21 151.95 74.0 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.446 0.698 . . . . 0.0 112.572 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.39 134.13 55.98 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.529 2.82 . . . . 0.0 113.295 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.9 p -136.32 129.39 31.31 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.809 1.244 . . . . 0.0 111.929 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -53.71 123.1 11.33 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.333 1.453 . . . . 0.0 110.884 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 52.1 p -82.56 -10.72 58.86 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.964 0.905 . . . . 0.0 113.361 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 76.7 -6.93 36.36 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.889 1.233 . . . . 0.0 114.381 -168.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -102.7 18.94 20.16 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.042 1.421 . . . . 0.0 112.487 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.97 7.23 81.12 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.174 0.893 . . . . 0.0 113.41 -172.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 18.1 p -127.69 165.74 19.45 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.469 1.108 . . . . 0.0 112.295 -174.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.97 123.35 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 126.363 1.865 . . . . 0.0 107.701 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.3 135.06 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.304 1.041 . . . . 0.0 113.202 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -141.13 164.38 30.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.231 1.812 . . . . 0.0 112.998 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -121.74 126.05 48.0 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.191 1.396 . . . . 0.0 107.318 166.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.7 155.39 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.295 0.952 . . . . 0.0 112.204 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -140.32 147.75 40.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.351 1.46 . . . . 0.0 113.087 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 12.2 t -113.0 154.08 45.09 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 128.495 2.718 . . . . 0.0 108.486 167.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -108.32 -63.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.811 2.341 . . . . 0.0 115.187 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.27 170.53 15.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.358 1.063 . . . . 0.0 113.03 -173.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.53 -21.65 0.13 Allowed Glycine 0 CA--C 1.537 1.465 0 C-N-CA 127.676 2.56 . . . . 0.0 118.284 167.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.09 100.42 15.09 Favored Pre-proline 0 CA--C 1.552 1.043 0 CA-C-N 119.522 1.661 . . . . 0.0 113.936 -168.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.56 115.94 3.98 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.184 2.589 . . . . 0.0 109.198 158.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.7 p -162.79 154.69 18.26 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -170.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -78.46 112.24 15.31 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 155.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.283 1.1 pp -64.51 118.59 49.08 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.508 -163.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.25 113.67 1.77 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 124.039 3.16 . . . . 0.0 113.683 -172.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 69.2 t -121.88 111.41 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 125.428 1.491 . . . . 0.0 108.675 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.61 155.87 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.006 1.322 . . . . 0.0 110.108 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.5 t -140.31 111.89 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.62 -178.84 5.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.761 1.164 . . . . 0.0 113.287 -167.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -112.73 2.59 16.12 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.674 0.79 . . . . 0.0 112.988 176.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -126.49 8.7 7.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.366 1.466 . . . . 0.0 114.074 -157.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 50.7 mt 60.51 -14.81 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.123 2.569 . . . . 0.0 116.25 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.6 t -111.61 -9.88 14.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.133 1.333 . . . . 0.0 113.793 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 69.67 44.02 0.92 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.94 2.496 . . . . 0.0 113.148 -171.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.82 -46.96 82.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.464 0.306 . . . . 0.0 110.905 166.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 17.8 mm -118.3 99.5 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.588 1.155 . . . . 0.0 110.489 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -70.42 105.38 3.03 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 121.086 -1.009 . . . . 0.0 112.66 172.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -65.86 -56.88 9.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 129.586 3.155 . . . . 0.0 113.233 171.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -103.36 -178.65 26.15 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 -160.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mm -124.9 160.34 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.842 2.457 . . . . 0.0 111.23 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.32 130.74 35.17 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.797 1.239 . . . . 0.0 110.125 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 85.2 t -92.46 -19.66 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.34 0.656 . . . . 0.0 111.096 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 366' ' ' GLU . 6.1 t -137.76 174.43 10.58 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.366 1.067 . . . . 0.0 112.765 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.55 95.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 127.051 2.141 . . . . 0.0 113.687 -171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -57.83 119.1 31.03 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.512 1.125 . . . . 0.0 110.692 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -80.76 -176.62 3.26 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.337 3.358 . . . . 0.0 113.384 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.06 122.73 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.8 1.64 . . . . 0.0 107.883 171.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.01 64.28 0.33 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.799 1.64 . . . . 0.0 112.779 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 30.6 t -66.13 -10.81 44.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.591 1.156 . . . . 0.0 113.113 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 40.2 p -134.2 117.88 17.0 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.84 2.856 . . . . 0.0 106.475 163.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -61.4 -13.23 18.4 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -165.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -75.79 1.07 15.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.717 1.607 . . . . 0.0 114.012 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -35.56 119.7 0.54 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.455 2.302 . . . . 0.0 113.932 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.02 145.46 50.86 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.589 1.155 . . . . 0.0 112.183 170.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.32 147.16 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -160.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -78.73 123.42 27.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.766 2.426 . . . . 0.0 109.744 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 52.9 mt -132.81 137.34 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.485 0.66 . . . . 0.0 111.055 174.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' GLU . . . . . 0.487 ' H ' HG22 ' A' ' 351' ' ' THR . 26.9 mt-10 -105.26 140.96 37.61 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.949 1.3 . . . . 0.0 110.827 160.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 20.2 m -122.6 158.32 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.547 1.139 . . . . 0.0 111.298 168.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -118.02 101.53 51.64 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.52 1.928 . . . . 0.0 108.736 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.96 159.57 37.76 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.093 1.862 . . . . 0.0 110.304 163.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -57.7 171.35 1.5 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.702 2.268 . . . . 0.0 112.094 159.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -62.18 147.81 46.56 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.464 -0.772 . . . . 0.0 109.993 157.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.31 -171.29 23.14 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 122.57 1.095 . . . . 0.0 113.185 -169.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -72.7 163.36 28.21 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.313 -1.11 . . . . 0.0 113.802 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.9 m -164.62 170.36 15.81 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.187 1.395 . . . . 0.0 112.222 164.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -124.95 114.49 19.21 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 129.381 3.073 . . . . 0.0 106.43 163.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.1 mm -71.74 135.02 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 74.8 mt -129.42 128.03 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 125.238 1.415 . . . . 0.0 108.83 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 83.9 t -118.71 105.02 16.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 126.196 1.798 . . . . 0.0 107.6 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.23 175.42 21.99 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 123.052 1.362 . . . . 0.0 115.935 175.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.82 167.61 21.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.656 2.382 . . . . 0.0 110.113 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 85.31 -156.9 31.19 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 123.356 0.503 . . . . 0.0 111.909 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -67.59 -36.8 81.56 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.534 0.667 . . . . 0.0 110.805 161.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.3 m -51.54 11.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 1 C-N-CA 132.981 4.513 . . . . 0.0 119.546 -173.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -114.36 139.58 49.35 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.63 1.105 . . . . 0.0 112.176 -165.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 30.9 mt -111.57 161.55 16.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.431 0.692 . . . . 0.0 110.252 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.8 t -145.57 156.64 43.82 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.047 0.539 . . . . 0.0 112.36 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -142.27 121.7 13.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.211 1.405 . . . . 0.0 109.812 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -67.92 134.42 50.78 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.194 1.397 . . . . 0.0 111.341 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -136.87 161.1 36.94 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 123.097 1.427 . . . . 0.0 112.592 173.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -136.87 103.24 5.11 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.56 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -92.29 138.61 31.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -39.38 111.87 0.21 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.813 2.845 . . . . 0.0 113.455 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 109.91 18.91 8.47 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.336 1.922 . . . . 0.0 113.271 -164.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 3.3 t -76.03 155.21 35.1 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.449 1.899 . . . . 0.0 113.271 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 6.7 m -56.18 -20.29 17.26 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.81 1.644 . . . . 0.0 113.812 169.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 5.6 tt -79.34 -10.94 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.051 0.94 . . . . 0.0 112.799 174.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 93.07 3.25 65.69 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.945 1.26 . . . . 0.0 114.62 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? . . . . . 0 C--O 1.246 0.886 0 C-N-CA 125.888 1.675 . . . . 0.0 110.683 172.972 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 15.4 mmt . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.49 -0.76 29.44 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -173.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.98 13.29 0.11 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.63 1.972 . . . . 0.0 115.283 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 37.9 tp -124.17 147.29 48.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.866 2.066 . . . . 0.0 109.641 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.1 p -38.96 -59.85 0.93 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.11 2.164 . . . . 0.0 113.373 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.5 -9.96 0.85 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.67 1.988 . . . . 0.0 115.093 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.42 ' HE2' ' OD1' ' A' ' 345' ' ' ASN . 10.2 mmmm -121.4 83.06 2.02 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.598 1.09 . . . . 0.0 110.905 -165.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 69.12 -28.07 0.31 Allowed Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.807 1.67 . . . . 0.0 115.755 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 79.2 m -71.05 -63.51 1.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.554 1.541 . . . . 0.0 113.073 -167.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.1 m -175.14 132.88 0.31 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.222 1.374 . . . . 0.0 112.988 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -160.55 158.03 28.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.569 1.548 . . . . 0.0 111.091 169.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.04 101.57 13.59 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.055 1.342 . . . . 0.0 107.611 168.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.09 149.8 39.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.216 2.206 . . . . 0.0 114.89 -171.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 4.7 m -86.52 144.52 27.19 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 164.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 61.1 p -137.37 0.73 2.33 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -71.32 166.17 22.17 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.603 1.092 . . . . 0.0 110.089 165.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -69.43 109.51 4.25 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.194 0.998 . . . . 0.0 111.203 -165.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 34.5 mtm -94.82 166.59 11.9 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.544 1.138 . . . . 0.0 112.255 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 58.5 m -160.89 157.75 27.08 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.734 1.214 . . . . 0.0 110.168 165.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.73 125.44 29.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.153 160.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 45.6 t -71.12 -18.92 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 126.18 1.792 . . . . 0.0 110.807 166.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -147.57 112.67 5.49 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.601 2.361 . . . . 0.0 106.76 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -55.31 147.59 36.1 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 118.553 0.615 . . . . 0.0 110.04 171.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.81 145.13 99.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.175 1.25 . . . . 0.0 111.168 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 23.3 p -131.24 135.98 47.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.222 1.409 . . . . 0.0 110.791 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -58.31 121.46 10.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.828 1.251 . . . . 0.0 110.601 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 60.1 p -81.78 -13.82 57.22 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.51 -0.96 7.89 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-N 119.391 0.996 . . . . 0.0 114.052 -165.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -95.11 8.22 43.65 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.257 1.528 . . . . 0.0 111.771 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.85 10.71 58.57 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.642 1.115 . . . . 0.0 114.056 -171.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 16.2 p -136.25 169.86 16.96 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.476 1.138 . . . . 0.0 112.741 -169.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.69 127.31 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.994 2.118 . . . . 0.0 108.829 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 11.3 p -118.15 124.15 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -163.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -130.95 157.17 43.67 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.694 1.598 . . . . 0.0 114.291 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -106.36 137.89 43.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.34 1.456 . . . . 0.0 107.215 161.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.56 136.99 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.739 1.216 . . . . 0.0 110.704 -175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -122.64 144.2 49.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.052 0.941 . . . . 0.0 112.199 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.7 143.59 31.67 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.746 2.818 . . . . 0.0 106.613 170.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -109.85 -63.68 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 CA-C-N 121.881 1.707 . . . . 0.0 115.875 -174.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 169.16 18.05 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 120.613 1.552 . . . . 0.0 113.233 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 68.6 -6.0 3.86 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.447 1.975 . . . . 0.0 117.341 169.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.61 102.07 45.32 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 119.135 1.468 . . . . 0.0 113.306 -163.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.29 118.42 2.94 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.249 2.632 . . . . 0.0 110.051 154.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.7 p -163.17 146.98 10.88 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -172.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -72.98 117.51 14.8 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 154.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.297 0.8 OUTLIER -69.89 122.65 86.69 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.884 -160.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.459 ' HG2' ' HA2' ' A' ' 379' ' ' GLY . 71.5 Cg_endo -72.65 110.09 2.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 1 C-N-CA 125.781 4.32 . . . . 0.0 112.894 -166.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 98.6 t -122.66 124.79 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.534 1.534 . . . . 0.0 110.653 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.51 156.93 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.089 1.355 . . . . 0.0 110.817 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' VAL . . . . . 0.53 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 40.5 t -136.32 129.52 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -147.65 174.2 12.0 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.974 0.796 . . . . 0.0 112.145 -172.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -101.29 -1.01 34.65 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.513 0.725 . . . . 0.0 112.14 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -128.46 8.18 5.91 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -152.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 59.7 mt 62.51 -22.94 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.653 2.381 . . . . 0.0 115.95 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.1 t -106.99 -7.87 16.8 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.849 1.26 . . . . 0.0 113.873 -172.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 337' ' ' ALA 0.261 . . 71.72 32.76 1.9 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.331 2.653 . . . . 0.0 113.917 -177.706 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -59.1 -46.27 88.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.684 0.394 . . . . 0.0 110.767 169.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 16.0 mm -96.81 129.23 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.596 1.158 . . . . 0.0 109.095 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.42 ' OD1' ' HE2' ' A' ' 293' ' ' LYS . 0.8 OUTLIER -103.65 64.17 0.8 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 123.042 1.401 . . . . 0.0 112.18 -174.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -66.2 -45.62 80.13 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 128.623 2.769 . . . . 0.0 116.544 -156.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.53 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -107.33 -175.32 22.61 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.799 1.666 . . . . 0.0 115.282 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.35 145.67 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 125.165 1.386 . . . . 0.0 112.305 -174.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.49 118.34 12.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.791 1.636 . . . . 0.0 109.688 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.9 t -87.84 -52.23 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.902 0.774 . . . . 0.0 111.647 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.4 t -84.44 171.87 12.2 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.647 0.737 . . . . 0.0 111.642 170.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.28 120.28 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.201 1.0 . . . . 0.0 111.761 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -79.32 128.17 76.43 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.282 1.433 . . . . 0.0 110.499 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.47 ' HG3' HG11 ' A' ' 363' ' ' VAL . 2.4 Cg_endo -85.75 -168.14 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 124.906 3.737 . . . . 0.0 113.493 -168.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.12 123.51 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.782 1.633 . . . . 0.0 109.009 172.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.23 80.74 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.503 1.121 . . . . 0.0 110.756 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 47.6 t -69.2 -25.53 64.37 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.585 -0.697 . . . . 0.0 111.303 163.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 21.5 p -120.93 124.54 45.18 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.246 2.619 . . . . 0.0 107.425 169.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -59.19 -23.81 62.57 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -168.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.15 3.9 1.9 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.359 1.863 . . . . 0.0 114.337 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -45.91 135.0 7.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.567 1.547 . . . . 0.0 113.792 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -150.87 111.51 4.24 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.963 1.705 . . . . 0.0 108.61 -165.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' VAL . . . . . 0.47 HG11 ' HG3' ' A' ' 354' ' ' PRO . 9.9 p -138.98 153.43 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -165.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -80.38 123.72 28.26 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 128.117 2.567 . . . . 0.0 109.383 165.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.34 143.07 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.138 0.881 . . . . 0.0 111.922 169.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -108.98 142.16 40.05 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.187 1.795 . . . . 0.0 111.224 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.47 152.77 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.703 0.801 . . . . 0.0 111.326 170.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -109.0 116.82 54.98 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.398 1.879 . . . . 0.0 109.807 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -91.18 145.91 3.51 Favored 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 123.771 2.98 . . . . 0.0 111.096 166.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.14 171.57 1.65 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.231 2.621 . . . . 0.0 112.582 153.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -61.71 140.78 58.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.115 0.566 . . . . 0.0 110.724 170.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 95.97 -164.63 23.89 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-O 122.749 1.194 . . . . 0.0 115.803 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.89 155.05 11.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 129.095 2.958 . . . . 0.0 113.618 -169.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.8 m -173.95 162.56 3.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.234 1.414 . . . . 0.0 113.409 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -129.22 115.99 18.49 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 130.986 3.714 . . . . 0.0 107.909 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.3 mm -82.5 118.71 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 26.3 mt -108.83 126.07 65.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.413 1.085 . . . . 0.0 108.605 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.7 110.8 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.823 1.649 . . . . 0.0 106.942 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 333' ' ' PRO . . . 116.25 172.29 16.55 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 124.043 1.913 . . . . 0.0 116.343 174.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.69 162.76 36.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.736 2.414 . . . . 0.0 109.175 177.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.59 -167.37 52.29 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -162.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.36 -26.35 68.72 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.787 -0.831 . . . . 0.0 111.918 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 64.0 m -63.29 3.19 0.3 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 128.822 2.849 . . . . 0.0 116.329 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -87.43 123.68 32.62 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.149 0.886 . . . . 0.0 111.41 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.71 162.58 12.82 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 172.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.3 t -140.23 155.03 47.05 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.5 133.11 47.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.22 1.408 . . . . 0.0 109.218 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -75.3 133.06 41.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.629 1.571 . . . . 0.0 111.071 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -141.94 106.28 4.81 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.096 0.959 . . . . 0.0 112.559 175.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -100.15 112.79 25.11 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -80.11 151.46 29.81 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -39.55 131.71 1.67 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.357 2.263 . . . . 0.0 113.556 173.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 119.28 4.13 12.44 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 160.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 94.1 p -131.41 -80.98 0.52 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.694 2.247 . . . . 0.0 112.133 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 91.9 p -105.56 -6.19 19.53 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.731 2.012 . . . . 0.0 113.464 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 13.7 tt -133.9 150.55 31.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.299 1.84 . . . . 0.0 109.43 166.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -67.87 -58.98 6.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.148 0.88 . . . . 0.0 112.307 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 3.1 tptp . . . . . 0 C--O 1.253 1.253 0 C-N-CA 128.559 2.744 . . . . 0.0 108.406 179.325 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.21 4.76 9.76 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -176.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.4 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.563 2.345 . . . . 0.0 116.027 -170.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 15.7 mt -138.88 153.9 48.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.558 1.543 . . . . 0.0 110.214 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 13.7 p -42.64 -64.19 0.65 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.563 2.345 . . . . 0.0 111.643 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.1 -22.95 43.53 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.725 2.01 . . . . 0.0 114.08 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.84 58.84 2.7 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.895 -1.128 . . . . 0.0 111.134 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.07 1.16 62.46 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.836 1.684 . . . . 0.0 115.493 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 61.1 m -84.84 -45.66 12.09 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.2 1.5 . . . . 0.0 112.259 -173.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.2 m -174.75 120.09 0.22 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.047 1.339 . . . . 0.0 112.146 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -161.92 154.64 20.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.612 1.165 . . . . 0.0 111.34 167.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.81 101.36 1.32 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 161.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.06 157.48 22.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.493 1.917 . . . . 0.0 114.171 -173.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 12.1 m -92.66 142.77 27.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.3 0.64 . . . . 0.0 109.958 170.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 80.4 p -136.71 5.98 2.92 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 174.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -83.61 164.81 19.49 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.92 1.236 . . . . 0.0 110.738 165.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -66.49 92.94 0.21 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.785 2.434 . . . . 0.0 112.173 -161.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' MET . . . . . 0.401 ' HE1' ' H ' ' A' ' 380' ' ' THR . 33.4 mtm -80.66 166.52 20.99 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.204 1.002 . . . . 0.0 112.381 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.5 m -158.87 157.76 32.11 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.287 -0.883 . . . . 0.0 112.531 167.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.03 120.03 24.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.418 0.687 . . . . 0.0 109.847 159.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.94 -25.03 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.638 1.175 . . . . 0.0 110.845 169.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -140.01 130.49 25.52 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.121 2.168 . . . . 0.0 108.034 168.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -60.86 144.89 89.56 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.624 1.169 . . . . 0.0 112.324 172.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.02 137.9 78.72 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.76 2.307 . . . . 0.0 112.145 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 37.2 p -132.32 126.74 34.02 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.259 1.424 . . . . 0.0 111.05 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -59.83 121.56 12.04 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.447 1.099 . . . . 0.0 110.569 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 65.3 p -80.19 -10.45 59.76 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.944 1.298 . . . . 0.0 113.123 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.13 -8.34 1.39 Allowed Glycine 0 CA--C 1.538 1.503 0 CA-C-N 119.186 0.903 . . . . 0.0 114.389 -166.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -82.71 2.59 32.96 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.251 1.525 . . . . 0.0 111.863 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.94 5.35 61.07 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.253 1.406 . . . . 0.0 113.413 -169.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 16.3 p -123.69 161.78 24.41 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.623 1.211 . . . . 0.0 112.039 -175.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 6.7 t -133.92 112.59 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.218 1.407 . . . . 0.0 107.863 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.0 p -108.87 130.88 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.383 1.073 . . . . 0.0 113.668 -160.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -140.84 163.27 33.38 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.936 2.094 . . . . 0.0 112.901 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -114.12 131.39 56.43 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.979 1.312 . . . . 0.0 107.585 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.04 153.72 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.413 1.006 . . . . 0.0 112.307 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -140.42 147.8 40.24 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.625 1.57 . . . . 0.0 113.071 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.46 147.7 38.61 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 128.14 2.576 . . . . 0.0 107.633 162.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -106.14 -56.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.057 0 CA-C-N 122.899 2.071 . . . . 0.0 115.816 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 172.35 12.94 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.944 -1.098 . . . . 0.0 112.293 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.99 0.58 7.42 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 117.354 1.702 . . . . 0.0 117.354 169.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.34 94.08 48.72 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 118.91 1.355 . . . . 0.0 113.065 -162.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.57 117.45 3.38 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.398 2.732 . . . . 0.0 108.984 156.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.9 p -166.54 155.31 10.7 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -174.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.31 111.2 15.32 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 154.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.16 116.17 23.05 Favored Pre-proline 0 CA--C 1.557 1.237 0 CA-C-O 119.056 -0.497 . . . . 0.0 111.651 -163.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -62.81 117.33 4.23 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.932 3.088 . . . . 0.0 113.912 -172.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.98 107.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.675 1.19 . . . . 0.0 110.131 173.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.43 157.82 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.437 1.495 . . . . 0.0 109.453 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 91.0 t -137.9 121.12 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -135.3 172.27 13.24 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -167.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -104.9 -0.42 27.07 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.712 1.205 . . . . 0.0 112.403 170.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -129.02 7.9 5.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.071 1.348 . . . . 0.0 114.575 -157.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.8 mt 67.46 -8.31 0.49 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.621 2.369 . . . . 0.0 115.644 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 7.8 t -129.14 -9.73 4.77 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 120.726 1.603 . . . . 0.0 115.235 -174.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 69.5 44.58 0.9 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.702 2.401 . . . . 0.0 113.114 -170.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.08 72.13 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.202 158.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 27.3 mt -125.2 109.65 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 127.611 2.365 . . . . 0.0 107.939 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -77.2 118.14 19.43 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.333 0.97 . . . . 0.0 110.382 162.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -77.68 -62.97 1.49 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.634 2.774 . . . . 0.0 111.498 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -112.19 171.14 13.93 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 117.086 1.594 . . . . 0.0 117.086 -162.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mm -109.91 156.33 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.95 2.1 . . . . 0.0 111.589 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.56 136.06 34.93 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.227 1.411 . . . . 0.0 109.696 170.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.7 t -110.48 -61.64 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.186 0.594 . . . . 0.0 110.374 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.8 m -79.98 153.3 28.99 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.756 0.822 . . . . 0.0 109.645 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.6 m -51.54 144.53 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.865 2.066 . . . . 0.0 115.471 -167.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -112.02 111.65 53.3 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.986 1.714 . . . . 0.0 108.845 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.16 -171.48 1.09 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.493 3.462 . . . . 0.0 113.866 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.71 117.15 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 127.575 2.35 . . . . 0.0 107.066 168.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.84 71.06 0.21 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.691 1.996 . . . . 0.0 112.559 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.0 t -67.79 -14.9 63.33 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.422 -0.799 . . . . 0.0 112.913 167.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 10.2 p -116.25 129.15 56.14 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 127.041 2.137 . . . . 0.0 106.959 161.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -66.83 -14.87 63.17 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -173.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.11 6.3 26.16 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.515 1.926 . . . . 0.0 113.407 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -42.95 124.43 3.14 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.427 1.891 . . . . 0.0 113.715 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.15 148.15 46.42 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.613 1.165 . . . . 0.0 111.529 172.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.55 152.52 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.658 0.742 . . . . 0.0 112.482 -164.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.0 123.24 31.89 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.796 2.439 . . . . 0.0 108.929 169.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 42.7 mt -130.99 149.75 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.863 0.865 . . . . 0.0 110.678 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -121.18 142.01 50.3 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.567 1.547 . . . . 0.0 110.569 167.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.36 153.92 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.387 0.675 . . . . 0.0 111.595 167.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -117.46 99.42 52.5 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 127.134 2.174 . . . . 0.0 108.536 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -80.86 161.8 21.15 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.675 2.25 . . . . 0.0 110.65 165.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.83 -174.42 1.51 Allowed 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.776 2.318 . . . . 0.0 110.604 158.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -61.28 160.71 10.13 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.446 -0.784 . . . . 0.0 111.859 164.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 97.58 -177.8 32.17 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.318 1.437 . . . . 0.0 113.445 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.26 163.06 16.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.46 1.504 . . . . 0.0 112.866 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.1 m -162.51 154.36 18.47 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.119 -0.988 . . . . 0.0 112.533 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -120.16 104.81 10.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.796 2.439 . . . . 0.0 106.966 166.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.2 mm -70.15 121.31 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 64.3 mt -118.28 125.28 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.943 1.297 . . . . 0.0 109.108 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.8 103.78 15.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.18 1.792 . . . . 0.0 107.815 -177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.87 177.71 23.75 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 123.308 1.505 . . . . 0.0 116.511 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' THR . . . . . 0.401 ' H ' ' HE1' ' A' ' 304' ' ' MET . 2.2 p -134.91 172.22 13.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.031 2.532 . . . . 0.0 110.722 175.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 81.64 -162.2 43.13 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 123.617 0.627 . . . . 0.0 111.642 -168.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -67.25 -38.04 84.49 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.717 -0.872 . . . . 0.0 110.764 162.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 47.2 m -53.81 8.12 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.54 1 C-N-CA 132.127 4.171 . . . . 0.0 119.016 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -99.88 146.91 26.1 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.108 1.363 . . . . 0.0 111.835 -172.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 19.7 mt -114.55 165.94 12.24 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.505 0.722 . . . . 0.0 110.918 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.6 t -146.82 158.17 43.85 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -139.2 132.04 29.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.943 1.697 . . . . 0.0 110.089 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -80.73 138.76 36.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.976 1.31 . . . . 0.0 112.193 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -132.51 159.79 38.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.702 1.601 . . . . 0.0 110.861 165.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -139.42 97.86 3.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.168 1.387 . . . . 0.0 108.534 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -96.68 132.31 42.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.241 0.543 . . . . 0.0 111.023 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 392' ' ' GLU . 0.1 OUTLIER -28.66 109.96 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 130.508 3.523 . . . . 0.0 113.754 -176.656 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 115.02 25.01 4.03 Favored Glycine 0 CA--C 1.54 1.648 0 C-N-CA 127.11 2.29 . . . . 0.0 113.233 -157.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 23.7 p -114.6 160.94 18.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 120.068 1.934 . . . . 0.0 116.187 -162.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 83.1 p -54.22 -32.9 57.07 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 127.364 2.266 . . . . 0.0 115.039 -174.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.45 0.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.823 1.249 . . . . 0.0 113.263 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 87.83 15.4 61.42 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.286 0.945 . . . . 0.0 113.117 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.437 0 C-N-CA 125.936 1.694 . . . . 0.0 108.733 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 8.0 tmm? . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 59.2 p -77.18 -4.3 43.91 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -166.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.62 27.23 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -172.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 71.6 mt -139.71 160.26 40.29 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.479 1.512 . . . . 0.0 111.24 171.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 22.3 p -54.88 -53.76 51.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.85 1.66 . . . . 0.0 110.896 167.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -22.47 60.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.546 1.938 . . . . 0.0 114.283 177.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 293' ' ' LYS . 0.2 OUTLIER -96.1 66.91 2.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.839 1.255 . . . . 0.0 110.267 -173.617 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 80.78 -27.37 2.99 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.456 1.503 . . . . 0.0 114.748 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 19.1 m -59.48 -58.87 6.72 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.781 1.633 . . . . 0.0 113.692 -173.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.5 m -173.92 126.75 0.37 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.803 1.241 . . . . 0.0 112.751 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -156.79 151.21 25.39 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.757 1.223 . . . . 0.0 111.413 165.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.01 109.93 14.92 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -77.96 153.52 32.4 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.976 1.711 . . . . 0.0 114.745 -172.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -99.41 145.42 27.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.894 0.877 . . . . 0.0 108.974 162.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 53.0 p -135.0 10.5 3.58 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -75.96 160.8 29.5 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.086 0.857 . . . . 0.0 110.934 164.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -63.01 97.19 0.1 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.829 2.052 . . . . 0.0 111.506 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 5.9 mtm -76.66 164.79 25.56 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.001 0.92 . . . . 0.0 112.451 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 25.9 m -158.7 154.47 26.41 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.234 -0.916 . . . . 0.0 112.458 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 121.08 29.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.341 0.656 . . . . 0.0 110.106 170.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.8 t -70.12 -23.75 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.352 1.061 . . . . 0.0 110.488 164.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -144.86 119.41 9.72 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.716 2.006 . . . . 0.0 108.72 169.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -55.13 142.69 56.85 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.906 1.283 . . . . 0.0 111.315 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -51.59 134.88 47.59 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.865 2.377 . . . . 0.0 113.423 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.13 127.41 35.92 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.505 1.122 . . . . 0.0 111.693 173.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.24 124.93 21.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.053 0.541 . . . . 0.0 111.085 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 19.0 p -83.25 -8.32 59.47 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.268 1.027 . . . . 0.0 113.481 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 79.31 -14.62 15.15 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.481 1.038 . . . . 0.0 114.671 -169.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -87.14 5.84 35.86 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.479 1.64 . . . . 0.0 112.984 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.35 2.92 65.42 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.834 1.206 . . . . 0.0 113.743 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.8 p -115.69 165.73 12.72 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.322 1.449 . . . . 0.0 111.585 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.6 115.48 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.853 1.661 . . . . 0.0 108.87 -178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.8 p -102.78 130.95 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.567 1.547 . . . . 0.0 113.29 -167.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -137.76 164.2 29.47 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.536 1.934 . . . . 0.0 112.827 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -123.17 124.6 43.42 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.086 1.354 . . . . 0.0 107.718 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.14 138.22 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.071 0.948 . . . . 0.0 112.069 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -117.76 143.16 46.49 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.064 1.746 . . . . 0.0 111.501 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 10.2 t -111.79 149.95 41.56 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.354 1.862 . . . . 0.0 108.001 165.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 3.5 Cg_endo -105.97 -74.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 122.038 1.825 . . . . 0.0 114.906 -172.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.88 165.84 25.02 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 121.323 1.874 . . . . 0.0 114.642 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 71.9 -4.87 14.54 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.053 1.787 . . . . 0.0 116.279 172.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -112.63 98.62 44.98 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.979 1.311 . . . . 0.0 113.093 -168.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.43 117.89 5.14 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.388 2.059 . . . . 0.0 108.226 152.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 8.9 p -161.37 154.99 21.77 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -88.57 102.11 14.62 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.093 2.157 . . . . 0.0 106.39 158.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 333' ' ' PRO 0.255 3.7 pt -59.73 123.5 71.77 Favored Pre-proline 0 CA--C 1.554 1.12 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -156.162 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 9.7 Cg_exo -62.79 113.28 1.92 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.419 2.746 . . . . 0.0 112.933 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.91 110.14 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 109.801 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.85 163.37 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.971 1.708 . . . . 0.0 109.265 -172.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.22 113.67 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.55 171.4 12.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.222 0.534 . . . . 0.0 112.038 -170.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' ASP . . . . . 0.452 ' CG ' ' HZ3' ' A' ' 346' ' ' LYS . 33.7 m-20 -114.61 2.74 14.61 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.149 1.38 . . . . 0.0 111.599 173.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -109.97 -5.29 15.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.894 2.077 . . . . 0.0 114.027 -167.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.7 mt 58.72 -1.95 0.1 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.233 2.613 . . . . 0.0 116.049 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -112.63 -7.06 13.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.419 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 384' ' ' ARG . . . 45.11 77.13 0.08 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 130.279 3.432 . . . . 0.0 114.669 -166.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -92.99 -40.97 10.26 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.423 149.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 84.5 mt -74.57 150.06 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.872 1.669 . . . . 0.0 110.783 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.415 HD21 ' CB ' ' A' ' 293' ' ' LYS . 15.3 t30 -143.86 94.52 2.6 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.2 1.4 . . . . 0.0 111.521 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' A' ' 338' ' ' ASP . 30.7 ttpt -102.57 -31.04 10.6 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -166.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -116.41 159.42 13.92 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.657 1.122 . . . . 0.0 115.638 -168.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.81 145.23 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.633 1.973 . . . . 0.0 110.758 -169.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.61 120.01 22.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.776 1.63 . . . . 0.0 108.633 166.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.8 t -92.72 -41.25 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.149 0.58 . . . . 0.0 111.32 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 366' ' ' GLU . 3.0 t -98.01 176.41 5.77 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.695 0.759 . . . . 0.0 112.01 171.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 6.1 m -62.1 107.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.93 1.692 . . . . 0.0 113.493 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.77 121.06 79.88 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 118.14 -0.933 . . . . 0.0 109.29 160.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -82.69 -174.36 2.03 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 124.918 3.745 . . . . 0.0 113.717 -171.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 112.04 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 126.596 1.959 . . . . 0.0 108.168 169.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -72.22 77.83 0.98 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.668 1.187 . . . . 0.0 111.785 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 19.3 t -69.32 -19.94 63.88 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.351 -0.843 . . . . 0.0 113.149 171.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 17.7 p -118.82 118.21 30.95 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 127.134 2.173 . . . . 0.0 106.337 163.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -56.8 -24.22 49.06 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -165.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.67 0.98 7.45 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.712 2.005 . . . . 0.0 113.967 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -46.81 134.63 9.81 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.317 1.447 . . . . 0.0 113.385 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -137.97 133.01 33.16 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.587 1.155 . . . . 0.0 111.148 175.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.89 143.2 24.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.739 0.781 . . . . 0.0 112.954 -160.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.83 118.67 18.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.286 2.235 . . . . 0.0 109.469 166.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 32.5 mt -126.97 143.52 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.049 0.54 . . . . 0.0 110.458 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' GLU . . . . . 0.668 ' H ' HG22 ' A' ' 351' ' ' THR . 33.2 mt-10 -116.85 134.33 54.91 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.768 1.627 . . . . 0.0 110.06 167.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.4 159.63 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.594 1.158 . . . . 0.0 111.96 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -124.92 104.65 29.86 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.911 1.684 . . . . 0.0 109.944 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -86.47 163.08 9.59 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.786 2.991 . . . . 0.0 111.078 161.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.5 177.15 9.04 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.204 2.603 . . . . 0.0 112.467 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -63.52 116.95 6.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.861 1.264 . . . . 0.0 110.928 167.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 133.83 -145.74 17.76 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.921 1.248 . . . . 0.0 111.589 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -97.02 160.44 14.34 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.934 1.294 . . . . 0.0 113.3 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 21.9 m -169.17 152.38 5.02 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.801 1.64 . . . . 0.0 111.827 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -122.37 107.43 12.07 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 166.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.3 mm -73.71 120.66 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 72.0 mt -116.41 134.47 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.331 1.052 . . . . 0.0 110.996 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 67.4 t -120.93 107.15 19.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 126.04 1.736 . . . . 0.0 107.973 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.34 -175.6 19.07 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.85 159.34 42.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.195 1.798 . . . . 0.0 110.432 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.83 -173.22 53.71 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.296 0.474 . . . . 0.0 112.529 -168.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -55.93 -27.9 54.39 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.842 1.257 . . . . 0.0 112.291 171.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 24.6 m -59.43 -7.61 1.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.532 3.133 . . . . 0.0 116.608 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' ARG . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 342' ' ' ALA . 3.5 ptm180 -87.04 125.93 34.42 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.08 0.952 . . . . 0.0 112.23 -173.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 15.1 mt -95.67 164.63 12.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.665 0.386 . . . . 0.0 111.897 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.3 t -135.12 152.08 51.31 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.321 1.048 . . . . 0.0 113.154 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -141.06 142.33 34.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.562 1.145 . . . . 0.0 111.583 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.03 140.58 36.49 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -140.98 138.61 33.87 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.173 0.987 . . . . 0.0 112.308 163.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -142.4 122.46 13.71 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -173.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -92.32 157.16 16.79 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -161.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -32.38 119.69 0.29 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 129.725 3.21 . . . . 0.0 115.424 168.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 62.55 7.82 16.94 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.329 1.443 . . . . 0.0 114.784 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.0 m -129.47 -42.12 1.34 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.898 1.279 . . . . 0.0 111.061 -161.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 23.2 t -141.86 -24.47 0.69 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.364 1.066 . . . . 0.0 112.929 169.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 2.7 tp -148.97 -170.33 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 O-C-N 120.908 -1.12 . . . . 0.0 111.529 163.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -73.13 -21.1 80.06 Favored Glycine 0 CA--C 1.539 1.562 0 O-C-N 120.397 -1.439 . . . . 0.0 116.226 -172.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.655 1.982 . . . . 0.0 108.565 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 26.8 p90 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.055 0.455 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 104.03 6.36 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.26 144.06 42.36 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.184 2.193 . . . . 0.0 115.053 -176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 39.8 m -90.48 131.92 35.96 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.755 0.822 . . . . 0.0 109.005 160.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 78.8 p -133.41 3.6 3.62 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.73 158.5 20.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.515 1.052 . . . . 0.0 110.356 163.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.14 102.33 0.49 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.846 2.058 . . . . 0.0 112.132 -161.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.5 mtm -82.91 161.84 21.74 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.609 0.763 . . . . 0.0 112.166 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 92.2 p -147.36 163.26 37.01 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -84.11 126.52 33.16 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 161.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.02 -24.31 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.059 0.544 . . . . 0.0 110.235 163.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -145.23 126.3 14.62 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.132 2.173 . . . . 0.0 107.822 170.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -57.45 149.73 48.08 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.299 1.04 . . . . 0.0 112.099 173.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -57.32 136.74 78.04 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.263 1.975 . . . . 0.0 111.242 170.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 38.1 p -132.1 127.13 35.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.502 1.121 . . . . 0.0 111.017 171.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -56.32 117.39 3.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.451 1.5 . . . . 0.0 110.887 174.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 79.7 p -79.12 -12.27 59.99 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.169 0.987 . . . . 0.0 113.274 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.61 -8.16 1.22 Allowed Glycine 0 CA--C 1.539 1.538 0 CA-C-N 119.299 0.954 . . . . 0.0 114.468 -165.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -83.85 4.2 30.32 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.213 1.506 . . . . 0.0 111.706 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 99.48 4.18 56.17 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.858 1.694 . . . . 0.0 113.782 -172.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.8 p -127.18 165.14 20.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.512 1.156 . . . . 0.0 112.114 -168.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.11 112.14 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.494 1.517 . . . . 0.0 107.834 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.1 127.14 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.229 1.012 . . . . 0.0 112.952 -167.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -135.07 167.84 20.23 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.86 1.664 . . . . 0.0 113.263 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -125.16 135.38 52.57 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.062 1.345 . . . . 0.0 107.76 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.59 157.66 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.704 0.801 . . . . 0.0 112.062 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -132.75 145.99 51.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.503 1.521 . . . . 0.0 112.089 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.04 147.98 38.98 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 127.356 2.262 . . . . 0.0 107.354 163.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -109.37 -51.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 0 CA-C-N 122.923 2.08 . . . . 0.0 115.918 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 168.21 25.14 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.917 -1.115 . . . . 0.0 112.348 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.54 -0.17 3.16 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.578 2.037 . . . . 0.0 117.531 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.98 96.46 50.18 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.869 1.335 . . . . 0.0 112.961 -162.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.38 114.99 3.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.297 2.665 . . . . 0.0 108.82 152.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 13.6 p -160.63 146.0 14.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.26 104.36 13.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.295 1.838 . . . . 0.0 107.042 164.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.289 0.6 OUTLIER -68.06 118.73 61.49 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 119.42 -0.324 . . . . 0.0 110.944 -153.089 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.01 106.65 2.19 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.771 2.314 . . . . 0.0 112.147 -171.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 91.7 t -106.15 116.73 50.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 126.349 1.86 . . . . 0.0 109.686 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.42 160.8 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.093 1.357 . . . . 0.0 110.046 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . 0.48 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 60.0 t -143.73 128.13 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -141.8 175.8 9.42 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.575 0.75 . . . . 0.0 112.576 -164.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . 0.474 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 64.2 m-20 -115.38 5.52 14.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.795 1.238 . . . . 0.0 111.949 171.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -132.85 6.56 3.99 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.33 1.852 . . . . 0.0 114.241 -159.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 40.1 mt 63.89 -6.34 0.25 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.382 2.273 . . . . 0.0 115.869 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.9 t -125.19 -7.17 7.09 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.606 1.548 . . . . 0.0 114.721 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 337' ' ' ALA . . . 73.22 37.29 0.76 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.813 2.045 . . . . 0.0 113.028 -176.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.78 -48.17 80.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 162.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 45.3 mm -75.03 152.53 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.219 1.008 . . . . 0.0 109.038 160.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.73 66.72 1.5 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.391 1.567 . . . . 0.0 109.682 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . 0.474 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 43.7 tttt -70.6 -62.68 1.3 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.393 2.277 . . . . 0.0 111.986 -161.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . 0.48 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -98.94 156.78 20.11 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.256 1.407 . . . . 0.0 115.757 -159.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.91 147.24 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.973 2.509 . . . . 0.0 109.51 -167.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.5 117.24 19.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.422 1.489 . . . . 0.0 108.877 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.2 t -79.62 -46.55 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.693 0.797 . . . . 0.0 110.622 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 366' ' ' GLU . 7.3 t -95.12 179.56 5.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.819 0.848 . . . . 0.0 110.745 169.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 26.3 m -57.08 139.47 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.027 0.931 . . . . 0.0 111.039 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -77.26 112.7 25.16 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.548 -0.72 . . . . 0.0 109.636 168.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.6 175.01 11.78 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.936 2.424 . . . . 0.0 113.298 -171.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.66 121.98 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 126.822 2.049 . . . . 0.0 107.716 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.16 98.09 0.97 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.441 1.096 . . . . 0.0 109.578 168.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.1 t -98.9 -15.59 19.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.873 1.269 . . . . 0.0 112.573 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.23 133.62 55.88 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.927 1.691 . . . . 0.0 106.582 156.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -65.65 -16.98 64.26 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.604 -1.31 . . . . 0.0 114.093 -169.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -88.52 3.75 49.16 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.957 1.703 . . . . 0.0 113.584 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -53.05 135.61 36.88 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.717 -1.24 . . . . 0.0 113.313 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.21 146.7 52.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.542 1.537 . . . . 0.0 110.952 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.9 p -159.35 146.54 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -157.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.95 128.09 34.63 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.051 2.54 . . . . 0.0 110.053 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 13.8 mt -136.1 142.33 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.258 0.552 . . . . 0.0 109.767 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . 0.477 ' H ' HG22 ' A' ' 351' ' ' THR . 22.7 mt-10 -114.54 140.67 48.57 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.692 1.197 . . . . 0.0 110.031 167.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.58 160.54 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.257 1.023 . . . . 0.0 111.448 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -132.38 104.28 13.54 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 126.146 1.778 . . . . 0.0 109.443 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.81 164.26 32.16 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.62 1.547 . . . . 0.0 109.985 159.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.5 -176.67 1.78 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.367 2.045 . . . . 0.0 110.347 160.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -57.23 149.27 20.32 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.526 -0.734 . . . . 0.0 111.096 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 89.4 -162.33 30.6 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 122.39 0.994 . . . . 0.0 115.292 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.33 158.64 33.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.663 1.985 . . . . 0.0 113.836 -167.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.5 m -169.28 161.0 9.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.38 1.472 . . . . 0.0 112.755 171.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -124.7 113.1 17.54 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.961 2.104 . . . . 0.0 106.879 161.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.6 mm -71.58 130.01 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.74 130.71 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.48 1.112 . . . . 0.0 109.375 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.2 104.08 14.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 125.474 1.509 . . . . 0.0 107.566 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 115.21 175.32 18.38 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 123.307 1.504 . . . . 0.0 116.383 170.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.34 161.13 34.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.267 2.227 . . . . 0.0 110.396 172.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.03 179.77 37.33 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.789 0.709 . . . . 0.0 112.751 -167.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.05 -25.72 46.08 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.216 -1.167 . . . . 0.0 112.321 172.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.3 m -58.41 -8.34 1.16 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 130.209 3.404 . . . . 0.0 117.337 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -85.79 149.89 24.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.323 0.965 . . . . 0.0 112.424 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 41.3 mt -119.22 166.87 12.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.969 0.908 . . . . 0.0 111.149 171.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 10.8 t -140.59 157.2 45.83 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 171.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -139.0 125.91 21.02 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.892 1.677 . . . . 0.0 109.522 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -70.64 131.49 44.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 111.897 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -144.22 126.69 15.9 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.825 0.85 . . . . 0.0 111.529 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 . . . . . 0 C--N 1.331 -0.205 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.266 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.4 p90 . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.31 104.8 8.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 160.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.3 ptm -65.9 149.82 49.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.892 1.677 . . . . 0.0 115.157 -173.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.7 m -99.7 143.13 30.29 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.526 1.13 . . . . 0.0 110.125 165.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.9 p -138.81 21.69 2.67 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -96.48 163.57 12.99 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.298 0.954 . . . . 0.0 110.606 165.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -66.3 105.03 1.32 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.231 2.212 . . . . 0.0 112.453 -159.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.6 mmt -70.61 160.27 32.86 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.001 0.92 . . . . 0.0 112.818 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 29.0 m -156.53 148.75 23.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.208 -0.932 . . . . 0.0 111.991 162.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.28 125.99 33.99 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 168.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.7 -27.62 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.629 0.772 . . . . 0.0 110.144 164.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -139.25 120.36 14.64 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.011 2.124 . . . . 0.0 107.706 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -56.74 154.3 18.6 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.933 0.893 . . . . 0.0 111.609 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -57.56 125.52 19.04 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.317 2.011 . . . . 0.0 111.115 166.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 8.0 p -130.16 129.16 43.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.038 0.935 . . . . 0.0 112.759 169.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -56.42 122.65 12.39 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.327 1.851 . . . . 0.0 111.562 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 82.2 p -78.07 -12.08 59.96 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.774 1.23 . . . . 0.0 113.191 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.66 -11.43 3.3 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.474 1.035 . . . . 0.0 113.796 -167.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -87.37 2.49 50.19 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.436 1.494 . . . . 0.0 112.239 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 101.52 9.72 43.15 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.241 1.401 . . . . 0.0 113.848 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.0 p -131.03 166.45 20.99 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.908 1.283 . . . . 0.0 112.12 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.64 120.38 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.75 2.02 . . . . 0.0 107.626 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.2 p -106.01 137.17 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.452 1.101 . . . . 0.0 112.655 -171.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -143.84 164.75 29.64 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.555 1.942 . . . . 0.0 113.45 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -123.87 127.0 47.39 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.136 1.774 . . . . 0.0 107.849 164.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.95 147.6 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.654 0.782 . . . . 0.0 111.695 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -124.62 144.11 50.35 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.539 1.935 . . . . 0.0 110.429 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 7.6 p -118.13 150.78 48.14 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.414 1.886 . . . . 0.0 107.943 163.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 72.2 Cg_endo -110.03 -50.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 0 CA-C-N 122.203 1.822 . . . . 0.0 116.7 -165.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.89 169.21 19.61 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.049 1.295 . . . . 0.0 113.327 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.04 -15.62 0.08 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 128.182 2.801 . . . . 0.0 118.648 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -104.29 108.03 59.18 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 119.711 1.755 . . . . 0.0 113.822 -166.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.99 121.51 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.845 3.03 . . . . 0.0 109.904 155.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 8.1 p -162.77 149.42 12.85 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.36 108.45 16.56 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 161.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.296 0.5 OUTLIER -67.01 119.84 67.33 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.505 -153.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.53 114.32 3.68 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.141 2.561 . . . . 0.0 111.295 -171.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 349' ' ' LEU . 52.4 t -116.18 114.48 46.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.365 1.466 . . . . 0.0 109.542 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.83 159.4 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.926 1.691 . . . . 0.0 108.835 -175.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.1 t -146.05 122.56 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.22 166.69 32.69 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -168.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -90.59 -5.33 56.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -114.87 6.15 15.35 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.618 1.567 . . . . 0.0 114.252 -160.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 25.4 mt 64.94 -7.96 0.25 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.25 2.22 . . . . 0.0 115.175 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.2 t -122.71 -12.07 8.13 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.191 1.359 . . . . 0.0 114.343 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 82.37 35.48 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.498 2.719 . . . . 0.0 113.261 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.68 67.32 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.093 0.557 . . . . 0.0 111.389 170.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.84 159.47 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.746 1.218 . . . . 0.0 108.227 162.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.12 123.46 16.96 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.328 -1.482 . . . . 0.0 110.903 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -128.2 -17.59 4.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -159.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -145.69 151.28 23.51 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -166.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.3 147.2 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.538 1.535 . . . . 0.0 111.921 -163.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 334' ' ' VAL . 2.7 mm? -67.84 112.39 4.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.816 2.047 . . . . 0.0 109.399 171.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.49 -33.75 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.021 0.528 . . . . 0.0 110.938 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.1 t -96.61 179.27 5.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.035 0.934 . . . . 0.0 111.172 167.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.48 125.72 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.062 1.345 . . . . 0.0 110.662 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -66.69 113.37 12.69 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 118.427 0.558 . . . . 0.0 110.757 171.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.8 179.63 6.11 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.142 2.561 . . . . 0.0 113.781 -171.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.09 130.28 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 127.023 2.129 . . . . 0.0 108.038 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -78.45 96.76 5.46 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.852 1.261 . . . . 0.0 109.206 166.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -97.21 -18.64 19.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.55 1.14 . . . . 0.0 112.481 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.89 135.95 51.83 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 155.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -66.67 -14.24 62.23 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.774 -1.204 . . . . 0.0 113.913 -171.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -89.01 0.42 56.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.683 1.993 . . . . 0.0 113.499 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -53.89 138.27 36.8 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.612 1.196 . . . . 0.0 113.079 -172.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.42 142.05 49.11 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.921 1.288 . . . . 0.0 111.053 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.4 p -154.93 145.48 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -158.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.26 126.29 30.72 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.101 2.96 . . . . 0.0 110.563 173.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.61 137.14 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.248 0.619 . . . . 0.0 110.757 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -107.17 140.29 40.27 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.849 1.26 . . . . 0.0 111.019 161.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.23 158.34 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.249 1.02 . . . . 0.0 112.702 171.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -111.27 114.32 53.41 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.362 1.865 . . . . 0.0 110.526 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -76.82 174.02 13.53 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 124.063 3.175 . . . . 0.0 111.182 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.54 -174.4 2.25 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.4 2.067 . . . . 0.0 110.463 159.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -67.5 146.01 54.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 154.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 84.8 -159.85 34.93 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 122.043 0.802 . . . . 0.0 114.752 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.48 157.39 30.47 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.911 2.084 . . . . 0.0 113.994 -166.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.0 m -170.57 171.91 6.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.431 1.892 . . . . 0.0 112.051 170.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.34 125.83 46.78 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 126.801 2.04 . . . . 0.0 108.314 158.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.2 mm -77.65 119.78 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.5 mt -111.24 128.37 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.317 1.447 . . . . 0.0 109.819 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 66.6 t -116.19 107.47 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.466 1.907 . . . . 0.0 108.189 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.25 177.78 24.25 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 122.449 1.027 . . . . 0.0 114.94 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.48 169.82 16.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.213 1.805 . . . . 0.0 111.382 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 83.86 -157.39 33.93 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.922 0.772 . . . . 0.0 112.345 -172.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -72.9 -33.08 65.79 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.555 -0.968 . . . . 0.0 110.975 163.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 28.6 m -59.87 -6.96 1.44 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 130.005 3.322 . . . . 0.0 117.741 -173.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -80.25 153.73 28.33 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.876 1.27 . . . . 0.0 111.467 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 46.0 mt -121.48 165.24 15.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.382 0.673 . . . . 0.0 110.464 170.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.1 t -150.42 160.54 43.68 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -140.82 124.93 17.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.036 1.734 . . . . 0.0 110.077 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -67.77 133.44 49.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.035 1.334 . . . . 0.0 111.711 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -133.11 152.5 51.95 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.165 0.986 . . . . 0.0 111.545 170.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 . . . . . 0 C--N 1.332 -0.189 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 173.758 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.4 p90 . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.49 100.01 1.04 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 160.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.02 136.53 56.3 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.517 1.927 . . . . 0.0 113.888 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 22.1 m -87.53 135.41 33.36 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 153.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 68.3 p -138.12 -0.89 2.0 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 174.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.64 166.63 20.32 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 120.101 1.319 . . . . 0.0 110.498 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -67.08 101.03 0.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.713 1.605 . . . . 0.0 112.438 -165.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 37.9 mtm -90.51 165.07 13.99 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.778 1.231 . . . . 0.0 111.837 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.0 m -161.28 161.01 30.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.148 -0.97 . . . . 0.0 112.491 167.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.7 125.54 29.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.982 0.513 . . . . 0.0 109.952 161.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 81.2 t -76.9 -25.56 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.436 1.494 . . . . 0.0 110.677 165.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -137.61 131.24 31.29 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.191 1.796 . . . . 0.0 107.925 164.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -59.9 151.39 64.67 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.097 0.559 . . . . 0.0 111.858 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -55.74 130.21 39.17 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.383 2.056 . . . . 0.0 111.498 166.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 16.5 p -120.5 125.0 46.76 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.506 1.522 . . . . 0.0 110.629 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -55.75 118.07 4.22 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.567 1.147 . . . . 0.0 110.067 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.3 p -79.53 -16.38 56.08 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 60.31 -0.39 0.94 Allowed Glycine 0 CA--C 1.539 1.581 0 CA-C-N 119.467 1.03 . . . . 0.0 115.057 -161.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -86.46 18.15 3.43 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.284 1.542 . . . . 0.0 110.652 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.34 -2.84 87.94 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.771 1.177 . . . . 0.0 114.1 -168.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 25.0 p -122.47 175.37 6.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.043 1.421 . . . . 0.0 113.608 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.7 125.11 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 127.043 2.137 . . . . 0.0 107.938 172.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.84 131.72 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.903 1.281 . . . . 0.0 113.531 -169.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -140.73 169.37 17.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.7 2.0 . . . . 0.0 113.526 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.27 135.73 52.81 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.361 1.064 . . . . 0.0 108.411 164.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.95 152.77 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.247 1.019 . . . . 0.0 112.412 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -137.53 150.94 47.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.685 1.194 . . . . 0.0 113.008 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.2 t -119.66 141.13 30.5 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 128.243 2.617 . . . . 0.0 107.947 169.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -97.4 -67.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.88 2.387 . . . . 0.0 115.313 -174.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 174.87 10.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.88 1.272 . . . . 0.0 112.881 -173.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.9 -12.43 0.81 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.504 2.002 . . . . 0.0 117.712 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -123.58 96.62 43.23 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 119.525 1.663 . . . . 0.0 113.797 -160.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.81 120.5 6.43 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.84 1.693 . . . . 0.0 109.084 155.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.7 p -162.62 150.62 14.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -171.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -83.8 97.36 9.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.535 1.534 . . . . 0.0 107.265 162.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.252 1.2 pp -58.1 112.11 4.42 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.578 0.751 . . . . 0.0 111.87 -159.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.29 117.1 4.95 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.706 2.271 . . . . 0.0 112.991 -170.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 88.0 t -120.4 120.59 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 126.2 1.8 . . . . 0.0 108.765 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.26 160.01 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.035 1.734 . . . . 0.0 109.454 -175.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 3.9 t -138.53 113.62 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.82 -176.83 4.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.697 0.799 . . . . 0.0 112.163 -168.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -115.74 6.59 14.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.325 1.05 . . . . 0.0 112.194 171.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -131.87 1.48 3.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -152.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 16.1 mt 64.48 0.11 1.02 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.304 2.242 . . . . 0.0 115.198 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.5 t -135.84 -6.16 2.16 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -170.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 57.54 48.29 14.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.552 1.941 . . . . 0.0 113.645 -174.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.78 66.28 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.102 0.561 . . . . 0.0 110.012 159.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 8.9 mm -101.99 147.15 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 126.054 1.741 . . . . 0.0 108.479 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -126.05 108.35 11.29 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.431 -0.793 . . . . 0.0 111.847 163.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -66.4 -69.83 0.28 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 128.352 2.661 . . . . 0.0 111.425 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -100.33 169.32 21.51 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 -160.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.2 mp -115.82 154.99 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 128.0 2.52 . . . . 0.0 110.193 -169.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.47 134.94 40.71 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.115 0.966 . . . . 0.0 109.931 168.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.88 -47.08 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.382 0.673 . . . . 0.0 110.944 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 366' ' ' GLU . 3.6 t -92.42 172.57 8.3 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.652 0.739 . . . . 0.0 111.647 168.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.2 m -66.64 126.36 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.118 1.367 . . . . 0.0 112.667 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.04 126.59 64.93 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.978 1.311 . . . . 0.0 110.099 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -80.98 -172.54 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.027 3.152 . . . . 0.0 112.926 -173.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.08 119.22 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 127.112 2.165 . . . . 0.0 107.451 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.78 90.16 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.377 1.071 . . . . 0.0 110.685 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 10.7 t -73.92 -37.94 64.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.733 -0.604 . . . . 0.0 110.247 159.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 39.7 p -102.37 123.46 46.2 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.389 1.875 . . . . 0.0 109.192 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -54.73 -19.8 7.03 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.9 5.98 8.6 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.605 1.562 . . . . 0.0 113.708 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -43.67 134.28 4.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.529 1.932 . . . . 0.0 114.203 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -150.88 129.62 12.36 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.846 1.658 . . . . 0.0 110.067 -167.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.3 p -154.16 145.77 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -166.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -78.68 123.03 26.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.484 2.714 . . . . 0.0 109.473 165.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 40.6 mt -129.16 144.21 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 118.464 0.574 . . . . 0.0 111.519 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 351' ' ' THR . 21.6 mt-10 -118.9 140.38 50.08 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.649 1.58 . . . . 0.0 110.947 164.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.2 160.46 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.074 1.35 . . . . 0.0 111.515 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -130.95 98.58 18.98 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.697 1.999 . . . . 0.0 109.788 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.17 166.65 16.32 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.33 2.687 . . . . 0.0 111.375 162.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.77 175.07 7.71 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.885 2.39 . . . . 0.0 110.857 163.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.82 154.35 30.18 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.842 -0.536 . . . . 0.0 111.04 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 91.03 -163.25 29.15 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 121.404 0.447 . . . . 0.0 113.24 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -66.03 157.12 31.79 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -168.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 20.5 m -168.03 164.62 13.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.061 1.744 . . . . 0.0 112.086 168.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -128.25 111.45 13.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.887 2.875 . . . . 0.0 107.543 166.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 1.8 mm -74.37 124.38 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 79.9 mt -113.58 129.83 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.835 1.254 . . . . 0.0 108.91 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.65 109.38 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 125.282 1.433 . . . . 0.0 107.863 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 107.52 177.89 22.48 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 123.363 1.535 . . . . 0.0 115.747 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.4 163.93 28.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 127.669 2.387 . . . . 0.0 110.78 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.54 -179.97 36.05 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.199 0.428 . . . . 0.0 112.241 -166.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -56.81 -27.38 59.87 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.279 1.031 . . . . 0.0 112.375 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 46.6 m -58.95 -7.61 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.567 3.147 . . . . 0.0 116.651 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -81.15 149.07 29.28 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.503 1.121 . . . . 0.0 112.299 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 27.6 mt -118.69 165.22 14.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.957 0.903 . . . . 0.0 111.315 171.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.6 t -148.49 162.12 40.26 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -144.24 127.75 16.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.872 2.069 . . . . 0.0 110.14 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -75.21 135.83 41.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.817 1.647 . . . . 0.0 112.548 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -134.38 157.2 47.02 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.631 1.173 . . . . 0.0 111.763 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 . . . . . 0 CA--C 1.535 0.383 0 C-N-CA 125.844 1.657 . . . . 0.0 106.922 173.183 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.7 p90 . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -73.28 101.68 3.47 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 164.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -82.11 165.91 20.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.54 1.536 . . . . 0.0 113.679 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.7 m -101.6 152.49 20.75 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.523 1.529 . . . . 0.0 109.86 167.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.7 p -142.67 6.44 1.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.47 160.92 31.87 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.096 1.316 . . . . 0.0 110.966 165.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.06 97.01 0.05 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.212 1.405 . . . . 0.0 112.39 -171.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 34.2 mtm -84.99 169.0 14.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.021 1.328 . . . . 0.0 111.708 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.1 m -159.78 158.37 31.04 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.176 -0.953 . . . . 0.0 112.515 170.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.12 123.56 28.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.554 0.742 . . . . 0.0 110.111 161.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.68 -25.03 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.514 1.126 . . . . 0.0 110.574 165.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -141.88 137.75 31.6 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.685 1.994 . . . . 0.0 109.16 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -62.9 143.99 97.07 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.994 1.317 . . . . 0.0 112.989 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -54.64 124.8 17.08 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.52 2.813 . . . . 0.0 112.542 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 10.2 p -123.53 130.07 52.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.132 1.373 . . . . 0.0 111.802 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -57.83 123.27 15.19 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.846 0.858 . . . . 0.0 111.005 171.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 26.8 p -80.64 -11.72 59.6 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.841 1.256 . . . . 0.0 113.085 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 84.0 -11.16 58.34 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.863 1.221 . . . . 0.0 114.341 -169.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -92.59 10.13 31.75 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.176 1.488 . . . . 0.0 112.509 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.47 13.19 71.1 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.848 0.737 . . . . 0.0 113.216 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 11.6 p -124.63 153.76 41.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.964 1.306 . . . . 0.0 110.959 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 26.0 t -128.48 118.16 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.869 1.668 . . . . 0.0 107.94 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.04 133.8 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.069 1.348 . . . . 0.0 113.299 -163.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 7.0 ptp -137.53 165.51 26.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.84 2.056 . . . . 0.0 112.023 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -115.69 133.96 55.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 163.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 6.8 m -136.41 149.01 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.543 1.137 . . . . 0.0 112.213 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -132.92 149.52 52.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.939 1.696 . . . . 0.0 112.621 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 8.2 t -119.1 151.93 51.33 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 127.644 2.378 . . . . 0.0 108.796 169.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 1.1 Cg_endo -103.05 -76.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 123.255 2.637 . . . . 0.0 115.127 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.65 165.12 27.75 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 121.221 1.828 . . . . 0.0 114.465 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 70.89 15.59 74.04 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.255 0.931 . . . . 0.0 114.946 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.57 87.1 56.89 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 112.44 -164.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -79.74 114.31 3.18 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.028 2.485 . . . . 0.0 108.974 159.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.4 p -163.02 155.23 18.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -171.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -79.12 109.02 13.05 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 154.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.271 1.1 pp -64.34 122.96 81.06 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.993 -162.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.423 ' HG2' ' HA2' ' A' ' 379' ' ' GLY . 73.8 Cg_endo -73.63 106.16 2.14 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.449 3.433 . . . . 0.0 113.334 -163.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 72.2 t -116.16 118.04 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.36 1.864 . . . . 0.0 109.844 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.47 158.65 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.934 1.294 . . . . 0.0 110.837 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 37.0 t -135.14 123.55 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.76 170.25 16.24 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -105.09 3.83 30.82 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.989 1.316 . . . . 0.0 112.039 169.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -129.4 10.75 5.76 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.732 1.613 . . . . 0.0 114.761 -161.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 46.9 mt 63.48 -10.83 0.11 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.692 2.397 . . . . 0.0 116.344 -175.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.5 t -127.93 -6.94 5.53 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.934 1.697 . . . . 0.0 114.594 -171.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.98 42.61 7.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.736 2.015 . . . . 0.0 112.87 -170.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -61.15 -31.27 70.99 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.726 159.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 7.9 mt -117.93 128.98 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 127.909 2.483 . . . . 0.0 107.199 167.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -95.52 108.57 20.83 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.192 0.905 . . . . 0.0 110.32 164.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -66.24 -57.85 6.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.791 2.036 . . . . 0.0 111.947 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -111.34 -177.46 20.35 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 -159.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.05 152.77 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.336 1.454 . . . . 0.0 111.438 -172.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.36 130.12 35.13 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.568 1.147 . . . . 0.0 109.51 169.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.79 -53.41 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 117.891 0.314 . . . . 0.0 111.032 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.2 m -83.66 153.19 24.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.923 0.889 . . . . 0.0 110.393 168.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 6.0 m -53.1 117.36 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.362 2.265 . . . . 0.0 114.989 -173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -82.79 118.85 73.11 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.763 1.225 . . . . 0.0 110.321 168.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.49 -177.32 3.78 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.549 3.5 . . . . 0.0 113.423 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.33 112.74 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.27 1.428 . . . . 0.0 107.223 167.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.2 85.23 0.37 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.15 1.38 . . . . 0.0 110.782 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 34.8 t -66.4 -58.6 4.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.936 0.494 . . . . 0.0 109.745 166.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 25.2 p -78.91 122.88 26.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.098 1.359 . . . . 0.0 109.963 163.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -62.54 -21.85 65.86 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.04 4.06 4.73 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.963 1.305 . . . . 0.0 113.519 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -42.32 129.4 3.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.72 2.008 . . . . 0.0 113.171 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.98 128.37 20.01 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.943 1.297 . . . . 0.0 110.309 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.2 p -149.29 150.79 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.583 0.706 . . . . 0.0 112.625 -159.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -89.12 121.74 31.74 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.298 2.639 . . . . 0.0 109.35 171.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 43.8 mt -135.31 146.86 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.444 0.698 . . . . 0.0 111.516 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -111.97 143.34 43.12 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.004 1.722 . . . . 0.0 111.624 167.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.78 149.15 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 123.513 0.725 . . . . 0.0 111.424 164.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -97.76 110.2 54.29 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.27 1.428 . . . . 0.0 109.466 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.8 126.03 6.37 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.979 2.452 . . . . 0.0 110.225 164.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.1 167.22 2.59 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.369 2.046 . . . . 0.0 111.444 155.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -60.26 155.79 16.91 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.429 0.633 . . . . 0.0 112.62 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.95 -169.88 39.03 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 123.007 1.337 . . . . 0.0 113.914 -173.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.57 163.01 9.55 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.151 1.78 . . . . 0.0 113.775 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 35.9 m -164.07 148.8 10.22 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.637 -1.289 . . . . 0.0 113.231 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -113.11 111.08 21.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.422 2.289 . . . . 0.0 106.87 161.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.4 mm -74.77 120.49 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 32.0 mt -117.7 126.59 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 122.273 1.035 . . . . 0.0 109.405 -171.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 54.9 t -118.02 99.29 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 127.361 2.265 . . . . 0.0 107.217 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . 0.423 ' HA2' ' HG2' ' A' ' 333' ' ' PRO . . . 118.73 170.54 14.8 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 122.981 1.323 . . . . 0.0 115.502 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.49 165.55 24.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.514 2.326 . . . . 0.0 109.556 166.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.28 -172.66 55.11 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 123.211 0.434 . . . . 0.0 112.163 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -60.35 -32.3 71.13 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.324 -1.104 . . . . 0.0 111.708 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.9 m -56.58 -4.3 0.15 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 130.338 3.455 . . . . 0.0 117.782 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -86.96 144.09 27.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.129 0.877 . . . . 0.0 111.816 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.99 165.94 11.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.884 0.873 . . . . 0.0 110.142 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.2 t -146.97 158.71 44.0 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 169.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -139.92 131.51 27.16 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.642 1.977 . . . . 0.0 108.63 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.68 141.3 32.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.764 1.226 . . . . 0.0 111.739 -171.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -140.0 146.92 39.69 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.162 1.385 . . . . 0.0 109.578 170.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.714 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.5 p90 . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.053 0.454 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 112.05 23.83 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.186 1.794 . . . . 0.0 107.072 165.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -61.08 142.67 56.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.975 1.71 . . . . 0.0 115.054 -174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 4.5 m -94.8 148.77 21.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.818 0.847 . . . . 0.0 109.013 156.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.1 p -137.11 1.42 2.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -77.92 163.11 26.3 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.677 1.126 . . . . 0.0 110.958 168.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.44 98.81 0.51 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.148 1.779 . . . . 0.0 112.096 -164.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 32.5 mtm -84.54 166.29 17.33 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.736 1.214 . . . . 0.0 112.23 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.7 m -161.81 162.7 29.55 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.149 -0.969 . . . . 0.0 112.255 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.36 117.0 24.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.07 0.948 . . . . 0.0 110.602 164.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 74.7 t -68.25 -30.16 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.595 1.558 . . . . 0.0 110.684 167.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -136.16 118.37 15.54 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.165 1.786 . . . . 0.0 107.575 170.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -52.74 144.61 24.81 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.216 1.006 . . . . 0.0 111.24 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.09 130.78 37.95 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.325 1.35 . . . . 0.0 111.878 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.3 p -130.69 130.74 44.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.277 1.431 . . . . 0.0 111.2 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.4 140.21 58.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.735 1.214 . . . . 0.0 112.61 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 39.4 p -95.79 -9.85 30.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.851 1.26 . . . . 0.0 113.996 -174.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 68.11 -2.78 6.37 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 119.283 0.947 . . . . 0.0 115.231 -167.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -97.06 19.14 13.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.009 1.405 . . . . 0.0 111.43 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.02 0.43 88.97 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.817 1.199 . . . . 0.0 113.788 -171.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 22.3 p -121.76 169.75 10.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.526 1.163 . . . . 0.0 112.547 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.8 t -140.63 124.5 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.23 1.812 . . . . 0.0 108.287 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.82 134.16 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.665 1.186 . . . . 0.0 112.308 -170.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -142.57 168.7 19.11 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.583 1.953 . . . . 0.0 113.062 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -122.42 131.93 54.11 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.182 1.393 . . . . 0.0 107.932 164.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.58 153.27 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.057 0.943 . . . . 0.0 111.582 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -136.98 146.22 45.1 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.426 1.49 . . . . 0.0 112.89 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.27 149.91 42.22 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 128.483 2.713 . . . . 0.0 107.735 164.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -107.04 -57.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.354 2.036 . . . . 0.0 115.594 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.22 170.68 15.29 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.949 -1.094 . . . . 0.0 112.966 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 69.21 -3.81 7.03 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.292 1.901 . . . . 0.0 117.718 168.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.97 99.59 41.02 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 119.248 1.524 . . . . 0.0 113.579 -163.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.07 112.27 2.56 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.67 2.913 . . . . 0.0 109.417 157.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.2 p -157.61 155.48 30.18 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -87.65 93.36 9.41 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.793 2.037 . . . . 0.0 106.695 162.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.254 1.4 pp -56.93 111.69 3.65 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.526 0.73 . . . . 0.0 112.456 -155.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.34 115.75 3.06 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.096 2.531 . . . . 0.0 114.197 -167.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 82.0 t -122.73 109.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.317 1.447 . . . . 0.0 109.71 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.93 162.77 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.663 1.585 . . . . 0.0 109.519 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.65 127.08 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -140.27 168.8 18.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.495 0.589 . . . . 0.0 112.352 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -102.13 -2.92 28.37 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.005 0.922 . . . . 0.0 111.851 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -106.07 0.49 25.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.582 1.953 . . . . 0.0 114.558 -168.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 34.4 mt 61.4 0.7 0.47 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.324 2.249 . . . . 0.0 115.967 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.1 t -127.99 -2.44 5.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.238 1.381 . . . . 0.0 114.515 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.524 ' HB3' HH22 ' A' ' 384' ' ' ARG . . . 62.55 45.04 6.48 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.802 2.441 . . . . 0.0 113.209 -172.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.86 -33.7 76.17 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 119.646 -0.216 . . . . 0.0 111.231 164.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 33.3 mt -131.9 117.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.346 1.458 . . . . 0.0 110.215 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -80.1 104.26 10.55 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.367 -0.833 . . . . 0.0 112.773 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -66.34 -56.09 12.8 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.585 2.354 . . . . 0.0 112.943 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -115.77 169.76 13.06 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 116.914 1.525 . . . . 0.0 116.914 -159.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.87 155.24 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.096 2.158 . . . . 0.0 111.863 -165.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.12 123.68 32.43 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.558 1.543 . . . . 0.0 108.723 166.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 93.3 t -89.47 -34.97 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.0 0.52 . . . . 0.0 111.446 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.0 t -113.3 175.12 5.58 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.213 1.005 . . . . 0.0 112.209 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.6 m -65.26 101.8 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.76 1.624 . . . . 0.0 112.474 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -63.09 125.31 86.59 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.854 165.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -82.09 -177.25 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.536 3.491 . . . . 0.0 114.007 -169.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.11 114.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 127.236 2.214 . . . . 0.0 107.674 171.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.86 75.39 0.11 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.837 1.655 . . . . 0.0 112.892 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -66.73 -11.46 54.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 169.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 31.5 p -134.52 127.34 31.16 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 127.846 2.458 . . . . 0.0 106.575 165.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -62.24 -15.29 46.1 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -170.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.79 5.98 10.08 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.237 1.815 . . . . 0.0 113.552 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -39.22 119.12 0.87 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 127.314 2.245 . . . . 0.0 113.584 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.57 144.59 50.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.057 0.943 . . . . 0.0 111.613 170.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.71 142.59 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -161.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.59 120.4 19.14 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.692 2.397 . . . . 0.0 109.455 165.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 48.0 mt -131.46 131.77 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.284 0.564 . . . . 0.0 110.732 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -96.51 139.8 32.07 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.989 0.916 . . . . 0.0 111.052 158.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.15 160.72 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.323 1.449 . . . . 0.0 110.957 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -125.41 92.87 46.09 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.068 1.747 . . . . 0.0 109.487 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.08 140.78 20.3 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.481 2.121 . . . . 0.0 109.987 160.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.35 179.93 3.65 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.812 2.341 . . . . 0.0 111.706 168.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -59.33 160.14 7.02 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.355 1.062 . . . . 0.0 113.444 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 86.83 -145.41 20.03 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.094 0.378 . . . . 0.0 112.193 -170.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -93.91 169.21 10.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.318 1.047 . . . . 0.0 113.653 -173.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 29.7 m -164.94 160.7 19.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.868 1.267 . . . . 0.0 112.423 168.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -129.05 109.4 11.16 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.636 1.974 . . . . 0.0 107.017 163.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.28 128.78 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 91.7 mt -119.42 125.65 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.122 1.369 . . . . 0.0 108.734 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.5 104.39 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.525 1.53 . . . . 0.0 108.02 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.32 -179.62 20.98 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 123.363 1.535 . . . . 0.0 116.644 171.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.95 170.0 16.82 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.581 2.752 . . . . 0.0 110.027 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 82.69 -158.6 37.32 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -168.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -72.82 -35.74 67.37 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.702 -0.881 . . . . 0.0 111.037 163.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.4 m -52.14 6.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 1 C-N-CA 132.202 4.201 . . . . 0.0 119.198 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . 0.524 HH22 ' HB3' ' A' ' 342' ' ' ALA . 0.5 OUTLIER -99.53 138.15 37.02 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.923 1.289 . . . . 0.0 111.808 -169.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.7 mt -107.76 166.55 10.61 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.027 0.531 . . . . 0.0 110.814 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.8 t -142.57 158.18 43.94 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 171.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -141.08 130.78 24.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.811 1.244 . . . . 0.0 110.948 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -64.41 137.13 57.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.439 2.296 . . . . 0.0 112.668 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -138.92 154.1 48.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.469 1.128 . . . . 0.0 113.012 163.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 126.86 2.064 . . . . 0.0 106.221 177.671 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 2.5 p90 . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 100.11 0.74 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 161.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 158.97 30.21 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.714 1.206 . . . . 0.0 114.08 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.4 m -105.71 137.63 43.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.709 1.204 . . . . 0.0 109.401 167.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.6 p -132.3 7.87 4.27 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -82.35 163.48 21.71 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.401 1.001 . . . . 0.0 110.735 165.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -62.22 109.04 1.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.613 1.965 . . . . 0.0 111.584 -165.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 15.1 mmt -72.99 159.27 33.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.769 0.795 . . . . 0.0 112.729 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.5 p -150.8 150.78 31.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.2 1.0 . . . . 0.0 111.134 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.3 119.44 35.83 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.651 0.78 . . . . 0.0 109.074 163.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -25.28 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.869 0.868 . . . . 0.0 110.425 165.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -142.31 127.84 19.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.911 2.084 . . . . 0.0 108.49 168.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -60.61 144.31 89.25 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.503 1.121 . . . . 0.0 111.443 171.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -54.79 136.57 72.2 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.22 1.947 . . . . 0.0 111.285 173.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 64.5 p -134.87 126.17 28.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.316 1.046 . . . . 0.0 111.198 171.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -55.76 119.18 5.34 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.327 1.451 . . . . 0.0 110.823 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 65.1 p -80.72 -12.59 59.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.906 0.883 . . . . 0.0 112.975 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.83 -7.49 1.54 Allowed Glycine 0 CA--C 1.538 1.494 0 CA-C-O 119.073 -0.848 . . . . 0.0 114.456 -166.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -81.77 2.66 28.97 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.352 1.576 . . . . 0.0 111.965 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.82 9.61 54.11 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.246 1.403 . . . . 0.0 113.677 -170.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.9 p -131.84 165.96 22.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.887 1.275 . . . . 0.0 112.874 -172.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.32 117.99 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.542 2.337 . . . . 0.0 107.152 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.0 p -102.45 132.08 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.586 0.755 . . . . 0.0 112.508 -174.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -137.59 165.29 26.68 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.853 1.661 . . . . 0.0 112.82 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.18 128.24 48.06 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.525 1.53 . . . . 0.0 107.177 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.93 148.45 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.666 0.787 . . . . 0.0 112.005 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -137.12 134.43 36.41 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.592 1.557 . . . . 0.0 112.114 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 m -98.86 159.26 30.74 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.995 1.718 . . . . 0.0 110.735 164.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -112.56 -55.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.886 2.391 . . . . 0.0 116.146 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 172.12 13.68 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.713 1.142 . . . . 0.0 113.139 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.11 -21.12 0.16 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 127.776 2.607 . . . . 0.0 118.291 168.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.39 107.86 56.91 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 119.366 1.583 . . . . 0.0 113.332 -165.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.57 125.91 5.8 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.996 2.464 . . . . 0.0 109.366 152.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 10.7 p -161.85 148.02 13.69 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.78 107.08 15.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.228 1.811 . . . . 0.0 106.635 163.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.284 0.6 OUTLIER -68.31 128.7 93.11 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.03 -153.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.97 109.48 2.89 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.117 3.211 . . . . 0.0 112.014 -172.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 93.5 t -111.18 108.89 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.861 1.665 . . . . 0.0 110.255 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.71 157.86 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 125.2 1.4 . . . . 0.0 110.019 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.6 t -144.48 125.54 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -149.59 170.18 19.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.098 0.559 . . . . 0.0 112.436 -170.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -89.68 -1.09 57.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.434 1.094 . . . . 0.0 113.293 174.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -127.47 1.2 6.26 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -152.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.9 mt 61.8 -1.39 0.35 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.151 2.181 . . . . 0.0 115.392 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.7 t -129.91 -7.66 4.46 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -171.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.4 49.23 4.23 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.908 2.083 . . . . 0.0 114.096 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -78.24 -38.03 43.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.834 0.454 . . . . 0.0 110.379 158.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 67.0 mt -97.51 153.12 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 126.919 2.088 . . . . 0.0 108.284 170.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.59 125.83 18.65 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.65 -1.281 . . . . 0.0 112.555 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . 0.484 ' HE2' ' HG3' ' A' ' 370' ' ' PRO . 2.9 mmmm -129.7 -17.38 3.64 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -159.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -142.56 148.34 20.04 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 119.219 0.918 . . . . 0.0 114.813 -167.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.1 148.83 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.528 1.131 . . . . 0.0 113.095 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.14 115.47 3.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.33 2.652 . . . . 0.0 110.939 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 70.9 t -81.33 -38.41 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.074 0.949 . . . . 0.0 110.532 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 t -92.23 175.1 6.98 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 111.286 168.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.8 m -66.87 135.3 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.329 1.052 . . . . 0.0 111.052 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.39 113.54 13.14 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 121.608 -0.682 . . . . 0.0 111.558 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.58 175.8 10.62 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.282 2.655 . . . . 0.0 113.708 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.29 132.01 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.152 1.781 . . . . 0.0 109.062 -173.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -78.29 97.84 5.72 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.352 1.461 . . . . 0.0 109.797 166.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.0 t -92.5 -16.04 26.29 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.269 1.028 . . . . 0.0 112.618 170.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.27 135.38 54.73 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.716 2.006 . . . . 0.0 107.01 163.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.2 -14.82 63.27 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.563 -1.335 . . . . 0.0 114.443 -167.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.73 0.82 56.09 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.674 1.59 . . . . 0.0 113.146 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -53.18 138.51 31.49 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.743 -1.223 . . . . 0.0 113.28 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.11 142.63 49.57 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.939 1.296 . . . . 0.0 111.069 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.47 144.89 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -162.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -69.63 127.2 32.12 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.82 2.848 . . . . 0.0 110.195 169.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 18.0 mt -137.05 138.24 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.011 0.434 . . . . 0.0 110.308 168.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -110.19 143.43 40.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.201 1.001 . . . . 0.0 110.964 163.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.52 151.54 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.966 0.906 . . . . 0.0 112.406 173.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -94.23 115.93 65.81 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.438 1.895 . . . . 0.0 109.435 172.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.91 168.99 23.59 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.141 2.56 . . . . 0.0 111.07 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . 0.484 ' HG3' ' HE2' ' A' ' 346' ' ' LYS . 17.0 Cg_endo -75.7 -177.24 3.45 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.94 2.427 . . . . 0.0 109.813 163.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -75.05 152.56 38.64 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.293 -0.879 . . . . 0.0 109.639 149.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 75.32 -156.2 48.27 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.809 1.084 . . . . 0.0 115.809 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.97 145.83 55.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.255 2.622 . . . . 0.0 113.151 -166.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 6.2 m -179.24 160.46 1.03 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.709 1.603 . . . . 0.0 114.545 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -126.99 119.0 25.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 129.078 2.951 . . . . 0.0 108.586 170.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.2 mm -75.14 119.58 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.5 132.24 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 120.235 1.38 . . . . 0.0 110.076 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.6 106.49 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 126.069 1.748 . . . . 0.0 108.302 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 114.03 176.15 19.06 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 122.496 1.053 . . . . 0.0 115.234 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.63 166.4 23.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.851 2.061 . . . . 0.0 110.223 170.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.1 -175.65 45.14 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 123.09 0.376 . . . . 0.0 112.45 -165.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -58.55 -28.82 65.86 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.674 -0.897 . . . . 0.0 111.921 171.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 50.6 m -57.72 -10.44 1.62 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 130.106 3.362 . . . . 0.0 116.933 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -79.63 146.77 32.34 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.347 1.059 . . . . 0.0 112.039 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 44.3 mt -116.03 166.17 12.3 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.895 0.878 . . . . 0.0 110.513 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.2 t -152.5 161.37 42.68 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -139.66 131.78 28.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.625 1.57 . . . . 0.0 110.205 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -69.12 125.44 26.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.846 1.258 . . . . 0.0 111.264 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -137.29 90.44 2.52 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.5 1.12 . . . . 0.0 110.488 172.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.3 m170 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 171.597 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 121.173 0.511 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 95.43 0.35 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 156.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -65.93 162.38 19.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.728 2.011 . . . . 0.0 114.275 -172.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 32.7 m -103.25 139.34 38.83 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.195 0.998 . . . . 0.0 110.558 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.2 p -138.76 7.12 2.5 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.663 1.356 . . . . 0.0 114.663 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.33 165.55 19.21 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.795 1.18 . . . . 0.0 110.634 163.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -66.98 95.01 0.36 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.673 1.989 . . . . 0.0 111.375 -169.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 23.8 mtm -76.75 170.18 16.93 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.118 1.367 . . . . 0.0 112.653 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.1 m -156.48 158.94 38.11 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.037 -1.039 . . . . 0.0 112.976 166.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.82 114.95 23.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.598 0.759 . . . . 0.0 109.745 162.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.8 -29.81 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.866 1.267 . . . . 0.0 110.318 168.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -140.77 132.47 27.28 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.634 1.974 . . . . 0.0 108.53 165.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -61.17 148.13 85.39 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.417 1.487 . . . . 0.0 112.846 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.67 130.27 37.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.886 2.391 . . . . 0.0 111.619 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.5 p -127.11 125.14 40.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.615 1.166 . . . . 0.0 111.29 173.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -60.03 126.44 27.56 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.301 1.44 . . . . 0.0 111.89 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -77.78 -16.15 58.59 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.326 1.451 . . . . 0.0 113.762 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.81 -5.79 5.7 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 118.937 -0.924 . . . . 0.0 114.139 -165.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -89.42 -2.24 58.33 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.201 1.501 . . . . 0.0 112.115 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 102.91 -1.73 48.16 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.233 1.396 . . . . 0.0 114.035 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 17.1 p -121.09 159.15 26.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.768 1.227 . . . . 0.0 111.679 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.3 123.74 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.484 1.914 . . . . 0.0 108.091 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.3 p -111.96 129.14 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.183 0.993 . . . . 0.0 113.418 -166.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -136.11 168.13 19.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.886 2.075 . . . . 0.0 113.071 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -125.84 129.17 48.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.796 1.238 . . . . 0.0 108.083 166.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.07 153.0 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 119.21 0.914 . . . . 0.0 112.528 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -141.65 146.68 36.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.706 1.602 . . . . 0.0 113.455 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.99 155.41 41.71 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.835 2.054 . . . . 0.0 109.702 160.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -109.18 -49.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.286 1.991 . . . . 0.0 116.46 -175.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 173.81 13.8 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.738 1.154 . . . . 0.0 112.79 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.11 0.83 10.5 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.439 1.971 . . . . 0.0 117.645 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -119.37 97.28 50.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 119.015 1.408 . . . . 0.0 113.868 -160.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -81.19 111.71 2.45 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.845 3.03 . . . . 0.0 109.88 152.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 7.5 p -159.68 153.47 22.95 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -81.37 110.45 16.81 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 159.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.263 1.3 pp -66.14 112.74 9.83 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 119.429 -0.319 . . . . 0.0 111.387 -162.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.84 113.88 3.72 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.908 2.406 . . . . 0.0 112.345 -165.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 94.8 t -112.35 108.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 126.171 1.788 . . . . 0.0 110.004 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.0 158.22 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.62 1.568 . . . . 0.0 110.168 -176.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 77.7 t -145.8 116.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -171.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -131.01 -179.17 5.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.172 0.989 . . . . 0.0 113.048 -165.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -111.07 -0.13 16.72 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.96 0.904 . . . . 0.0 112.33 163.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -123.35 6.72 9.03 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.751 1.621 . . . . 0.0 113.952 -159.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.2 mt 65.27 -6.02 0.4 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.252 2.221 . . . . 0.0 115.194 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -128.49 -3.08 5.48 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' A' ' 337' ' ' ALA . . . 68.33 37.43 2.76 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.825 2.05 . . . . 0.0 113.536 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.17 -49.07 68.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 165.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.46 150.39 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 126.626 1.97 . . . . 0.0 107.59 164.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.58 129.47 21.83 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.161 -0.962 . . . . 0.0 112.221 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -133.95 -8.55 2.71 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -160.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -127.72 130.14 6.63 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 -164.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -89.12 157.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.12 1.368 . . . . 0.0 111.905 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.77 119.92 32.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.091 2.156 . . . . 0.0 109.177 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.41 -25.22 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.502 0.721 . . . . 0.0 112.187 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 366' ' ' GLU . 8.7 t -125.66 175.54 7.51 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.544 1.537 . . . . 0.0 111.084 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.78 107.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.155 1.782 . . . . 0.0 113.427 -175.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -71.55 113.53 20.47 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.826 1.25 . . . . 0.0 110.055 162.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -82.63 179.1 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.705 2.937 . . . . 0.0 114.419 -169.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.62 119.79 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 127.19 2.196 . . . . 0.0 106.058 163.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.0 84.63 0.08 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.56 1.144 . . . . 0.0 110.501 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.1 t -81.92 -9.73 59.49 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.54 122.84 37.71 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 127.399 2.28 . . . . 0.0 106.898 168.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -66.87 -10.8 52.23 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.285 -1.509 . . . . 0.0 114.752 -166.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -89.86 4.33 50.19 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.333 1.853 . . . . 0.0 113.375 170.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.33 134.89 11.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.222 1.409 . . . . 0.0 113.811 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.93 151.43 49.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.774 1.23 . . . . 0.0 111.56 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.29 144.57 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -166.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -79.23 121.47 25.1 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.708 2.403 . . . . 0.0 109.79 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 61.0 mt -131.1 136.35 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.359 0.599 . . . . 0.0 111.177 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . 0.454 ' H ' HG22 ' A' ' 351' ' ' THR . 24.7 mt-10 -101.89 141.27 35.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.976 1.31 . . . . 0.0 110.762 161.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.7 159.49 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.391 1.076 . . . . 0.0 112.001 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -117.13 102.06 52.86 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.703 1.601 . . . . 0.0 109.949 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.78 179.89 3.89 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.676 2.917 . . . . 0.0 110.866 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -78.83 -179.85 5.84 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.219 1.946 . . . . 0.0 110.869 161.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -60.48 148.61 37.06 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 153.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.92 -163.72 43.96 Favored Glycine 0 CA--C 1.539 1.583 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -62.86 158.9 17.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.631 1.972 . . . . 0.0 114.471 -169.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.6 m -166.54 168.57 14.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.137 1.375 . . . . 0.0 113.079 166.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.91 111.29 12.41 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.659 2.383 . . . . 0.0 107.326 164.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 17.4 mm -69.44 129.04 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 59.2 mt -121.32 124.18 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.357 1.063 . . . . 0.0 108.926 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.99 100.56 11.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 126.069 1.747 . . . . 0.0 107.58 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 114.68 178.72 18.89 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 123.071 1.373 . . . . 0.0 116.159 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.57 167.25 22.04 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.744 2.418 . . . . 0.0 110.167 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.29 -174.85 46.81 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.569 0.604 . . . . 0.0 112.338 -167.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -59.22 -30.5 68.29 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 122.037 -0.684 . . . . 0.0 111.228 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 15.6 m -60.15 -6.98 1.61 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 129.88 3.272 . . . . 0.0 117.22 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.65 148.5 31.61 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.018 0.927 . . . . 0.0 112.005 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 18.0 mt -111.89 165.46 12.06 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.504 0.722 . . . . 0.0 110.563 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.9 t -147.06 157.74 43.71 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -139.71 121.29 15.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.334 1.854 . . . . 0.0 109.657 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -66.64 140.5 57.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.094 1.358 . . . . 0.0 111.89 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -135.95 155.95 49.49 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.46 1.104 . . . . 0.0 111.773 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.031 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 34.9 p90 . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 120.656 0.265 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.45 104.21 7.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.856 0.863 . . . . 0.0 108.995 170.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -66.84 146.95 53.88 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.972 2.109 . . . . 0.0 115.945 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.9 m -96.49 144.62 26.42 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.728 1.211 . . . . 0.0 109.075 159.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 57.8 p -139.56 2.1 1.99 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -69.23 161.19 29.72 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 120.181 1.355 . . . . 0.0 111.157 165.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.87 95.46 0.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.0 1.72 . . . . 0.0 112.277 -171.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 31.6 mtm -81.38 166.64 20.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.927 1.291 . . . . 0.0 112.003 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 22.2 m -160.21 162.57 33.82 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.441 -0.787 . . . . 0.0 112.085 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -74.46 135.17 42.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.514 0.726 . . . . 0.0 109.426 166.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.99 -17.97 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.342 0.657 . . . . 0.0 110.81 161.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 28.6 tttm -147.87 123.72 10.61 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.452 2.301 . . . . 0.0 108.034 173.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.28 146.2 84.41 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.992 0.917 . . . . 0.0 112.069 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.77 130.06 35.53 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.694 2.929 . . . . 0.0 112.848 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.6 p -128.55 134.18 48.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.551 1.141 . . . . 0.0 110.585 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -60.55 122.12 13.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.29 0.636 . . . . 0.0 109.893 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.7 p -72.79 -14.16 61.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.284 1.034 . . . . 0.0 112.801 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.74 -4.94 13.3 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.277 0.942 . . . . 0.0 113.492 -165.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -90.16 1.14 56.74 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.886 1.343 . . . . 0.0 112.036 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.87 13.41 43.49 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.804 1.193 . . . . 0.0 113.72 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.8 p -133.66 153.9 51.32 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.044 1.338 . . . . 0.0 111.687 -174.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.49 121.14 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.669 1.187 . . . . 0.0 107.912 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.0 p -112.37 134.33 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.35 1.06 . . . . 0.0 113.067 -164.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -141.79 159.83 41.43 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.936 1.695 . . . . 0.0 112.893 -175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -107.92 132.36 53.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.1 1.36 . . . . 0.0 107.373 164.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.35 144.66 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.641 0.776 . . . . 0.0 111.314 -177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -131.04 144.28 51.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.368 1.467 . . . . 0.0 112.901 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.62 153.36 44.31 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 127.986 2.514 . . . . 0.0 108.835 168.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -108.93 -70.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.843 2.362 . . . . 0.0 116.277 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.18 164.45 27.66 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 121.226 1.83 . . . . 0.0 114.339 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 71.6 0.07 37.74 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.89 1.709 . . . . 0.0 117.037 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.87 102.53 53.99 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 118.879 1.34 . . . . 0.0 113.525 -166.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.06 120.22 2.95 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.717 2.944 . . . . 0.0 109.611 152.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 7.7 p -162.51 157.37 22.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -89.39 109.19 20.13 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 157.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.265 0.9 OUTLIER -65.3 122.79 81.88 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.744 -157.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -61.77 117.41 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.712 2.941 . . . . 0.0 113.522 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.1 t -124.94 111.43 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.251 1.421 . . . . 0.0 110.721 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.28 157.26 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.338 1.455 . . . . 0.0 110.096 -173.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.79 118.36 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.46 171.45 13.38 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -165.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . 0.435 ' CG ' ' HE2' ' A' ' 346' ' ' LYS . 4.6 m-20 -90.89 -13.45 33.6 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.351 2.26 . . . . 0.0 112.577 166.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -114.99 0.18 13.59 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -154.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 36.4 mt 60.7 -25.95 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.664 2.786 . . . . 0.0 115.533 -171.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 11.1 t -99.8 -4.56 30.26 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.822 2.049 . . . . 0.0 114.567 -172.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.87 78.15 0.05 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 130.658 3.583 . . . . 0.0 115.175 -171.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -99.53 -38.91 8.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.295 1.438 . . . . 0.0 110.837 153.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 35.2 mm -98.96 128.5 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.771 1.228 . . . . 0.0 109.521 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -108.65 125.23 51.64 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.754 -0.591 . . . . 0.0 112.054 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . 0.435 ' HE2' ' CG ' ' A' ' 338' ' ' ASP . 47.8 mttm -75.49 -73.45 0.26 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.691 2.796 . . . . 0.0 110.902 166.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -98.31 167.16 22.35 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.063 1.316 . . . . 0.0 115.582 -155.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 12.6 mt -120.03 152.24 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.633 1.573 . . . . 0.0 110.318 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.3 135.97 54.16 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.472 1.909 . . . . 0.0 110.312 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.58 -50.14 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.949 0.5 . . . . 0.0 110.693 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.408 ' H ' ' HB2' ' A' ' 366' ' ' GLU . 1.1 m -81.45 156.81 25.16 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.001 0.92 . . . . 0.0 109.348 160.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.05 161.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.255 1.422 . . . . 0.0 113.922 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -125.02 121.05 25.39 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.158 1.783 . . . . 0.0 109.227 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -82.28 -175.29 2.44 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.265 3.31 . . . . 0.0 113.548 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 123.12 63.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.578 1.551 . . . . 0.0 108.037 168.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.63 84.71 0.87 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.34 1.056 . . . . 0.0 111.548 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 25.0 t -79.29 -12.34 59.94 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 167.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.7 p -131.31 121.98 25.64 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 127.785 2.434 . . . . 0.0 105.939 167.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -59.51 -20.34 54.66 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.8 0.06 9.93 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.466 1.906 . . . . 0.0 113.737 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -37.13 121.82 0.83 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.481 2.312 . . . . 0.0 113.58 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.65 143.18 47.13 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.269 1.028 . . . . 0.0 111.285 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.2 p -154.17 150.47 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -163.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.93 121.82 27.48 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.793 2.437 . . . . 0.0 109.469 168.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 37.0 mt -135.71 150.13 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.956 0.798 . . . . 0.0 111.455 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . 0.408 ' HB2' ' H ' ' A' ' 351' ' ' THR . 48.3 mt-10 -118.4 142.63 47.35 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.55 1.94 . . . . 0.0 111.467 170.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 3.8 m -123.11 145.47 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.569 1.148 . . . . 0.0 110.733 168.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -83.18 119.08 73.49 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.936 0.894 . . . . 0.0 109.787 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -82.34 151.33 15.54 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 122.844 2.363 . . . . 0.0 111.045 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.47 178.13 7.07 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.747 2.298 . . . . 0.0 110.442 158.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.73 151.66 46.88 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.611 -0.68 . . . . 0.0 110.449 163.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 77.63 -151.33 37.64 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 121.92 -0.488 . . . . 0.0 113.297 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.28 143.45 57.78 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -173.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 47.2 m -157.41 145.49 19.12 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.487 1.115 . . . . 0.0 112.512 167.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -122.77 105.2 9.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.404 1.082 . . . . 0.0 108.651 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 13.8 mm -76.69 113.78 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 127.444 2.298 . . . . 0.0 109.022 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 25.1 mt -116.79 133.96 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 122.449 1.118 . . . . 0.0 111.78 -168.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 81.6 t -116.77 114.58 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 C-N-CA 126.647 1.979 . . . . 0.0 108.023 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 96.98 -173.05 28.82 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 122.875 1.264 . . . . 0.0 115.521 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.95 164.01 31.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.308 2.243 . . . . 0.0 110.018 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.55 -174.12 42.68 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.008 0.337 . . . . 0.0 112.359 -167.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -59.17 -25.79 64.22 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.074 0.95 . . . . 0.0 112.497 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 63.4 m -60.38 -10.72 5.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.824 2.449 . . . . 0.0 115.684 172.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -77.39 124.71 28.24 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.508 1.049 . . . . 0.0 112.167 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 9.8 mt -97.71 161.3 13.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.983 0.513 . . . . 0.0 111.401 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.9 t -132.65 157.88 43.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.879 1.272 . . . . 0.0 112.042 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -145.0 136.52 25.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.078 1.351 . . . . 0.0 110.979 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.14 137.22 38.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.465 1.506 . . . . 0.0 113.139 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -138.01 147.39 44.14 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.917 1.287 . . . . 0.0 111.352 158.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 . . . . . 0 CA--C 1.536 0.435 0 C-N-CA 125.603 1.561 . . . . 0.0 107.598 169.185 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 29.5 p90 . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 121.477 0.656 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.35 105.94 13.83 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.123 1.769 . . . . 0.0 109.173 172.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -80.44 161.83 24.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.125 1.77 . . . . 0.0 114.162 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 13.7 m -100.86 148.58 24.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.343 1.057 . . . . 0.0 110.939 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 42.9 p -139.08 11.47 2.61 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 170.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -83.17 160.61 21.78 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.804 1.183 . . . . 0.0 110.039 163.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -65.29 98.72 0.35 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.095 1.758 . . . . 0.0 111.825 -163.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 27.6 mtm -83.01 164.06 20.6 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.716 0.806 . . . . 0.0 111.79 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.3 m -159.53 161.29 35.25 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.316 -0.865 . . . . 0.0 111.993 167.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.67 115.47 25.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.798 0.839 . . . . 0.0 110.573 167.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.69 -26.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.948 1.299 . . . . 0.0 110.548 168.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -142.31 130.86 22.52 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.539 1.936 . . . . 0.0 109.022 167.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -61.34 149.75 82.16 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.928 1.691 . . . . 0.0 113.313 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -55.86 130.57 41.07 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.345 2.697 . . . . 0.0 112.389 173.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.3 p -128.58 127.54 42.5 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.474 1.109 . . . . 0.0 111.297 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -60.82 123.89 18.83 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.73 1.612 . . . . 0.0 112.133 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.2 p -79.57 -11.81 59.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.487 1.515 . . . . 0.0 113.307 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 68.71 -10.36 1.55 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.418 1.009 . . . . 0.0 114.224 -168.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -83.23 3.63 30.33 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.618 1.567 . . . . 0.0 111.702 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 101.97 -1.47 51.59 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 126.043 1.782 . . . . 0.0 113.612 -174.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.2 p -118.06 159.11 23.79 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.771 1.286 . . . . 0.0 112.451 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.79 111.43 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.406 1.482 . . . . 0.0 107.916 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.46 133.1 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.245 1.018 . . . . 0.0 113.615 -162.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -139.69 161.54 37.27 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.245 2.218 . . . . 0.0 112.496 -172.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -113.33 130.12 56.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.454 1.102 . . . . 0.0 108.158 164.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.2 150.57 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.074 0.95 . . . . 0.0 111.874 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.8 tttp -135.73 148.38 48.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.826 1.651 . . . . 0.0 113.044 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.51 153.11 46.68 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 128.322 2.649 . . . . 0.0 108.17 165.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -107.97 -55.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.454 2.102 . . . . 0.0 115.695 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.94 171.01 16.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.275 1.03 . . . . 0.0 112.575 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.63 -5.14 1.8 Allowed Glycine 0 CA--C 1.537 1.425 0 C-N-CA 126.975 2.226 . . . . 0.0 118.093 166.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.53 95.59 48.09 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 119.286 1.543 . . . . 0.0 113.331 -161.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.93 117.82 4.83 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.114 2.543 . . . . 0.0 109.345 158.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.1 p -165.51 150.88 9.11 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.18 101.56 6.23 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.104 1.762 . . . . 0.0 106.588 158.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.253 1.3 pp -61.08 120.4 54.04 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-O 118.555 -0.735 . . . . 0.0 111.543 -158.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -61.89 114.85 2.47 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.492 2.795 . . . . 0.0 113.552 -171.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.62 120.15 62.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.979 1.312 . . . . 0.0 108.781 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 163.63 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.013 1.325 . . . . 0.0 110.643 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . 0.498 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 48.2 t -142.81 118.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.69 163.39 38.23 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.1 6.2 38.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.069 0.948 . . . . 0.0 111.913 -175.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -115.14 1.98 14.01 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.937 2.495 . . . . 0.0 113.457 -164.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 32.8 mt 61.31 8.03 1.94 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.495 2.318 . . . . 0.0 114.994 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.9 t -142.62 -6.6 0.89 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 55.95 50.18 14.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.767 2.027 . . . . 0.0 114.925 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.71 72.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 152.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 34.2 mm -70.57 148.18 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 123.718 0.807 . . . . 0.0 108.927 162.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.08 74.26 1.51 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.432 -1.418 . . . . 0.0 109.349 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -75.27 -60.63 2.21 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.296 1.838 . . . . 0.0 112.886 -160.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . 0.498 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -94.44 175.88 34.9 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.655 1.598 . . . . 0.0 115.406 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -113.79 150.73 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.143 2.577 . . . . 0.0 110.377 -173.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.78 135.46 36.5 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.493 1.517 . . . . 0.0 109.685 165.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.8 t -114.86 -65.34 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.885 0.766 . . . . 0.0 111.208 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.526 ' H ' ' HB2' ' A' ' 366' ' ' GLU . 1.5 m -68.8 157.34 36.64 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 162.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 35.2 m -55.71 161.44 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.959 1.704 . . . . 0.0 114.759 -172.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -125.67 125.35 24.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.445 1.898 . . . . 0.0 108.108 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -80.88 -174.49 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.85 3.033 . . . . 0.0 112.667 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.27 120.49 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 162.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.97 67.25 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.778 2.031 . . . . 0.0 113.444 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -71.03 -20.81 62.35 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.912 0.885 . . . . 0.0 112.402 169.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.81 123.05 43.66 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 154.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -65.65 -16.31 63.61 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.55 -1.344 . . . . 0.0 112.803 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -81.13 2.79 25.91 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.29 1.836 . . . . 0.0 113.751 170.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.22 126.14 3.98 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.303 1.441 . . . . 0.0 113.243 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.14 149.19 52.46 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.064 0.946 . . . . 0.0 111.539 167.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.0 p -158.56 151.38 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -163.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.74 122.61 28.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.172 2.589 . . . . 0.0 109.624 169.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 20.7 mt -134.02 149.67 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.932 0.787 . . . . 0.0 110.619 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' A' ' 351' ' ' THR . 45.4 mt-10 -116.22 143.38 45.58 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.608 1.563 . . . . 0.0 110.977 167.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.02 157.8 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.448 0.699 . . . . 0.0 111.635 164.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -121.47 102.19 42.74 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 127.164 2.186 . . . . 0.0 108.501 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.36 165.33 27.73 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.17 1.914 . . . . 0.0 110.628 166.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -59.7 177.2 0.49 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.078 2.518 . . . . 0.0 111.668 156.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -59.65 142.59 52.61 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.845 -0.534 . . . . 0.0 110.527 165.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 101.92 -154.18 18.72 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.957 1.265 . . . . 0.0 115.381 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.82 140.97 38.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.412 2.685 . . . . 0.0 112.533 -170.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.63 174.04 8.05 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 159.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -111.94 119.64 39.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.272 1.429 . . . . 0.0 108.926 170.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.5 mm -78.28 119.79 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 173.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 83.4 mt -112.19 134.83 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.685 1.194 . . . . 0.0 109.783 -172.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.6 t -115.86 108.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 126.097 1.759 . . . . 0.0 107.982 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.78 -179.27 24.21 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.11 167.29 21.83 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.433 2.693 . . . . 0.0 110.245 175.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.33 -169.62 54.9 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.606 0.622 . . . . 0.0 112.247 -169.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -63.11 -32.48 73.87 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.089 -1.242 . . . . 0.0 111.352 168.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 70.3 m -54.89 8.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 1 C-N-CA 131.877 4.071 . . . . 0.0 118.474 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -103.95 146.42 28.71 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.628 1.171 . . . . 0.0 111.704 -172.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 21.6 mt -120.95 168.66 11.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.044 0.938 . . . . 0.0 110.926 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.0 t -145.88 159.38 43.3 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 172.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -132.72 130.46 40.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.347 1.459 . . . . 0.0 109.678 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -76.71 132.58 39.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.287 1.835 . . . . 0.0 111.63 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -133.2 151.22 51.95 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 122.208 1.004 . . . . 0.0 111.796 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 171.136 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 121.15 0.5 . . . . 0.0 111.801 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.82 96.89 0.31 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.329 1.452 . . . . 0.0 108.506 166.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -69.7 156.91 38.25 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.416 2.686 . . . . 0.0 115.177 -172.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 14.9 m -100.53 137.81 38.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.874 1.27 . . . . 0.0 109.787 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 66.7 p -138.15 4.31 2.46 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -80.54 165.55 22.01 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.876 1.216 . . . . 0.0 110.707 166.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -66.68 94.95 0.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.848 2.059 . . . . 0.0 111.366 -165.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 30.7 mtm -79.69 163.32 24.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.853 1.261 . . . . 0.0 112.317 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.4 p -150.43 161.88 41.65 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.556 1.143 . . . . 0.0 112.476 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -93.93 125.82 38.77 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.152 0.981 . . . . 0.0 108.723 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.72 -26.7 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 163.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -144.06 128.46 17.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.59 1.956 . . . . 0.0 108.743 171.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -59.22 143.81 84.29 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.961 0.904 . . . . 0.0 111.752 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -56.31 137.95 81.84 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.082 1.855 . . . . 0.0 111.513 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 41.2 p -132.49 124.59 28.83 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.37 1.068 . . . . 0.0 111.805 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -54.09 122.05 9.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.307 1.843 . . . . 0.0 111.517 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -84.24 -12.39 54.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.137 0.975 . . . . 0.0 113.296 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.95 -10.01 1.32 Allowed Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.271 0.939 . . . . 0.0 114.584 -167.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -83.38 7.02 17.95 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.29 1.545 . . . . 0.0 111.971 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 96.2 5.9 59.16 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.48 1.514 . . . . 0.0 113.713 -171.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.5 p -127.75 167.48 16.43 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.708 1.254 . . . . 0.0 112.825 -172.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.35 123.59 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.693 1.997 . . . . 0.0 107.817 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -110.32 131.7 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.74 1.216 . . . . 0.0 113.005 -170.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -138.45 167.13 22.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.685 1.594 . . . . 0.0 113.756 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -126.26 129.44 48.93 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.028 1.331 . . . . 0.0 108.594 166.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.1 m -127.26 154.87 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.79 0.836 . . . . 0.0 111.792 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -139.65 144.28 37.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.581 1.552 . . . . 0.0 111.717 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 12.7 p -120.04 154.23 55.56 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.153 2.181 . . . . 0.0 108.518 168.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 10.2 Cg_endo -113.31 -45.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.2 0 CA-C-N 122.205 1.823 . . . . 0.0 116.602 -165.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.7 164.68 32.79 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.928 -1.107 . . . . 0.0 112.447 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.37 4.95 26.21 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.888 1.709 . . . . 0.0 117.188 168.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.89 95.66 46.04 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.0 1.4 . . . . 0.0 113.094 -164.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.62 115.08 1.51 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.048 3.166 . . . . 0.0 109.249 154.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 9.3 p -163.36 144.39 9.3 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.99 107.11 9.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 162.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.278 0.7 OUTLIER -68.87 122.2 84.16 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.13 -155.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -64.2 116.02 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.062 2.508 . . . . 0.0 112.987 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.91 108.17 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.828 1.651 . . . . 0.0 110.312 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.09 156.92 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.437 1.495 . . . . 0.0 109.581 -170.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 42.5 t -142.62 122.13 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 120.98 -1.075 . . . . 0.0 109.39 -170.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.19 173.71 11.27 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -161.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -110.54 -1.99 16.67 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.517 1.527 . . . . 0.0 112.205 168.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -125.83 4.58 7.36 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.703 1.601 . . . . 0.0 113.996 -159.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 35.7 mt 62.56 -4.9 0.21 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.339 2.256 . . . . 0.0 115.52 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 5.0 t -125.33 0.71 7.73 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.074 1.307 . . . . 0.0 113.963 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 77.87 21.2 0.95 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.59 2.356 . . . . 0.0 113.945 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -61.43 -46.45 90.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.268 1.027 . . . . 0.0 111.475 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.7 mm -94.37 135.39 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.64 86.68 2.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 123.415 1.579 . . . . 0.0 113.31 -167.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -82.6 -49.08 10.24 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.708 2.403 . . . . 0.0 113.097 -158.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -104.84 154.13 17.36 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -160.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.15 149.1 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 127.102 2.161 . . . . 0.0 109.749 -169.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.12 120.35 24.14 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.054 1.341 . . . . 0.0 109.277 170.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.93 -38.3 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.963 0.505 . . . . 0.0 111.052 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 366' ' ' GLU . 6.1 t -97.59 175.41 6.21 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.351 0.66 . . . . 0.0 111.058 166.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.74 128.52 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.726 1.211 . . . . 0.0 110.507 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -66.31 114.96 19.29 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.673 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.86 174.7 10.71 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.311 2.674 . . . . 0.0 113.394 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.33 120.99 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 127.223 2.209 . . . . 0.0 107.986 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.95 99.53 0.5 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.553 1.141 . . . . 0.0 109.506 167.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 26.1 t -102.16 -11.12 19.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.689 1.596 . . . . 0.0 112.79 175.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.59 152.33 33.27 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 147.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -72.86 -11.66 60.68 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 117.847 -1.073 . . . . 0.0 113.597 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.99 1.46 55.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.311 1.444 . . . . 0.0 112.457 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -54.18 134.14 44.44 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.443 1.116 . . . . 0.0 113.034 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.41 140.44 52.17 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.442 1.497 . . . . 0.0 110.634 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.35 142.63 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -158.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.06 127.8 33.63 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 129.491 3.116 . . . . 0.0 110.419 170.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 44.2 mt -137.85 144.62 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.096 0.558 . . . . 0.0 110.655 170.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . 0.557 ' H ' HG22 ' A' ' 351' ' ' THR . 11.1 mt-10 -116.1 139.05 50.7 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.562 1.545 . . . . 0.0 111.125 165.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.36 158.32 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.737 1.215 . . . . 0.0 111.801 175.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -118.1 105.26 47.28 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 126.978 2.111 . . . . 0.0 108.687 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -80.84 169.63 16.31 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.533 2.822 . . . . 0.0 111.147 172.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.83 175.96 8.95 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.422 2.082 . . . . 0.0 110.846 162.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -65.72 148.42 51.8 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.797 -0.564 . . . . 0.0 109.853 161.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.41 -162.51 33.4 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-O 122.426 1.014 . . . . 0.0 114.833 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.3 156.31 29.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.563 1.945 . . . . 0.0 113.941 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 64.0 m -170.03 159.79 7.84 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.667 1.987 . . . . 0.0 112.063 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -124.42 123.56 40.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.887 1.675 . . . . 0.0 107.934 157.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.6 mm -76.69 111.0 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 87.1 mt -100.95 130.98 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.687 1.131 . . . . 0.0 109.391 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 83.5 t -117.76 109.45 27.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.898 1.679 . . . . 0.0 107.838 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.9 -176.21 22.72 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 123.333 1.518 . . . . 0.0 116.604 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.57 171.96 13.39 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.167 2.587 . . . . 0.0 110.357 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.37 -171.87 45.83 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -61.16 -31.1 70.83 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.811 -0.817 . . . . 0.0 111.7 170.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 53.2 m -61.39 -8.15 3.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 129.571 3.148 . . . . 0.0 117.364 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -74.38 144.89 44.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.855 0.752 . . . . 0.0 111.449 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 31.8 mt -116.8 167.64 10.92 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.263 0.625 . . . . 0.0 110.719 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.3 t -146.55 159.12 43.83 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -134.57 131.25 37.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.418 1.487 . . . . 0.0 109.57 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -73.89 131.51 41.55 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.312 2.245 . . . . 0.0 112.344 -173.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -142.59 118.02 10.28 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.24 1.016 . . . . 0.0 111.888 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.737 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 31.5 p90 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 111.39 23.13 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 166.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.37 134.76 57.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.872 1.669 . . . . 0.0 114.594 -173.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.2 m -85.26 132.77 34.22 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 152.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 66.8 p -132.94 6.21 3.93 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -83.32 161.35 21.46 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.176 0.898 . . . . 0.0 111.052 164.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -63.62 104.32 0.64 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.137 1.775 . . . . 0.0 112.711 -159.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 24.3 mtm -87.63 164.86 15.82 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.047 0.927 . . . . 0.0 112.004 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.5 m -160.6 160.48 31.77 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.24 -0.912 . . . . 0.0 111.717 170.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.91 126.13 30.29 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 165.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 40.6 t -78.97 -24.21 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.506 0.722 . . . . 0.0 110.527 161.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -139.94 127.23 21.24 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.226 1.81 . . . . 0.0 108.203 166.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -55.41 144.11 53.96 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.642 1.177 . . . . 0.0 111.719 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -55.07 133.09 56.13 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.309 2.006 . . . . 0.0 110.989 170.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 61.4 p -133.74 129.73 37.08 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.202 1.001 . . . . 0.0 110.742 171.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.24 125.65 24.13 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.342 1.057 . . . . 0.0 111.143 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 61.9 p -80.47 -9.2 59.77 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.192 0.997 . . . . 0.0 113.093 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 74.66 -8.49 14.33 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.798 1.19 . . . . 0.0 114.033 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -90.0 4.82 49.0 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.88 1.34 . . . . 0.0 112.468 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.65 6.73 62.15 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.674 1.13 . . . . 0.0 113.59 -169.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.6 p -120.73 157.04 30.53 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.843 1.257 . . . . 0.0 111.214 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 15.0 t -130.86 118.76 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.346 1.458 . . . . 0.0 108.038 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.9 p -108.01 129.78 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.978 1.311 . . . . 0.0 113.134 -166.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -139.76 162.71 34.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.972 1.709 . . . . 0.0 113.374 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -116.26 129.25 56.18 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.099 1.359 . . . . 0.0 107.764 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.6 m -126.17 145.75 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.594 0.757 . . . . 0.0 111.312 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -125.92 144.09 50.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.641 1.176 . . . . 0.0 112.526 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.7 t -111.86 150.88 42.99 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 127.501 2.32 . . . . 0.0 107.785 163.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -110.26 -59.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.576 2.184 . . . . 0.0 116.169 -176.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.02 164.61 29.81 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.03 -1.044 . . . . 0.0 112.743 -176.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 64.41 7.07 24.46 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 117.622 1.809 . . . . 0.0 117.622 168.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.26 98.05 44.66 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 119.071 1.436 . . . . 0.0 113.279 -162.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.56 119.19 1.63 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.53 3.487 . . . . 0.0 110.072 157.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.2 p -161.1 157.91 26.8 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -172.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -88.46 112.51 23.04 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 157.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 333' ' ' PRO 0.297 0.5 OUTLIER -66.09 124.89 89.03 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.655 -160.477 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 4.7 Cg_exo -74.75 104.53 1.9 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.457 2.771 . . . . 0.0 111.824 -171.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 75.2 t -105.08 107.88 23.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.471 1.508 . . . . 0.0 109.87 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.43 160.18 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 122.276 1.036 . . . . 0.0 110.992 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 23.0 t -142.93 134.39 24.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -147.94 178.29 8.64 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.401 0.681 . . . . 0.0 112.046 -168.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -114.24 -6.2 13.0 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.648 0.779 . . . . 0.0 112.26 166.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -111.53 5.83 19.72 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.859 2.464 . . . . 0.0 113.788 -165.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 13.6 mt 64.16 -3.59 0.47 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.223 2.209 . . . . 0.0 115.048 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.6 t -126.89 -6.34 6.17 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -174.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 337' ' ' ALA . . . 80.04 25.67 0.36 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 127.968 2.507 . . . . 0.0 113.832 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.2 81.24 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 166.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.83 138.42 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.826 0.85 . . . . 0.0 109.27 159.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.98 74.44 0.88 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 123.014 1.387 . . . . 0.0 109.178 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -76.61 -51.42 11.63 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 126.656 1.982 . . . . 0.0 114.089 -158.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -112.61 153.34 17.53 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 116.065 1.186 . . . . 0.0 116.065 -161.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.3 152.77 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 129.724 3.209 . . . . 0.0 110.171 -168.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.96 123.66 30.78 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.919 1.288 . . . . 0.0 110.101 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.66 -47.25 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.066 0.546 . . . . 0.0 110.16 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.7 t -86.79 178.19 7.08 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.262 1.025 . . . . 0.0 111.901 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.1 m -60.78 131.44 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.275 1.43 . . . . 0.0 111.063 169.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.26 116.03 46.89 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 120.989 -1.07 . . . . 0.0 110.036 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.69 -179.03 5.08 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 124.058 3.172 . . . . 0.0 113.777 -172.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.26 141.2 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.32 1.448 . . . . 0.0 108.598 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -86.84 100.37 12.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.997 0.919 . . . . 0.0 109.577 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -96.4 -16.0 21.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.81 0.844 . . . . 0.0 112.549 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.59 130.67 53.66 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 126.502 1.921 . . . . 0.0 106.676 165.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -66.04 -18.19 65.18 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.326 -1.484 . . . . 0.0 114.133 -165.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -78.84 -2.62 40.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.919 1.687 . . . . 0.0 113.637 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -51.42 133.04 29.9 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.4 1.571 . . . . 0.0 112.937 -170.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -140.81 123.73 16.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.742 2.017 . . . . 0.0 108.665 -164.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 10.5 p -149.04 142.28 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -155.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.97 125.31 26.51 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 128.566 2.747 . . . . 0.0 110.195 170.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 23.6 mt -135.44 140.54 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.195 0.522 . . . . 0.0 110.965 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -116.33 136.06 53.33 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.593 1.557 . . . . 0.0 110.775 166.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.68 159.0 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.768 1.227 . . . . 0.0 112.2 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -129.23 103.88 18.16 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.481 1.912 . . . . 0.0 109.768 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.79 163.85 30.85 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 121.886 1.724 . . . . 0.0 110.642 167.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -60.34 177.27 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.101 2.534 . . . . 0.0 111.746 157.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -60.98 141.12 57.56 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.623 -0.673 . . . . 0.0 110.595 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 96.31 -161.26 22.3 Favored Glycine 0 CA--C 1.535 1.327 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -67.6 159.53 29.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.772 1.629 . . . . 0.0 114.657 -169.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 22.6 m -170.02 164.37 9.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.729 1.612 . . . . 0.0 112.663 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -127.24 116.09 20.04 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 129.453 3.101 . . . . 0.0 107.395 165.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.6 mm -77.11 121.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.18 130.33 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.571 1.078 . . . . 0.0 109.511 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.7 t -114.92 105.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.584 1.154 . . . . 0.0 108.456 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.22 -177.41 20.87 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 123.091 1.384 . . . . 0.0 116.312 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.9 163.93 28.42 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.627 2.371 . . . . 0.0 110.46 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 80.76 -170.09 52.82 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.018 0.818 . . . . 0.0 112.989 -170.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -65.07 -23.87 67.29 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.951 -1.323 . . . . 0.0 111.814 167.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 72.8 m -62.61 -2.52 1.13 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 130.676 3.59 . . . . 0.0 117.676 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.52 147.92 22.55 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.452 1.024 . . . . 0.0 112.371 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 17.6 mt -113.39 165.41 12.48 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.416 0.686 . . . . 0.0 110.951 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.4 t -145.23 158.59 43.79 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 167.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -140.79 134.88 30.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.567 1.947 . . . . 0.0 109.029 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -74.29 138.08 43.33 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.225 1.41 . . . . 0.0 111.699 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -144.53 118.52 9.39 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.653 0.781 . . . . 0.0 112.991 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 . . . . . 0 CA--C 1.531 0.217 0 C-N-CA 124.84 1.256 . . . . 0.0 109.109 175.638 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 4.7 p90 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 121.166 0.508 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.98 103.9 11.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.377 2.271 . . . . 0.0 105.082 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -73.9 151.88 40.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.2 1.4 . . . . 0.0 114.165 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.2 m -95.75 150.92 19.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.354 0.661 . . . . 0.0 110.205 166.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.1 p -133.41 9.36 4.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.787 1.235 . . . . 0.0 113.705 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -79.24 154.55 29.1 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 120.348 1.431 . . . . 0.0 111.107 164.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 109.58 0.9 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.387 2.275 . . . . 0.0 111.89 -170.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 19.0 mtt -87.54 170.47 11.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.9 m -156.93 153.28 27.86 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.346 -0.846 . . . . 0.0 112.685 157.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.82 125.52 29.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.88 0.872 . . . . 0.0 109.343 160.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 5.3 t -82.43 -24.35 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.03 1.332 . . . . 0.0 110.873 172.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -134.24 125.6 28.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.283 2.233 . . . . 0.0 106.708 170.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -56.8 146.93 55.46 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 123.655 0.597 . . . . 0.0 111.154 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -56.66 124.35 16.05 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.507 1.471 . . . . 0.0 110.019 166.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.3 p -125.41 125.78 43.92 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.229 1.011 . . . . 0.0 110.977 170.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.62 121.32 11.9 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.839 0.712 . . . . 0.0 110.54 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 59.1 p -79.45 -7.28 58.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.201 1.4 . . . . 0.0 113.224 -173.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.56 -7.06 2.21 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.738 -164.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -86.68 6.17 32.47 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.659 1.729 . . . . 0.0 111.856 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.47 -2.0 67.23 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.088 1.328 . . . . 0.0 113.648 -170.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 27.9 p -119.07 166.89 12.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.112 1.365 . . . . 0.0 112.002 -170.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.48 114.79 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.014 1.726 . . . . 0.0 108.027 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.29 136.34 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.322 1.049 . . . . 0.0 113.235 -168.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -147.24 167.09 25.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.675 1.99 . . . . 0.0 112.996 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -115.32 134.89 54.7 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.47 1.908 . . . . 0.0 106.819 161.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 23.5 m -132.13 148.54 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.678 0.672 . . . . 0.0 111.703 176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -135.31 146.8 48.83 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.709 1.204 . . . . 0.0 112.272 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 22.8 m -115.13 157.65 43.03 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.604 1.561 . . . . 0.0 110.704 165.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 24.2 Cg_endo -114.99 -54.49 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.479 2.119 . . . . 0.0 116.673 -171.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.64 175.3 9.8 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.164 1.802 . . . . 0.0 113.596 177.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.18 -13.47 0.23 Allowed Glycine 0 CA--C 1.541 1.716 0 N-CA-C 119.314 2.486 . . . . 0.0 119.314 164.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.48 104.78 54.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 119.939 1.87 . . . . 0.0 114.715 -159.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.41 117.25 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.746 2.964 . . . . 0.0 110.524 158.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.0 p -163.45 148.72 11.2 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -76.06 98.94 4.46 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 155.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.71 113.58 6.28 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 123.701 0.801 . . . . 0.0 111.305 -161.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.52 104.18 1.67 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.251 2.634 . . . . 0.0 112.942 -168.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 81.1 t -101.4 116.98 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 127.076 2.15 . . . . 0.0 109.726 172.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.26 161.43 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.375 1.07 . . . . 0.0 110.782 -176.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . 0.52 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 46.8 t -138.67 133.62 42.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -142.8 169.55 17.35 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.374 0.67 . . . . 0.0 111.652 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -102.22 1.74 36.31 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.243 0.617 . . . . 0.0 111.622 162.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -117.99 5.1 12.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.078 1.751 . . . . 0.0 114.473 -165.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 15.9 mt 61.89 -7.76 0.11 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.492 2.317 . . . . 0.0 116.098 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.7 t -121.75 -5.6 9.14 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.393 1.452 . . . . 0.0 114.132 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 63.47 44.57 5.27 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.78 2.032 . . . . 0.0 113.008 -173.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.91 99.06 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 159.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 22.1 mt -92.84 138.13 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.945 1.698 . . . . 0.0 108.745 166.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -109.25 70.97 0.75 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.226 1.012 . . . . 0.0 109.375 171.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -64.24 -63.0 1.26 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.647 2.379 . . . . 0.0 112.556 -161.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . 0.52 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -96.67 171.21 27.38 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.864 1.697 . . . . 0.0 115.537 -168.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.1 150.58 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 128.299 2.64 . . . . 0.0 110.915 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.98 122.82 30.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.059 1.744 . . . . 0.0 108.358 165.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 28.2 t -86.54 -43.79 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.359 0.527 . . . . 0.0 111.033 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 366' ' ' GLU . 4.9 t -101.1 175.3 5.64 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.551 0.691 . . . . 0.0 112.017 172.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.41 124.17 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.587 1.555 . . . . 0.0 112.859 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -81.01 122.17 81.51 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.1 0.96 . . . . 0.0 109.709 166.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -81.75 -171.45 1.21 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.615 3.543 . . . . 0.0 112.815 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.42 129.32 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.332 1.453 . . . . 0.0 107.321 165.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.68 81.93 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.794 1.238 . . . . 0.0 111.666 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 27.7 t -85.57 -10.53 55.78 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.143 0.977 . . . . 0.0 112.49 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.8 127.54 50.7 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 128.201 2.6 . . . . 0.0 106.036 170.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -67.6 -17.46 64.63 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.405 -1.434 . . . . 0.0 113.595 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.24 1.84 26.84 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 127.488 2.315 . . . . 0.0 114.032 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.77 133.55 6.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.667 1.222 . . . . 0.0 113.937 -168.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -141.87 138.31 32.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.454 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 13.8 p -147.82 146.03 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.79 0.805 . . . . 0.0 112.905 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -75.19 120.23 20.4 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.382 2.673 . . . . 0.0 109.193 166.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mt -132.37 139.3 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.892 0.769 . . . . 0.0 111.871 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . 0.468 ' H ' HG22 ' A' ' 351' ' ' THR . 31.3 mt-10 -111.17 135.66 51.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 110.206 161.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 31.4 m -117.74 161.01 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.344 1.057 . . . . 0.0 111.004 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -131.86 101.77 15.21 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.807 1.643 . . . . 0.0 109.153 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.36 164.71 28.54 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.075 1.85 . . . . 0.0 110.72 164.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.16 175.6 0.24 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.83 3.02 . . . . 0.0 113.313 160.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -58.55 144.23 43.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.278 0.631 . . . . 0.0 110.745 163.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 94.66 -142.97 16.31 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 115.469 0.948 . . . . 0.0 115.469 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.22 154.95 32.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.164 1.786 . . . . 0.0 113.21 -168.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 18.1 m -167.98 161.45 12.8 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.797 1.239 . . . . 0.0 113.5 168.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -124.75 110.34 14.22 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 127.963 2.505 . . . . 0.0 107.261 163.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 9.5 mm -73.85 124.97 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.2 mt -117.87 135.83 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.708 1.203 . . . . 0.0 109.145 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 68.6 t -126.51 97.13 3.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 126.393 1.877 . . . . 0.0 107.481 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 115.6 173.29 17.39 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 116.088 1.195 . . . . 0.0 116.088 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 74.0 p -130.58 173.06 11.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.989 1.716 . . . . 0.0 110.523 167.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 78.22 -161.31 48.74 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 -169.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -69.03 -30.78 69.22 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.476 -1.014 . . . . 0.0 111.597 167.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 54.7 m -58.44 -5.47 0.53 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 130.226 3.41 . . . . 0.0 118.411 -174.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -85.8 139.77 31.02 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.983 0.913 . . . . 0.0 111.669 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.1 mt -104.05 163.64 12.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 110.087 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.2 t -147.02 156.1 42.76 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 169.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -136.19 117.12 14.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.363 1.865 . . . . 0.0 108.69 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -65.21 134.92 54.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.17 0.988 . . . . 0.0 110.816 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -133.43 134.89 44.18 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.297 1.039 . . . . 0.0 110.891 171.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 C--N 1.329 -0.294 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.263 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 121.164 0.507 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.66 97.35 2.65 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 158.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -68.42 154.91 40.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.852 2.461 . . . . 0.0 115.153 -171.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.7 m -102.7 140.6 36.76 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.0 1.32 . . . . 0.0 109.428 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.7 p -138.16 5.9 2.56 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -78.63 160.43 27.55 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.781 1.173 . . . . 0.0 110.517 162.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.11 98.02 0.42 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.09 2.156 . . . . 0.0 112.236 -161.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . 0.408 ' HE1' ' H ' ' A' ' 380' ' ' THR . 32.2 mtm -82.38 165.71 20.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.098 0.959 . . . . 0.0 111.919 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.4 m -160.62 163.53 32.54 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.363 -0.835 . . . . 0.0 111.768 169.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.1 125.9 30.09 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 164.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.64 -27.74 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.621 0.768 . . . . 0.0 109.737 159.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -144.29 119.06 9.86 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.541 2.337 . . . . 0.0 108.062 170.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -52.86 145.16 23.42 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.785 1.234 . . . . 0.0 111.803 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.36 129.65 35.8 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.916 2.411 . . . . 0.0 111.948 173.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.9 p -126.56 132.49 51.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.839 0.856 . . . . 0.0 111.093 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -61.9 135.89 57.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.026 1.73 . . . . 0.0 112.026 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.3 p -91.26 -13.41 32.78 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 64.94 0.11 4.95 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.979 1.276 . . . . 0.0 114.752 -167.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -90.53 9.75 28.17 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.992 1.396 . . . . 0.0 111.748 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.59 15.5 65.83 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.771 -1.016 . . . . 0.0 113.583 -167.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 22.3 p -131.51 168.83 16.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.001 1.401 . . . . 0.0 113.021 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.84 130.75 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.104 1.762 . . . . 0.0 108.245 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.91 133.34 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.511 1.124 . . . . 0.0 112.368 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -140.61 163.47 32.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.835 1.654 . . . . 0.0 113.155 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -120.7 123.7 43.36 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.814 1.246 . . . . 0.0 107.742 164.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.44 147.96 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.786 0.835 . . . . 0.0 111.678 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -132.68 142.45 49.08 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.393 1.477 . . . . 0.0 113.205 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 t -107.73 143.24 26.88 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.35 2.66 . . . . 0.0 107.829 162.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -103.36 -62.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.264 1.976 . . . . 0.0 115.679 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.48 170.45 15.9 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.808 1.185 . . . . 0.0 113.166 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.09 -14.27 0.44 Allowed Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.968 2.223 . . . . 0.0 117.692 171.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.03 99.8 44.32 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 119.204 1.502 . . . . 0.0 113.327 -167.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.19 113.52 3.2 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.288 2.659 . . . . 0.0 108.878 157.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 16.2 p -158.92 148.19 18.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -170.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.57 99.34 5.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.44 1.496 . . . . 0.0 106.997 161.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.267 0.9 OUTLIER -61.28 114.13 9.91 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 123.222 0.326 . . . . 0.0 111.617 -159.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.07 113.5 3.72 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.954 2.436 . . . . 0.0 112.668 -167.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.12 115.81 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.0 2.12 . . . . 0.0 109.424 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 159.31 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.662 1.185 . . . . 0.0 110.434 -175.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . 0.484 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 51.0 t -140.22 114.71 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.472 1.109 . . . . 0.0 108.136 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -144.49 170.18 16.54 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.018 0.826 . . . . 0.0 113.055 -169.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -106.39 6.37 30.33 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.947 0.899 . . . . 0.0 112.07 171.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -115.87 2.5 13.58 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.093 1.757 . . . . 0.0 113.98 -163.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 49.4 mt 60.68 3.9 0.68 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.737 2.415 . . . . 0.0 115.397 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 3.7 t -137.13 -9.36 1.76 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -173.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 55.82 51.59 12.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.858 2.063 . . . . 0.0 113.423 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -68.83 -34.97 76.38 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 157.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 44.8 mm -111.24 141.55 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.341 1.456 . . . . 0.0 108.71 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -114.8 128.4 56.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.86 0.838 . . . . 0.0 110.899 165.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -87.56 -68.24 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.494 2.318 . . . . 0.0 110.227 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . 0.484 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -93.33 166.78 28.43 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.224 1.392 . . . . 0.0 116.41 -162.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.7 152.85 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 128.027 2.531 . . . . 0.0 110.026 -167.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.0 127.45 31.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.837 1.255 . . . . 0.0 109.448 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.1 t -90.19 -37.42 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.176 0.444 . . . . 0.0 111.141 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 366' ' ' GLU . 6.1 t -106.61 173.49 6.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 112.072 175.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.8 m -66.47 126.94 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.475 1.51 . . . . 0.0 112.177 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -96.0 129.57 33.67 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.653 1.581 . . . . 0.0 110.065 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -83.94 -176.48 2.67 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.263 3.309 . . . . 0.0 114.649 -168.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.47 120.81 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.686 2.394 . . . . 0.0 107.946 168.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.02 74.25 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.908 1.683 . . . . 0.0 112.97 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -67.09 -16.02 64.07 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 171.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.5 p -127.96 139.4 52.6 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 127.298 2.239 . . . . 0.0 106.074 157.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.7 -15.57 63.71 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -167.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.29 -2.0 14.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.03 2.532 . . . . 0.0 114.608 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -40.12 118.48 0.9 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.843 2.057 . . . . 0.0 114.264 -174.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.92 131.86 33.65 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.399 1.48 . . . . 0.0 111.427 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.76 148.76 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -160.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -75.8 126.26 30.66 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 128.513 2.725 . . . . 0.0 109.975 166.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 25.9 mt -136.1 137.59 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.76 0.709 . . . . 0.0 111.271 173.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . 0.424 ' H ' HG22 ' A' ' 351' ' ' THR . 16.1 mt-10 -105.93 137.74 43.32 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.648 1.179 . . . . 0.0 111.542 159.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.5 150.73 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.311 1.444 . . . . 0.0 111.294 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -110.57 101.0 47.56 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.081 2.153 . . . . 0.0 109.078 175.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.21 162.84 31.03 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.776 2.318 . . . . 0.0 110.935 166.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.76 176.42 3.63 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.427 2.085 . . . . 0.0 111.663 162.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -70.97 147.43 48.69 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.894 -0.504 . . . . 0.0 111.117 165.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 95.35 -159.42 22.55 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.218 0.913 . . . . 0.0 113.492 -172.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.1 158.58 25.47 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.496 1.518 . . . . 0.0 114.9 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.9 m -167.57 150.3 5.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.838 1.655 . . . . 0.0 111.419 162.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -104.74 116.63 32.35 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.379 1.472 . . . . 0.0 108.15 155.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.9 mm -67.33 130.83 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 165.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.29 130.45 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.85 1.26 . . . . 0.0 108.828 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.8 t -117.54 100.02 9.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.393 1.877 . . . . 0.0 107.772 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 106.73 -178.48 22.32 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 123.096 1.387 . . . . 0.0 115.604 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . 0.408 ' H ' ' HE1' ' A' ' 304' ' ' MET . 1.0 OUTLIER -135.5 169.76 17.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.098 2.559 . . . . 0.0 110.719 175.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 81.21 -166.9 48.67 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.925 0.774 . . . . 0.0 112.341 -171.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -65.21 -33.29 75.65 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.143 -1.21 . . . . 0.0 110.908 164.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 63.0 m -56.89 -1.59 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 131.041 3.736 . . . . 0.0 118.455 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -88.76 148.37 23.98 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.135 0.974 . . . . 0.0 111.684 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.0 mt -109.67 167.0 10.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.149 0.58 . . . . 0.0 110.837 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 9.9 t -147.06 159.27 43.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 172.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -149.82 125.99 10.68 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.55 1.54 . . . . 0.0 110.585 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.61 138.16 39.94 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 112.549 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -142.5 138.09 30.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.226 1.41 . . . . 0.0 111.457 164.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 10.1 t60 . . . . . 0 C--O 1.237 0.43 0 C-N-CA 124.82 1.248 . . . . 0.0 109.759 174.761 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.6 p90 . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.035 0.445 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.47 99.78 5.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.905 1.282 . . . . 0.0 108.723 169.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.91 162.34 22.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.029 1.332 . . . . 0.0 113.864 -177.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . 0.418 ' H ' ' HD3' ' A' ' 333' ' ' PRO . 3.3 m -92.94 149.47 21.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.424 0.689 . . . . 0.0 109.653 168.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 77.8 p -136.85 6.28 2.9 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -78.63 158.98 28.29 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.467 1.03 . . . . 0.0 111.457 165.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.35 92.15 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.51 2.324 . . . . 0.0 112.635 -167.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 15.3 mtm -76.26 166.96 22.7 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.905 1.282 . . . . 0.0 112.618 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.9 m -158.23 157.23 32.18 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.113 -0.992 . . . . 0.0 112.774 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.42 120.24 25.64 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.52 0.728 . . . . 0.0 110.363 166.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.91 -27.99 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.082 1.753 . . . . 0.0 110.67 165.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -142.63 125.87 16.5 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.532 1.933 . . . . 0.0 108.024 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -57.43 144.88 70.31 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.385 1.074 . . . . 0.0 111.513 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.95 129.33 33.68 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.827 2.351 . . . . 0.0 111.529 170.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 41.2 p -124.21 123.15 39.64 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.373 1.069 . . . . 0.0 110.289 171.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -63.65 136.34 57.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.983 1.313 . . . . 0.0 111.157 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.8 p -89.62 -14.95 33.84 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.326 1.05 . . . . 0.0 113.065 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.24 -12.13 1.31 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.408 1.004 . . . . 0.0 114.405 -164.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -84.57 14.46 4.57 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.903 1.681 . . . . 0.0 112.057 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.37 5.18 63.74 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.679 1.133 . . . . 0.0 114.14 -172.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 64.9 p -131.68 165.86 22.77 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.937 1.368 . . . . 0.0 113.819 -170.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.62 138.09 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 127.854 2.462 . . . . 0.0 107.675 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 6.7 p -119.62 132.16 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.309 0.959 . . . . 0.0 112.517 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -139.92 167.16 22.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.503 1.521 . . . . 0.0 113.454 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -124.0 129.87 51.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.437 1.495 . . . . 0.0 107.583 166.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.52 150.76 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.061 0.944 . . . . 0.0 112.378 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -132.51 142.41 49.19 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.49 1.516 . . . . 0.0 112.818 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.09 148.46 37.53 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 128.226 2.611 . . . . 0.0 108.216 167.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -100.13 -72.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.59 2.193 . . . . 0.0 115.745 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.79 165.37 27.18 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.556 1.525 . . . . 0.0 114.388 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 69.33 -8.19 3.04 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 126.497 1.999 . . . . 0.0 117.274 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -108.49 99.86 35.2 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 119.078 1.439 . . . . 0.0 113.199 -168.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.99 121.95 6.47 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.789 2.326 . . . . 0.0 108.746 152.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.1 p -165.59 154.17 11.58 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -173.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -83.33 110.77 18.4 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 156.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.257 1.3 pp -67.45 132.29 93.06 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 120.324 -0.55 . . . . 0.0 112.349 -155.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.418 ' HD3' ' H ' ' A' ' 300' ' ' CYS . 73.8 Cg_endo -72.42 91.47 0.77 Allowed 'Trans proline' 0 CA--C 1.54 0.784 1 C-N-CA 125.449 4.099 . . . . 0.0 113.734 -168.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.09 117.03 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.215 1.406 . . . . 0.0 109.365 166.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.48 162.56 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.206 1.803 . . . . 0.0 109.359 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.62 127.3 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -136.48 174.56 10.49 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -170.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -118.6 -6.68 10.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.028 2.131 . . . . 0.0 112.966 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 29.5 p30 -106.98 0.48 23.75 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.063 2.145 . . . . 0.0 113.61 -166.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 74.7 mt 57.17 5.22 0.24 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.795 2.438 . . . . 0.0 115.734 -170.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.9 t -127.74 -3.12 5.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.427 1.491 . . . . 0.0 114.461 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 52.39 45.72 27.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.919 2.088 . . . . 0.0 113.584 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -72.93 -38.76 66.7 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 163.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 19.1 mm -108.05 128.67 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.774 1.23 . . . . 0.0 109.717 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -97.17 109.31 22.09 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.62 0.724 . . . . 0.0 111.829 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -63.99 -62.98 1.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.752 3.221 . . . . 0.0 112.789 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -104.23 -171.5 25.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.499 1.523 . . . . 0.0 115.756 -160.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 3.3 mm -132.68 152.74 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.755 2.022 . . . . 0.0 111.302 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.9 129.01 34.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.414 1.485 . . . . 0.0 109.507 170.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.35 -36.86 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.266 0.626 . . . . 0.0 110.737 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.574 ' HB ' ' H ' ' A' ' 366' ' ' GLU . 1.2 m -105.4 162.06 13.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.013 1.325 . . . . 0.0 111.478 175.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.5 m -47.82 107.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 127.367 2.267 . . . . 0.0 114.215 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -73.89 117.66 63.0 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.306 1.042 . . . . 0.0 109.595 162.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -82.33 -175.73 2.63 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.334 3.356 . . . . 0.0 114.118 -171.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 117.79 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.308 2.243 . . . . 0.0 107.808 170.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.67 74.62 0.82 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.547 1.139 . . . . 0.0 112.552 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -69.53 -18.7 63.69 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 23.3 p -123.81 121.27 34.98 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 127.148 2.179 . . . . 0.0 105.936 162.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.43 -18.87 53.84 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -166.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -71.79 3.96 3.7 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.507 1.923 . . . . 0.0 113.791 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -39.59 126.48 1.88 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.593 2.357 . . . . 0.0 113.913 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -141.3 112.1 7.14 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.868 2.067 . . . . 0.0 109.058 -168.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.14 148.37 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -160.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -86.65 124.53 33.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.523 2.729 . . . . 0.0 109.221 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 55.9 mt -135.31 132.21 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.409 0.623 . . . . 0.0 111.2 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . 0.574 ' H ' ' HB ' ' A' ' 351' ' ' THR . 25.0 mp0 -97.36 138.63 34.52 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.648 1.579 . . . . 0.0 111.497 161.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 22.1 t -129.19 153.93 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 127.564 2.345 . . . . 0.0 109.152 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -118.96 114.99 35.01 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.808 2.043 . . . . 0.0 109.576 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -82.81 162.0 16.21 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.207 2.604 . . . . 0.0 110.685 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -74.41 178.46 7.0 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.541 2.16 . . . . 0.0 110.738 163.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -71.02 130.84 42.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.009 1.324 . . . . 0.0 109.733 171.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.55 -143.55 16.34 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.12 0.866 . . . . 0.0 112.884 -176.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.12 152.69 42.15 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.185 2.594 . . . . 0.0 114.477 -173.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 17.0 m -166.36 153.18 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 113.145 167.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -120.53 109.6 15.46 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 128.36 2.664 . . . . 0.0 106.846 165.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 16.3 mm -68.13 120.01 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 172.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 80.7 mt -114.18 126.9 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.488 1.115 . . . . 0.0 109.067 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.8 t -119.69 101.81 11.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.794 1.638 . . . . 0.0 107.176 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 123.07 172.28 13.83 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 123.074 1.374 . . . . 0.0 115.903 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.5 161.05 39.05 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.507 2.323 . . . . 0.0 109.057 173.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.47 -167.42 53.43 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 -163.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -62.36 -31.6 72.27 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.775 -0.838 . . . . 0.0 111.869 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.2 m -55.65 3.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 130.642 3.577 . . . . 0.0 117.875 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -97.1 142.86 28.52 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.401 1.08 . . . . 0.0 111.859 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 22.2 mt -114.93 166.4 11.83 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.77 0.828 . . . . 0.0 110.678 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.2 t -146.1 161.89 39.16 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -145.68 128.38 16.21 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.028 1.731 . . . . 0.0 109.353 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -78.92 138.28 38.02 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.733 1.213 . . . . 0.0 111.67 -175.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -143.12 140.3 30.78 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.704 1.202 . . . . 0.0 111.651 168.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.3 m80 . . . . . 0 CA--C 1.531 0.228 0 C-N-CA 123.765 0.826 . . . . 0.0 109.399 164.286 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.1 p90 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.42 101.37 6.36 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.788 1.235 . . . . 0.0 108.455 166.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.65 153.1 37.43 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.45 1.9 . . . . 0.0 115.003 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 12.8 m -94.08 141.4 28.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.205 1.002 . . . . 0.0 109.319 164.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 80.7 p -135.46 2.52 2.98 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.71 164.1 23.99 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.592 1.087 . . . . 0.0 111.012 166.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -62.01 105.59 0.6 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.286 1.834 . . . . 0.0 112.54 -161.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 30.2 mtm -94.79 163.57 13.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.685 0.755 . . . . 0.0 111.907 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 32.3 m -160.77 156.88 25.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.206 -0.934 . . . . 0.0 112.0 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.69 120.04 19.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.909 0.883 . . . . 0.0 110.665 167.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.86 -29.0 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.35 1.46 . . . . 0.0 109.966 163.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -140.89 133.65 28.89 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.598 1.959 . . . . 0.0 109.329 170.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -59.02 144.2 82.83 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.024 0.929 . . . . 0.0 111.87 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -58.37 138.83 87.95 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.224 1.949 . . . . 0.0 111.9 171.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 35.6 p -133.89 125.13 27.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.195 1.398 . . . . 0.0 111.336 174.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -61.85 122.39 15.29 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.462 1.505 . . . . 0.0 111.537 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 74.6 p -80.79 -13.84 58.61 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.001 1.321 . . . . 0.0 113.83 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.03 -1.44 4.81 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 120.972 -1.08 . . . . 0.0 114.293 -164.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -85.59 12.16 9.25 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.198 1.499 . . . . 0.0 111.263 176.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.26 0.81 88.5 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.003 1.287 . . . . 0.0 113.874 -165.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.2 p -119.15 162.26 18.95 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.136 1.468 . . . . 0.0 112.807 -172.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.3 t -133.85 117.05 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.616 1.566 . . . . 0.0 107.748 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.3 p -104.97 130.03 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.243 1.017 . . . . 0.0 112.825 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -139.07 166.82 23.5 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.787 2.035 . . . . 0.0 111.499 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -135.47 145.08 46.79 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.779 -0.576 . . . . 0.0 111.007 160.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.6 m -137.11 161.14 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.062 1.345 . . . . 0.0 110.833 -168.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -128.78 145.69 51.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.988 1.315 . . . . 0.0 112.258 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.1 t -113.06 147.84 38.15 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 128.523 2.729 . . . . 0.0 107.113 165.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -111.41 -64.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 CA-C-N 122.538 1.942 . . . . 0.0 115.122 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 160.46 38.29 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -172.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.79 -0.08 2.52 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 127.385 2.422 . . . . 0.0 118.653 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.64 93.39 36.92 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 119.994 1.897 . . . . 0.0 114.464 -161.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.6 115.43 3.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.431 2.754 . . . . 0.0 109.864 161.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.2 p -164.2 153.58 13.91 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -172.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.92 105.39 12.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.009 1.723 . . . . 0.0 107.041 159.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.29 0.9 OUTLIER -67.16 120.31 71.27 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.045 -155.051 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.89 111.04 2.08 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.573 3.515 . . . . 0.0 114.237 -167.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.31 114.71 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 126.041 1.736 . . . . 0.0 109.114 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.04 159.03 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 126.659 1.984 . . . . 0.0 109.03 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 6.2 t -140.64 120.54 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -145.32 171.45 14.57 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.707 1.14 . . . . 0.0 113.385 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -101.11 -3.03 29.97 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.413 0.685 . . . . 0.0 112.67 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -112.58 1.95 16.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.819 1.647 . . . . 0.0 114.265 -162.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.1 mt 63.0 -15.58 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.028 2.531 . . . . 0.0 115.645 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.3 t -107.87 -4.39 18.04 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 113.884 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 59.97 61.07 1.96 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.926 2.49 . . . . 0.0 113.126 -171.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -88.09 -39.89 14.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.412 0.685 . . . . 0.0 111.601 166.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 42.3 mm -111.15 105.03 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.587 1.555 . . . . 0.0 110.117 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -78.01 102.2 7.28 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.705 1.139 . . . . 0.0 112.699 172.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -63.82 -53.63 47.76 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.2 2.6 . . . . 0.0 113.0 171.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -116.5 156.76 15.44 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.791 1.476 . . . . 0.0 116.791 -158.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.75 150.69 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.809 2.044 . . . . 0.0 109.772 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.69 130.4 36.75 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.132 1.373 . . . . 0.0 109.597 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 29.8 m -120.53 -30.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.3 m -101.0 152.93 19.99 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 160.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.5 m -48.78 132.33 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.135 1.774 . . . . 0.0 114.812 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -110.19 119.34 47.35 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.191 1.796 . . . . 0.0 108.337 168.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.88 -179.02 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.876 3.051 . . . . 0.0 114.394 -166.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.67 110.39 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 127.911 2.485 . . . . 0.0 106.517 169.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.89 84.05 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.537 1.535 . . . . 0.0 111.957 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 25.4 t -75.35 -8.93 57.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 166.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 13.6 p -131.25 128.47 39.93 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.997 2.119 . . . . 0.0 107.245 164.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.28 -19.25 65.28 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -172.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -84.66 6.99 21.88 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.64 1.176 . . . . 0.0 113.43 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -47.58 133.64 13.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.485 1.514 . . . . 0.0 113.582 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -138.54 132.59 31.39 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.087 1.355 . . . . 0.0 110.542 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.93 146.98 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -158.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.39 124.98 35.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.615 2.766 . . . . 0.0 109.799 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 12.7 mt -135.71 150.03 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.35 1.46 . . . . 0.0 109.859 -170.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -123.51 146.56 47.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.806 0.842 . . . . 0.0 111.223 163.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.25 151.96 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 124.664 1.186 . . . . 0.0 111.381 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -121.75 100.9 43.26 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.021 2.128 . . . . 0.0 109.499 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.63 168.93 12.45 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 123.677 2.918 . . . . 0.0 110.936 160.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.85 179.91 4.86 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.728 2.285 . . . . 0.0 111.046 166.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -58.12 145.24 37.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.288 0.635 . . . . 0.0 110.742 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.15 -163.96 28.18 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 121.783 0.657 . . . . 0.0 114.062 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.41 157.38 34.25 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.655 1.982 . . . . 0.0 114.778 -164.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.2 m -173.94 164.09 4.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.039 2.135 . . . . 0.0 112.203 169.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -122.47 117.21 25.41 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.83 2.852 . . . . 0.0 108.127 164.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mm -68.68 136.46 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 167.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 67.9 mt -127.94 123.76 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.977 1.311 . . . . 0.0 108.694 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 53.3 t -110.62 109.6 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.885 1.674 . . . . 0.0 107.363 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 117.2 171.82 15.84 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 122.923 1.291 . . . . 0.0 115.746 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.79 166.09 25.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.314 2.246 . . . . 0.0 109.329 169.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 68.61 -165.26 47.77 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 -166.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -64.65 -26.37 68.36 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.794 0.837 . . . . 0.0 112.539 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.7 m -64.72 4.39 0.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 129.105 2.962 . . . . 0.0 117.026 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -93.77 140.93 29.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.044 0.838 . . . . 0.0 112.659 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 20.8 mt -113.45 164.62 13.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.742 1.217 . . . . 0.0 110.701 173.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.0 t -146.66 160.78 41.77 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -151.07 127.62 10.78 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.849 1.66 . . . . 0.0 110.341 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -76.46 134.35 39.57 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.766 1.226 . . . . 0.0 111.894 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -143.67 135.5 26.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.687 1.195 . . . . 0.0 111.274 171.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 174.415 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 p90 . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.05 101.17 2.67 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 164.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.99 154.93 41.31 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.182 1.793 . . . . 0.0 113.831 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 141.25 38.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 162.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 76.0 p -130.94 10.48 5.02 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.906 0.883 . . . . 0.0 113.234 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -79.38 161.36 26.23 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.895 0.77 . . . . 0.0 110.981 165.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -65.22 103.76 0.83 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.127 2.171 . . . . 0.0 112.358 -163.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 33.6 mtt -83.71 168.5 16.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.961 0.886 . . . . 0.0 113.035 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.3 m -157.34 160.18 38.24 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.436 -0.79 . . . . 0.0 111.721 156.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -82.67 120.12 25.16 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.272 0.629 . . . . 0.0 110.155 166.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 22.6 t -66.61 -30.76 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.184 1.394 . . . . 0.0 110.698 163.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -142.17 123.33 14.65 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.557 1.943 . . . . 0.0 107.651 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -57.8 154.54 26.54 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.241 0.616 . . . . 0.0 111.797 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -56.22 124.39 16.14 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.876 2.384 . . . . 0.0 111.909 165.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.8 p -129.81 128.75 42.96 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.419 1.088 . . . . 0.0 111.569 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -61.78 126.75 28.45 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.344 0.658 . . . . 0.0 110.412 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.2 p -79.09 -12.97 60.02 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.818 1.247 . . . . 0.0 113.128 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.04 -6.69 1.98 Allowed Glycine 0 CA--C 1.539 1.553 0 CA-C-N 119.186 0.903 . . . . 0.0 114.231 -164.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -87.84 2.05 52.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.599 1.559 . . . . 0.0 111.643 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.99 2.31 39.25 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.756 1.646 . . . . 0.0 114.022 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.9 p -128.97 166.32 19.4 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.017 1.327 . . . . 0.0 111.975 -168.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 6.8 t -131.24 111.77 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.64 1.576 . . . . 0.0 108.377 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.58 137.07 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.064 1.346 . . . . 0.0 112.993 -168.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -142.47 164.45 30.11 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.998 2.119 . . . . 0.0 112.772 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -118.31 132.12 56.3 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.816 1.246 . . . . 0.0 108.016 161.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.3 152.44 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.741 0.817 . . . . 0.0 111.095 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -135.07 148.23 49.81 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.013 1.325 . . . . 0.0 112.327 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.43 150.65 46.92 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 128.043 2.537 . . . . 0.0 108.173 169.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -105.66 -68.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.366 2.044 . . . . 0.0 114.466 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 167.79 20.11 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -171.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.75 -6.73 0.32 Allowed Glycine 0 CA--C 1.537 1.46 0 C-N-CA 127.596 2.522 . . . . 0.0 118.496 170.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.15 94.03 37.42 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 119.872 1.836 . . . . 0.0 114.754 -160.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.8 121.32 7.26 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.753 2.302 . . . . 0.0 109.956 157.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.0 p -163.34 157.43 20.09 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -175.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -90.84 98.71 11.94 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 160.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.255 1.0 OUTLIER -60.9 123.03 73.2 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.811 -154.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.97 116.84 4.86 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.206 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 88.1 t -125.52 112.02 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.234 1.814 . . . . 0.0 109.812 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 157.41 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.362 1.065 . . . . 0.0 110.339 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 39.0 t -137.54 112.02 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -135.98 167.0 22.03 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -167.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -101.13 -2.4 31.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.671 0.788 . . . . 0.0 112.387 174.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 27.2 p30 -114.48 2.83 14.74 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.578 1.951 . . . . 0.0 113.723 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 20.4 mt 62.78 5.13 1.64 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.544 2.338 . . . . 0.0 115.436 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.9 t -135.94 -10.52 2.04 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 61.29 58.76 2.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.84 2.456 . . . . 0.0 113.83 -171.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.44 -36.12 58.13 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.189 152.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 15.8 mm -120.1 111.19 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.126 1.77 . . . . 0.0 109.956 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -89.67 120.25 30.79 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.294 -0.879 . . . . 0.0 112.241 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -72.3 -63.24 1.19 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.937 2.495 . . . . 0.0 111.722 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -106.2 161.03 14.37 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 116.903 1.521 . . . . 0.0 116.903 -155.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -104.39 152.25 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 127.108 2.163 . . . . 0.0 110.553 -173.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.12 125.9 30.03 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.288 1.435 . . . . 0.0 109.568 169.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 66.6 t -94.4 -45.84 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.426 0.69 . . . . 0.0 111.219 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 366' ' ' GLU . 1.5 t -105.05 -179.15 3.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.413 0.685 . . . . 0.0 112.031 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 29.5 m -53.72 123.14 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.574 1.55 . . . . 0.0 113.168 -176.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -95.03 119.3 66.06 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.097 0.959 . . . . 0.0 108.84 165.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -80.36 179.61 6.0 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.984 3.123 . . . . 0.0 113.583 -167.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.89 114.74 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.834 2.054 . . . . 0.0 106.961 167.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.02 71.72 0.17 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.815 1.246 . . . . 0.0 111.547 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 26.4 t -69.15 -8.85 49.34 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.247 -0.908 . . . . 0.0 112.507 163.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 41.0 p -128.13 116.9 20.66 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 128.408 2.683 . . . . 0.0 106.501 166.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -53.34 -20.97 4.96 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -77.08 4.09 11.0 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.352 1.861 . . . . 0.0 113.604 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -41.45 127.8 3.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.503 1.921 . . . . 0.0 113.957 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.13 146.92 43.4 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.303 1.041 . . . . 0.0 111.356 171.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.7 p -156.83 145.81 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -163.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.14 121.3 23.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.366 2.267 . . . . 0.0 108.78 164.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.93 142.15 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.678 0.672 . . . . 0.0 111.076 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . 0.66 ' H ' HG22 ' A' ' 351' ' ' THR . 32.1 mt-10 -114.39 139.18 49.7 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.144 1.778 . . . . 0.0 110.491 166.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.16 163.7 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.61 1.164 . . . . 0.0 111.547 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -131.25 98.79 18.2 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.244 1.817 . . . . 0.0 109.518 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -75.33 161.93 37.04 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.052 2.501 . . . . 0.0 111.458 160.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.21 -176.48 2.7 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.631 2.887 . . . . 0.0 111.154 163.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -55.75 151.68 10.78 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.124 1.37 . . . . 0.0 112.734 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 79.45 -159.06 44.26 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 121.283 0.38 . . . . 0.0 113.668 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -62.23 156.08 22.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.503 1.521 . . . . 0.0 114.116 -167.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.4 m -168.58 161.5 11.54 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.112 1.765 . . . . 0.0 111.946 165.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -122.33 113.48 19.47 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.944 2.098 . . . . 0.0 108.052 166.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.4 mm -74.03 120.3 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 79.4 mt -116.4 127.63 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.243 1.417 . . . . 0.0 109.566 -174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 70.3 t -118.36 105.22 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 126.417 1.887 . . . . 0.0 108.12 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 111.5 175.83 20.13 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 122.485 1.047 . . . . 0.0 115.256 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 1.8 p -134.74 164.86 26.58 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.359 1.864 . . . . 0.0 110.548 169.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 82.64 -170.03 49.68 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 123.827 0.727 . . . . 0.0 112.594 -168.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -63.39 -29.96 71.17 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.995 -1.297 . . . . 0.0 111.317 165.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 27.3 m -55.66 1.35 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 131.478 3.911 . . . . 0.0 118.101 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -102.04 147.11 26.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.484 1.513 . . . . 0.0 111.573 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 40.9 mt -119.62 165.76 14.05 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.585 0.754 . . . . 0.0 111.036 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.1 t -148.32 158.97 44.42 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -141.55 137.81 32.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.838 1.655 . . . . 0.0 109.537 174.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -76.93 145.25 38.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.098 1.359 . . . . 0.0 111.927 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -140.34 159.38 42.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.831 1.252 . . . . 0.0 111.992 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 . . . . . 0 CA--C 1.533 0.311 0 C-N-CA 125.633 1.573 . . . . 0.0 107.553 173.978 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.9 p90 . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 120.828 0.347 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.87 92.74 1.63 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 169.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.54 152.15 46.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.344 2.258 . . . . 0.0 115.051 -175.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 22.4 m -91.73 145.21 24.76 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.083 0.953 . . . . 0.0 109.433 163.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 41.9 p -136.15 0.75 2.63 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -84.63 155.91 21.8 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.464 1.483 . . . . 0.0 111.307 168.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 100.48 0.05 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.552 1.941 . . . . 0.0 113.131 -163.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 31.7 mtm -86.97 168.75 13.06 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.579 1.152 . . . . 0.0 111.999 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 37.6 m -159.61 164.62 33.99 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.997 -1.064 . . . . 0.0 112.265 168.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.48 124.78 32.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.002 0.521 . . . . 0.0 110.362 163.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.8 t -70.52 -31.14 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.396 1.478 . . . . 0.0 110.269 163.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -135.92 124.47 23.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.904 2.082 . . . . 0.0 107.795 165.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -61.21 151.95 74.0 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.446 0.698 . . . . 0.0 112.572 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.39 134.13 55.98 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.529 2.82 . . . . 0.0 113.295 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.9 p -136.32 129.39 31.31 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.809 1.244 . . . . 0.0 111.929 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -53.71 123.1 11.33 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.333 1.453 . . . . 0.0 110.884 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 52.1 p -82.56 -10.72 58.86 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.964 0.905 . . . . 0.0 113.361 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 76.7 -6.93 36.36 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.889 1.233 . . . . 0.0 114.381 -168.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -102.7 18.94 20.16 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.042 1.421 . . . . 0.0 112.487 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.97 7.23 81.12 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.174 0.893 . . . . 0.0 113.41 -172.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 18.1 p -127.69 165.74 19.45 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.469 1.108 . . . . 0.0 112.295 -174.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.97 123.35 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 126.363 1.865 . . . . 0.0 107.701 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.3 135.06 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.304 1.041 . . . . 0.0 113.202 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -141.13 164.38 30.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.231 1.812 . . . . 0.0 112.998 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -121.74 126.05 48.0 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.191 1.396 . . . . 0.0 107.318 166.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.7 155.39 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.295 0.952 . . . . 0.0 112.204 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -140.32 147.75 40.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.351 1.46 . . . . 0.0 113.087 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 12.2 t -113.0 154.08 45.09 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 128.495 2.718 . . . . 0.0 108.486 167.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -108.32 -63.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.811 2.341 . . . . 0.0 115.187 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.27 170.53 15.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.358 1.063 . . . . 0.0 113.03 -173.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.53 -21.65 0.13 Allowed Glycine 0 CA--C 1.537 1.465 0 C-N-CA 127.676 2.56 . . . . 0.0 118.284 167.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.09 100.42 15.09 Favored Pre-proline 0 CA--C 1.552 1.043 0 CA-C-N 119.522 1.661 . . . . 0.0 113.936 -168.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.56 115.94 3.98 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.184 2.589 . . . . 0.0 109.198 158.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.7 p -162.79 154.69 18.26 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -170.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -78.46 112.24 15.31 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 155.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.283 1.1 pp -64.51 118.59 49.08 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.508 -163.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.25 113.67 1.77 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 124.039 3.16 . . . . 0.0 113.683 -172.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 69.2 t -121.88 111.41 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 125.428 1.491 . . . . 0.0 108.675 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.61 155.87 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.006 1.322 . . . . 0.0 110.108 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.5 t -140.31 111.89 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.62 -178.84 5.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.761 1.164 . . . . 0.0 113.287 -167.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -112.73 2.59 16.12 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.674 0.79 . . . . 0.0 112.988 176.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -126.49 8.7 7.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.366 1.466 . . . . 0.0 114.074 -157.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 50.7 mt 60.51 -14.81 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.123 2.569 . . . . 0.0 116.25 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.6 t -111.61 -9.88 14.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.133 1.333 . . . . 0.0 113.793 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 69.67 44.02 0.92 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.94 2.496 . . . . 0.0 113.148 -171.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.82 -46.96 82.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.464 0.306 . . . . 0.0 110.905 166.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 17.8 mm -118.3 99.5 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.588 1.155 . . . . 0.0 110.489 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -70.42 105.38 3.03 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 121.086 -1.009 . . . . 0.0 112.66 172.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -65.86 -56.88 9.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 129.586 3.155 . . . . 0.0 113.233 171.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -103.36 -178.65 26.15 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 -160.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mm -124.9 160.34 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.842 2.457 . . . . 0.0 111.23 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.32 130.74 35.17 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.797 1.239 . . . . 0.0 110.125 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 85.2 t -92.46 -19.66 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.34 0.656 . . . . 0.0 111.096 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 366' ' ' GLU . 6.1 t -137.76 174.43 10.58 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.366 1.067 . . . . 0.0 112.765 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.55 95.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 127.051 2.141 . . . . 0.0 113.687 -171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -57.83 119.1 31.03 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.512 1.125 . . . . 0.0 110.692 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -80.76 -176.62 3.26 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.337 3.358 . . . . 0.0 113.384 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.06 122.73 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.8 1.64 . . . . 0.0 107.883 171.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.01 64.28 0.33 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.799 1.64 . . . . 0.0 112.779 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 30.6 t -66.13 -10.81 44.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.591 1.156 . . . . 0.0 113.113 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 40.2 p -134.2 117.88 17.0 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.84 2.856 . . . . 0.0 106.475 163.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -61.4 -13.23 18.4 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -165.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -75.79 1.07 15.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.717 1.607 . . . . 0.0 114.012 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -35.56 119.7 0.54 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.455 2.302 . . . . 0.0 113.932 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.02 145.46 50.86 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.589 1.155 . . . . 0.0 112.183 170.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.32 147.16 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -160.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -78.73 123.42 27.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.766 2.426 . . . . 0.0 109.744 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 52.9 mt -132.81 137.34 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.485 0.66 . . . . 0.0 111.055 174.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . 0.487 ' H ' HG22 ' A' ' 351' ' ' THR . 26.9 mt-10 -105.26 140.96 37.61 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.949 1.3 . . . . 0.0 110.827 160.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 20.2 m -122.6 158.32 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.547 1.139 . . . . 0.0 111.298 168.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -118.02 101.53 51.64 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.52 1.928 . . . . 0.0 108.736 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.96 159.57 37.76 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.093 1.862 . . . . 0.0 110.304 163.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -57.7 171.35 1.5 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.702 2.268 . . . . 0.0 112.094 159.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -62.18 147.81 46.56 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.464 -0.772 . . . . 0.0 109.993 157.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.31 -171.29 23.14 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 122.57 1.095 . . . . 0.0 113.185 -169.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -72.7 163.36 28.21 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.313 -1.11 . . . . 0.0 113.802 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.9 m -164.62 170.36 15.81 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.187 1.395 . . . . 0.0 112.222 164.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -124.95 114.49 19.21 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 129.381 3.073 . . . . 0.0 106.43 163.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.1 mm -71.74 135.02 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 74.8 mt -129.42 128.03 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 125.238 1.415 . . . . 0.0 108.83 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 83.9 t -118.71 105.02 16.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 126.196 1.798 . . . . 0.0 107.6 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.23 175.42 21.99 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 123.052 1.362 . . . . 0.0 115.935 175.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.82 167.61 21.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.656 2.382 . . . . 0.0 110.113 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 85.31 -156.9 31.19 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 123.356 0.503 . . . . 0.0 111.909 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -67.59 -36.8 81.56 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.534 0.667 . . . . 0.0 110.805 161.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.3 m -51.54 11.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 1 C-N-CA 132.981 4.513 . . . . 0.0 119.546 -173.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -114.36 139.58 49.35 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.63 1.105 . . . . 0.0 112.176 -165.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 30.9 mt -111.57 161.55 16.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.431 0.692 . . . . 0.0 110.252 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.8 t -145.57 156.64 43.82 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.047 0.539 . . . . 0.0 112.36 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -142.27 121.7 13.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.211 1.405 . . . . 0.0 109.812 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -67.92 134.42 50.78 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.194 1.397 . . . . 0.0 111.341 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -136.87 161.1 36.94 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 123.097 1.427 . . . . 0.0 112.592 173.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 . . . . . 0 N--CA 1.451 -0.42 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.56 -172.822 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 27.6 p90 . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 120.826 0.346 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.04 101.57 13.59 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.055 1.342 . . . . 0.0 107.611 168.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.09 149.8 39.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.216 2.206 . . . . 0.0 114.89 -171.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 4.7 m -86.52 144.52 27.19 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 164.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 61.1 p -137.37 0.73 2.33 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -71.32 166.17 22.17 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.603 1.092 . . . . 0.0 110.089 165.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -69.43 109.51 4.25 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.194 0.998 . . . . 0.0 111.203 -165.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 34.5 mtm -94.82 166.59 11.9 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.544 1.138 . . . . 0.0 112.255 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 58.5 m -160.89 157.75 27.08 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.734 1.214 . . . . 0.0 110.168 165.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.73 125.44 29.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.153 160.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 45.6 t -71.12 -18.92 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 126.18 1.792 . . . . 0.0 110.807 166.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -147.57 112.67 5.49 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.601 2.361 . . . . 0.0 106.76 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -55.31 147.59 36.1 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 118.553 0.615 . . . . 0.0 110.04 171.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.81 145.13 99.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.175 1.25 . . . . 0.0 111.168 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 23.3 p -131.24 135.98 47.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.222 1.409 . . . . 0.0 110.791 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -58.31 121.46 10.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.828 1.251 . . . . 0.0 110.601 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 60.1 p -81.78 -13.82 57.22 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.51 -0.96 7.89 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-N 119.391 0.996 . . . . 0.0 114.052 -165.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -95.11 8.22 43.65 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.257 1.528 . . . . 0.0 111.771 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.85 10.71 58.57 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.642 1.115 . . . . 0.0 114.056 -171.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 16.2 p -136.25 169.86 16.96 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.476 1.138 . . . . 0.0 112.741 -169.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.69 127.31 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.994 2.118 . . . . 0.0 108.829 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 11.3 p -118.15 124.15 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -163.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -130.95 157.17 43.67 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.694 1.598 . . . . 0.0 114.291 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -106.36 137.89 43.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.34 1.456 . . . . 0.0 107.215 161.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.56 136.99 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.739 1.216 . . . . 0.0 110.704 -175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -122.64 144.2 49.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.052 0.941 . . . . 0.0 112.199 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.7 143.59 31.67 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.746 2.818 . . . . 0.0 106.613 170.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -109.85 -63.68 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 CA-C-N 121.881 1.707 . . . . 0.0 115.875 -174.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 169.16 18.05 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 120.613 1.552 . . . . 0.0 113.233 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 68.6 -6.0 3.86 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.447 1.975 . . . . 0.0 117.341 169.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.61 102.07 45.32 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 119.135 1.468 . . . . 0.0 113.306 -163.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.29 118.42 2.94 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.249 2.632 . . . . 0.0 110.051 154.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.7 p -163.17 146.98 10.88 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -172.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -72.98 117.51 14.8 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 154.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.297 0.8 OUTLIER -69.89 122.65 86.69 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.884 -160.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.459 ' HG2' ' HA2' ' A' ' 379' ' ' GLY . 71.5 Cg_endo -72.65 110.09 2.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 1 C-N-CA 125.781 4.32 . . . . 0.0 112.894 -166.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 98.6 t -122.66 124.79 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.534 1.534 . . . . 0.0 110.653 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.51 156.93 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.089 1.355 . . . . 0.0 110.817 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . 0.53 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 40.5 t -136.32 129.52 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -147.65 174.2 12.0 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.974 0.796 . . . . 0.0 112.145 -172.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -101.29 -1.01 34.65 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.513 0.725 . . . . 0.0 112.14 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -128.46 8.18 5.91 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -152.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 59.7 mt 62.51 -22.94 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.653 2.381 . . . . 0.0 115.95 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.1 t -106.99 -7.87 16.8 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.849 1.26 . . . . 0.0 113.873 -172.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 337' ' ' ALA 0.261 . . 71.72 32.76 1.9 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.331 2.653 . . . . 0.0 113.917 -177.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -59.1 -46.27 88.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.684 0.394 . . . . 0.0 110.767 169.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 16.0 mm -96.81 129.23 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.596 1.158 . . . . 0.0 109.095 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.65 64.17 0.8 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 123.042 1.401 . . . . 0.0 112.18 -174.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -66.2 -45.62 80.13 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 128.623 2.769 . . . . 0.0 116.544 -156.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . 0.53 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -107.33 -175.32 22.61 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.799 1.666 . . . . 0.0 115.282 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.35 145.67 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 125.165 1.386 . . . . 0.0 112.305 -174.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.49 118.34 12.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.791 1.636 . . . . 0.0 109.688 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.9 t -87.84 -52.23 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.902 0.774 . . . . 0.0 111.647 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.4 t -84.44 171.87 12.2 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.647 0.737 . . . . 0.0 111.642 170.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.28 120.28 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.201 1.0 . . . . 0.0 111.761 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -79.32 128.17 76.43 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.282 1.433 . . . . 0.0 110.499 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.47 ' HG3' HG11 ' A' ' 363' ' ' VAL . 2.4 Cg_endo -85.75 -168.14 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 124.906 3.737 . . . . 0.0 113.493 -168.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.12 123.51 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.782 1.633 . . . . 0.0 109.009 172.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.23 80.74 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.503 1.121 . . . . 0.0 110.756 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 47.6 t -69.2 -25.53 64.37 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.585 -0.697 . . . . 0.0 111.303 163.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 21.5 p -120.93 124.54 45.18 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.246 2.619 . . . . 0.0 107.425 169.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -59.19 -23.81 62.57 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -168.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.15 3.9 1.9 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.359 1.863 . . . . 0.0 114.337 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -45.91 135.0 7.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.567 1.547 . . . . 0.0 113.792 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -150.87 111.51 4.24 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.963 1.705 . . . . 0.0 108.61 -165.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . 0.47 HG11 ' HG3' ' A' ' 354' ' ' PRO . 9.9 p -138.98 153.43 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -165.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -80.38 123.72 28.26 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 128.117 2.567 . . . . 0.0 109.383 165.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.34 143.07 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.138 0.881 . . . . 0.0 111.922 169.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -108.98 142.16 40.05 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.187 1.795 . . . . 0.0 111.224 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.47 152.77 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.703 0.801 . . . . 0.0 111.326 170.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -109.0 116.82 54.98 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.398 1.879 . . . . 0.0 109.807 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -91.18 145.91 3.51 Favored 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 123.771 2.98 . . . . 0.0 111.096 166.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.14 171.57 1.65 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.231 2.621 . . . . 0.0 112.582 153.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -61.71 140.78 58.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.115 0.566 . . . . 0.0 110.724 170.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 95.97 -164.63 23.89 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-O 122.749 1.194 . . . . 0.0 115.803 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.89 155.05 11.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 129.095 2.958 . . . . 0.0 113.618 -169.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.8 m -173.95 162.56 3.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.234 1.414 . . . . 0.0 113.409 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -129.22 115.99 18.49 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 130.986 3.714 . . . . 0.0 107.909 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.3 mm -82.5 118.71 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 26.3 mt -108.83 126.07 65.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.413 1.085 . . . . 0.0 108.605 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.7 110.8 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.823 1.649 . . . . 0.0 106.942 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 333' ' ' PRO . . . 116.25 172.29 16.55 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 124.043 1.913 . . . . 0.0 116.343 174.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.69 162.76 36.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.736 2.414 . . . . 0.0 109.175 177.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.59 -167.37 52.29 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -162.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.36 -26.35 68.72 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.787 -0.831 . . . . 0.0 111.918 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 64.0 m -63.29 3.19 0.3 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 128.822 2.849 . . . . 0.0 116.329 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -87.43 123.68 32.62 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.149 0.886 . . . . 0.0 111.41 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.71 162.58 12.82 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 172.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.3 t -140.23 155.03 47.05 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.5 133.11 47.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.22 1.408 . . . . 0.0 109.218 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -75.3 133.06 41.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.629 1.571 . . . . 0.0 111.071 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -141.94 106.28 4.81 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.096 0.959 . . . . 0.0 112.559 175.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 C--N 1.33 -0.24 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.801 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.9 p90 . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 120.88 0.371 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.81 101.36 1.32 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 161.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.06 157.48 22.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.493 1.917 . . . . 0.0 114.171 -173.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 12.1 m -92.66 142.77 27.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.3 0.64 . . . . 0.0 109.958 170.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 80.4 p -136.71 5.98 2.92 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 174.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -83.61 164.81 19.49 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.92 1.236 . . . . 0.0 110.738 165.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -66.49 92.94 0.21 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.785 2.434 . . . . 0.0 112.173 -161.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . 0.401 ' HE1' ' H ' ' A' ' 380' ' ' THR . 33.4 mtm -80.66 166.52 20.99 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.204 1.002 . . . . 0.0 112.381 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.5 m -158.87 157.76 32.11 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.287 -0.883 . . . . 0.0 112.531 167.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.03 120.03 24.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.418 0.687 . . . . 0.0 109.847 159.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.94 -25.03 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.638 1.175 . . . . 0.0 110.845 169.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -140.01 130.49 25.52 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.121 2.168 . . . . 0.0 108.034 168.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -60.86 144.89 89.56 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.624 1.169 . . . . 0.0 112.324 172.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.02 137.9 78.72 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.76 2.307 . . . . 0.0 112.145 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 37.2 p -132.32 126.74 34.02 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.259 1.424 . . . . 0.0 111.05 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -59.83 121.56 12.04 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.447 1.099 . . . . 0.0 110.569 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 65.3 p -80.19 -10.45 59.76 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.944 1.298 . . . . 0.0 113.123 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.13 -8.34 1.39 Allowed Glycine 0 CA--C 1.538 1.503 0 CA-C-N 119.186 0.903 . . . . 0.0 114.389 -166.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -82.71 2.59 32.96 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.251 1.525 . . . . 0.0 111.863 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.94 5.35 61.07 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.253 1.406 . . . . 0.0 113.413 -169.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 16.3 p -123.69 161.78 24.41 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.623 1.211 . . . . 0.0 112.039 -175.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 6.7 t -133.92 112.59 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.218 1.407 . . . . 0.0 107.863 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.0 p -108.87 130.88 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.383 1.073 . . . . 0.0 113.668 -160.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -140.84 163.27 33.38 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.936 2.094 . . . . 0.0 112.901 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -114.12 131.39 56.43 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.979 1.312 . . . . 0.0 107.585 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.04 153.72 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.413 1.006 . . . . 0.0 112.307 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -140.42 147.8 40.24 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.625 1.57 . . . . 0.0 113.071 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.46 147.7 38.61 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 128.14 2.576 . . . . 0.0 107.633 162.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -106.14 -56.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.057 0 CA-C-N 122.899 2.071 . . . . 0.0 115.816 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 172.35 12.94 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.944 -1.098 . . . . 0.0 112.293 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.99 0.58 7.42 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 117.354 1.702 . . . . 0.0 117.354 169.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.34 94.08 48.72 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 118.91 1.355 . . . . 0.0 113.065 -162.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.57 117.45 3.38 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.398 2.732 . . . . 0.0 108.984 156.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.9 p -166.54 155.31 10.7 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -174.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.31 111.2 15.32 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 154.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.16 116.17 23.05 Favored Pre-proline 0 CA--C 1.557 1.237 0 CA-C-O 119.056 -0.497 . . . . 0.0 111.651 -163.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -62.81 117.33 4.23 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.932 3.088 . . . . 0.0 113.912 -172.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.98 107.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.675 1.19 . . . . 0.0 110.131 173.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.43 157.82 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.437 1.495 . . . . 0.0 109.453 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 91.0 t -137.9 121.12 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -135.3 172.27 13.24 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -167.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -104.9 -0.42 27.07 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.712 1.205 . . . . 0.0 112.403 170.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -129.02 7.9 5.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.071 1.348 . . . . 0.0 114.575 -157.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.8 mt 67.46 -8.31 0.49 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.621 2.369 . . . . 0.0 115.644 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 7.8 t -129.14 -9.73 4.77 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 120.726 1.603 . . . . 0.0 115.235 -174.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 69.5 44.58 0.9 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.702 2.401 . . . . 0.0 113.114 -170.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.08 72.13 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.202 158.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 27.3 mt -125.2 109.65 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 127.611 2.365 . . . . 0.0 107.939 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -77.2 118.14 19.43 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.333 0.97 . . . . 0.0 110.382 162.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -77.68 -62.97 1.49 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.634 2.774 . . . . 0.0 111.498 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -112.19 171.14 13.93 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 117.086 1.594 . . . . 0.0 117.086 -162.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mm -109.91 156.33 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.95 2.1 . . . . 0.0 111.589 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.56 136.06 34.93 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.227 1.411 . . . . 0.0 109.696 170.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.7 t -110.48 -61.64 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.186 0.594 . . . . 0.0 110.374 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.8 m -79.98 153.3 28.99 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.756 0.822 . . . . 0.0 109.645 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.6 m -51.54 144.53 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.865 2.066 . . . . 0.0 115.471 -167.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -112.02 111.65 53.3 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.986 1.714 . . . . 0.0 108.845 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.16 -171.48 1.09 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.493 3.462 . . . . 0.0 113.866 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.71 117.15 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 127.575 2.35 . . . . 0.0 107.066 168.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.84 71.06 0.21 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.691 1.996 . . . . 0.0 112.559 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.0 t -67.79 -14.9 63.33 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.422 -0.799 . . . . 0.0 112.913 167.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 10.2 p -116.25 129.15 56.14 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 127.041 2.137 . . . . 0.0 106.959 161.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -66.83 -14.87 63.17 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -173.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.11 6.3 26.16 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.515 1.926 . . . . 0.0 113.407 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -42.95 124.43 3.14 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.427 1.891 . . . . 0.0 113.715 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.15 148.15 46.42 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.613 1.165 . . . . 0.0 111.529 172.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.55 152.52 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.658 0.742 . . . . 0.0 112.482 -164.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.0 123.24 31.89 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.796 2.439 . . . . 0.0 108.929 169.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 42.7 mt -130.99 149.75 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.863 0.865 . . . . 0.0 110.678 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -121.18 142.01 50.3 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.567 1.547 . . . . 0.0 110.569 167.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.36 153.92 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.387 0.675 . . . . 0.0 111.595 167.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -117.46 99.42 52.5 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 127.134 2.174 . . . . 0.0 108.536 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -80.86 161.8 21.15 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.675 2.25 . . . . 0.0 110.65 165.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.83 -174.42 1.51 Allowed 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.776 2.318 . . . . 0.0 110.604 158.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -61.28 160.71 10.13 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.446 -0.784 . . . . 0.0 111.859 164.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 97.58 -177.8 32.17 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.318 1.437 . . . . 0.0 113.445 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.26 163.06 16.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.46 1.504 . . . . 0.0 112.866 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.1 m -162.51 154.36 18.47 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.119 -0.988 . . . . 0.0 112.533 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -120.16 104.81 10.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.796 2.439 . . . . 0.0 106.966 166.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.2 mm -70.15 121.31 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 64.3 mt -118.28 125.28 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.943 1.297 . . . . 0.0 109.108 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.8 103.78 15.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.18 1.792 . . . . 0.0 107.815 -177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.87 177.71 23.75 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 123.308 1.505 . . . . 0.0 116.511 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . 0.401 ' H ' ' HE1' ' A' ' 304' ' ' MET . 2.2 p -134.91 172.22 13.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.031 2.532 . . . . 0.0 110.722 175.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 81.64 -162.2 43.13 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 123.617 0.627 . . . . 0.0 111.642 -168.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -67.25 -38.04 84.49 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.717 -0.872 . . . . 0.0 110.764 162.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 47.2 m -53.81 8.12 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.54 1 C-N-CA 132.127 4.171 . . . . 0.0 119.016 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -99.88 146.91 26.1 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.108 1.363 . . . . 0.0 111.835 -172.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 19.7 mt -114.55 165.94 12.24 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.505 0.722 . . . . 0.0 110.918 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.6 t -146.82 158.17 43.85 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -139.2 132.04 29.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.943 1.697 . . . . 0.0 110.089 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -80.73 138.76 36.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.976 1.31 . . . . 0.0 112.193 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -132.51 159.79 38.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.702 1.601 . . . . 0.0 110.861 165.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 . . . . . 0 C--O 1.235 0.312 0 C-N-CA 125.168 1.387 . . . . 0.0 108.534 -177.099 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 42.8 p90 . . . . . 0 CA--C 1.541 0.604 0 CA-C-O 120.885 0.374 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.01 109.93 14.92 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -77.96 153.52 32.4 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.976 1.711 . . . . 0.0 114.745 -172.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -99.41 145.42 27.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.894 0.877 . . . . 0.0 108.974 162.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 53.0 p -135.0 10.5 3.58 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -75.96 160.8 29.5 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.086 0.857 . . . . 0.0 110.934 164.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -63.01 97.19 0.1 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.829 2.052 . . . . 0.0 111.506 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 5.9 mtm -76.66 164.79 25.56 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.001 0.92 . . . . 0.0 112.451 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 25.9 m -158.7 154.47 26.41 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.234 -0.916 . . . . 0.0 112.458 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 121.08 29.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.341 0.656 . . . . 0.0 110.106 170.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.8 t -70.12 -23.75 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.352 1.061 . . . . 0.0 110.488 164.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -144.86 119.41 9.72 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.716 2.006 . . . . 0.0 108.72 169.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -55.13 142.69 56.85 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.906 1.283 . . . . 0.0 111.315 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -51.59 134.88 47.59 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.865 2.377 . . . . 0.0 113.423 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.13 127.41 35.92 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.505 1.122 . . . . 0.0 111.693 173.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.24 124.93 21.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.053 0.541 . . . . 0.0 111.085 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 19.0 p -83.25 -8.32 59.47 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.268 1.027 . . . . 0.0 113.481 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 79.31 -14.62 15.15 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.481 1.038 . . . . 0.0 114.671 -169.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -87.14 5.84 35.86 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.479 1.64 . . . . 0.0 112.984 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.35 2.92 65.42 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.834 1.206 . . . . 0.0 113.743 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.8 p -115.69 165.73 12.72 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.322 1.449 . . . . 0.0 111.585 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.6 115.48 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.853 1.661 . . . . 0.0 108.87 -178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.8 p -102.78 130.95 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.567 1.547 . . . . 0.0 113.29 -167.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -137.76 164.2 29.47 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.536 1.934 . . . . 0.0 112.827 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -123.17 124.6 43.42 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.086 1.354 . . . . 0.0 107.718 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.14 138.22 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.071 0.948 . . . . 0.0 112.069 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -117.76 143.16 46.49 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.064 1.746 . . . . 0.0 111.501 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 10.2 t -111.79 149.95 41.56 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.354 1.862 . . . . 0.0 108.001 165.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 3.5 Cg_endo -105.97 -74.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 122.038 1.825 . . . . 0.0 114.906 -172.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.88 165.84 25.02 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 121.323 1.874 . . . . 0.0 114.642 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 71.9 -4.87 14.54 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.053 1.787 . . . . 0.0 116.279 172.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -112.63 98.62 44.98 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.979 1.311 . . . . 0.0 113.093 -168.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.43 117.89 5.14 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.388 2.059 . . . . 0.0 108.226 152.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 8.9 p -161.37 154.99 21.77 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -88.57 102.11 14.62 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.093 2.157 . . . . 0.0 106.39 158.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 333' ' ' PRO 0.255 3.7 pt -59.73 123.5 71.77 Favored Pre-proline 0 CA--C 1.554 1.12 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -156.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 9.7 Cg_exo -62.79 113.28 1.92 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.419 2.746 . . . . 0.0 112.933 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.91 110.14 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 109.801 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.85 163.37 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.971 1.708 . . . . 0.0 109.265 -172.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.22 113.67 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.55 171.4 12.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.222 0.534 . . . . 0.0 112.038 -170.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . 0.452 ' CG ' ' HZ3' ' A' ' 346' ' ' LYS . 33.7 m-20 -114.61 2.74 14.61 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.149 1.38 . . . . 0.0 111.599 173.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -109.97 -5.29 15.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.894 2.077 . . . . 0.0 114.027 -167.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.7 mt 58.72 -1.95 0.1 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.233 2.613 . . . . 0.0 116.049 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -112.63 -7.06 13.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.419 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 384' ' ' ARG . . . 45.11 77.13 0.08 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 130.279 3.432 . . . . 0.0 114.669 -166.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -92.99 -40.97 10.26 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.423 149.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 84.5 mt -74.57 150.06 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.872 1.669 . . . . 0.0 110.783 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -143.86 94.52 2.6 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.2 1.4 . . . . 0.0 111.521 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' A' ' 338' ' ' ASP . 30.7 ttpt -102.57 -31.04 10.6 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -166.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -116.41 159.42 13.92 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.657 1.122 . . . . 0.0 115.638 -168.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.81 145.23 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.633 1.973 . . . . 0.0 110.758 -169.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.61 120.01 22.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.776 1.63 . . . . 0.0 108.633 166.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.8 t -92.72 -41.25 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.149 0.58 . . . . 0.0 111.32 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 366' ' ' GLU . 3.0 t -98.01 176.41 5.77 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.695 0.759 . . . . 0.0 112.01 171.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 6.1 m -62.1 107.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.93 1.692 . . . . 0.0 113.493 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.77 121.06 79.88 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 118.14 -0.933 . . . . 0.0 109.29 160.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -82.69 -174.36 2.03 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 124.918 3.745 . . . . 0.0 113.717 -171.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 112.04 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 126.596 1.959 . . . . 0.0 108.168 169.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -72.22 77.83 0.98 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.668 1.187 . . . . 0.0 111.785 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 19.3 t -69.32 -19.94 63.88 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.351 -0.843 . . . . 0.0 113.149 171.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 17.7 p -118.82 118.21 30.95 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 127.134 2.173 . . . . 0.0 106.337 163.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -56.8 -24.22 49.06 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -165.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.67 0.98 7.45 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.712 2.005 . . . . 0.0 113.967 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -46.81 134.63 9.81 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.317 1.447 . . . . 0.0 113.385 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -137.97 133.01 33.16 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.587 1.155 . . . . 0.0 111.148 175.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.89 143.2 24.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.739 0.781 . . . . 0.0 112.954 -160.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.83 118.67 18.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.286 2.235 . . . . 0.0 109.469 166.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 32.5 mt -126.97 143.52 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.049 0.54 . . . . 0.0 110.458 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . 0.668 ' H ' HG22 ' A' ' 351' ' ' THR . 33.2 mt-10 -116.85 134.33 54.91 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.768 1.627 . . . . 0.0 110.06 167.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.4 159.63 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.594 1.158 . . . . 0.0 111.96 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -124.92 104.65 29.86 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.911 1.684 . . . . 0.0 109.944 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -86.47 163.08 9.59 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.786 2.991 . . . . 0.0 111.078 161.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.5 177.15 9.04 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.204 2.603 . . . . 0.0 112.467 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -63.52 116.95 6.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.861 1.264 . . . . 0.0 110.928 167.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 133.83 -145.74 17.76 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.921 1.248 . . . . 0.0 111.589 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -97.02 160.44 14.34 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.934 1.294 . . . . 0.0 113.3 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 21.9 m -169.17 152.38 5.02 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.801 1.64 . . . . 0.0 111.827 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -122.37 107.43 12.07 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 166.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.3 mm -73.71 120.66 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 72.0 mt -116.41 134.47 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.331 1.052 . . . . 0.0 110.996 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 67.4 t -120.93 107.15 19.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 126.04 1.736 . . . . 0.0 107.973 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.34 -175.6 19.07 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.85 159.34 42.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.195 1.798 . . . . 0.0 110.432 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.83 -173.22 53.71 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.296 0.474 . . . . 0.0 112.529 -168.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -55.93 -27.9 54.39 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.842 1.257 . . . . 0.0 112.291 171.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 24.6 m -59.43 -7.61 1.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.532 3.133 . . . . 0.0 116.608 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 342' ' ' ALA . 3.5 ptm180 -87.04 125.93 34.42 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.08 0.952 . . . . 0.0 112.23 -173.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 15.1 mt -95.67 164.63 12.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.665 0.386 . . . . 0.0 111.897 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.3 t -135.12 152.08 51.31 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.321 1.048 . . . . 0.0 113.154 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -141.06 142.33 34.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.562 1.145 . . . . 0.0 111.583 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.03 140.58 36.49 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -140.98 138.61 33.87 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.173 0.987 . . . . 0.0 112.308 163.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--N 1.33 -0.272 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -173.099 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.3 m -69.82 4.58 1.91 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.33 -12.49 42.64 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.567 1.147 . . . . 0.0 113.55 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 51.2 mt -131.33 158.82 39.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.611 1.565 . . . . 0.0 110.343 170.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 16.2 m -48.07 -60.9 2.27 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.91 2.084 . . . . 0.0 115.029 -158.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.63 74.18 7.61 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.577 0.626 . . . . 0.0 111.31 -171.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.76 91.5 1.3 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 169.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.49 2.87 51.85 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.855 1.217 . . . . 0.0 115.756 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 18.3 p -72.44 -69.91 0.37 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.998 2.119 . . . . 0.0 112.017 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.5 m -169.75 140.0 2.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.636 1.575 . . . . 0.0 111.14 171.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -160.67 146.79 15.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.842 1.257 . . . . 0.0 110.693 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 104.03 6.36 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.26 144.06 42.36 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.184 2.193 . . . . 0.0 115.053 -176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 39.8 m -90.48 131.92 35.96 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.755 0.822 . . . . 0.0 109.005 160.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 78.8 p -133.41 3.6 3.62 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.73 158.5 20.73 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.515 1.052 . . . . 0.0 110.356 163.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.14 102.33 0.49 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.846 2.058 . . . . 0.0 112.132 -161.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.5 mtm -82.91 161.84 21.74 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.609 0.763 . . . . 0.0 112.166 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 92.2 p -147.36 163.26 37.01 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -84.11 126.52 33.16 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 161.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.02 -24.31 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.059 0.544 . . . . 0.0 110.235 163.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -145.23 126.3 14.62 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.132 2.173 . . . . 0.0 107.822 170.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -57.45 149.73 48.08 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.299 1.04 . . . . 0.0 112.099 173.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -57.32 136.74 78.04 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.263 1.975 . . . . 0.0 111.242 170.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 38.1 p -132.1 127.13 35.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.502 1.121 . . . . 0.0 111.017 171.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -56.32 117.39 3.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.451 1.5 . . . . 0.0 110.887 174.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 79.7 p -79.12 -12.27 59.99 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.169 0.987 . . . . 0.0 113.274 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.61 -8.16 1.22 Allowed Glycine 0 CA--C 1.539 1.538 0 CA-C-N 119.299 0.954 . . . . 0.0 114.468 -165.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -83.85 4.2 30.32 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 119.213 1.506 . . . . 0.0 111.706 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 99.48 4.18 56.17 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.858 1.694 . . . . 0.0 113.782 -172.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.8 p -127.18 165.14 20.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.512 1.156 . . . . 0.0 112.114 -168.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.11 112.14 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.494 1.517 . . . . 0.0 107.834 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.8 p -101.1 127.14 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.229 1.012 . . . . 0.0 112.952 -167.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -135.07 167.84 20.23 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.86 1.664 . . . . 0.0 113.263 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -125.16 135.38 52.57 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.062 1.345 . . . . 0.0 107.76 166.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.59 157.66 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.704 0.801 . . . . 0.0 112.062 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -132.75 145.99 51.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.503 1.521 . . . . 0.0 112.089 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.04 147.98 38.98 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 127.356 2.262 . . . . 0.0 107.354 163.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -109.37 -51.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 0 CA-C-N 122.923 2.08 . . . . 0.0 115.918 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 168.21 25.14 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.917 -1.115 . . . . 0.0 112.348 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.54 -0.17 3.16 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.578 2.037 . . . . 0.0 117.531 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.98 96.46 50.18 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.869 1.335 . . . . 0.0 112.961 -162.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.38 114.99 3.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.297 2.665 . . . . 0.0 108.82 152.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 13.6 p -160.63 146.0 14.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.26 104.36 13.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.295 1.838 . . . . 0.0 107.042 164.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.289 0.6 OUTLIER -68.06 118.73 61.49 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 119.42 -0.324 . . . . 0.0 110.944 -153.089 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.01 106.65 2.19 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.771 2.314 . . . . 0.0 112.147 -171.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 91.7 t -106.15 116.73 50.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 126.349 1.86 . . . . 0.0 109.686 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.42 160.8 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.093 1.357 . . . . 0.0 110.046 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . 0.48 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 60.0 t -143.73 128.13 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -141.8 175.8 9.42 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.575 0.75 . . . . 0.0 112.576 -164.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . 0.474 ' CG ' ' HZ2' ' A' ' 346' ' ' LYS . 64.2 m-20 -115.38 5.52 14.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.795 1.238 . . . . 0.0 111.949 171.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -132.85 6.56 3.99 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.33 1.852 . . . . 0.0 114.241 -159.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 40.1 mt 63.89 -6.34 0.25 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.382 2.273 . . . . 0.0 115.869 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.9 t -125.19 -7.17 7.09 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.606 1.548 . . . . 0.0 114.721 -174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 337' ' ' ALA . . . 73.22 37.29 0.76 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.813 2.045 . . . . 0.0 113.028 -176.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.78 -48.17 80.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 162.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 45.3 mm -75.03 152.53 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.219 1.008 . . . . 0.0 109.038 160.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.73 66.72 1.5 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.391 1.567 . . . . 0.0 109.682 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . 0.474 ' HZ2' ' CG ' ' A' ' 338' ' ' ASP . 43.7 tttt -70.6 -62.68 1.3 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.393 2.277 . . . . 0.0 111.986 -161.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.48 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -98.94 156.78 20.11 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.256 1.407 . . . . 0.0 115.757 -159.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.91 147.24 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.973 2.509 . . . . 0.0 109.51 -167.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.5 117.24 19.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.422 1.489 . . . . 0.0 108.877 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.2 t -79.62 -46.55 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.693 0.797 . . . . 0.0 110.622 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 366' ' ' GLU . 7.3 t -95.12 179.56 5.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.819 0.848 . . . . 0.0 110.745 169.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 26.3 m -57.08 139.47 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.027 0.931 . . . . 0.0 111.039 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -77.26 112.7 25.16 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.548 -0.72 . . . . 0.0 109.636 168.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.6 175.01 11.78 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.936 2.424 . . . . 0.0 113.298 -171.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.66 121.98 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 126.822 2.049 . . . . 0.0 107.716 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.16 98.09 0.97 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.441 1.096 . . . . 0.0 109.578 168.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.1 t -98.9 -15.59 19.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.873 1.269 . . . . 0.0 112.573 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.23 133.62 55.88 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.927 1.691 . . . . 0.0 106.582 156.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -65.65 -16.98 64.26 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.604 -1.31 . . . . 0.0 114.093 -169.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -88.52 3.75 49.16 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.957 1.703 . . . . 0.0 113.584 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -53.05 135.61 36.88 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.717 -1.24 . . . . 0.0 113.313 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.21 146.7 52.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.542 1.537 . . . . 0.0 110.952 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.9 p -159.35 146.54 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -157.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -71.95 128.09 34.63 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.051 2.54 . . . . 0.0 110.053 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 13.8 mt -136.1 142.33 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.258 0.552 . . . . 0.0 109.767 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . 0.477 ' H ' HG22 ' A' ' 351' ' ' THR . 22.7 mt-10 -114.54 140.67 48.57 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.692 1.197 . . . . 0.0 110.031 167.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.58 160.54 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.257 1.023 . . . . 0.0 111.448 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -132.38 104.28 13.54 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 126.146 1.778 . . . . 0.0 109.443 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.81 164.26 32.16 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.62 1.547 . . . . 0.0 109.985 159.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -70.5 -176.67 1.78 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.367 2.045 . . . . 0.0 110.347 160.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -57.23 149.27 20.32 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.526 -0.734 . . . . 0.0 111.096 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 89.4 -162.33 30.6 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 122.39 0.994 . . . . 0.0 115.292 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.33 158.64 33.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.663 1.985 . . . . 0.0 113.836 -167.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.5 m -169.28 161.0 9.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.38 1.472 . . . . 0.0 112.755 171.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -124.7 113.1 17.54 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.961 2.104 . . . . 0.0 106.879 161.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.6 mm -71.58 130.01 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.74 130.71 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.48 1.112 . . . . 0.0 109.375 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.2 104.08 14.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 125.474 1.509 . . . . 0.0 107.566 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 115.21 175.32 18.38 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 123.307 1.504 . . . . 0.0 116.383 170.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.34 161.13 34.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.267 2.227 . . . . 0.0 110.396 172.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.03 179.77 37.33 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.789 0.709 . . . . 0.0 112.751 -167.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -56.05 -25.72 46.08 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.216 -1.167 . . . . 0.0 112.321 172.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.3 m -58.41 -8.34 1.16 Allowed 'General case' 0 C--O 1.235 0.339 0 C-N-CA 130.209 3.404 . . . . 0.0 117.337 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -85.79 149.89 24.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.323 0.965 . . . . 0.0 112.424 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 41.3 mt -119.22 166.87 12.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.969 0.908 . . . . 0.0 111.149 171.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 10.8 t -140.59 157.2 45.83 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 171.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -139.0 125.91 21.02 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.892 1.677 . . . . 0.0 109.522 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -70.64 131.49 44.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 111.897 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -144.22 126.69 15.9 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.825 0.85 . . . . 0.0 111.529 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -108.99 130.26 55.47 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -96.9 148.39 22.99 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 11.9 pm0 -43.7 125.71 4.23 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.381 1.872 . . . . 0.0 113.572 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 125.95 4.49 6.62 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 118.24 2.056 . . . . 0.0 118.24 160.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 90.0 p -120.96 -83.22 0.66 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.391 2.096 . . . . 0.0 112.299 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 81.1 p -91.98 -19.37 22.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.921 2.088 . . . . 0.0 113.205 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 17.8 tt -148.82 158.99 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.102 1.761 . . . . 0.0 110.138 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.02 -11.02 77.36 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.546 -1.141 . . . . 0.0 115.179 -174.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 6.8 tptp . . . . . 0 C--O 1.25 1.107 0 C-N-CA 127.062 2.145 . . . . 0.0 109.758 176.375 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 118.327 -0.844 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.2 p -115.63 -14.62 11.45 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -75.34 38.86 0.14 Allowed 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 73.7 mt -137.86 178.35 7.18 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.132 1.373 . . . . 0.0 111.686 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 14.7 m -40.67 -63.86 0.6 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 128.716 2.806 . . . . 0.0 115.436 -164.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.7 67.69 10.13 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.035 0.922 . . . . 0.0 111.072 -173.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.441 ' HA ' ' HE3' ' A' ' 293' ' ' LYS . 0.9 OUTLIER -149.16 99.6 2.96 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.728 0.811 . . . . 0.0 111.23 171.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 68.8 -21.94 0.33 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.772 1.653 . . . . 0.0 116.457 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.1 p -46.11 -63.08 1.07 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.91 2.484 . . . . 0.0 113.666 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 14.2 m -169.66 150.48 4.06 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.665 1.186 . . . . 0.0 112.54 167.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -162.6 154.0 17.86 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.094 1.758 . . . . 0.0 109.997 161.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.31 104.8 8.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 160.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.3 ptm -65.9 149.82 49.59 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.892 1.677 . . . . 0.0 115.157 -173.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.7 m -99.7 143.13 30.29 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.526 1.13 . . . . 0.0 110.125 165.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.9 p -138.81 21.69 2.67 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -96.48 163.57 12.99 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.298 0.954 . . . . 0.0 110.606 165.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -66.3 105.03 1.32 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.231 2.212 . . . . 0.0 112.453 -159.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.6 mmt -70.61 160.27 32.86 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.001 0.92 . . . . 0.0 112.818 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 29.0 m -156.53 148.75 23.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.208 -0.932 . . . . 0.0 111.991 162.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.28 125.99 33.99 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 168.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.7 -27.62 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.629 0.772 . . . . 0.0 110.144 164.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -139.25 120.36 14.64 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.011 2.124 . . . . 0.0 107.706 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -56.74 154.3 18.6 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.933 0.893 . . . . 0.0 111.609 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -57.56 125.52 19.04 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.317 2.011 . . . . 0.0 111.115 166.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 8.0 p -130.16 129.16 43.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.038 0.935 . . . . 0.0 112.759 169.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -56.42 122.65 12.39 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.327 1.851 . . . . 0.0 111.562 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 82.2 p -78.07 -12.08 59.96 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.774 1.23 . . . . 0.0 113.191 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.66 -11.43 3.3 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.474 1.035 . . . . 0.0 113.796 -167.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -87.37 2.49 50.19 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.436 1.494 . . . . 0.0 112.239 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 101.52 9.72 43.15 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.241 1.401 . . . . 0.0 113.848 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.0 p -131.03 166.45 20.99 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.908 1.283 . . . . 0.0 112.12 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.64 120.38 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 126.75 2.02 . . . . 0.0 107.626 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.2 p -106.01 137.17 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.452 1.101 . . . . 0.0 112.655 -171.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -143.84 164.75 29.64 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.555 1.942 . . . . 0.0 113.45 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -123.87 127.0 47.39 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.136 1.774 . . . . 0.0 107.849 164.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.95 147.6 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.654 0.782 . . . . 0.0 111.695 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -124.62 144.11 50.35 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.539 1.935 . . . . 0.0 110.429 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 7.6 p -118.13 150.78 48.14 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.414 1.886 . . . . 0.0 107.943 163.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 72.2 Cg_endo -110.03 -50.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 0 CA-C-N 122.203 1.822 . . . . 0.0 116.7 -165.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.89 169.21 19.61 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.049 1.295 . . . . 0.0 113.327 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.04 -15.62 0.08 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 128.182 2.801 . . . . 0.0 118.648 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -104.29 108.03 59.18 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 119.711 1.755 . . . . 0.0 113.822 -166.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.99 121.51 2.81 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.845 3.03 . . . . 0.0 109.904 155.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 8.1 p -162.77 149.42 12.85 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.36 108.45 16.56 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 161.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.296 0.5 OUTLIER -67.01 119.84 67.33 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.505 -153.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.53 114.32 3.68 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.141 2.561 . . . . 0.0 111.295 -171.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 349' ' ' LEU . 52.4 t -116.18 114.48 46.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.365 1.466 . . . . 0.0 109.542 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.83 159.4 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.926 1.691 . . . . 0.0 108.835 -175.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.1 t -146.05 122.56 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -156.22 166.69 32.69 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -168.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -90.59 -5.33 56.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -114.87 6.15 15.35 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.618 1.567 . . . . 0.0 114.252 -160.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 25.4 mt 64.94 -7.96 0.25 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.25 2.22 . . . . 0.0 115.175 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.2 t -122.71 -12.07 8.13 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.191 1.359 . . . . 0.0 114.343 -172.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 82.37 35.48 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.498 2.719 . . . . 0.0 113.261 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.68 67.32 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.093 0.557 . . . . 0.0 111.389 170.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.84 159.47 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.746 1.218 . . . . 0.0 108.227 162.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.12 123.46 16.96 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.328 -1.482 . . . . 0.0 110.903 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -128.2 -17.59 4.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -159.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -145.69 151.28 23.51 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 115.861 1.104 . . . . 0.0 115.861 -166.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.3 147.2 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.538 1.535 . . . . 0.0 111.921 -163.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 334' ' ' VAL . 2.7 mm? -67.84 112.39 4.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.816 2.047 . . . . 0.0 109.399 171.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.49 -33.75 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.021 0.528 . . . . 0.0 110.938 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.1 t -96.61 179.27 5.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.035 0.934 . . . . 0.0 111.172 167.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.48 125.72 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.062 1.345 . . . . 0.0 110.662 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -66.69 113.37 12.69 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 118.427 0.558 . . . . 0.0 110.757 171.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.8 179.63 6.11 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.142 2.561 . . . . 0.0 113.781 -171.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.09 130.28 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 127.023 2.129 . . . . 0.0 108.038 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -78.45 96.76 5.46 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.852 1.261 . . . . 0.0 109.206 166.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -97.21 -18.64 19.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.55 1.14 . . . . 0.0 112.481 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.89 135.95 51.83 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 155.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -66.67 -14.24 62.23 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.774 -1.204 . . . . 0.0 113.913 -171.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -89.01 0.42 56.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.683 1.993 . . . . 0.0 113.499 174.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -53.89 138.27 36.8 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.612 1.196 . . . . 0.0 113.079 -172.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.42 142.05 49.11 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.921 1.288 . . . . 0.0 111.053 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.4 p -154.93 145.48 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -158.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -76.26 126.29 30.72 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.101 2.96 . . . . 0.0 110.563 173.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 59.1 mt -137.61 137.14 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.248 0.619 . . . . 0.0 110.757 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -107.17 140.29 40.27 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.849 1.26 . . . . 0.0 111.019 161.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.23 158.34 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.249 1.02 . . . . 0.0 112.702 171.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -111.27 114.32 53.41 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.362 1.865 . . . . 0.0 110.526 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -76.82 174.02 13.53 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 124.063 3.175 . . . . 0.0 111.182 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.54 -174.4 2.25 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.4 2.067 . . . . 0.0 110.463 159.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -67.5 146.01 54.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 154.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 84.8 -159.85 34.93 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 122.043 0.802 . . . . 0.0 114.752 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.48 157.39 30.47 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.911 2.084 . . . . 0.0 113.994 -166.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.0 m -170.57 171.91 6.16 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.431 1.892 . . . . 0.0 112.051 170.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.34 125.83 46.78 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 126.801 2.04 . . . . 0.0 108.314 158.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.2 mm -77.65 119.78 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.5 mt -111.24 128.37 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.317 1.447 . . . . 0.0 109.819 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 66.6 t -116.19 107.47 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.466 1.907 . . . . 0.0 108.189 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.25 177.78 24.25 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 122.449 1.027 . . . . 0.0 114.94 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.48 169.82 16.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.213 1.805 . . . . 0.0 111.382 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 83.86 -157.39 33.93 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.922 0.772 . . . . 0.0 112.345 -172.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -72.9 -33.08 65.79 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.555 -0.968 . . . . 0.0 110.975 163.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 28.6 m -59.87 -6.96 1.44 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 130.005 3.322 . . . . 0.0 117.741 -173.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -80.25 153.73 28.33 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.876 1.27 . . . . 0.0 111.467 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 46.0 mt -121.48 165.24 15.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.382 0.673 . . . . 0.0 110.464 170.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.1 t -150.42 160.54 43.68 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -140.82 124.93 17.34 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.036 1.734 . . . . 0.0 110.077 -175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -67.77 133.44 49.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.035 1.334 . . . . 0.0 111.711 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -133.11 152.5 51.95 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.165 0.986 . . . . 0.0 111.545 170.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -134.58 136.81 43.24 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 173.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -117.54 130.85 56.67 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 124.217 1.007 . . . . 0.0 109.135 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -22.91 105.05 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 129.814 3.245 . . . . 0.0 115.247 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 133.43 17.69 1.08 Allowed Glycine 0 CA--C 1.534 1.247 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 167.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 94.0 p -133.22 -101.98 0.26 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 120.803 2.302 . . . . 0.0 112.775 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 92.0 p -70.49 -19.29 62.95 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.535 1.934 . . . . 0.0 112.77 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 16.3 tt -147.49 160.71 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 126.533 1.933 . . . . 0.0 110.063 175.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.86 -11.97 64.68 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.335 -1.258 . . . . 0.0 115.081 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 6.8 tptp . . . . . 0 C--O 1.249 1.062 0 C-N-CA 127.301 2.24 . . . . 0.0 109.501 176.251 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 8.4 mmt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 118.474 -0.774 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 26.1 p -101.0 -13.36 18.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.528 1.531 . . . . 0.0 114.274 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.21 -7.04 20.81 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.21 129.2 38.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.019 1.328 . . . . 0.0 109.275 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 21.6 p -43.04 -56.54 3.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.926 1.69 . . . . 0.0 113.162 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 31.3 tp -55.74 -16.58 4.51 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.446 ' HE2' HD21 ' A' ' 345' ' ' ASN . 25.8 mmmt -104.13 70.21 0.97 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.672 1.589 . . . . 0.0 111.209 -171.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 78.82 -25.68 2.5 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.06 1.79 . . . . 0.0 114.804 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 10.0 m -76.13 -42.13 47.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -168.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.8 m -171.94 120.06 0.44 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.178 1.391 . . . . 0.0 113.384 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -153.71 155.35 35.8 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.322 1.849 . . . . 0.0 109.073 167.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.49 100.01 1.04 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 160.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.02 136.53 56.3 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.517 1.927 . . . . 0.0 113.888 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 22.1 m -87.53 135.41 33.36 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 153.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 68.3 p -138.12 -0.89 2.0 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 174.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.64 166.63 20.32 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 120.101 1.319 . . . . 0.0 110.498 164.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -67.08 101.03 0.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.713 1.605 . . . . 0.0 112.438 -165.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 37.9 mtm -90.51 165.07 13.99 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.778 1.231 . . . . 0.0 111.837 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.0 m -161.28 161.01 30.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.148 -0.97 . . . . 0.0 112.491 167.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.7 125.54 29.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.982 0.513 . . . . 0.0 109.952 161.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 81.2 t -76.9 -25.56 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.436 1.494 . . . . 0.0 110.677 165.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -137.61 131.24 31.29 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.191 1.796 . . . . 0.0 107.925 164.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -59.9 151.39 64.67 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.097 0.559 . . . . 0.0 111.858 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -55.74 130.21 39.17 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.383 2.056 . . . . 0.0 111.498 166.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 16.5 p -120.5 125.0 46.76 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.506 1.522 . . . . 0.0 110.629 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -55.75 118.07 4.22 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.567 1.147 . . . . 0.0 110.067 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.3 p -79.53 -16.38 56.08 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 60.31 -0.39 0.94 Allowed Glycine 0 CA--C 1.539 1.581 0 CA-C-N 119.467 1.03 . . . . 0.0 115.057 -161.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -86.46 18.15 3.43 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.284 1.542 . . . . 0.0 110.652 174.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.34 -2.84 87.94 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.771 1.177 . . . . 0.0 114.1 -168.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 25.0 p -122.47 175.37 6.49 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.043 1.421 . . . . 0.0 113.608 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.3 t -136.7 125.11 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 127.043 2.137 . . . . 0.0 107.938 172.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 p -114.84 131.72 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.903 1.281 . . . . 0.0 113.531 -169.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -140.73 169.37 17.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.7 2.0 . . . . 0.0 113.526 -175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.27 135.73 52.81 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.361 1.064 . . . . 0.0 108.411 164.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.95 152.77 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.247 1.019 . . . . 0.0 112.412 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -137.53 150.94 47.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.685 1.194 . . . . 0.0 113.008 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.2 t -119.66 141.13 30.5 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 128.243 2.617 . . . . 0.0 107.947 169.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -97.4 -67.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.88 2.387 . . . . 0.0 115.313 -174.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 174.87 10.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.88 1.272 . . . . 0.0 112.881 -173.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.9 -12.43 0.81 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.504 2.002 . . . . 0.0 117.712 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -123.58 96.62 43.23 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 119.525 1.663 . . . . 0.0 113.797 -160.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.81 120.5 6.43 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.84 1.693 . . . . 0.0 109.084 155.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.7 p -162.62 150.62 14.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -171.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.3 mmmt -83.8 97.36 9.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.535 1.534 . . . . 0.0 107.265 162.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.252 1.2 pp -58.1 112.11 4.42 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.578 0.751 . . . . 0.0 111.87 -159.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.29 117.1 4.95 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.706 2.271 . . . . 0.0 112.991 -170.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 88.0 t -120.4 120.59 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 126.2 1.8 . . . . 0.0 108.765 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.26 160.01 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.035 1.734 . . . . 0.0 109.454 -175.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 3.9 t -138.53 113.62 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.82 -176.83 4.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.697 0.799 . . . . 0.0 112.163 -168.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -115.74 6.59 14.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.325 1.05 . . . . 0.0 112.194 171.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -131.87 1.48 3.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -152.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 16.1 mt 64.48 0.11 1.02 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.304 2.242 . . . . 0.0 115.198 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.5 t -135.84 -6.16 2.16 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -170.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 57.54 48.29 14.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.552 1.941 . . . . 0.0 113.645 -174.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.78 66.28 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.102 0.561 . . . . 0.0 110.012 159.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 8.9 mm -101.99 147.15 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 126.054 1.741 . . . . 0.0 108.479 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.446 HD21 ' HE2' ' A' ' 293' ' ' LYS . 11.3 t30 -126.05 108.35 11.29 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.431 -0.793 . . . . 0.0 111.847 163.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -66.4 -69.83 0.28 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 128.352 2.661 . . . . 0.0 111.425 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -100.33 169.32 21.51 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 -160.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.2 mp -115.82 154.99 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 128.0 2.52 . . . . 0.0 110.193 -169.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.47 134.94 40.71 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.115 0.966 . . . . 0.0 109.931 168.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.0 t -103.88 -47.08 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.382 0.673 . . . . 0.0 110.944 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 366' ' ' GLU . 3.6 t -92.42 172.57 8.3 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.652 0.739 . . . . 0.0 111.647 168.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.2 m -66.64 126.36 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.118 1.367 . . . . 0.0 112.667 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.04 126.59 64.93 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.978 1.311 . . . . 0.0 110.099 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -80.98 -172.54 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.027 3.152 . . . . 0.0 112.926 -173.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.08 119.22 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 127.112 2.165 . . . . 0.0 107.451 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.78 90.16 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.377 1.071 . . . . 0.0 110.685 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 10.7 t -73.92 -37.94 64.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.733 -0.604 . . . . 0.0 110.247 159.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 39.7 p -102.37 123.46 46.2 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.389 1.875 . . . . 0.0 109.192 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -54.73 -19.8 7.03 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.9 5.98 8.6 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.605 1.562 . . . . 0.0 113.708 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -43.67 134.28 4.29 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.529 1.932 . . . . 0.0 114.203 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -150.88 129.62 12.36 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.846 1.658 . . . . 0.0 110.067 -167.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.3 p -154.16 145.77 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -166.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -78.68 123.03 26.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.484 2.714 . . . . 0.0 109.473 165.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 40.6 mt -129.16 144.21 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 118.464 0.574 . . . . 0.0 111.519 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . 0.595 ' H ' HG22 ' A' ' 351' ' ' THR . 21.6 mt-10 -118.9 140.38 50.08 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.649 1.58 . . . . 0.0 110.947 164.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 28.9 m -126.2 160.46 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.074 1.35 . . . . 0.0 111.515 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -130.95 98.58 18.98 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.697 1.999 . . . . 0.0 109.788 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.17 166.65 16.32 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.33 2.687 . . . . 0.0 111.375 162.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.77 175.07 7.71 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.885 2.39 . . . . 0.0 110.857 163.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.82 154.35 30.18 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.842 -0.536 . . . . 0.0 111.04 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 91.03 -163.25 29.15 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 121.404 0.447 . . . . 0.0 113.24 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -66.03 157.12 31.79 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -168.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 20.5 m -168.03 164.62 13.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.061 1.744 . . . . 0.0 112.086 168.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -128.25 111.45 13.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.887 2.875 . . . . 0.0 107.543 166.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 1.8 mm -74.37 124.38 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 79.9 mt -113.58 129.83 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.835 1.254 . . . . 0.0 108.91 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.65 109.38 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 125.282 1.433 . . . . 0.0 107.863 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 107.52 177.89 22.48 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 123.363 1.535 . . . . 0.0 115.747 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.4 163.93 28.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 127.669 2.387 . . . . 0.0 110.78 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.54 -179.97 36.05 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.199 0.428 . . . . 0.0 112.241 -166.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -56.81 -27.38 59.87 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.279 1.031 . . . . 0.0 112.375 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 46.6 m -58.95 -7.61 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.567 3.147 . . . . 0.0 116.651 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -81.15 149.07 29.28 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.503 1.121 . . . . 0.0 112.299 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 27.6 mt -118.69 165.22 14.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.957 0.903 . . . . 0.0 111.315 171.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.6 t -148.49 162.12 40.26 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -144.24 127.75 16.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.872 2.069 . . . . 0.0 110.14 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -75.21 135.83 41.01 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.817 1.647 . . . . 0.0 112.548 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -134.38 157.2 47.02 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.631 1.173 . . . . 0.0 111.763 169.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -129.65 107.45 9.45 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.844 1.657 . . . . 0.0 106.922 173.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -93.12 126.11 38.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.092 1.357 . . . . 0.0 112.709 -160.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 50.71 102.73 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 129.328 3.051 . . . . 0.0 114.845 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -61.81 70.3 0.02 OUTLIER Glycine 0 CA--C 1.533 1.161 0 C-N-CA 128.324 2.869 . . . . 0.0 115.321 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 27.1 t -54.92 8.74 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 130.269 3.428 . . . . 0.0 116.902 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 33.5 t -128.5 1.17 5.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.234 1.814 . . . . 0.0 113.646 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 11.2 tt -144.48 -17.48 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 143.82 -48.27 0.75 Allowed Glycine 0 CA--C 1.53 0.992 0 CA-C-N 119.414 1.007 . . . . 0.0 113.754 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.003 0 C-N-CA 127.007 2.123 . . . . 0.0 108.504 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 33.9 m -93.36 10.3 32.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.967 1.307 . . . . 0.0 113.125 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -103.29 6.5 38.08 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.434 1.494 . . . . 0.0 114.803 -166.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 91.1 mt -120.61 159.23 25.7 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.139 0.976 . . . . 0.0 111.068 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 29.4 p -42.69 -73.44 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.778 2.431 . . . . 0.0 113.152 -168.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 19.8 tp -65.66 3.8 0.69 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 128.563 2.745 . . . . 0.0 113.887 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.53 71.64 1.3 Allowed 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.073 -1.642 . . . . 0.0 109.824 -171.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.79 -23.38 1.32 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.478 1.514 . . . . 0.0 115.661 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 46.7 m -67.62 -61.81 1.71 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.388 1.594 . . . . 0.0 112.502 -173.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 9.5 m -174.73 134.53 0.37 Allowed 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 119.573 1.079 . . . . 0.0 112.844 174.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -162.08 153.52 18.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.76 2.024 . . . . 0.0 109.591 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -73.28 101.68 3.47 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 164.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -82.11 165.91 20.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.54 1.536 . . . . 0.0 113.679 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.7 m -101.6 152.49 20.75 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.523 1.529 . . . . 0.0 109.86 167.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.7 p -142.67 6.44 1.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.47 160.92 31.87 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.096 1.316 . . . . 0.0 110.966 165.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.06 97.01 0.05 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.212 1.405 . . . . 0.0 112.39 -171.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 34.2 mtm -84.99 169.0 14.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.021 1.328 . . . . 0.0 111.708 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.1 m -159.78 158.37 31.04 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.176 -0.953 . . . . 0.0 112.515 170.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.12 123.56 28.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.554 0.742 . . . . 0.0 110.111 161.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.68 -25.03 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.514 1.126 . . . . 0.0 110.574 165.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -141.88 137.75 31.6 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.685 1.994 . . . . 0.0 109.16 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -62.9 143.99 97.07 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.994 1.317 . . . . 0.0 112.989 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -54.64 124.8 17.08 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.52 2.813 . . . . 0.0 112.542 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 10.2 p -123.53 130.07 52.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.132 1.373 . . . . 0.0 111.802 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -57.83 123.27 15.19 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.846 0.858 . . . . 0.0 111.005 171.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 26.8 p -80.64 -11.72 59.6 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.841 1.256 . . . . 0.0 113.085 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 84.0 -11.16 58.34 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.863 1.221 . . . . 0.0 114.341 -169.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -92.59 10.13 31.75 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.176 1.488 . . . . 0.0 112.509 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.47 13.19 71.1 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.848 0.737 . . . . 0.0 113.216 -169.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 11.6 p -124.63 153.76 41.76 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.964 1.306 . . . . 0.0 110.959 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 26.0 t -128.48 118.16 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.869 1.668 . . . . 0.0 107.94 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.2 p -112.04 133.8 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.069 1.348 . . . . 0.0 113.299 -163.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 7.0 ptp -137.53 165.51 26.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.84 2.056 . . . . 0.0 112.023 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -115.69 133.96 55.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 163.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 6.8 m -136.41 149.01 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.543 1.137 . . . . 0.0 112.213 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -132.92 149.52 52.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.939 1.696 . . . . 0.0 112.621 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 8.2 t -119.1 151.93 51.33 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 127.644 2.378 . . . . 0.0 108.796 169.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 1.1 Cg_endo -103.05 -76.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.305 0 C-N-CA 123.255 2.637 . . . . 0.0 115.127 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.65 165.12 27.75 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 121.221 1.828 . . . . 0.0 114.465 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 70.89 15.59 74.04 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.255 0.931 . . . . 0.0 114.946 172.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.57 87.1 56.89 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 112.44 -164.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -79.74 114.31 3.18 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.028 2.485 . . . . 0.0 108.974 159.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.4 p -163.02 155.23 18.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -171.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -79.12 109.02 13.05 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 154.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.271 1.1 pp -64.34 122.96 81.06 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.993 -162.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.423 ' HG2' ' HA2' ' A' ' 379' ' ' GLY . 73.8 Cg_endo -73.63 106.16 2.14 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 124.449 3.433 . . . . 0.0 113.334 -163.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 72.2 t -116.16 118.04 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 126.36 1.864 . . . . 0.0 109.844 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.47 158.65 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.934 1.294 . . . . 0.0 110.837 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 37.0 t -135.14 123.55 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.76 170.25 16.24 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -105.09 3.83 30.82 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.989 1.316 . . . . 0.0 112.039 169.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -129.4 10.75 5.76 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.732 1.613 . . . . 0.0 114.761 -161.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 46.9 mt 63.48 -10.83 0.11 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.692 2.397 . . . . 0.0 116.344 -175.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.5 t -127.93 -6.94 5.53 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.934 1.697 . . . . 0.0 114.594 -171.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.98 42.61 7.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.736 2.015 . . . . 0.0 112.87 -170.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -61.15 -31.27 70.99 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.726 159.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 7.9 mt -117.93 128.98 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 127.909 2.483 . . . . 0.0 107.199 167.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -95.52 108.57 20.83 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.192 0.905 . . . . 0.0 110.32 164.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -66.24 -57.85 6.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.791 2.036 . . . . 0.0 111.947 176.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -111.34 -177.46 20.35 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 -159.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.05 152.77 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.336 1.454 . . . . 0.0 111.438 -172.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.36 130.12 35.13 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.568 1.147 . . . . 0.0 109.51 169.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.79 -53.41 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 117.891 0.314 . . . . 0.0 111.032 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.2 m -83.66 153.19 24.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.923 0.889 . . . . 0.0 110.393 168.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 6.0 m -53.1 117.36 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.362 2.265 . . . . 0.0 114.989 -173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -82.79 118.85 73.11 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.763 1.225 . . . . 0.0 110.321 168.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.49 -177.32 3.78 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 124.549 3.5 . . . . 0.0 113.423 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.33 112.74 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.27 1.428 . . . . 0.0 107.223 167.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.2 85.23 0.37 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.15 1.38 . . . . 0.0 110.782 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 34.8 t -66.4 -58.6 4.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.936 0.494 . . . . 0.0 109.745 166.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 25.2 p -78.91 122.88 26.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.098 1.359 . . . . 0.0 109.963 163.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -62.54 -21.85 65.86 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.04 4.06 4.73 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.963 1.305 . . . . 0.0 113.519 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -42.32 129.4 3.85 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.72 2.008 . . . . 0.0 113.171 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.98 128.37 20.01 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.943 1.297 . . . . 0.0 110.309 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.2 p -149.29 150.79 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.583 0.706 . . . . 0.0 112.625 -159.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -89.12 121.74 31.74 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.298 2.639 . . . . 0.0 109.35 171.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 43.8 mt -135.31 146.86 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.444 0.698 . . . . 0.0 111.516 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -111.97 143.34 43.12 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.004 1.722 . . . . 0.0 111.624 167.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.78 149.15 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 123.513 0.725 . . . . 0.0 111.424 164.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -97.76 110.2 54.29 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.27 1.428 . . . . 0.0 109.466 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.8 126.03 6.37 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.979 2.452 . . . . 0.0 110.225 164.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.1 167.22 2.59 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.369 2.046 . . . . 0.0 111.444 155.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -60.26 155.79 16.91 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.429 0.633 . . . . 0.0 112.62 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.95 -169.88 39.03 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 123.007 1.337 . . . . 0.0 113.914 -173.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.57 163.01 9.55 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.151 1.78 . . . . 0.0 113.775 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 35.9 m -164.07 148.8 10.22 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.637 -1.289 . . . . 0.0 113.231 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -113.11 111.08 21.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.422 2.289 . . . . 0.0 106.87 161.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.4 mm -74.77 120.49 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 32.0 mt -117.7 126.59 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 122.273 1.035 . . . . 0.0 109.405 -171.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 54.9 t -118.02 99.29 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 127.361 2.265 . . . . 0.0 107.217 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.423 ' HA2' ' HG2' ' A' ' 333' ' ' PRO . . . 118.73 170.54 14.8 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 122.981 1.323 . . . . 0.0 115.502 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.49 165.55 24.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.514 2.326 . . . . 0.0 109.556 166.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.28 -172.66 55.11 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 123.211 0.434 . . . . 0.0 112.163 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -60.35 -32.3 71.13 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.324 -1.104 . . . . 0.0 111.708 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.9 m -56.58 -4.3 0.15 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 130.338 3.455 . . . . 0.0 117.782 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -86.96 144.09 27.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.129 0.877 . . . . 0.0 111.816 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.99 165.94 11.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.884 0.873 . . . . 0.0 110.142 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.2 t -146.97 158.71 44.0 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 169.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -139.92 131.51 27.16 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.642 1.977 . . . . 0.0 108.63 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.68 141.3 32.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.764 1.226 . . . . 0.0 111.739 -171.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -140.0 146.92 39.69 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.162 1.385 . . . . 0.0 109.578 170.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -122.77 105.78 10.34 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 20.3 tptt -89.3 141.68 28.32 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 392' ' ' GLU . 0.0 OUTLIER -40.74 124.38 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.082 2.553 . . . . 0.0 113.286 -172.451 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 100.76 19.96 16.03 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.545 1.545 . . . . 0.0 113.893 -163.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 85.5 p -87.6 163.19 16.74 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -171.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 95.9 p -50.7 -37.17 39.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 127.367 2.267 . . . . 0.0 114.455 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 24.7 pt -76.47 -0.42 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.16 1.384 . . . . 0.0 113.426 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 88.14 12.36 65.78 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.771 -1.016 . . . . 0.0 114.048 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.484 0 C-N-CA 125.047 1.339 . . . . 0.0 109.435 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 118.8 -0.619 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 33.4 p -102.6 -7.52 21.73 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.603 1.561 . . . . 0.0 114.572 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.02 -24.89 66.84 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -171.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 37.4 tp -82.32 139.44 34.14 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.049 0.94 . . . . 0.0 110.048 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 38.0 p -33.52 -67.98 0.12 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.017 2.527 . . . . 0.0 114.52 -174.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -6.93 7.04 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.317 1.447 . . . . 0.0 114.431 -174.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.03 68.44 3.77 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 120.467 -1.395 . . . . 0.0 110.925 -173.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 79.8 -53.26 4.3 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.2 0.905 . . . . 0.0 112.143 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 90.8 m -48.4 -37.63 17.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 128.382 2.673 . . . . 0.0 115.498 -171.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 36.7 m -161.25 103.44 1.26 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 120.304 1.411 . . . . 0.0 113.118 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -151.94 153.02 33.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.434 1.094 . . . . 0.0 110.995 163.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 112.05 23.83 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.186 1.794 . . . . 0.0 107.072 165.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -61.08 142.67 56.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.975 1.71 . . . . 0.0 115.054 -174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 4.5 m -94.8 148.77 21.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.818 0.847 . . . . 0.0 109.013 156.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.1 p -137.11 1.42 2.45 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 173.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -77.92 163.11 26.3 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.677 1.126 . . . . 0.0 110.958 168.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.44 98.81 0.51 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.148 1.779 . . . . 0.0 112.096 -164.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 32.5 mtm -84.54 166.29 17.33 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.736 1.214 . . . . 0.0 112.23 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.7 m -161.81 162.7 29.55 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.149 -0.969 . . . . 0.0 112.255 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.36 117.0 24.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.07 0.948 . . . . 0.0 110.602 164.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 74.7 t -68.25 -30.16 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.595 1.558 . . . . 0.0 110.684 167.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -136.16 118.37 15.54 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.165 1.786 . . . . 0.0 107.575 170.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -52.74 144.61 24.81 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.216 1.006 . . . . 0.0 111.24 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.09 130.78 37.95 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.325 1.35 . . . . 0.0 111.878 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.3 p -130.69 130.74 44.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.277 1.431 . . . . 0.0 111.2 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.4 140.21 58.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.735 1.214 . . . . 0.0 112.61 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 39.4 p -95.79 -9.85 30.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.851 1.26 . . . . 0.0 113.996 -174.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 68.11 -2.78 6.37 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 119.283 0.947 . . . . 0.0 115.231 -167.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -97.06 19.14 13.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.009 1.405 . . . . 0.0 111.43 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.02 0.43 88.97 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.817 1.199 . . . . 0.0 113.788 -171.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 22.3 p -121.76 169.75 10.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.526 1.163 . . . . 0.0 112.547 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.8 t -140.63 124.5 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.23 1.812 . . . . 0.0 108.287 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.82 134.16 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.665 1.186 . . . . 0.0 112.308 -170.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -142.57 168.7 19.11 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.583 1.953 . . . . 0.0 113.062 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -122.42 131.93 54.11 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.182 1.393 . . . . 0.0 107.932 164.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.58 153.27 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.057 0.943 . . . . 0.0 111.582 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -136.98 146.22 45.1 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.426 1.49 . . . . 0.0 112.89 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.27 149.91 42.22 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 128.483 2.713 . . . . 0.0 107.735 164.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -107.04 -57.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.354 2.036 . . . . 0.0 115.594 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.22 170.68 15.29 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.949 -1.094 . . . . 0.0 112.966 -176.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 69.21 -3.81 7.03 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.292 1.901 . . . . 0.0 117.718 168.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.97 99.59 41.02 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 119.248 1.524 . . . . 0.0 113.579 -163.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.07 112.27 2.56 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.67 2.913 . . . . 0.0 109.417 157.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.2 p -157.61 155.48 30.18 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -87.65 93.36 9.41 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.793 2.037 . . . . 0.0 106.695 162.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.254 1.4 pp -56.93 111.69 3.65 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.526 0.73 . . . . 0.0 112.456 -155.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.34 115.75 3.06 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 123.096 2.531 . . . . 0.0 114.197 -167.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 82.0 t -122.73 109.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.317 1.447 . . . . 0.0 109.71 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.93 162.77 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 125.663 1.585 . . . . 0.0 109.519 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.65 127.08 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -140.27 168.8 18.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.495 0.589 . . . . 0.0 112.352 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -102.13 -2.92 28.37 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.005 0.922 . . . . 0.0 111.851 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -106.07 0.49 25.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.582 1.953 . . . . 0.0 114.558 -168.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 34.4 mt 61.4 0.7 0.47 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.324 2.249 . . . . 0.0 115.967 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.1 t -127.99 -2.44 5.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.238 1.381 . . . . 0.0 114.515 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.524 ' HB3' HH22 ' A' ' 384' ' ' ARG . . . 62.55 45.04 6.48 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.802 2.441 . . . . 0.0 113.209 -172.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.86 -33.7 76.17 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 119.646 -0.216 . . . . 0.0 111.231 164.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 33.3 mt -131.9 117.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.346 1.458 . . . . 0.0 110.215 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -80.1 104.26 10.55 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.367 -0.833 . . . . 0.0 112.773 171.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -66.34 -56.09 12.8 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.585 2.354 . . . . 0.0 112.943 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -115.77 169.76 13.06 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 116.914 1.525 . . . . 0.0 116.914 -159.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.87 155.24 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.096 2.158 . . . . 0.0 111.863 -165.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.12 123.68 32.43 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.558 1.543 . . . . 0.0 108.723 166.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 93.3 t -89.47 -34.97 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.0 0.52 . . . . 0.0 111.446 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.0 t -113.3 175.12 5.58 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.213 1.005 . . . . 0.0 112.209 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.6 m -65.26 101.8 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.76 1.624 . . . . 0.0 112.474 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -63.09 125.31 86.59 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.854 165.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -82.09 -177.25 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.536 3.491 . . . . 0.0 114.007 -169.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.11 114.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 127.236 2.214 . . . . 0.0 107.674 171.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.86 75.39 0.11 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.837 1.655 . . . . 0.0 112.892 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -66.73 -11.46 54.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 169.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 31.5 p -134.52 127.34 31.16 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 127.846 2.458 . . . . 0.0 106.575 165.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -62.24 -15.29 46.1 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -170.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.79 5.98 10.08 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.237 1.815 . . . . 0.0 113.552 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -39.22 119.12 0.87 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 127.314 2.245 . . . . 0.0 113.584 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.57 144.59 50.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.057 0.943 . . . . 0.0 111.613 170.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.71 142.59 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -161.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.59 120.4 19.14 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.692 2.397 . . . . 0.0 109.455 165.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 48.0 mt -131.46 131.77 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.284 0.564 . . . . 0.0 110.732 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -96.51 139.8 32.07 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.989 0.916 . . . . 0.0 111.052 158.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.15 160.72 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.323 1.449 . . . . 0.0 110.957 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -125.41 92.87 46.09 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.068 1.747 . . . . 0.0 109.487 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.08 140.78 20.3 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.481 2.121 . . . . 0.0 109.987 160.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.35 179.93 3.65 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.812 2.341 . . . . 0.0 111.706 168.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -59.33 160.14 7.02 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.355 1.062 . . . . 0.0 113.444 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 86.83 -145.41 20.03 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.094 0.378 . . . . 0.0 112.193 -170.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -93.91 169.21 10.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.318 1.047 . . . . 0.0 113.653 -173.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 29.7 m -164.94 160.7 19.47 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.868 1.267 . . . . 0.0 112.423 168.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -129.05 109.4 11.16 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.636 1.974 . . . . 0.0 107.017 163.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.28 128.78 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 91.7 mt -119.42 125.65 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.122 1.369 . . . . 0.0 108.734 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.5 104.39 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.525 1.53 . . . . 0.0 108.02 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.32 -179.62 20.98 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 123.363 1.535 . . . . 0.0 116.644 171.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.95 170.0 16.82 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.581 2.752 . . . . 0.0 110.027 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 82.69 -158.6 37.32 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -168.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -72.82 -35.74 67.37 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.702 -0.881 . . . . 0.0 111.037 163.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.4 m -52.14 6.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 1 C-N-CA 132.202 4.201 . . . . 0.0 119.198 -176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . 0.524 HH22 ' HB3' ' A' ' 342' ' ' ALA . 0.5 OUTLIER -99.53 138.15 37.02 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.923 1.289 . . . . 0.0 111.808 -169.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.7 mt -107.76 166.55 10.61 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.027 0.531 . . . . 0.0 110.814 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.8 t -142.57 158.18 43.94 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 171.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -141.08 130.78 24.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.811 1.244 . . . . 0.0 110.948 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -64.41 137.13 57.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.439 2.296 . . . . 0.0 112.668 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -138.92 154.1 48.31 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.469 1.128 . . . . 0.0 113.012 163.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -138.27 121.49 16.93 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.86 2.064 . . . . 0.0 106.221 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -79.51 157.82 27.35 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.963 0.887 . . . . 0.0 111.645 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.14 155.38 11.29 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.799 1.639 . . . . 0.0 113.414 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 49.07 12.78 0.28 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 127.003 2.239 . . . . 0.0 116.764 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 53.9 p -148.64 -44.58 0.15 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.109 1.455 . . . . 0.0 114.006 -161.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 23.6 t -125.45 -27.04 3.49 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.09 0.859 . . . . 0.0 112.953 168.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.0 tt -131.93 172.64 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.905 0.882 . . . . 0.0 109.845 163.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -58.89 -65.33 3.56 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.921 0.772 . . . . 0.0 112.0 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? . . . . . 0 C--O 1.253 1.25 0 CA-C-O 116.489 -1.719 . . . . 0.0 109.697 170.437 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 118.333 -0.841 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.4 p -122.34 -6.93 8.76 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -170.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.92 22.02 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -170.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.36 174.68 7.18 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.978 1.263 . . . . 0.0 112.1 -176.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 11.0 p -46.88 -63.1 1.11 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.819 2.448 . . . . 0.0 115.166 -168.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.24 71.24 4.7 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.907 0.86 . . . . 0.0 110.769 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.509 ' HA ' ' HE3' ' A' ' 293' ' ' LYS . 0.5 OUTLIER -149.43 90.59 1.74 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.496 0.718 . . . . 0.0 112.156 176.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 67.82 -14.64 0.55 Allowed Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.585 1.564 . . . . 0.0 116.157 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 23.2 p -56.26 -68.06 0.24 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.212 2.605 . . . . 0.0 113.925 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 18.5 m -168.2 138.27 2.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.108 0.963 . . . . 0.0 112.686 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -164.26 147.96 9.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.402 1.881 . . . . 0.0 109.549 167.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 100.11 0.74 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 161.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 158.97 30.21 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.714 1.206 . . . . 0.0 114.08 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.4 m -105.71 137.63 43.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.709 1.204 . . . . 0.0 109.401 167.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.6 p -132.3 7.87 4.27 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -82.35 163.48 21.71 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.401 1.001 . . . . 0.0 110.735 165.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -62.22 109.04 1.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.613 1.965 . . . . 0.0 111.584 -165.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 15.1 mmt -72.99 159.27 33.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.769 0.795 . . . . 0.0 112.729 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.5 p -150.8 150.78 31.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.2 1.0 . . . . 0.0 111.134 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.3 119.44 35.83 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.651 0.78 . . . . 0.0 109.074 163.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -25.28 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.869 0.868 . . . . 0.0 110.425 165.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -142.31 127.84 19.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.911 2.084 . . . . 0.0 108.49 168.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -60.61 144.31 89.25 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.503 1.121 . . . . 0.0 111.443 171.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -54.79 136.57 72.2 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.22 1.947 . . . . 0.0 111.285 173.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 64.5 p -134.87 126.17 28.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.316 1.046 . . . . 0.0 111.198 171.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -55.76 119.18 5.34 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.327 1.451 . . . . 0.0 110.823 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 65.1 p -80.72 -12.59 59.44 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.906 0.883 . . . . 0.0 112.975 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.83 -7.49 1.54 Allowed Glycine 0 CA--C 1.538 1.494 0 CA-C-O 119.073 -0.848 . . . . 0.0 114.456 -166.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -81.77 2.66 28.97 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.352 1.576 . . . . 0.0 111.965 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.82 9.61 54.11 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.246 1.403 . . . . 0.0 113.677 -170.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.9 p -131.84 165.96 22.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.887 1.275 . . . . 0.0 112.874 -172.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.32 117.99 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.542 2.337 . . . . 0.0 107.152 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.0 p -102.45 132.08 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.586 0.755 . . . . 0.0 112.508 -174.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -137.59 165.29 26.68 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.853 1.661 . . . . 0.0 112.82 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.18 128.24 48.06 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.525 1.53 . . . . 0.0 107.177 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.93 148.45 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.666 0.787 . . . . 0.0 112.005 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -137.12 134.43 36.41 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.592 1.557 . . . . 0.0 112.114 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 m -98.86 159.26 30.74 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.995 1.718 . . . . 0.0 110.735 164.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -112.56 -55.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.886 2.391 . . . . 0.0 116.146 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 172.12 13.68 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.713 1.142 . . . . 0.0 113.139 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.11 -21.12 0.16 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 127.776 2.607 . . . . 0.0 118.291 168.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.39 107.86 56.91 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 119.366 1.583 . . . . 0.0 113.332 -165.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.57 125.91 5.8 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.996 2.464 . . . . 0.0 109.366 152.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 10.7 p -161.85 148.02 13.69 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.78 107.08 15.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.228 1.811 . . . . 0.0 106.635 163.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.284 0.6 OUTLIER -68.31 128.7 93.11 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.03 -153.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.97 109.48 2.89 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.117 3.211 . . . . 0.0 112.014 -172.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 93.5 t -111.18 108.89 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.861 1.665 . . . . 0.0 110.255 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.71 157.86 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 125.2 1.4 . . . . 0.0 110.019 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.6 t -144.48 125.54 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -149.59 170.18 19.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.098 0.559 . . . . 0.0 112.436 -170.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -89.68 -1.09 57.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.434 1.094 . . . . 0.0 113.293 174.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -127.47 1.2 6.26 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -152.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.9 mt 61.8 -1.39 0.35 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.151 2.181 . . . . 0.0 115.392 -173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.7 t -129.91 -7.66 4.46 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -171.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 62.4 49.23 4.23 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.908 2.083 . . . . 0.0 114.096 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -78.24 -38.03 43.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.834 0.454 . . . . 0.0 110.379 158.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 67.0 mt -97.51 153.12 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 126.919 2.088 . . . . 0.0 108.284 170.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.59 125.83 18.65 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.65 -1.281 . . . . 0.0 112.555 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . 0.484 ' HE2' ' HG3' ' A' ' 370' ' ' PRO . 2.9 mmmm -129.7 -17.38 3.64 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -159.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -142.56 148.34 20.04 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 119.219 0.918 . . . . 0.0 114.813 -167.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.1 148.83 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.528 1.131 . . . . 0.0 113.095 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.14 115.47 3.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.33 2.652 . . . . 0.0 110.939 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 70.9 t -81.33 -38.41 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.074 0.949 . . . . 0.0 110.532 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 t -92.23 175.1 6.98 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 111.286 168.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.8 m -66.87 135.3 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.329 1.052 . . . . 0.0 111.052 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -66.39 113.54 13.14 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 121.608 -0.682 . . . . 0.0 111.558 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.58 175.8 10.62 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.282 2.655 . . . . 0.0 113.708 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.29 132.01 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.152 1.781 . . . . 0.0 109.062 -173.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -78.29 97.84 5.72 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.352 1.461 . . . . 0.0 109.797 166.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.0 t -92.5 -16.04 26.29 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.269 1.028 . . . . 0.0 112.618 170.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.27 135.38 54.73 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.716 2.006 . . . . 0.0 107.01 163.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -67.2 -14.82 63.27 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.563 -1.335 . . . . 0.0 114.443 -167.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.73 0.82 56.09 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.674 1.59 . . . . 0.0 113.146 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -53.18 138.51 31.49 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.743 -1.223 . . . . 0.0 113.28 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.11 142.63 49.57 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.939 1.296 . . . . 0.0 111.069 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.47 144.89 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -162.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -69.63 127.2 32.12 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.82 2.848 . . . . 0.0 110.195 169.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 18.0 mt -137.05 138.24 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.011 0.434 . . . . 0.0 110.308 168.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -110.19 143.43 40.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.201 1.001 . . . . 0.0 110.964 163.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.52 151.54 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.966 0.906 . . . . 0.0 112.406 173.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -94.23 115.93 65.81 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.438 1.895 . . . . 0.0 109.435 172.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.91 168.99 23.59 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.141 2.56 . . . . 0.0 111.07 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . 0.484 ' HG3' ' HE2' ' A' ' 346' ' ' LYS . 17.0 Cg_endo -75.7 -177.24 3.45 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.94 2.427 . . . . 0.0 109.813 163.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -75.05 152.56 38.64 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.293 -0.879 . . . . 0.0 109.639 149.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 75.32 -156.2 48.27 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 115.809 1.084 . . . . 0.0 115.809 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.97 145.83 55.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.255 2.622 . . . . 0.0 113.151 -166.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 6.2 m -179.24 160.46 1.03 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.709 1.603 . . . . 0.0 114.545 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -126.99 119.0 25.62 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 129.078 2.951 . . . . 0.0 108.586 170.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.2 mm -75.14 119.58 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.5 132.24 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 120.235 1.38 . . . . 0.0 110.076 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 58.3 t -121.6 106.49 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 126.069 1.748 . . . . 0.0 108.302 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 114.03 176.15 19.06 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 122.496 1.053 . . . . 0.0 115.234 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.63 166.4 23.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.851 2.061 . . . . 0.0 110.223 170.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.1 -175.65 45.14 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 123.09 0.376 . . . . 0.0 112.45 -165.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -58.55 -28.82 65.86 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.674 -0.897 . . . . 0.0 111.921 171.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 50.6 m -57.72 -10.44 1.62 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 130.106 3.362 . . . . 0.0 116.933 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -79.63 146.77 32.34 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.347 1.059 . . . . 0.0 112.039 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 44.3 mt -116.03 166.17 12.3 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.895 0.878 . . . . 0.0 110.513 172.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.2 t -152.5 161.37 42.68 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -139.66 131.78 28.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.625 1.57 . . . . 0.0 110.205 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -69.12 125.44 26.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.846 1.258 . . . . 0.0 111.264 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -137.29 90.44 2.52 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.5 1.12 . . . . 0.0 110.488 172.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -85.35 126.34 33.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -104.91 158.21 16.69 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.65 1.58 . . . . 0.0 109.533 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -42.38 124.51 2.89 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.172 1.789 . . . . 0.0 112.672 174.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 126.06 -0.53 7.71 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 167.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 91.7 p -135.47 -81.11 0.42 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 120.081 1.94 . . . . 0.0 112.45 170.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 67.6 p -104.09 0.77 30.1 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.105 1.762 . . . . 0.0 113.798 -170.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 7.4 tp -143.24 156.75 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.908 1.283 . . . . 0.0 110.323 167.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.19 -36.65 14.23 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.127 0.87 . . . . 0.0 113.492 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 5.8 tptp . . . . . 0 C--O 1.25 1.128 0 C-N-CA 128.577 2.751 . . . . 0.0 108.07 173.982 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 2.0 p -95.65 -7.9 36.27 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -170.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.6 21.98 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -165.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 51.8 tp -147.69 148.73 31.35 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.859 1.209 . . . . 0.0 112.188 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 72.6 p 23.28 -92.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 130.529 3.532 . . . . 0.0 116.98 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 11.6 tp -83.84 75.53 10.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.582 1.153 . . . . 0.0 112.026 -167.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.48 92.68 1.96 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.857 0.863 . . . . 0.0 111.425 171.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 67.7 -2.74 5.77 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.744 1.164 . . . . 0.0 115.757 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 1.5 p -64.42 -58.23 7.05 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.49 2.316 . . . . 0.0 112.592 -172.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.6 m -170.37 135.6 1.26 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.312 1.045 . . . . 0.0 112.365 171.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -163.83 143.22 8.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.613 1.165 . . . . 0.0 112.064 168.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 95.43 0.35 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 156.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -65.93 162.38 19.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.728 2.011 . . . . 0.0 114.275 -172.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 32.7 m -103.25 139.34 38.83 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.195 0.998 . . . . 0.0 110.558 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.2 p -138.76 7.12 2.5 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.663 1.356 . . . . 0.0 114.663 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.33 165.55 19.21 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.795 1.18 . . . . 0.0 110.634 163.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -66.98 95.01 0.36 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.673 1.989 . . . . 0.0 111.375 -169.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 23.8 mtm -76.75 170.18 16.93 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.118 1.367 . . . . 0.0 112.653 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.1 m -156.48 158.94 38.11 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.037 -1.039 . . . . 0.0 112.976 166.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.82 114.95 23.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.598 0.759 . . . . 0.0 109.745 162.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.8 -29.81 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.866 1.267 . . . . 0.0 110.318 168.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -140.77 132.47 27.28 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.634 1.974 . . . . 0.0 108.53 165.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -61.17 148.13 85.39 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.417 1.487 . . . . 0.0 112.846 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.67 130.27 37.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.886 2.391 . . . . 0.0 111.619 171.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.5 p -127.11 125.14 40.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.615 1.166 . . . . 0.0 111.29 173.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -60.03 126.44 27.56 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.301 1.44 . . . . 0.0 111.89 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -77.78 -16.15 58.59 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.326 1.451 . . . . 0.0 113.762 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.81 -5.79 5.7 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 118.937 -0.924 . . . . 0.0 114.139 -165.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -89.42 -2.24 58.33 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.201 1.501 . . . . 0.0 112.115 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 102.91 -1.73 48.16 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.233 1.396 . . . . 0.0 114.035 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 17.1 p -121.09 159.15 26.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.768 1.227 . . . . 0.0 111.679 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.3 123.74 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.484 1.914 . . . . 0.0 108.091 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.3 p -111.96 129.14 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.183 0.993 . . . . 0.0 113.418 -166.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -136.11 168.13 19.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.886 2.075 . . . . 0.0 113.071 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -125.84 129.17 48.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.796 1.238 . . . . 0.0 108.083 166.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.07 153.0 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 119.21 0.914 . . . . 0.0 112.528 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -141.65 146.68 36.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.706 1.602 . . . . 0.0 113.455 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.99 155.41 41.71 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.835 2.054 . . . . 0.0 109.702 160.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -109.18 -49.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.286 1.991 . . . . 0.0 116.46 -175.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 173.81 13.8 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.738 1.154 . . . . 0.0 112.79 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.11 0.83 10.5 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.439 1.971 . . . . 0.0 117.645 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -119.37 97.28 50.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 119.015 1.408 . . . . 0.0 113.868 -160.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -81.19 111.71 2.45 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.845 3.03 . . . . 0.0 109.88 152.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 7.5 p -159.68 153.47 22.95 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -81.37 110.45 16.81 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 159.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.263 1.3 pp -66.14 112.74 9.83 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 119.429 -0.319 . . . . 0.0 111.387 -162.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.84 113.88 3.72 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.908 2.406 . . . . 0.0 112.345 -165.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 94.8 t -112.35 108.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 126.171 1.788 . . . . 0.0 110.004 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.0 158.22 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.62 1.568 . . . . 0.0 110.168 -176.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 77.7 t -145.8 116.62 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -171.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -131.01 -179.17 5.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.172 0.989 . . . . 0.0 113.048 -165.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -111.07 -0.13 16.72 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.96 0.904 . . . . 0.0 112.33 163.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -123.35 6.72 9.03 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.751 1.621 . . . . 0.0 113.952 -159.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.2 mt 65.27 -6.02 0.4 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.252 2.221 . . . . 0.0 115.194 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -128.49 -3.08 5.48 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' A' ' 337' ' ' ALA . . . 68.33 37.43 2.76 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.825 2.05 . . . . 0.0 113.536 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.17 -49.07 68.65 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 165.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.46 150.39 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 126.626 1.97 . . . . 0.0 107.59 164.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.58 129.47 21.83 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.161 -0.962 . . . . 0.0 112.221 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -133.95 -8.55 2.71 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -160.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -127.72 130.14 6.63 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 116.482 1.353 . . . . 0.0 116.482 -164.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -89.12 157.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.12 1.368 . . . . 0.0 111.905 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.77 119.92 32.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.091 2.156 . . . . 0.0 109.177 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.41 -25.22 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.502 0.721 . . . . 0.0 112.187 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 366' ' ' GLU . 8.7 t -125.66 175.54 7.51 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.544 1.537 . . . . 0.0 111.084 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.78 107.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.155 1.782 . . . . 0.0 113.427 -175.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -71.55 113.53 20.47 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.826 1.25 . . . . 0.0 110.055 162.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -82.63 179.1 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.705 2.937 . . . . 0.0 114.419 -169.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.62 119.79 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 127.19 2.196 . . . . 0.0 106.058 163.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.0 84.63 0.08 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.56 1.144 . . . . 0.0 110.501 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.1 t -81.92 -9.73 59.49 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.54 122.84 37.71 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 127.399 2.28 . . . . 0.0 106.898 168.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -66.87 -10.8 52.23 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.285 -1.509 . . . . 0.0 114.752 -166.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -89.86 4.33 50.19 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.333 1.853 . . . . 0.0 113.375 170.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.33 134.89 11.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.222 1.409 . . . . 0.0 113.811 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.93 151.43 49.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.774 1.23 . . . . 0.0 111.56 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.29 144.57 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -166.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -79.23 121.47 25.1 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.708 2.403 . . . . 0.0 109.79 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 61.0 mt -131.1 136.35 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.359 0.599 . . . . 0.0 111.177 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . 0.454 ' H ' HG22 ' A' ' 351' ' ' THR . 24.7 mt-10 -101.89 141.27 35.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.976 1.31 . . . . 0.0 110.762 161.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.7 159.49 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.391 1.076 . . . . 0.0 112.001 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -117.13 102.06 52.86 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.703 1.601 . . . . 0.0 109.949 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.78 179.89 3.89 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.676 2.917 . . . . 0.0 110.866 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -78.83 -179.85 5.84 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.219 1.946 . . . . 0.0 110.869 161.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -60.48 148.61 37.06 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 153.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.92 -163.72 43.96 Favored Glycine 0 CA--C 1.539 1.583 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -62.86 158.9 17.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.631 1.972 . . . . 0.0 114.471 -169.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.6 m -166.54 168.57 14.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.137 1.375 . . . . 0.0 113.079 166.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.91 111.29 12.41 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.659 2.383 . . . . 0.0 107.326 164.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 17.4 mm -69.44 129.04 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 59.2 mt -121.32 124.18 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.357 1.063 . . . . 0.0 108.926 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.99 100.56 11.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 126.069 1.747 . . . . 0.0 107.58 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 114.68 178.72 18.89 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 123.071 1.373 . . . . 0.0 116.159 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.57 167.25 22.04 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.744 2.418 . . . . 0.0 110.167 174.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.29 -174.85 46.81 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.569 0.604 . . . . 0.0 112.338 -167.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -59.22 -30.5 68.29 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 122.037 -0.684 . . . . 0.0 111.228 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 15.6 m -60.15 -6.98 1.61 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 129.88 3.272 . . . . 0.0 117.22 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -79.65 148.5 31.61 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.018 0.927 . . . . 0.0 112.005 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 18.0 mt -111.89 165.46 12.06 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.504 0.722 . . . . 0.0 110.563 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.9 t -147.06 157.74 43.71 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -139.71 121.29 15.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.334 1.854 . . . . 0.0 109.657 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -66.64 140.5 57.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.094 1.358 . . . . 0.0 111.89 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -135.95 155.95 49.49 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.46 1.104 . . . . 0.0 111.773 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -133.39 108.21 8.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 9.9 tptp -81.04 154.34 26.91 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -43.22 132.57 4.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.021 1.728 . . . . 0.0 112.313 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 114.07 12.7 10.78 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 118.018 1.967 . . . . 0.0 118.018 162.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 90.9 p -135.26 -79.59 0.43 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.189 1.994 . . . . 0.0 111.853 169.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 85.8 p -98.33 -12.77 21.16 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 127.803 2.441 . . . . 0.0 113.118 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 7.9 tp -131.84 147.99 32.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 125.979 1.711 . . . . 0.0 109.59 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.88 -55.56 6.38 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 3.9 tptp . . . . . 0 C--O 1.25 1.131 0 C-N-CA 128.212 2.605 . . . . 0.0 108.492 171.749 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.411 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 54.3 p -120.57 -6.12 9.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.831 1.652 . . . . 0.0 113.95 175.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.52 11.21 0.27 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.25 1.82 . . . . 0.0 115.719 -170.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.87 151.74 49.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.582 1.553 . . . . 0.0 110.136 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 26.9 p -41.89 -68.65 0.17 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.578 2.351 . . . . 0.0 113.206 -172.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.47 -11.52 16.57 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.169 1.788 . . . . 0.0 114.087 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.415 ' HE2' ' ND2' ' A' ' 345' ' ' ASN . 1.2 mmmt -103.34 64.19 0.82 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.779 -1.201 . . . . 0.0 111.34 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 80.41 -18.85 7.71 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.421 -1.211 . . . . 0.0 115.026 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 23.0 m -71.66 -51.61 22.22 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.444 1.622 . . . . 0.0 112.65 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.3 m -171.44 124.81 0.6 Allowed 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.232 1.378 . . . . 0.0 113.239 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -158.01 155.82 30.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.106 1.762 . . . . 0.0 110.431 167.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.45 104.21 7.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.856 0.863 . . . . 0.0 108.995 170.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 21.4 ptt? -66.84 146.95 53.88 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.972 2.109 . . . . 0.0 115.945 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.9 m -96.49 144.62 26.42 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.728 1.211 . . . . 0.0 109.075 159.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 57.8 p -139.56 2.1 1.99 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -69.23 161.19 29.72 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 120.181 1.355 . . . . 0.0 111.157 165.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.87 95.46 0.06 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.0 1.72 . . . . 0.0 112.277 -171.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 31.6 mtm -81.38 166.64 20.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.927 1.291 . . . . 0.0 112.003 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 22.2 m -160.21 162.57 33.82 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.441 -0.787 . . . . 0.0 112.085 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -74.46 135.17 42.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.514 0.726 . . . . 0.0 109.426 166.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.99 -17.97 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.342 0.657 . . . . 0.0 110.81 161.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 28.6 tttm -147.87 123.72 10.61 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.452 2.301 . . . . 0.0 108.034 173.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.28 146.2 84.41 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.992 0.917 . . . . 0.0 112.069 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.77 130.06 35.53 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.694 2.929 . . . . 0.0 112.848 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.6 p -128.55 134.18 48.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.551 1.141 . . . . 0.0 110.585 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -60.55 122.12 13.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.29 0.636 . . . . 0.0 109.893 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.7 p -72.79 -14.16 61.47 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.284 1.034 . . . . 0.0 112.801 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.74 -4.94 13.3 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.277 0.942 . . . . 0.0 113.492 -165.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -90.16 1.14 56.74 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.886 1.343 . . . . 0.0 112.036 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.87 13.41 43.49 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.804 1.193 . . . . 0.0 113.72 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.8 p -133.66 153.9 51.32 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.044 1.338 . . . . 0.0 111.687 -174.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.49 121.14 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.669 1.187 . . . . 0.0 107.912 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.0 p -112.37 134.33 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.35 1.06 . . . . 0.0 113.067 -164.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -141.79 159.83 41.43 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.936 1.695 . . . . 0.0 112.893 -175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -107.92 132.36 53.56 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.1 1.36 . . . . 0.0 107.373 164.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.35 144.66 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.641 0.776 . . . . 0.0 111.314 -177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -131.04 144.28 51.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.368 1.467 . . . . 0.0 112.901 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.62 153.36 44.31 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 127.986 2.514 . . . . 0.0 108.835 168.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -108.93 -70.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 122.843 2.362 . . . . 0.0 116.277 -178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.18 164.45 27.66 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 121.226 1.83 . . . . 0.0 114.339 -175.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 71.6 0.07 37.74 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.89 1.709 . . . . 0.0 117.037 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.87 102.53 53.99 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 118.879 1.34 . . . . 0.0 113.525 -166.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.06 120.22 2.95 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.717 2.944 . . . . 0.0 109.611 152.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 7.7 p -162.51 157.37 22.17 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -89.39 109.19 20.13 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 157.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.265 0.9 OUTLIER -65.3 122.79 81.88 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.744 -157.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -61.77 117.41 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.712 2.941 . . . . 0.0 113.522 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.1 t -124.94 111.43 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.251 1.421 . . . . 0.0 110.721 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.28 157.26 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.338 1.455 . . . . 0.0 110.096 -173.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.79 118.36 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.46 171.45 13.38 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -165.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . 0.435 ' CG ' ' HE2' ' A' ' 346' ' ' LYS . 4.6 m-20 -90.89 -13.45 33.6 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.351 2.26 . . . . 0.0 112.577 166.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -114.99 0.18 13.59 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -154.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 36.4 mt 60.7 -25.95 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.664 2.786 . . . . 0.0 115.533 -171.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 11.1 t -99.8 -4.56 30.26 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.822 2.049 . . . . 0.0 114.567 -172.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.87 78.15 0.05 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 130.658 3.583 . . . . 0.0 115.175 -171.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -99.53 -38.91 8.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.295 1.438 . . . . 0.0 110.837 153.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 35.2 mm -98.96 128.5 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.771 1.228 . . . . 0.0 109.521 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.415 ' ND2' ' HE2' ' A' ' 293' ' ' LYS . 12.8 t30 -108.65 125.23 51.64 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.754 -0.591 . . . . 0.0 112.054 172.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . 0.435 ' HE2' ' CG ' ' A' ' 338' ' ' ASP . 47.8 mttm -75.49 -73.45 0.26 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.691 2.796 . . . . 0.0 110.902 166.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -98.31 167.16 22.35 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.063 1.316 . . . . 0.0 115.582 -155.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 12.6 mt -120.03 152.24 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.633 1.573 . . . . 0.0 110.318 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.3 135.97 54.16 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.472 1.909 . . . . 0.0 110.312 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.58 -50.14 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.949 0.5 . . . . 0.0 110.693 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.408 ' H ' ' HB2' ' A' ' 366' ' ' GLU . 1.1 m -81.45 156.81 25.16 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.001 0.92 . . . . 0.0 109.348 160.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.05 161.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.255 1.422 . . . . 0.0 113.922 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -125.02 121.05 25.39 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.158 1.783 . . . . 0.0 109.227 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -82.28 -175.29 2.44 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.265 3.31 . . . . 0.0 113.548 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 123.12 63.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.578 1.551 . . . . 0.0 108.037 168.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.63 84.71 0.87 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.34 1.056 . . . . 0.0 111.548 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 25.0 t -79.29 -12.34 59.94 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 167.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.7 p -131.31 121.98 25.64 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 127.785 2.434 . . . . 0.0 105.939 167.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -59.51 -20.34 54.66 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.8 0.06 9.93 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.466 1.906 . . . . 0.0 113.737 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -37.13 121.82 0.83 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.481 2.312 . . . . 0.0 113.58 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -134.65 143.18 47.13 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.269 1.028 . . . . 0.0 111.285 171.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.2 p -154.17 150.47 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -163.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.93 121.82 27.48 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.793 2.437 . . . . 0.0 109.469 168.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 37.0 mt -135.71 150.13 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.956 0.798 . . . . 0.0 111.455 174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . 0.408 ' HB2' ' H ' ' A' ' 351' ' ' THR . 48.3 mt-10 -118.4 142.63 47.35 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.55 1.94 . . . . 0.0 111.467 170.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 3.8 m -123.11 145.47 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.569 1.148 . . . . 0.0 110.733 168.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -83.18 119.08 73.49 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.936 0.894 . . . . 0.0 109.787 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -82.34 151.33 15.54 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 122.844 2.363 . . . . 0.0 111.045 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.47 178.13 7.07 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.747 2.298 . . . . 0.0 110.442 158.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.73 151.66 46.88 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.611 -0.68 . . . . 0.0 110.449 163.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 77.63 -151.33 37.64 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 121.92 -0.488 . . . . 0.0 113.297 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.28 143.45 57.78 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -173.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 47.2 m -157.41 145.49 19.12 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.487 1.115 . . . . 0.0 112.512 167.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -122.77 105.2 9.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.404 1.082 . . . . 0.0 108.651 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 13.8 mm -76.69 113.78 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 127.444 2.298 . . . . 0.0 109.022 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 25.1 mt -116.79 133.96 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 122.449 1.118 . . . . 0.0 111.78 -168.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 81.6 t -116.77 114.58 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 C-N-CA 126.647 1.979 . . . . 0.0 108.023 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 96.98 -173.05 28.82 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 122.875 1.264 . . . . 0.0 115.521 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.95 164.01 31.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.308 2.243 . . . . 0.0 110.018 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.55 -174.12 42.68 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.008 0.337 . . . . 0.0 112.359 -167.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -59.17 -25.79 64.22 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.074 0.95 . . . . 0.0 112.497 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 63.4 m -60.38 -10.72 5.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.824 2.449 . . . . 0.0 115.684 172.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -77.39 124.71 28.24 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.508 1.049 . . . . 0.0 112.167 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 9.8 mt -97.71 161.3 13.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.983 0.513 . . . . 0.0 111.401 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.9 t -132.65 157.88 43.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.879 1.272 . . . . 0.0 112.042 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -145.0 136.52 25.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.078 1.351 . . . . 0.0 110.979 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.14 137.22 38.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.465 1.506 . . . . 0.0 113.139 -175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -138.01 147.39 44.14 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.917 1.287 . . . . 0.0 111.352 158.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -123.53 111.74 16.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.603 1.561 . . . . 0.0 107.598 169.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -98.62 117.82 33.93 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.494 1.118 . . . . 0.0 112.156 -167.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 70.78 140.88 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.693 3.197 . . . . 0.0 113.591 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -64.81 66.88 0.07 OUTLIER Glycine 0 C--N 1.341 0.837 0 C-N-CA 128.567 2.984 . . . . 0.0 112.754 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 50.8 m -67.5 -4.97 12.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.809 2.444 . . . . 0.0 113.919 -167.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 34.1 t -104.25 4.01 33.34 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.294 1.838 . . . . 0.0 113.813 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 15.2 tt -134.2 -31.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.319 1.047 . . . . 0.0 113.147 170.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 144.36 -24.47 2.03 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.927 1.251 . . . . 0.0 114.893 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? . . . . . 0 C--O 1.247 0.946 0 C-N-CA 126.389 1.876 . . . . 0.0 109.446 178.591 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 119.608 -0.234 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 26.3 p -67.01 9.63 0.19 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.765 2.426 . . . . 0.0 117.12 -170.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.63 -2.43 6.78 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -172.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 33.2 tp -138.86 146.07 40.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.066 1.346 . . . . 0.0 109.26 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 11.5 m -46.57 -49.06 19.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.556 1.942 . . . . 0.0 114.506 -165.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.93 49.71 0.19 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.752 1.621 . . . . 0.0 112.053 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.05 89.19 0.92 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.39 1.476 . . . . 0.0 110.157 174.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.87 -22.07 2.41 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 117.847 -1.529 . . . . 0.0 116.765 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 30.9 p -56.42 -69.29 0.15 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.872 1.836 . . . . 0.0 113.354 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.0 m -176.31 120.91 0.15 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 127.608 2.363 . . . . 0.0 109.727 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -155.42 156.33 35.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.477 0.656 . . . . 0.0 112.526 173.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.35 105.94 13.83 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.123 1.769 . . . . 0.0 109.173 172.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -80.44 161.83 24.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.125 1.77 . . . . 0.0 114.162 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 13.7 m -100.86 148.58 24.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.343 1.057 . . . . 0.0 110.939 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 42.9 p -139.08 11.47 2.61 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 170.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -83.17 160.61 21.78 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.804 1.183 . . . . 0.0 110.039 163.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -65.29 98.72 0.35 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.095 1.758 . . . . 0.0 111.825 -163.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 27.6 mtm -83.01 164.06 20.6 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.716 0.806 . . . . 0.0 111.79 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.3 m -159.53 161.29 35.25 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.316 -0.865 . . . . 0.0 111.993 167.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.67 115.47 25.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.798 0.839 . . . . 0.0 110.573 167.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.69 -26.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.948 1.299 . . . . 0.0 110.548 168.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -142.31 130.86 22.52 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.539 1.936 . . . . 0.0 109.022 167.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -61.34 149.75 82.16 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.928 1.691 . . . . 0.0 113.313 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -55.86 130.57 41.07 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.345 2.697 . . . . 0.0 112.389 173.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 44.3 p -128.58 127.54 42.5 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.474 1.109 . . . . 0.0 111.297 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -60.82 123.89 18.83 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.73 1.612 . . . . 0.0 112.133 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.2 p -79.57 -11.81 59.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.487 1.515 . . . . 0.0 113.307 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 68.71 -10.36 1.55 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.418 1.009 . . . . 0.0 114.224 -168.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -83.23 3.63 30.33 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.618 1.567 . . . . 0.0 111.702 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 101.97 -1.47 51.59 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 126.043 1.782 . . . . 0.0 113.612 -174.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.2 p -118.06 159.11 23.79 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.771 1.286 . . . . 0.0 112.451 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.79 111.43 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.406 1.482 . . . . 0.0 107.916 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.46 133.1 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.245 1.018 . . . . 0.0 113.615 -162.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -139.69 161.54 37.27 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.245 2.218 . . . . 0.0 112.496 -172.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -113.33 130.12 56.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.454 1.102 . . . . 0.0 108.158 164.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.2 150.57 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.074 0.95 . . . . 0.0 111.874 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.8 tttp -135.73 148.38 48.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.826 1.651 . . . . 0.0 113.044 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.51 153.11 46.68 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 128.322 2.649 . . . . 0.0 108.17 165.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -107.97 -55.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.454 2.102 . . . . 0.0 115.695 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.94 171.01 16.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.275 1.03 . . . . 0.0 112.575 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.63 -5.14 1.8 Allowed Glycine 0 CA--C 1.537 1.425 0 C-N-CA 126.975 2.226 . . . . 0.0 118.093 166.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.53 95.59 48.09 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 119.286 1.543 . . . . 0.0 113.331 -161.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.93 117.82 4.83 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.114 2.543 . . . . 0.0 109.345 158.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.1 p -165.51 150.88 9.11 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.18 101.56 6.23 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.104 1.762 . . . . 0.0 106.588 158.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.253 1.3 pp -61.08 120.4 54.04 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-O 118.555 -0.735 . . . . 0.0 111.543 -158.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -61.89 114.85 2.47 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.492 2.795 . . . . 0.0 113.552 -171.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.62 120.15 62.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.979 1.312 . . . . 0.0 108.781 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 163.63 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.013 1.325 . . . . 0.0 110.643 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . 0.498 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 48.2 t -142.81 118.26 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.69 163.39 38.23 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.1 6.2 38.42 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.069 0.948 . . . . 0.0 111.913 -175.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -115.14 1.98 14.01 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.937 2.495 . . . . 0.0 113.457 -164.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 32.8 mt 61.31 8.03 1.94 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.495 2.318 . . . . 0.0 114.994 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.9 t -142.62 -6.6 0.89 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 55.95 50.18 14.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.767 2.027 . . . . 0.0 114.925 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -70.13 -42.71 72.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 152.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 34.2 mm -70.57 148.18 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 123.718 0.807 . . . . 0.0 108.927 162.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.08 74.26 1.51 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.432 -1.418 . . . . 0.0 109.349 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -75.27 -60.63 2.21 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.296 1.838 . . . . 0.0 112.886 -160.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.498 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -94.44 175.88 34.9 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 125.655 1.598 . . . . 0.0 115.406 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -113.79 150.73 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 128.143 2.577 . . . . 0.0 110.377 -173.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.78 135.46 36.5 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.493 1.517 . . . . 0.0 109.685 165.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.8 t -114.86 -65.34 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 118.885 0.766 . . . . 0.0 111.208 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.526 ' H ' ' HB2' ' A' ' 366' ' ' GLU . 1.5 m -68.8 157.34 36.64 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 162.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 35.2 m -55.71 161.44 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.959 1.704 . . . . 0.0 114.759 -172.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -125.67 125.35 24.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.445 1.898 . . . . 0.0 108.108 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -80.88 -174.49 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.85 3.033 . . . . 0.0 112.667 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.27 120.49 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 162.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.97 67.25 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.778 2.031 . . . . 0.0 113.444 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.2 t -71.03 -20.81 62.35 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.912 0.885 . . . . 0.0 112.402 169.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.81 123.05 43.66 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 154.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -65.65 -16.31 63.61 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.55 -1.344 . . . . 0.0 112.803 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -81.13 2.79 25.91 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.29 1.836 . . . . 0.0 113.751 170.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.22 126.14 3.98 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.303 1.441 . . . . 0.0 113.243 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.14 149.19 52.46 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.064 0.946 . . . . 0.0 111.539 167.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 14.0 p -158.56 151.38 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -163.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.74 122.61 28.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.172 2.589 . . . . 0.0 109.624 169.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 20.7 mt -134.02 149.67 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.932 0.787 . . . . 0.0 110.619 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' A' ' 351' ' ' THR . 45.4 mt-10 -116.22 143.38 45.58 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.608 1.563 . . . . 0.0 110.977 167.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.02 157.8 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.448 0.699 . . . . 0.0 111.635 164.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -121.47 102.19 42.74 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 127.164 2.186 . . . . 0.0 108.501 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -77.36 165.33 27.73 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 122.17 1.914 . . . . 0.0 110.628 166.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -59.7 177.2 0.49 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.078 2.518 . . . . 0.0 111.668 156.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -59.65 142.59 52.61 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.845 -0.534 . . . . 0.0 110.527 165.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 101.92 -154.18 18.72 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.957 1.265 . . . . 0.0 115.381 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.82 140.97 38.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.412 2.685 . . . . 0.0 112.533 -170.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.63 174.04 8.05 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 159.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -111.94 119.64 39.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.272 1.429 . . . . 0.0 108.926 170.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.5 mm -78.28 119.79 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 173.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 83.4 mt -112.19 134.83 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.685 1.194 . . . . 0.0 109.783 -172.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.6 t -115.86 108.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 126.097 1.759 . . . . 0.0 107.982 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.78 -179.27 24.21 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 170.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.11 167.29 21.83 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.433 2.693 . . . . 0.0 110.245 175.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.33 -169.62 54.9 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.606 0.622 . . . . 0.0 112.247 -169.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -63.11 -32.48 73.87 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.089 -1.242 . . . . 0.0 111.352 168.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 70.3 m -54.89 8.05 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 1 C-N-CA 131.877 4.071 . . . . 0.0 118.474 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -103.95 146.42 28.71 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.628 1.171 . . . . 0.0 111.704 -172.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 21.6 mt -120.95 168.66 11.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.044 0.938 . . . . 0.0 110.926 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.0 t -145.88 159.38 43.3 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 172.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -132.72 130.46 40.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.347 1.459 . . . . 0.0 109.678 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -76.71 132.58 39.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.287 1.835 . . . . 0.0 111.63 -176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -133.2 151.22 51.95 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 122.208 1.004 . . . . 0.0 111.796 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -137.75 123.76 20.24 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 171.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -128.16 110.88 12.86 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.689 0.796 . . . . 0.0 111.755 -168.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 30.76 87.31 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 128.87 2.868 . . . . 0.0 117.175 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 120.34 29.05 1.68 Allowed Glycine 0 CA--C 1.533 1.202 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 159.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 99.7 p -128.73 -86.13 0.56 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.411 1.606 . . . . 0.0 111.307 167.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 88.0 p -91.53 -11.68 36.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.44 2.296 . . . . 0.0 112.938 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.3 tp -139.31 153.22 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.028 1.731 . . . . 0.0 110.528 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.64 -17.11 66.72 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.995 0.807 . . . . 0.0 114.483 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 6.8 tptp . . . . . 0 C--O 1.245 0.826 0 C-N-CA 126.548 1.939 . . . . 0.0 109.217 175.789 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 28.1 p -71.72 -5.17 31.99 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.493 1.517 . . . . 0.0 115.066 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -62.17 -12.05 17.77 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.823 1.649 . . . . 0.0 115.028 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.8 tt -125.86 125.83 43.47 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 163.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.5 m -55.6 -25.95 41.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.983 1.713 . . . . 0.0 114.699 -161.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.54 68.64 0.58 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.938 1.295 . . . . 0.0 111.411 171.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.494 ' HA ' ' HE3' ' A' ' 293' ' ' LYS . 0.4 OUTLIER -155.18 82.62 1.06 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.451 1.5 . . . . 0.0 110.865 169.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 70.31 -9.67 3.1 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 117.099 1.6 . . . . 0.0 117.099 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 65.1 p -54.92 -64.01 0.97 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.216 1.807 . . . . 0.0 113.232 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.9 m -173.23 128.69 0.45 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.678 1.991 . . . . 0.0 110.764 173.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -158.14 147.36 19.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.715 0.806 . . . . 0.0 111.801 168.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.82 96.89 0.31 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.329 1.452 . . . . 0.0 108.506 166.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -69.7 156.91 38.25 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.416 2.686 . . . . 0.0 115.177 -172.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 14.9 m -100.53 137.81 38.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.874 1.27 . . . . 0.0 109.787 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 66.7 p -138.15 4.31 2.46 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -80.54 165.55 22.01 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.876 1.216 . . . . 0.0 110.707 166.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -66.68 94.95 0.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.848 2.059 . . . . 0.0 111.366 -165.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 30.7 mtm -79.69 163.32 24.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.853 1.261 . . . . 0.0 112.317 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.4 p -150.43 161.88 41.65 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.556 1.143 . . . . 0.0 112.476 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -93.93 125.82 38.77 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.152 0.981 . . . . 0.0 108.723 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.72 -26.7 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 163.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -144.06 128.46 17.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.59 1.956 . . . . 0.0 108.743 171.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -59.22 143.81 84.29 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 123.961 0.904 . . . . 0.0 111.752 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -56.31 137.95 81.84 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.082 1.855 . . . . 0.0 111.513 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 41.2 p -132.49 124.59 28.83 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.37 1.068 . . . . 0.0 111.805 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -54.09 122.05 9.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.307 1.843 . . . . 0.0 111.517 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -84.24 -12.39 54.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.137 0.975 . . . . 0.0 113.296 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.95 -10.01 1.32 Allowed Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.271 0.939 . . . . 0.0 114.584 -167.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -83.38 7.02 17.95 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 119.29 1.545 . . . . 0.0 111.971 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 96.2 5.9 59.16 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.48 1.514 . . . . 0.0 113.713 -171.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.5 p -127.75 167.48 16.43 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.708 1.254 . . . . 0.0 112.825 -172.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 22.0 t -137.35 123.59 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.693 1.997 . . . . 0.0 107.817 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -110.32 131.7 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.74 1.216 . . . . 0.0 113.005 -170.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -138.45 167.13 22.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.685 1.594 . . . . 0.0 113.756 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -126.26 129.44 48.93 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.028 1.331 . . . . 0.0 108.594 166.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.1 m -127.26 154.87 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.79 0.836 . . . . 0.0 111.792 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -139.65 144.28 37.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.581 1.552 . . . . 0.0 111.717 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 12.7 p -120.04 154.23 55.56 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 127.153 2.181 . . . . 0.0 108.518 168.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 10.2 Cg_endo -113.31 -45.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.2 0 CA-C-N 122.205 1.823 . . . . 0.0 116.602 -165.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.7 164.68 32.79 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.928 -1.107 . . . . 0.0 112.447 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.37 4.95 26.21 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.888 1.709 . . . . 0.0 117.188 168.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.89 95.66 46.04 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.0 1.4 . . . . 0.0 113.094 -164.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -85.62 115.08 1.51 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.048 3.166 . . . . 0.0 109.249 154.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 9.3 p -163.36 144.39 9.3 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.99 107.11 9.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 162.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.278 0.7 OUTLIER -68.87 122.2 84.16 Favored Pre-proline 0 CA--C 1.551 1.0 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.13 -155.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -64.2 116.02 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.062 2.508 . . . . 0.0 112.987 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.91 108.17 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.828 1.651 . . . . 0.0 110.312 175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.09 156.92 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.437 1.495 . . . . 0.0 109.581 -170.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 42.5 t -142.62 122.13 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 120.98 -1.075 . . . . 0.0 109.39 -170.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -139.19 173.71 11.27 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -161.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -110.54 -1.99 16.67 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.517 1.527 . . . . 0.0 112.205 168.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -125.83 4.58 7.36 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.703 1.601 . . . . 0.0 113.996 -159.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 35.7 mt 62.56 -4.9 0.21 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.339 2.256 . . . . 0.0 115.52 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 5.0 t -125.33 0.71 7.73 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.074 1.307 . . . . 0.0 113.963 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 77.87 21.2 0.95 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.59 2.356 . . . . 0.0 113.945 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -61.43 -46.45 90.03 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.268 1.027 . . . . 0.0 111.475 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.7 mm -94.37 135.39 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' A' ' 293' ' ' LYS . 0.6 OUTLIER -132.64 86.68 2.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 123.415 1.579 . . . . 0.0 113.31 -167.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 14.3 mtpp -82.6 -49.08 10.24 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.708 2.403 . . . . 0.0 113.097 -158.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -104.84 154.13 17.36 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -160.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.15 149.1 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 127.102 2.161 . . . . 0.0 109.749 -169.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.12 120.35 24.14 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.054 1.341 . . . . 0.0 109.277 170.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.93 -38.3 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.963 0.505 . . . . 0.0 111.052 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 366' ' ' GLU . 6.1 t -97.59 175.41 6.21 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.351 0.66 . . . . 0.0 111.058 166.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 13.5 t -62.74 128.52 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.726 1.211 . . . . 0.0 110.507 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -66.31 114.96 19.29 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.673 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.86 174.7 10.71 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.311 2.674 . . . . 0.0 113.394 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.33 120.99 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 127.223 2.209 . . . . 0.0 107.986 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.95 99.53 0.5 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.553 1.141 . . . . 0.0 109.506 167.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 26.1 t -102.16 -11.12 19.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.689 1.596 . . . . 0.0 112.79 175.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.59 152.33 33.27 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 147.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -72.86 -11.66 60.68 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 117.847 -1.073 . . . . 0.0 113.597 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.99 1.46 55.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.311 1.444 . . . . 0.0 112.457 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -54.18 134.14 44.44 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.443 1.116 . . . . 0.0 113.034 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.41 140.44 52.17 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.442 1.497 . . . . 0.0 110.634 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.35 142.63 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -158.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -73.06 127.8 33.63 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 129.491 3.116 . . . . 0.0 110.419 170.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 44.2 mt -137.85 144.62 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.096 0.558 . . . . 0.0 110.655 170.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . 0.557 ' H ' HG22 ' A' ' 351' ' ' THR . 11.1 mt-10 -116.1 139.05 50.7 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.562 1.545 . . . . 0.0 111.125 165.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.1 m -125.36 158.32 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.737 1.215 . . . . 0.0 111.801 175.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -118.1 105.26 47.28 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 126.978 2.111 . . . . 0.0 108.687 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -80.84 169.63 16.31 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.533 2.822 . . . . 0.0 111.147 172.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.83 175.96 8.95 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.422 2.082 . . . . 0.0 110.846 162.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -65.72 148.42 51.8 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.797 -0.564 . . . . 0.0 109.853 161.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.41 -162.51 33.4 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-O 122.426 1.014 . . . . 0.0 114.833 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.3 156.31 29.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.563 1.945 . . . . 0.0 113.941 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 64.0 m -170.03 159.79 7.84 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.667 1.987 . . . . 0.0 112.063 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -124.42 123.56 40.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.887 1.675 . . . . 0.0 107.934 157.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.6 mm -76.69 111.0 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 87.1 mt -100.95 130.98 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.687 1.131 . . . . 0.0 109.391 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 83.5 t -117.76 109.45 27.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.898 1.679 . . . . 0.0 107.838 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.9 -176.21 22.72 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 123.333 1.518 . . . . 0.0 116.604 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.57 171.96 13.39 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.167 2.587 . . . . 0.0 110.357 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.37 -171.87 45.83 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -61.16 -31.1 70.83 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.811 -0.817 . . . . 0.0 111.7 170.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 53.2 m -61.39 -8.15 3.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 129.571 3.148 . . . . 0.0 117.364 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -74.38 144.89 44.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.855 0.752 . . . . 0.0 111.449 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 31.8 mt -116.8 167.64 10.92 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.263 0.625 . . . . 0.0 110.719 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.3 t -146.55 159.12 43.83 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -134.57 131.25 37.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.418 1.487 . . . . 0.0 109.57 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -73.89 131.51 41.55 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.312 2.245 . . . . 0.0 112.344 -173.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -142.59 118.02 10.28 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.24 1.016 . . . . 0.0 111.888 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -105.78 105.14 15.04 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -74.93 150.88 38.95 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 -42.29 125.68 3.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.859 2.064 . . . . 0.0 114.209 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 120.23 10.27 7.47 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 117.78 1.872 . . . . 0.0 117.78 158.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 94.4 p -126.87 -94.66 0.45 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.299 2.049 . . . . 0.0 112.408 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 85.8 p -77.91 -11.59 59.91 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.508 1.923 . . . . 0.0 112.874 175.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.3 tt -142.09 156.42 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.819 1.647 . . . . 0.0 110.911 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -80.66 -38.75 15.85 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.122 -0.821 . . . . 0.0 113.51 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 4.8 tptp . . . . . 0 C--O 1.25 1.094 0 C-N-CA 127.632 2.373 . . . . 0.0 109.278 178.943 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 33.6 tpp . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 12.8 m -56.99 -15.49 5.08 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -167.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -82.6 -12.63 57.56 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.62 117.79 20.94 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.198 1.363 . . . . 0.0 114.113 -164.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 29.2 p 65.26 -154.09 0.27 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.806 2.042 . . . . 0.0 112.317 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.53 94.15 0.11 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.15 -0.968 . . . . 0.0 109.207 174.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 293' ' ' LYS . 1.0 OUTLIER -150.9 92.46 1.82 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 176.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.55 -25.2 0.61 Allowed Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.92 1.724 . . . . 0.0 117.174 167.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 22.2 p -58.0 -45.21 87.19 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.257 1.528 . . . . 0.0 113.519 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 18.3 m -167.37 131.21 1.81 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.371 1.068 . . . . 0.0 112.124 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -153.64 158.49 41.18 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.141 1.376 . . . . 0.0 109.832 157.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 111.39 23.13 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 166.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.37 134.76 57.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.872 1.669 . . . . 0.0 114.594 -173.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.2 m -85.26 132.77 34.22 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 152.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 66.8 p -132.94 6.21 3.93 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -83.32 161.35 21.46 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.176 0.898 . . . . 0.0 111.052 164.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -63.62 104.32 0.64 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.137 1.775 . . . . 0.0 112.711 -159.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 24.3 mtm -87.63 164.86 15.82 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.047 0.927 . . . . 0.0 112.004 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.5 m -160.6 160.48 31.77 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.24 -0.912 . . . . 0.0 111.717 170.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.91 126.13 30.29 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 165.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 40.6 t -78.97 -24.21 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.506 0.722 . . . . 0.0 110.527 161.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -139.94 127.23 21.24 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.226 1.81 . . . . 0.0 108.203 166.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -55.41 144.11 53.96 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.642 1.177 . . . . 0.0 111.719 172.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -55.07 133.09 56.13 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.309 2.006 . . . . 0.0 110.989 170.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 61.4 p -133.74 129.73 37.08 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.202 1.001 . . . . 0.0 110.742 171.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.24 125.65 24.13 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.342 1.057 . . . . 0.0 111.143 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 61.9 p -80.47 -9.2 59.77 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.192 0.997 . . . . 0.0 113.093 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 74.66 -8.49 14.33 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.798 1.19 . . . . 0.0 114.033 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -90.0 4.82 49.0 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.88 1.34 . . . . 0.0 112.468 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.65 6.73 62.15 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.674 1.13 . . . . 0.0 113.59 -169.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.6 p -120.73 157.04 30.53 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.843 1.257 . . . . 0.0 111.214 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 15.0 t -130.86 118.76 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.346 1.458 . . . . 0.0 108.038 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.9 p -108.01 129.78 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.978 1.311 . . . . 0.0 113.134 -166.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -139.76 162.71 34.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.972 1.709 . . . . 0.0 113.374 -177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -116.26 129.25 56.18 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.099 1.359 . . . . 0.0 107.764 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 14.6 m -126.17 145.75 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.594 0.757 . . . . 0.0 111.312 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 39.0 tttp -125.92 144.09 50.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.641 1.176 . . . . 0.0 112.526 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.7 t -111.86 150.88 42.99 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 127.501 2.32 . . . . 0.0 107.785 163.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -110.26 -59.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.576 2.184 . . . . 0.0 116.169 -176.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.02 164.61 29.81 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.03 -1.044 . . . . 0.0 112.743 -176.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 64.41 7.07 24.46 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 117.622 1.809 . . . . 0.0 117.622 168.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.26 98.05 44.66 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 119.071 1.436 . . . . 0.0 113.279 -162.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.56 119.19 1.63 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.53 3.487 . . . . 0.0 110.072 157.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.2 p -161.1 157.91 26.8 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -172.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -88.46 112.51 23.04 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 157.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 333' ' ' PRO 0.297 0.5 OUTLIER -66.09 124.89 89.03 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.655 -160.477 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 4.7 Cg_exo -74.75 104.53 1.9 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.457 2.771 . . . . 0.0 111.824 -171.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 75.2 t -105.08 107.88 23.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.471 1.508 . . . . 0.0 109.87 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.43 160.18 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 122.276 1.036 . . . . 0.0 110.992 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 23.0 t -142.93 134.39 24.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -147.94 178.29 8.64 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.401 0.681 . . . . 0.0 112.046 -168.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -114.24 -6.2 13.0 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.648 0.779 . . . . 0.0 112.26 166.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -111.53 5.83 19.72 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.859 2.464 . . . . 0.0 113.788 -165.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 13.6 mt 64.16 -3.59 0.47 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.223 2.209 . . . . 0.0 115.048 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 6.6 t -126.89 -6.34 6.17 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -174.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 337' ' ' ALA . . . 80.04 25.67 0.36 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 127.968 2.507 . . . . 0.0 113.832 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.2 81.24 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 166.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.83 138.42 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.826 0.85 . . . . 0.0 109.27 159.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.98 74.44 0.88 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 123.014 1.387 . . . . 0.0 109.178 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -76.61 -51.42 11.63 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 126.656 1.982 . . . . 0.0 114.089 -158.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -112.61 153.34 17.53 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 116.065 1.186 . . . . 0.0 116.065 -161.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.3 152.77 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 129.724 3.209 . . . . 0.0 110.171 -168.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.96 123.66 30.78 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.919 1.288 . . . . 0.0 110.101 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.66 -47.25 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.066 0.546 . . . . 0.0 110.16 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.7 t -86.79 178.19 7.08 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.262 1.025 . . . . 0.0 111.901 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.1 m -60.78 131.44 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.275 1.43 . . . . 0.0 111.063 169.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -73.26 116.03 46.89 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 120.989 -1.07 . . . . 0.0 110.036 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.69 -179.03 5.08 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 124.058 3.172 . . . . 0.0 113.777 -172.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.26 141.2 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.32 1.448 . . . . 0.0 108.598 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -86.84 100.37 12.49 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.997 0.919 . . . . 0.0 109.577 169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -96.4 -16.0 21.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.81 0.844 . . . . 0.0 112.549 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.59 130.67 53.66 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 126.502 1.921 . . . . 0.0 106.676 165.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -66.04 -18.19 65.18 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.326 -1.484 . . . . 0.0 114.133 -165.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -78.84 -2.62 40.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.919 1.687 . . . . 0.0 113.637 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -51.42 133.04 29.9 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.4 1.571 . . . . 0.0 112.937 -170.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -140.81 123.73 16.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.742 2.017 . . . . 0.0 108.665 -164.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 10.5 p -149.04 142.28 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -155.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.97 125.31 26.51 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 128.566 2.747 . . . . 0.0 110.195 170.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 23.6 mt -135.44 140.54 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.195 0.522 . . . . 0.0 110.965 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -116.33 136.06 53.33 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.593 1.557 . . . . 0.0 110.775 166.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.68 159.0 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.768 1.227 . . . . 0.0 112.2 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -129.23 103.88 18.16 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.481 1.912 . . . . 0.0 109.768 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.79 163.85 30.85 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 121.886 1.724 . . . . 0.0 110.642 167.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -60.34 177.27 0.61 Allowed 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.101 2.534 . . . . 0.0 111.746 157.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -60.98 141.12 57.56 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.623 -0.673 . . . . 0.0 110.595 169.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 96.31 -161.26 22.3 Favored Glycine 0 CA--C 1.535 1.327 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -67.6 159.53 29.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.772 1.629 . . . . 0.0 114.657 -169.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 22.6 m -170.02 164.37 9.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.729 1.612 . . . . 0.0 112.663 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -127.24 116.09 20.04 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 129.453 3.101 . . . . 0.0 107.395 165.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.6 mm -77.11 121.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.18 130.33 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.571 1.078 . . . . 0.0 109.511 -176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.7 t -114.92 105.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.584 1.154 . . . . 0.0 108.456 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.22 -177.41 20.87 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 123.091 1.384 . . . . 0.0 116.312 169.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.9 163.93 28.42 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.627 2.371 . . . . 0.0 110.46 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 80.76 -170.09 52.82 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.018 0.818 . . . . 0.0 112.989 -170.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -65.07 -23.87 67.29 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.951 -1.323 . . . . 0.0 111.814 167.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 72.8 m -62.61 -2.52 1.13 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 130.676 3.59 . . . . 0.0 117.676 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.52 147.92 22.55 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.452 1.024 . . . . 0.0 112.371 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 17.6 mt -113.39 165.41 12.48 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.416 0.686 . . . . 0.0 110.951 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.4 t -145.23 158.59 43.79 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 167.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -140.79 134.88 30.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.567 1.947 . . . . 0.0 109.029 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -74.29 138.08 43.33 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.225 1.41 . . . . 0.0 111.699 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -144.53 118.52 9.39 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.653 0.781 . . . . 0.0 112.991 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.92 117.09 33.49 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.84 1.256 . . . . 0.0 109.109 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -95.7 151.48 19.32 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.66 0.784 . . . . 0.0 110.059 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -37.97 110.89 0.14 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.796 2.438 . . . . 0.0 112.022 171.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 152.73 -97.99 0.18 Allowed Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.708 -0.495 . . . . 0.0 113.76 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.4 p -66.67 -41.27 88.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 63.8 p -135.59 -5.41 2.25 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -162.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 5.7 tp -147.66 158.92 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.796 0.838 . . . . 0.0 110.378 168.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -78.89 -50.66 5.8 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.429 1.014 . . . . 0.0 112.103 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 3.8 tptp . . . . . 0 C--O 1.251 1.167 0 C-N-CA 128.832 2.853 . . . . 0.0 107.262 167.828 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 13.3 mmt . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 118.967 -0.539 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 22.7 p -75.38 -4.34 38.83 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 117.577 2.436 . . . . 0.0 117.577 -165.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -63.75 -6.01 5.03 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.934 1.294 . . . . 0.0 114.34 174.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 67.4 tp -117.97 123.09 44.91 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.601 1.96 . . . . 0.0 109.265 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.4 m -40.09 -45.86 2.05 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.777 2.431 . . . . 0.0 116.357 -163.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.81 -22.04 65.19 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.029 0.931 . . . . 0.0 112.837 -177.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.473 ' HE3' HD23 ' A' ' 349' ' ' LEU . 0.0 OUTLIER -80.97 70.14 7.72 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.179 -1.575 . . . . 0.0 109.08 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 86.04 -50.0 4.2 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.078 1.323 . . . . 0.0 113.548 177.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.9 m -48.71 -41.91 33.33 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.6 1.96 . . . . 0.0 115.111 -167.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.6 m -162.12 123.3 2.66 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.603 1.547 . . . . 0.0 113.278 166.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -159.12 159.58 34.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.197 1.399 . . . . 0.0 111.157 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.98 103.9 11.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.377 2.271 . . . . 0.0 105.082 169.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -73.9 151.88 40.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.2 1.4 . . . . 0.0 114.165 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 1.2 m -95.75 150.92 19.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.354 0.661 . . . . 0.0 110.205 166.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 70.1 p -133.41 9.36 4.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.787 1.235 . . . . 0.0 113.705 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -79.24 154.55 29.1 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 120.348 1.431 . . . . 0.0 111.107 164.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 109.58 0.9 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.387 2.275 . . . . 0.0 111.89 -170.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 19.0 mtt -87.54 170.47 11.29 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.9 m -156.93 153.28 27.86 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.346 -0.846 . . . . 0.0 112.685 157.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.82 125.52 29.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.88 0.872 . . . . 0.0 109.343 160.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 5.3 t -82.43 -24.35 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.03 1.332 . . . . 0.0 110.873 172.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -134.24 125.6 28.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.283 2.233 . . . . 0.0 106.708 170.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -56.8 146.93 55.46 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 123.655 0.597 . . . . 0.0 111.154 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -56.66 124.35 16.05 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.507 1.471 . . . . 0.0 110.019 166.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 6.3 p -125.41 125.78 43.92 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.229 1.011 . . . . 0.0 110.977 170.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.62 121.32 11.9 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.839 0.712 . . . . 0.0 110.54 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 59.1 p -79.45 -7.28 58.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.201 1.4 . . . . 0.0 113.224 -173.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.56 -7.06 2.21 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.738 -164.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -86.68 6.17 32.47 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.659 1.729 . . . . 0.0 111.856 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.47 -2.0 67.23 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.088 1.328 . . . . 0.0 113.648 -170.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 27.9 p -119.07 166.89 12.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.112 1.365 . . . . 0.0 112.002 -170.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.48 114.79 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.014 1.726 . . . . 0.0 108.027 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.29 136.34 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.322 1.049 . . . . 0.0 113.235 -168.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -147.24 167.09 25.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.675 1.99 . . . . 0.0 112.996 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -115.32 134.89 54.7 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.47 1.908 . . . . 0.0 106.819 161.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 23.5 m -132.13 148.54 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.678 0.672 . . . . 0.0 111.703 176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -135.31 146.8 48.83 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.709 1.204 . . . . 0.0 112.272 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 22.8 m -115.13 157.65 43.03 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.604 1.561 . . . . 0.0 110.704 165.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 24.2 Cg_endo -114.99 -54.49 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.479 2.119 . . . . 0.0 116.673 -171.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.64 175.3 9.8 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 121.164 1.802 . . . . 0.0 113.596 177.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.18 -13.47 0.23 Allowed Glycine 0 CA--C 1.541 1.716 0 N-CA-C 119.314 2.486 . . . . 0.0 119.314 164.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.48 104.78 54.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 119.939 1.87 . . . . 0.0 114.715 -159.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.41 117.25 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.746 2.964 . . . . 0.0 110.524 158.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.0 p -163.45 148.72 11.2 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -76.06 98.94 4.46 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 155.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.71 113.58 6.28 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 123.701 0.801 . . . . 0.0 111.305 -161.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.52 104.18 1.67 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.251 2.634 . . . . 0.0 112.942 -168.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 81.1 t -101.4 116.98 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 127.076 2.15 . . . . 0.0 109.726 172.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.26 161.43 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.375 1.07 . . . . 0.0 110.782 -176.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . 0.52 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 46.8 t -138.67 133.62 42.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 169.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -142.8 169.55 17.35 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.374 0.67 . . . . 0.0 111.652 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -102.22 1.74 36.31 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.243 0.617 . . . . 0.0 111.622 162.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -117.99 5.1 12.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.078 1.751 . . . . 0.0 114.473 -165.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 15.9 mt 61.89 -7.76 0.11 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.492 2.317 . . . . 0.0 116.098 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.7 t -121.75 -5.6 9.14 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.393 1.452 . . . . 0.0 114.132 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 63.47 44.57 5.27 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.78 2.032 . . . . 0.0 113.008 -173.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.91 99.06 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 159.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 22.1 mt -92.84 138.13 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.945 1.698 . . . . 0.0 108.745 166.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -109.25 70.97 0.75 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.226 1.012 . . . . 0.0 109.375 171.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -64.24 -63.0 1.26 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.647 2.379 . . . . 0.0 112.556 -161.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.52 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -96.67 171.21 27.38 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.864 1.697 . . . . 0.0 115.537 -168.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.1 150.58 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 128.299 2.64 . . . . 0.0 110.915 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.473 HD23 ' HE3' ' A' ' 293' ' ' LYS . 3.7 mm? -85.98 122.82 30.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.059 1.744 . . . . 0.0 108.358 165.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 28.2 t -86.54 -43.79 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.359 0.527 . . . . 0.0 111.033 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 366' ' ' GLU . 4.9 t -101.1 175.3 5.64 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.551 0.691 . . . . 0.0 112.017 172.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.41 124.17 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.587 1.555 . . . . 0.0 112.859 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -81.01 122.17 81.51 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.1 0.96 . . . . 0.0 109.709 166.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -81.75 -171.45 1.21 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.615 3.543 . . . . 0.0 112.815 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.42 129.32 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.332 1.453 . . . . 0.0 107.321 165.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.68 81.93 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.794 1.238 . . . . 0.0 111.666 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 27.7 t -85.57 -10.53 55.78 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.143 0.977 . . . . 0.0 112.49 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.8 127.54 50.7 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 128.201 2.6 . . . . 0.0 106.036 170.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -67.6 -17.46 64.63 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.405 -1.434 . . . . 0.0 113.595 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.24 1.84 26.84 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 127.488 2.315 . . . . 0.0 114.032 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -44.77 133.55 6.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.667 1.222 . . . . 0.0 113.937 -168.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -141.87 138.31 32.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.454 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 13.8 p -147.82 146.03 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.79 0.805 . . . . 0.0 112.905 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -75.19 120.23 20.4 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.382 2.673 . . . . 0.0 109.193 166.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mt -132.37 139.3 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.892 0.769 . . . . 0.0 111.871 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . 0.468 ' H ' HG22 ' A' ' 351' ' ' THR . 31.3 mt-10 -111.17 135.66 51.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 110.206 161.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 31.4 m -117.74 161.01 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.344 1.057 . . . . 0.0 111.004 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -131.86 101.77 15.21 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.807 1.643 . . . . 0.0 109.153 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.36 164.71 28.54 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.075 1.85 . . . . 0.0 110.72 164.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.16 175.6 0.24 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.83 3.02 . . . . 0.0 113.313 160.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -58.55 144.23 43.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.278 0.631 . . . . 0.0 110.745 163.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 94.66 -142.97 16.31 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 115.469 0.948 . . . . 0.0 115.469 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.22 154.95 32.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.164 1.786 . . . . 0.0 113.21 -168.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 18.1 m -167.98 161.45 12.8 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.797 1.239 . . . . 0.0 113.5 168.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -124.75 110.34 14.22 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 127.963 2.505 . . . . 0.0 107.261 163.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 9.5 mm -73.85 124.97 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 55.2 mt -117.87 135.83 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.708 1.203 . . . . 0.0 109.145 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 68.6 t -126.51 97.13 3.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 126.393 1.877 . . . . 0.0 107.481 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 115.6 173.29 17.39 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 116.088 1.195 . . . . 0.0 116.088 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 74.0 p -130.58 173.06 11.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.989 1.716 . . . . 0.0 110.523 167.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 78.22 -161.31 48.74 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 -169.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -69.03 -30.78 69.22 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.476 -1.014 . . . . 0.0 111.597 167.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 54.7 m -58.44 -5.47 0.53 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 130.226 3.41 . . . . 0.0 118.411 -174.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -85.8 139.77 31.02 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.983 0.913 . . . . 0.0 111.669 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.1 mt -104.05 163.64 12.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 110.087 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.2 t -147.02 156.1 42.76 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 169.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -136.19 117.12 14.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.363 1.865 . . . . 0.0 108.69 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -65.21 134.92 54.73 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.17 0.988 . . . . 0.0 110.816 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -133.43 134.89 44.18 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.297 1.039 . . . . 0.0 110.891 171.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -115.64 126.76 54.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -127.0 150.23 49.53 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.582 1.553 . . . . 0.0 109.001 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -27.39 107.69 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.979 1.711 . . . . 0.0 114.326 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 159.75 -124.35 1.34 Allowed Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.971 -0.455 . . . . 0.0 114.167 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 4.5 p -55.72 -38.59 69.95 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.227 2.211 . . . . 0.0 115.067 -171.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 57.5 p -132.21 -1.74 3.6 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -166.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.4 tp -154.3 157.29 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.816 0.846 . . . . 0.0 111.212 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.8 -16.45 67.93 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.94 -0.922 . . . . 0.0 115.072 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 10.5 tptp . . . . . 0 C--O 1.276 2.483 0 CA-C-O 115.951 -1.976 . . . . 0.0 109.699 175.534 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 119.418 -0.325 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 40.7 p -113.06 -14.36 12.97 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.468 1.907 . . . . 0.0 114.316 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.99 1.34 2.76 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 10.4 mp -98.91 140.35 33.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.435 1.894 . . . . 0.0 109.223 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 22.3 p -41.01 -69.05 0.15 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.93 2.092 . . . . 0.0 113.148 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 35.8 tp -61.43 -12.84 16.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.51 1.524 . . . . 0.0 113.817 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.45 59.12 0.87 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.899 -1.125 . . . . 0.0 111.544 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 88.38 -43.15 3.1 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.671 1.605 . . . . 0.0 113.477 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 19.1 m -63.17 -34.55 77.86 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -168.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 34.3 m -165.41 110.58 0.89 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 121.16 1.8 . . . . 0.0 114.252 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.51 156.77 43.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.94 1.296 . . . . 0.0 111.309 164.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.66 97.35 2.65 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 158.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -68.42 154.91 40.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.852 2.461 . . . . 0.0 115.153 -171.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.7 m -102.7 140.6 36.76 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.0 1.32 . . . . 0.0 109.428 164.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 72.7 p -138.16 5.9 2.56 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -78.63 160.43 27.55 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.781 1.173 . . . . 0.0 110.517 162.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.11 98.02 0.42 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.09 2.156 . . . . 0.0 112.236 -161.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . 0.408 ' HE1' ' H ' ' A' ' 380' ' ' THR . 32.2 mtm -82.38 165.71 20.06 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.098 0.959 . . . . 0.0 111.919 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.4 m -160.62 163.53 32.54 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.363 -0.835 . . . . 0.0 111.768 169.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.1 125.9 30.09 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 164.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.64 -27.74 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.621 0.768 . . . . 0.0 109.737 159.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -144.29 119.06 9.86 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.541 2.337 . . . . 0.0 108.062 170.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -52.86 145.16 23.42 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.785 1.234 . . . . 0.0 111.803 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.36 129.65 35.8 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.916 2.411 . . . . 0.0 111.948 173.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 69.9 p -126.56 132.49 51.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.839 0.856 . . . . 0.0 111.093 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -61.9 135.89 57.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.026 1.73 . . . . 0.0 112.026 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.3 p -91.26 -13.41 32.78 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 64.94 0.11 4.95 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.979 1.276 . . . . 0.0 114.752 -167.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -90.53 9.75 28.17 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.992 1.396 . . . . 0.0 111.748 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.59 15.5 65.83 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 118.771 -1.016 . . . . 0.0 113.583 -167.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 22.3 p -131.51 168.83 16.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.001 1.401 . . . . 0.0 113.021 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.84 130.75 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 126.104 1.762 . . . . 0.0 108.245 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.91 133.34 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.511 1.124 . . . . 0.0 112.368 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -140.61 163.47 32.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.835 1.654 . . . . 0.0 113.155 -176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -120.7 123.7 43.36 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.814 1.246 . . . . 0.0 107.742 164.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.3 m -127.44 147.96 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.786 0.835 . . . . 0.0 111.678 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -132.68 142.45 49.08 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.393 1.477 . . . . 0.0 113.205 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 t -107.73 143.24 26.88 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.35 2.66 . . . . 0.0 107.829 162.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -103.36 -62.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.264 1.976 . . . . 0.0 115.679 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.48 170.45 15.9 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.808 1.185 . . . . 0.0 113.166 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 67.09 -14.27 0.44 Allowed Glycine 0 CA--C 1.539 1.553 0 C-N-CA 126.968 2.223 . . . . 0.0 117.692 171.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.03 99.8 44.32 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 119.204 1.502 . . . . 0.0 113.327 -167.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.19 113.52 3.2 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.288 2.659 . . . . 0.0 108.878 157.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 16.2 p -158.92 148.19 18.8 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -170.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.57 99.34 5.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.44 1.496 . . . . 0.0 106.997 161.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.267 0.9 OUTLIER -61.28 114.13 9.91 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 123.222 0.326 . . . . 0.0 111.617 -159.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.07 113.5 3.72 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.954 2.436 . . . . 0.0 112.668 -167.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 64.0 t -109.12 115.81 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.0 2.12 . . . . 0.0 109.424 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 159.31 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.662 1.185 . . . . 0.0 110.434 -175.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . 0.484 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 51.0 t -140.22 114.71 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.472 1.109 . . . . 0.0 108.136 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -144.49 170.18 16.54 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.018 0.826 . . . . 0.0 113.055 -169.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -106.39 6.37 30.33 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.947 0.899 . . . . 0.0 112.07 171.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 41.6 p30 -115.87 2.5 13.58 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.093 1.757 . . . . 0.0 113.98 -163.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 49.4 mt 60.68 3.9 0.68 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.737 2.415 . . . . 0.0 115.397 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 3.7 t -137.13 -9.36 1.76 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -173.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 55.82 51.59 12.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.858 2.063 . . . . 0.0 113.423 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -68.83 -34.97 76.38 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 157.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 44.8 mm -111.24 141.55 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.341 1.456 . . . . 0.0 108.71 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -114.8 128.4 56.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.86 0.838 . . . . 0.0 110.899 165.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -87.56 -68.24 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.494 2.318 . . . . 0.0 110.227 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.484 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -93.33 166.78 28.43 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.224 1.392 . . . . 0.0 116.41 -162.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.7 152.85 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 128.027 2.531 . . . . 0.0 110.026 -167.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.0 127.45 31.99 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.837 1.255 . . . . 0.0 109.448 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.1 t -90.19 -37.42 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.176 0.444 . . . . 0.0 111.141 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 366' ' ' GLU . 6.1 t -106.61 173.49 6.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.243 1.017 . . . . 0.0 112.072 175.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.8 m -66.47 126.94 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.475 1.51 . . . . 0.0 112.177 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -96.0 129.57 33.67 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.653 1.581 . . . . 0.0 110.065 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -83.94 -176.48 2.67 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.263 3.309 . . . . 0.0 114.649 -168.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.47 120.81 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.686 2.394 . . . . 0.0 107.946 168.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.02 74.25 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.908 1.683 . . . . 0.0 112.97 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -67.09 -16.02 64.07 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 171.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.5 p -127.96 139.4 52.6 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 127.298 2.239 . . . . 0.0 106.074 157.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.7 -15.57 63.71 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -167.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.29 -2.0 14.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 128.03 2.532 . . . . 0.0 114.608 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -40.12 118.48 0.9 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.843 2.057 . . . . 0.0 114.264 -174.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.92 131.86 33.65 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.399 1.48 . . . . 0.0 111.427 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.76 148.76 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -160.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -75.8 126.26 30.66 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 128.513 2.725 . . . . 0.0 109.975 166.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 25.9 mt -136.1 137.59 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.76 0.709 . . . . 0.0 111.271 173.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . 0.424 ' H ' HG22 ' A' ' 351' ' ' THR . 16.1 mt-10 -105.93 137.74 43.32 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.648 1.179 . . . . 0.0 111.542 159.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.5 150.73 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.311 1.444 . . . . 0.0 111.294 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -110.57 101.0 47.56 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.081 2.153 . . . . 0.0 109.078 175.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.21 162.84 31.03 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.776 2.318 . . . . 0.0 110.935 166.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.76 176.42 3.63 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.427 2.085 . . . . 0.0 111.663 162.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -70.97 147.43 48.69 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.894 -0.504 . . . . 0.0 111.117 165.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 95.35 -159.42 22.55 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.218 0.913 . . . . 0.0 113.492 -172.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.1 158.58 25.47 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.496 1.518 . . . . 0.0 114.9 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.9 m -167.57 150.3 5.97 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.838 1.655 . . . . 0.0 111.419 162.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -104.74 116.63 32.35 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.379 1.472 . . . . 0.0 108.15 155.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.9 mm -67.33 130.83 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 165.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.29 130.45 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.85 1.26 . . . . 0.0 108.828 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.8 t -117.54 100.02 9.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.393 1.877 . . . . 0.0 107.772 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 106.73 -178.48 22.32 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 123.096 1.387 . . . . 0.0 115.604 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . 0.408 ' H ' ' HE1' ' A' ' 304' ' ' MET . 1.0 OUTLIER -135.5 169.76 17.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.098 2.559 . . . . 0.0 110.719 175.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 81.21 -166.9 48.67 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.925 0.774 . . . . 0.0 112.341 -171.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -65.21 -33.29 75.65 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.143 -1.21 . . . . 0.0 110.908 164.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 63.0 m -56.89 -1.59 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 131.041 3.736 . . . . 0.0 118.455 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -88.76 148.37 23.98 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.135 0.974 . . . . 0.0 111.684 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.0 mt -109.67 167.0 10.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.149 0.58 . . . . 0.0 110.837 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 9.9 t -147.06 159.27 43.79 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 172.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -149.82 125.99 10.68 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.55 1.54 . . . . 0.0 110.585 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.61 138.16 39.94 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 112.549 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -142.5 138.09 30.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.226 1.41 . . . . 0.0 111.457 164.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -118.31 129.09 55.25 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.82 1.248 . . . . 0.0 109.759 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -85.63 144.81 27.64 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 392' ' ' GLU . 5.6 pm0 -56.9 156.2 7.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 130.407 3.483 . . . . 0.0 115.857 -173.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 83.6 28.78 34.54 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.551 1.072 . . . . 0.0 113.499 -170.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . 0.407 ' OG ' ' OXT' ' A' ' 398' ' ' LYS . 63.6 p -108.93 175.44 5.46 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.086 1.754 . . . . 0.0 115.465 -163.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 42.5 p -66.84 -18.59 65.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.127 1.771 . . . . 0.0 114.486 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 14.1 pt -91.79 6.38 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.69 1.132 . . . . 0.0 113.314 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 86.71 5.95 80.79 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 123.954 0.788 . . . . 0.0 114.441 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.407 ' OXT' ' OG ' ' A' ' 394' ' ' SER . 54.2 tttm . . . . . 0 C--O 1.246 0.871 0 C-N-CA 127.234 2.213 . . . . 0.0 108.14 169.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 118.58 -0.724 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 33.7 p -123.29 -12.69 7.8 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -172.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.85 23.31 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.5 2.32 . . . . 0.0 115.853 -172.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 45.0 tp -142.46 148.41 37.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.885 1.674 . . . . 0.0 110.052 -175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 23.6 p -41.6 -63.15 0.75 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.307 2.643 . . . . 0.0 113.26 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.04 -13.84 13.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.356 2.262 . . . . 0.0 114.037 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.78 64.11 0.79 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.093 -1.63 . . . . 0.0 110.177 -177.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 78.13 -38.04 1.77 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.971 1.748 . . . . 0.0 114.095 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.1 m -54.01 -47.54 71.4 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.917 1.287 . . . . 0.0 114.273 -170.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 8.6 m -178.26 115.0 0.07 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 120.262 1.392 . . . . 0.0 112.458 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -155.89 155.62 33.2 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.567 0.747 . . . . 0.0 111.468 164.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.47 99.78 5.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.905 1.282 . . . . 0.0 108.723 169.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.91 162.34 22.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.029 1.332 . . . . 0.0 113.864 -177.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . 0.418 ' H ' ' HD3' ' A' ' 333' ' ' PRO . 3.3 m -92.94 149.47 21.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.424 0.689 . . . . 0.0 109.653 168.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 77.8 p -136.85 6.28 2.9 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -78.63 158.98 28.29 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.467 1.03 . . . . 0.0 111.457 165.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.35 92.15 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.51 2.324 . . . . 0.0 112.635 -167.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 15.3 mtm -76.26 166.96 22.7 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.905 1.282 . . . . 0.0 112.618 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.9 m -158.23 157.23 32.18 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.113 -0.992 . . . . 0.0 112.774 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.42 120.24 25.64 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.52 0.728 . . . . 0.0 110.363 166.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.91 -27.99 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.082 1.753 . . . . 0.0 110.67 165.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -142.63 125.87 16.5 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.532 1.933 . . . . 0.0 108.024 170.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -57.43 144.88 70.31 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.385 1.074 . . . . 0.0 111.513 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.95 129.33 33.68 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.827 2.351 . . . . 0.0 111.529 170.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 41.2 p -124.21 123.15 39.64 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.373 1.069 . . . . 0.0 110.289 171.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -63.65 136.34 57.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.983 1.313 . . . . 0.0 111.157 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.8 p -89.62 -14.95 33.84 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.326 1.05 . . . . 0.0 113.065 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.24 -12.13 1.31 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.408 1.004 . . . . 0.0 114.405 -164.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -84.57 14.46 4.57 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.903 1.681 . . . . 0.0 112.057 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.37 5.18 63.74 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.679 1.133 . . . . 0.0 114.14 -172.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 64.9 p -131.68 165.86 22.77 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.937 1.368 . . . . 0.0 113.819 -170.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.62 138.09 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 127.854 2.462 . . . . 0.0 107.675 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 6.7 p -119.62 132.16 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.309 0.959 . . . . 0.0 112.517 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -139.92 167.16 22.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.503 1.521 . . . . 0.0 113.454 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -124.0 129.87 51.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.437 1.495 . . . . 0.0 107.583 166.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.52 150.76 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.061 0.944 . . . . 0.0 112.378 -175.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -132.51 142.41 49.19 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.49 1.516 . . . . 0.0 112.818 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.09 148.46 37.53 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 128.226 2.611 . . . . 0.0 108.216 167.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -100.13 -72.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.59 2.193 . . . . 0.0 115.745 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.79 165.37 27.18 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.556 1.525 . . . . 0.0 114.388 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 69.33 -8.19 3.04 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 126.497 1.999 . . . . 0.0 117.274 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -108.49 99.86 35.2 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 119.078 1.439 . . . . 0.0 113.199 -168.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.99 121.95 6.47 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.789 2.326 . . . . 0.0 108.746 152.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.1 p -165.59 154.17 11.58 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -173.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -83.33 110.77 18.4 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 156.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.257 1.3 pp -67.45 132.29 93.06 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 120.324 -0.55 . . . . 0.0 112.349 -155.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.418 ' HD3' ' H ' ' A' ' 300' ' ' CYS . 73.8 Cg_endo -72.42 91.47 0.77 Allowed 'Trans proline' 0 CA--C 1.54 0.784 1 C-N-CA 125.449 4.099 . . . . 0.0 113.734 -168.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.09 117.03 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.215 1.406 . . . . 0.0 109.365 166.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.48 162.56 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.206 1.803 . . . . 0.0 109.359 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.62 127.3 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -136.48 174.56 10.49 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -170.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -118.6 -6.68 10.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 127.028 2.131 . . . . 0.0 112.966 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 29.5 p30 -106.98 0.48 23.75 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.063 2.145 . . . . 0.0 113.61 -166.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 74.7 mt 57.17 5.22 0.24 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.795 2.438 . . . . 0.0 115.734 -170.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.9 t -127.74 -3.12 5.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.427 1.491 . . . . 0.0 114.461 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 52.39 45.72 27.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.919 2.088 . . . . 0.0 113.584 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -72.93 -38.76 66.7 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 163.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 19.1 mm -108.05 128.67 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.774 1.23 . . . . 0.0 109.717 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -97.17 109.31 22.09 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.62 0.724 . . . . 0.0 111.829 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -63.99 -62.98 1.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.752 3.221 . . . . 0.0 112.789 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -104.23 -171.5 25.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.499 1.523 . . . . 0.0 115.756 -160.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 3.3 mm -132.68 152.74 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.755 2.022 . . . . 0.0 111.302 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.9 129.01 34.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.414 1.485 . . . . 0.0 109.507 170.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 43.4 t -99.35 -36.86 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.266 0.626 . . . . 0.0 110.737 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.574 ' HB ' ' H ' ' A' ' 366' ' ' GLU . 1.2 m -105.4 162.06 13.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.013 1.325 . . . . 0.0 111.478 175.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.5 m -47.82 107.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 127.367 2.267 . . . . 0.0 114.215 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -73.89 117.66 63.0 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.306 1.042 . . . . 0.0 109.595 162.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -82.33 -175.73 2.63 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.334 3.356 . . . . 0.0 114.118 -171.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 117.79 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 127.308 2.243 . . . . 0.0 107.808 170.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.67 74.62 0.82 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.547 1.139 . . . . 0.0 112.552 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 22.6 t -69.53 -18.7 63.69 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 23.3 p -123.81 121.27 34.98 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 127.148 2.179 . . . . 0.0 105.936 162.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.43 -18.87 53.84 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -166.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -71.79 3.96 3.7 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.507 1.923 . . . . 0.0 113.791 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -39.59 126.48 1.88 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.593 2.357 . . . . 0.0 113.913 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -141.3 112.1 7.14 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.868 2.067 . . . . 0.0 109.058 -168.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.14 148.37 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -160.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -86.65 124.53 33.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.523 2.729 . . . . 0.0 109.221 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 55.9 mt -135.31 132.21 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.409 0.623 . . . . 0.0 111.2 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . 0.574 ' H ' ' HB ' ' A' ' 351' ' ' THR . 25.0 mp0 -97.36 138.63 34.52 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.648 1.579 . . . . 0.0 111.497 161.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 22.1 t -129.19 153.93 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 127.564 2.345 . . . . 0.0 109.152 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -118.96 114.99 35.01 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.808 2.043 . . . . 0.0 109.576 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -82.81 162.0 16.21 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.207 2.604 . . . . 0.0 110.685 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -74.41 178.46 7.0 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.541 2.16 . . . . 0.0 110.738 163.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -71.02 130.84 42.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.009 1.324 . . . . 0.0 109.733 171.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.55 -143.55 16.34 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.12 0.866 . . . . 0.0 112.884 -176.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -72.12 152.69 42.15 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.185 2.594 . . . . 0.0 114.477 -173.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 17.0 m -166.36 153.18 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.052 1.341 . . . . 0.0 113.145 167.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -120.53 109.6 15.46 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 128.36 2.664 . . . . 0.0 106.846 165.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 16.3 mm -68.13 120.01 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 172.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 80.7 mt -114.18 126.9 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.488 1.115 . . . . 0.0 109.067 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.8 t -119.69 101.81 11.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.794 1.638 . . . . 0.0 107.176 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 123.07 172.28 13.83 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 123.074 1.374 . . . . 0.0 115.903 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.5 161.05 39.05 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.507 2.323 . . . . 0.0 109.057 173.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.47 -167.42 53.43 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 -163.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -62.36 -31.6 72.27 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.775 -0.838 . . . . 0.0 111.869 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.2 m -55.65 3.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 130.642 3.577 . . . . 0.0 117.875 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -97.1 142.86 28.52 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.401 1.08 . . . . 0.0 111.859 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 22.2 mt -114.93 166.4 11.83 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.77 0.828 . . . . 0.0 110.678 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.2 t -146.1 161.89 39.16 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -145.68 128.38 16.21 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.028 1.731 . . . . 0.0 109.353 176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -78.92 138.28 38.02 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.733 1.213 . . . . 0.0 111.67 -175.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -143.12 140.3 30.78 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.704 1.202 . . . . 0.0 111.651 168.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -110.04 138.18 46.77 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.765 0.826 . . . . 0.0 109.399 164.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.95 113.27 25.48 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.851 1.66 . . . . 0.0 108.383 173.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 88.16 146.44 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 129.706 3.202 . . . . 0.0 112.069 -172.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -86.36 60.81 4.51 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.456 1.027 . . . . 0.0 113.815 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 26.2 m -60.24 12.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.185 2.194 . . . . 0.0 116.603 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 63.9 p -81.76 -15.73 53.36 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.17 1.788 . . . . 0.0 113.976 172.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.87 -24.66 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.596 1.158 . . . . 0.0 113.173 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 165.75 178.32 38.62 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 126.58 2.038 . . . . 0.0 109.548 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.873 -1.537 . . . . 0.0 109.942 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 12.5 mmt . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 118.967 -0.539 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 59.7 p -96.62 -2.77 44.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.99 1.316 . . . . 0.0 114.488 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.63 18.39 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.474 2.31 . . . . 0.0 116.15 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 39.7 tp -133.7 138.16 45.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.707 2.003 . . . . 0.0 108.088 172.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.6 p -35.66 -62.93 0.38 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.733 2.413 . . . . 0.0 113.619 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 49.1 tp -55.76 -12.21 1.22 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.184 2.594 . . . . 0.0 115.319 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.98 69.1 0.85 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 120.443 -1.41 . . . . 0.0 110.948 -170.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.89 -45.03 2.15 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.272 1.415 . . . . 0.0 113.277 -174.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 90.9 m -48.91 -51.74 28.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.807 2.443 . . . . 0.0 115.013 -171.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 14.0 m -175.38 122.56 0.21 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.674 1.579 . . . . 0.0 113.119 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -157.79 154.14 27.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.385 1.074 . . . . 0.0 112.135 168.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.42 101.37 6.36 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.788 1.235 . . . . 0.0 108.455 166.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.65 153.1 37.43 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.45 1.9 . . . . 0.0 115.003 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 12.8 m -94.08 141.4 28.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.205 1.002 . . . . 0.0 109.319 164.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 80.7 p -135.46 2.52 2.98 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -79.71 164.1 23.99 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.592 1.087 . . . . 0.0 111.012 166.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -62.01 105.59 0.6 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.286 1.834 . . . . 0.0 112.54 -161.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 30.2 mtm -94.79 163.57 13.29 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.685 0.755 . . . . 0.0 111.907 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 32.3 m -160.77 156.88 25.94 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.206 -0.934 . . . . 0.0 112.0 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.69 120.04 19.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.909 0.883 . . . . 0.0 110.665 167.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.86 -29.0 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.35 1.46 . . . . 0.0 109.966 163.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -140.89 133.65 28.89 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.598 1.959 . . . . 0.0 109.329 170.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -59.02 144.2 82.83 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.024 0.929 . . . . 0.0 111.87 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -58.37 138.83 87.95 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.224 1.949 . . . . 0.0 111.9 171.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 35.6 p -133.89 125.13 27.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.195 1.398 . . . . 0.0 111.336 174.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -61.85 122.39 15.29 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.462 1.505 . . . . 0.0 111.537 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 74.6 p -80.79 -13.84 58.61 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.001 1.321 . . . . 0.0 113.83 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.03 -1.44 4.81 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 120.972 -1.08 . . . . 0.0 114.293 -164.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -85.59 12.16 9.25 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.198 1.499 . . . . 0.0 111.263 176.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.26 0.81 88.5 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.003 1.287 . . . . 0.0 113.874 -165.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 7.2 p -119.15 162.26 18.95 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.136 1.468 . . . . 0.0 112.807 -172.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.3 t -133.85 117.05 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.616 1.566 . . . . 0.0 107.748 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.3 p -104.97 130.03 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.243 1.017 . . . . 0.0 112.825 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -139.07 166.82 23.5 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.787 2.035 . . . . 0.0 111.499 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -135.47 145.08 46.79 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.779 -0.576 . . . . 0.0 111.007 160.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.6 m -137.11 161.14 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.062 1.345 . . . . 0.0 110.833 -168.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -128.78 145.69 51.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.988 1.315 . . . . 0.0 112.258 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.1 t -113.06 147.84 38.15 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 128.523 2.729 . . . . 0.0 107.113 165.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -111.41 -64.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 CA-C-N 122.538 1.942 . . . . 0.0 115.122 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 160.46 38.29 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -172.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.79 -0.08 2.52 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 127.385 2.422 . . . . 0.0 118.653 170.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.64 93.39 36.92 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 119.994 1.897 . . . . 0.0 114.464 -161.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.6 115.43 3.87 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.431 2.754 . . . . 0.0 109.864 161.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.2 p -164.2 153.58 13.91 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -172.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.92 105.39 12.11 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.009 1.723 . . . . 0.0 107.041 159.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.29 0.9 OUTLIER -67.16 120.31 71.27 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.045 -155.051 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.89 111.04 2.08 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.573 3.515 . . . . 0.0 114.237 -167.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.31 114.71 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 126.041 1.736 . . . . 0.0 109.114 170.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.04 159.03 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 126.659 1.984 . . . . 0.0 109.03 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 6.2 t -140.64 120.54 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -145.32 171.45 14.57 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.707 1.14 . . . . 0.0 113.385 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -101.11 -3.03 29.97 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.413 0.685 . . . . 0.0 112.67 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -112.58 1.95 16.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.819 1.647 . . . . 0.0 114.265 -162.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 19.1 mt 63.0 -15.58 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 128.028 2.531 . . . . 0.0 115.645 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.3 t -107.87 -4.39 18.04 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 113.884 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 59.97 61.07 1.96 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.926 2.49 . . . . 0.0 113.126 -171.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -88.09 -39.89 14.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.412 0.685 . . . . 0.0 111.601 166.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 42.3 mm -111.15 105.03 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.587 1.555 . . . . 0.0 110.117 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -78.01 102.2 7.28 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.705 1.139 . . . . 0.0 112.699 172.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -63.82 -53.63 47.76 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 128.2 2.6 . . . . 0.0 113.0 171.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -116.5 156.76 15.44 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 116.791 1.476 . . . . 0.0 116.791 -158.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.75 150.69 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.809 2.044 . . . . 0.0 109.772 -174.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.69 130.4 36.75 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.132 1.373 . . . . 0.0 109.597 170.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 29.8 m -120.53 -30.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.3 m -101.0 152.93 19.99 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 160.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.5 m -48.78 132.33 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.135 1.774 . . . . 0.0 114.812 -169.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -110.19 119.34 47.35 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.191 1.796 . . . . 0.0 108.337 168.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.88 -179.02 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.876 3.051 . . . . 0.0 114.394 -166.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.67 110.39 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 127.911 2.485 . . . . 0.0 106.517 169.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.89 84.05 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.537 1.535 . . . . 0.0 111.957 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 25.4 t -75.35 -8.93 57.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 166.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 13.6 p -131.25 128.47 39.93 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.997 2.119 . . . . 0.0 107.245 164.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.28 -19.25 65.28 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -172.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -84.66 6.99 21.88 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.64 1.176 . . . . 0.0 113.43 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -47.58 133.64 13.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.485 1.514 . . . . 0.0 113.582 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -138.54 132.59 31.39 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.087 1.355 . . . . 0.0 110.542 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.93 146.98 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -158.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.39 124.98 35.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 128.615 2.766 . . . . 0.0 109.799 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 12.7 mt -135.71 150.03 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.35 1.46 . . . . 0.0 109.859 -170.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -123.51 146.56 47.99 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.806 0.842 . . . . 0.0 111.223 163.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 3.1 m -123.25 151.96 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 124.664 1.186 . . . . 0.0 111.381 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -121.75 100.9 43.26 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.021 2.128 . . . . 0.0 109.499 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.63 168.93 12.45 Favored 'Trans proline' 0 CA--C 1.55 1.308 0 C-N-CA 123.677 2.918 . . . . 0.0 110.936 160.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.85 179.91 4.86 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.728 2.285 . . . . 0.0 111.046 166.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -58.12 145.24 37.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.288 0.635 . . . . 0.0 110.742 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.15 -163.96 28.18 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 121.783 0.657 . . . . 0.0 114.062 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.41 157.38 34.25 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.655 1.982 . . . . 0.0 114.778 -164.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.2 m -173.94 164.09 4.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.039 2.135 . . . . 0.0 112.203 169.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -122.47 117.21 25.41 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.83 2.852 . . . . 0.0 108.127 164.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mm -68.68 136.46 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 167.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 67.9 mt -127.94 123.76 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.977 1.311 . . . . 0.0 108.694 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 53.3 t -110.62 109.6 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.885 1.674 . . . . 0.0 107.363 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 117.2 171.82 15.84 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 122.923 1.291 . . . . 0.0 115.746 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.79 166.09 25.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.314 2.246 . . . . 0.0 109.329 169.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 68.61 -165.26 47.77 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 -166.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -64.65 -26.37 68.36 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.794 0.837 . . . . 0.0 112.539 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.7 m -64.72 4.39 0.41 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 129.105 2.962 . . . . 0.0 117.026 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -93.77 140.93 29.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.044 0.838 . . . . 0.0 112.659 -172.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 20.8 mt -113.45 164.62 13.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.742 1.217 . . . . 0.0 110.701 173.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 15.0 t -146.66 160.78 41.77 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -151.07 127.62 10.78 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.849 1.66 . . . . 0.0 110.341 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -76.46 134.35 39.57 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.766 1.226 . . . . 0.0 111.894 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -143.67 135.5 26.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.687 1.195 . . . . 0.0 111.274 171.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -116.16 116.32 27.62 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -82.96 123.57 29.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.226 1.011 . . . . 0.0 112.04 -172.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 64.33 132.62 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 1 C-N-CA 131.782 4.033 . . . . 0.0 115.259 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -58.71 60.35 0.01 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 129.271 3.32 . . . . 0.0 113.681 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 68.8 m -64.76 7.57 0.15 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 130.547 3.539 . . . . 0.0 116.169 -157.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 33.5 t -107.71 -5.5 17.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.122 1.369 . . . . 0.0 113.399 169.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.5 tt -152.02 -24.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 171.6 -147.34 10.12 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 120.268 1.394 . . . . 0.0 114.207 -173.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.247 0.929 0 C-N-CA 125.993 1.717 . . . . 0.0 111.502 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.96 6.87 5.5 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -173.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.51 -0.17 4.74 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -169.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.65 146.02 32.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.776 1.23 . . . . 0.0 109.957 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 p -31.42 -63.44 0.17 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.146 2.579 . . . . 0.0 113.003 173.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.37 -9.47 5.44 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.393 1.877 . . . . 0.0 115.067 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.27 74.53 0.89 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.744 1.218 . . . . 0.0 110.532 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 69.2 -5.27 5.22 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.489 1.519 . . . . 0.0 116.023 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 22.1 m -89.53 -42.65 11.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.199 1.499 . . . . 0.0 112.675 -167.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.8 m -176.93 126.26 0.16 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.215 1.806 . . . . 0.0 112.285 172.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -161.29 152.08 18.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.634 1.574 . . . . 0.0 110.109 169.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.05 101.17 2.67 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 164.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.99 154.93 41.31 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.182 1.793 . . . . 0.0 113.831 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 141.25 38.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 162.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 76.0 p -130.94 10.48 5.02 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.906 0.883 . . . . 0.0 113.234 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -79.38 161.36 26.23 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.895 0.77 . . . . 0.0 110.981 165.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -65.22 103.76 0.83 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.127 2.171 . . . . 0.0 112.358 -163.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 33.6 mtt -83.71 168.5 16.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.961 0.886 . . . . 0.0 113.035 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.3 m -157.34 160.18 38.24 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.436 -0.79 . . . . 0.0 111.721 156.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -82.67 120.12 25.16 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.272 0.629 . . . . 0.0 110.155 166.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 22.6 t -66.61 -30.76 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.184 1.394 . . . . 0.0 110.698 163.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -142.17 123.33 14.65 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.557 1.943 . . . . 0.0 107.651 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -57.8 154.54 26.54 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.241 0.616 . . . . 0.0 111.797 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -56.22 124.39 16.14 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.876 2.384 . . . . 0.0 111.909 165.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.8 p -129.81 128.75 42.96 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.419 1.088 . . . . 0.0 111.569 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -61.78 126.75 28.45 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.344 0.658 . . . . 0.0 110.412 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.2 p -79.09 -12.97 60.02 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.818 1.247 . . . . 0.0 113.128 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.04 -6.69 1.98 Allowed Glycine 0 CA--C 1.539 1.553 0 CA-C-N 119.186 0.903 . . . . 0.0 114.231 -164.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -87.84 2.05 52.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.599 1.559 . . . . 0.0 111.643 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.99 2.31 39.25 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.756 1.646 . . . . 0.0 114.022 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.9 p -128.97 166.32 19.4 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.017 1.327 . . . . 0.0 111.975 -168.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 6.8 t -131.24 111.77 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.64 1.576 . . . . 0.0 108.377 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.58 137.07 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.064 1.346 . . . . 0.0 112.993 -168.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 11.6 ptt? -142.47 164.45 30.11 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.998 2.119 . . . . 0.0 112.772 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -118.31 132.12 56.3 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.816 1.246 . . . . 0.0 108.016 161.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.3 152.44 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.741 0.817 . . . . 0.0 111.095 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -135.07 148.23 49.81 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.013 1.325 . . . . 0.0 112.327 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.43 150.65 46.92 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 128.043 2.537 . . . . 0.0 108.173 169.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -105.66 -68.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.366 2.044 . . . . 0.0 114.466 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 167.79 20.11 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -171.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.75 -6.73 0.32 Allowed Glycine 0 CA--C 1.537 1.46 0 C-N-CA 127.596 2.522 . . . . 0.0 118.496 170.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -115.15 94.03 37.42 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 119.872 1.836 . . . . 0.0 114.754 -160.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.8 121.32 7.26 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.753 2.302 . . . . 0.0 109.956 157.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.0 p -163.34 157.43 20.09 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -175.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -90.84 98.71 11.94 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 160.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.255 1.0 OUTLIER -60.9 123.03 73.2 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.811 -154.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.97 116.84 4.86 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.289 3.326 . . . . 0.0 113.206 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 88.1 t -125.52 112.02 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.234 1.814 . . . . 0.0 109.812 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.97 157.41 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.362 1.065 . . . . 0.0 110.339 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 39.0 t -137.54 112.02 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -135.98 167.0 22.03 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -167.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -101.13 -2.4 31.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.671 0.788 . . . . 0.0 112.387 174.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 27.2 p30 -114.48 2.83 14.74 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.578 1.951 . . . . 0.0 113.723 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 20.4 mt 62.78 5.13 1.64 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.544 2.338 . . . . 0.0 115.436 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 4.9 t -135.94 -10.52 2.04 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 61.29 58.76 2.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.84 2.456 . . . . 0.0 113.83 -171.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.44 -36.12 58.13 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.189 152.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 15.8 mm -120.1 111.19 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.126 1.77 . . . . 0.0 109.956 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -89.67 120.25 30.79 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.294 -0.879 . . . . 0.0 112.241 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -72.3 -63.24 1.19 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.937 2.495 . . . . 0.0 111.722 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -106.2 161.03 14.37 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 116.903 1.521 . . . . 0.0 116.903 -155.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.4 mp -104.39 152.25 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 127.108 2.163 . . . . 0.0 110.553 -173.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.12 125.9 30.03 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.288 1.435 . . . . 0.0 109.568 169.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 66.6 t -94.4 -45.84 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.426 0.69 . . . . 0.0 111.219 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 366' ' ' GLU . 1.5 t -105.05 -179.15 3.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.413 0.685 . . . . 0.0 112.031 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 29.5 m -53.72 123.14 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.574 1.55 . . . . 0.0 113.168 -176.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -95.03 119.3 66.06 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.097 0.959 . . . . 0.0 108.84 165.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -80.36 179.61 6.0 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.984 3.123 . . . . 0.0 113.583 -167.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.89 114.74 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.834 2.054 . . . . 0.0 106.961 167.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.02 71.72 0.17 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.815 1.246 . . . . 0.0 111.547 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 26.4 t -69.15 -8.85 49.34 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.247 -0.908 . . . . 0.0 112.507 163.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 41.0 p -128.13 116.9 20.66 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 128.408 2.683 . . . . 0.0 106.501 166.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -53.34 -20.97 4.96 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -77.08 4.09 11.0 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.352 1.861 . . . . 0.0 113.604 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -41.45 127.8 3.03 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.503 1.921 . . . . 0.0 113.957 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.13 146.92 43.4 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.303 1.041 . . . . 0.0 111.356 171.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 8.7 p -156.83 145.81 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -163.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.14 121.3 23.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.366 2.267 . . . . 0.0 108.78 164.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.93 142.15 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 118.678 0.672 . . . . 0.0 111.076 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . 0.66 ' H ' HG22 ' A' ' 351' ' ' THR . 32.1 mt-10 -114.39 139.18 49.7 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.144 1.778 . . . . 0.0 110.491 166.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.16 163.7 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.61 1.164 . . . . 0.0 111.547 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -131.25 98.79 18.2 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.244 1.817 . . . . 0.0 109.518 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -75.33 161.93 37.04 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.052 2.501 . . . . 0.0 111.458 160.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.21 -176.48 2.7 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.631 2.887 . . . . 0.0 111.154 163.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -55.75 151.68 10.78 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.124 1.37 . . . . 0.0 112.734 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 79.45 -159.06 44.26 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 121.283 0.38 . . . . 0.0 113.668 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -62.23 156.08 22.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.503 1.521 . . . . 0.0 114.116 -167.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.4 m -168.58 161.5 11.54 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.112 1.765 . . . . 0.0 111.946 165.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -122.33 113.48 19.47 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.944 2.098 . . . . 0.0 108.052 166.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.4 mm -74.03 120.3 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 79.4 mt -116.4 127.63 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.243 1.417 . . . . 0.0 109.566 -174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 70.3 t -118.36 105.22 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 126.417 1.887 . . . . 0.0 108.12 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 111.5 175.83 20.13 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 122.485 1.047 . . . . 0.0 115.256 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 1.8 p -134.74 164.86 26.58 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.359 1.864 . . . . 0.0 110.548 169.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 82.64 -170.03 49.68 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 123.827 0.727 . . . . 0.0 112.594 -168.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -63.39 -29.96 71.17 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.995 -1.297 . . . . 0.0 111.317 165.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 27.3 m -55.66 1.35 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 131.478 3.911 . . . . 0.0 118.101 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -102.04 147.11 26.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.484 1.513 . . . . 0.0 111.573 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 40.9 mt -119.62 165.76 14.05 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.585 0.754 . . . . 0.0 111.036 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.1 t -148.32 158.97 44.42 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -141.55 137.81 32.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.838 1.655 . . . . 0.0 109.537 174.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -76.93 145.25 38.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.098 1.359 . . . . 0.0 111.927 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -140.34 159.38 42.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.831 1.252 . . . . 0.0 111.992 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -139.77 114.74 9.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.633 1.573 . . . . 0.0 107.553 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.73 120.85 29.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.131 0.973 . . . . 0.0 111.792 -172.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 75.15 132.68 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 130.924 3.69 . . . . 0.0 114.647 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -65.04 64.72 0.08 OUTLIER Glycine 0 C--N 1.343 0.97 0 C-N-CA 128.817 3.103 . . . . 0.0 113.345 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 45.5 m -65.05 -10.59 31.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.607 1.963 . . . . 0.0 113.613 -173.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 30.1 t -74.84 -5.86 45.85 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.166 1.387 . . . . 0.0 114.127 167.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 5.5 tp -140.68 -41.52 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.779 1.632 . . . . 0.0 112.009 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 155.7 -33.1 0.63 Allowed Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.219 0.914 . . . . 0.0 114.525 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? . . . . . 0 C--O 1.248 1.009 0 C-N-CA 126.063 1.745 . . . . 0.0 109.832 -179.037 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.3 p -83.67 -14.08 52.64 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.97 1.308 . . . . 0.0 113.59 170.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.47 23.89 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.561 2.744 . . . . 0.0 116.34 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 61.3 tp -138.13 139.83 39.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.808 1.643 . . . . 0.0 108.75 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 38.8 p -42.65 -61.67 1.18 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.584 1.954 . . . . 0.0 113.188 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 54.7 tp -56.2 -14.43 2.76 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.191 2.197 . . . . 0.0 114.913 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -110.74 72.12 0.77 Allowed 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.96 1.304 . . . . 0.0 109.274 -168.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 77.7 -45.83 2.5 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.934 1.254 . . . . 0.0 113.637 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 5.9 m -49.04 -56.84 7.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.865 1.666 . . . . 0.0 114.801 -172.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 18.4 m -173.14 114.53 0.25 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.439 1.472 . . . . 0.0 112.136 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -149.98 150.61 32.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.598 1.159 . . . . 0.0 111.155 169.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.87 92.74 1.63 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 169.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.54 152.15 46.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.344 2.258 . . . . 0.0 115.051 -175.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 22.4 m -91.73 145.21 24.76 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.083 0.953 . . . . 0.0 109.433 163.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 41.9 p -136.15 0.75 2.63 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -84.63 155.91 21.8 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.464 1.483 . . . . 0.0 111.307 168.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.45 100.48 0.05 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.552 1.941 . . . . 0.0 113.131 -163.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 31.7 mtm -86.97 168.75 13.06 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.579 1.152 . . . . 0.0 111.999 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 37.6 m -159.61 164.62 33.99 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.997 -1.064 . . . . 0.0 112.265 168.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.48 124.78 32.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.002 0.521 . . . . 0.0 110.362 163.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.8 t -70.52 -31.14 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.396 1.478 . . . . 0.0 110.269 163.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -135.92 124.47 23.6 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.904 2.082 . . . . 0.0 107.795 165.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -61.21 151.95 74.0 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.446 0.698 . . . . 0.0 112.572 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.39 134.13 55.98 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.529 2.82 . . . . 0.0 113.295 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 66.9 p -136.32 129.39 31.31 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.809 1.244 . . . . 0.0 111.929 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -53.71 123.1 11.33 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.333 1.453 . . . . 0.0 110.884 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 52.1 p -82.56 -10.72 58.86 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.964 0.905 . . . . 0.0 113.361 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 76.7 -6.93 36.36 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.889 1.233 . . . . 0.0 114.381 -168.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -102.7 18.94 20.16 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.042 1.421 . . . . 0.0 112.487 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.97 7.23 81.12 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.174 0.893 . . . . 0.0 113.41 -172.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 18.1 p -127.69 165.74 19.45 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.469 1.108 . . . . 0.0 112.295 -174.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.97 123.35 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 126.363 1.865 . . . . 0.0 107.701 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.3 135.06 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.304 1.041 . . . . 0.0 113.202 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -141.13 164.38 30.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.231 1.812 . . . . 0.0 112.998 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -121.74 126.05 48.0 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.191 1.396 . . . . 0.0 107.318 166.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.7 155.39 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.295 0.952 . . . . 0.0 112.204 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -140.32 147.75 40.33 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.351 1.46 . . . . 0.0 113.087 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 12.2 t -113.0 154.08 45.09 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 128.495 2.718 . . . . 0.0 108.486 167.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -108.32 -63.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.811 2.341 . . . . 0.0 115.187 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.27 170.53 15.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.358 1.063 . . . . 0.0 113.03 -173.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.53 -21.65 0.13 Allowed Glycine 0 CA--C 1.537 1.465 0 C-N-CA 127.676 2.56 . . . . 0.0 118.284 167.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -102.09 100.42 15.09 Favored Pre-proline 0 CA--C 1.552 1.043 0 CA-C-N 119.522 1.661 . . . . 0.0 113.936 -168.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.56 115.94 3.98 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.184 2.589 . . . . 0.0 109.198 158.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.7 p -162.79 154.69 18.26 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -170.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -78.46 112.24 15.31 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 155.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.283 1.1 pp -64.51 118.59 49.08 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.508 -163.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.25 113.67 1.77 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 124.039 3.16 . . . . 0.0 113.683 -172.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 69.2 t -121.88 111.41 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 125.428 1.491 . . . . 0.0 108.675 173.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.61 155.87 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.006 1.322 . . . . 0.0 110.108 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.5 t -140.31 111.89 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -141.62 -178.84 5.84 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.761 1.164 . . . . 0.0 113.287 -167.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -112.73 2.59 16.12 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.674 0.79 . . . . 0.0 112.988 176.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -126.49 8.7 7.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.366 1.466 . . . . 0.0 114.074 -157.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 50.7 mt 60.51 -14.81 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.123 2.569 . . . . 0.0 116.25 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.6 t -111.61 -9.88 14.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.133 1.333 . . . . 0.0 113.793 -175.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 69.67 44.02 0.92 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.94 2.496 . . . . 0.0 113.148 -171.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.82 -46.96 82.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.464 0.306 . . . . 0.0 110.905 166.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 17.8 mm -118.3 99.5 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.588 1.155 . . . . 0.0 110.489 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -70.42 105.38 3.03 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 121.086 -1.009 . . . . 0.0 112.66 172.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -65.86 -56.88 9.56 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 129.586 3.155 . . . . 0.0 113.233 171.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -103.36 -178.65 26.15 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.546 1.378 . . . . 0.0 116.546 -160.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mm -124.9 160.34 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.842 2.457 . . . . 0.0 111.23 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.32 130.74 35.17 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.797 1.239 . . . . 0.0 110.125 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 85.2 t -92.46 -19.66 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.34 0.656 . . . . 0.0 111.096 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 366' ' ' GLU . 6.1 t -137.76 174.43 10.58 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.366 1.067 . . . . 0.0 112.765 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.55 95.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 127.051 2.141 . . . . 0.0 113.687 -171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -57.83 119.1 31.03 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.512 1.125 . . . . 0.0 110.692 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -80.76 -176.62 3.26 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.337 3.358 . . . . 0.0 113.384 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.06 122.73 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.8 1.64 . . . . 0.0 107.883 171.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.01 64.28 0.33 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.799 1.64 . . . . 0.0 112.779 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 30.6 t -66.13 -10.81 44.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.591 1.156 . . . . 0.0 113.113 173.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 40.2 p -134.2 117.88 17.0 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.84 2.856 . . . . 0.0 106.475 163.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -61.4 -13.23 18.4 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -165.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -75.79 1.07 15.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.717 1.607 . . . . 0.0 114.012 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -35.56 119.7 0.54 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.455 2.302 . . . . 0.0 113.932 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.02 145.46 50.86 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.589 1.155 . . . . 0.0 112.183 170.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 12.2 p -157.32 147.16 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -160.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -78.73 123.42 27.15 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.766 2.426 . . . . 0.0 109.744 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 52.9 mt -132.81 137.34 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.485 0.66 . . . . 0.0 111.055 174.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . 0.487 ' H ' HG22 ' A' ' 351' ' ' THR . 26.9 mt-10 -105.26 140.96 37.61 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.949 1.3 . . . . 0.0 110.827 160.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 20.2 m -122.6 158.32 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.547 1.139 . . . . 0.0 111.298 168.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -118.02 101.53 51.64 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.52 1.928 . . . . 0.0 108.736 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.96 159.57 37.76 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.093 1.862 . . . . 0.0 110.304 163.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -57.7 171.35 1.5 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.702 2.268 . . . . 0.0 112.094 159.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -62.18 147.81 46.56 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.464 -0.772 . . . . 0.0 109.993 157.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 100.31 -171.29 23.14 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 122.57 1.095 . . . . 0.0 113.185 -169.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -72.7 163.36 28.21 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.313 -1.11 . . . . 0.0 113.802 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.9 m -164.62 170.36 15.81 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.187 1.395 . . . . 0.0 112.222 164.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -124.95 114.49 19.21 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 129.381 3.073 . . . . 0.0 106.43 163.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.1 mm -71.74 135.02 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 74.8 mt -129.42 128.03 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 125.238 1.415 . . . . 0.0 108.83 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 83.9 t -118.71 105.02 16.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 126.196 1.798 . . . . 0.0 107.6 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.23 175.42 21.99 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 123.052 1.362 . . . . 0.0 115.935 175.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.82 167.61 21.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.656 2.382 . . . . 0.0 110.113 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 85.31 -156.9 31.19 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 123.356 0.503 . . . . 0.0 111.909 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -67.59 -36.8 81.56 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.534 0.667 . . . . 0.0 110.805 161.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.3 m -51.54 11.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 1 C-N-CA 132.981 4.513 . . . . 0.0 119.546 -173.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -114.36 139.58 49.35 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.63 1.105 . . . . 0.0 112.176 -165.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 30.9 mt -111.57 161.55 16.08 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.431 0.692 . . . . 0.0 110.252 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.8 t -145.57 156.64 43.82 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.047 0.539 . . . . 0.0 112.36 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -142.27 121.7 13.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.211 1.405 . . . . 0.0 109.812 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -67.92 134.42 50.78 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.194 1.397 . . . . 0.0 111.341 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -136.87 161.1 36.94 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 123.097 1.427 . . . . 0.0 112.592 173.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -136.87 103.24 5.11 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.56 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -92.29 138.61 31.37 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -39.38 111.87 0.21 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.813 2.845 . . . . 0.0 113.455 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 109.91 18.91 8.47 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.336 1.922 . . . . 0.0 113.271 -164.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 3.3 t -76.03 155.21 35.1 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.449 1.899 . . . . 0.0 113.271 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 6.7 m -56.18 -20.29 17.26 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.81 1.644 . . . . 0.0 113.812 169.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 5.6 tt -79.34 -10.94 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.051 0.94 . . . . 0.0 112.799 174.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 93.07 3.25 65.69 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.945 1.26 . . . . 0.0 114.62 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? . . . . . 0 C--O 1.246 0.886 0 C-N-CA 125.888 1.675 . . . . 0.0 110.683 172.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 15.4 mmt . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.49 -0.76 29.44 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -173.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.98 13.29 0.11 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.63 1.972 . . . . 0.0 115.283 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 37.9 tp -124.17 147.29 48.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.866 2.066 . . . . 0.0 109.641 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.1 p -38.96 -59.85 0.93 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.11 2.164 . . . . 0.0 113.373 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.5 -9.96 0.85 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.67 1.988 . . . . 0.0 115.093 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.42 ' HE2' ' OD1' ' A' ' 345' ' ' ASN . 10.2 mmmm -121.4 83.06 2.02 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.598 1.09 . . . . 0.0 110.905 -165.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 69.12 -28.07 0.31 Allowed Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.807 1.67 . . . . 0.0 115.755 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 79.2 m -71.05 -63.51 1.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.554 1.541 . . . . 0.0 113.073 -167.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.1 m -175.14 132.88 0.31 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.222 1.374 . . . . 0.0 112.988 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -160.55 158.03 28.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.569 1.548 . . . . 0.0 111.091 169.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.04 101.57 13.59 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.055 1.342 . . . . 0.0 107.611 168.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.09 149.8 39.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.216 2.206 . . . . 0.0 114.89 -171.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 4.7 m -86.52 144.52 27.19 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 164.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 61.1 p -137.37 0.73 2.33 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 171.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -71.32 166.17 22.17 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.603 1.092 . . . . 0.0 110.089 165.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -69.43 109.51 4.25 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.194 0.998 . . . . 0.0 111.203 -165.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 34.5 mtm -94.82 166.59 11.9 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.544 1.138 . . . . 0.0 112.255 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 58.5 m -160.89 157.75 27.08 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.734 1.214 . . . . 0.0 110.168 165.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.73 125.44 29.37 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.153 160.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 45.6 t -71.12 -18.92 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 126.18 1.792 . . . . 0.0 110.807 166.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -147.57 112.67 5.49 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.601 2.361 . . . . 0.0 106.76 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -55.31 147.59 36.1 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 118.553 0.615 . . . . 0.0 110.04 171.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.81 145.13 99.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.175 1.25 . . . . 0.0 111.168 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 23.3 p -131.24 135.98 47.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.222 1.409 . . . . 0.0 110.791 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -58.31 121.46 10.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.828 1.251 . . . . 0.0 110.601 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 60.1 p -81.78 -13.82 57.22 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.51 -0.96 7.89 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-N 119.391 0.996 . . . . 0.0 114.052 -165.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -95.11 8.22 43.65 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.257 1.528 . . . . 0.0 111.771 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.85 10.71 58.57 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.642 1.115 . . . . 0.0 114.056 -171.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 16.2 p -136.25 169.86 16.96 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.476 1.138 . . . . 0.0 112.741 -169.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.69 127.31 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.994 2.118 . . . . 0.0 108.829 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 11.3 p -118.15 124.15 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -163.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -130.95 157.17 43.67 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.694 1.598 . . . . 0.0 114.291 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -106.36 137.89 43.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.34 1.456 . . . . 0.0 107.215 161.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.56 136.99 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.739 1.216 . . . . 0.0 110.704 -175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -122.64 144.2 49.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.052 0.941 . . . . 0.0 112.199 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.7 143.59 31.67 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.746 2.818 . . . . 0.0 106.613 170.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -109.85 -63.68 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 CA-C-N 121.881 1.707 . . . . 0.0 115.875 -174.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 169.16 18.05 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 120.613 1.552 . . . . 0.0 113.233 -175.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 68.6 -6.0 3.86 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.447 1.975 . . . . 0.0 117.341 169.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.61 102.07 45.32 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 119.135 1.468 . . . . 0.0 113.306 -163.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.29 118.42 2.94 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.249 2.632 . . . . 0.0 110.051 154.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.7 p -163.17 146.98 10.88 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -172.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -72.98 117.51 14.8 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 154.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.297 0.8 OUTLIER -69.89 122.65 86.69 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.884 -160.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.459 ' HG2' ' HA2' ' A' ' 379' ' ' GLY . 71.5 Cg_endo -72.65 110.09 2.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 1 C-N-CA 125.781 4.32 . . . . 0.0 112.894 -166.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 98.6 t -122.66 124.79 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.534 1.534 . . . . 0.0 110.653 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.51 156.93 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.089 1.355 . . . . 0.0 110.817 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . 0.53 ' HB ' ' H ' ' A' ' 347' ' ' GLY . 40.5 t -136.32 129.52 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 342' ' ' ALA . . . -147.65 174.2 12.0 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.974 0.796 . . . . 0.0 112.145 -172.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -101.29 -1.01 34.65 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.513 0.725 . . . . 0.0 112.14 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -128.46 8.18 5.91 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -152.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 59.7 mt 62.51 -22.94 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.653 2.381 . . . . 0.0 115.95 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.1 t -106.99 -7.87 16.8 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.849 1.26 . . . . 0.0 113.873 -172.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 337' ' ' ALA 0.261 . . 71.72 32.76 1.9 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.331 2.653 . . . . 0.0 113.917 -177.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -59.1 -46.27 88.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.684 0.394 . . . . 0.0 110.767 169.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 16.0 mm -96.81 129.23 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.596 1.158 . . . . 0.0 109.095 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.42 ' OD1' ' HE2' ' A' ' 293' ' ' LYS . 0.8 OUTLIER -103.65 64.17 0.8 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 123.042 1.401 . . . . 0.0 112.18 -174.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -66.2 -45.62 80.13 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 128.623 2.769 . . . . 0.0 116.544 -156.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.53 ' H ' ' HB ' ' A' ' 336' ' ' VAL . . . -107.33 -175.32 22.61 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.799 1.666 . . . . 0.0 115.282 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.35 145.67 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 125.165 1.386 . . . . 0.0 112.305 -174.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.49 118.34 12.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.791 1.636 . . . . 0.0 109.688 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 2.9 t -87.84 -52.23 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.902 0.774 . . . . 0.0 111.647 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.4 t -84.44 171.87 12.2 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.647 0.737 . . . . 0.0 111.642 170.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.28 120.28 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.201 1.0 . . . . 0.0 111.761 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -79.32 128.17 76.43 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.282 1.433 . . . . 0.0 110.499 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.47 ' HG3' HG11 ' A' ' 363' ' ' VAL . 2.4 Cg_endo -85.75 -168.14 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 124.906 3.737 . . . . 0.0 113.493 -168.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.12 123.51 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 125.782 1.633 . . . . 0.0 109.009 172.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.23 80.74 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.503 1.121 . . . . 0.0 110.756 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 47.6 t -69.2 -25.53 64.37 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.585 -0.697 . . . . 0.0 111.303 163.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 21.5 p -120.93 124.54 45.18 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.246 2.619 . . . . 0.0 107.425 169.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -59.19 -23.81 62.57 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -168.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.15 3.9 1.9 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.359 1.863 . . . . 0.0 114.337 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -45.91 135.0 7.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.567 1.547 . . . . 0.0 113.792 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -150.87 111.51 4.24 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.963 1.705 . . . . 0.0 108.61 -165.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . 0.47 HG11 ' HG3' ' A' ' 354' ' ' PRO . 9.9 p -138.98 153.43 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -165.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -80.38 123.72 28.26 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 128.117 2.567 . . . . 0.0 109.383 165.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.34 143.07 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.138 0.881 . . . . 0.0 111.922 169.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -108.98 142.16 40.05 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.187 1.795 . . . . 0.0 111.224 168.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.47 152.77 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.703 0.801 . . . . 0.0 111.326 170.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -109.0 116.82 54.98 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.398 1.879 . . . . 0.0 109.807 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -91.18 145.91 3.51 Favored 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 123.771 2.98 . . . . 0.0 111.096 166.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.14 171.57 1.65 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.231 2.621 . . . . 0.0 112.582 153.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -61.71 140.78 58.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.115 0.566 . . . . 0.0 110.724 170.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 95.97 -164.63 23.89 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-O 122.749 1.194 . . . . 0.0 115.803 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.89 155.05 11.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 129.095 2.958 . . . . 0.0 113.618 -169.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.8 m -173.95 162.56 3.91 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.234 1.414 . . . . 0.0 113.409 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -129.22 115.99 18.49 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 130.986 3.714 . . . . 0.0 107.909 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.3 mm -82.5 118.71 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 26.3 mt -108.83 126.07 65.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.413 1.085 . . . . 0.0 108.605 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.7 110.8 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.823 1.649 . . . . 0.0 106.942 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 333' ' ' PRO . . . 116.25 172.29 16.55 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 124.043 1.913 . . . . 0.0 116.343 174.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.69 162.76 36.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.736 2.414 . . . . 0.0 109.175 177.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.59 -167.37 52.29 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -162.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.36 -26.35 68.72 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.787 -0.831 . . . . 0.0 111.918 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 64.0 m -63.29 3.19 0.3 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 128.822 2.849 . . . . 0.0 116.329 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -87.43 123.68 32.62 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.149 0.886 . . . . 0.0 111.41 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.71 162.58 12.82 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 172.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.3 t -140.23 155.03 47.05 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.5 133.11 47.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.22 1.408 . . . . 0.0 109.218 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -75.3 133.06 41.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.629 1.571 . . . . 0.0 111.071 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -141.94 106.28 4.81 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.096 0.959 . . . . 0.0 112.559 175.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -100.15 112.79 25.11 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -80.11 151.46 29.81 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -39.55 131.71 1.67 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.357 2.263 . . . . 0.0 113.556 173.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 119.28 4.13 12.44 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 160.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 94.1 p -131.41 -80.98 0.52 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.694 2.247 . . . . 0.0 112.133 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 91.9 p -105.56 -6.19 19.53 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.731 2.012 . . . . 0.0 113.464 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 13.7 tt -133.9 150.55 31.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.299 1.84 . . . . 0.0 109.43 166.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -67.87 -58.98 6.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.148 0.88 . . . . 0.0 112.307 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 3.1 tptp . . . . . 0 C--O 1.253 1.253 0 C-N-CA 128.559 2.744 . . . . 0.0 108.406 179.325 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 119.2 -0.429 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.21 4.76 9.76 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -176.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.4 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.563 2.345 . . . . 0.0 116.027 -170.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 15.7 mt -138.88 153.9 48.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.558 1.543 . . . . 0.0 110.214 170.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 13.7 p -42.64 -64.19 0.65 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.563 2.345 . . . . 0.0 111.643 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.1 -22.95 43.53 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.725 2.01 . . . . 0.0 114.08 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.84 58.84 2.7 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.895 -1.128 . . . . 0.0 111.134 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.07 1.16 62.46 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.836 1.684 . . . . 0.0 115.493 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 61.1 m -84.84 -45.66 12.09 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.2 1.5 . . . . 0.0 112.259 -173.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.2 m -174.75 120.09 0.22 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.047 1.339 . . . . 0.0 112.146 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -161.92 154.64 20.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.612 1.165 . . . . 0.0 111.34 167.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.81 101.36 1.32 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 161.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.06 157.48 22.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.493 1.917 . . . . 0.0 114.171 -173.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 12.1 m -92.66 142.77 27.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.3 0.64 . . . . 0.0 109.958 170.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 80.4 p -136.71 5.98 2.92 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 174.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -83.61 164.81 19.49 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 119.92 1.236 . . . . 0.0 110.738 165.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -66.49 92.94 0.21 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.785 2.434 . . . . 0.0 112.173 -161.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . 0.401 ' HE1' ' H ' ' A' ' 380' ' ' THR . 33.4 mtm -80.66 166.52 20.99 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.204 1.002 . . . . 0.0 112.381 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.5 m -158.87 157.76 32.11 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.287 -0.883 . . . . 0.0 112.531 167.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.03 120.03 24.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.418 0.687 . . . . 0.0 109.847 159.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.94 -25.03 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.638 1.175 . . . . 0.0 110.845 169.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -140.01 130.49 25.52 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.121 2.168 . . . . 0.0 108.034 168.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -60.86 144.89 89.56 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.624 1.169 . . . . 0.0 112.324 172.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.02 137.9 78.72 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.76 2.307 . . . . 0.0 112.145 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 37.2 p -132.32 126.74 34.02 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.259 1.424 . . . . 0.0 111.05 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -59.83 121.56 12.04 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.447 1.099 . . . . 0.0 110.569 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 65.3 p -80.19 -10.45 59.76 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.944 1.298 . . . . 0.0 113.123 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 67.13 -8.34 1.39 Allowed Glycine 0 CA--C 1.538 1.503 0 CA-C-N 119.186 0.903 . . . . 0.0 114.389 -166.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -82.71 2.59 32.96 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.251 1.525 . . . . 0.0 111.863 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.94 5.35 61.07 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.253 1.406 . . . . 0.0 113.413 -169.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 16.3 p -123.69 161.78 24.41 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.623 1.211 . . . . 0.0 112.039 -175.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 6.7 t -133.92 112.59 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.218 1.407 . . . . 0.0 107.863 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.0 p -108.87 130.88 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.383 1.073 . . . . 0.0 113.668 -160.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -140.84 163.27 33.38 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.936 2.094 . . . . 0.0 112.901 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -114.12 131.39 56.43 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.979 1.312 . . . . 0.0 107.585 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.04 153.72 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.413 1.006 . . . . 0.0 112.307 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -140.42 147.8 40.24 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.625 1.57 . . . . 0.0 113.071 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.46 147.7 38.61 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 128.14 2.576 . . . . 0.0 107.633 162.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -106.14 -56.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.057 0 CA-C-N 122.899 2.071 . . . . 0.0 115.816 -174.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 172.35 12.94 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.944 -1.098 . . . . 0.0 112.293 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.99 0.58 7.42 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 117.354 1.702 . . . . 0.0 117.354 169.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.34 94.08 48.72 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 118.91 1.355 . . . . 0.0 113.065 -162.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.57 117.45 3.38 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.398 2.732 . . . . 0.0 108.984 156.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.9 p -166.54 155.31 10.7 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -174.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.31 111.2 15.32 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 154.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.16 116.17 23.05 Favored Pre-proline 0 CA--C 1.557 1.237 0 CA-C-O 119.056 -0.497 . . . . 0.0 111.651 -163.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -62.81 117.33 4.23 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.932 3.088 . . . . 0.0 113.912 -172.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.98 107.36 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.675 1.19 . . . . 0.0 110.131 173.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.43 157.82 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.437 1.495 . . . . 0.0 109.453 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 91.0 t -137.9 121.12 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -135.3 172.27 13.24 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -167.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -104.9 -0.42 27.07 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.712 1.205 . . . . 0.0 112.403 170.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -129.02 7.9 5.58 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.071 1.348 . . . . 0.0 114.575 -157.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.8 mt 67.46 -8.31 0.49 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.621 2.369 . . . . 0.0 115.644 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 7.8 t -129.14 -9.73 4.77 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 120.726 1.603 . . . . 0.0 115.235 -174.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 69.5 44.58 0.9 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.702 2.401 . . . . 0.0 113.114 -170.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.08 72.13 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.202 158.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 27.3 mt -125.2 109.65 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 127.611 2.365 . . . . 0.0 107.939 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -77.2 118.14 19.43 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.333 0.97 . . . . 0.0 110.382 162.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -77.68 -62.97 1.49 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.634 2.774 . . . . 0.0 111.498 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -112.19 171.14 13.93 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 117.086 1.594 . . . . 0.0 117.086 -162.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mm -109.91 156.33 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.95 2.1 . . . . 0.0 111.589 -168.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.56 136.06 34.93 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.227 1.411 . . . . 0.0 109.696 170.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.7 t -110.48 -61.64 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.186 0.594 . . . . 0.0 110.374 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.8 m -79.98 153.3 28.99 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.756 0.822 . . . . 0.0 109.645 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.6 m -51.54 144.53 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.865 2.066 . . . . 0.0 115.471 -167.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -112.02 111.65 53.3 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.986 1.714 . . . . 0.0 108.845 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.16 -171.48 1.09 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.493 3.462 . . . . 0.0 113.866 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.71 117.15 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 127.575 2.35 . . . . 0.0 107.066 168.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.84 71.06 0.21 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.691 1.996 . . . . 0.0 112.559 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.0 t -67.79 -14.9 63.33 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.422 -0.799 . . . . 0.0 112.913 167.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 10.2 p -116.25 129.15 56.14 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 127.041 2.137 . . . . 0.0 106.959 161.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -66.83 -14.87 63.17 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -173.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.11 6.3 26.16 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.515 1.926 . . . . 0.0 113.407 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -42.95 124.43 3.14 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.427 1.891 . . . . 0.0 113.715 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.15 148.15 46.42 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.613 1.165 . . . . 0.0 111.529 172.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 7.4 p -159.55 152.52 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.658 0.742 . . . . 0.0 112.482 -164.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -87.0 123.24 31.89 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.796 2.439 . . . . 0.0 108.929 169.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 42.7 mt -130.99 149.75 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.863 0.865 . . . . 0.0 110.678 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -121.18 142.01 50.3 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.567 1.547 . . . . 0.0 110.569 167.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.36 153.92 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.387 0.675 . . . . 0.0 111.595 167.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -117.46 99.42 52.5 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 127.134 2.174 . . . . 0.0 108.536 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -80.86 161.8 21.15 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 122.675 2.25 . . . . 0.0 110.65 165.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.83 -174.42 1.51 Allowed 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.776 2.318 . . . . 0.0 110.604 158.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -61.28 160.71 10.13 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.446 -0.784 . . . . 0.0 111.859 164.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 97.58 -177.8 32.17 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.318 1.437 . . . . 0.0 113.445 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.26 163.06 16.07 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.46 1.504 . . . . 0.0 112.866 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.1 m -162.51 154.36 18.47 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.119 -0.988 . . . . 0.0 112.533 172.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -120.16 104.81 10.4 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.796 2.439 . . . . 0.0 106.966 166.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 8.2 mm -70.15 121.31 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 64.3 mt -118.28 125.28 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.943 1.297 . . . . 0.0 109.108 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 75.6 t -112.8 103.78 15.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.18 1.792 . . . . 0.0 107.815 -177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.87 177.71 23.75 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 123.308 1.505 . . . . 0.0 116.511 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . 0.401 ' H ' ' HE1' ' A' ' 304' ' ' MET . 2.2 p -134.91 172.22 13.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.031 2.532 . . . . 0.0 110.722 175.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 81.64 -162.2 43.13 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 123.617 0.627 . . . . 0.0 111.642 -168.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -67.25 -38.04 84.49 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.717 -0.872 . . . . 0.0 110.764 162.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 47.2 m -53.81 8.12 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.54 1 C-N-CA 132.127 4.171 . . . . 0.0 119.016 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -99.88 146.91 26.1 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.108 1.363 . . . . 0.0 111.835 -172.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 19.7 mt -114.55 165.94 12.24 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.505 0.722 . . . . 0.0 110.918 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.6 t -146.82 158.17 43.85 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 172.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -139.2 132.04 29.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.943 1.697 . . . . 0.0 110.089 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -80.73 138.76 36.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.976 1.31 . . . . 0.0 112.193 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -132.51 159.79 38.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.702 1.601 . . . . 0.0 110.861 165.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -139.42 97.86 3.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.168 1.387 . . . . 0.0 108.534 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -96.68 132.31 42.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.241 0.543 . . . . 0.0 111.023 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 392' ' ' GLU . 0.1 OUTLIER -28.66 109.96 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 130.508 3.523 . . . . 0.0 113.754 -176.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 115.02 25.01 4.03 Favored Glycine 0 CA--C 1.54 1.648 0 C-N-CA 127.11 2.29 . . . . 0.0 113.233 -157.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 23.7 p -114.6 160.94 18.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 120.068 1.934 . . . . 0.0 116.187 -162.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 83.1 p -54.22 -32.9 57.07 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 127.364 2.266 . . . . 0.0 115.039 -174.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.45 0.92 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.823 1.249 . . . . 0.0 113.263 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 87.83 15.4 61.42 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.286 0.945 . . . . 0.0 113.117 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.437 0 C-N-CA 125.936 1.694 . . . . 0.0 108.733 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 8.0 tmm? . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 59.2 p -77.18 -4.3 43.91 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -166.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.62 27.23 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -172.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 71.6 mt -139.71 160.26 40.29 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.479 1.512 . . . . 0.0 111.24 171.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 22.3 p -54.88 -53.76 51.29 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.85 1.66 . . . . 0.0 110.896 167.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -22.47 60.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.546 1.938 . . . . 0.0 114.283 177.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 293' ' ' LYS . 0.2 OUTLIER -96.1 66.91 2.58 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.839 1.255 . . . . 0.0 110.267 -173.617 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 80.78 -27.37 2.99 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.456 1.503 . . . . 0.0 114.748 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 19.1 m -59.48 -58.87 6.72 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.781 1.633 . . . . 0.0 113.692 -173.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 16.5 m -173.92 126.75 0.37 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.803 1.241 . . . . 0.0 112.751 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -156.79 151.21 25.39 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.757 1.223 . . . . 0.0 111.413 165.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.01 109.93 14.92 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -77.96 153.52 32.4 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.976 1.711 . . . . 0.0 114.745 -172.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -99.41 145.42 27.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.894 0.877 . . . . 0.0 108.974 162.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 53.0 p -135.0 10.5 3.58 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -75.96 160.8 29.5 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.086 0.857 . . . . 0.0 110.934 164.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -63.01 97.19 0.1 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.829 2.052 . . . . 0.0 111.506 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 5.9 mtm -76.66 164.79 25.56 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.001 0.92 . . . . 0.0 112.451 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 25.9 m -158.7 154.47 26.41 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.234 -0.916 . . . . 0.0 112.458 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 121.08 29.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.341 0.656 . . . . 0.0 110.106 170.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.8 t -70.12 -23.75 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.352 1.061 . . . . 0.0 110.488 164.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -144.86 119.41 9.72 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.716 2.006 . . . . 0.0 108.72 169.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -55.13 142.69 56.85 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.906 1.283 . . . . 0.0 111.315 171.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -51.59 134.88 47.59 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.865 2.377 . . . . 0.0 113.423 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.13 127.41 35.92 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.505 1.122 . . . . 0.0 111.693 173.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.24 124.93 21.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.053 0.541 . . . . 0.0 111.085 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 19.0 p -83.25 -8.32 59.47 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.268 1.027 . . . . 0.0 113.481 -174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 79.31 -14.62 15.15 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.481 1.038 . . . . 0.0 114.671 -169.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -87.14 5.84 35.86 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.479 1.64 . . . . 0.0 112.984 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 93.35 2.92 65.42 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.834 1.206 . . . . 0.0 113.743 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.8 p -115.69 165.73 12.72 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.322 1.449 . . . . 0.0 111.585 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.6 115.48 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.853 1.661 . . . . 0.0 108.87 -178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.8 p -102.78 130.95 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.567 1.547 . . . . 0.0 113.29 -167.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -137.76 164.2 29.47 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.536 1.934 . . . . 0.0 112.827 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -123.17 124.6 43.42 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.086 1.354 . . . . 0.0 107.718 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.14 138.22 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.071 0.948 . . . . 0.0 112.069 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -117.76 143.16 46.49 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.064 1.746 . . . . 0.0 111.501 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . 10.2 t -111.79 149.95 41.56 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.354 1.862 . . . . 0.0 108.001 165.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 324' ' ' VAL . 3.5 Cg_endo -105.97 -74.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 122.038 1.825 . . . . 0.0 114.906 -172.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.88 165.84 25.02 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 121.323 1.874 . . . . 0.0 114.642 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 71.9 -4.87 14.54 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.053 1.787 . . . . 0.0 116.279 172.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -112.63 98.62 44.98 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.979 1.311 . . . . 0.0 113.093 -168.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.43 117.89 5.14 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.388 2.059 . . . . 0.0 108.226 152.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 8.9 p -161.37 154.99 21.77 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -88.57 102.11 14.62 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.093 2.157 . . . . 0.0 106.39 158.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 333' ' ' PRO 0.255 3.7 pt -59.73 123.5 71.77 Favored Pre-proline 0 CA--C 1.554 1.12 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -156.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 9.7 Cg_exo -62.79 113.28 1.92 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.419 2.746 . . . . 0.0 112.933 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.91 110.14 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 109.801 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.85 163.37 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.971 1.708 . . . . 0.0 109.265 -172.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.22 113.67 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.55 171.4 12.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.222 0.534 . . . . 0.0 112.038 -170.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . 0.452 ' CG ' ' HZ3' ' A' ' 346' ' ' LYS . 33.7 m-20 -114.61 2.74 14.61 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.149 1.38 . . . . 0.0 111.599 173.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -109.97 -5.29 15.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.894 2.077 . . . . 0.0 114.027 -167.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.7 mt 58.72 -1.95 0.1 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.233 2.613 . . . . 0.0 116.049 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -112.63 -7.06 13.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.419 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 384' ' ' ARG . . . 45.11 77.13 0.08 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 130.279 3.432 . . . . 0.0 114.669 -166.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -92.99 -40.97 10.26 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.423 149.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 84.5 mt -74.57 150.06 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.872 1.669 . . . . 0.0 110.783 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . 0.415 HD21 ' CB ' ' A' ' 293' ' ' LYS . 15.3 t30 -143.86 94.52 2.6 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.2 1.4 . . . . 0.0 111.521 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' A' ' 338' ' ' ASP . 30.7 ttpt -102.57 -31.04 10.6 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -166.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -116.41 159.42 13.92 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.657 1.122 . . . . 0.0 115.638 -168.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.81 145.23 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.633 1.973 . . . . 0.0 110.758 -169.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.61 120.01 22.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.776 1.63 . . . . 0.0 108.633 166.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.8 t -92.72 -41.25 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.149 0.58 . . . . 0.0 111.32 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.668 HG22 ' H ' ' A' ' 366' ' ' GLU . 3.0 t -98.01 176.41 5.77 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.695 0.759 . . . . 0.0 112.01 171.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 6.1 m -62.1 107.73 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.93 1.692 . . . . 0.0 113.493 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.77 121.06 79.88 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 118.14 -0.933 . . . . 0.0 109.29 160.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -82.69 -174.36 2.03 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 124.918 3.745 . . . . 0.0 113.717 -171.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.47 112.04 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 126.596 1.959 . . . . 0.0 108.168 169.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -72.22 77.83 0.98 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.668 1.187 . . . . 0.0 111.785 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 19.3 t -69.32 -19.94 63.88 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.351 -0.843 . . . . 0.0 113.149 171.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 17.7 p -118.82 118.21 30.95 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 127.134 2.173 . . . . 0.0 106.337 163.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -56.8 -24.22 49.06 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -165.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.67 0.98 7.45 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.712 2.005 . . . . 0.0 113.967 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -46.81 134.63 9.81 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.317 1.447 . . . . 0.0 113.385 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -137.97 133.01 33.16 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.587 1.155 . . . . 0.0 111.148 175.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 9.2 p -143.89 143.2 24.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.739 0.781 . . . . 0.0 112.954 -160.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.83 118.67 18.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.286 2.235 . . . . 0.0 109.469 166.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 32.5 mt -126.97 143.52 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.049 0.54 . . . . 0.0 110.458 176.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . 0.668 ' H ' HG22 ' A' ' 351' ' ' THR . 33.2 mt-10 -116.85 134.33 54.91 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.768 1.627 . . . . 0.0 110.06 167.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.4 159.63 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.594 1.158 . . . . 0.0 111.96 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -124.92 104.65 29.86 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.911 1.684 . . . . 0.0 109.944 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -86.47 163.08 9.59 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.786 2.991 . . . . 0.0 111.078 161.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.5 177.15 9.04 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.204 2.603 . . . . 0.0 112.467 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -63.52 116.95 6.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.861 1.264 . . . . 0.0 110.928 167.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 133.83 -145.74 17.76 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.921 1.248 . . . . 0.0 111.589 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -97.02 160.44 14.34 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.934 1.294 . . . . 0.0 113.3 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 21.9 m -169.17 152.38 5.02 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.801 1.64 . . . . 0.0 111.827 171.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -122.37 107.43 12.07 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 166.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 7.3 mm -73.71 120.66 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 72.0 mt -116.41 134.47 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.331 1.052 . . . . 0.0 110.996 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 67.4 t -120.93 107.15 19.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 126.04 1.736 . . . . 0.0 107.973 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.34 -175.6 19.07 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.85 159.34 42.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.195 1.798 . . . . 0.0 110.432 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.83 -173.22 53.71 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.296 0.474 . . . . 0.0 112.529 -168.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -55.93 -27.9 54.39 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.842 1.257 . . . . 0.0 112.291 171.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 24.6 m -59.43 -7.61 1.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.532 3.133 . . . . 0.0 116.608 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 342' ' ' ALA . 3.5 ptm180 -87.04 125.93 34.42 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.08 0.952 . . . . 0.0 112.23 -173.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 15.1 mt -95.67 164.63 12.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.665 0.386 . . . . 0.0 111.897 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.3 t -135.12 152.08 51.31 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.321 1.048 . . . . 0.0 113.154 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -141.06 142.33 34.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.562 1.145 . . . . 0.0 111.583 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.03 140.58 36.49 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -140.98 138.61 33.87 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.173 0.987 . . . . 0.0 112.308 163.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -142.4 122.46 13.71 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -173.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -92.32 157.16 16.79 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -161.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -32.38 119.69 0.29 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 129.725 3.21 . . . . 0.0 115.424 168.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 62.55 7.82 16.94 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.329 1.443 . . . . 0.0 114.784 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.0 m -129.47 -42.12 1.34 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.898 1.279 . . . . 0.0 111.061 -161.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 23.2 t -141.86 -24.47 0.69 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.364 1.066 . . . . 0.0 112.929 169.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 2.7 tp -148.97 -170.33 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 O-C-N 120.908 -1.12 . . . . 0.0 111.529 163.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -73.13 -21.1 80.06 Favored Glycine 0 CA--C 1.539 1.562 0 O-C-N 120.397 -1.439 . . . . 0.0 116.226 -172.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.655 1.982 . . . . 0.0 108.565 179.713 . . . . . . . . 1 1 . 1 stop_ save_